
<html lang="en"     class="pb-page"  data-request-id="234e1565-1fea-419a-a0c6-dad5ab5a6009"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00606;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-21"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="COVID-19: Drug Targets and Potential Treatments" /></meta><meta name="dc.Creator" content="Carmen  Gil" /></meta><meta name="dc.Creator" content="Tiziana  Ginex" /></meta><meta name="dc.Creator" content="Inés  Maestro" /></meta><meta name="dc.Creator" content="Vanesa  Nozal" /></meta><meta name="dc.Creator" content="Lucía  Barrado-Gil" /></meta><meta name="dc.Creator" content="Miguel Ángel  Cuesta-Geijo" /></meta><meta name="dc.Creator" content="Jesús  Urquiza" /></meta><meta name="dc.Creator" content="David  Ramírez" /></meta><meta name="dc.Creator" content="Covadonga  Alonso" /></meta><meta name="dc.Creator" content="Nuria E.  Campillo" /></meta><meta name="dc.Creator" content="Ana  Martinez" /></meta><meta name="dc.Description" content="Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccin..." /></meta><meta name="Description" content="Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 8, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00606" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00606" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00606" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00606" /></link>
        
    
    

<title>COVID-19: Drug Targets and Potential Treatments | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00606" /></meta><meta property="og:title" content="COVID-19: Drug Targets and Potential Treatments" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0024.jpeg" /></meta><meta property="og:description" content="Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19. In this paper, we will focus on the main virus-based and host-based targets that can guide efforts in medicinal chemistry to discover new drugs for this devastating disease. In principle, all CoV enzymes and proteins involved in viral replication and the control of host cellular machineries are potentially druggable targets in the search for therapeutic options for SARS-CoV-2. This Perspective provides an overview of the main targets from a structural point of view, together with reported therapeutic compounds with activity against SARS-CoV-2 and/or other CoVs. Also, the role of innate immune response to coronavirus infection and the related therapeutic options will be presented." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00606"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00606">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00606&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00606&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00606&amp;href=/doi/10.1021/acs.jmedchem.0c00606" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 12359-12386</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00530" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00643" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">COVID-19: Drug Targets and Potential Treatments</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Carmen Gil</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carmen Gil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#610200130c040f4f06080d21021208024f0412"><span class="__cf_email__" data-cfemail="cfacaebda2aaa1e1a8a6a38facbca6ace1aabc">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++Gil">Carmen Gil</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3882-6081" title="Orcid link">http://orcid.org/0000-0002-3882-6081</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tiziana Ginex</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tiziana Ginex</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tiziana++Ginex">Tiziana Ginex</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5739-8713" title="Orcid link">http://orcid.org/0000-0002-5739-8713</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Inés Maestro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Inés Maestro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=In%C3%A9s++Maestro">Inés Maestro</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5026-5803" title="Orcid link">http://orcid.org/0000-0002-5026-5803</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vanesa Nozal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vanesa Nozal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vanesa++Nozal">Vanesa Nozal</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5260-5683" title="Orcid link">http://orcid.org/0000-0001-5260-5683</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lucía Barrado-Gil</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lucía Barrado-Gil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luc%C3%ADa++Barrado-Gil">Lucía Barrado-Gil</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1053-2997" title="Orcid link">http://orcid.org/0000-0002-1053-2997</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Miguel Ángel Cuesta-Geijo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Miguel Ángel Cuesta-Geijo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Miguel+%C3%81ngel++Cuesta-Geijo">Miguel Ángel Cuesta-Geijo</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4694-1968" title="Orcid link">http://orcid.org/0000-0003-4694-1968</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jesús Urquiza</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jesús Urquiza</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra. de la Coruña km 7.5, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jes%C3%BAs++Urquiza">Jesús Urquiza</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7870-4580" title="Orcid link">http://orcid.org/0000-0002-7870-4580</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Ramírez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Ramírez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Ciencias Biomédicas, Universidad Autónoma de Chile, Llano Subercaseaux 2801- piso 6, 7500912 Santiago, Chile</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Ram%C3%ADrez">David Ramírez</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath8">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0002-1189" title="Orcid link">http://orcid.org/0000-0003-0002-1189</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Covadonga Alonso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Covadonga Alonso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra. de la Coruña km 7.5, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Covadonga++Alonso">Covadonga Alonso</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath9">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0862-6177" title="Orcid link">http://orcid.org/0000-0002-0862-6177</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nuria E. Campillo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nuria E. Campillo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nuria+E.++Campillo">Nuria E. Campillo</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath10">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9948-2665" title="Orcid link">http://orcid.org/0000-0002-9948-2665</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ana Martinez</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Martinez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centro de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#50313e317e3d312224393e352a10332339337e3523"><span class="__cf_email__" data-cfemail="ed8c838cc3808c9f9984838897ad8e9e848ec3889e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Martinez">Ana Martinez</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath11">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2707-8110" title="Orcid link">http://orcid.org/0000-0002-2707-8110</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00606&amp;href=/doi/10.1021%2Facs.jmedchem.0c00606" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 12359–12386</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 8, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 April 2020</li><li><span class="item_label"><b>Published</b> online</span>8 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 November 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00606" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00606</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 <span class="NLM_copyright-holder">American Chemical Society</span></strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00606"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">40402</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">90</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00606" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;COVID-19: Drug Targets and Potential Treatments&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Gil&quot;},{&quot;first_name&quot;:&quot;Tiziana&quot;,&quot;last_name&quot;:&quot;Ginex&quot;},{&quot;first_name&quot;:&quot;Inés&quot;,&quot;last_name&quot;:&quot;Maestro&quot;},{&quot;first_name&quot;:&quot;Vanesa&quot;,&quot;last_name&quot;:&quot;Nozal&quot;},{&quot;first_name&quot;:&quot;Lucía&quot;,&quot;last_name&quot;:&quot;Barrado-Gil&quot;},{&quot;first_name&quot;:&quot;Miguel&quot;,&quot;last_name&quot;:&quot;Ángel Cuesta-Geijo&quot;},{&quot;first_name&quot;:&quot;Jesús&quot;,&quot;last_name&quot;:&quot;Urquiza&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Ramírez&quot;},{&quot;first_name&quot;:&quot;Covadonga&quot;,&quot;last_name&quot;:&quot;Alonso&quot;},{&quot;first_name&quot;:&quot;Nuria&quot;,&quot;last_name&quot;:&quot;E. Campillo&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Martinez&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;12359-12386&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00606&quot;},&quot;abstract&quot;:&quot;Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19. In this paper, we will focus on the main virus-based and host-based targets that can guide efforts in medicinal chemistry to discover new drugs for this devastating disease. In principle, all CoV enzymes and proteins involved in viral replication and the control of host cellular machineries are potentially druggable targets in the search for therapeutic options for SARS-CoV-2. This Perspective provides an overview of the main targets from a structural point of view, together with reported therapeutic compounds with activity against SARS-CoV-2 and/or other CoVs. Also, the role of innate immune response to coronavirus infection and the related therapeutic options will be presented.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00606&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00606" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00606&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00606" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00606&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00606" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00606&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00606&amp;href=/doi/10.1021/acs.jmedchem.0c00606" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00606" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00606" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00606%26sid%3Dliteratum%253Aachs%26pmid%3D32511912%26genre%3Darticle%26aulast%3DGil%26date%3D2020%26atitle%3DCOVID-19%253A%2BDrug%2BTargets%2Band%2BPotential%2BTreatments%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D21%26spage%3D12359%26epage%3D12386%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292644" title="SARS-CoV-2">SARS-CoV-2</a>,</li><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292641" title="SARS-CoV">SARS-CoV</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/jmcmar.2020.63.issue-21/20201112/jmcmar.2020.63.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19. In this paper, we will focus on the main virus-based and host-based targets that can guide efforts in medicinal chemistry to discover new drugs for this devastating disease. In principle, all CoV enzymes and proteins involved in viral replication and the control of host cellular machineries are potentially druggable targets in the search for therapeutic options for SARS-CoV-2. This Perspective provides an overview of the main targets from a structural point of view, together with reported therapeutic compounds with activity against SARS-CoV-2 and/or other CoVs. Also, the role of innate immune response to coronavirus infection and the related therapeutic options will be presented.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span>  Note</h4><p class="first last">This article is made available via the <a href="/page/vi/chemistry_coronavirus_research" class="ext-link">ACS COVID-19 subset</a> for unrestricted RESEARCH re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The coronavirus pandemic known as COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is a highly pathogenic human coronavirus (CoV) first reported in Wuhan, China, where a pneumonia of unknown cause was detected in December 2019.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This novel CoV belongs to the <i>Coronaviridae</i> family, along with SARS-CoV and the Middle East respiratory syndrome coronavirus (MERS-CoV). The three of them are zoonotic viruses and have in common their ability to cause severe infection in humans, in contrast to other human CoVs (HCoV-NL63, HCoV-229E, HCoV-OC43, and HCoVHKU1), which are responsible for mild respiratory tract infections.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Highly pathogenic CoVs are enveloped, positive polarity, single-stranded RNA betacoronaviruses, and their genomes encode non-structural proteins (nsps), structural proteins, and several accessory proteins.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> The publication of the genome sequence of SARS-CoV-2<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> has allowed researchers to determine that the new virus is closely related to SARS-CoV (82% sequence identity) and, to a lesser extent, to MERS-CoV.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> As a starting point, this sequence identity could pave the way to the identification of druggable targets based on previous studies focused on SARS-CoV and MERS-CoV.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Knowledge of the life cycle of CoVs is essential to achieve this aim (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SARS-CoV-2 infection cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The SARS-CoV-2 infection process starts with the viral entry mediated by the interaction of the spike (S) glycoprotein with the host angiotensin-converting enzyme 2 (ACE2) receptor,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and cleavage of the S protein by the host transmembrane serine protease 2 (TMPRSS2) prior to the fusion to the host cell membrane.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Entry mechanisms of coronavirus were controversial 15 years ago. In early studies, a non-endosomal pathway was initially thought to be the CoVs mechanism to enter the host cell. In 2004, it was shown that SARS-CoV fused with the cellular surface after attaching the host cell membrane.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The nucleocapsids were then blurred after the virions lost their envelopes, and no endocytic-related events were described. However, recent evidence points to the endosomal pathway as the main entry route for CoVs to infect the cells. Remarkably, Ng et al. had published one year earlier a study with a SARS-CoV isolated from a SARS patient in Singapore.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> They certainly observed fusion events at the plasma membrane, followed by a movement of spherical viral cores into the cytoplasm within large cellular vacuoles during the first 15 min after infection.</div><div class="NLM_p">In 2008, Wang and colleagues established the endocytic pathway as an alternative entry pathway apart from direct fusion with the plasma membrane based on their observations of SARS-CoV.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> They showed that this virus enters the cell via a pH- and receptor-mediated endocytosis-dependent manner. In fact, the spike (S) protein itself or a pseudovirus bearing S protein induced internalization of SARS-CoV receptor ACE2 from the cell surface to cytoplasmic compartments. Furthermore, lysosomotropic drugs blocked the ACE2 receptor in vesicles, impairing their recycling to the plasma membrane. Pseudoviruses were also affected by inhibition of pH acidification, which indicates that SARS-CoV exploits the endocytic pathway to infect the cells, as they found, in a clathrin- and caveolin-independent manner.</div><div class="NLM_p">Currently, we are immersed in a pandemic caused by the emerging SARS-CoV-2,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> which is severely threatening the public human health care system worldwide. Some years ago, two other coronaviruses also crossed the species barrier, triggering deadly pneumonia in humans: SARS-CoV<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> and MERS-CoV.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Similarities in the entry pathways of these betacoronaviruses need to be elucidated.</div><div class="NLM_p">Coronavirus entry relies on the spike (S) protein, and depending on the viral strain and cell type studied, the S protein is cleaved by several different cellular proteases.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23 ref24">(18−24)</a> SARS-CoV-2 presents entry requirements similar to those of SARS-CoV. Both viruses are coincident in the cellular receptor ACE2. Similar to SARS-CoV, SARS-CoV-2 infection is profoundly inhibited by lysosomotropic drugs (99% and 98%, respectively) in cells transduced with pseudovirus.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> These results point out that the endocytic pathway is the preferred route for SARS-CoV-2 entry into the host cell.</div><div class="NLM_p">Furthermore, SARS-CoV and SARS-CoV-2 pseudovirions’ entry is dependent on late endosomal compartments, given their dependence on endosomal acidification. Thus, the inhibition of endosomal maturation would result in the impairment of SARS-CoV-2 infection. In fact, pseudovirions’ entry is impaired by treating cells with chemical inhibitors (YM201636 and apilimod) of the PIKfyve enzyme, involved in the phosphoinositides metabolism regulating endosomal maturation. Other viruses depending on PIKfyve enzyme described have been Ebola virus (EBOV) and African swine fever virus, both dependent on the late endosome for entry.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26−28)</a> SARS-CoV-2 infection is impaired by blocking other proteins characteristic of the late endosomal compartments, like two-pore channel 2 (TPC2) (but not TRMPL1), indicating that TPC2 is important for SARS-CoV-2 pseudovirions’ entry.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Protease activation of S glycoprotein is crucial for coronavirus entry. Lysosomal cathepsins are necessary for SARS- and MERS-CoV entry via endocytosis. SARS-CoV-2 also requires cathepsin L for a successful infection since its inhibition decreased by 76% the entry of SARS-CoV-2 S pseudovirions, suggesting that cathepsin L should be crucial for SARS-CoV-2 S priming into lysosomes to enter the cells. Conversely, cathepsin B inhibition did not seem to have any effect.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Once the virus enters the host cell, it gets disassembled to release the nucleocapsid and the viral genome. Host ribosomes translate the open reading frame (ORF) 1a/b into two polyproteins (pp1a and pp1ab) that encode 16 nsps, while the remaining ORFs encode structural and accessory proteins. Two proteases participate in the cleavage of the polyproteins, the main protease (3CLpro, nsp5) and the papain-like protease (PLpro, nsp3), to produce nsp2–16 involved in the replication–transcription complex (RTC).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Some of those are the RNA-dependent RNA polymerase (RdRp, nsp12) and helicase (nsp13). In coronavirus, this process is followed by assembly of the virion components into the endoplasmic reticulum Golgi intermediate compartment complex and release from the infected cells by exocytosis.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p last">In principle, all CoV enzymes and proteins involved in viral replication and the control of host cellular machineries are potentially druggable targets in the search for therapeutic options for SARS-CoV-2. In this Perspective, we will give an overview of the main virus-based and host-based targets from a structural point of view, together with reported therapeutic compounds with activity against SARS-CoV-2 and/or other CoVs. Also, the role of innate immune response to coronavirus infection and the therapeutic options based on this response will be presented.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Virus-Based Targets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Structural Proteins</h3><div class="NLM_p">The coronavirus structural proteins that form the viral particle are the spike (S) glycoprotein, envelope (E) protein, membrane (M) protein, and the nucleocapsid (N) protein (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). These proteins are less conserved than nsps, playing important functions in the viral life cycle. Spike (S) protein has an important role in virus pathogenesis and organ tropism, being responsible for the viral entry through receptor recognition and membrane fusion.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The envelope (E) protein is the smallest of the structural proteins but has a crucial role in assembly, budding, envelope formation, and virulence.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The main function of the membrane (M) protein is to promote viral assembly due to its membrane-bending properties.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The nucleocapsid (N) protein is a multifunctional protein that packages the viral RNA genome into a ribonucleoprotein complex called nucleocapsid to protect the genome.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> With regard to the search for new therapeutics based on structural proteins of SARS-CoV-2, some computational studies were carried out to identify the structure and function of E protein<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and the other structural proteins.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of SARS-CoV-2 and its structural proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We will focus our attention on the N protein recently crystallized (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M3M">6M3M</a><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VYO">6VYO</a>) and on the S protein due to its fundamental role in viral entry and its available structures that will allow structure-based drug design.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a></div><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5">2.1.1.  Nucleocapsid (N) Protein</h4><div class="NLM_p last">As mentioned above, coronavirus N protein is a multifunctional RNA-binding protein considered to be an interesting pharmacological target that merits further attention due to its critical function in viral RNA transcription and replication.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> This major CoV protein contains two highly conserved domains, an N-terminal RNA-binding domain and a C-terminal dimerization domain, together with a disordered central Ser/Arg-rich linker. Previous studies revealed that the N-terminal domain is responsible for RNA binding, the C-terminal for oligomerization, and the Ser/Arg-rich linker for primary phosphorylation.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> The crystal structure of SARS-CoV-2 nucleocapsid N-terminal domain has been solved (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M3M">6M3M</a>),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> showing an overall similarity with the same domain from other CoVs, although the surface electrostatic potential showed a specific distribution. These important structural findings will significantly stimulate the drug discovery of ligands focused on this appealing target to block coronavirus replication and transcription. The success in the development of compounds that interfere with N proteins of other CoVs, such as the recent discovery of stabilizers of the protein–protein interaction of MERS-CoV N protein,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> reinforces the potential of the N protein as druggable target for SARS-CoV-2 infection. Remarkably, the N protein is highly immunogenic and is being considered as a potential vaccine target and for the development of COVID-19 diagnostic methods.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a></div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6">2.1.2.  Spike (S) Glycoprotein</h4><div class="NLM_p">The S glycoprotein is a structural transmembrane protein of about 1200–1400 amino acid residues per monomer located on the outer envelope of the virion. As has been observed for other viruses of the <i>Coronaviridae</i> family,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> it mediates virus entry by contacting specific host-receptors located on the surface of the cell. Host–guest recognition is virus-specific, and the specificity and selectivity of this process determine both (i) virus tropism and (ii) pathogenesis.<a onclick="showRef(event, 'ref25 ref39'); return false;" href="javascript:void(0);" class="ref ref25 ref39">(25,39)</a> In its functional form, S protein assembles as a homotrimer. Each of the three monomeric units are formed by two functional groups, the S1 subunit which is responsible for host recognition and the S2 subunit which guides host–guest membrane fusion.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The S1 domain is characterized by an N-terminal domain (NTD) and a C-terminal domain (CTD) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The former can recognize carbohydrate moieties and is considered a derivation of ancestral sugar-based recognition domains, while the latter, also known as receptor-binding domain (RBD) or S<sup>B</sup>, mediates host–guest interaction and promotes virus entry by recognizing protein receptors of the infected organism. In particular, the region directly involved in the recognition process is defined as the receptor-binding motif (RBM). A C-terminal, transmembrane domain in the S2 subunit connects the S glycoprotein to the virus membrane.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural diagrams of spike glycoproteins of SARS-CoV-2. The spike protein contains an S1 subunit and an S2 subunit, which are divided by the S cleavage sites. Abbreviations: FP, fusion peptide; HR, heptad repeat 1 and heptad repeat 2, RBD, receptor-binding domain, containing the core binding motif in the external subdomain; SP, signal peptide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several conformational states of S exist in a dynamic equilibrium between them: the uncleaved, S0; the cleaved, pre-fusogenic S1/S2; and the post-fusogenic forms. S protein is generally biosynthesized in an uncleaved, fusion-incompetent S0 form, which is then cleaved and activated by proteases. S proteins of less pathogenic CoV are initially exposed uncleaved (S0) on the virus membrane, and their activation is later promoted by host proteases. Conversely, S proteins of the highly pathogenic SARS-CoV-2 are cleaved during protein egress and, thus, are exposed on the virion in its cleaved (S1/S2) form<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Schematic diagram of SARS-CoV S2-mediated membrane fusion. In the receptor-binding stage, S protein, which exists as a trimer, binds to the cellular receptor ACE2 via S1-RBD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the S1/S2 form, a dynamic equilibrium between open (“up”, U) and closed (“down”, D) conformations characterizes the three RBD domains of the S protein (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The receptor-binding site of S is generally occluded when the RBD is in “down” conformation and makes extensive contacts with the NTD of S1. Significant conformational modifications are required for “down-to-up” conversion. A masking and 3D sorting strategy applied on SARS-CoV by Kirchdoerfer et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> suggested that ACE2 does not directly participate in down-to-up conversion of S protein and RBD. It is more likely that ACE2 binds an S-RBD in an already “up” conformation.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representation of the open “up” (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VSB">6VSB</a>) and closed “down” (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VXX">6VXX</a>) states for the pre-fusion S1/S2 glycoprotein of SARS-CoV-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">So, according to these data, the S protein of SARS-CoV should sample 56% of the triple “down” and 44% of the single “up” S1 RBD; no double or triple “up” S1 RBD conformations have been observed. Introduction of some stabilizing mutations at positions 968 and 969 of the S protein seems to move the equilibrium toward the open forms: 58% of the single “up”, 39%/3% of the double/triple “up”, and 0% of the triple “down” S1 RBD. Although intriguing, the exact role and the significance of the dynamic equilibrium of S1 RBD remain unclear. In this regard, it might be interesting to compare with the more pathogenic SARS-CoV-2, but data are not yet available. This strategy has proved useful to produce pre-fusion stabilized S protein for structure-based drug discovery approaches focused on direct inhibition of the interaction between S-RBD and the host protein ACE2 and has been also applied on SARS-CoV-2.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">Priming of the S protein could occur in several ways, depending on the (guest) type of CoV and the pool of available (host) proteases involved in the event.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> As previously introduced, the pre-fusion conformation is originated by the proteolytic cleavage of the S1/S2 site, catalyzed by serine-proteases like furin, cathepsin L, or TMPRSS2 in correspondence of the (R/K)-(2X)n-(R/K) motif of S.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Given their undoubted role in virus entry by S priming, all these proteases could represent valuable targets for effective antiviral therapies based on protease inhibition or modulation and are presented in different sections of this Perspective.</div><div class="NLM_p">Sequence analyses for this region within CoV of the same clade revealed a significant heterogeneity, posing the bases as the explanation for the higher pathogenicity of SARS-CoV-2. Accordingly, a major exposure of the furin-like (S1/S2) cleavage site and, thus, an efficient priming of S protein would derive from insertion of polybasic amino acids at the S1/S2 cleavage site for SARS-CoV-2.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Conversely, the S protein of SARS-CoV is inefficiently cleaved by furin at the S1/S2 cleavage site during biosynthesis due to the low exposure of the cleavage site. Unlike SARS-CoV-2, which is exposed in an already cleaved prefusion form, the uncleaved (S0) form seems to be predominant in the case of SARS-CoV, leading to a lower pathogenicity profile.</div><div class="NLM_p">Conformational changes induced by the first cleavage are not sufficient to promote host–guest membrane fusion, which seems to be finally induced by a second cleavage event at the S2′ site (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref39 ref51'); return false;" href="javascript:void(0);" class="ref ref39 ref51">(39,51)</a> This event appears to be subordinated by recognition of attachment host receptors at the level of the S1 domain.</div><div class="NLM_p">Coronaviruses use different regions of the S1 subdomain to bind the host cell. In SARS-CoVs, recognition is mediated by the RBD of S, which binds an N-terminal α-helical region (peptidase domain) of the ACE2, which is accommodated in a concave region, named a receptor-binding motif (S-RBM, highlighted in violet in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), of the S-RBD.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Polar contacts between the S-RBM (in violet) of S-RBD and ACE2 (in green) for SARS-CoV-2 (A) and SARS-CoV (B) and electrostatic potential map for the S-RBD. Some additional polar contacts (Q493-E35 and K417-D30) are visible in the central region of the contact surface for SARS-CoV-2 and ACE2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A close look at the contact region for SARS-CoV and SARS-CoV-2 with ACE2 revealed a different interaction pattern among the two viruses.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> In the case of SARS-CoV-2, a total of 18 residues of the RBD contacting 20 residues of the ACE2 can be detected, whereas a total of 16 residues of the SARS-CoV RBD contact 20 residues of the ACE2. The main polar contacts are reported in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. Interestingly, two additional polar interactions, consisting on one hydrogen-bonding interaction between Q439 of S-RBM and E35 of ACE2 and one salt bridge between K417 of S-RBM and D30 of ACE2, can be observed in the central part of the S-RBM–ACE2 surface, as a clear consequence of the different electrostatic profiles envisaged for the two CoVs. These additional contacts are facilitated by the deeper insertion of the peptidase domain of ACE2,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> as a consequence of rearrangement of the receptor-binding ridge (residues 482–485 of S-RBD). The slight reorientation of the peptide domain (PD) of ACE2 also allows a better stabilization of two other hotspots, Q493(S-RBM)–E35(ACE2) and G496(S-RBM)–K353, previously identified as critical in the stabilization of the complex.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div class="NLM_p">No polar contacts can be observed in the central region of the S-RBM–ACE2 interface for SARS-CoV, where K417 is replaced by a valine residue.</div><div class="NLM_p">Taken together, these findings can shed some light on the reasons for the pandemic behavior of the new SARS-CoV-2. More factors need to be examined in the attempts to properly characterize the virus’s pathogenicity. In this direction, a novel route for virus entry, involving the immunoglobulin-like host protein CD147, well known to “open the door” to <i>Plasmodium falciparum</i>, the etiological agent of malaria,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> has been proposed by Wang et al.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Preliminary <i>in vitro</i> antiviral tests indicated that meplazumab, an anti-CD147 humanized antibody, could significantly inhibit virus entry. Formation of the CD147–S-RBD complex was then confirmed by co-immunoprecipitation and ELISA tests.</div><div class="NLM_p">Another distinctive trait of obligate parasites such as SARS-CoVs is high-level post-translational modifications. Viral glycans have been proposed to exert a pivotal role contributing to virus functionality and immune selection, and thus to its pathobiology.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Viral O- and N-glycosylation, with this last generally occurring on asparagine included in the Asn-X-Ser/Thr sequences, extensively characterizes envelope glycoproteins of human immunodeficiency virus (HIV-1),<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> EBOV,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> and hemagglutinin<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> in influenza virus (IFV). These modifications, originated from selective pressure induced by immune evasion, could contribute to regulate glycoprotein folding, assembly, and maturation. The extreme heterogenicity of the number and the distribution of these glycosylated sites makes it difficult to discern their exact role in the virus’s life cycle. However, recent advancements on mass spectrometric and chromatographic techniques as well as the availability of recombinant glycosidases have allowed researchers to better study and analyze their impact on folding, structure, sorting, trafficking, and stability of glycoproteins. Glycosylation can help to stabilize protein folding by enhancing its solubility. Moreover, glycoproteins can also participate in intramolecular stabilizing interactions. Another interesting aspect observed for glycoproteins of coronaviruses is that N-glycosylation could help in shielding antigenic sites (as receptor-binding sites) to promote immune evasion.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> This phenomenon, defined as “glycan shielding”, could represent a critical factor during the design of vaccines. A direct comparison between S glycoprotein of SARS-CoV and SARS-CoV-2 revealed a different pattern of glycosylation,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> which might contribute to the different profiles in trafficking and interaction with adhesion factors. Some of these differences in glycosylation sites correspondence to antibody-accessible regions of the S protein, thus reinforcing the idea of their effect in hiding the vulnerable region of the protein.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p">Taken together, these aspects highlight the relevance of a probably overlooked aspect—the glycosylation—during vaccine design.</div><div class="NLM_p">For viral-based therapeutic options, S protein and its RBD represent a very interesting and intriguing target for antiviral research. The more efficient recognition of the ACE2 host protein, together with the expanded host cell tropism given by the existence of a potential new entry route mediated by CD147, highlight S protein as an even more important and central target for therapeutic intervention.</div><div class="NLM_p">In this direction, common and trusted antiviral strategies directed to S protein consist of inhibition of host recognition by acting on the S1 RBD and inhibition of the fusion process by acting at the level of the S2 subunit. Both of these effects could be exerted by small inhibitors, peptides, or human monoclonal antibodies, which are able to efficiently recognize these regions of the protein.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> A good efficiency has been demonstrated by anti-ACE2 and other S1 human antibodies on SARS-CoV.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66,67)</a> The small inhibitor SSA09E2, a piperazine carboxamide derivative,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> was also able to interfere with ACE2 recognition (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compounds and peptides directed to S protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Systemic peptide mapping on SARS-CoV led to the discovery of the peptide CP-1, which binds with high affinity the heptad-repeat 2 region of S2 and interferes with the conformational changes leading to the 6-helix bundle formation, thus blocking the virus–cell fusion process (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Recently, a pan-coronavirus fusion inhibitor lipopeptide (EK1C4) has been designed, targeting a structure formed by two specific regions in the S2 subunit.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p last">Collectively, all these strategies could be also applied to the discovery of inhibitors specifically designed to act on the SARS-CoV-2 S protein with a more selective and effective antiviral profile.</div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.2.  Non-structural Proteins (nsps)</h3><div class="NLM_p">SARS-CoV-2, like other coronaviruses, has 16 nsps that are highly conserved and present different functions, including the formation of the RTC. The specific roles of most of the nsps have been reported, although the functions of some nsps remain elusive.<a onclick="showRef(event, 'ref6 ref29'); return false;" href="javascript:void(0);" class="ref ref6 ref29">(6,29)</a> Focused on reported studies on SARS-CoV-2, it is interesting to highlight the number of nsp structures of this virus available: the main protease (3CLpro, nsp5; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Y2E">6Y2E</a>),<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> the papain-like protease (PLpro, nsp3; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W9C">6W9C</a>), the RNA-dependent RNA polymerase (RdRp, nsp12) in complex with cofactors nsp7 and nsp8 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M71">6M71</a>),<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> the methyltransferase-stimulatory factor complex of nsp16 and nsp10 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W61">6W61</a>), the complex nspP10-nsp16 (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W75">6W75</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W4H">6W4H</a>), the nsp9-binding protein (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W4B">6W4B</a>), and the nsp15 endoribonuclease (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VWW">6VWW</a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">Although any nsp could be exploited as a druggable target,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> the availability of the crystal structure and described ligand, together with an essential role in viral infection, significantly increase the chances of success. On this premise, we will now focus on the two proteases (3CLpro and PLpro), the RNA-dependent RNA polymerase (RdRp), and helicase (nsp13).</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">2.2.1.  Proteases 3CLpro and PLpro</h4><div class="NLM_p">SARS-CoV-2’s genome—like most of the <i>Coronaviridae</i> genome—encodes two large polyproteins, pp1a and pp1ab.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> These polyproteins are cleaved and transformed in mature nsps by the two proteases 3CLpro (3C-like protease or main protease) and PLpro (papain-like protease) encoded by the ORF 1a/b<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> as mentioned above. Both proteins are crucial for virus replication and controlling the host cell response; therefore, they stand as key targets in the development of antiviral drugs.</div><div class="NLM_p">3CLpro forms a dimer, and each monomer contains two regions, the N-terminal catalytic region and the C-terminal region.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The sequences of 3CLpro in SARS-CoV and SARS-CoV-2 share 96% identity, and the minimal differences between the two enzymes are at the surface of the proteins. Therefore, inhibitors against SARS-CoV 3CLpro are expected to inhibit SARS-CoV-2 3CLpro. Recently, the structure of 3CLpro (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Y2E">6Y2E</a>)<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> has been resolved, confirming the high structural similarity between the two enzymes.</div><div class="NLM_p">During recent years, there has been a large development of small molecules, peptides, and peptidomimetics that are able to inhibit SARS-CoV or both SARS-CoV and MERS-CoV 3CLPro, or even both proteases 3CLpro and PLpro.<a onclick="showRef(event, 'ref7 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref7 ref77 ref78">(7,77,78)</a> In <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, some of the most interesting compounds are classified by the proteases they inhibit.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative CoV protease inhibitors: (A) SARS 3CLpro inhibitors, (B) SARS and MERS 3CLpro inhibitor, and (C) SARS dual 3CLpro and PLpro inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As 3CLpro is a cysteine protease, therefore covalent inhibitors have been developed (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). It is worth mentioning a family of vinylsulfones that inhibit SARS-CoV in the nanomolar range. Indeed, Zhou et al.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> published an <i>in vivo</i> study in which the combination of the vinylsulfone protease inhibitors and camostat was tested in mice infected with SARS-CoV. Survival of mice treated with the combination therapy significantly increased compared to the control group. Very recently, Yang’s group has determined the crystal structure of SARS-CoV-2 virus 3CLpro in complex with an irreversible peptidomimetic inhibitor N3 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LU7">6LU7</a>).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> In addition, they have performed a combination of structure-based virtual and high-throughput screenings of different chemical libraries including approved drugs, drug candidates in clinical trials, and other pharmacologically active compounds as inhibitors of 3CLpro. As a result, they have identified eight compounds with IC<sub>50</sub> in a range from 0.67 to 21.4 μM (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Some of them, such as disulfiram and carmofur, are FDA-approved drugs, while ebselen, shikonin, tideglusib, and PX-12 are currently in clinical trials or preclinical studies. Finally, based on a family of α-ketoamide inhibitors of MERS-CoV, Zhang et al. have designed and crystallized a new family of α-ketoamide inhibitors of the SARS-CoV-2 3CLpro, among them compound <b>13b</b> with an IC<sub>50</sub> of 0.65 μM<a onclick="showRef(event, 'ref71 ref81'); return false;" href="javascript:void(0);" class="ref ref71 ref81">(71,81)</a> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative SARS-CoV-2 3CLpro inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Moreover, there are two SARS-CoV 3CLpro inhibitors approved for the treatment of other viral infections, lopinavir and ritonavir, which are being used in patients in the currently pandemic.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> PLpro is a key target not only to inhibit viral replication but also to inhibit the dysregulation of signaling cascades in infected cells that may lead to cell death of neighboring, uninfected cells.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> SARS-CoV-2 PLpro shares 83% sequence identity with SARS-CoV PLpro. That is not as high as it was with 3CLpro; however, the differing residues are located on the surface. It is thus very likely that the SARS-CoV PLpro inhibitors could also be active against PLpro of SARS-CoV-2. Very recently, the structure of PLpro of SARS-CoV-2 has been deciphered (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W9C">6W9C</a>), but to date, no compound able to inhibit it has been reported.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">2.2.2.  RNA-Dependent RNA Polymerase (RdRp)</h4><div class="NLM_p">RdRp is a crucial enzyme in the coronavirus life cycle as well as in other RNA viruses. This enzyme is conserved in structure and function among viruses with RNA genomes belonging to different families. RdRp mediates the transcription and replication of the RNA genome during infection. The fact that this enzyme has no human counterpart, together with its essentiality for the virus’s life cycle, improves its chances as a drug target for antiviral development,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> as has been done in other viral infections.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><div class="NLM_p">As mentioned above, the replication–transcription complex in coronavirus is formed after cleavage of the polyproteins pp1a and pp1ab into nsps. Moreover, SARS-CoV RdRp requires nsp7 and nsp8 as cofactors to stimulate its polymerase activity. Also, the association with exoribonuclease/N7-guanine cap methyltransferase nsp14 contributes to the formation of a macromolecular assembly for efficient nucleotide polymerization, proofreading, and cap-modifying. Combination of this multifunctional protein assembly with the helicase/RNA triphosphatase nsp13 and the 2′-<i>O</i>-methyltransferase nsp16 could coordinate the replication–transcription machinery of SARS-CoV.<a onclick="showRef(event, 'ref29 ref85'); return false;" href="javascript:void(0);" class="ref ref29 ref85">(29,85)</a> All these facts are partially elucidated with the structural characterization of some complexes: nsp10/nsp16 complex,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> nsp14/nsp10 complex,<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and RdRp with its cofactors nsp7 and nsp8.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p">The structure of SARS-CoV-2 RdRp in complex with cofactors nsp7 and nsp8 has been recently deposited in the Protein Data Bank (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M71">6M71</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> This structure will significantly accelerate the structure-based drug design toward this essential target. Moreover, a 96% sequence identity between RdRp’s from SARS-CoV and SARS-CoV-2<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> contributes to the translation of results with therapeutic agents from one virus to the other. Approved nucleoside analogues acting in other viruses have been successfully used against SARS-CoV and are now being used in the new coronavirus infection.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Molecular modeling studies using the structure of RdRp have identified well-known drugs such as ribavirin, remdesivir, sofosbuvir, galidesvir, and tenofovir as inhibitors of RdRp and potential therapies for COVID-19.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Of interest is the reported lack of activity of non-nucleoside analogues in SARS-CoV due to the absence of a hydrophobic pocket in the polymerase to allocate this class of compounds present in other viruses, such as HIV-1 or hepatitis C virus (HCV).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><div class="NLM_p">Remdesivir (GS-5734) (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), an adenosine analogue with broad antiviral spectrum in RNA viruses, has proven to be efficacious against different CoVs <i>in vitro</i> and in a mouse model of SARS-CoV infection.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> During the COVID-19 pandemic, it has been evaluated against a clinical isolate of the new virus,<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> showing a half-maximal effective concentration (EC<sub>50</sub>) of 0.77 μM and a selectivity index of 129.87 (Vero E6 cells). Moreover, the crystal structure of this drug with RdRp has been recently elucidated.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Furthermore, several clinical trials around the world have been approved to demonstrate its therapeutic potential in patients.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> During the preparation of this manuscript, results from the first trial in China were published, and remdesivir was not associated with statistically significant clinical benefits for COVID-19 patients.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> However, the FDA authorized the use of this intravenous antiviral drug for emergency treatment of COVID-19 patients. Remdesivir can be administered only to hospitalized patients with severe illness, defined as patients with low oxygen in blood or needing breathing assistance.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. RdRp inhibitors active against SARS-CoV-2 and under clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This drug initially showed efficacy for the treatment of Ebola disease, being in fact in clinical development for this devastating infectious disease.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> The mechanism of action of this nucleoside prodrug is through the RdRp, by delaying chain termination in EBOV. In CoVs, remdesivir is able not only to inhibit the RdRp but also to evade the action of the exoribonuclease (nsp14).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> This fact is of utmost importance,<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> because poor activities of some nucleosides such as ribavirin are attributed to their removal by the exoribonuclease.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><div class="NLM_p last">Together with remdesivir, other broad-spectrum antivirals targeting RdRp were tested in SARS-CoV-2. The half-maximal effective concentration (EC<sub>50</sub>) and half-cytotoxic concentration (CC<sub>50</sub>) in Vero E6 cells of selected compounds are as follow: ribavirin EC<sub>50</sub> = 109.50 μM, CC<sub>50</sub> > 400 μM; penciclovir, EC<sub>50</sub> = 95.96 μM, CC<sub>50</sub> > 400 μM; and favipiravir, EC<sub>50</sub> = 61.88 μM, CC<sub>50</sub> > 400 μM.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> From this set of compounds, only favipiravir (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), already approved for the treatment of influenza, was recommended to be further evaluated as a therapeutic option for COVID-19 patients, although there are some concerns with regard to the pharmacokinetics properties of this drug.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">2.2.3.  Helicase (nsp13)</h4><div class="NLM_p">NTPase/helicase (nsp13) is a critical protein in the replication–transcription complex of CoVs that catalyzes the separation of duplex oligonucleotides into single strands in a nucleotide triphosphate (NTP) hydrolysis-dependent manner. Due to the fact that this protein is essential for RNA viral synthesis and one of the most conserved proteins in nidoviruses, it is considered an interesting target for drug development, and several chemical inhibitors have been reported.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><div class="NLM_p">Bananins are oligo-oxa-adamantanes that, after conjugation with vitamin 6 (pyridoxal), show antiviral activities (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Four derivatives, bananin, iodobananin, vanillinbananin, and eubananin, inhibited both the ATPase and the helicase activity of the nsp13 from SARS-CoV. Remarkably, these compounds also inhibited the replication of the virus through a process that occurs after the viral entry.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Another family of antivirals acting through the target enzyme are the 5-hydroxychromone derivatives,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> which were synthesized as bioisosteres of the previous reported aryl diketoacids.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Representative SARS-CoV helicase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A screen using a FRET-based helicase assay of the Maybridge Hitfinder chemical library allowed the identification of triazole SSYA10-001 (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>), which specifically blocks the helicase activity of nsp13 and also shows anti-SARS-CoV activity. Kinetic studies to determine the enzyme inhibition mechanism showed that SSYA10-001 acts as a non-competitive inhibitor of nsp13 with respect to nucleic acid and ATP substrates.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Further studies with this 1,2,4-triazole showed that it is also able to inhibit two other CoVs (MERS-CoV and mouse hepatitis virus). A putative binding pocket was identified corresponding to a conserved pocket in CoVs nsp13, where Y277 and K508 are the key residues to maintain the interaction.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><div class="NLM_p last">At the time of writing of this manuscript, the structure of nsp13 full-length (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JYT">6JYT</a>) SARS-CoV is available.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> So far, no structural information is available on the SARS-CoV-2 helicase, but due to the high sequence similarity (99.8%), the SARS-CoV structure available significantly encourages the search for drugs to treat COVID-19 acting through this target enzyme.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">3.  Host-Based Druggable Targets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Coronavirus entry is mainly achieved by the virus binding to the ACE2 host receptor in the cell surface in a receptor-mediated endocytosis pathway. Other molecules such as proteases activate the spike (S) protein and facilitate the fusion with the receptor and cell membrane, allowing entry into the host of viral RNA via an endocytic pathway.</div><div class="NLM_p">Host-targeted anti-SARS-CoV-2 agents presented here are based on the molecular study of virus entry, identifying key proteins involved in the process. Targeting host proteins may avoid different limitations frequent in antiviral research, probably offering a genetic barrier to viral resistance.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.1.  Angiotensin I Converting Enzyme 2 (ACE2) Receptor</h3><div class="NLM_p">Coronavirus entry is mainly produced by the virus binding to different host receptors in the cell surface. In SARS-CoV-2, ACE2 has been recently confirmed as the main virus receptor.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, inhibition or modulation of ACE2 represents one of the proposed host-based strategies for treatment of SARS-CoV-2.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><div class="NLM_p">Activity of ACE2 is related to the renin–angiotensin system (RAS), which is involved in the maintenance of blood pressure homeostasis, fluid, and salt balance in mammals.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> While renin cleaves angiotensinogen to generate angiotensin (Ang) I, the angiotensin-converting enzyme (ACE) catalyzes the formation of Ang II, a critical signaling molecule, through the proteolytic cleavage of Ang I. Although not exclusive,<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> the activity of ACE has been considered to be of pivotal importance in the regulation of Ang II within the RAS.</div><div class="NLM_p">ACE2, a homologue of ACE, is a multifunctional zinc metalloprotease consisting of 805 amino acids, which can be functionally divided into (i) the amino-terminal catalytic domain and (ii) the carboxy-terminal domain.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The enzyme has been observed to negatively regulate RAS through the degradation of Ang II to the heptapeptide Ang 1–7.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><div class="NLM_p">ACE2 can be found in epithelial cells of lung, liver, and testis.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Unlike ACE, ACE2 populates the apical membrane of respiratory epithelial cells, by which infection can occur. ACE2 receptors have been also observed in nasal and mouth epithelial cells.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Interestingly, an enhanced expression of ACE2 receptors in the lungs has been correlated with age, thus partially explaining the higher viral load and severity of symptoms observed in older patients infected by SARS-CoV-2.<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114,115)</a></div><div class="NLM_p">The cryogenic electron microscopy (cryo-EM) structure of the full-length human ACE2 with the transporter B0AT1, with (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M17">6M17</a>) or without (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M18">6M18</a>) the RBD of the surface S glycoprotein of SARS-CoV-2, has been recently published.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The complex appears as a dimer of heterodimers with the collectrin-like domain (CLD) located among B0AT1 and the peptidase extracellular domain (PD) of ACE2 (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). CLD consists of a small extra-cellular domain, a long linker, and a single transmembrane (TM) helix; the central region (the neck domain) between the PD and the TM helix constitutes the most relevant part of the dimerization surface. Here, coordination between the two dimers is mediated by extensive polar contacts such as R716′-D713, E639′-R710, N636′-Q653, and N638′-R652. A weaker interaction surface can be also observed between the two N-terminal PDs of ACE2, where Q175′ directly interacts with Q139. It was suggested that ACE2 is natively dimeric and thus able to bind two trimeric S proteins.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (Right) Cryo-EM structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M17">6M17</a>) of full-length human ACE2 with the transporter (B<sup>0</sup>AT1) and the receptor-binding domain of the spike glycoprotein (S1-RBD). (Left) S1-RBD–ACE2 interaction interface for SARS-CoV-2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M0J">6M0J</a>), front and back views. Relevant ACE2 residues involved in direct polar interaction with S1-RBD (in particular, D30, K31, and D35) are represented in yellow sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">ACE2 was already known for mediating infection of the less pathogenic SARS-CoV,<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> in particular, by recognizing the receptor-binding domain of the S protein (S1-RBD) with an α-helical region located in the peptidase domain.</div><div class="NLM_p">D30, K31, and D35 have been identified as critical residues in the interaction with S1-RBD.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Their specific localization with respect to the S-RBD is shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>. More details about the S-RBD–ACE2 interaction pattern are given in the <a class="ref internalNav" href="#sec2_1_2" aria-label="Spike (S) Glycoprotein">Spike (S) Glycoprotein</a> section.</div><div class="NLM_p">Therapeutic strategies devoted to combat SARS-CoV-2 infection via ACE2 could involve the following:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(i)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Interfering with the dynamics of the virus–host ACE2–S-RBD interface. This can be achieved by using relatively small molecules able to disrupt or negatively affect the efficiency in the dynamic network of protein–protein interaction that guides viral entry. In this regard, 77 molecular candidates have been identified from the FDA database through an <i>in silico</i>-guided repurposing study, which combines replica exchange molecular dynamics and ensemble docking, although no experimental decrease of virus infection has been reported.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Furthermore, machine learning and ensemble docking simulations have also provided new different scaffolds able to interrupt the spike protein–ACE2 interaction.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></p></td></tr><tr class="li1"><td valign="top">(ii)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Inhibiting the ACE receptor. Since myocardial injuries caused by SARS-CoV-2 might be related to ACE2, therapies based on the use of ACE inhibitors or angiotensin blockers might be used for organ-protection purposes. In that sense, telmisartan has been proposed as a real option for COVID-19 therapy,<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> and a clinical trial has recently started (NCT04355936). However, the real impact of ACE inhibitors on COVID-19 still remains controversial.<a onclick="showRef(event, 'ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref120 ref121">(120,121)</a></p></td></tr><tr class="li1"><td valign="top">(iii)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Delivery of soluble ACE2. It has been demonstrated that SARS-CoV-2 downregulates<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> expression of ACE2. Accordingly, it has been proposed that the delivery of soluble ACE2 could exert a beneficial effect by competing with the host ACE2 for binding with S glycoprotein. Soluble recombinant ACE2 or APN01 imitates the human enzyme ACE2, which is used by the virus to enter cells.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The virus binds to soluble ACE2/APN01, instead of ACE2 on the cell surface, which means that the virus can no longer infect the cells. At the same time, APN01 reduces harmful inflammatory reactions in the lungs and protects against lung injury due to acute respiratory distress syndrome (ARDS). In this regard, a recombinant human ACE2 (rhACE2; APN01, GSK2586881) has been tested on a small cohort of patients with ARDS, demonstrating encouraging positive results.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122,123)</a> In a very recent paper, researchers tested the potential of direct treatment with soluble human ACE2 to prevent the entrance of the virus to the host cells in engineered human kidney organoids.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></p></td></tr></table></div><div class="NLM_p last">In combination with other host-based or virus-based approaches, these strategies offer a vast reservoir of opportunities to combat SARS-CoV-2. Careful examination of their real therapeutic impact and a proper validation are needed to fully address their clinical validity.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">3.2.  Transmembrane Serine Protease 2 (TMPRSS2)</h3><div class="NLM_p">Following receptor interaction, or in addition to it, different host proteases can activate the virus–host cell membrane fusion for subsequent genome delivery. The host cell surface transmembrane serine protease 2 (TMPRSS2) activates S protein present in the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Human TMPRSS2 is expressed in the epithelia of the gastrointestinal, urogenital, and respiratory tracts.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Cleavage of S protein by TMPRSS2 is preferred for coronavirus infection over other proteases, such as the endosomal cathepsins.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Recent research has confirmed that SARS-CoV-2 entry is facilitated by TMPRSS2 and the viral infection is decreased by the use of the protease inhibitor camostat.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Moreover, as viral infection is enhanced by TMPRSS2, the Vero E6 cell line overexpressing TMPRSS2 has been described as a useful pharmacological tool for SARS-CoV-2 research.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Last, but not least, TMPRSS2 is expressed in different cell types of lung tissue, increasing their vulnerability for SARS-CoV-2 infection.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><div class="NLM_p">TMPRSS2 has emerged as a useful drug target for antiviral drug discovery,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and the lack of influenza and coronavirus infection has been confirmed in TMPRSS2 knock-out mice.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> COVID-19 may find a potential therapy among different repurposed drugs with inhibitory activity against TMPRSS2. At the moment, only camostat has shown <i>in vitro</i> activity against SARS-CoV-2, but other clinical drugs such as nafamostat and 4-(2-aminoethyl)benzenesulfonyl fluoride, all of them protease inhibitors,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> may offer some therapeutic options for the pandemic (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A). Repurposing of the mucolytic agent called bromhexine, a TMPRSS2 inhibitor, has been also proposed for COVID-19 therapy.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Furthermore, transcriptional inhibition of TMPRSS2 has been proposed as a new therapeutic option. Using computational and experimental methods, estrogen and androgen-related compounds such as genistein, estradiol, and enzatulamide (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B) have been shown to reduce TMPRSS2 expression in different cell lines.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> As TMPRSS2 expression in the human lungs seems to be modulated by estrogens and androgens, data suggest that the activation of estrogen pathways or inhibition of androgen pathways may be a new target for therapeutic clinical intervention for symptom amelioration in COVID-19 patients.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. TMPRSS2 modulators: (A) chemical structure of TMPRSS2 inhibitors and (B) some transcriptional inhibitors of TMPRSS2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Currently, the crystal structure of TMPRSS2 is not available, and target-based drug discovery and design should be done using different homology models based on other well-known serine protease structures.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">3.3.  Furin</h3><div class="NLM_p">Recent studies have discovered a “furin-like cleavage site” (FCS) in the S protein of SARS-CoV-2 that may explain the high pathogenicity of the virus.<a onclick="showRef(event, 'ref39 ref48'); return false;" href="javascript:void(0);" class="ref ref39 ref48">(39,48)</a> Moreover, this highly cleavable site is not found in closely related CoVs.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Furin, a type 1 membrane-bound protease expressed in multiple tissues, belongs to the subtilisin-like proprotein convertase family. This family includes proteases with specific roles in the secretory pathway. The insertion of such cleavage sites in other CoVs, such as the infectious bronchitis virus, increased the pathogenicity, including neural symptoms in infected chickens.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> As furin is highly expressed in lungs, it is very likely to be involved in SARS-CoV-2 infection, increasing its pathogenicity over other betacoronaviruses, as they lack this cleavage site.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Recently, it has been proposed that the FCS may be an important site of coronavirus evolution. In samples isolated from mild COVID-19 patients from Zhejiang Province, China, mutations appeared near FCS (F1–2) that affected the electrostatic distribution of the S protein surface and its structure, and thus its ability to bind to furin.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Experimental results in samples from those patients showed that furin had low protein expression levels in the lungs compared with other tissues, such as colon, glands, liver, and kidney. The FCS may contribute to SARS-CoV-2 infection of these organs. Recent reviews describe the close interaction between ACE2 and furin in the viral infection of SARS-CoV-2,<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> showing a potential relationship between furin activities of different populations and the different clinical scenarios of the SARS-CoV-2 infection.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p last">Inhibition of furin with peptides and, more recently, with small molecules is a strategy pursued to arrest tumor growth, inflammation, and some viral and bacterial infections.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> However, due to the pleiotropic role of furin-like enzymes in a large number of cellular processes, side effects are a concern.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Determination of the crystal structure of furin will aid the design of specific small molecules.<a onclick="showRef(event, 'ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref140 ref141">(140,141)</a> For example, furin’s unliganded form (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JXG">5JXG</a>) suggests activation by a substrate-induced mechanism,<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> while the recent complexes with substrate analogue inhibitors (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQV">6EQV</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQW">6EQW</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQX">6EQX</a>)<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> decipher some new pockets to be exploited by a next generation of furin inhibitors that may be a potential therapy for COVID-19.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">3.4.  Cathepsin L</h3><div class="NLM_p">Activation of SARS-CoV-2 spike protein by cleavage of proteases is a key step in viral infection. Different lysosomal cathepsins were relevant in human coronavirus entry through endocytosis.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> In a recent study, it has been shown that only cathepsin L, and not cathepsin B or calpain, is involved in SARS-CoV-2 endocytosis entry.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Treatment of HEK 293/hACE2 cells with the cathepsin L-selective inhibitor SID26681509 reduced the entry of SARS-CoV-2 pseudovirus by more than 76%, underscoring the potential role of cathepsin L for priming of SARS-CoV-2 S protein in the lysosome.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Previously, the cathepsin L inhibitor named SSAA09E1 was revealed as a novel antiviral agent for SARS-CoV infection (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical probes targeting cathepsin L with inhibitory activity against SARS-CoV-2 and SARS-CoV infection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Cathepsin L inhibitors may be therapeutic options for COVID-19 also because they can prevent the progression of pulmonary fibrosis.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Furthermore, a synergistic effect may be also achieved by targeting simultaneously cathepsin L and TMPRSS2.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> The main challenge for the design of specific cathepsin inhibitors is to obtain selectivity. In this sense, several computational methods have been developed to solve this problem using information from the known 3D structures.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Several crystallographic structures of human cathepsin L are available both in the apo form (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AXL">4AXL</a>)<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> and in complex with different nitrile molecules (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJC">2YJC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJB">2YJB</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ9">2YJ9</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ8">2YJ8</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ2">2YJ2</a>)<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> or (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU5">2XU5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU4">2XU4</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU3">2XU3</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU1">2XU1</a>).<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">3.5.  Adaptor-Associated Kinase 1 (AAK1) and Cyclin G-Associated Kinase (GAK)</h3><div class="NLM_p">As already explained, the main entry pathway for SARS-CoVs is receptor-mediated endocytosis. AAK1 and GAK are host serine–threonine protein kinases that regulate intracellular viral trafficking during entry, assembly, and release of multiple unrelated RNA viruses such as rabies, Ebola, dengue, or hepatitis C virus.<a onclick="showRef(event, 'ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref150 ref151">(150,151)</a> AAK1 plays a key role in receptor-mediated endocytosis by specific phosphorylation of adaptor protein 2, which stimulates the binding to cargo proteins. GAK shares some biological functions with AAK1, being a key player in clathrin-mediated trafficking. GAK mediates the binding of clathrin to the plasma membrane and the trans-Golgi network.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><div class="NLM_p">Although several molecules have been synthesized to inhibit AAK1, none of these compounds have been optimized and developed as antiviral agents.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> A rationale for repurposing a combination of the pan-kinase inhibitors sunitinib and erlotinib (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>) based on AAK1 and GAK inhibition has been proposed for treatment of dengue and Ebola patients in future outbreaks. However, these have not been included in current clinical trials until now.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Recently, baricitinib, a potent AAK1 and GAK inhibitor, has been proposed as an effective therapy for COVID-19, reducing the viral entry, although no experimental work has been done to prove its mechanism of action.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Moreover, as this compound targets also the janus kinase (JNK1/2), it may act also to reduce inflammation in these patients, increasing its therapeutic benefit for COVID-19.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> However, some data coming from the clinical trial program used for baricitinib registration in Europe showed that the most significant side effect seen was a small increase in upper respiratory tract infections, which may be not well tolerated by COVID-19 patients.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. AAK1 and GAK inhibitors with therapeutic potential for COVID-19.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Several crystal structures of AAK1 have been reported in complex with different inhibitors, such as the pan-kinase inhibitor K252a (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WSQ">4WSQ</a>),<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> BIBF 1120 (nintedanib) (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TE0">5TE0</a>), and LKB1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L4Q">5L4Q</a>),<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> offering useful tools for rational drug discovery and/or optimization. The GAK 3D structure presents many different conformations when it is bound to nanobodies (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C57">4C57</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C58">4C58</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C59">4C59</a>)<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> or to gefitinib (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y7Z">5Y7Z</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y80">5Y80</a>).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Recently, it has been discovered that AAK1 and GAK share cysteine residues (C193 and C190, respectively) at equivalent positions that may be targeted by covalent inhibition, offering a good opportunity to develop selective covalent inhibitors.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Both structures suggest possibilities for the development of selective AAK1 and GAK inhibitors for viral infections. Nowadays, repurposing marketed drugs or optimizing valuable hits such as 3,5-disubstituted pyrrolo[2,3-<i>b</i>]pyridines as potent AAK1 and GAK inhibitors could be a good strategy to prevent SARS-CoV-2 entry.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">3.6.  Phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve)</h3><div class="NLM_p">In endocytosis, one of the molecules that regulates the dynamic process of endosome maturation is phosphatidylinositol-3,5-bisphosphate (PI(3,5)P2).<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> This phospholipid is synthesized in the late endosome by PIKfyve, an enzyme with lipid and protein kinase activity.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> PIKfyve plays a key role in several trafficking events associated with the endocytic pathway.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Very recently, a significantly reduced entry of SARS-CoV-2 pseudovirus on 293/hACE2 cells was found after the treatment with apilimod (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>), a potent inhibitor of PIKfyve,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> which was previously identified as an inhibitor of production of interleukins IL-12 and IL-23.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> The same effect was also observed with YM201636 (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>), another chemically diverse PIKfyve inhibitor.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Like apilimod, YM201636 also blocks viral entry and infection by other viruses like African swine fever virus or EBOV.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> These data suggest that PIKfyve is a suitable drug target to modulate infection by viruses that enter through endocytosis, including SARS-CoV-2.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> At the moment, the 3D structure of this lipid kinase has not been determined yet.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. PIKfyve inhibitors active on SARS-CoV-2 infection in cell culture.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">3.7.  Two-Pore Channel (TPC2)</h3><div class="NLM_p">Among different channels in the endolysosomal system, the two-pore channels (TPC1–3) regulate the conductance of sodium and calcium ions across cellular membranes.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> They are voltage-gated channels, and TPC2 is one of the major downstream effectors of PI(3,5)P2 opening after its binding with such a phosphoinositide.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> These are involved in the regulation of endolysosomal trafficking and Ebola entry in the host cell.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> The structure of human TPC2 has been reported using cryo-EM, providing useful structural information about the open, closed, and apo forms for TPC2 (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ0">6NQ0</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ2">6NQ2</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ1">6NQ1</a>, respectively).<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> By virtual screening, dopamine receptor antagonists and selective estrogen receptor modulators (SERMs) have been recently identified as blockers of TPC2. Specifically, the dopamine antagonists fluphenazine and pimozide, together with the SERMs raloxifene, clomiphene, and tamoxifen, inhibit EBOV infection in experimental models (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>).<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Clinically used drugs to block TPC2: (A) dopamine antagonists and (B) SERMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It has been recently shown that TPC2 plays a relevant role during SARS-CoV-2 infection, and a decrease of SARS-CoV-2 pseudovirus entry was demonstrated after treatment with tetrandrine, a potent calcium blocker used as a pharmacological tool. Altogether, TPC2 emerges as a druggable host-target for SARS-CoV-2 infection, and repurposing of dopamine antagonist such fluphenazine or SERMs as raloxifene merits being tested in clinical trials for COVID-19.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">4.  Host Immune Response</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Innate immune cells display an effective antiviral response to coronavirus infection. This response is based on detection of viral infection by using pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs). PRRs include C-type lectin-like receptors, Toll-like receptor (TLR), NOD-like receptor (NLR), RIG-I-like receptor (RLR), and free-molecule receptors in the cytoplasm, such as cGAS-STING, IFI16, and so on.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> For RNA viruses such as coronavirus, viral genomic RNA or replication intermediates like double-stranded RNA (dsRNA) are recognized either by the endosomal RNA receptors TLR3 and TLR7 or by the cytosolic RNA sensor RIG-I/MDA5, among others. This recognition induces the activation of several signaling pathways, resulting in inflammation and initiation of cellular immune response. These pathways activate crucial transcription factors including interferon regulatory factor 3 (IRF3), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and AP-1. Consequently, these factors ultimately promote the production of type I interferons (IFN-I), inflammatory cytokines, and chemokines.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">4.1.  Viral Proteins Involved in Innate Immune Modulation</h3><div class="NLM_p">The immune response can be exaggerated, leading to an inordinate inflammatory reaction that causes severe clinical signs of COVID-19. These include pneumonia and lung inflammation, respiratory distress, and a life-threatening cytokine storm and circulatory shock.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Other human CoVs have developed strategies to counteract the immune response, which still need to be deeply studied in SARS-CoV-2.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> SARS-CoV-2 typically reduces IFN-I response and elevates the expression of IL-6 and IL1RA cytokines.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> SARS-CoV and MERS-CoV infections also suppress IFN synthesis,<a onclick="showRef(event, 'ref177 ref178'); return false;" href="javascript:void(0);" class="ref ref177 ref178">(177,178)</a> which determines their virulence.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> In this Perspective, we sum up the main CoVs proteins implicated in innate immune response.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">4.1.1.  Structural Proteins’ Modulation of Immune Response</h4><div class="NLM_p">The SARS-CoV and MERS-CoV M protein binds TRAF3 to block its binding and subsequent nuclear translocation of TANK-binding kinase 1 (TBK1), which blocks IRF3-mediated signaling and inhibits type I IFN production.<a onclick="showRef(event, 'ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref180 ref181">(180,181)</a></div><div class="NLM_p">SARS-CoV N protein also interferes with the function of IRF3.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> The N protein of SARS-CoV targets type I IFN synthesis at early recognition stages of innate immune signaling viral RNA infection.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Potentially, it may also act on other viral RNA recognition strategies of the host. The N protein of SARS-CoV also binds to the SPRY domain of TRIM25 and inhibits TRIM25-dependent RIG-I activation, thereby suppressing its ubiquitination and type I IFN production.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></div><div class="NLM_p">It was also described that purified SARS-CoV S protein induces an inflammatory response, possibly through TLR2 activation.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Finally, the SARS-CoV E protein is a viroporin that aids NLRP3 (NLR family) inflammasome, thereby secreting IL-1β.<a onclick="showRef(event, 'ref32 ref186'); return false;" href="javascript:void(0);" class="ref ref32 ref186">(32,186)</a></div><div class="NLM_p">SARS-CoV-2 viral protein interactions and their role in acting against the immune system response are still unknown. However, the first protein–protein interaction studies have elucidated that N protein could target stress granule protein G3BP1, an essential antiviral protein which is known to induce innate immune response.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Indeed, this interactome identifies that N protein binds stress granule-related factors G3BP1/2, the mTOR repressors LARP1, and the kinases CK2. Stress granule induction depends on dsRNA recognition by a protein kinase R (PKR)-mediated pathway, which induces pro-inflammatory cytokines<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Schematic representation of the main pathways of the innate immune response to HCoV. These pathways lead to the activation of nuclear factor kappa B (NF-kB), AP-1, and interferon (IFN), resulting in the secretion of pro-inflammatory cytokines and interferons and the activation of a cellular immune response. Like most viruses, HCoVs have evolved mechanisms to evade the innate immune response. Most of their proteins have been found to be inhibitory (depicted in red) toward several arms of the innate immune response. Remarkably, SARS-CoV-2 ORF9b and nsp15 activate (in green) the IFN route, while other HCoVs proteins have the opposite effect, leading to destruction of both the cell and the virus. Also, SARS-CoV-2 activates PKR, while MERS—and several other viruses—typically inhibit this enzyme for recovery from ER stress and viral protein synthesis shut-off.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">4.1.2.  Non-structural Proteins’ Regulation of the Immune Response</h4><div class="NLM_p">Nsps and accessory proteins of HCoVs also have important roles in the modulation of innate immunity. SARS-CoV nsp1 affects IFN-dependent signaling,<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> and SARS-CoV PLpro domain (nsp3) protein inhibits IRF3 phosphorylation and nuclear translocation, thereby blocking type I IFN production.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a></div><div class="NLM_p">Apart from its protease activity, SARS-CoV and MERS-CoV PLpro also has de-ubiquitinating activity.<a onclick="showRef(event, 'ref191 ref192'); return false;" href="javascript:void(0);" class="ref ref191 ref192">(191,192)</a> PLpro of SARS-CoV inhibits TLR7 signaling by removing K63-linked ubiquitin chains from TRAF3 and TRAF6.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> A subsequent analysis showed that PLpro of both SARS-CoV and MERS-CoV also recognized another ubiquitin-like modifier, interferon-stimulated gene 15 (ISG15). In those cases, PLpro acts as a de-ISGylating enzyme. This domain downregulates mRNA levels of pro-inflammatory cytokines such as CCL5, IFN-β, and CXCL10.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> Furthermore, it has been identified that the ADP-ribose-1-monophosphatase macrodomain encoded within nsp3 in HCoV-229E and SARS-CoV is responsible for suppressing IFN induction.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a></div><div class="NLM_p">The SARS-unique domain encoded in nsp3 of SARS-CoV can also enhance a cellular E3 ubiquitin ligase called ring-finger and RCHY1, which leads to proteasomal degradation of p53.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a></div><div class="NLM_p">Endonuclease U (EndoU) domain is encoded in nsp15, and it is an important component of CoVs RTC. EndoU activity prevents dsDNA recognition by PPRs such as MAD5, thereby evading early innate immune response.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> CoVs also encode ribonucleases that counteract dsRNA antiviral response. This is the case of the exoribonuclease domain of nsp14, which modulates dsRNA levels and innate immune sensing.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div><div class="NLM_p">Despite being dispensable in viral replication, HCoV accessory proteins get involved in processes such as cell proliferation, apoptosis, and interferon signaling.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> SARS-CoV, ORF3b, and ORF6 are shown to interfere with IFN-β synthesis and IFN signaling by preventing IFN-β-induced activation of interferon-stimulated response element (ISRE), found in the promoter region of ISG.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> SARS-CoV ORF3a induces TRAF3-mediated ubiquitination of apoptosis-associated speck-like protein containing a caspase recruitment domain, which activates NLRP3 inflammasome and NF-κB pathway.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> The SARS-CoV ORF6 protein was shown to interact with nuclear pores and blocks p-STAT1 import into the nucleus, reducing innate immune responses and increasing pathogenesis.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> The accessory proteins of MERS-CoV, ORF4a, ORF4b, and ORF5, could similarly suppress IRF3 nuclear translocation,<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> while P4a suppresses PKR-dependent stress response, an additional antiviral response.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> Moreover, SARS-CoV ORF9b might also hijack a ubiquitin E3 ligase called AIP4 to trigger the degradation of MAVS, TRAF3, and TRAF6, thereby significantly suppressing IFN responses.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> Indeed, SARS-CoV accessory protein P6 interacts with the IFN-signaling pathway-mediating protein Nmi and promotes its ubiquitin-dependent proteasomal degradation, thereby potentially modulating the virus-induced innate immune response.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a></div><div class="NLM_p last">SARS-CoV-2 protein–protein interaction maps have shown so far that nsp5 (3CLpro) could interact with the epigenetic regulator histone deacetylase 2 (HDAC2).<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> A previous study demonstrated that HDAC2 mediates inflammation and interferon response.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> The same study showed that nsp13 interacts with two elements of the IFN signaling pathway, TBK1 and TBK1-binding protein 1 (TBKBP1), modulating the NF-κB inflammatory response. E3 ubiquitin ligase RNF41/Nrdp1 is targeted by nsp15 protein, which would increase type I interferon production.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Two other E3 ubiquitin ligases, TRIM59 and MIB1, regulate antiviral innate immune signaling and are hijacked by ORF3a and nsp9.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> ORF9c protein was found to modulate IκB kinase and NF-kB signaling pathway, and ORF9b interacts with a mitochondrial import receptor, Tom70, a linker between MAVS and TBK1/IRF3, inducing IRF-3 activation<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). Nsp3, ORF3b, and ORF6 of SARS-CoV-2—with less homology with SARS-CoV proteins—could induce IFN-I sensitivity.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> However, it has been described that truncated ORF3b of SARS-CoV-2 acts as an IFN antagonist more efficiently than does that of SARS-CoV.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> These studies at the cellular level await further clinical or animal model investigations before the role of the immune response in this disease can be fully understand.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.2.  Therapeutic Targeting of the Innate Immune Response</h3><div class="NLM_p">It has been known that a cytokine storm results from an overreaction of the immune system in SARS and MERS patients.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> Clinical findings showed exuberant inflammatory responses during SARS-CoV-2 infection, further resulting in uncontrolled pulmonary inflammation, likely leading to fatality. The repurposing of host-based therapeutics to control the immune response may counterattack COVID-19.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a></div><div class="NLM_p">Some of these treatments include the use of recombinant IFN-α and IFN-β as antiviral cytokines that inhibit viral replication in targeted cells. Some studies have reported that IFN-β alone has more effect against SARS-CoV-2 than IFN-α <i>in vitro</i>. In fact, combinations of IFN-α and IFN-β with other antivirals such as ribavirin (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) and/or lopinavir/ritonavir (HIV treatment) (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) have a synergistic effect <i>in vitro</i><a onclick="showRef(event, 'ref212 ref213'); return false;" href="javascript:void(0);" class="ref ref212 ref213">(212,213)</a> and in animal models.<a onclick="showRef(event, 'ref214 ref215'); return false;" href="javascript:void(0);" class="ref ref214 ref215">(214,215)</a> Recent results from an open-label, randomized, phase 2 trial (NCT04276688) conducted in China proved that the triple therapy (IFN/β-lopinavir/ritonavir) is safe and more effective than lopinavir/ritonavir alone in alleviating symptoms and shortening the duration of viral shedding in mild to moderate COVID-19 cases.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a><i>In vitro</i> and <i>in vivo</i> studies show the protective effect of Type III IFN (IFN-γ) treatment against SARS-CoV infection<a onclick="showRef(event, 'ref217 ref218'); return false;" href="javascript:void(0);" class="ref ref217 ref218">(217,218)</a> that possibly, in combination with IFN-I, could be an effective treatment for SARS-CoV-2.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Potential immunosuppression treatments: (A) antiviral used in combination with IFNα and IFNβ, (B) JAK inhibitors, and (C) HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A recent study showed the potential benefits from low-dose corticosteroids treatment in SARS-CoV-2 critically ill patients.<a onclick="showRef(event, 'ref219 ref220'); return false;" href="javascript:void(0);" class="ref ref219 ref220">(219,220)</a> Another immunosuppressor, tocilizumab, a humanized monoclonal antibody against the interleukin IL-6 receptor, reduces pro-inflammatory response in COVID-19 patients.<a onclick="showRef(event, 'ref221'); return false;" href="javascript:void(0);" class="ref ref221">(221)</a> Immunosuppressor treatments successfully used against other viruses could be also used for COVID-19. These would include JAK inhibitors such as tofacitinib, baricitinib, and the recently approved upadacitinib (previously used in rheumatoid arthritis),<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a> blinatumomab,<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a> and HDAC inhibitors, such as vorinostat or belinostat (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>B,C).<a onclick="showRef(event, 'ref224'); return false;" href="javascript:void(0);" class="ref ref224">(224)</a> Baricitinib (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>), as mentioned before, is also a potent inhibitor of AAK1 and may also lead to a decrease in viral infectivity, making it a good candidate for clinical trials of COVID-19.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></div><div class="NLM_p">Another therapy that could control SARS-Cov-2 would be polyinosinic:polycytidylic acid (poly(I:C)), which is a synthetic analogue of dsRNA that induces type I IFN and decreases MERS-CoV load in BALB/c.<a onclick="showRef(event, 'ref225'); return false;" href="javascript:void(0);" class="ref ref225">(225)</a></div><div class="NLM_p">Nitazoxanide is another potent type I IFN inducer that has been used in humans as an antiparasitic agent (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>). It is a synthetic nitrothiazolyl–salicylamide derivative that exhibits broad-spectrum antiviral activities against both RNA and DNA viruses.<a onclick="showRef(event, 'ref226'); return false;" href="javascript:void(0);" class="ref ref226">(226)</a> It is effective in the treatment of HCV and IFV-A and -B infection, currently in Phase II and Phase III clinical studies,<a onclick="showRef(event, 'ref227 ref228'); return false;" href="javascript:void(0);" class="ref ref227 ref228">(227,228)</a> and could be also tested in SARS-CoV-2 infection. This drug could inhibit expression of the viral N protein and pro-inflammatory cytokines (IL-6) in MERS-CoV-infected mice.<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Anti-IFV-A agents with potential therapeutic effects on SARS-CoV-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other IFV antivirals could be useful in SARS-CoV-2 therapeutic treatments. Glycyrrhizin (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) is an antioxidant, anti-inflammatory, immunomodulatory, and antiviral agent<a onclick="showRef(event, 'ref230 ref231'); return false;" href="javascript:void(0);" class="ref ref230 ref231">(230,231)</a> that inhibits IFV-A infection through inhibiting pro-inflammatory gene expression.<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a> Glycyrrhizin can suppress SARS-CoV infection at the early virus entry and the late replication stages in Vero E6 cells.<a onclick="showRef(event, 'ref233'); return false;" href="javascript:void(0);" class="ref ref233">(233)</a> 14-Deoxy-11,12- dehydroandrographolide suppresses pro-inflammatory cytokines and chemokines as well as IFV-A replication.<a onclick="showRef(event, 'ref234'); return false;" href="javascript:void(0);" class="ref ref234">(234)</a> NSC61610 (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) induces lanthionine synthetase C-like 2 (LANCL2), a therapeutic target for treating infectious diseases such as IFV-A infection.<a onclick="showRef(event, 'ref235'); return false;" href="javascript:void(0);" class="ref ref235">(235)</a> The <i>Ligustrum purpurascens</i> extract phenylethanoid glycoside (LPG) induces IFN-γ, which can inhibit IFV-A replication <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref236'); return false;" href="javascript:void(0);" class="ref ref236">(236)</a> Some of these agents could be considered in clinical trials for treating COVID-19, although adverse effects need to be deeply studied.<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a></div><div class="NLM_p last">Other strategies attempting to control host immune response in HCoV include cyclophilin-targeting drugs such as cyclosporin A and alispovir. SARS-CoV-2 uses not only ACE2 receptor for cell entry but also CD147, as described for SARS-CoV.<a onclick="showRef(event, 'ref238 ref239'); return false;" href="javascript:void(0);" class="ref ref238 ref239">(238,239)</a> CD147 receptor regulates cytokine secretion and chemotaxis of inflammatory cells through cyclophilin A and cyclophilin B. Another group of drugs with potential applications are other kinase inhibitors used in cancer treatment, e.g., imatinib mesylate, dasatimib, trametinib, saracatinib, etc.<a onclick="showRef(event, 'ref240 ref241'); return false;" href="javascript:void(0);" class="ref ref240 ref241">(240,241)</a> or the immunosuppressor mycophenolic acid.<a onclick="showRef(event, 'ref242'); return false;" href="javascript:void(0);" class="ref ref242">(242)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">5.  Therapeutic Options in Clinical Trials for COVID-19</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Antiviral lopinavir/ritonavir (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) has been recommended for clinical treatment for COVID-19. Recent results from clinical trials do not confirm any benefit in hospitalized adult patients with severe COVID-19,<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> but the combination of these two antivirals with interferon, as previously mentioned, is more promising.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a></div><div class="NLM_p">Remdesivir (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) is an adenosine analogue RdRp inhibitor with antiviral protection against SARS-CoV-2<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> and other viruses.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> In addition, intravenous administration has been found to be efficacious in an American patient with COVID-19.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> Based on these results, Gilead Company provided the compound to China to perform the first clinical trials in SARS-CoV-2-infected individuals (Clinical trials NCT04257654/6). As it has been mentioned before, the FDA has approved the emergency use of this drug for COVID-19 patients with severe symptoms.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><div class="NLM_p">Arbidol (umifenovir) is able to block viral fusion against IFVs. The antiviral activity of umifenovir against SARS-CoV-2 has been confirmed <i>in vitro</i>.<a onclick="showRef(event, 'ref245'); return false;" href="javascript:void(0);" class="ref ref245">(245)</a> The first clinical data from patients with laboratory-confirmed COVID-19 points to a superior efficacy of umifenovir monotherapy over lopinavir/ritonavit treatment.<a onclick="showRef(event, 'ref246'); return false;" href="javascript:void(0);" class="ref ref246">(246)</a> Also, other drugs used for influenza, such as Avigan (favipiravir) (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) and Tamiflu (oseltamivir), have been used in COVID-19 patients (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>).</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Antivirals used in clinics as potential COVID-19 treatments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Importantly, in this pandemic, clinical trials have been started from the beginning (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The clinical management of the critically ill COVID-19 patient includes not only compounds targeting the viral replication but also therapeutic compounds seeking to modulate the immune dysregulation and the inflammatory storm that cause severe disease and frequent fatalities. Interestingly, some compounds have been shown to control hyper-activated immune response, and simultaneously, they are able to inhibit viral replication to some extent. Antiviral therapeutic options under clinical trials could be classified as follows:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(a)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Antivirals against viral components: EBOV viral polymerase inhibitor remdesivir (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>),<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> developed for EBOV, IFV antiviral favipiravir (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>),<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> and others developed for HIV or HCV, such as lopinavir/ritonavir (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), capable of inhibiting 3CLpro.</p></td></tr><tr class="li1"><td valign="top">(b)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Antivirals developed against host targets: viral endocytosis inhibitors such as chloroquine and hydroxychloroquine (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>), which are drugs for malaria that decrease endosomal acidity, i.e., kinase inhibitors.</p></td></tr><tr class="li1"><td valign="top">(c)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Anti-inflammatory drugs, corticosteroids, or immunosuppressors.</p></td></tr></table></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Approved drugs in clinical trials for COVID-19: (A) inhibitors of viral RNA polymerase, (B) antipsychotics effective in clathrin-mediated endocytosis, and (C) miscellaneous drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Drugs Currently Used in Clinical Trials<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">antiviral treatment</th><th class="colsep0 rowsep0" align="center">use</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">RNA polymerase</td><td class="colsep0 rowsep0" align="left">remdesivir*</td><td class="colsep0 rowsep0" align="left">Ebola virus (EBOV)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">favipiravir, ribavirin, oseltamivir, galidesivir, sofosbuvir, umifenovir</td><td class="colsep0 rowsep0" align="left">influenza virus (IFV), hepatitis C virus (HCV), human immunodeficiency virus (HIV)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3CL protease</td><td class="colsep0 rowsep0" align="left">lopinavir/ritonavir*, ivermectin</td><td class="colsep0 rowsep0" align="left">HIV</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PL protease</td><td class="colsep0 rowsep0" align="left">disulfiram</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein S</td><td class="colsep0 rowsep0" align="left">griffithsin</td><td class="colsep0 rowsep0" align="left">HIV transmission</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"><i>Inhibition of Virus Entry</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inhibition of TMPRSS2</td><td class="colsep0 rowsep0" align="left">camostat mesylate, nafamostat, bromhexine, enzatulamide</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inhibition of endocytosis</td><td class="colsep0 rowsep0" align="left">chlorpromazine, fluphenacine</td><td class="colsep0 rowsep0" align="left">other uses</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">acidification of endosome</td><td class="colsep0 rowsep0" align="left">chloroquine/hydroxychloroquine</td><td class="colsep0 rowsep0" align="left">malaria</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inhibition of entry</td><td class="colsep0 rowsep0" align="left">convalescent plasma</td><td class="colsep0 rowsep0" align="left">antibodies</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinase inhibitors</td><td class="colsep0 rowsep0" align="left">imatinib, baricitinib</td><td class="colsep0 rowsep0" align="left">antitumor agents</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"><i>Immune Response Control</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left">anti-inflammatory drugs</td><td class="colsep0 rowsep0" align="left">corticosteroids</td><td class="colsep0 rowsep0" align="left">inflammatory response</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">interferons*</td><td class="colsep0 rowsep0" align="left">HCV</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nitazoxanide, mycophenolic acid</td><td class="colsep0 rowsep0" align="left">interferon induction or synergy</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tocilizumab</td><td class="colsep0 rowsep0" align="left">IL6 antagonist</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cyclosporin/alispovir</td><td class="colsep0 rowsep0" align="left">immune suppressors</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Miscellaneous</i></td><td class="colsep0 rowsep0" align="left">resveratrol, loperamide, losartan, telmisartan, etc.</td><td class="colsep0 rowsep0" align="left">control organ damage</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">The WHO clinical trial Solidarity compares treatment strategies with several compounds, marked with asterisks.</p></div></div></div><div class="NLM_p last">A therapeutic combination (including a and c) has been selected for a randomized large clinical trial launched by WHO, called Solidarity, to collect clinical data from several thousand patients from dozens of countries.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Other antivirals used against viral RNA polymerase include ribavirin (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>)<a onclick="showRef(event, 'ref214 ref247'); return false;" href="javascript:void(0);" class="ref ref214 ref247">(214,247)</a> and galidesivir (BCX4430) (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>).<a onclick="showRef(event, 'ref248'); return false;" href="javascript:void(0);" class="ref ref248">(248)</a> Others are selected on the basis of their protease inhibition activity, such as disulfiram (a PLpro inhibitor)<a onclick="showRef(event, 'ref249'); return false;" href="javascript:void(0);" class="ref ref249">(249)</a> or camostat mesylate (a TMPRSS inhibitor) (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>),<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> or their spike protein inhibition, such as griffithsin.<a onclick="showRef(event, 'ref250'); return false;" href="javascript:void(0);" class="ref ref250">(250)</a> Some other antivirals used are clathrin-mediated endocytosis inhibitors. This is the case of chlorpromazine (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>) and fluphenazine (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>), dopamine inhibitors which are FDA-approved drugs,<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> and miscellaneous compounds (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>) such as resveratrol,<a onclick="showRef(event, 'ref251'); return false;" href="javascript:void(0);" class="ref ref251">(251)</a> gemcitabine, mefloquine,<a onclick="showRef(event, 'ref240'); return false;" href="javascript:void(0);" class="ref ref240">(240)</a> and loperamide.<a onclick="showRef(event, 'ref252'); return false;" href="javascript:void(0);" class="ref ref252">(252)</a> Losartan and, more recently, telmisartan have been used as ACE2 receptor inhibitors. Furthermore, ivermectin has recently shown SARS-CoV-2 inhibition <i>in vitro</i>.<a onclick="showRef(event, 'ref253'); return false;" href="javascript:void(0);" class="ref ref253">(253)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">6.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As mentioned in the <a class="ref internalNav" href="#sec1" aria-label="Introduction">Introduction</a>, a deep knowledge of the life cycle of SARS-CoV-2 is essential to identify druggable targets that will allow the development of effective therapeutics against this coronavirus. Through the journey across the life cycle of the virus presented in this Perspective, we have considered several virus-based and host-based targets as objectives for pharmacological intervention as well as the host immune response. Among the virus-based targets, the importance of the structural spike (S) protein is remarkable due to its key role in SARS-CoV-2 entry through the interaction with the host receptor ACE2. We have also reviewed structural druggable sites and determinants of antibodies’ efficacy against S protein. This coronavirus has 16 nsps. Of special relevance for virus replication, and thus relevant as drug targets, are the two proteases (3CLpro and PLpro), the RNA-dependent RNA polymerase (RdRp), and the helicase. Those are highly conserved proteins and represent suitable targets for the development of pan-coronavirus antivirals. Study of the molecular basis of virus entry pointed to key cellular proteins involved in this process. This is the case of the already mentioned host receptor ACE2, host proteases like TMPRSS2, furin, or cathepsin L, or kinases that are implicated in the regulation of intracellular viral trafficking during endocytic entry, such AAK1, GAK, or PIKfyve. TPC2 is also an important host channel involved in the regulation of endolysosomal trafficking. Host immune modulation has proven to be a useful alternative for the clinical management of viral diseases lacking specific treatment. Moreover, targeting human proteins is an excellent alternative to avoid viral scape by mutation. Another promising alternative could be the combination of antiviral drugs acting through different targets in a multi-target strategy that has proven to increase efficacy and overall prevent viral resistance.</div><div class="NLM_p">Given the urgency of the COVID-19 pandemic, the repurposing of approved drugs is the only alternative to find a timely effective treatment.<a onclick="showRef(event, 'ref254'); return false;" href="javascript:void(0);" class="ref ref254">(254)</a> In fact, drugs currently under clinical trials were initially approved for other indications. However, the past and present coronavirus outbreaks require our preparedness not only for the current situation but also for a future potential re-emergence of novel coronaviruses. In this sense, it is of utmost importance to design drugs acting as pan-coronavirus antivirals or through a multi-target approach to avoid a lack of effectiveness by viral mutation escape.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Addendum (May 29, 2020)</h3><div class="NLM_p">Since the submission of this manuscript, the number of tridimensional structures determined for different SARS-CoV-2 proteins available in the PDB has been increasing dramatically. On average, in February 2020, a total of 4 structures were found deposited in the PDB, increasing by 99 in March, by 45 in April, and by 65 in May. As of late May 2020, a total of 214 structures were available in the PDB, although some of them have not yet been published (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00606/suppl_file/jm0c00606_si_001.pdf" class="ext-link">Table S1</a>). Different experimental techniques in addition to X-ray diffraction have been used, including electron microscopy and NMR, and the structure of the SARS-CoV-2 main protease has been the most studied, with more than 136 different crystals deposited. This huge data explosion confirms the relevance of proteomic data in relation with the pandemic.</div><div class="NLM_p last">As the number of PDB structures, as well as the compounds with potential antiviral action against SARS-CoV-2 being studied, will increase sharply in the next months, essential Web resources have been made available where the COVID-19 information that may be of utmost importance for medicinal chemists is continuously updated. These Web sites are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00606/suppl_file/jm0c00606_si_001.pdf" class="ext-link">Table S2</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00606" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00606?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00606</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">3D structures available (PDB) of SARS-CoV-2 proteins (Table S1); Web resources for COVID-19 drug discovery (Table S2) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00606/suppl_file/jm0c00606_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00606/suppl_file/jm0c00606_si_001.pdf">jm0c00606_si_001.pdf (96.38 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00606" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Gil</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3882-6081" title="Orcid link">http://orcid.org/0000-0002-3882-6081</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#670406150a020949000e0b2704140e04490214"><span class="__cf_email__" data-cfemail="8deeecffe0e8e3a3eae4e1cdeefee4eea3e8fe">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Martinez</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2707-8110" title="Orcid link">http://orcid.org/0000-0002-2707-8110</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#89e8e7e8a7e4e8fbfde0e7ecf3c9eafae0eaa7ecfa"><span class="__cf_email__" data-cfemail="294847480744485b5d40474c53694a5a404a074c5a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tiziana Ginex</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5739-8713" title="Orcid link">http://orcid.org/0000-0002-5739-8713</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Inés Maestro</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5026-5803" title="Orcid link">http://orcid.org/0000-0002-5026-5803</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanesa Nozal</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5260-5683" title="Orcid link">http://orcid.org/0000-0001-5260-5683</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucía Barrado-Gil</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1053-2997" title="Orcid link">http://orcid.org/0000-0002-1053-2997</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miguel Ángel Cuesta-Geijo</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4694-1968" title="Orcid link">http://orcid.org/0000-0003-4694-1968</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesús Urquiza</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Instituto Nacional de
Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra. de la Coruña km 7.5, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7870-4580" title="Orcid link">http://orcid.org/0000-0002-7870-4580</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Ramírez</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Ciencias Biomédicas, Universidad
Autónoma de Chile, Llano Subercaseaux 2801- piso 6, 7500912 Santiago, Chile</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0002-1189" title="Orcid link">http://orcid.org/0000-0003-0002-1189</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Covadonga Alonso</span> - <span class="hlFld-Affiliation affiliation">Department
of Biotechnology, Instituto Nacional de
Investigación y Tecnología Agraria y Alimentaria (INIA), Ctra. de la Coruña km 7.5, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0862-6177" title="Orcid link">http://orcid.org/0000-0002-0862-6177</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nuria E. Campillo</span> - <span class="hlFld-Affiliation affiliation">Centro
de Investigaciones Biológicas Margarita Salas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9948-2665" title="Orcid link">http://orcid.org/0000-0002-9948-2665</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Carmen Gil</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2378-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Carmen Gil</b> received her Ph.D. from Complutense University of Madrid (Spain) in 2001. After a postdoctoral appointment at Bonn University (Germany), she joined the Medicinal Chemistry Institute (IQM-CSIC) in 2004 (first as Associate Researcher and since 2007 as Tenured Scientist). In 2014, she cofounded the spin-off Ankar Pharma. Currently, she is Research Scientist at CIB-CSIC. Her main expertise is in the drug discovery field. With a strong background in medicinal chemistry, her research is applied with a high content of translational research and focuses on those areas that will impact on treatment of human diseases.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Tiziana Ginex</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2383-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tiziana Ginex</b> received her degree in Pharmaceutical Chemistry (CTF) in 2012 and her European Ph.D. in Food Sciences from the University of Parma (Italy) in 2016. From 2016 to 2019, she was a postdoctoral researcher in the Computational Biology and Drug Design group at the University of Barcelona (Spain). Financed by an HPC-Europa3 grant, she was a visiting researcher in the CCBioSim group of the University of Bristol (UK). In 2019, she was awarded a PRACE Preparatory Access (2010PA5217) related to the study of Influenza A. She is currently a postdoctoral researcher in the Translational Medicinal and Biological Chemistry group at CIB-CSIC (Spain). Her area of expertise covers computational methods applied to the study of mechanistic events related to neurodegenerative and infectious diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Inés Maestro</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2388-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Inés Maestro</b> received her bachelor’s degree in Biotechnology in 2014 from the Polytechnic University of Valencia (Spain). She finished her master’s degree in Biomedical Sciences in 2016 from the Catholic University of Leuven (Belgium) and her master’s degree in Clinical Trials Monitoring in 2018 from INESEM Business School. From 2016 until 2018 she worked as an Associate Scientist in Galápagos NV (Belgium). Currently, she is a predoctoral researcher at CIB-CSIC in the Translational Medicinal and Biological Chemistry group, granted with a MSCA fellowship.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Vanesa Nozal</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2393-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Vanesa Nozal</b> received her M.Sc. in Organic Chemistry in 2016 from the Complutense University of Madrid (Spain) and her degree in Chemistry from the University of Valladolid (Spain) in 2015. Currently, she is working on her Ph.D. thesis under the supervision of Prof. Ana Martinez at CIB-CSIC, funded by a FPU fellowship. Her main research interest is the design and synthesis of new drugs for the treatment of unmet diseases.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Lucía Barrado-Gil</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2398-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lucía Barrado-Gil</b> received her degree in Biochemistry in 2012. She received her M.Sc. degree in Molecular Biomedicine in 2013 and her Ph.D. in Molecular Biosciences in 2018 from the Autónoma University of Madrid (Spain). Her field of interest is focused on the study of virus–host interactions and their molecular implications in infection. Currently, she is a postdoctoral researcher at CIB-CSIC in the department of Structural and Chemical Biology.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Miguel Ángel Cuesta-Geijo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2403-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Miguel Ángel Cuesta-Geijo</b> received his M.Sc. in Microbiology and obtained his Ph.D. in Virology in 2013 from the Autónoma University of Madrid (Spain). In 2011 he enjoyed an International Fellowship as part of his Ph.D. student training in the Cell Biology Division at The Netherlands Cancer Institute in Amsterdam (The Netherlands). After a postdoctoral position at King’s College of London (UK), he returned to Spain where currently he is a postdoctoral researcher in Virology at CIB-CSIC.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Jesús Urquiza</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2408-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jesús Urquiza</b> received his Biology degree from the Alcalá de Henares University of Madrid (Spain). He spent 6 months in an internship in Klinikum Rech der Isar, München (Germany), and obtained a Virology Master degree from the Complutense University of Madrid (Spain). Currently, he is a Ph.D. Microbiology student at Autónoma University of Madrid (Spain), under a predoctoral grant at the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) in Madrid. His fields of interest cover virus–host interactions and therapeutic developments thereby.</p></figure></div><div class="bio" rid="ath8"><figure id="ath8" data-index="30" class="article__inlineFigure"><h2 class="fig-label">David Ramírez</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2413-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>David Ramírez</b> received his Ph.D. in Applied Sciences in early 2017 from the Center for Bioinformatics, Simulation and Modelling (CBSM) at the University of Talca (Chile) in the laboratory of Prof. Wendy González. He spent one year of postdoctoral fellowship in the same group. Then, he joined the Laboratory of Prof. José Argüello for one year as a postdoctoral fellow at the Worcester Polytechnic Institute (USA). In early 2019 he was appointed as Assistant Professor at the Biomedical Sciences Institute, Autónoma University (Chile). His research is focused on membrane proteins using both experimental and theoretical approaches, pharmacology, and modulation of ion channels as well as transport mechanisms in plant and bacteria transporters.</p></figure></div><div class="bio" rid="ath9"><figure id="ath9" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Covadonga Alonso</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2418-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Covadonga Alonso</b> received her medical degree with honors from the Complutense University of Madrid (Spain) and obtained her Ph.D. from the Autónoma University of Madrid (Spain). After postdoctoral work in the Microbiology and Molecular Biology Department of the Tufts University School of Medicine in Boston (USA), she became a Staff Researcher at the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) in Madrid. She has been Director of the Biotechnology Department at INIA and recently became Professor of Research at the same institution. She has developed target-based antiviral peptides after the characterization of the interaction between viral proteins and microtubular motor proteins and is cofounder of the biotech company Algenex.</p></figure></div><div class="bio" rid="ath10"><figure id="ath10" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Nuria E. Campillo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2423-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nuria E. Campillo</b> received her Ph.D. from Autónoma University of Madrid in 1997. After a postdoctoral position at Cambridge University (UK), she became an Associate Researcher (2001–2003) at Instituto de Química Médica-CSIC (Madrid, Spain) and Staff Scientist (2003–2014) later. At present, Dr. Campillo works at CIB-CSIC. Her research interests are focused on the design, synthesis, and pharmacological evaluation of new compounds as potential drugs for neurodegenerative disorders and neglected diseases. She is also interested in the use of machine learning and deep learning for the prediction of biological properties (activity, ADMETox).</p></figure></div><div class="bio" rid="ath11"><figure id="ath11" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Ana Martinez</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=BIO-d7e2428-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ana Martinez</b> received her organic chemistry degree and Ph.D. in medicinal chemist from Complutense University (Spain). Since 1990, she is a tenured research staff member of CSIC. She has great experience in technological transfer, being R&D Director of NeuroPharma from 2002 to 2008 and founder of Ankar Pharma in 2014. Currently, she is a research professor at CSIC and head of the Medicinal and Biological Chemistry group at CIB. Her interests are focused on drug discovery and development for severe unmet diseases, having some compounds in clinical trials.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Funding from CSIC (201980E024 and 202020E103) is acknowledged. This research was partially supported through “la Caixa” Banking Foundation (HR18-00469), Instituto de Salud Carlos III (ISCIII-COV20/01007), Spanish Ministry of Science and Innovation (RTI2018-097305-R-I00), CONICYT-PCI (REDES190074 to D.R. and A.M.), and FONDECYT (11180604 to D.R.). I.M. was funded by H2020-MSCA-ITN-2017 (grant no. 765912), V.N. holds a predoctoral FPU grant (FPU16/04466), and J.U. was financed by FPI-SGIT2018-04.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AAK1</td><td class="NLM_def"><p class="first last">adaptor-associated kinase 1</p></td></tr><tr><td class="NLM_term">ACE2</td><td class="NLM_def"><p class="first last">angiotensin-converting enzyme 2</p></td></tr><tr><td class="NLM_term">Ang</td><td class="NLM_def"><p class="first last">angiotensin</p></td></tr><tr><td class="NLM_term">ARDS</td><td class="NLM_def"><p class="first last">acute respiratory distress syndrome</p></td></tr><tr><td class="NLM_term">3CLpro</td><td class="NLM_def"><p class="first last">3C-like protease or main protease</p></td></tr><tr><td class="NLM_term">COVID-19</td><td class="NLM_def"><p class="first last">coronavirus infection disease (2019 pandemia)</p></td></tr><tr><td class="NLM_term">CoV</td><td class="NLM_def"><p class="first last">coronavirus</p></td></tr><tr><td class="NLM_term">E protein</td><td class="NLM_def"><p class="first last">envelope protein</p></td></tr><tr><td class="NLM_term">EBOV</td><td class="NLM_def"><p class="first last">Ebola virus</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">furin-like cleavage site</p></td></tr><tr><td class="NLM_term">GAK</td><td class="NLM_def"><p class="first last">cyclin G-associated kinase</p></td></tr><tr><td class="NLM_term">IFN</td><td class="NLM_def"><p class="first last">interferon</p></td></tr><tr><td class="NLM_term">IRF3</td><td class="NLM_def"><p class="first last">interferon regulatory factor 3</p></td></tr><tr><td class="NLM_term">ISRE</td><td class="NLM_def"><p class="first last">interferon-stimulated response element</p></td></tr><tr><td class="NLM_term">M protein</td><td class="NLM_def"><p class="first last">membrane protein</p></td></tr><tr><td class="NLM_term">MERS-CoV</td><td class="NLM_def"><p class="first last">Middle East respiratory syndrome coronavirus</p></td></tr><tr><td class="NLM_term">N protein</td><td class="NLM_def"><p class="first last">nucleocapsid protein</p></td></tr><tr><td class="NLM_term">nsp</td><td class="NLM_def"><p class="first last">non-structural proteins</p></td></tr><tr><td class="NLM_term">NTD</td><td class="NLM_def"><p class="first last">N-terminal domain</p></td></tr><tr><td class="NLM_term">ORF</td><td class="NLM_def"><p class="first last">open reading frame</p></td></tr><tr><td class="NLM_term">PIKfyve</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-phosphate 5-kinase</p></td></tr><tr><td class="NLM_term">PI(3,5)P2</td><td class="NLM_def"><p class="first last">phosphatidylinositol-3,5-bisphosphate</p></td></tr><tr><td class="NLM_term">PLpro</td><td class="NLM_def"><p class="first last">papain-like protease</p></td></tr><tr><td class="NLM_term">RAS</td><td class="NLM_def"><p class="first last">renin-angiotensin system</p></td></tr><tr><td class="NLM_term">RBD</td><td class="NLM_def"><p class="first last">receptor-binding domain</p></td></tr><tr><td class="NLM_term">RBM</td><td class="NLM_def"><p class="first last">receptor-binding motif</p></td></tr><tr><td class="NLM_term">RdRp</td><td class="NLM_def"><p class="first last">RNA-dependent RNA polymerase</p></td></tr><tr><td class="NLM_term">RTC</td><td class="NLM_def"><p class="first last">replication–transcription complex</p></td></tr><tr><td class="NLM_term">S protein</td><td class="NLM_def"><p class="first last">spike protein</p></td></tr><tr><td class="NLM_term">SARS-CoV-2</td><td class="NLM_def"><p class="first last">severe acute respiratory syndrome coronavirus 2</p></td></tr><tr><td class="NLM_term">SERMs</td><td class="NLM_def"><p class="first last">selective estrogen receptor modulators</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">Toll-like receptor</p></td></tr><tr><td class="NLM_term">TMPRSS2</td><td class="NLM_def"><p class="first last">transmembrane serine protease 2</p></td></tr><tr><td class="NLM_term">TPC2</td><td class="NLM_def"><p class="first last">two-pore channel 2</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 254 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z. L.</span></span> <span> </span><span class="NLM_article-title">A pneumonia outbreak associated with a new coronavirus of probable bat origin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>579</i></span> (<span class="NLM_issue">7798</span>),  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2012-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2012-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32015507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFKlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2020&pages=270-273&issue=7798&author=P.+Zhouauthor=X.+L.+Yangauthor=X.+G.+Wangauthor=B.+Huauthor=L.+Zhangauthor=W.+Zhangauthor=H.+R.+Siauthor=Y.+Zhuauthor=B.+Liauthor=C.+L.+Huangauthor=H.+D.+Chenauthor=J.+Chenauthor=Y.+Luoauthor=H.+Guoauthor=R.+D.+Jiangauthor=M.+Q.+Liuauthor=Y.+Chenauthor=X.+R.+Shenauthor=X.+Wangauthor=X.+S.+Zhengauthor=K.+Zhaoauthor=Q.+J.+Chenauthor=F.+Dengauthor=L.+L.+Liuauthor=B.+Yanauthor=F.+X.+Zhanauthor=Y.+Y.+Wangauthor=G.+F.+Xiaoauthor=Z.+L.+Shi&title=A+pneumonia+outbreak+associated+with+a+new+coronavirus+of+probable+bat+origin&doi=10.1038%2Fs41586-020-2012-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A pneumonia outbreak associated with a new coronavirus of probable bat origin</span></div><div class="casAuthors">Zhou, Peng; Yang, Xing-Lou; Wang, Xian-Guang; Hu, Ben; Zhang, Lei; Zhang, Wei; Si, Hao-Rui; Zhu, Yan; Li, Bei; Huang, Chao-Lin; Chen, Hui-Dong; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai; Chen, Quan-Jiao; Deng, Fei; Liu, Lin-Lin; Yan, Bing; Zhan, Fa-Xian; Wang, Yan-Yi; Xiao, Geng-Fu; Shi, Zheng-Li</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">7798</span>),
    <span class="NLM_cas:pages">270-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large no. of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats1-4.  Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans5-7.  Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China.  The epidemic, which started on 12 Dec. 2019, had caused 2,794 lab.-confirmed infections including 80 deaths by 26 Jan. 2020.  Full-length genome sequences were obtained from five patients at an early stage of the outbreak.  The sequences are almost identical and share 79.6% sequence identity to SARS-CoV.  Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus.  Pairwise protein sequence anal. of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV.  In addn., 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients.  Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV_Wb_iUsbFrVg90H21EOLACvtfcHk0li4ek-uzj7LrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFKlsLg%253D&md5=236f17d4d3c7978d72513e5e0258f1b3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2012-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2012-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DX.%2BL.%26aulast%3DWang%26aufirst%3DX.%2BG.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSi%26aufirst%3DH.%2BR.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%2BL.%26aulast%3DChen%26aufirst%3DH.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DR.%2BD.%26aulast%3DLiu%26aufirst%3DM.%2BQ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DX.%2BS.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DQ.%2BJ.%26aulast%3DDeng%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DL.%2BL.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DZhan%26aufirst%3DF.%2BX.%26aulast%3DWang%26aufirst%3DY.%2BY.%26aulast%3DXiao%26aufirst%3DG.%2BF.%26aulast%3DShi%26aufirst%3DZ.%2BL.%26atitle%3DA%2520pneumonia%2520outbreak%2520associated%2520with%2520a%2520new%2520coronavirus%2520of%2520probable%2520bat%2520origin%26jtitle%3DNature%26date%3D2020%26volume%3D579%26issue%3D7798%26spage%3D270%26epage%3D273%26doi%3D10.1038%2Fs41586-020-2012-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z. L.</span></span> <span> </span><span class="NLM_article-title">Origin and evolution of pathogenic coronaviruses</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1038/s41579-018-0118-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41579-018-0118-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30531947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=181-192&issue=3&author=J.+Cuiauthor=F.+Liauthor=Z.+L.+Shi&title=Origin+and+evolution+of+pathogenic+coronaviruses&doi=10.1038%2Fs41579-018-0118-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Origin and evolution of pathogenic coronaviruses</span></div><div class="casAuthors">Cui, Jie; Li, Fang; Shi, Zheng-Li</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-192</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are two highly transmissible and pathogenic viruses that emerged in humans at the beginning of the 21st century.  Both viruses likely originated in bats, and genetically diverse coronaviruses that are related to SARS-CoV and MERS-CoV were discovered in bats worldwide.  In this Review, we summarize the current knowledge on the origin and evolution of these two pathogenic coronaviruses and discuss their receptor usage; we also highlight the diversity and potential of spillover of bat-borne coronaviruses, as evidenced by the recent spillover of swine acute diarrhoea syndrome coronavirus (SADS-CoV) to pigs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosxL8lhv4N5rVg90H21EOLACvtfcHk0li4ek-uzj7LrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhtbnL&md5=b2b2c40c0cdf30107d8c70f482fc4f63</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fs41579-018-0118-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41579-018-0118-9%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DZ.%2BL.%26atitle%3DOrigin%2520and%2520evolution%2520of%2520pathogenic%2520coronaviruses%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2019%26volume%3D17%26issue%3D3%26spage%3D181%26epage%3D192%26doi%3D10.1038%2Fs41579-018-0118-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stadler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masignani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eickmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrignani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappuoli, R.</span></span> <span> </span><span class="NLM_article-title">SARS--beginning to understand a new virus</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1038/nrmicro775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnrmicro775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15035025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVaqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=209-218&issue=3&author=K.+Stadlerauthor=V.+Masignaniauthor=M.+Eickmannauthor=S.+Beckerauthor=S.+Abrignaniauthor=H.+D.+Klenkauthor=R.+Rappuoli&title=SARS%2D%2Dbeginning+to+understand+a+new+virus&doi=10.1038%2Fnrmicro775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-beginning to understand a new virus</span></div><div class="casAuthors">Stadler, Konrad; Masignani, Vega; Eickmann, Markus; Becker, Stephan; Abrignani, Sergio; Klenk, Hans-Dieter; Rappuoli, Rino</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-218</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The 114-day epidemic of the severe acute respiratory syndrome (SARS) swept 29 countries, affected a report 8,098 people, left 774 patients dead and almost paralyzed the Asian economy.  Aggressive quarantine measures, possibly aided by rising summer temps., successfully terminated the first eruption of SARS and provided at least a temporal break, which allows us to consolidate what we have learned so far and plan for the future.  Here, we review the genomics of the SARS coronavirus (SARS-CoV), its phylogeny, antigenic structure, immune response and potential therapeutic interventions should the SARS epidemic flare up again.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu0Swc3sbe-LVg90H21EOLACvtfcHk0lgRKwfVoLIbXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVaqsb0%253D&md5=07a3280a917df5f1727e964c534f78ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro775%26sid%3Dliteratum%253Aachs%26aulast%3DStadler%26aufirst%3DK.%26aulast%3DMasignani%26aufirst%3DV.%26aulast%3DEickmann%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DAbrignani%26aufirst%3DS.%26aulast%3DKlenk%26aufirst%3DH.%2BD.%26aulast%3DRappuoli%26aufirst%3DR.%26atitle%3DSARS--beginning%2520to%2520understand%2520a%2520new%2520virus%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2003%26volume%3D1%26issue%3D3%26spage%3D209%26epage%3D218%26doi%3D10.1038%2Fnrmicro775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span> <span> </span><span class="NLM_article-title">Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">E60</span>, <span class="refDoi"> DOI: 10.3390/v11010060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv11010060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30646569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlOrtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=E60&issue=1&author=Y.+Zhouauthor=Y.+Yangauthor=J.+Huangauthor=S.+Jiangauthor=L.+Du&title=Advances+in+MERS-CoV+vaccines+and+therapeutics+based+on+the+receptor-binding+domain&doi=10.3390%2Fv11010060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain</span></div><div class="casAuthors">Zhou, Yusen; Yang, Yang; Huang, Jingwei; Jiang, Shibo; Du, Lanying</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is an infectious virus that was first reported in 2012.  The MERS-CoV genome encodes four major structural proteins, among which the spike (S) protein has a key role in viral infection and pathogenesis.  The receptor-binding domain (RBD) of the S protein contains a crit. neutralizing domain and is an important target for development of MERS vaccines and therapeutics.  In this review, we describe the relevant features of the MERS-CoV S-protein RBD, summarize recent advances in the development of MERS-CoV RBD-based vaccines and therapeutic antibodies, and illustrate potential challenges and strategies to further improve their efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7AGx4ZFaf1LVg90H21EOLACvtfcHk0lgRKwfVoLIbXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlOrtL3E&md5=e9fd9f33003eafdc7e71b1b1061a75d8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3390%2Fv11010060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv11010060%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DL.%26atitle%3DAdvances%2520in%2520MERS-CoV%2520vaccines%2520and%2520therapeutics%2520based%2520on%2520the%2520receptor-binding%2520domain%26jtitle%3DViruses%26date%3D2019%26volume%3D11%26issue%3D1%26spage%3DE60%26doi%3D10.3390%2Fv11010060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Z.</span></span> <span> </span><span class="NLM_article-title">A new coronavirus associated with human respiratory disease in China</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>579</i></span> (<span class="NLM_issue">7798</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2008-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2008-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32015508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFKlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2020&pages=265-269&issue=7798&author=F.+Wuauthor=S.+Zhaoauthor=B.+Yuauthor=Y.+M.+Chenauthor=W.+Wangauthor=Z.+G.+Songauthor=Y.+Huauthor=Z.+W.+Taoauthor=J.+H.+Tianauthor=Y.+Y.+Peiauthor=M.+L.+Yuanauthor=Y.+L.+Zhangauthor=F.+H.+Daiauthor=Y.+Liuauthor=Q.+M.+Wangauthor=J.+J.+Zhengauthor=L.+Xuauthor=E.+C.+Holmesauthor=Y.+Z.+Zhang&title=A+new+coronavirus+associated+with+human+respiratory+disease+in+China&doi=10.1038%2Fs41586-020-2008-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A new coronavirus associated with human respiratory disease in China</span></div><div class="casAuthors">Wu, Fan; Zhao, Su; Yu, Bin; Chen, Yan-Mei; Wang, Wen; Song, Zhi-Gang; Hu, Yi; Tao, Zhao-Wu; Tian, Jun-Hua; Pei, Yuan-Yuan; Yuan, Ming-Li; Zhang, Yu-Ling; Dai, Fa-Hui; Liu, Yi; Wang, Qi-Min; Zheng, Jiao-Jiao; Xu, Lin; Holmes, Edward C.; Zhang, Yong-Zhen</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">7798</span>),
    <span class="NLM_cas:pages">265-269</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health.  Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty.  A severe respiratory disease was recently reported in Wuhan, Hubei province, China.  As of 25 Jan. 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 Dec. 2019.  Epidemiol. investigations have suggested that the outbreak was assocd. with a seafood market in Wuhan.  Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 Dec. 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough.  Metagenomic RNA sequencing of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here 'WH-Human 1' coronavirus (and has also been referred to as '2019-nCoV').  Phylogenetic anal. of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China.  This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5h_VHfuDuTbVg90H21EOLACvtfcHk0lhkdLlY9Tb__Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFKlsLc%253D&md5=0163a684829e880a0c3347e19f0ce52a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2008-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2008-3%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%2BM.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DZ.%2BG.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DTao%26aufirst%3DZ.%2BW.%26aulast%3DTian%26aufirst%3DJ.%2BH.%26aulast%3DPei%26aufirst%3DY.%2BY.%26aulast%3DYuan%26aufirst%3DM.%2BL.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DDai%26aufirst%3DF.%2BH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DHolmes%26aufirst%3DE.%2BC.%26aulast%3DZhang%26aufirst%3DY.%2BZ.%26atitle%3DA%2520new%2520coronavirus%2520associated%2520with%2520human%2520respiratory%2520disease%2520in%2520China%26jtitle%3DNature%26date%3D2020%26volume%3D579%26issue%3D7798%26spage%3D265%26epage%3D269%26doi%3D10.1038%2Fs41586-020-2008-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kok, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span> <span> </span><span class="NLM_article-title">Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1080/22221751.2020.1719902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F22221751.2020.1719902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31987001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFOktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=221-236&issue=1&author=J.+F.+Chanauthor=K.+H.+Kokauthor=Z.+Zhuauthor=H.+Chuauthor=K.+K.+Toauthor=S.+Yuanauthor=K.+Y.+Yuen&title=Genomic+characterization+of+the+2019+novel+human-pathogenic+coronavirus+isolated+from+a+patient+with+atypical+pneumonia+after+visiting+Wuhan&doi=10.1080%2F22221751.2020.1719902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</span></div><div class="casAuthors">Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Zhu, Zheng; Chu, Hin; To, Kelvin Kai-Wang; Yuan, Shuofeng; Yuen, Kwok-Yung</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Microbes & Infections</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">221-236</span>CODEN:
                <span class="NLM_cas:coden">EMIMC4</span>;
        ISSN:<span class="NLM_cas:issn">2222-1751</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China.  Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health Organization.  We performed bioinformatics anal. on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes.  Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV.  The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses.  However, the external subdomain of Spike's receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses.  Remarkably, its orf3b encodes a completely novel short protein.  Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet(s) contg. six strands.  Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus.  These findings provide the basis for starting further studies on the pathogenesis, and optimizing the design of diagnostic, antiviral and vaccination strategies for this emerging infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2BxE9eKNpaLVg90H21EOLACvtfcHk0lhkdLlY9Tb__Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFOktLg%253D&md5=1ff0b451da73344406c7485aa5018a45</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F22221751.2020.1719902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F22221751.2020.1719902%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DKok%26aufirst%3DK.%2BH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChu%26aufirst%3DH.%26aulast%3DTo%26aufirst%3DK.%2BK.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26atitle%3DGenomic%2520characterization%2520of%2520the%25202019%2520novel%2520human-pathogenic%2520coronavirus%2520isolated%2520from%2520a%2520patient%2520with%2520atypical%2520pneumonia%2520after%2520visiting%2520Wuhan%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2020%26volume%3D9%26issue%3D1%26spage%3D221%26epage%3D236%26doi%3D10.1080%2F22221751.2020.1719902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. R.</span></span> <span> </span><span class="NLM_article-title">Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1002/cbic.202000047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcbic.202000047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32022370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1ans74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=730-738&issue=5&author=J.+S.+Morseauthor=T.+Lalondeauthor=S.+Xuauthor=W.+R.+Liu&title=Learning+from+the+past%3A+Possible+urgent+prevention+and+treatment+options+for+severe+acute+respiratory+infections+caused+by+2019-nCoV&doi=10.1002%2Fcbic.202000047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV</span></div><div class="casAuthors">Morse, Jared S.; Lalonde, Tyler; Xu, Shiqing; Liu, Wenshe Ray</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  With the current trajectory of the 2019-nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes.  Although little is known about the virus, an examn. of the genome sequence shows strong homol. with its better-studied cousin, SARS-CoV.  The spike protein used for host cell infection shows key nonsynonymous mutations that might hamper the efficacy of previously developed therapeutics but remains a viable target for the development of biologics and macrocyclic peptides.  Other key drug targets, including RNA-dependent RNA polymerase and coronavirus main proteinase (3CLpro), share a strikingly high (>95 %) homol. to SARS-CoV.  Herein, we suggest four potential drug candidates (an ACE2-based peptide, remdesivir, 3CLpro-1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019-nCoV.  We also summarize previous efforts into drugging these targets and hope to help in the development of broad-spectrum anti-coronaviral agents for future epidemics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQKe18V4rt9rVg90H21EOLACvtfcHk0lhkdLlY9Tb__Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1ans74%253D&md5=57c88df2259222d0a25a545493c66630</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcbic.202000047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.202000047%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DJ.%2BS.%26aulast%3DLalonde%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%2BR.%26atitle%3DLearning%2520from%2520the%2520past%253A%2520Possible%2520urgent%2520prevention%2520and%2520treatment%2520options%2520for%2520severe%2520acute%2520respiratory%2520infections%2520caused%2520by%25202019-nCoV%26jtitle%3DChemBioChem%26date%3D2020%26volume%3D21%26issue%3D5%26spage%3D730%26epage%3D738%26doi%3D10.1002%2Fcbic.202000047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azhar, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span> <span> </span><span class="NLM_article-title">Coronaviruses - drug discovery and therapeutic options</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1038/nrd.2015.37</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnrd.2015.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26868298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVyru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=327-347&issue=5&author=A.+Zumlaauthor=J.+F.+Chanauthor=E.+I.+Azharauthor=D.+S.+Huiauthor=K.+Y.+Yuen&title=Coronaviruses+-+drug+discovery+and+therapeutic+options&doi=10.1038%2Fnrd.2015.37"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Coronaviruses - drug discovery and therapeutic options</span></div><div class="casAuthors">Zumla, Alimuddin; Chan, Jasper F. W.; Azhar, Esam I.; Hui, David S. C.; Yuen, Kwok-Yung</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">327-347</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In humans, infections with the human coronavirus (HCoV) strains HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 usually result in mild, self-limiting upper respiratory tract infections, such as the common cold.  By contrast, the CoVs responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), which were discovered in Hong Kong, China, in 2003, and in Saudi Arabia in 2012, resp., have received global attention over the past 12 years owing to their ability to cause community and health-care-assocd. outbreaks of severe infections in human populations.  These two viruses pose major challenges to clin. management because there are no specific antiviral drugs available.  In this Review, we summarize the epidemiol., virol., clin. features and current treatment strategies of SARS and MERS, and discuss the discovery and development of new virus-based and host-based therapeutic options for CoV infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIRcMBSEE637Vg90H21EOLACvtfcHk0ljwKZx5THdwdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVyru70%253D&md5=437159fc2f3885395268bd6d97e34a0b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2015.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2015.37%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DAzhar%26aufirst%3DE.%2BI.%26aulast%3DHui%26aufirst%3DD.%2BS.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26atitle%3DCoronaviruses%2520-%2520drug%2520discovery%2520and%2520therapeutic%2520options%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26issue%3D5%26spage%3D327%26epage%3D347%26doi%3D10.1038%2Fnrd.2015.37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleine-Weber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erichsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiergens, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitsche, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cell.2020.02.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32142651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktl2qtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=271-280&issue=2&author=M.+Hoffmannauthor=H.+Kleine-Weberauthor=S.+Schroederauthor=N.+Krugerauthor=T.+Herrlerauthor=S.+Erichsenauthor=T.+S.+Schiergensauthor=G.+Herrlerauthor=N.+H.+Wuauthor=A.+Nitscheauthor=M.+A.+Mullerauthor=C.+Drostenauthor=S.+Pohlmann&title=SARS-CoV-2+cell+entry+depends+on+ACE2+and+TMPRSS2+and+is+blocked+by+a+clinically+proven+protease+inhibitor&doi=10.1016%2Fj.cell.2020.02.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</span></div><div class="casAuthors">Hoffmann, Markus; Kleine-Weber, Hannah; Schroeder, Simon; Krueger, Nadine; Herrler, Tanja; Erichsen, Sandra; Schiergens, Tobias S.; Herrler, Georg; Wu, Nai-Huei; Nitsche, Andreas; Mueller, Marcel A.; Drosten, Christian; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-280.e8</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency.  Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases.  Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets.  Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming.  A TMPRSS2 inhibitor approved for clin. use blocked entry and might constitute a treatment option.  Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry.  Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq92X1lVQaLirVg90H21EOLACvtfcHk0ljwKZx5THdwdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktl2qtb8%253D&md5=60aea5c939a2d4df034a91d6198fb3ef</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DKleine-Weber%26aufirst%3DH.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DKruger%26aufirst%3DN.%26aulast%3DHerrler%26aufirst%3DT.%26aulast%3DErichsen%26aufirst%3DS.%26aulast%3DSchiergens%26aufirst%3DT.%2BS.%26aulast%3DHerrler%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DN.%2BH.%26aulast%3DNitsche%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DSARS-CoV-2%2520cell%2520entry%2520depends%2520on%2520ACE2%2520and%2520TMPRSS2%2520and%2520is%2520blocked%2520by%2520a%2520clinically%2520proven%2520protease%2520inhibitor%26jtitle%3DCell%26date%3D2020%26volume%3D181%26issue%3D2%26spage%3D271%26epage%3D280%26doi%3D10.1016%2Fj.cell.2020.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qinfen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinming, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiaojun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huanying, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jicheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunpeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jingqiang, Z.</span></span> <span> </span><span class="NLM_article-title">The life cycle of SARS coronavirus in Vero E6 cells</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1002/jmv.20095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fjmv.20095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15170625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ntFKmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=332-337&issue=3&author=Z.+Qinfenauthor=C.+Jinmingauthor=H.+Xiaojunauthor=Z.+Huanyingauthor=H.+Jichengauthor=F.+Lingauthor=L.+Kunpengauthor=Z.+Jingqiang&title=The+life+cycle+of+SARS+coronavirus+in+Vero+E6+cells&doi=10.1002%2Fjmv.20095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The life cycle of SARS coronavirus in Vero E6 cells</span></div><div class="casAuthors">Qinfen Zhang; Jinming Cui; Xiaojun Huang; Huanying Zheng; Jicheng Huang; Ling Fang; Kunpeng Li; Jingqiang Zhang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">332-7</span>
        ISSN:<span class="NLM_cas:issn">0146-6615</span>.
    </div><div class="casAbstract">The aim of the study was to establish the life cycle of severe acute respiratory syndrome-associated coronavirus (SARS CoV) in host cells and determine the pathogenesis of SARS.  Vero E6 cells (African green monkey kidney cells) were inoculated with SARS coronavirus for 3, 7, 24, 48, and 72 hr, respectively, and were observed under electron microscope.  It was found that the SARS coronavirus entered the cells through membrane fusion instead of endocytosis, and then the nucleocapsids assembled in the RER and matured by budding into the smooth vesicles, which were derived from the Golgi apparatus.  The smooth vesicles fused with the cell membrane, and the mature particles were released.  A special phenomenon was that some virus-like particles appeared in the nucleus.  We propose a scheme of the life cycle of SARS coronavirus and discuss the mechanism of its replication in Vero E6 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQe2FWOfRZpaDdblLE_E9PWfW6udTcc2eajd6xB3QhfR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ntFKmtQ%253D%253D&md5=427a5d7bd75272c572e950e871257e70</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fjmv.20095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.20095%26sid%3Dliteratum%253Aachs%26aulast%3DQinfen%26aufirst%3DZ.%26aulast%3DJinming%26aufirst%3DC.%26aulast%3DXiaojun%26aufirst%3DH.%26aulast%3DHuanying%26aufirst%3DZ.%26aulast%3DJicheng%26aufirst%3DH.%26aulast%3DLing%26aufirst%3DF.%26aulast%3DKunpeng%26aufirst%3DL.%26aulast%3DJingqiang%26aufirst%3DZ.%26atitle%3DThe%2520life%2520cycle%2520of%2520SARS%2520coronavirus%2520in%2520Vero%2520E6%2520cells%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2004%26volume%3D73%26issue%3D3%26spage%3D332%26epage%3D337%26doi%3D10.1002%2Fjmv.20095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, A. E.</span></span> <span> </span><span class="NLM_article-title">Early events of SARS coronavirus infection in Vero cells</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1002/jmv.10499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fjmv.10499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=12966536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BD3svisFKmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2003&pages=323-331&issue=3&author=M.+L.+Ngauthor=S.+H.+Tanauthor=E.+E.+Seeauthor=E.+E.+Ooiauthor=A.+E.+Ling&title=Early+events+of+SARS+coronavirus+infection+in+Vero+cells&doi=10.1002%2Fjmv.10499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Early events of SARS coronavirus infection in vero cells</span></div><div class="casAuthors">Ng M L; Tan S H; See E E; Ooi E E; Ling A E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-31</span>
        ISSN:<span class="NLM_cas:issn">0146-6615</span>.
    </div><div class="casAbstract">An isolate from a patient in the recent severe acute respiratory syndrome (SARS) outbreak in Singapore was used to infect Vero E6 cells.  This study concentrated on the first 30 min of infection.  It was discovered that the SARS coronavirus attached, entered, and uncoated the nucleocapsids, all within a 30-min period.  At 5 min after infection, several virus particles lined the Vero cell plasma membrane.  Virus particles were at various stages of fusion at the cell surface, since entry was not a synchronised process.  After entry (10 and 15 min), spherical core particles moved into the cytoplasm within large vacuoles.  Quite surprising at such early stages of infection (20 min), a virus-induced change in the infected cells was evident.  The induction of myelin-like membrane whorls was obvious within the same vacuoles as the core particles.  The significance of this virus-induced change is unknown at this stage.  By 25-30 min postinfection (p.i.), the spherical core particles appeared to be disassociating and, in their place, doughnut-shaped electron-dense structures were observed.  These could be the virus genomes together with the helical nucleocapsids.  They were no longer in large vacuoles but packaged into smaller vacuoles in the cytoplasm, and occasionally in small groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUMb0kI7yUv7JzI8owOhpDfW6udTcc2eajd6xB3QhfR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svisFKmtQ%253D%253D&md5=042b91742c8e8925e538172f6c8c2f80</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fjmv.10499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.10499%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DM.%2BL.%26aulast%3DTan%26aufirst%3DS.%2BH.%26aulast%3DSee%26aufirst%3DE.%2BE.%26aulast%3DOoi%26aufirst%3DE.%2BE.%26aulast%3DLing%26aufirst%3DA.%2BE.%26atitle%3DEarly%2520events%2520of%2520SARS%2520coronavirus%2520infection%2520in%2520Vero%2520cells%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2003%26volume%3D71%26issue%3D3%26spage%3D323%26epage%3D331%26doi%3D10.1002%2Fjmv.10499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span> <span> </span><span class="NLM_article-title">SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1038/cr.2008.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fcr.2008.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18227861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1OmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=290-301&issue=2&author=H.+Wangauthor=P.+Yangauthor=K.+Liuauthor=F.+Guoauthor=Y.+Zhangauthor=G.+Zhangauthor=C.+Jiang&title=SARS+coronavirus+entry+into+host+cells+through+a+novel+clathrin-+and+caveolae-independent+endocytic+pathway&doi=10.1038%2Fcr.2008.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway</span></div><div class="casAuthors">Wang, Hongliang; Yang, Peng; Liu, Kangtai; Guo, Feng; Zhang, Yanli; Zhang, Gongyi; Jiang, Chengyu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">290-301</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">While severe acute respiratory syndrome coronavirus (SARS-CoV) was initially thought to enter cells through direct fusion with the plasma membrane, more recent evidence suggests that virus entry may also involve endocytosis.  We have found that SARS-CoV enters cells via pH- and receptor-dependent endocytosis.  Treatment of cells with either SARS-CoV spike protein or spike-bearing pseudoviruses resulted in the translocation of angiotensin-converting enzyme 2 (ACE2), the functional receptor of SARS-CoV, from the cell surface to endosomes.  In addn., the spike-bearing pseudoviruses and early endosome antigen 1 were found to colocalize in endosomes.  Further analyses using specific endocytic pathway inhibitors and dominant-neg. Eps15 as well as caveolin-1 colocalization study suggested that virus entry was mediated by a clathrin- and caveolae-independent mechanism.  Moreover, cholesterol- and sphingolipid-rich lipid raft microdomains in the plasma membrane, which have been shown to act as platforms for many physiol. signaling pathways, were shown to be involved in virus entry.  Endocytic entry of SARS-CoV may expand the cellular range of SARS-CoV infection, and our findings here contribute to the understanding of SARS-CoV pathogenesis, providing new information for anti-viral drug research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSu75e3vYMcLVg90H21EOLACvtfcHk0lhjMfH-jl0pbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1OmtLc%253D&md5=28ce193edc17b23d4b4348e1d400501f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fcr.2008.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2008.15%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DC.%26atitle%3DSARS%2520coronavirus%2520entry%2520into%2520host%2520cells%2520through%2520a%2520novel%2520clathrin-%2520and%2520caveolae-independent%2520endocytic%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2008%26volume%3D18%26issue%3D2%26spage%3D290%26epage%3D301%26doi%3D10.1038%2Fcr.2008.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span> <span> </span><span class="NLM_article-title">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span> (<span class="NLM_issue">10223</span>),  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)30183-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2930183-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31986264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1Kqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=497-506&issue=10223&author=C.+Huangauthor=Y.+Wangauthor=X.+Liauthor=L.+Renauthor=J.+Zhaoauthor=Y.+Huauthor=L.+Zhangauthor=G.+Fanauthor=J.+Xuauthor=X.+Guauthor=Z.+Chengauthor=T.+Yuauthor=J.+Xiaauthor=Y.+Weiauthor=W.+Wuauthor=X.+Xieauthor=W.+Yinauthor=H.+Liauthor=M.+Liuauthor=Y.+Xiaoauthor=H.+Gaoauthor=L.+Guoauthor=J.+Xieauthor=G.+Wangauthor=R.+Jiangauthor=Z.+Gaoauthor=Q.+Jinauthor=J.+Wangauthor=B.+Cao&title=Clinical+features+of+patients+infected+with+2019+novel+coronavirus+in+Wuhan%2C+China&doi=10.1016%2FS0140-6736%2820%2930183-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</span></div><div class="casAuthors">Huang, Chaolin; Wang, Yeming; Li, Xingwang; Ren, Lili; Zhao, Jianping; Hu, Yi; Zhang, Li; Fan, Guohui; Xu, Jiuyang; Gu, Xiaoying; Cheng, Zhenshun; Yu, Ting; Xia, Jiaan; Wei, Yuan; Wu, Wenjuan; Xie, Xuelei; Yin, Wen; Li, Hui; Liu, Min; Xiao, Yan; Gao, Hong; Guo, Li; Xie, Jungang; Wang, Guangfa; Jiang, Rongmeng; Gao, Zhancheng; Jin, Qi; Wang, Jianwei; Cao, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10223</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV).  We report the epidemiol., clin., lab., and radiol. characteristics and treatment and clin. outcomes of these patients.  All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan.  We prospectively collected and analyzed data on patients with lab.-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing.  Data were obtained with standardised data collection forms shared by the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records.  Researchers also directly communicated with patients or their families to ascertain epidemiol. and symptom data.  Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not.  By Jan 2, 2020, 41 admitted hospital patients had been identified as having lab.-confirmed 2019-nCoV infection.  Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]).  Median age was 49·0 years (IQR 41·0-58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market.  One family cluster was found.  Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum prodn. (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38).  Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0-13·0]).  26 (63%) Of 41 patients had lymphopenia.  All 41 patients had pneumonia with abnormal findings on chest CT.  Complications included acute respiratory distress syndrome (12 [29%]), RNAemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died.  Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα.  The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was assocd. with ICU admission and high mortality.  Major gaps in our knowledge of the origin, epidemiol., duration of human transmission, and clin. spectrum of disease need fulfilment by future studies.  Ministry of Science and Technol., Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technol. Commission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1VbprmL3SvLVg90H21EOLACvtfcHk0lgPwL8-dYvazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1Kqu7c%253D&md5=b279b965c1054d99e60f673859c03b49</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2930183-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252930183-5%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DB.%26atitle%3DClinical%2520features%2520of%2520patients%2520infected%2520with%25202019%2520novel%2520coronavirus%2520in%2520Wuhan%252C%2520China%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26issue%3D10223%26spage%3D497%26epage%3D506%26doi%3D10.1016%2FS0140-6736%2820%2930183-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span> <span> </span><span class="NLM_article-title">A novel coronavirus from patients with pneumonia in China, 2019</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa2001017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa2001017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31978945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjslGmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2020&pages=727-733&issue=8&author=N.+Zhuauthor=D.+Zhangauthor=W.+Wangauthor=X.+Liauthor=B.+Yangauthor=J.+Songauthor=X.+Zhaoauthor=B.+Huangauthor=W.+Shiauthor=R.+Luauthor=P.+Niuauthor=F.+Zhanauthor=X.+Maauthor=D.+Wangauthor=W.+Xuauthor=G.+Wuauthor=G.+F.+Gaoauthor=W.+Tan&title=A+novel+coronavirus+from+patients+with+pneumonia+in+China%2C+2019&doi=10.1056%2FNEJMoa2001017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A novel coronavirus from patients with pneumonia in China, 2019</span></div><div class="casAuthors">Zhu, Na; Zhang, Dingyu; Wang, Wenling; Li, Xingwang; Yang, Bo; Song, Jingdong; Zhao, Xiang; Huang, Baoying; Shi, Weifeng; Lu, Roujian; Niu, Peihua; Zhan, Faxian; Ma, Xuejun; Wang, Dayan; Xu, Wenbo; Wu, Guizhen; Gao, George F.; Tan, Wenjie</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">727-733</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">In Dec. 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China.  A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia.  Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily.  Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans.  Enhanced surveillance and further investigation are ongoing.  Complete genome sequences of the three novel coronaviruses were submitted to GISAID (BetaCoV/Wuhan/ IVDC-HB-01/2019, accession ID: EPI_ISL_402119; BetaCoV/Wuhan/IVDC-HB-04/2020, accession ID: EPI_ISL_402120; BetaCoV/Wuhan/IVDC-HB-05/2019, accession ID: EPI_ISL_402121).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoibbAn_VqfXbVg90H21EOLACvtfcHk0lgPwL8-dYvazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjslGmsrc%253D&md5=73cc5c839e1e934da69b39537063b7b3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa2001017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa2001017%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DR.%26aulast%3DNiu%26aufirst%3DP.%26aulast%3DZhan%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DG.%2BF.%26aulast%3DTan%26aufirst%3DW.%26atitle%3DA%2520novel%2520coronavirus%2520from%2520patients%2520with%2520pneumonia%2520in%2520China%252C%25202019%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D382%26issue%3D8%26spage%3D727%26epage%3D733%26doi%3D10.1056%2FNEJMoa2001017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Werf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabenau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panning, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burguiere, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinatl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eickmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escriou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grywna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramme, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manuguerra, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickerts, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterhaus, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerr, H. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel coronavirus in patients with severe acute respiratory syndrome</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">1967</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa030747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa030747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=12690091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslajurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1967-1976&issue=20&author=C.+Drostenauthor=S.+Guntherauthor=W.+Preiserauthor=S.+van+der+Werfauthor=H.+R.+Brodtauthor=S.+Beckerauthor=H.+Rabenauauthor=M.+Panningauthor=L.+Kolesnikovaauthor=R.+A.+Fouchierauthor=A.+Bergerauthor=A.+M.+Burguiereauthor=J.+Cinatlauthor=M.+Eickmannauthor=N.+Escriouauthor=K.+Grywnaauthor=S.+Krammeauthor=J.+C.+Manuguerraauthor=S.+Mullerauthor=V.+Rickertsauthor=M.+Sturmerauthor=S.+Viethauthor=H.+D.+Klenkauthor=A.+D.+Osterhausauthor=H.+Schmitzauthor=H.+W.+Doerr&title=Identification+of+a+novel+coronavirus+in+patients+with+severe+acute+respiratory+syndrome&doi=10.1056%2FNEJMoa030747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel coronavirus in patients with severe acute respiratory syndrome</span></div><div class="casAuthors">Drosten, Christian; Guenther, Stephan; Preiser, Wolfgang; van der Werf, Sylvie; Brodt, Hans-Reinhard; Becker, Stephan; Rabenau, Holger; Panning, Marcus; Kolesnikova, Larissa; Fouchier, Ron A. M.; Berger, Annemarie; Burguiere, Ana-Maria; Cinatl, Jindrich; Eickmann, Markus; Escriou, Nicolas; Grywna, Klaus; Kramme, Stefanie; Manuguerra, Jean-Claude; Mueller, Stefanie; Rickerts, Volker; Stuermer, Martin; Vieth, Simon; Klenk, Hans-Dieter; Osterhaus, Albert D. M. E.; Schmitz, Herbert; Doerr, Hans Wilheim</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1967-1976</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The severe acute respiratory syndrome (SARS) has recently been identified as a new clin. entity.  SARS is thought to be caused by an unknown infectious agent.  Clin. specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and mol. techniques.  A novel coronavirus was identified in patients with SARS.  The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a PCR (PCR)-based random-amplification procedure.  Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60% of the nucleotide sequence).  On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established.  Virus was detected in a variety of clin. specimens from patients with SARS but not in controls.  High concns. of viral RNA of up to 100 million mols. per mL were found in sputum.  Viral RNA was also detected at extremely low concns. in plasma during the acute phase and in feces during the late convalescent phase.  Infected patients showed seroconversion on the Vero cells in which the virus was isolated.  The novel coronavirus might have a role in causing SARS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqN8uHpwOG07Vg90H21EOLACvtfcHk0lhqVWNb5qnxuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslajurw%253D&md5=3838a7a01273f688e53dc86088bfa9db</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030747%26sid%3Dliteratum%253Aachs%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DPreiser%26aufirst%3DW.%26aulast%3Dvan%2Bder%2BWerf%26aufirst%3DS.%26aulast%3DBrodt%26aufirst%3DH.%2BR.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DRabenau%26aufirst%3DH.%26aulast%3DPanning%26aufirst%3DM.%26aulast%3DKolesnikova%26aufirst%3DL.%26aulast%3DFouchier%26aufirst%3DR.%2BA.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DBurguiere%26aufirst%3DA.%2BM.%26aulast%3DCinatl%26aufirst%3DJ.%26aulast%3DEickmann%26aufirst%3DM.%26aulast%3DEscriou%26aufirst%3DN.%26aulast%3DGrywna%26aufirst%3DK.%26aulast%3DKramme%26aufirst%3DS.%26aulast%3DManuguerra%26aufirst%3DJ.%2BC.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DRickerts%26aufirst%3DV.%26aulast%3DSturmer%26aufirst%3DM.%26aulast%3DVieth%26aufirst%3DS.%26aulast%3DKlenk%26aufirst%3DH.%2BD.%26aulast%3DOsterhaus%26aufirst%3DA.%2BD.%26aulast%3DSchmitz%26aufirst%3DH.%26aulast%3DDoerr%26aufirst%3DH.%2BW.%26atitle%3DIdentification%2520of%2520a%2520novel%2520coronavirus%2520in%2520patients%2520with%2520severe%2520acute%2520respiratory%2520syndrome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26issue%3D20%26spage%3D1967%26epage%3D1976%26doi%3D10.1056%2FNEJMoa030747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ksiazek, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaki, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peret, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollin, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, A.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paddock, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rota, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRisi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeDuc, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellini, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span> <span> </span><span class="NLM_article-title">A novel coronavirus associated with severe acute respiratory syndrome</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">1953</span>– <span class="NLM_lpage">1966</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa030781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa030781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=12690092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslajtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1953-1966&issue=20&author=T.+G.+Ksiazekauthor=D.+Erdmanauthor=C.+S.+Goldsmithauthor=S.+R.+Zakiauthor=T.+Peretauthor=S.+Emeryauthor=S.+Tongauthor=C.+Urbaniauthor=J.+A.+Comerauthor=W.+Limauthor=P.+E.+Rollinauthor=S.+F.+Dowellauthor=A.-E.+Lingauthor=C.+D.+Humphreyauthor=W.-J.+Shiehauthor=J.+Guarnerauthor=C.+D.+Paddockauthor=P.+Rotaauthor=B.+Fieldsauthor=J.+DeRisiauthor=J.-Y.+Yangauthor=N.+Coxauthor=J.+M.+Hughesauthor=J.+W.+LeDucauthor=W.+J.+Belliniauthor=L.+J.+Anderson&title=A+novel+coronavirus+associated+with+severe+acute+respiratory+syndrome&doi=10.1056%2FNEJMoa030781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel coronavirus associated with severe acute respiratory syndrome</span></div><div class="casAuthors">Ksiazek, Thomas G.; Erdman, Dean; Goldsmith, Cynthia S.; Zaki, Sherif R.; Peret, Teresa; Emery, Shannon; Tong, Suxiang; Urbani, Carlo; Comer, James A.; Lim, Wilina; Rollin, Pierre E.; Dowell, Scott F.; Ling, Ai-Ee; Humphrey, Charles D.; Shieh, Wan-Ju; Guarner, Jeannette; Paddock, Christopher D.; Rota, Paul; Fields, Barry; DeRisi, Joseph; Yang, Jyh-Yuan; Cox, Nancy; Hughes, James M.; LeDuc, James W.; Bellini, William J.; Anderson, Larry J.; Cannon, A. D. L.; Curtis, M.; Farrar, B.; Morgan, L.; Pezzanite, L.; Sanchez, A. J.; Slaughter, K. A.; Stevens, T. L.; Stockton, P. C.; Wagoner, K. D.; Sanchez, A.; Nichol, S.; Vincent, M.; Osborne, J.; Honig, J.; Brickson, B. R.; Holloway, B.; McCaustland, K.; Lingappa, J.; Lowe, L.; Scott, S.; Lu, X.; Villamarzo, Y.; Cook, B.; Chen, Q.; Birge, C.; Shu, B.; Pallansch, M.; Tatti, K. M.; Morken, T.; Smith, C.; Greer, P.; White, E.; McGlothen, T.; Bhatnagar, J.; Patel, M.; Bartlett, J.; Montague, J.; Lee, W.; Packard, M.; Thompson, H. A.; Moen, A.; Fukuda, K.; Uyeki, T.; Harper, S.; Klimov, A.; Lindstrom, S.; Benson, R.; Carlone, G.; Facklam, R.; Fields, P.; Levett, P.; Mayer, L.; Talkington, D.; Thacker, W. L.; Tondella, M. L. C.; Whitney, C.; Robertson, B.; Warnock, D.; Brooks, T.; Schrag, S.; Rosenstein, N.; Arthur, R.; Ganem, D.; Poutanen, S. M.; Chen, T.-J.; Hsiao, C.-H.; Wai-Fu, N. G.; Ho, M.; Keung, T.-K.; Nghiem, K. H.; Nguyen, H. K. L.; Le, M. Q.; Nguyen, H. H. T.; Hoang, L. T.; Vu, T. H.; Vu, H. Q.; Chunsuttiwat, S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1953-1966</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A worldwide outbreak of severe acute respiratory syndrome (SARS) was assocd. with exposures originating from a single ill health care worker from Guangdong Province, China.  We conducted studies to identify the etiol. agent of this outbreak.  We received clin. specimens from patients in 7 countries and tested them, using virus-isolation techniques, electron-microscopical and histol. studies, and mol. and serol. assays, in an attempt to identify a wide range of potential pathogens.  None of the previously described respiratory pathogens were consistently identified.  However, a novel coronavirus was isolated from patients who met the case definition of SARS.  Cytopathol. features were noted in Vero E6 cells inoculated with a throat-swab specimen.  Electron-microscopical examn. revealed ultrastructural features characteristic of coronaviruses.  Immunohistochem. and immunofluorescence staining revealed reactivity with group I coronavirus polyclonal antibodies.  Consensus coronavirus primers designed to amplify a fragment of the polymerase gene by reverse transcription-polymerase chain reaction (RT-PCR) were used to obtain a sequence that clearly identified the isolate as a unique coronavirus only distantly related to previously sequenced coronaviruses.  With specific diagnostic RT-PCR primers the authors identified several identical nucleotide sequences in 12 patients from several locations, a finding consistent with a point-source outbreak.  Indirect fluorescence antibody tests and enzyme-linked immunosorbent assays made with the new isolate were used to demonstrate a virus-specific serol. response.  This virus may never before have circulated in the U.S. population.  Conclusions: A novel coronavirus is assocd. with this outbreak, and the evidence indicates that this virus has an etiol. role in SARS.  Because of the death of Dr. Carlo Urbani, the authors propose that this first isolate be named the Urbani strain of SARS-assocd. coronavirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDbaKH5pboQbVg90H21EOLACvtfcHk0liSpqlxAkq83g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslajtbk%253D&md5=2116912733cd023a05c440dd1e53f174</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030781%26sid%3Dliteratum%253Aachs%26aulast%3DKsiazek%26aufirst%3DT.%2BG.%26aulast%3DErdman%26aufirst%3DD.%26aulast%3DGoldsmith%26aufirst%3DC.%2BS.%26aulast%3DZaki%26aufirst%3DS.%2BR.%26aulast%3DPeret%26aufirst%3DT.%26aulast%3DEmery%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DS.%26aulast%3DUrbani%26aufirst%3DC.%26aulast%3DComer%26aufirst%3DJ.%2BA.%26aulast%3DLim%26aufirst%3DW.%26aulast%3DRollin%26aufirst%3DP.%2BE.%26aulast%3DDowell%26aufirst%3DS.%2BF.%26aulast%3DLing%26aufirst%3DA.-E.%26aulast%3DHumphrey%26aufirst%3DC.%2BD.%26aulast%3DShieh%26aufirst%3DW.-J.%26aulast%3DGuarner%26aufirst%3DJ.%26aulast%3DPaddock%26aufirst%3DC.%2BD.%26aulast%3DRota%26aufirst%3DP.%26aulast%3DFields%26aufirst%3DB.%26aulast%3DDeRisi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.-Y.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DHughes%26aufirst%3DJ.%2BM.%26aulast%3DLeDuc%26aufirst%3DJ.%2BW.%26aulast%3DBellini%26aufirst%3DW.%2BJ.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26atitle%3DA%2520novel%2520coronavirus%2520associated%2520with%2520severe%2520acute%2520respiratory%2520syndrome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26issue%3D20%26spage%3D1953%26epage%3D1966%26doi%3D10.1056%2FNEJMoa030781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaki, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Boheemen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestebroer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterhaus, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchier, R. A.</span></span> <span> </span><span class="NLM_article-title">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1814</span>– <span class="NLM_lpage">1820</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1211721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa1211721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23075143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=1814-1820&issue=19&author=A.+M.+Zakiauthor=S.+van+Boheemenauthor=T.+M.+Bestebroerauthor=A.+D.+Osterhausauthor=R.+A.+Fouchier&title=Isolation+of+a+novel+coronavirus+from+a+man+with+pneumonia+in+Saudi+Arabia&doi=10.1056%2FNEJMoa1211721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</span></div><div class="casAuthors">Zaki, Ali Moh; van Boheemen, Sander; Bestebroer, Theo M.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1814-1820</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A previously unknown coronavirus was isolated from the sputum of a 60-yr-old man who presented with acute pneumonia and subsequent renal failure with a fatal outcome in Saudi Arabia.  The virus (called HCoV-EMC) replicated readily in cell culture, producing cytopathic effects of rounding, detachment, and syncytium formation.  The virus represents a novel betacoronavirus species.  The closest known relatives are bat coronaviruses HKU4 and HKU5.  Here, the clin. data, virus isolation, and mol. identification are presented.  The clin. picture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 2003 and reminds us that animal coronaviruses can cause severe disease in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzvqXZfyam-bVg90H21EOLACvtfcHk0liSpqlxAkq83g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73P&md5=4fc960f8008c5a4b76a08fbdeb224ac8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1211721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1211721%26sid%3Dliteratum%253Aachs%26aulast%3DZaki%26aufirst%3DA.%2BM.%26aulast%3Dvan%2BBoheemen%26aufirst%3DS.%26aulast%3DBestebroer%26aufirst%3DT.%2BM.%26aulast%3DOsterhaus%26aufirst%3DA.%2BD.%26aulast%3DFouchier%26aufirst%3DR.%2BA.%26atitle%3DIsolation%2520of%2520a%2520novel%2520coronavirus%2520from%2520a%2520man%2520with%2520pneumonia%2520in%2520Saudi%2520Arabia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26issue%3D19%26spage%3D1814%26epage%3D1820%26doi%3D10.1056%2FNEJMoa1211721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millet, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, G. R.</span></span> <span> </span><span class="NLM_article-title">Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">15214</span>– <span class="NLM_lpage">15219</span>, <span class="refDoi"> DOI: 10.1073/pnas.1407087111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1407087111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25288733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yhtb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=15214-15219&issue=42&author=J.+K.+Milletauthor=G.+R.+Whittaker&title=Host+cell+entry+of+Middle+East+respiratory+syndrome+coronavirus+after+two-step%2C+furin-mediated+activation+of+the+spike+protein&doi=10.1073%2Fpnas.1407087111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein</span></div><div class="casAuthors">Millet, Jean Kaoru; Whittaker, Gary R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15214-15219</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly identified betacoronavirus causing high morbidity and mortality in humans.  The coronavirus spike (S) protein is the main determinant of viral entry, and although it was previously shown that MERS-CoV S can be activated by various proteases, the details of the mechanisms of proteolytic activation of fusion are still incompletely characterized.  Here, we have uncovered distinctive characteristics of MERS-CoV S.  We identify, by bioinformatics and peptide cleavage assays, two cleavage sites for furin, a ubiquitously expressed protease, which are located at the S1/S2 interface and at the S2' position of the S protein.  We show that although the S1/S2 site is proteolytically processed by furin during protein biosynthesis, the S2' site is cleaved upon viral entry.  MERS-CoV pseudovirion infection was shown to be enhanced by elevated levels of furin expression, and entry could be decreased by furin siRNA silencing.  Enhanced furin activity appeared to partially override the low pH-dependent nature of MERS-CoV entry.  Inhibition of furin activity was shown to decrease MERS-CoV S-mediated entry, as well as infection by the virus.  Overall, we show that MERS-CoV has evolved an unusual two-step furin activation for fusion, suggestive of a role during the process of emergence into the human population.  The ability of MERS-CoV to use furin in this manner, along with other proteases, may explain the polytropic nature of the virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs39E8QqNtEbVg90H21EOLACvtfcHk0ljNgIlV5H53Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yhtb7E&md5=21bea9924d802dd56de1dac9d38bd509</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1407087111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1407087111%26sid%3Dliteratum%253Aachs%26aulast%3DMillet%26aufirst%3DJ.%2BK.%26aulast%3DWhittaker%26aufirst%3DG.%2BR.%26atitle%3DHost%2520cell%2520entry%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520after%2520two-step%252C%2520furin-mediated%2520activation%2520of%2520the%2520spike%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D42%26spage%3D15214%26epage%3D15219%26doi%3D10.1073%2Fpnas.1407087111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habjan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heurich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glowacka, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann-Winkler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">6150</span>– <span class="NLM_lpage">6160</span>, <span class="refDoi"> DOI: 10.1128/JVI.03372-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.03372-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23536651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFaktrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=6150-6160&issue=11&author=S.+Bertramauthor=R.+Dijkmanauthor=M.+Habjanauthor=A.+Heurichauthor=S.+Giererauthor=I.+Glowackaauthor=K.+Welschauthor=M.+Winklerauthor=H.+Schneiderauthor=H.+Hofmann-Winklerauthor=V.+Thielauthor=S.+Pohlmann&title=TMPRSS2+activates+the+human+coronavirus+229E+for+cathepsin-independent+host+cell+entry+and+is+expressed+in+viral+target+cells+in+the+respiratory+epithelium&doi=10.1128%2FJVI.03372-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium</span></div><div class="casAuthors">Bertram, Stephanie; Dijkman, Ronald; Habjan, Matthias; Heurich, Adeline; Gierer, Stefanie; Glowacka, Ilona; Welsch, Kathrin; Winkler, Michael; Schneider, Heike; Hofmann-Winkler, Heike; Thiel, Volker; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6150-6160</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Infection with human coronavirus 229E (HCoV-229E) is assocd. with the common cold and may result in pneumonia in immunocompromised patients.  The viral spike (S) protein is incorporated into the viral envelope and mediates infectious entry of HCoV-229E into host cells, a process that depends on the activation of the S-protein by host cell proteases.  However, the proteases responsible for HCoV-229E activation are incompletely defined.  Here we show that the type II transmembrane serine proteases TMPRSS2 and HAT cleave the HCoV-229E S-protein (229E-S) and augment 229E-S-driven cell-cell fusion, suggesting that TMPRSS2 and HAT can activate 229E-S.  Indeed, engineered expression of TMPRSS2 and HAT rendered 229E-S-driven virus-cell fusion insensitive to an inhibitor of cathepsin L, a protease previously shown to facilitate HCoV-229E infection.  Inhibition of endogenous cathepsin L or TMPRSS2 demonstrated that both proteases can activate 229E-S for entry into cells that are naturally susceptible to infection.  In addn., evidence was obtained that activation by TMPRSS2 rescues 229E-S-dependent cell entry from inhibition by IFITM proteins.  Finally, immunohistochem. revealed that TMPRSS2 is coexpressed with CD13, the HCoV-229E receptor, in human airway epithelial (HAE) cells, and that CD13+ TMPRSS2+ cells are preferentially targeted by HCoV-229E, suggesting that TMPRSS2 can activate HCoV-229E in infected humans.  In sum, our results indicate that HCoV-229E can employ redundant proteolytic pathways to ensure its activation in host cells.  In addn., our observations and previous work suggest that diverse human respiratory viruses are activated by TMPRSS2, which may constitute a target for antiviral intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvA0mnqiPuHbVg90H21EOLACvtfcHk0ljNgIlV5H53Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFaktrbI&md5=5186c4b9b7eb87684c1034a371dec4cb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FJVI.03372-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.03372-12%26sid%3Dliteratum%253Aachs%26aulast%3DBertram%26aufirst%3DS.%26aulast%3DDijkman%26aufirst%3DR.%26aulast%3DHabjan%26aufirst%3DM.%26aulast%3DHeurich%26aufirst%3DA.%26aulast%3DGierer%26aufirst%3DS.%26aulast%3DGlowacka%26aufirst%3DI.%26aulast%3DWelsch%26aufirst%3DK.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DHofmann-Winkler%26aufirst%3DH.%26aulast%3DThiel%26aufirst%3DV.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DTMPRSS2%2520activates%2520the%2520human%2520coronavirus%2520229E%2520for%2520cathepsin-independent%2520host%2520cell%2520entry%2520and%2520is%2520expressed%2520in%2520viral%2520target%2520cells%2520in%2520the%2520respiratory%2520epithelium%26jtitle%3DJ.%2520Virol%26date%3D2013%26volume%3D87%26issue%3D11%26spage%3D6150%26epage%3D6160%26doi%3D10.1128%2FJVI.03372-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glowacka, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavender, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnirss, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehlmeier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemeyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soilleux, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahn, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">13363</span>– <span class="NLM_lpage">13372</span>, <span class="refDoi"> DOI: 10.1128/JVI.05300-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.05300-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21994442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ShsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=13363-13372&issue=24&author=S.+Bertramauthor=I.+Glowackaauthor=M.+A.+Mullerauthor=H.+Lavenderauthor=K.+Gnirssauthor=I.+Nehlmeierauthor=D.+Niemeyerauthor=Y.+Heauthor=G.+Simmonsauthor=C.+Drostenauthor=E.+J.+Soilleuxauthor=O.+Jahnauthor=I.+Steffenauthor=S.+Pohlmann&title=Cleavage+and+activation+of+the+severe+acute+respiratory+syndrome+coronavirus+spike+protein+by+human+airway+trypsin-like+protease&doi=10.1128%2FJVI.05300-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease</span></div><div class="casAuthors">Bertram, Stephanie; Glowacka, Ilona; Mueller, Marcel A.; Lavender, Hayley; Gnirss, Kerstin; Nehlmeier, Inga; Niemeyer, Daniela; He, Yuxian; Simmons, Graham; Drosten, Christian; Soilleux, Elizabeth J.; Jahn, Olaf; Steffen, Imke; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13363-13372</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV) poses a const. threat to human health.  The viral spike protein (SARS-S) mediates host cell entry and is a potential target for antiviral intervention.  Activation of SARS-S by host cell proteases is essential for SARS-CoV infectivity but remains incompletely understood.  Here, we analyzed the role of the type II transmembrane serine proteases (TTSPs) human airway trypsin-like protease (HAT) and transmembrane protease, serine 2 (TMPRSS2), in SARS-S activation.  We found that HAT activates SARS-S in the context of surrogate systems and authentic SARS-CoV infection and is coexpressed with the viral receptor angiotensin-converting enzyme 2 (ACE2) in bronchial epithelial cells and pneumocytes.  HAT cleaved SARS-S at R667, as detd. by mutagenesis and mass spectrometry, and activated SARS-S for cell-cell fusion in cis and trans, while the related pulmonary protease TMPRSS2 cleaved SARS-S at multiple sites and activated SARS-S only in trans.  However, TMPRSS2 but not HAT expression rendered SARS-S-driven virus-cell fusion independent of cathepsin activity, indicating that HAT and TMPRSS2 activate SARS-S differentially.  Collectively, our results show that HAT cleaves and activates SARS-S and might support viral spread in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmFYPWOkvPPbVg90H21EOLACvtfcHk0liNK9yyQFhwjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ShsL7M&md5=116e8f1e5869bf52c95d0ed50e2494e2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FJVI.05300-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.05300-11%26sid%3Dliteratum%253Aachs%26aulast%3DBertram%26aufirst%3DS.%26aulast%3DGlowacka%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DLavender%26aufirst%3DH.%26aulast%3DGnirss%26aufirst%3DK.%26aulast%3DNehlmeier%26aufirst%3DI.%26aulast%3DNiemeyer%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DSimmons%26aufirst%3DG.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DSoilleux%26aufirst%3DE.%2BJ.%26aulast%3DJahn%26aufirst%3DO.%26aulast%3DSteffen%26aufirst%3DI.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DCleavage%2520and%2520activation%2520of%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520spike%2520protein%2520by%2520human%2520airway%2520trypsin-like%2520protease%26jtitle%3DJ.%2520Virol%26date%3D2011%26volume%3D85%26issue%3D24%26spage%3D13363%26epage%3D13372%26doi%3D10.1128%2FJVI.05300-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gierer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaup, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrensch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heurich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer-Kuhl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittmer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Hahn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">5502</span>– <span class="NLM_lpage">5511</span>, <span class="refDoi"> DOI: 10.1128/JVI.00128-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.00128-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23468491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsV2ls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=5502-5511&issue=10&author=S.+Giererauthor=S.+Bertramauthor=F.+Kaupauthor=F.+Wrenschauthor=A.+Heurichauthor=A.+Kramer-Kuhlauthor=K.+Welschauthor=M.+Winklerauthor=B.+Meyerauthor=C.+Drostenauthor=U.+Dittmerauthor=T.+von+Hahnauthor=G.+Simmonsauthor=H.+Hofmannauthor=S.+Pohlmann&title=The+spike+protein+of+the+emerging+betacoronavirus+EMC+uses+a+novel+coronavirus+receptor+for+entry%2C+can+be+activated+by+TMPRSS2%2C+and+is+targeted+by+neutralizing+antibodies&doi=10.1128%2FJVI.00128-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies</span></div><div class="casAuthors">Gierer, Stefanie; Bertram, Stephanie; Kaup, Franziska; Wrensch, Florian; Heurich, Adeline; Kraemer-Kuehl, Annika; Welsch, Kathrin; Winkler, Michael; Meyer, Benjamin; Drosten, Christian; Dittmer, Ulf; von Hahn, Thomas; Simmons, Graham; Hofmann, Heike; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5502-5511</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The novel human coronavirus EMC (hCoV-EMC), which recently emerged in Saudi Arabia, is highly pathogenic and could pose a significant threat to public health.  The elucidation of hCoV-EMC interactions with host cells is crit. to our understanding of the pathogenesis of this virus and to the identification of targets for antiviral intervention.  Here we investigated the viral and cellular determinants governing hCoV-EMC entry into host cells.  We found that the spike protein of hCoV-EMC (EMC-S) is incorporated into lentiviral particles and mediates transduction of human cell lines derived from different organs, including the lungs, kidneys, and colon, as well as primary human macrophages.  Expression of the known coronavirus receptors ACE2, CD13, and CEACAM1 did not facilitate EMC-S-driven transduction, suggesting that hCoV-EMC uses a novel receptor for entry.  Directed protease expression and inhibition analyses revealed that TMPRSS2 and endosomal cathepsins activate EMC-S for virus-cell fusion and constitute potential targets for antiviral intervention.  Finally, EMC-S-driven transduction was abrogated by serum from an hCoV-EMC-infected patient, indicating that EMC-S-specific neutralizing antibodies can be generated in patients.  Collectively, our results indicate that hCoV-EMC uses a novel receptor for protease-activated entry into human cells and might be capable of extrapulmonary spread.  In addn., they define TMPRSS2 and cathepsins B and L as potential targets for intervention and suggest that neutralizing antibodies contribute to the control of hCoV-EMC infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsCFRLU_b5rrVg90H21EOLACvtfcHk0liNK9yyQFhwjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsV2ls7Y%253D&md5=8cc463c255b68c3d41c7cbea7b49607a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FJVI.00128-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00128-13%26sid%3Dliteratum%253Aachs%26aulast%3DGierer%26aufirst%3DS.%26aulast%3DBertram%26aufirst%3DS.%26aulast%3DKaup%26aufirst%3DF.%26aulast%3DWrensch%26aufirst%3DF.%26aulast%3DHeurich%26aufirst%3DA.%26aulast%3DKramer-Kuhl%26aufirst%3DA.%26aulast%3DWelsch%26aufirst%3DK.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DDittmer%26aufirst%3DU.%26aulast%3Dvon%2BHahn%26aufirst%3DT.%26aulast%3DSimmons%26aufirst%3DG.%26aulast%3DHofmann%26aufirst%3DH.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DThe%2520spike%2520protein%2520of%2520the%2520emerging%2520betacoronavirus%2520EMC%2520uses%2520a%2520novel%2520coronavirus%2520receptor%2520for%2520entry%252C%2520can%2520be%2520activated%2520by%2520TMPRSS2%252C%2520and%2520is%2520targeted%2520by%2520neutralizing%2520antibodies%26jtitle%3DJ.%2520Virol%26date%3D2013%26volume%3D87%26issue%3D10%26spage%3D5502%26epage%3D5511%26doi%3D10.1128%2FJVI.00128-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuyama, S.</span></span> <span> </span><span class="NLM_article-title">Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">12552</span>– <span class="NLM_lpage">12561</span>, <span class="refDoi"> DOI: 10.1128/JVI.01890-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.01890-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24027332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVygsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=12552-12561&issue=23&author=K.+Shiratoauthor=M.+Kawaseauthor=S.+Matsuyama&title=Middle+East+respiratory+syndrome+coronavirus+infection+mediated+by+the+transmembrane+serine+protease+TMPRSS2&doi=10.1128%2FJVI.01890-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Middle east respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2</span></div><div class="casAuthors">Shirato, Kazuya; Kawase, Miyuki; Matsuyama, Shutoku</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12552-12561</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Middle East respiratory syndrome coronavirus (MERS-CoV) utilizes host proteases for virus entry into lung cells.  In the current study, Vero cells constitutively expressing type II transmembrane serine protease (Vero-TMPRSS2 cells) showed larger syncytia at 18 h after infection with MERS-CoV than after infection with other coronaviruses.  Furthermore, the susceptibility of Vero-TMPRSS2 cells to MERS-CoV was 100-fold higher than that of non-TMPRSS2-expressing parental Vero cells.  The serine protease inhibitor camostat, which inhibits TMPRSS2 activity, completely blocked syncytium formation but only partially blocked virus entry into Vero-TMPRSS2 cells.  Importantly, the coronavirus is thought to enter cells via two distinct pathways, one mediated by TMPRSS2 at the cell surface and the other mediated by cathepsin L in the endosome.  Simultaneous treatment with inhibitors of cathepsin L and TMPRSS2 completely blocked virus entry into Vero-TMPRSS2 cells, indicating that MERS-CoV employs both the cell surface and the endosomal pathway to infect Vero-TMPRSS2 cells.  In contrast, a single camostat treatment suppressed MERS-CoV entry into human bronchial submucosal gland-derived Calu-3 cells by 10-fold and virus growth by 270-fold, although treatment with both camostat and (23,25)-trans-epoxysuccinyl-L-leucylamindo-3-methylbutane Et ester, a cathepsin inhibitor, or treatment with leupeptin, an inhibitor of cysteine, serine, and threonine peptidases, was no more efficacious than treatment with camostat alone.  Further, these inhibitors were not efficacious against MERS-CoV infection of MRC-5 and WI-38 cells, which were derived from lung, but these characters differed from those of mature pneumocytes.  These results suggest that a single treatment with camostat is sufficient to block MERS-CoV entry into a well-differentiated lung-derived cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUQYSrh_mBe7Vg90H21EOLACvtfcHk0lgOvwWZM6NqiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVygsrjM&md5=808a19ec6bbba3b9f0829f82b37bfd89</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FJVI.01890-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01890-13%26sid%3Dliteratum%253Aachs%26aulast%3DShirato%26aufirst%3DK.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DMatsuyama%26aufirst%3DS.%26atitle%3DMiddle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520infection%2520mediated%2520by%2520the%2520transmembrane%2520serine%2520protease%2520TMPRSS2%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26issue%3D23%26spage%3D12552%26epage%3D12561%26doi%3D10.1128%2FJVI.01890-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirogane, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagi, Y.</span></span> <span> </span><span class="NLM_article-title">Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">8942</span>– <span class="NLM_lpage">8946</span>, <span class="refDoi"> DOI: 10.1128/JVI.00676-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.00676-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18562527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVClt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=8942-8946&issue=17&author=Y.+Shiroganeauthor=M.+Takedaauthor=M.+Iwasakiauthor=N.+Ishiguroauthor=H.+Takeuchiauthor=Y.+Nakatsuauthor=M.+Taharaauthor=H.+Kikutaauthor=Y.+Yanagi&title=Efficient+multiplication+of+human+metapneumovirus+in+Vero+cells+expressing+the+transmembrane+serine+protease+TMPRSS2&doi=10.1128%2FJVI.00676-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2</span></div><div class="casAuthors">Shirogane, Yuta; Takeda, Makoto; Iwasaki, Masaharu; Ishiguro, Nobuhisa; Takeuchi, Hiroki; Nakatsu, Yuichiro; Tahara, Maino; Kikuta, Hideaki; Yanagi, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8942-8946</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human metapneumovirus (HMPV) is a major causative agent of severe bronchiolitis and pneumonia.  Its fusion (F) protein must be cleaved by host proteases to cause membrane fusion, a crit. step for virus infection.  By generating Vero cells constitutively expressing the transmembrane serine protease TMPRSS2 and green fluorescent protein-expressing recombinant HMPV, we show that TMPRSS2, which is expressed in the human lung epithelium, cleaves the HMPV F protein efficiently and supports HMPV multiplication.  The results indicate that TMPRSS2 is a possible candidate protease involved in the development of lower respiratory tract illness in HMPV-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopIbkVq71hb7Vg90H21EOLACvtfcHk0lgOvwWZM6NqiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVClt7rF&md5=b7cf8016a5c7c697f9ed74702c005bba</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FJVI.00676-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00676-08%26sid%3Dliteratum%253Aachs%26aulast%3DShirogane%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DIwasaki%26aufirst%3DM.%26aulast%3DIshiguro%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DH.%26aulast%3DNakatsu%26aufirst%3DY.%26aulast%3DTahara%26aufirst%3DM.%26aulast%3DKikuta%26aufirst%3DH.%26aulast%3DYanagi%26aufirst%3DY.%26atitle%3DEfficient%2520multiplication%2520of%2520human%2520metapneumovirus%2520in%2520Vero%2520cells%2520expressing%2520the%2520transmembrane%2520serine%2520protease%2520TMPRSS2%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26issue%3D17%26spage%3D8942%26epage%3D8946%26doi%3D10.1128%2FJVI.00676-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehr, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCray, P. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T.</span></span> <span> </span><span class="NLM_article-title">Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">12262</span>– <span class="NLM_lpage">12267</span>, <span class="refDoi"> DOI: 10.1073/pnas.1608147113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1608147113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27791014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1elur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=12262-12267&issue=43&author=J.+E.+Parkauthor=K.+Liauthor=A.+Barlanauthor=A.+R.+Fehrauthor=S.+Perlmanauthor=P.+B.+McCrayauthor=T.+Gallagher&title=Proteolytic+processing+of+Middle+East+respiratory+syndrome+coronavirus+spikes+expands+virus+tropism&doi=10.1073%2Fpnas.1608147113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism</span></div><div class="casAuthors">Park, Jung-Eun; Li, Kun; Barlan, Arlene; Fehr, Anthony R.; Perlman, Stanley; McCray, Paul B. Jr.; Gallagher, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">12262-12267</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) infects humans from zoonotic sources and causes severe pulmonary disease.  Virions require spike (S) glycoproteins for binding to cell receptors and for catalyzing virus-cell membrane fusion.  Fusion occurs only after S proteins are cleaved sequentially, first during their secretion through the exocytic organelles of virus-producing cells, and second after virus binding to target-cell receptors.  To more precisely det. how sequential proteolysis contributes to CoV infection, we introduced S mutations obstructing the first cleavages.  These mutations severely compromised MERS-CoV infection into human lung-derived cells, but had little effect on infection into several other cell types.  These cell type-specific requirements for proteolysis correlated with S conformations during cell entry.  Without the first cleavages, S proteins resisted cell receptor-induced conformational changes, which restricted the second, fusion-activating cleavages.  Consistent with these findings, precleaved MERS viruses used receptor-proximal, cell-surface proteases to effect the second fusion-activating cleavages during cell entry, whereas the more rigid uncleaved MERS viruses trafficked past these cell-surface proteases and into endosomes.  Uncleaved viruses were less infectious to human airway epithelial and Calu3 cell cultures because they lacked sufficient endosomal fusion-activating proteases.  Thus, by sensitizing viruses to receptor-induced conformational changes, the first S cleavages expand virus tropism to cell types that are relevant to lung infection, and therefore may be significant determinants of MERS-CoV virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbWppC9-pA2LVg90H21EOLACvtfcHk0lhbivI7gJJ6SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1elur3F&md5=25764c2eb9d46c8ab09f70c461f8cb95</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1608147113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1608147113%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DBarlan%26aufirst%3DA.%26aulast%3DFehr%26aufirst%3DA.%2BR.%26aulast%3DPerlman%26aufirst%3DS.%26aulast%3DMcCray%26aufirst%3DP.%2BB.%26aulast%3DGallagher%26aufirst%3DT.%26atitle%3DProteolytic%2520processing%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520spikes%2520expands%2520virus%2520tropism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D43%26spage%3D12262%26epage%3D12267%26doi%3D10.1073%2Fpnas.1608147113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Z.</span></span> <span> </span><span class="NLM_article-title">Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1620</span>, <span class="refDoi"> DOI: 10.1038/s41467-020-15562-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41467-020-15562-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32221306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFyjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1620&issue=1&author=X.+Ouauthor=Y.+Liuauthor=X.+Leiauthor=P.+Liauthor=D.+Miauthor=L.+Renauthor=L.+Guoauthor=R.+Guoauthor=T.+Chenauthor=J.+Huauthor=Z.+Xiangauthor=Z.+Muauthor=X.+Chenauthor=J.+Chenauthor=K.+Huauthor=Q.+Jinauthor=J.+Wangauthor=Z.+Qian&title=Characterization+of+spike+glycoprotein+of+SARS-CoV-2+on+virus+entry+and+its+immune+cross-reactivity+with+SARS-CoV&doi=10.1038%2Fs41467-020-15562-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV</span></div><div class="casAuthors">Ou, Xiuyuan; Liu, Yan; Lei, Xiaobo; Li, Pei; Mi, Dan; Ren, Lili; Guo, Li; Guo, Ruixuan; Chen, Ting; Hu, Jiaxin; Xiang, Zichun; Mu, Zhixia; Chen, Xing; Chen, Jieyong; Hu, Keping; Jin, Qi; Wang, Jianwei; Qian, Zhaohui</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1620</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Since 2002, beta coronaviruses (CoV) have caused three zoonotic outbreaks, SARS-CoV in 2002-2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in late 2019.  However, little is currently known about the biol. of SARS-CoV-2.  Here, using SARS-CoV-2 S protein pseudovirus system, we confirm that human angiotensin converting enzyme 2 (hACE2) is the receptor for SARS-CoV-2, find that SARS-CoV-2 enters 293/hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are crit. for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S.  Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions.  Further studies using recovered SARS and COVID-19 patients' sera show limited cross-neutralization, suggesting that recovery from one infection might not protect against the other.  Our results present potential targets for development of drugs and vaccines for SARS-CoV-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMJdEJrxmpDrVg90H21EOLACvtfcHk0lhbivI7gJJ6SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFyjt78%253D&md5=6b0b1ef5a68f4a35da4aabecb0f99544</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-15562-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-15562-9%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMi%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DMu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DZ.%26atitle%3DCharacterization%2520of%2520spike%2520glycoprotein%2520of%2520SARS-CoV-2%2520on%2520virus%2520entry%2520and%2520its%2520immune%2520cross-reactivity%2520with%2520SARS-CoV%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D1620%26doi%3D10.1038%2Fs41467-020-15562-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoenen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelotti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewey, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWald, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumpp-Thomas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrling, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J. M.</span></span> <span> </span><span class="NLM_article-title">The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e0005540</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0005540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pntd.0005540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28403145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWrsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&issue=4&author=E.+A.+Nelsonauthor=J.+Dyallauthor=T.+Hoenenauthor=A.+B.+Barnesauthor=H.+Zhouauthor=J.+Y.+Liangauthor=J.+Michelottiauthor=W.+H.+Deweyauthor=L.+E.+DeWaldauthor=R.+S.+Bennettauthor=P.+J.+Morrisauthor=R.+Guhaauthor=C.+Klumpp-Thomasauthor=C.+McKnightauthor=Y.+C.+Chenauthor=X.+Xuauthor=A.+Wangauthor=E.+Hughesauthor=S.+Martinauthor=C.+Thomasauthor=P.+B.+Jahrlingauthor=L.+E.+Hensleyauthor=G.+G.+Olingerauthor=J.+M.+White&title=The+phosphatidylinositol-3-phosphate+5-kinase+inhibitor+apilimod+blocks+filoviral+entry+and+infection&doi=10.1371%2Fjournal.pntd.0005540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection</span></div><div class="casAuthors">Nelson, Elizabeth A.; Dyall, Julie; Hoenen, Thomas; Barnes, Alyson B.; Zhou, Huanying; Liang, Janie Y.; Michelotti, Julia; Dewey, William H.; DeWald, Lisa Evans; Bennett, Richard S.; Morris, Patrick J.; Guha, Rajarshi; Klumpp-Thomas, Carleen; McKnight, Crystal; Chen, Yu-Chi; Xu, Xin; Wang, Amy; Hughes, Emma; Martin, Scott; Thomas, Craig; Jahrling, Peter B.; Hensley, Lisa E.; Olinger, Gene G. Jr.; White, Judith M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0005540/1-e0005540/22</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) is a lipid kinase involved in endosome maturation that emerged from a haploid genetic screen as being required for Ebola virus (EBOV) infection.  Here we analyzed the effects of apilimod, a PIKfyve inhibitor that was reported to be well tolerated in humans in phase 2 clin. trials, for its effects on entry and infection of EBOV and Marburg virus (MARV).  We first found that apilimod blocks infections by EBOV and MARV in Huh 7, Vero E6 and primary human macrophage cells, with notable potency in the macrophages (IC50, 10 nM).  We next obsd. that similar doses of apilimod block EBOV-glycoprotein-virus like particle (VLP) entry and transcription-replication competent VLP infection, suggesting that the primary mode of action of apilimod is as an entry inhibitor, preventing release of the viral genome into the cytoplasm to initiate replication.  After providing evidence that the anti-EBOV action of apilimod is via PIKfyve, we showed that it blocks trafficking of EBOV VLPs to endolysosomes contg. Niemann-Pick C1 (NPC1), the intracellular receptor for EBOV.  Concurrently apilimod caused VLPs to accumulate in early endosome antigen 1-pos. endosomes.  We did not detect any effects of apilimod on bulk endosome acidification, on the activity of cathepsins B and L, or on cholesterol export from endolysosomes.  Hence by antagonizing PIKfyve, apilimod appears to block EBOV trafficking to its site of fusion and entry into the cytoplasm.  Given the drug's obsd. anti-filoviral activity, relatively unexplored mechanism of entry inhibition, and reported tolerability in humans, we propose that apilimod be further explored as part of a therapeutic regimen to treat filoviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlUaAMvLkQT7Vg90H21EOLACvtfcHk0liYI4vyWDLW4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWrsb3O&md5=c2f72fa69b941bcc8c97dcacf0e210bd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0005540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0005540%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DE.%2BA.%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DHoenen%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DA.%2BB.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DJ.%2BY.%26aulast%3DMichelotti%26aufirst%3DJ.%26aulast%3DDewey%26aufirst%3DW.%2BH.%26aulast%3DDeWald%26aufirst%3DL.%2BE.%26aulast%3DBennett%26aufirst%3DR.%2BS.%26aulast%3DMorris%26aufirst%3DP.%2BJ.%26aulast%3DGuha%26aufirst%3DR.%26aulast%3DKlumpp-Thomas%26aufirst%3DC.%26aulast%3DMcKnight%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%2BC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DJahrling%26aufirst%3DP.%2BB.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520phosphatidylinositol-3-phosphate%25205-kinase%2520inhibitor%2520apilimod%2520blocks%2520filoviral%2520entry%2520and%2520infection%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2017%26volume%3D11%26issue%3D4%26doi%3D10.1371%2Fjournal.pntd.0005540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta-Geijo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galindo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernaez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quetglas, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalmau-Mena, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, C.</span></span> <span> </span><span class="NLM_article-title">Endosomal maturation, Rab7 GTPase and phosphoinositides in African swine fever virus entry</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">11</span>), <span class="NLM_elocation-id">e48853</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0048853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0048853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23133661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslWjsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=11&author=M.+A.+Cuesta-Geijoauthor=I.+Galindoauthor=B.+Hernaezauthor=J.+I.+Quetglasauthor=I.+Dalmau-Menaauthor=C.+Alonso&title=Endosomal+maturation%2C+Rab7+GTPase+and+phosphoinositides+in+African+swine+fever+virus+entry&doi=10.1371%2Fjournal.pone.0048853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal maturation, Rab7 GTPase and phosphoinositides in African swine fever virus entry</span></div><div class="casAuthors">Cuesta-Geijo, Miguel A.; Galindo, Inmaculada; Hernaez, Bruno; Quetglas, Jose Ignacio; Dalmau-Mena, Inmaculada; Alonso, Covadonga</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e48853</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The authors analyzed the dependence of African swine fever virus (ASFV) infection on the integrity of the endosomal pathway.  Using confocal immunofluorescence with antibodies against viral capsid proteins, we found colocalization of incoming viral particles with early endosomes (EE) during the first minutes of infection.  Conversely, viral capsid protein was not detected in acidic late endosomal compartments, multivesicular bodies (MVBs), late endosomes (LEs) or lysosomes (LY).  Using an antibody against a viral inner core protein, we found colocalization of viral cores with late compartments from 30 to 60 min postinfection.  The absence of capsid protein staining in LEs and LYs suggested that virus desencapsidation would take place at the acid pH of these organelles.  In fact, inhibitors of intraluminal acidification of endosomes caused retention of viral capsid staining virions in Rab7 expressing endosomes and more importantly, severely impaired subsequent viral protein prodn.  Endosomal acidification in the first hour after virus entry was essential for successful infection but not thereafter.  In addn., altering the balance of phosphoinositides (PIs) which are responsible of the maintenance of the endocytic pathway impaired ASFV infection.  Early infection steps were dependent on the prodn. of phosphatidylinositol 3-phosphate (PtdIns3P) which is involved in EE maturation and multivesicular body (MVB) biogenesis and on the interconversion of PtdIns3P to phosphatidylinositol 3,5-biphosphate (PtdIns(3,5)P2).  Likewise, GTPase Rab7 activity should remain intact, as well as processes related to LE compartment physiol., which are crucial during early infection.  The data demonstrate that the EE and LE compartments and the integrity of the endosomal maturation pathway orchestrated by Rab proteins and PIs play a central role during early stages of ASFV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgQBz20LmA_rVg90H21EOLACvtfcHk0liYI4vyWDLW4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslWjsbzN&md5=256c351c18985dab5f4002e90b263d75</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0048853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0048853%26sid%3Dliteratum%253Aachs%26aulast%3DCuesta-Geijo%26aufirst%3DM.%2BA.%26aulast%3DGalindo%26aufirst%3DI.%26aulast%3DHernaez%26aufirst%3DB.%26aulast%3DQuetglas%26aufirst%3DJ.%2BI.%26aulast%3DDalmau-Mena%26aufirst%3DI.%26aulast%3DAlonso%26aufirst%3DC.%26atitle%3DEndosomal%2520maturation%252C%2520Rab7%2520GTPase%2520and%2520phosphoinositides%2520in%2520African%2520swine%2520fever%2520virus%2520entry%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D11%26doi%3D10.1371%2Fjournal.pone.0048853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozak, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warkentin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salambanga, F. D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobasa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, M.</span></span> <span> </span><span class="NLM_article-title">Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2017.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2017.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29031163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GlsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2018&pages=17-28&author=S.+Qiuauthor=A.+Leungauthor=Y.+Boauthor=R.+A.+Kozakauthor=S.+P.+Anandauthor=C.+Warkentinauthor=F.+D.+R.+Salambangaauthor=J.+Cuiauthor=G.+Kobingerauthor=D.+Kobasaauthor=M.+Cote&title=Ebola+virus+requires+phosphatidylinositol+%283%2C5%29+bisphosphate+production+for+efficient+viral+entry&doi=10.1016%2Fj.virol.2017.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry</span></div><div class="casAuthors">Qiu, Shirley; Leung, Anders; Bo, Yuxia; Kozak, Robert A.; Anand, Sai Priya; Warkentin, Corina; Salambanga, Fabiola D. R.; Cui, Jennifer; Kobinger, Gary; Kobasa, Darwyn; Cote, Marceline</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-28</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">For entry, Ebola virus (EBOV) requires the interaction of its viral glycoprotein with the cellular protein Niemann-Pick C1 (NPC1) which resides in late endosomes and lysosomes.  How EBOV is trafficked and delivered to NPC1 and whether this is pos. regulated during entry remain unclear.  Here, we show that the PIKfyve-ArPIKfyve-Sac3 cellular complex, which is involved in the metab. of phosphatidylinositol (3,5) bisphosphate (PtdIns(3,5)P2), is crit. for EBOV infection.  Although the expression of all subunits of the complex was required for efficient entry, PIKfyve kinase activity was specifically crit. for entry by all pathogenic filoviruses.  Inhibition of PIKfyve prevented colocalization of EBOV with NPC1 and led to virus accumulation in intracellular vesicles with characteristics of early endosomes.  Importantly, genetically-encoded phosphoinositide probes revealed an increase in PtdIns(3,5)P2-pos. vesicles in cells during EBOV entry.  Taken together, our studies suggest that EBOV requires PtdIns(3,5)P2 prodn. in cells to promote efficient delivery to NPC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBj4bGDkDZELVg90H21EOLACvtfcHk0ljA8ITQHYjmgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GlsrbI&md5=1a0bed541a6186ca937abcc2cabc4bb6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2017.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2017.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DA.%26aulast%3DBo%26aufirst%3DY.%26aulast%3DKozak%26aufirst%3DR.%2BA.%26aulast%3DAnand%26aufirst%3DS.%2BP.%26aulast%3DWarkentin%26aufirst%3DC.%26aulast%3DSalambanga%26aufirst%3DF.%2BD.%2BR.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DKobinger%26aufirst%3DG.%26aulast%3DKobasa%26aufirst%3DD.%26aulast%3DCote%26aufirst%3DM.%26atitle%3DEbola%2520virus%2520requires%2520phosphatidylinositol%2520%25283%252C5%2529%2520bisphosphate%2520production%2520for%2520efficient%2520viral%2520entry%26jtitle%3DVirology%26date%3D2018%26volume%3D513%26spage%3D17%26epage%3D28%26doi%3D10.1016%2Fj.virol.2017.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">V’Kovski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaender, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braga Lagache, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simillion, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaschen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span> <span> </span><span class="NLM_article-title">Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e42037</span> <span class="refDoi"> DOI: 10.7554/eLife.42037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.7554%2FeLife.42037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30632963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVegtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=P.+V%E2%80%99Kovskiauthor=M.+Gerberauthor=J.+Kellyauthor=S.+Pfaenderauthor=N.+Ebertauthor=S.+Braga+Lagacheauthor=C.+Simillionauthor=J.+Portmannauthor=H.+Stalderauthor=V.+Gaschenauthor=R.+Bruggmannauthor=M.+H.+Stoffelauthor=M.+Hellerauthor=R.+Dijkmanauthor=V.+Thiel&title=Determination+of+host+proteins+composing+the+microenvironment+of+coronavirus+replicase+complexes+by+proximity-labeling&doi=10.7554%2FeLife.42037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling</span></div><div class="casAuthors">V'kovski, Philip; Gerber, Markus; Kelly, Jenna; Pfaender, Stephanie; Ebert, Nadine; Lagache, Sophie Braga; Simillion, Cedric; Portmann, Jasmine; Stalder, Hanspeter; Gaschen, Veronique; Bruggmann, Remy; Stoffel, Michael H.; Heller, Manfred; Dijkman, Ronald; Thiel, Volker</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42037</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Pos.-sense RNA viruses hijack intracellular membranes that provide niches for viral RNA synthesis and a platform for interactions with host proteins.  However, little is known about host factors at the interface between replicase complexes and the host cytoplasm.  We engineered a biotin ligase into a coronaviral replication/transcription complex (RTC) and identified >500 host proteins constituting the RTC microenvironment. siRNA-silencing of each RTC-proximal host factor demonstrated importance of vesicular trafficking pathways, ubiquitin-dependent and autophagy- related processes, and translation initiation factors.  Notably, detection of translation initiation factors at the RTC was instrumental to visualize and demonstrate active translation proximal to replication complexes of several coronaviruses.  Collectively, we establish a spatial link between viral RNA synthesis and diverse host factors of unprecedented breadth.  Our data may serve as a paradigm for other pos.-strand RNA viruses and provide a starting point for a comprehensive anal. of crit. virus-host interactions that represent targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs8nSvGBoVj7Vg90H21EOLACvtfcHk0ljA8ITQHYjmgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVegtLnN&md5=1da3f38802c756d517f0fa8dde8a6d03</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.7554%2FeLife.42037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.42037%26sid%3Dliteratum%253Aachs%26aulast%3DV%25E2%2580%2599Kovski%26aufirst%3DP.%26aulast%3DGerber%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DJ.%26aulast%3DPfaender%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DN.%26aulast%3DBraga%2BLagache%26aufirst%3DS.%26aulast%3DSimillion%26aufirst%3DC.%26aulast%3DPortmann%26aufirst%3DJ.%26aulast%3DStalder%26aufirst%3DH.%26aulast%3DGaschen%26aufirst%3DV.%26aulast%3DBruggmann%26aufirst%3DR.%26aulast%3DStoffel%26aufirst%3DM.%2BH.%26aulast%3DHeller%26aufirst%3DM.%26aulast%3DDijkman%26aufirst%3DR.%26aulast%3DThiel%26aufirst%3DV.%26atitle%3DDetermination%2520of%2520host%2520proteins%2520composing%2520the%2520microenvironment%2520of%2520coronavirus%2520replicase%2520complexes%2520by%2520proximity-labeling%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2FeLife.42037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McBride, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machamer, C. E.</span></span> <span> </span><span class="NLM_article-title">The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2418</span>– <span class="NLM_lpage">2428</span>, <span class="refDoi"> DOI: 10.1128/JVI.02146-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.02146-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=17166901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=2418-2428&issue=5&author=C.+E.+McBrideauthor=J.+Liauthor=C.+E.+Machamer&title=The+cytoplasmic+tail+of+the+severe+acute+respiratory+syndrome+coronavirus+spike+protein+contains+a+novel+endoplasmic+reticulum+retrieval+signal+that+binds+COPI+and+promotes+interaction+with+membrane+protein&doi=10.1128%2FJVI.02146-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein</span></div><div class="casAuthors">McBride, Corrin E.; Li, Jie; Machamer, Carolyn E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2418-2428</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Like other coronaviruses, severe acute respiratory syndrome coronavirus (SARS CoV) assembles at and buds into the lumen of the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC).  Accumulation of the viral envelope proteins at this compartment is a prerequisite for virus assembly.  Previously, we reported the identification of a dibasic motif (KxHxx) in the cytoplasmic tail of the SARS CoV spike (S) protein that was similar to a canonical dilysine ER retrieval signal.  Here we demonstrate that this motif is a novel and functional ER retrieval signal which reduced the rate of traffic of the full-length S protein through the Golgi complex.  The KxHxx motif also partially retained two different reporter proteins in the ERGIC region and reduced their rates of trafficking, although the motif was less potent than the canonical dilysine signal.  The dibasic motif bound the coatomer complex I (COPI) in an in vitro binding assay, suggesting that ER retrieval may contribute to the accumulation of SARS CoV S protein near the virus assembly site for interaction with other viral structural proteins.  In support of this, we found that the dibasic motif on the SARS S protein was required for its localization to the ERGIC/Golgi region when coexpressed with SARS membrane (M) protein.  Thus, the cycling of SARS S through the ER-Golgi system may be required for its incorporation into assembling virions in the ERGIC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtkWd7mTnEFLVg90H21EOLACvtfcHk0lhJR3fdavaifA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOgs7Y%253D&md5=16f33836bbd3a764bb3ef9bf1288a0d3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FJVI.02146-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02146-06%26sid%3Dliteratum%253Aachs%26aulast%3DMcBride%26aufirst%3DC.%2BE.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMachamer%26aufirst%3DC.%2BE.%26atitle%3DThe%2520cytoplasmic%2520tail%2520of%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520spike%2520protein%2520contains%2520a%2520novel%2520endoplasmic%2520reticulum%2520retrieval%2520signal%2520that%2520binds%2520COPI%2520and%2520promotes%2520interaction%2520with%2520membrane%2520protein%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26issue%3D5%26spage%3D2418%26epage%3D2428%26doi%3D10.1128%2FJVI.02146-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmeier, M. J.</span></span> <span> </span><span class="NLM_article-title">Coronavirus spike proteins in viral entry and pathogenesis</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1006/viro.2000.0757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1006%2Fviro.2000.0757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=11162792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2001&pages=371-374&issue=2&author=T.+M.+Gallagherauthor=M.+J.+Buchmeier&title=Coronavirus+spike+proteins+in+viral+entry+and+pathogenesis&doi=10.1006%2Fviro.2000.0757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Coronavirus spike proteins in viral entry and pathogenesis</span></div><div class="casAuthors">Gallagher, Thomas M.; Buchmeier, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">371-374</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 24 refs.  Receptor interactions and membrane fusion properties of spike proteins are discussed.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVxuFZ27QjdbVg90H21EOLACvtfcHk0lhJR3fdavaifA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFOgsA%253D%253D&md5=d35d47926621128c62d9380dfcd68f86</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1006%2Fviro.2000.0757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fviro.2000.0757%26sid%3Dliteratum%253Aachs%26aulast%3DGallagher%26aufirst%3DT.%2BM.%26aulast%3DBuchmeier%26aufirst%3DM.%2BJ.%26atitle%3DCoronavirus%2520spike%2520proteins%2520in%2520viral%2520entry%2520and%2520pathogenesis%26jtitle%3DVirology%26date%3D2001%26volume%3D279%26issue%3D2%26spage%3D371%26epage%3D374%26doi%3D10.1006%2Fviro.2000.0757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castaño-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honrubia, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez-Alvarez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeDiego, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto-Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Guardeno, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regla-Nava, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Delgado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdia-Baguena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queralt-Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilella, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span> <span> </span><span class="NLM_article-title">Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in peplication and pathogenesis</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>), <span class="NLM_elocation-id">e02325-17</span> <span class="refDoi"> DOI: 10.1128/mBio.02325-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FmBio.02325-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29789363" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&issue=3&author=C.+Casta%C3%B1o-Rodriguezauthor=J.+M.+Honrubiaauthor=J.+Gutierrez-Alvarezauthor=M.+L.+DeDiegoauthor=J.+L.+Nieto-Torresauthor=J.+M.+Jimenez-Guardenoauthor=J.+A.+Regla-Navaauthor=R.+Fernandez-Delgadoauthor=C.+Verdia-Baguenaauthor=M.+Queralt-Martinauthor=G.+Kochanauthor=S.+Perlmanauthor=V.+M.+Aguilellaauthor=I.+Solaauthor=L.+Enjuanes&title=Role+of+severe+acute+respiratory+syndrome+coronavirus+viroporins+E%2C+3a%2C+and+8a+in+peplication+and+pathogenesis&doi=10.1128%2FmBio.02325-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FmBio.02325-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.02325-17%26sid%3Dliteratum%253Aachs%26aulast%3DCasta%25C3%25B1o-Rodriguez%26aufirst%3DC.%26aulast%3DHonrubia%26aufirst%3DJ.%2BM.%26aulast%3DGutierrez-Alvarez%26aufirst%3DJ.%26aulast%3DDeDiego%26aufirst%3DM.%2BL.%26aulast%3DNieto-Torres%26aufirst%3DJ.%2BL.%26aulast%3DJimenez-Guardeno%26aufirst%3DJ.%2BM.%26aulast%3DRegla-Nava%26aufirst%3DJ.%2BA.%26aulast%3DFernandez-Delgado%26aufirst%3DR.%26aulast%3DVerdia-Baguena%26aufirst%3DC.%26aulast%3DQueralt-Martin%26aufirst%3DM.%26aulast%3DKochan%26aufirst%3DG.%26aulast%3DPerlman%26aufirst%3DS.%26aulast%3DAguilella%26aufirst%3DV.%2BM.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DEnjuanes%26aufirst%3DL.%26atitle%3DRole%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520viroporins%2520E%252C%25203a%252C%2520and%25208a%2520in%2520peplication%2520and%2520pathogenesis%26jtitle%3DmBio%26date%3D2018%26volume%3D9%26issue%3D3%26doi%3D10.1128%2FmBio.02325-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neuman, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunding, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baksh, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Droese, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawicki, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddell, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamou, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmeier, M. J.</span></span> <span> </span><span class="NLM_article-title">A structural analysis of M protein in coronavirus assembly and morphology</span>. <i>J. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>174</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.jsb.2010.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jsb.2010.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21130884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2011&pages=11-22&issue=1&author=B.+W.+Neumanauthor=G.+Kissauthor=A.+H.+Kundingauthor=D.+Bhellaauthor=M.+F.+Bakshauthor=S.+Connellyauthor=B.+Droeseauthor=J.+P.+Klausauthor=S.+Makinoauthor=S.+G.+Sawickiauthor=S.+G.+Siddellauthor=D.+G.+Stamouauthor=I.+A.+Wilsonauthor=P.+Kuhnauthor=M.+J.+Buchmeier&title=A+structural+analysis+of+M+protein+in+coronavirus+assembly+and+morphology&doi=10.1016%2Fj.jsb.2010.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A structural analysis of M protein in coronavirus assembly and morphology</span></div><div class="casAuthors">Neuman, Benjamin W.; Kiss, Gabriella; Kunding, Andreas H.; Bhella, David; Baksh, M. Fazil; Connelly, Stephen; Droese, Ben; Klaus, Joseph P.; Makino, Shinji; Sawicki, Stanley G.; Siddell, Stuart G.; Stamou, Dimitrios G.; Wilson, Ian A.; Kuhn, Peter; Buchmeier, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-22</span>CODEN:
                <span class="NLM_cas:coden">JSBIEM</span>;
        ISSN:<span class="NLM_cas:issn">1047-8477</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The M protein of coronavirus plays a central role in virus assembly, turning cellular membranes into workshops where virus and host factors come together to make new virus particles.  We investigated how M structure and organization is related to virus shape and size using cryo-electron microscopy, tomog. and statistical anal.  We present evidence that suggests M can adopt two conformations and that membrane curvature is regulated by one M conformer.  Elongated M protein is assocd. with rigidity, clusters of spikes and a relatively narrow range of membrane curvature.  In contrast, compact M protein is assocd. with flexibility and low spike d.  Anal. of several types of virus-like particles and virions revealed that S protein, N protein and genomic RNA each help to regulate virion size and variation, presumably through interactions with M. These findings provide insight into how M protein functions to promote virus assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol6PiYyze14rVg90H21EOLACvtfcHk0liWyud-pgVLFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSrt7w%253D&md5=a86cd24ccfa9d6a3dda1741900dbef60</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2010.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2010.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DNeuman%26aufirst%3DB.%2BW.%26aulast%3DKiss%26aufirst%3DG.%26aulast%3DKunding%26aufirst%3DA.%2BH.%26aulast%3DBhella%26aufirst%3DD.%26aulast%3DBaksh%26aufirst%3DM.%2BF.%26aulast%3DConnelly%26aufirst%3DS.%26aulast%3DDroese%26aufirst%3DB.%26aulast%3DKlaus%26aufirst%3DJ.%2BP.%26aulast%3DMakino%26aufirst%3DS.%26aulast%3DSawicki%26aufirst%3DS.%2BG.%26aulast%3DSiddell%26aufirst%3DS.%2BG.%26aulast%3DStamou%26aufirst%3DD.%2BG.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DBuchmeier%26aufirst%3DM.%2BJ.%26atitle%3DA%2520structural%2520analysis%2520of%2520M%2520protein%2520in%2520coronavirus%2520assembly%2520and%2520morphology%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D174%26issue%3D1%26spage%3D11%26epage%3D22%26doi%3D10.1016%2Fj.jsb.2010.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McBride, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zyl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielding, B. C.</span></span> <span> </span><span class="NLM_article-title">The coronavirus nucleocapsid is a multifunctional protein</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2991</span>– <span class="NLM_lpage">3018</span>, <span class="refDoi"> DOI: 10.3390/v6082991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv6082991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25105276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyiu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=2991-3018&issue=8&author=R.+McBrideauthor=M.+van+Zylauthor=B.+C.+Fielding&title=The+coronavirus+nucleocapsid+is+a+multifunctional+protein&doi=10.3390%2Fv6082991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The coronavirus nucleocapsid is a multifunctional protein</span></div><div class="casAuthors">McBride, Ruth; van Zyl, Marjorie; Fielding, Burtram C.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2991-3018, 28 pp.</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The coronavirus nucleocapsid (N) is a structural protein that forms complexes with genomic RNA, interacts with the viral membrane protein during virion assembly and plays a crit. role in enhancing the efficiency of virus transcription and assembly.  Recent studies have confirmed that N is a multifunctional protein.  The aim of this review is to highlight the properties and functions of the N protein, with specific ref. to (i) the topol.; (ii) the intracellular localization and (iii) the functions of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqko49yucsC57Vg90H21EOLACvtfcHk0lhkqlF7-X6vYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyiu7%252FJ&md5=5ed29616bfb0a71386a7b92a33105dd8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fv6082991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv6082991%26sid%3Dliteratum%253Aachs%26aulast%3DMcBride%26aufirst%3DR.%26aulast%3Dvan%2BZyl%26aufirst%3DM.%26aulast%3DFielding%26aufirst%3DB.%2BC.%26atitle%3DThe%2520coronavirus%2520nucleocapsid%2520is%2520a%2520multifunctional%2520protein%26jtitle%3DViruses%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D2991%26epage%3D3018%26doi%3D10.3390%2Fv6082991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemula, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donde, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadde, R.</span></span> <span> </span><span class="NLM_article-title">In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1080/07391102.2020.1751300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F07391102.2020.1751300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=M.+K.+Guptaauthor=S.+Vemulaauthor=R.+Dondeauthor=G.+Goudaauthor=L.+Beheraauthor=R.+Vadde&title=In-silico+approaches+to+detect+inhibitors+of+the+human+severe+acute+respiratory+syndrome+coronavirus+envelope+protein+ion+channel&doi=10.1080%2F07391102.2020.1751300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1080%2F07391102.2020.1751300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2020.1751300%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DM.%2BK.%26aulast%3DVemula%26aufirst%3DS.%26aulast%3DDonde%26aufirst%3DR.%26aulast%3DGouda%26aufirst%3DG.%26aulast%3DBehera%26aufirst%3DL.%26aulast%3DVadde%26aufirst%3DR.%26atitle%3DIn-silico%2520approaches%2520to%2520detect%2520inhibitors%2520of%2520the%2520human%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520envelope%2520protein%2520ion%2520channel%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2020%26doi%3D10.1080%2F07391102.2020.1751300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV)</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/jmv.25768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fjmv.25768" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=S.+Dongauthor=J.+Sunauthor=Z.+Maoauthor=L.+Wangauthor=Y.+L.+Luauthor=J.+Li&title=A+guideline+for+homology+modeling+of+the+proteins+from+newly+discovered+betacoronavirus%2C+2019+novel+coronavirus+%282019-nCoV%29&doi=10.1002%2Fjmv.25768"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fjmv.25768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.25768%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DA%2520guideline%2520for%2520homology%2520modeling%2520of%2520the%2520proteins%2520from%2520newly%2520discovered%2520betacoronavirus%252C%25202019%2520novel%2520coronavirus%2520%25282019-nCoV%2529%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2020%26doi%3D10.1002%2Fjmv.25768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2020.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.apsb.2020.04.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=S.+Kangauthor=M.+Yangauthor=Z.+Hongauthor=L.+Zhangauthor=Z.+Huangauthor=X.+Chenauthor=S.+Heauthor=Z.+Zhouauthor=Z.+Zhouauthor=Q.+Chenauthor=Y.+Yanauthor=C.+Zhangauthor=H.+Shanauthor=S.+Chen&title=Crystal+structure+of+SARS-CoV-2+nucleocapsid+protein+RNA+binding+domain+reveals+potential+unique+drug+targeting+sites&doi=10.1016%2Fj.apsb.2020.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2020.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2020.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DShan%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520SARS-CoV-2%2520nucleocapsid%2520protein%2520RNA%2520binding%2520domain%2520reveals%2520potential%2520unique%2520drug%2520targeting%2520sites%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2020%26doi%3D10.1016%2Fj.apsb.2020.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wrapp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiona, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, J. S.</span></span> <span> </span><span class="NLM_article-title">Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">6483</span>),  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1263</span>, <span class="refDoi"> DOI: 10.1126/science.abb2507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abb2507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32075877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvFemt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2020&pages=1260-1263&issue=6483&author=D.+Wrappauthor=N.+Wangauthor=K.+S.+Corbettauthor=J.+A.+Goldsmithauthor=C.+L.+Hsiehauthor=O.+Abionaauthor=B.+S.+Grahamauthor=J.+S.+McLellan&title=Cryo-EM+structure+of+the+2019-nCoV+spike+in+the+prefusion+conformation&doi=10.1126%2Fscience.abb2507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</span></div><div class="casAuthors">Wrapp, Daniel; Wang, Nianshuang; Corbett, Kizzmekia S.; Goldsmith, Jory A.; Hsieh, Ching-Lin; Abiona, Olubukola; Graham, Barney S.; McLellan, Jason S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6483</span>),
    <span class="NLM_cas:pages">1260-1263</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern.  The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics.  To facilitate medical countermeasure development, we detd. a 3.5-angstrom-resoln. cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation.  The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation.  We also provide biophys. and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S.  Addnl., we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs.  The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFmIhnTBqdt7Vg90H21EOLACvtfcHk0lhdNe0EAkv8hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvFemt70%253D&md5=27d08cbb9a43d1da051a8a92a9f68aa5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb2507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb2507%26sid%3Dliteratum%253Aachs%26aulast%3DWrapp%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCorbett%26aufirst%3DK.%2BS.%26aulast%3DGoldsmith%26aufirst%3DJ.%2BA.%26aulast%3DHsieh%26aufirst%3DC.%2BL.%26aulast%3DAbiona%26aufirst%3DO.%26aulast%3DGraham%26aufirst%3DB.%2BS.%26aulast%3DMcLellan%26aufirst%3DJ.%2BS.%26atitle%3DCryo-EM%2520structure%2520of%2520the%25202019-nCoV%2520spike%2520in%2520the%2520prefusion%2520conformation%26jtitle%3DScience%26date%3D2020%26volume%3D367%26issue%3D6483%26spage%3D1260%26epage%3D1263%26doi%3D10.1126%2Fscience.abb2507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walls, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veesler, D.</span></span> <span> </span><span class="NLM_article-title">Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.02.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cell.2020.02.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32155444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvVejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=281-292&issue=2&author=A.+C.+Wallsauthor=Y.+J.+Parkauthor=M.+A.+Tortoriciauthor=A.+Wallauthor=A.+T.+McGuireauthor=D.+Veesler&title=Structure%2C+function%2C+and+antigenicity+of+the+SARS-CoV-2+spike+glycoprotein&doi=10.1016%2Fj.cell.2020.02.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</span></div><div class="casAuthors">Walls, Alexandra C.; Park, Young-Jun; Tortorici, M. Alejandra; Wall, Abigail; McGuire, Andrew T.; Veesler, David</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-292.e6</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The emergence of SARS-CoV-2 has resulted in >90,000 infections and >3000 deaths.  Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies.  We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, correlating with the efficient spread of SARS-CoV-2 among humans.  We found that the SARS-CoV-2 S glycoprotein harbors a furin cleavage site at the boundary between the S1/S2 subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and SARS-related CoVs.  We detd. cryo-EM structures of the SARS-CoV-2 S ectodomain trimer, providing a blueprint for the design of vaccines and inhibitors of viral entry.  Finally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited SARS-CoV-2 S mediated entry into cells, indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpiIU58FB3rVg90H21EOLACvtfcHk0lhdNe0EAkv8hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvVejsLk%253D&md5=ac8a8a208d9c26f88f702fb7634ab1ab</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.02.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.02.058%26sid%3Dliteratum%253Aachs%26aulast%3DWalls%26aufirst%3DA.%2BC.%26aulast%3DPark%26aufirst%3DY.%2BJ.%26aulast%3DTortorici%26aufirst%3DM.%2BA.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DMcGuire%26aufirst%3DA.%2BT.%26aulast%3DVeesler%26aufirst%3DD.%26atitle%3DStructure%252C%2520function%252C%2520and%2520antigenicity%2520of%2520the%2520SARS-CoV-2%2520spike%2520glycoprotein%26jtitle%3DCell%26date%3D2020%26volume%3D181%26issue%3D2%26spage%3D281%26epage%3D292%26doi%3D10.1016%2Fj.cell.2020.02.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, M. H.</span></span> <span> </span><span class="NLM_article-title">Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.drudis.2015.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26691874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVemt7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=562-572&issue=4&author=C.+K.+Changauthor=S.+C.+Loauthor=Y.+S.+Wangauthor=M.+H.+Hou&title=Recent+insights+into+the+development+of+therapeutics+against+coronavirus+diseases+by+targeting+N+protein&doi=10.1016%2Fj.drudis.2015.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein</span></div><div class="casAuthors">Chang, Chung-ke; Lo, Shou-Chen; Wang, Yong-Sheng; Hou, Ming-Hon</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">562-572</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The advent of severe acute respiratory syndrome (SARS) in the 21st century and the recent outbreak of Middle-East respiratory syndrome (MERS) highlight the importance of coronaviruses (CoVs) as human pathogens, emphasizing the need for development of novel antiviral strategies to combat acute respiratory infections caused by CoVs.  Recent studies suggest that nucleocapsid (N) proteins from coronaviruses and other viruses can be useful antiviral drug targets against viral infections.  This review aims to provide readers with a concise survey of the structural features of coronavirus N proteins and how these features provide insights into structure-based development of therapeutics against coronaviruses.  We will also present our latest results on MERS-CoV N protein and its potential as an antiviral drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNuHrvMgDnibVg90H21EOLACvtfcHk0lhLd3_57PavfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVemt7bF&md5=f6f949b2b3fe7f56e014075f73fb2e2d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DHou%26aufirst%3DM.%2BH.%26atitle%3DRecent%2520insights%2520into%2520the%2520development%2520of%2520therapeutics%2520against%2520coronavirus%2520diseases%2520by%2520targeting%2520N%2520protein%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D562%26epage%3D572%26doi%3D10.1016%2Fj.drudis.2015.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sue, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. H.</span></span> <span> </span><span class="NLM_article-title">Modular organization of SARS coronavirus nucleocapsid protein</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1007/s11373-005-9035-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs11373-005-9035-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16228284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XntV2ht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=59-72&issue=1&author=C.+K.+Changauthor=S.+C.+Sueauthor=T.+H.+Yuauthor=C.+M.+Hsiehauthor=C.+K.+Tsaiauthor=Y.+C.+Chiangauthor=S.+J.+Leeauthor=H.+H.+Hsiaoauthor=W.+J.+Wuauthor=W.+L.+Changauthor=C.+H.+Linauthor=T.+H.+Huang&title=Modular+organization+of+SARS+coronavirus+nucleocapsid+protein&doi=10.1007%2Fs11373-005-9035-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Modular organization of SARS coronavirus nucleocapsid protein</span></div><div class="casAuthors">Chang, Chung-ke; Sue, Shih-Che; Yu, Tsan-hung; Hsieh, Chiu-Min; Tsai, Cheng-Kun; Chiang, Yen-Chieh; Lee, Shin-jye; Hsiao, Hsin-hao; Wu, Wen-Jin; Chang, Wei-Lun; Lin, Chung-Hung; Huang, Tai-huang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Science (Dordrecht, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-72</span>CODEN:
                <span class="NLM_cas:coden">JBCIEA</span>;
        ISSN:<span class="NLM_cas:issn">1021-7770</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The SARS-CoV nucleocapsid (N) protein is a major antigen in severe acute respiratory syndrome.  It binds to the viral RNA genome and forms the ribonucleoprotein core.  The SARS-CoV N protein has also been suggested to be involved in other important functions in the viral life cycle.  Here we show that the N protein consists of two non-interacting structural domains, the N-terminal RNA-binding domain (RBD) (residues 45-181) and the C-terminal dimerization domain (residues 248-365) (DD), surrounded by flexible linkers.  The C-terminal domain exists exclusively as a dimer in soln.  The flexible linkers are intrinsically disordered and represent potential interaction sites with other protein and protein-RNA partners.  Bioinformatics reveal that other coronavirus N proteins could share the same modular organization.  This study provides information on the domain structure partition of SARS-CoV N protein and insights into the differing roles of structured and disordered regions in coronavirus nucleocapsid proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD70v9DrYd_bVg90H21EOLACvtfcHk0lhLd3_57PavfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntV2ht7w%253D&md5=6893641b9cc6430fca74a8ea077fbe23</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs11373-005-9035-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11373-005-9035-9%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DSue%26aufirst%3DS.%2BC.%26aulast%3DYu%26aufirst%3DT.%2BH.%26aulast%3DHsieh%26aufirst%3DC.%2BM.%26aulast%3DTsai%26aufirst%3DC.%2BK.%26aulast%3DChiang%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DHsiao%26aufirst%3DH.%2BH.%26aulast%3DWu%26aufirst%3DW.%2BJ.%26aulast%3DChang%26aufirst%3DW.%2BL.%26aulast%3DLin%26aufirst%3DC.%2BH.%26aulast%3DHuang%26aufirst%3DT.%2BH.%26atitle%3DModular%2520organization%2520of%2520SARS%2520coronavirus%2520nucleocapsid%2520protein%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2006%26volume%3D13%26issue%3D1%26spage%3D59%26epage%3D72%26doi%3D10.1007%2Fs11373-005-9035-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">17134</span>– <span class="NLM_lpage">17139</span>, <span class="refDoi"> DOI: 10.1074/jbc.M602107200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M602107200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16627473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVGksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=17134-17139&issue=25&author=I.+M.+Yuauthor=M.+L.+Oldhamauthor=J.+Zhangauthor=J.+Chen&title=Crystal+structure+of+the+severe+acute+respiratory+syndrome+%28SARS%29+coronavirus+nucleocapsid+protein+dimerization+domain+reveals+evolutionary+linkage+between+corona-+and+arteriviridae&doi=10.1074%2Fjbc.M602107200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein Dimerization Domain Reveals Evolutionary Linkage between Corona- and Arteriviridae</span></div><div class="casAuthors">Yu, I-Mei; Oldham, Michael L.; Zhang, Jingqiang; Chen, Jue</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">17134-17139</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The causative agent of severe acute respiratory syndrome (SARS) is the SARS-assocd. coronavirus, SARS-CoV.  The nucleocapsid (N) protein plays an essential role in SARS-CoV genome packaging and virion assembly.  We have previously shown that SARS-CoV N protein forms a dimer in soln. through its C-terminal domain.  In this study, the crystal structure of the dimerization domain, consisting of residues 270-370, is detd. to 1.75Å resoln.  The structure shows a dimer with extensive interactions between the two subunits, suggesting that the dimeric form of the N protein is the functional unit in vivo.  Although lacking significant sequence similarity, the dimerization domain of SARS-CoV N protein has a fold similar to that of the nucleocapsid protein of the porcine reproductive and respiratory syndrome virus.  This finding provides structural evidence of the evolutionary link between Coronaviridae and Arteriviridae, suggesting that the N proteins of both viruses have a common origin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobnd_sO534aLVg90H21EOLACvtfcHk0lgFMDeaZQKVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVGksbw%253D&md5=b546a5d031d2a20cd48abeb2f2da25e9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M602107200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M602107200%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DI.%2BM.%26aulast%3DOldham%26aufirst%3DM.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520%2528SARS%2529%2520coronavirus%2520nucleocapsid%2520protein%2520dimerization%2520domain%2520reveals%2520evolutionary%2520linkage%2520between%2520corona-%2520and%2520arteriviridae%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D25%26spage%3D17134%26epage%3D17139%26doi%3D10.1074%2Fjbc.M602107200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, M. H.</span></span> <span> </span><span class="NLM_article-title">Crystallographic analysis of the N-terminal domain of Middle East respiratory syndrome coronavirus nucleocapsid protein</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">977</span>– <span class="NLM_lpage">980</span>, <span class="refDoi"> DOI: 10.1107/S2053230X15010146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1107%2FS2053230X15010146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26249685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12gs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=977-980&issue=8&author=Y.+S.+Wangauthor=C.+K.+Changauthor=M.+H.+Hou&title=Crystallographic+analysis+of+the+N-terminal+domain+of+Middle+East+respiratory+syndrome+coronavirus+nucleocapsid+protein&doi=10.1107%2FS2053230X15010146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic analysis of the N-terminal domain of Middle East respiratory syndrome coronavirus nucleocapsid protein</span></div><div class="casAuthors">Wang, Yong-Sheng; Chang, Chung-ke; Hou, Ming-Hon</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">977-980</span>CODEN:
                <span class="NLM_cas:coden">ACSFEN</span>;
        ISSN:<span class="NLM_cas:issn">2053-230X</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The N-terminal domain of the nucleocapsid protein from Middle East respiratory syndrome coronavirus (MERS-CoV NP-NTD) contains many pos. charged residues and has been identified to be responsible for RNA binding during ribonucleocapsid formation by the virus.  The crystn. and crystallog. anal. of MERS-CoV NP-NTD (amino acids 39-165), with a mol. wt. of 14.7 kDa, are reported.  MERS-CoV NP-NTD was crystd. at 293 K using PEG 3350 as a precipitant and a 94.5% complete native data set was collected from a cooled crystal at 77 K to 2.63 Å resoln. with an overall R merge of 9.6%.  The crystals were monoclinic and belonged to space group P21, with a 35.60, b 109.64, c 91.99 Å, β 101.22°.  The asym. unit contained four MERS-CoV NP-NTD mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoen0Q4nKqiyLVg90H21EOLACvtfcHk0lgFMDeaZQKVPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12gs7bN&md5=e7cd9bb84b6a153faf3164cc440d6290</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS2053230X15010146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053230X15010146%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DHou%26aufirst%3DM.%2BH.%26atitle%3DCrystallographic%2520analysis%2520of%2520the%2520N-terminal%2520domain%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520nucleocapsid%2520protein%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Commun.%26date%3D2015%26volume%3D71%26issue%3D8%26spage%3D977%26epage%3D980%26doi%3D10.1107%2FS2053230X15010146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehn-Hall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, M. H.</span></span> <span> </span><span class="NLM_article-title">Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3141</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01913</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01913" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3131-3141&issue=6&author=S.+M.+Linauthor=S.+C.+Linauthor=J.+N.+Hsuauthor=C.+K.+Changauthor=C.+M.+Chienauthor=Y.+S.+Wangauthor=H.+Y.+Wuauthor=U.+S.+Jengauthor=K.+Kehn-Hallauthor=M.+H.+Hou&title=Structure-based+stabilization+of+non-native+protein-protein+interactions+of+coronavirus+nucleocapsid+proteins+in+antiviral+drug+design&doi=10.1021%2Facs.jmedchem.9b01913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design</span></div><div class="casAuthors">Lin, Shan-Meng; Lin, Shih-Chao; Hsu, Jia-Ning; Chang, Chung-ke; Chien, Ching-Ming; Wang, Yong-Sheng; Wu, Hung-Yi; Jeng, U-Ser; Kehn-Hall, Kylene; Hou, Ming-Hon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3131-3141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based stabilization of protein-protein interactions (PPIs) is a promising strategy for drug discovery.  However, this approach has mainly focused on the stabilization of native PPIs, and non-native PPIs have received little consideration.  Here, we identified a non-native interaction interface on the three-dimensional dimeric structure of the N-terminal domain of the MERS-CoV nucleocapsid protein (MERS-CoV N-NTD).  The interface formed a conserved hydrophobic cavity suitable for targeted drug screening.  By considering the hydrophobic complementarity during the virtual screening step, we identified 5-benzyloxygramine as a new N protein PPI orthosteric stabilizer that exhibits both antiviral and N-NTD protein-stabilizing activities.  X-ray crystallog. and small-angle X-ray scattering showed that 5-benzyloxygramine stabilizes the N-NTD dimers through simultaneous hydrophobic interactions with both partners, resulting in abnormal N protein oligomerization that was further confirmed in the cell.  This unique approach based on the identification and stabilization of non-native PPIs of N protein could be applied toward drug discovery against CoV diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVm43csqQD9rVg90H21EOLACvtfcHk0lj3fLZkzyDyjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOgtro%253D&md5=7a38254192c8fd901ff85ba3d0086259</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01913%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%2BM.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DHsu%26aufirst%3DJ.%2BN.%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DChien%26aufirst%3DC.%2BM.%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DJeng%26aufirst%3DU.%2BS.%26aulast%3DKehn-Hall%26aufirst%3DK.%26aulast%3DHou%26aufirst%3DM.%2BH.%26atitle%3DStructure-based%2520stabilization%2520of%2520non-native%2520protein-protein%2520interactions%2520of%2520coronavirus%2520nucleocapsid%2520proteins%2520in%2520antiviral%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D6%26spage%3D3131%26epage%3D3141%26doi%3D10.1021%2Facs.jmedchem.9b01913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quadeer, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, M. R.</span></span> <span> </span><span class="NLM_article-title">Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">254</span>, <span class="refDoi"> DOI: 10.3390/v12030254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv12030254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVKlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=254&issue=3&author=S.+F.+Ahmedauthor=A.+A.+Quadeerauthor=M.+R.+McKay&title=Preliminary+identification+of+potential+vaccine+targets+for+the+COVID-19+coronavirus+%28SARS-CoV-2%29+based+on+SARS-CoV+immunological+studies&doi=10.3390%2Fv12030254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies</span></div><div class="casAuthors">Ahmed, Syed Faraz; Quadeer, Ahmed A.; McKay, Matthew R.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">254</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).  There is an imminent need to better understand this new virus and to develop ways to control its spread.  In this study, we sought to gain insights for vaccine design against SARS-CoV-2 by considering the high genetic similarity between SARS-CoV-2 and SARS-CoV, which caused the outbreak in 2003, and leveraging existing immunol. studies of SARS-CoV.  By screening the exptl.-detd. SARS-CoV-derived B cell and T cell epitopes in the immunogenic structural proteins of SARS-CoV, we identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins.  As no mutation has been obsd. in these identified epitopes among the 120 available SARS-CoV-2 sequences (as of 21 Feb. 2020), immune targeting of these epitopes may potentially offer protection against this novel virus.  For the T cell epitopes, we performed a population coverage anal. of the assocd. MHC alleles and proposed a set of epitopes that is estd. to provide broad coverage globally, as well as in China.  Our findings provide a screened set of epitopes that can help guide exptl. efforts towards the development of vaccines against SARS-CoV-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLk6VGbroshLVg90H21EOLACvtfcHk0lj3fLZkzyDyjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVKlsLk%253D&md5=257427542d56c4b904f0d92562b493fa</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3390%2Fv12030254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv12030254%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BF.%26aulast%3DQuadeer%26aufirst%3DA.%2BA.%26aulast%3DMcKay%26aufirst%3DM.%2BR.%26atitle%3DPreliminary%2520identification%2520of%2520potential%2520vaccine%2520targets%2520for%2520the%2520COVID-19%2520coronavirus%2520%2528SARS-CoV-2%2529%2520based%2520on%2520SARS-CoV%2520immunological%2520studies%26jtitle%3DViruses%26date%3D2020%26volume%3D12%26issue%3D3%26spage%3D254%26doi%3D10.3390%2Fv12030254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span> <span> </span><span class="NLM_article-title">Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">6</span>), <span class="NLM_elocation-id">e00461-20</span> <span class="refDoi"> DOI: 10.1128/JCM.00461-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJCM.00461-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32229605" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2020&issue=6&author=W.+Liuauthor=L.+Liuauthor=G.+Kouauthor=Y.+Zhengauthor=Y.+Dingauthor=W.+Niauthor=Q.+Wangauthor=L.+Tanauthor=W.+Wuauthor=S.+Tangauthor=Z.+Xiongauthor=S.+Zheng&title=Evaluation+of+nucleocapsid+and+spike+protein-based+enzyme-linked+immunosorbent+assays+for+detecting+antibodies+against+SARS-CoV-2&doi=10.1128%2FJCM.00461-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FJCM.00461-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.00461-20%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKou%26aufirst%3DG.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DS.%26atitle%3DEvaluation%2520of%2520nucleocapsid%2520and%2520spike%2520protein-based%2520enzyme-linked%2520immunosorbent%2520assays%2520for%2520detecting%2520antibodies%2520against%2520SARS-CoV-2%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2020%26volume%3D58%26issue%3D6%26doi%3D10.1128%2FJCM.00461-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belouzard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licitra, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, G. R.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of coronavirus cell entry mediated by the viral spike protein</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.3390/v4061011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv4061011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22816037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFyltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1011-1033&issue=6&author=S.+Belouzardauthor=J.+K.+Milletauthor=B.+N.+Licitraauthor=G.+R.+Whittaker&title=Mechanisms+of+coronavirus+cell+entry+mediated+by+the+viral+spike+protein&doi=10.3390%2Fv4061011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of coronavirus cell entry mediated by the viral spike protein</span></div><div class="casAuthors">Belouzard, Sandrine; Millet, Jean K.; Licitra, Beth N.; Whittaker, Gary R.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1011-1033</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Coronaviruses are enveloped pos.-stranded RNA viruses that replicate in the cytoplasm.  To deliver their nucleocapsid into the host cell, they rely on the fusion of their envelope with the host cell membrane.  The spike glycoprotein (S) mediates virus entry and is a primary determinant of cell tropism and pathogenesis.  It is classified as a class I fusion protein, and is responsible for binding to the receptor on the host cell as well as mediating the fusion of host and viral membranes - A process driven by major conformational changes of the S protein.  This review discusses coronavirus entry mechanisms focusing on the different triggers used by coronaviruses to initiate the conformational change of the S protein: receptor binding, low pH exposure and proteolytic activation.  We also highlight commonalities between coronavirus S proteins and other class I viral fusion proteins, as well as distinctive features that confer distinct tropism, pathogenicity and host interspecies transmission characteristics to coronaviruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCenM_gs7LW7Vg90H21EOLACvtfcHk0lgyDZ5vyV1L9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFyltrk%253D&md5=327223944a652c715b0a1550d0e4038a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fv4061011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv4061011%26sid%3Dliteratum%253Aachs%26aulast%3DBelouzard%26aufirst%3DS.%26aulast%3DMillet%26aufirst%3DJ.%2BK.%26aulast%3DLicitra%26aufirst%3DB.%2BN.%26aulast%3DWhittaker%26aufirst%3DG.%2BR.%26atitle%3DMechanisms%2520of%2520coronavirus%2520cell%2520entry%2520mediated%2520by%2520the%2520viral%2520spike%2520protein%26jtitle%3DViruses%26date%3D2012%26volume%3D4%26issue%3D6%26spage%3D1011%26epage%3D1033%26doi%3D10.3390%2Fv4061011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lamballerie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span> <span> </span><span class="NLM_article-title">The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">104742</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2020.104742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2020.104742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32057769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFertr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2020&pages=104742&author=B.+Coutardauthor=C.+Valleauthor=X.+de+Lamballerieauthor=B.+Canardauthor=N.+G.+Seidahauthor=E.+Decroly&title=The+spike+glycoprotein+of+the+new+coronavirus+2019-nCoV+contains+a+furin-like+cleavage+site+absent+in+CoV+of+the+same+clade&doi=10.1016%2Fj.antiviral.2020.104742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade</span></div><div class="casAuthors">Coutard, B.; Valle, C.; de Lamballerie, X.; Canard, B.; Seidah, N. G.; Decroly, E.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104742</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In 2019, a new coronavirus (2019-nCoV) infecting Humans has emerged in Wuhan, China.  Its genome has been sequenced and the genomic information promptly released.  Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs.  In this article, we discuss the possible functional consequences of this cleavage site in the viral cycle, pathogenicity and its potential implication in the development of antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplFPbfI9oPe7Vg90H21EOLACvtfcHk0lgyDZ5vyV1L9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFertr0%253D&md5=144e90f8ac4dc1a517c899b10c4a7a98</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2020.104742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2020.104742%26sid%3Dliteratum%253Aachs%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DValle%26aufirst%3DC.%26aulast%3Dde%2BLamballerie%26aufirst%3DX.%26aulast%3DCanard%26aufirst%3DB.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DDecroly%26aufirst%3DE.%26atitle%3DThe%2520spike%2520glycoprotein%2520of%2520the%2520new%2520coronavirus%25202019-nCoV%2520contains%2520a%2520furin-like%2520cleavage%2520site%2520absent%2520in%2520CoV%2520of%2520the%2520same%2520clade%26jtitle%3DAntiviral%2520Res.%26date%3D2020%26volume%3D176%26spage%3D104742%26doi%3D10.1016%2Fj.antiviral.2020.104742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirchdoerfer, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrapp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottrell, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span> <span> </span><span class="NLM_article-title">Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15701</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-34171-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41598-018-34171-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30356097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB3cvivVWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=15701&issue=1&author=R.+N.+Kirchdoerferauthor=N.+Wangauthor=J.+Pallesenauthor=D.+Wrappauthor=H.+L.+Turnerauthor=C.+A.+Cottrellauthor=K.+S.+Corbettauthor=B.+S.+Grahamauthor=J.+S.+McLellanauthor=A.+B.+Ward&title=Stabilized+coronavirus+spikes+are+resistant+to+conformational+changes+induced+by+receptor+recognition+or+proteolysis&doi=10.1038%2Fs41598-018-34171-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis</span></div><div class="casAuthors">Kirchdoerfer Robert N; Pallesen Jesper; Turner Hannah L; Cottrell Christopher A; Ward Andrew B; Wang Nianshuang; Wrapp Daniel; McLellan Jason S; Wang Nianshuang; Wrapp Daniel; McLellan Jason S; Corbett Kizzmekia S; Graham Barney S</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15701</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 as a highly transmissible pathogenic human betacoronavirus.  The viral spike glycoprotein (S) utilizes angiotensin-converting enzyme 2 (ACE2) as a host protein receptor and mediates fusion of the viral and host membranes, making S essential to viral entry into host cells and host species tropism.  As SARS-CoV enters host cells, the viral S is believed to undergo a number of conformational transitions as it is cleaved by host proteases and binds to host receptors.  We recently developed stabilizing mutations for coronavirus spikes that prevent the transition from the pre-fusion to post-fusion states.  Here, we present cryo-EM analyses of a stabilized trimeric SARS-CoV S, as well as the trypsin-cleaved, stabilized S, and its interactions with ACE2.  Neither binding to ACE2 nor cleavage by trypsin at the S1/S2 cleavage site impart large conformational changes within stabilized SARS-CoV S or expose the secondary cleavage site, S2'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMhgmGs8bVb3O4gDb7JggCfW6udTcc2eaYoIHzSSQWkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvivVWmtw%253D%253D&md5=183ae3b2751cabbb4c132b7d931b3c34</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-34171-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-34171-7%26sid%3Dliteratum%253Aachs%26aulast%3DKirchdoerfer%26aufirst%3DR.%2BN.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DPallesen%26aufirst%3DJ.%26aulast%3DWrapp%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DH.%2BL.%26aulast%3DCottrell%26aufirst%3DC.%2BA.%26aulast%3DCorbett%26aufirst%3DK.%2BS.%26aulast%3DGraham%26aufirst%3DB.%2BS.%26aulast%3DMcLellan%26aufirst%3DJ.%2BS.%26aulast%3DWard%26aufirst%3DA.%2BB.%26atitle%3DStabilized%2520coronavirus%2520spikes%2520are%2520resistant%2520to%2520conformational%2520changes%2520induced%2520by%2520receptor%2520recognition%2520or%2520proteolysis%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26issue%3D1%26spage%3D15701%26doi%3D10.1038%2Fs41598-018-34171-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takayama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekizuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutsuna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmagari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kageyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span> <span> </span><span class="NLM_article-title">Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">7001</span>– <span class="NLM_lpage">7003</span>, <span class="refDoi"> DOI: 10.1073/pnas.2002589117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.2002589117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32165541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmt1Gju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=7001-7003&issue=13&author=S.+Matsuyamaauthor=N.+Naoauthor=K.+Shiratoauthor=M.+Kawaseauthor=S.+Saitoauthor=I.+Takayamaauthor=N.+Nagataauthor=T.+Sekizukaauthor=H.+Katohauthor=F.+Katoauthor=M.+Sakataauthor=M.+Taharaauthor=S.+Kutsunaauthor=N.+Ohmagariauthor=M.+Kurodaauthor=T.+Suzukiauthor=T.+Kageyamaauthor=M.+Takeda&title=Enhanced+isolation+of+SARS-CoV-2+by+TMPRSS2-expressing+cells&doi=10.1073%2Fpnas.2002589117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells</span></div><div class="casAuthors">Matsuyama, Shutoku; Nao, Naganori; Shirato, Kazuya; Kawase, Miyuki; Saito, Shinji; Takayama, Ikuyo; Nagata, Noriyo; Sekizuka, Tsuyoshi; Katoh, Hiroshi; Kato, Fumihiro; Sakata, Masafumi; Tahara, Maino; Kutsuna, Satoshi; Ohmagari, Norio; Kuroda, Makoto; Suzuki, Tadaki; Kageyama, Tsutomu; Takeda, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">7001-7003</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused a large respiratory outbreak in Wuhan, China in Dec. 2019, is currently spreading across many countries globally.  Here, we show that a TMPRSS2-expressing VeroE6 cell line is highly susceptible to SARS-CoV-2 infection, making it useful for isolating and propagating SARS-CoV-2.  Our results reveal that, in common with SARS- and Middle East respiratory syndrome-CoV, SARS-CoV-2 infection is enhanced by TMPRSS2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq65upK_3RQSLVg90H21EOLACvtfcHk0lj_FyJIUpkxWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmt1Gju7w%253D&md5=e56cdb5c3af49b0a518e291da54deaf6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2002589117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2002589117%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuyama%26aufirst%3DS.%26aulast%3DNao%26aufirst%3DN.%26aulast%3DShirato%26aufirst%3DK.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DTakayama%26aufirst%3DI.%26aulast%3DNagata%26aufirst%3DN.%26aulast%3DSekizuka%26aufirst%3DT.%26aulast%3DKatoh%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DF.%26aulast%3DSakata%26aufirst%3DM.%26aulast%3DTahara%26aufirst%3DM.%26aulast%3DKutsuna%26aufirst%3DS.%26aulast%3DOhmagari%26aufirst%3DN.%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKageyama%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3DEnhanced%2520isolation%2520of%2520SARS-CoV-2%2520by%2520TMPRSS2-expressing%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2020%26volume%3D117%26issue%3D13%26spage%3D7001%26epage%3D7003%26doi%3D10.1073%2Fpnas.2002589117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millet, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, G. R.</span></span> <span> </span><span class="NLM_article-title">Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis</span>. <i>Virus Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.virusres.2014.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virusres.2014.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25445340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2015&pages=120-134&author=J.+K.+Milletauthor=G.+R.+Whittaker&title=Host+cell+proteases%3A+Critical+determinants+of+coronavirus+tropism+and+pathogenesis&doi=10.1016%2Fj.virusres.2014.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis</span></div><div class="casAuthors">Millet, Jean Kaoru; Whittaker, Gary R.</div><div class="citationInfo"><span class="NLM_cas:title">Virus Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-134</span>CODEN:
                <span class="NLM_cas:coden">VIREDF</span>;
        ISSN:<span class="NLM_cas:issn">0168-1702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Coronaviruses are a large group of enveloped, single-stranded pos.-sense RNA viruses that infect a wide range of avian and mammalian species, including humans.  The emergence of deadly human coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) have bolstered research in these viral and often zoonotic pathogens.  While coronavirus cell and tissue tropism, host range, and pathogenesis are initially controlled by interactions between the spike envelope glycoprotein and host cell receptor, it is becoming increasingly apparent that proteolytic activation of spike by host cell proteases also plays a crit. role.  Coronavirus spike proteins are the main determinant of entry as they possess both receptor binding and fusion functions.  Whereas binding to the host cell receptor is an essential 1st step in establishing infection, the proteolytic activation step is often crit. for the fusion function of spike, as it allows for controlled release of the fusion peptide into target cellular membranes.  Coronaviruses have evolved multiple strategies for proteolytic activation of spike, and a large no. of host proteases have been shown to proteolytically process the spike protein.  These include, but are not limited to, endosomal cathepsins, cell surface transmembrane protease/serine (TMPRSS) proteases, furin, and trypsin.  This review focuses on the diversity of strategies coronaviruses have evolved to proteolytically activate their fusion protein during spike protein biosynthesis and the crit. entry step of their life cycle, and highlights important findings on how proteolytic activation of coronavirus spike influences tissue and cell tropism, host range, and pathogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzYtaR7rmObLVg90H21EOLACvtfcHk0lg1xXte3cP_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsbjN&md5=1f9248a8886148418b7f7e6109fd6796</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.virusres.2014.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virusres.2014.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DMillet%26aufirst%3DJ.%2BK.%26aulast%3DWhittaker%26aufirst%3DG.%2BR.%26atitle%3DHost%2520cell%2520proteases%253A%2520Critical%2520determinants%2520of%2520coronavirus%2520tropism%2520and%2520pathogenesis%26jtitle%3DVirus%2520Res.%26date%3D2015%26volume%3D202%26spage%3D120%26epage%3D134%26doi%3D10.1016%2Fj.virusres.2014.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">6485</span>),  <span class="NLM_fpage">1444</span>– <span class="NLM_lpage">1448</span>, <span class="refDoi"> DOI: 10.1126/science.abb2762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abb2762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32132184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslymsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2020&pages=1444-1448&issue=6485&author=R.+Yanauthor=Y.+Zhangauthor=Y.+Liauthor=L.+Xiaauthor=Y.+Guoauthor=Q.+Zhou&title=Structural+basis+for+the+recognition+of+SARS-CoV-2+by+full-length+human+ACE2&doi=10.1126%2Fscience.abb2762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2</span></div><div class="casAuthors">Yan, Renhong; Zhang, Yuanyuan; Li, Yaning; Xia, Lu; Guo, Yingying; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6485</span>),
    <span class="NLM_cas:pages">1444-1448</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for severe acute respiratory syndrome coronavirus (SARS-CoV) and the new coronavirus (SARS-CoV-2) that is causing the serious coronavirus disease 2019 (COVID-19) epidemic.  Here, we present cryo-electron microscopy structures of full-length human ACE2 in the presence of the neutral amino acid transporter B0AT1 with or without the receptor binding domain (RBD) of the surface spike glycoprotein (S protein) of SARS-CoV-2, both at an overall resoln. of 2.9 angstroms, with a local resoln. of 3.5 angstroms at the ACE2-RBD interface.  The ACE2-B0AT1 complex is assembled as a dimer of heterodimers, with the collectrin-like domain of ACE2 mediating homodimerization.  The RBD is recognized by the extracellular peptidase domain of ACE2 mainly through polar residues.  These findings provide important insights into the mol. basis for coronavirus recognition and infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryg8CJeTxdsrVg90H21EOLACvtfcHk0lg1xXte3cP_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslymsLo%253D&md5=ff4dfdfc646ea878cfb325019160e94a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb2762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb2762%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DStructural%2520basis%2520for%2520the%2520recognition%2520of%2520SARS-CoV-2%2520by%2520full-length%2520human%2520ACE2%26jtitle%3DScience%26date%3D2020%26volume%3D367%26issue%3D6485%26spage%3D1444%26epage%3D1448%26doi%3D10.1126%2Fscience.abb2762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>581</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2180-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2180-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32225176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXoslOqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2020&pages=215-220&author=J.+Lanauthor=J.+Geauthor=J.+Yuauthor=S.+Shanauthor=H.+Zhouauthor=S.+Fanauthor=Q.+Zhangauthor=X.+Shiauthor=Q.+Wangauthor=L.+Zhangauthor=X.+Wang&title=Structure+of+the+SARS-CoV-2+spike+receptor-binding+domain+bound+to+the+ACE2+receptor&doi=10.1038%2Fs41586-020-2180-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</span></div><div class="casAuthors">Lan, Jun; Ge, Jiwan; Yu, Jinfang; Shan, Sisi; Zhou, Huan; Fan, Shilong; Zhang, Qi; Shi, Xuanling; Wang, Qisheng; Zhang, Linqi; Wang, Xinquan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">7807</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from Dec. 2019 that quickly spread nationwide and to other countries around the world1-3.  Here, to better understand the initial step of infection at an at. level, we detd. the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2.  The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor4.  Structural anal. identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD.  Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses1-3,5.  The epitopes of two SARS-CoV antibodies that target the RBD are also analyzed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXsiu14u7z5bVg90H21EOLACvtfcHk0lgUfBpwvTJWbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXoslOqtL8%253D&md5=279c60143e8e5eb505457e0778baa8ef</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2180-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2180-5%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DShan%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DStructure%2520of%2520the%2520SARS-CoV-2%2520spike%2520receptor-binding%2520domain%2520bound%2520to%2520the%2520ACE2%2520receptor%26jtitle%3DNature%26date%3D2020%26volume%3D581%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fs41586-020-2180-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aihara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auerbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">Structural basis of receptor recognition by SARS-CoV-2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>581</i></span> (<span class="NLM_issue">7807</span>),  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2179-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2179-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32225175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXoslOqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2020&pages=221-224&issue=7807&author=J.+Shangauthor=G.+Yeauthor=K.+Shiauthor=Y.+Wanauthor=C.+Luoauthor=H.+Aiharaauthor=Q.+Gengauthor=A.+Auerbachauthor=F.+Li&title=Structural+basis+of+receptor+recognition+by+SARS-CoV-2&doi=10.1038%2Fs41586-020-2179-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of receptor recognition by SARS-CoV-2</span></div><div class="casAuthors">Shang, Jian; Ye, Gang; Shi, Ke; Wan, Yushun; Luo, Chuming; Aihara, Hideki; Geng, Qibin; Auerbach, Ashley; Li, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">7807</span>),
    <span class="NLM_cas:pages">221-224</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A novel severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2) recently emerged and is rapidly spreading in humans, causing COVID-191,2.  A key to tackling this pandemic is to understand the receptor recognition mechanism of the virus, which regulates its infectivity, pathogenesis and host range.  SARS-CoV-2 and SARS-CoV recognize the same receptor-angiotensin-converting enzyme 2 (ACE2)-in humans3,4.  Here we detd. the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 (engineered to facilitate crystn.) in complex with ACE2.  In comparison with the SARS-CoV RBD, an ACE2-binding ridge in SARS-CoV-2 RBD has a more compact conformation; moreover, several residue changes in the SARS-CoV-2 RBD stabilize two virus-binding hotspots at the RBD-ACE2 interface.  These structural features of SARS-CoV-2 RBD increase its ACE2-binding affinity.  Addnl., we show that RaTG13, a bat coronavirus that is closely related to SARS-CoV-2, also uses human ACE2 as its receptor.  The differences among SARS-CoV-2, SARS-CoV and RaTG13 in ACE2 recognition shed light on the potential animal-to-human transmission of SARS-CoV-2.  This study provides guidance for intervention strategies that target receptor recognition by SARS-CoV-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWGbLNpR7ZfrVg90H21EOLACvtfcHk0lgUfBpwvTJWbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXoslOqtbs%253D&md5=33bc9151641b2adcfb0dbf446621a1dc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2179-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2179-y%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DK.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DAihara%26aufirst%3DH.%26aulast%3DGeng%26aufirst%3DQ.%26aulast%3DAuerbach%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520of%2520receptor%2520recognition%2520by%2520SARS-CoV-2%26jtitle%3DNature%26date%3D2020%26volume%3D581%26issue%3D7807%26spage%3D221%26epage%3D224%26doi%3D10.1038%2Fs41586-020-2179-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraghty, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">8904</span>– <span class="NLM_lpage">8911</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.325803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M111.325803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22291007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvVehtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=8904-8911&issue=12&author=K.+Wuauthor=G.+Pengauthor=M.+Wilkenauthor=R.+J.+Geraghtyauthor=F.+Li&title=Mechanisms+of+host+receptor+adaptation+by+severe+acute+respiratory+syndrome+coronavirus&doi=10.1074%2Fjbc.M111.325803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus</span></div><div class="casAuthors">Wu, Kailang; Peng, Guiqing; Wilken, Matthew; Geraghty, Robert J.; Li, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8904-8911</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The severe acute respiratory syndrome coronavirus (SARS-CoV) from palm civets has twice evolved the capacity to infect humans by gaining binding affinity for human receptor angiotensin-converting enzyme 2 (ACE2).  Numerous mutations have been identified in the receptor-binding domain (RBD) of different SARS-CoV strains isolated from humans or civets.  Why these mutations were naturally selected or how SARS-CoV evolved to adapt to different host receptors has been poorly understood, presenting evolutionary and epidemic conundrums.  In this study, we investigated the impact of these mutations on receptor recognition, an important determinant of SARS-CoV infection and pathogenesis.  Using a combination of biochem., functional, and crystallog. approaches, we elucidated the mol. and structural mechanisms of each of these naturally selected RBD mutations.  These mutations either strengthen favorable interactions or reduce unfavorable interactions with two virus-binding hot spots on ACE2, and by doing so, they enhance viral interactions with either human (hACE2) or civet (cACE2) ACE2.  Therefore, these mutations were viral adaptations to either hACE2 or cACE2.  To corroborate the above anal., we designed and characterized two optimized RBDs.  The human-optimized RBD contains all of the hACE2-adapted residues (Phe-442, Phe-472, Asn-479, Asp-480, and Thr-487) and possesses exceptionally high affinity for hACE2 but relative low affinity for cACE2.  The civet-optimized RBD contains all of the cACE2-adapted residues (Tyr-442, Pro-472, Arg-479, Gly-480, and Thr-487) and possesses exceptionally high affinity for cACE2 and also substantial affinity for hACE2.  These results not only illustrate the detailed mechanisms of host receptor adaptation by SARS-CoV but also provide a mol. and structural basis for tracking future SARS-CoV evolution in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6_iUt1EsgKLVg90H21EOLACvtfcHk0ljKKO05mZEUyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvVehtbs%253D&md5=5ddec3e87883170a6bcb222d7e71b823</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.325803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.325803%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DG.%26aulast%3DWilken%26aufirst%3DM.%26aulast%3DGeraghty%26aufirst%3DR.%2BJ.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DMechanisms%2520of%2520host%2520receptor%2520adaptation%2520by%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D12%26spage%3D8904%26epage%3D8911%26doi%3D10.1074%2Fjbc.M111.325803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Ooij, C.</span></span> <span> </span><span class="NLM_article-title">Parasitology: Basigin opens the door to malaria</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnrmicro2715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeitrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=3&issue=1&author=C.+van%0AOoij&title=Parasitology%3A+Basigin+opens+the+door+to+malaria&doi=10.1038%2Fnrmicro2715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Parasitology: Basigin opens the door to malaria</span></div><div class="casAuthors">van Ooij, Christiaan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The erythrocyte surface protein basigin is identified as the receptor for Rh5 using a large-scale screen, and probably mediates invasion of all Plasmodium falciparum strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRtMzFOIzKQLVg90H21EOLACvtfcHk0ljKKO05mZEUyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeitrvO&md5=15f6b87aef6b79fd72c947a739a97c20</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2715%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BOoij%26aufirst%3DC.%26atitle%3DParasitology%253A%2520Basigin%2520opens%2520the%2520door%2520to%2520malaria%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2012%26volume%3D10%26issue%3D1%26spage%3D3%26doi%3D10.1038%2Fnrmicro2715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-N.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 invades host cells via a novel route: CD147-spike protein</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">2020.03.14.988345</span>, (accessed 2020-05-30) <span class="refDoi"> DOI: 10.1101/2020.03.14.988345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.03.14.988345" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=2020.03.14.988345&author=K.+Wangauthor=W.+Chenauthor=Y.-S.+Zhouauthor=J.-Q.+Lianauthor=Z.+Zhangauthor=P.+Duauthor=L.+Gongauthor=Y.+Zhangauthor=H.-Y.+Cuiauthor=J.-J.+Gengauthor=B.+Wangauthor=X.-X.+Sunauthor=C.-F.+Wangauthor=X.+Yangauthor=P.+Linauthor=Y.-Q.+Dengauthor=D.+Weiauthor=X.-M.+Yangauthor=Y.-M.+Zhuauthor=K.+Zhangauthor=Z.-H.+Hengauthor=J.-L.+Miaoauthor=T.+Guoauthor=Y.+Shiauthor=J.+Zhangauthor=L.+Fuauthor=Q.-Y.+Wangauthor=H.+Bianauthor=P.+Zhuauthor=Z.-N.+Chen&title=SARS-CoV-2+invades+host+cells+via+a+novel+route%3A+CD147-spike+protein&doi=10.1101%2F2020.03.14.988345"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1101%2F2020.03.14.988345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.03.14.988345%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.-S.%26aulast%3DLian%26aufirst%3DJ.-Q.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DP.%26aulast%3DGong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DH.-Y.%26aulast%3DGeng%26aufirst%3DJ.-J.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DX.-X.%26aulast%3DWang%26aufirst%3DC.-F.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DDeng%26aufirst%3DY.-Q.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DX.-M.%26aulast%3DZhu%26aufirst%3DY.-M.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DHeng%26aufirst%3DZ.-H.%26aulast%3DMiao%26aufirst%3DJ.-L.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.-Y.%26aulast%3DBian%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.-N.%26atitle%3DSARS-CoV-2%2520invades%2520host%2520cells%2520via%2520a%2520novel%2520route%253A%2520CD147-spike%2520protein%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26spage%3D2020.03.14.988345%26doi%3D10.1101%2F2020.03.14.988345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispin, M.</span></span> <span> </span><span class="NLM_article-title">Exploitation of glycosylation in enveloped virus pathobiology</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1863</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">1497</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2019.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bbagen.2019.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31121217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVynsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2019&pages=1480-1497&issue=10&author=Y.+Watanabeauthor=T.+A.+Bowdenauthor=I.+A.+Wilsonauthor=M.+Crispin&title=Exploitation+of+glycosylation+in+enveloped+virus+pathobiology&doi=10.1016%2Fj.bbagen.2019.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Exploitation of glycosylation in enveloped virus pathobiology</span></div><div class="casAuthors">Watanabe, Yasunori; Bowden, Thomas A.; Wilson, Ian A.; Crispin, Max</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1480-1497</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glycosylation is a ubiquitous post-translational modification responsible for a multitude of crucial biol. roles.  As obligate parasites, viruses exploit host-cell machinery to glycosylate their own proteins during replication.  Viral envelope proteins from a variety of human pathogens including HIV-1, influenza virus, Lassa virus, SARS, Zika virus, dengue virus, and Ebola virus have evolved to be extensively glycosylated.  These host-cell derived glycans facilitate diverse structural and functional roles during the viral life-cycle, ranging from immune evasion by glycan shielding to enhancement of immune cell infection.  In this review, we highlight the imperative and auxiliary roles glycans play, and how specific oligosaccharide structures facilitate these functions during viral pathogenesis.  We discuss the growing efforts to exploit viral glycobiol. in the development of anti-viral vaccines and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKbaYVFU4N57Vg90H21EOLACvtfcHk0liUK_IEkMZ09g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVynsbvE&md5=118babe3b318937a35757e0cd5b57521</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2019.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2019.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DBowden%26aufirst%3DT.%2BA.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DCrispin%26aufirst%3DM.%26atitle%3DExploitation%2520of%2520glycosylation%2520in%2520enveloped%2520virus%2520pathobiology%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2019%26volume%3D1863%26issue%3D10%26spage%3D1480%26epage%3D1497%26doi%3D10.1016%2Fj.bbagen.2019.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauthner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrabi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rantalainen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndsen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diedrich, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastidas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delahunty, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenaga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schief, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. C.</span></span> <span> </span><span class="NLM_article-title">Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3693</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06121-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41467-018-06121-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30209313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB3c3ot1aksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3693&issue=1&author=L.+Caoauthor=M.+Pauthnerauthor=R.+Andrabiauthor=K.+Rantalainenauthor=Z.+Berndsenauthor=J.+K.+Diedrichauthor=S.+Menisauthor=D.+Sokauthor=R.+Bastidasauthor=S.+R.+Parkauthor=C.+M.+Delahuntyauthor=L.+Heauthor=J.+Guenagaauthor=R.+T.+Wyattauthor=W.+R.+Schiefauthor=A.+B.+Wardauthor=J.+R.+Yatesauthor=D.+R.+Burtonauthor=J.+C.+Paulson&title=Differential+processing+of+HIV+envelope+glycans+on+the+virus+and+soluble+recombinant+trimer&doi=10.1038%2Fs41467-018-06121-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer</span></div><div class="casAuthors">Cao Liwei; Diedrich Jolene K; Park Sung-Kyu Robin; Delahunty Claire M; He Lin; Yates John R 3rd; Paulson James C; Cao Liwei; Pauthner Matthias; Andrabi Raiees; Menis Sergey; Sok Devin; Bastidas Raiza; Guenaga Javier; Wyatt Richard T; Schief William R; Burton Dennis R; Paulson James C; Cao Liwei; Pauthner Matthias; Andrabi Raiees; Rantalainen Kimmo; Berndsen Zachary; Menis Sergey; Sok Devin; Bastidas Raiza; Guenaga Javier; Wyatt Richard T; Schief William R; Ward Andrew B; Burton Dennis R; Paulson James C; Rantalainen Kimmo; Berndsen Zachary; Ward Andrew B; Burton Dennis R</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3693</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">As the sole target of broadly neutralizing antibodies (bnAbs) to HIV, the envelope glycoprotein (Env) trimer is the focus of vaccination strategies designed to elicit protective bnAbs in humans.  Because HIV Env is densely glycosylated with 75-90 N-glycans per trimer, most bnAbs use or accommodate them in their binding epitope, making the glycosylation of recombinant Env a key aspect of HIV vaccine design.  Upon analysis of three HIV strains, we here find that site-specific glycosylation of Env from infectious virus closely matches Envs from corresponding recombinant membrane-bound trimers.  However, viral Envs differ significantly from recombinant soluble, cleaved (SOSIP) Env trimers, strongly impacting antigenicity.  These results provide a benchmark for virus Env glycosylation needed for the design of soluble Env trimers as part of an overall HIV vaccine strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzp386o0m1EoNpW7w2tapOfW6udTcc2eaJBHbc778p8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3ot1aksA%253D%253D&md5=d4daee53f36dffe65dff73789b3bf39e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06121-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06121-4%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DL.%26aulast%3DPauthner%26aufirst%3DM.%26aulast%3DAndrabi%26aufirst%3DR.%26aulast%3DRantalainen%26aufirst%3DK.%26aulast%3DBerndsen%26aufirst%3DZ.%26aulast%3DDiedrich%26aufirst%3DJ.%2BK.%26aulast%3DMenis%26aufirst%3DS.%26aulast%3DSok%26aufirst%3DD.%26aulast%3DBastidas%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DS.%2BR.%26aulast%3DDelahunty%26aufirst%3DC.%2BM.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DGuenaga%26aufirst%3DJ.%26aulast%3DWyatt%26aufirst%3DR.%2BT.%26aulast%3DSchief%26aufirst%3DW.%2BR.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DPaulson%26aufirst%3DJ.%2BC.%26atitle%3DDifferential%2520processing%2520of%2520HIV%2520envelope%2520glycans%2520on%2520the%2520virus%2520and%2520soluble%2520recombinant%2520trimer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D3693%26doi%3D10.1038%2Fs41467-018-06121-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frabutt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. H.</span></span> <span> </span><span class="NLM_article-title">Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5860</span>– <span class="NLM_lpage">5870</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.768168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M116.768168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28196864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslCrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=5860-5870&issue=14&author=B.+Wangauthor=Y.+Wangauthor=D.+A.+Frabuttauthor=X.+Zhangauthor=X.+Yaoauthor=D.+Huauthor=Z.+Zhangauthor=C.+Liuauthor=S.+Zhengauthor=S.+H.+Xiangauthor=Y.+H.+Zheng&title=Mechanistic+understanding+of+N-glycosylation+in+Ebola+virus+glycoprotein+maturation+and+function&doi=10.1074%2Fjbc.M116.768168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function</span></div><div class="casAuthors">Wang, Bin; Wang, Yujie; Frabutt, Dylan A.; Zhang, Xihe; Yao, Xiaoyu; Hu, Dan; Zhang, Zhuo; Liu, Chaonan; Zheng, Shimin; Xiang, Shi-Hua; Zheng, Yong-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5860-5870</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Ebola virus (EBOV) trimeric envelope glycoprotein (GP) precursors are cleaved into the receptor-binding GP1 and the fusion-mediating GP2 subunits and incorporated into virions to initiate infection.  GP1 and GP2 form heterodimers that have 15 or 2 N-glycosylation sites (NGSs), resp.  Here we investigated the mechanism of how N-glycosylation contributes to GP expression, maturation, and function.  As reported before, we found that, although GP1 NGSs are not crit., the 2 GP2 NGSs, Asn563 and Asn618, are essential for GP function.  Further anal. uncovered that Asn563 and Asn618 regulate GP processing, demannosylation, oligomerization, and conformation.  Consequently, these 2 NGSs are required for GP incorporation into EBOV-like particles and HIV type 1 (HIV-1) pseudovirions and det. viral transduction efficiency.  Using CRISPR/Cas9 technol., we knocked out the 2 classical endoplasmic reticulum chaperones calnexin (CNX) and/or calreticulin (CRT) and found that both CNX and CRT increase GP expression.  Nevertheless, NGSs are not required for the GP interaction with CNX or CRT.  Together, we conclude that, although Asn563 and Asn618 are not required for EBOV GP expression, they synergistically regulate its maturation, which dets. its functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp07YJsehboBbVg90H21EOLACvtfcHk0lg4Gl_-X2l-Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslCrsLw%253D&md5=1ccb977ccf3c9d69176b050baf0d2713</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.768168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.768168%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFrabutt%26aufirst%3DD.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DXiang%26aufirst%3DS.%2BH.%26aulast%3DZheng%26aufirst%3DY.%2BH.%26atitle%3DMechanistic%2520understanding%2520of%2520N-glycosylation%2520in%2520Ebola%2520virus%2520glycoprotein%2520maturation%2520and%2520function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D14%26spage%3D5860%26epage%3D5870%26doi%3D10.1074%2Fjbc.M116.768168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span> <span> </span><span class="NLM_article-title">Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>86</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3446</span>– <span class="NLM_lpage">3451</span>, <span class="refDoi"> DOI: 10.1128/JVI.06147-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.06147-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22258255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlOkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=3446-3451&issue=7&author=Y.+Kobayashiauthor=Y.+Suzuki&title=Evidence+for+N-glycan+shielding+of+antigenic+sites+during+evolution+of+human+influenza+A+virus+hemagglutinin&doi=10.1128%2FJVI.06147-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin</span></div><div class="casAuthors">Kobayashi, Yuki; Suzuki, Yoshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3446-3451</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">After the emergence of influenza A viruses in the human population, the no. of N-glycosylation sites (NGS) in the globular head region of hemagglutinin (HA) has increased continuously for several decades.  It has been speculated that the addn. of NGS to the globular head region of HA has conferred selective advantages to the virus by preventing the binding of antibodies (Ab) to antigenic sites (AS).  Here, the effect of N-glycosylation on the binding of Ab to AS in human influenza A virus subtype H3N2 (A/H3N2) was examd. by inferring natural selection at AS and other sites (NAS) that are located close to and distantly from the NGS in the three-dimensional structure of HA through a comparison of the rates of synonymous (dS) and nonsynonymous (dN) substitutions.  When positions 63, 122, 126, 133, 144, and 246 in the globular head region of HA were non-NGS, the dN/dS was >1 and pos. selection was detected at the AS located near these positions.  However, the dN/dS value decreased and the evidence of pos. selection disappeared when these positions became NGS.  In contrast, dN/dS at the AS distantly located from the positions mentioned above and at the NAS of any location were generally <1 and did not decrease when these positions changed from non-NGS to NGS.  These results suggest that the attachment of N-glycans to the NGS in the globular head region of HA prevented the binding of Ab to AS in the evolutionary history of human A/H3N2 virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKJBRSlM4_QLVg90H21EOLACvtfcHk0liYurqSb15M0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlOkt7k%253D&md5=4411592534d867a7326821f3ba7fdcaa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1128%2FJVI.06147-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.06147-11%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DY.%26atitle%3DEvidence%2520for%2520N-glycan%2520shielding%2520of%2520antigenic%2520sites%2520during%2520evolution%2520of%2520human%2520influenza%2520A%2520virus%2520hemagglutinin%26jtitle%3DJ.%2520Virol%26date%3D2012%26volume%3D86%26issue%3D7%26spage%3D3446%26epage%3D3451%26doi%3D10.1128%2FJVI.06147-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13473</span>, <span class="refDoi"> DOI: 10.1038/ncomms13473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fncomms13473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27874853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13473&author=L.+Duauthor=W.+Taiauthor=Y.+Yangauthor=G.+Zhaoauthor=Q.+Zhuauthor=S.+Sunauthor=C.+Liuauthor=X.+Taoauthor=C.+K.+Tsengauthor=S.+Perlmanauthor=S.+Jiangauthor=Y.+Zhouauthor=F.+Li&title=Introduction+of+neutralizing+immunogenicity+index+to+the+rational+design+of+MERS+coronavirus+subunit+vaccines&doi=10.1038%2Fncomms13473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines</span></div><div class="casAuthors">Du, Lanying; Tai, Wanbo; Yang, Yang; Zhao, Guangyu; Zhu, Qing; Sun, Shihui; Liu, Chang; Tao, Xinrong; Tseng, Chien-Te K.; Perlman, Stanley; Jiang, Shibo; Zhou, Yusen; Li, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13473</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Viral subunit vaccines often contain immunodominant non-neutralizing epitopes that divert host immune responses.  These epitopes should be eliminated in vaccine design, but there is no reliable method for evaluating an epitope's capacity to elicit neutralizing immune responses.  Here we introduce a new concept 'neutralizing immunogenicity index' (NII) to evaluate an epitope's neutralizing immunogenicity.  To det. the NII, we mask the epitope with a glycan probe and then assess the epitope's contribution to the vaccine's overall neutralizing immunogenicity.  As proof-of-concept, we measure the NII for different epitopes on an immunogen comprised of the receptor-binding domain from MERS coronavirus (MERS-CoV).  Further, we design a variant form of this vaccine by masking an epitope that has a neg. NII score.  This engineered vaccine demonstrates significantly enhanced efficacy in protecting transgenic mice from lethal MERS-CoV challenge.  Our study may guide the rational design of highly effective subunit vaccines to combat MERS-CoV and other life-threatening viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSiUBJWm2vqbVg90H21EOLACvtfcHk0liYurqSb15M0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnsrbF&md5=319186420fafe6170d845a6b86d1c80b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fncomms13473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13473%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DL.%26aulast%3DTai%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTseng%26aufirst%3DC.%2BK.%26aulast%3DPerlman%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DIntroduction%2520of%2520neutralizing%2520immunogenicity%2520index%2520to%2520the%2520rational%2520design%2520of%2520MERS%2520coronavirus%2520subunit%2520vaccines%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13473%26doi%3D10.1038%2Fncomms13473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vankadari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilce, J. A.</span></span> <span> </span><span class="NLM_article-title">Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1080/22221751.2020.1739565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F22221751.2020.1739565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32178593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovVWmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=601-604&issue=1&author=N.+Vankadariauthor=J.+A.+Wilce&title=Emerging+WuHan+%28COVID-19%29+coronavirus%3A+glycan+shield+and+structure+prediction+of+spike+glycoprotein+and+its+interaction+with+human+CD26&doi=10.1080%2F22221751.2020.1739565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging WuHan COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</span></div><div class="casAuthors">Vankadari, Naveen; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Microbes & Infections</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">601-604</span>CODEN:
                <span class="NLM_cas:coden">EMIMC4</span>;
        ISSN:<span class="NLM_cas:issn">2222-1751</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The recent outbreak of pneumonia-causing COVID-19 in China is an urgent global public health issue with an increase in mortality and morbidity.  Here we report our modeled homo-trimer structure of COVID-19 spike glycoprotein in both closed (ligand-free) and open (ligand-bound) conformation, which is involved in host cell adhesion.  We also predict the unique N- and O-linked glycosylation sites of spike glycoprotein that distinguish it from the SARS and underlines shielding and camouflage of COVID-19 from the host the defense system.  Furthermore, our study also highlights the key finding that the S1 domain of COVID-19 spike glycoprotein potentially interacts with the human CD26, a key immunoregulatory factor for hijacking and virulence.  These findings accentuate the unique features of COVID-19 and assist in the development of new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5tmi4hUkTjbVg90H21EOLACvtfcHk0ljbvo9En-OQ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovVWmtLo%253D&md5=2c2b7e272585e9f5257191bb6e8df4c2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1080%2F22221751.2020.1739565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F22221751.2020.1739565%26sid%3Dliteratum%253Aachs%26aulast%3DVankadari%26aufirst%3DN.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DEmerging%2520WuHan%2520%2528COVID-19%2529%2520coronavirus%253A%2520glycan%2520shield%2520and%2520structure%2520prediction%2520of%2520spike%2520glycoprotein%2520and%2520its%2520interaction%2520with%2520human%2520CD26%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2020%26volume%3D9%26issue%3D1%26spage%3D601%26epage%3D604%26doi%3D10.1080%2F22221751.2020.1739565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndsen, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghwani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabright, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pybus, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispin, M.</span></span> <span> </span><span class="NLM_article-title">Vulnerabilities in coronavirus glycan shields despite extensive glycosylation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2688</span>, <span class="refDoi"> DOI: 10.1038/s41467-020-16567-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41467-020-16567-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32461612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVCmu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=2688&author=Y.+Watanabeauthor=Z.+T.+Berndsenauthor=J.+Raghwaniauthor=G.+E.+Seabrightauthor=J.+D.+Allenauthor=O.+G.+Pybusauthor=J.+S.+McLellanauthor=I.+A.+Wilsonauthor=T.+A.+Bowdenauthor=A.+B.+Wardauthor=M.+Crispin&title=Vulnerabilities+in+coronavirus+glycan+shields+despite+extensive+glycosylation&doi=10.1038%2Fs41467-020-16567-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Vulnerabilities in coronavirus glycan shields despite extensive glycosylation</span></div><div class="casAuthors">Watanabe, Yasunori; Berndsen, Zachary T.; Raghwani, Jayna; Seabright, Gemma E.; Allen, Joel D.; Pybus, Oliver G.; McLellan, Jason S.; Wilson, Ian A.; Bowden, Thomas A.; Ward, Andrew B.; Crispin, Max</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2688</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential.  Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.  Coronavirus S proteins are extensively glycosylated, encoding around 66-87 N-linked glycosylation sites per trimeric spike.  Here, we reveal a specific area of high glycan d. on MERS S that results in the formation of oligomannose-type glycan clusters, which were absent on SARS and HKU1 CoVs.  We provide a comparison of the global glycan d. of coronavirus spikes with other viral proteins including HIV-1 envelope, Lassa virus glycoprotein complex, and influenza hemagglutinin, where glycosylation plays a known role in shielding immunogenic epitopes.  Overall, our data reveal how organization of glycosylation across class I viral fusion proteins influence not only individual glycan compns. but also the immunol. pressure across the protein surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7yDcmatMh27Vg90H21EOLACvtfcHk0ljbvo9En-OQ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVCmu77L&md5=2c0ce9b10f2a8d10d6889e975e9e09b3</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-16567-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-16567-0%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DBerndsen%26aufirst%3DZ.%2BT.%26aulast%3DRaghwani%26aufirst%3DJ.%26aulast%3DSeabright%26aufirst%3DG.%2BE.%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3DPybus%26aufirst%3DO.%2BG.%26aulast%3DMcLellan%26aufirst%3DJ.%2BS.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DBowden%26aufirst%3DT.%2BA.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DCrispin%26aufirst%3DM.%26atitle%3DVulnerabilities%2520in%2520coronavirus%2520glycan%2520shields%2520despite%2520extensive%2520glycosylation%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26spage%3D2688%26doi%3D10.1038%2Fs41467-020-16567-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Potential antivirals and antiviral strategies against SARS coronavirus infections</span>. <i>Expert Rev. Anti-Infect. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1586/14787210.4.2.291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1586%2F14787210.4.2.291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16597209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVSjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=291-302&issue=2&author=E.+De%0AClercq&title=Potential+antivirals+and+antiviral+strategies+against+SARS+coronavirus+infections&doi=10.1586%2F14787210.4.2.291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Potential antivirals and antiviral strategies against SARS coronavirus infections</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-302</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  There are a no. of antivirals as well as antiviral strategies that could be envisaged to prevent or treat severe acute respiratory syndrome (SARS) (or similar) coronavirus (CoV) infections.  Targets for the prophylactic or therapeutic interventions include interaction of the spike (S) glycoprotein (S1 domain) with the host cell receptor, fusion of the S2 domain with the host cell membrane, processing of the replicase polyproteins by the virus-encoded proteases (3C-like cysteine protease (3CLpro) and papain-like cysteine protease) and other virus-encoded enzymes such as the NTPase/helicase and RNA-dependent RNA polymerase.  Human monoclonal antibody blocking S1 may play an important role in the immunoprophylaxis of SARS.  Fusion inhibitors reminiscent of enfuvirtide in the case of HIV may also be developed for SARS-CoV.  Various peptidomimetic and nonpeptidic inhibitors of 3CLpro have been described, the best ones inhibiting SARS-CoV replication with a selectivity index greater than 1000.  Human interferons, in particular α- and β-interferon, as well as short interfering RNAs could further be pursued for the control of SARS.  Various other compds., often with an ill-defined mode of action but selectivity indexes up to 100, have been reported to exhibit in vitro activity against SARS-CoV: valinomycin, glycopeptide antibiotics, plant lectins, hesperetin, glycyrrhizin, aurintricarboxylic acid, chloroquine, niclosamide, nelfinavir and calpain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXOPwb1SdlYrVg90H21EOLACvtfcHk0lgK-mD05Qgthg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVSjsbc%253D&md5=cfb032a429ff40c0340c00cca046b617</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1586%2F14787210.4.2.291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14787210.4.2.291%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DPotential%2520antivirals%2520and%2520antiviral%2520strategies%2520against%2520SARS%2520coronavirus%2520infections%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2006%26volume%3D4%26issue%3D2%26spage%3D291%26epage%3D302%26doi%3D10.1586%2F14787210.4.2.291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olurinde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellini, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marasco, W. A.</span></span> <span> </span><span class="NLM_article-title">Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2536</span>– <span class="NLM_lpage">2541</span>, <span class="refDoi"> DOI: 10.1073/pnas.0307140101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.0307140101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=14983044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=2536-2541&issue=8&author=J.+Suiauthor=W.+Liauthor=A.+Murakamiauthor=A.+Taminauthor=L.+J.+Matthewsauthor=S.+K.+Wongauthor=M.+J.+Mooreauthor=A.+S.+Tallaricoauthor=M.+Olurindeauthor=H.+Choeauthor=L.+J.+Andersonauthor=W.+J.+Belliniauthor=M.+Farzanauthor=W.+A.+Marasco&title=Potent+neutralization+of+severe+acute+respiratory+syndrome+%28SARS%29+coronavirus+by+a+human+mAb+to+S1+protein+that+blocks+receptor+association&doi=10.1073%2Fpnas.0307140101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association</span></div><div class="casAuthors">Sui, Jianhua; Li, Wenhui; Murakami, Akikazu; Tamin, Azaibi; Matthews, Leslie J.; Wong, Swee Kee; Moore, Michael J.; St. Clair Tallarico, Aimee; Olurinde, Mobolaji; Choe, Hyeryun; Anderson, Larry J.; Bellini, William J.; Farzan, Michael; Marasco, Wayne A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2536-2541</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Effective prophylaxis and antiviral therapies are urgently needed in the event of reemergence of the highly contagious and often fatal severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) infection.  We have identified eight recombinant human single-chain variable region fragments (scFvs) against the S1 domain of spike (S) protein of the SARS-CoV from two nonimmune human antibody libraries.  One scFv 80R efficiently neutralized SARS-CoV and inhibited syncytia formation between cells expressing the S protein and those expressing the SARS-CoV receptor angiotensin-converting enzyme 2 (ACE2).  Mapping of the 80R epitope showed it is located within the N-terminal 261-672 amino acids of S protein and is not glycosylation-dependent.  80R scFv competed with sol. ACE2 for assocn. with the S1 domain and bound S1 with high affinity (equil. dissocn. const., Kd = 32.3 nM).  A human IgG1 form of 80R bound S1 with a 20-fold higher affinity of 1.59 nM comparable to that of ACE2 (Kd = 1.70 nM), and neutralized virus 20-fold more efficiently than the 80R scFv.  These data suggest that the 80R human monoclonal antibody may be a useful viral entry inhibitor for the emergency prophylaxis and treatment of SARS, and that the ACE2-binding site of S1 could be an attractive target for subunit vaccine and drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCmGLS2n0GJ7Vg90H21EOLACvtfcHk0lgK-mD05Qgthg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVOit7o%253D&md5=aaad87eb1341be70f4d095cc28206a1d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0307140101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0307140101%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTamin%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DL.%2BJ.%26aulast%3DWong%26aufirst%3DS.%2BK.%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26aulast%3DTallarico%26aufirst%3DA.%2BS.%26aulast%3DOlurinde%26aufirst%3DM.%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DBellini%26aufirst%3DW.%2BJ.%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DMarasco%26aufirst%3DW.%2BA.%26atitle%3DPotent%2520neutralization%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520%2528SARS%2529%2520coronavirus%2520by%2520a%2520human%2520mAb%2520to%2520S1%2520protein%2520that%2520blocks%2520receptor%2520association%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D8%26spage%3D2536%26epage%3D2541%26doi%3D10.1073%2Fpnas.0307140101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span> <span> </span><span class="NLM_article-title">The spike protein of SARS-CoV--a target for vaccine and therapeutic development</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnrmicro2090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19198616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFeqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=226-236&issue=3&author=L.+Duauthor=Y.+Heauthor=Y.+Zhouauthor=S.+Liuauthor=B.+J.+Zhengauthor=S.+Jiang&title=The+spike+protein+of+SARS-CoV%2D%2Da+target+for+vaccine+and+therapeutic+development&doi=10.1038%2Fnrmicro2090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The spike protein of SARS-CoV - a target for vaccine and therapeutic development</span></div><div class="casAuthors">Du, Lanying; He, Yuxian; Zhou, Yusen; Liu, Shuwen; Zheng, Bo-Jian; Jiang, Shibo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">226-236</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused by a novel coronavirus, SARS-coronavirus (SARS-CoV).  The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes.  The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV.  In this Review, we highlight recent advances in the development of vaccines and therapeutics based on the S protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro2X_2acd0E7Vg90H21EOLACvtfcHk0lhkYRNkd0rd7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFeqs7Y%253D&md5=610a46a8fed820bf5d0076e7c7d03c13</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2090%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DB.%2BJ.%26aulast%3DJiang%26aufirst%3DS.%26atitle%3DThe%2520spike%2520protein%2520of%2520SARS-CoV--a%2520target%2520for%2520vaccine%2520and%2520therapeutic%2520development%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2009%26volume%3D7%26issue%3D3%26spage%3D226%26epage%3D236%26doi%3D10.1038%2Fnrmicro2090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adedeji, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">8017</span>– <span class="NLM_lpage">8028</span>, <span class="refDoi"> DOI: 10.1128/JVI.00998-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.00998-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23678171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFWjt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=8017-8028&issue=14&author=A.+O.+Adedejiauthor=W.+Seversonauthor=C.+Jonssonauthor=K.+Singhauthor=S.+R.+Weissauthor=S.+G.+Sarafianos&title=Novel+inhibitors+of+severe+acute+respiratory+syndrome+coronavirus+entry+that+act+by+three+distinct+mechanisms&doi=10.1128%2FJVI.00998-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms</span></div><div class="casAuthors">Adedeji, Adeyemi O.; Severson, William; Jonsson, Colleen; Singh, Kamalendra; Weiss, Susan R.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">8017-8028</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome (SARS) is an infectious and highly contagious disease that is caused by SARS coronavirus (SARS-CoV) and for which there are currently no approved treatments.  We report the discovery and characterization of small-mol. inhibitors of SARS-CoV replication that block viral entry by three different mechanisms.  The compds. were discovered by screening a chem. library of compds. for blocking of entry of HIV-1 pseudotyped with SARS-CoV surface glycoprotein S (SARS-S) but not that of HIV-1 pseudotyped with vesicular stomatitis virus surface glycoprotein G (VSV-G).  Studies on their mechanisms of action revealed that the compds. act by three distinct mechanisms: (i) SSAA09E2 {N-[[4-(4-methyl-piperazin-1-yl)phenyl]methyl]-1,2-oxazole-5-carboxamide} acts through a novel mechanism of action, by blocking early interactions of SARS-S with the receptor for SARS-CoV, angiotensin converting enzyme 2 (ACE2); (ii) SSAA09E1 {[(Z)-1-thiophen-2-ylethylideneamino]thiourea} acts later, by blocking cathepsin L, a host protease required for processing of SARS-S during viral entry; and (iii) SSAA09E3 [N-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide] also acts later and does not affect interactions of SARS-S with ACE2 or the enzymic functions of cathepsin L but prevents fusion of the viral membrane with the host cellular membrane.  Our work demonstrates that there are at least three independent strategies for blocking SARS-CoV entry, validates these mechanisms of inhibition, and introduces promising leads for the development of SARS therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHgZhKpvdh87Vg90H21EOLACvtfcHk0lg_Zzoa2RzEfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFWjt73N&md5=11a6f72e02435e32c86006993ec4487d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1128%2FJVI.00998-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00998-13%26sid%3Dliteratum%253Aachs%26aulast%3DAdedeji%26aufirst%3DA.%2BO.%26aulast%3DSeverson%26aufirst%3DW.%26aulast%3DJonsson%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DWeiss%26aufirst%3DS.%2BR.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DNovel%2520inhibitors%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520entry%2520that%2520act%2520by%2520three%2520distinct%2520mechanisms%26jtitle%3DJ.%2520Virol%26date%3D2013%26volume%3D87%26issue%3D14%26spage%3D8017%26epage%3D8028%26doi%3D10.1128%2FJVI.00998-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tien, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span> <span> </span><span class="NLM_article-title">Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>363</i></span> (<span class="NLM_issue">9413</span>),  <span class="NLM_fpage">938</span>– <span class="NLM_lpage">947</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(04)15788-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2804%2915788-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15043961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVSktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2004&pages=938-947&issue=9413&author=S.+Liuauthor=G.+Xiaoauthor=Y.+Chenauthor=Y.+Heauthor=J.+Niuauthor=C.+R.+Escalanteauthor=H.+Xiongauthor=J.+Farmarauthor=A.+K.+Debnathauthor=P.+Tienauthor=S.+Jiang&title=Interaction+between+heptad+repeat+1+and+2+regions+in+spike+protein+of+SARS-associated+coronavirus%3A+implications+for+virus+fusogenic+mechanism+and+identification+of+fusion+inhibitors&doi=10.1016%2FS0140-6736%2804%2915788-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors</span></div><div class="casAuthors">Liu, Shuwen; Xiao, Gengfu; Chen, Yibang; He, Yuxian; Niu, Jinkui; Escalante, Carlos R.; Xiong, Huabao; Farmar, James; Debnath, Asim K.; Tien, Po; Jiang, Shibo</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9413</span>),
    <span class="NLM_cas:pages">938-947</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Studies on the fusion-inhibitory peptides derived from the heptad repeat 1 and 2 (HR1 and HR2) regions of the HIV-1 envelope glycoprotein gp41 provided crucial information on the viral fusogenic mechanism.  We used a similar approach to study the fusogenic mechanism of severe-acute-respiratory-syndrome-assocd. coronavirus (SARS-CoV).  We tested the inhibitory activity against infection of two sets of peptides corresponding to sequences of SARS-CoV spike protein HR1 and HR2 regions and investigated the interactions between the HR1 and HR2 peptides by surface plasmon resonance, sedimentation equilibration anal., CD, native polyacrylamide-gel electrophoresis, size exclusion high-performance liq. chromatog., and computer-aided homol. modeling and mol. docking anal.  One peptide, CP-1, derived from the HR2 region, inhibited SARS-CoV infection in the micromolar range.  CP-1 bound with high affinity to a peptide from the HR1 region, NP-1.  CP-1 alone had low α-helicity and self-assocd. to form a trimer in phosphate buffer (pH 7.2).  CP-1 and NP-1 mixed in equimolar concns. formed a six-helix bundle, similar to the fusogenic core structure of HIV-1 gp41.  After binding to the target cell, the transmembrane spike protein might change conformation by assocn. between the HR1 and HR2 regions to form an oligomeric structure, leading to fusion between the viral and target-cell membranes.  At the pre-fusion intermediate state, CP-1 could bind to the HR1 region and interfere with the conformational changes, resulting in inhibition of SARS-CoV fusion with the target cells.  CP-1 might be modifiable to increase its anti-SARS-CoV activity and could be further developed as an antiviral agent for treatment or prophylaxis of SARS-CoV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyJ48QTsOnQbVg90H21EOLACvtfcHk0lg_Zzoa2RzEfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVSktbo%253D&md5=578507918c57e2419c24213bea2c978f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2804%2915788-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252804%252915788-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DJ.%26aulast%3DEscalante%26aufirst%3DC.%2BR.%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DFarmar%26aufirst%3DJ.%26aulast%3DDebnath%26aufirst%3DA.%2BK.%26aulast%3DTien%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DS.%26atitle%3DInteraction%2520between%2520heptad%2520repeat%25201%2520and%25202%2520regions%2520in%2520spike%2520protein%2520of%2520SARS-associated%2520coronavirus%253A%2520implications%2520for%2520virus%2520fusogenic%2520mechanism%2520and%2520identification%2520of%2520fusion%2520inhibitors%26jtitle%3DLancet%26date%3D2004%26volume%3D363%26issue%3D9413%26spage%3D938%26epage%3D947%26doi%3D10.1016%2FS0140-6736%2804%2915788-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1038/s41422-020-0305-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41422-020-0305-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32231345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=343-355&issue=4&author=S.+Xiaauthor=M.+Liuauthor=C.+Wangauthor=W.+Xuauthor=Q.+Lanauthor=S.+Fengauthor=F.+Qiauthor=L.+Baoauthor=L.+Duauthor=S.+Liuauthor=C.+Qinauthor=F.+Sunauthor=Z.+Shiauthor=Y.+Zhuauthor=S.+Jiangauthor=L.+Lu&title=Inhibition+of+SARS-CoV-2+%28previously+2019-nCoV%29+infection+by+a+highly+potent+pan-coronavirus+fusion+inhibitor+targeting+its+spike+protein+that+harbors+a+high+capacity+to+mediate+membrane+fusion&doi=10.1038%2Fs41422-020-0305-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion</span></div><div class="casAuthors">Xia, Shuai; Liu, Meiqin; Wang, Chao; Xu, Wei; Lan, Qiaoshuai; Feng, Siliang; Qi, Feifei; Bao, Linlin; Du, Lanying; Liu, Shuwen; Qin, Chuan; Sun, Fei; Shi, Zhengli; Zhu, Yun; Jiang, Shibo; Lu, Lu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-355</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The recent outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 infection in Wuhan, China has posed a serious threat to global public health.  To develop specific anti-coronavirus therapeutics and prophylactics, the mol. mechanism that underlies viral infection must first be defined.  Therefore, we herein established a SARS-CoV-2 spike (S) protein-mediated cell-cell fusion assay and found that SARS-CoV-2 showed a superior plasma membrane fusion capacity compared to that of SARS-CoV.  We solved the X-ray crystal structure of six-helical bundle (6-HB) core of the HR1 and HR2 domains in the SARS-CoV-2 S protein S2 subunit, revealing that several mutated amino acid residues in the HR1 domain may be assocd. with enhanced interactions with the HR2 domain.  We previously developed a pan-coronavirus fusion inhibitor, EK1, which targeted the HR1 domain and could inhibit infection by divergent human coronaviruses tested, including SARS-CoV and MERS-CoV.  Here we generated a series of lipopeptides derived from EK1 and found that EK1C4 was the most potent fusion inhibitor against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection with IC50s of 1.3 and 15.8 nM, about 241- and 149-fold more potent than the original EK1 peptide, resp.  EK1C4 was also highly effective against membrane fusion and infection of other human coronavirus pseudoviruses tested, including SARS-CoV and MERS-CoV, as well as SARSr-CoVs, and potently inhibited the replication of 5 live human coronaviruses examd., including SARS-CoV-2.  Intranasal application of EK1C4 before or after challenge with HCoV-OC43 protected mice from infection, suggesting that EK1C4 could be used for prevention and treatment of infection by the currently circulating SARS-CoV-2 and other emerging SARSr-CoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojKYayxDdc07Vg90H21EOLACvtfcHk0ljJk9Fzzd0wfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtL0%253D&md5=00a4a7fb87b1053fb1033973f3734af3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fs41422-020-0305-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-020-0305-x%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DQ.%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DQi%26aufirst%3DF.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520SARS-CoV-2%2520%2528previously%25202019-nCoV%2529%2520infection%2520by%2520a%2520highly%2520potent%2520pan-coronavirus%2520fusion%2520inhibitor%2520targeting%2520its%2520spike%2520protein%2520that%2520harbors%2520a%2520high%2520capacity%2520to%2520mediate%2520membrane%2520fusion%26jtitle%3DCell%2520Res.%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D343%26epage%3D355%26doi%3D10.1038%2Fs41422-020-0305-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerhering, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>368</i></span> (<span class="NLM_issue">6489</span>),  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1126/science.abb3405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abb3405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32198291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslKrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2020&pages=409-412&issue=6489&author=L.+Zhangauthor=D.+Linauthor=X.+Sunauthor=U.+Curthauthor=C.+Drostenauthor=L.+Sauerheringauthor=S.+Beckerauthor=K.+Roxauthor=R.+Hilgenfeld&title=Crystal+structure+of+SARS-CoV-2+main+protease+provides+a+basis+for+design+of+improved+alpha-ketoamide+inhibitors&doi=10.1126%2Fscience.abb3405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved   -ketoamide inhibitors</span></div><div class="casAuthors">Zhang, Linlin; Lin, Daizong; Sun, Xinyuanyuan; Curth, Ute; Drosten, Christian; Sauerhering, Lucie; Becker, Stephan; Rox, Katharina; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">6489</span>),
    <span class="NLM_cas:pages">409-412</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome   coronavirus 2 (SARS-CoV-2) is a global health emergency.  An attractive drug target among coronaviruses is the main protease (Mpro, also called 3CLpro) because of its essential role in processing the polyproteins that are translated from the viral RNA.  We report the x-ray structures of the unliganded SARS-CoV-2 Mpro and its complex with an   -ketoamide inhibitor.  This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compd. in plasma.  On the basis of the unliganded structure, we developed the lead compd. into a potent inhibitor of the SARS-CoV-2 Mpro.  The pharmacokinetic characterization of the optimized inhibitor reveals a pronounced lung tropism and suitability for administration by the inhalative route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT531N47m4BbVg90H21EOLACvtfcHk0lgxV35XvL-5fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslKrtL8%253D&md5=9ac417c20f54c3327f9de9088b512d52</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb3405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb3405%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DCurth%26aufirst%3DU.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DSauerhering%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DRox%26aufirst%3DK.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DCrystal%2520structure%2520of%2520SARS-CoV-2%2520main%2520protease%2520provides%2520a%2520basis%2520for%2520design%2520of%2520improved%2520alpha-ketoamide%2520inhibitors%26jtitle%3DScience%26date%3D2020%26volume%3D368%26issue%3D6489%26spage%3D409%26epage%3D412%26doi%3D10.1126%2Fscience.abb3405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span> <span> </span><span class="NLM_article-title">Structure of the RNA-dependent RNA polymerase from COVID-19 virus</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>368</i></span> (<span class="NLM_issue">6492</span>),  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">782</span>, <span class="refDoi"> DOI: 10.1126/science.abb7498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abb7498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32277040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsVyrsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2020&pages=779-782&issue=6492&author=Y.+Gaoauthor=L.+Yanauthor=Y.+Huangauthor=F.+Liuauthor=Y.+Zhaoauthor=L.+Caoauthor=T.+Wangauthor=Q.+Sunauthor=Z.+Mingauthor=L.+Zhangauthor=J.+Geauthor=L.+Zhengauthor=Y.+Zhangauthor=H.+Wangauthor=Y.+Zhuauthor=C.+Zhuauthor=T.+Huauthor=T.+Huaauthor=B.+Zhangauthor=X.+Yangauthor=J.+Liauthor=H.+Yangauthor=Z.+Liuauthor=W.+Xuauthor=L.+W.+Guddatauthor=Q.+Wangauthor=Z.+Louauthor=Z.+Rao&title=Structure+of+the+RNA-dependent+RNA+polymerase+from+COVID-19+virus&doi=10.1126%2Fscience.abb7498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the RNA-dependent RNA polymerase from COVID-19 virus</span></div><div class="casAuthors">Gao, Yan; Yan, Liming; Huang, Yucen; Liu, Fengjiang; Zhao, Yao; Cao, Lin; Wang, Tao; Sun, Qianqian; Ming, Zhenhua; Zhang, Lianqi; Ge, Ji; Zheng, Litao; Zhang, Ying; Wang, Haofeng; Zhu, Yan; Zhu, Chen; Hu, Tianyu; Hua, Tian; Zhang, Bing; Yang, Xiuna; Li, Jun; Yang, Haitao; Liu, Zhijie; Xu, Wenqing; Guddat, Luke W.; Wang, Quan; Lou, Zhiyong; Rao, Zihe</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">6492</span>),
    <span class="NLM_cas:pages">779-782</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] outbreak has caused a global coronavirus disease 2019 (COVID-19) pandemic, resulting in tens of thousands of infections and thousands of deaths worldwide.  The RNA-dependent RNA polymerase [(RdRp), also named nsp12] is the central component of coronaviral replication and transcription machinery, and it appears to be a primary target for the antiviral drug remdesivir.  We report the cryoelectron microscopy structure of COVID-19 virus full-length nsp12 in complex with cofactors nsp7 and nsp8 at 2.9-angstrom resoln.  In addn. to the conserved architecture of the polymerase core of the viral polymerase family, nsp12 possesses a newly identified β-hairpin domain at its N terminus.  A comparative anal. model shows how remdesivir binds to this polymerase.  The structure provides a basis for the design of new antiviral therapeutics that target viral RdRp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbDgKUj7ZIg7Vg90H21EOLACvtfcHk0lgxV35XvL-5fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsVyrsr4%253D&md5=07c9ca12ca757e52c2db2e4b4dcbf55b</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb7498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb7498%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DMing%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DHua%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DRao%26aufirst%3DZ.%26atitle%3DStructure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520COVID-19%2520virus%26jtitle%3DScience%26date%3D2020%26volume%3D368%26issue%3D6492%26spage%3D779%26epage%3D782%26doi%3D10.1126%2Fscience.abb7498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jedrzejczak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltseva, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilamowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godzik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joachimiak, A.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/pro.3873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fpro.3873" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+Kimauthor=R.+Jedrzejczakauthor=N.+I.+Maltsevaauthor=M.+Wilamowskiauthor=M.+Endresauthor=A.+Godzikauthor=K.+Michalskaauthor=A.+Joachimiak&title=Crystal+structure+of+Nsp15+endoribonuclease+NendoU+from+SARS-CoV-2&doi=10.1002%2Fpro.3873"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fpro.3873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3873%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DJedrzejczak%26aufirst%3DR.%26aulast%3DMaltseva%26aufirst%3DN.%2BI.%26aulast%3DWilamowski%26aufirst%3DM.%26aulast%3DEndres%26aufirst%3DM.%26aulast%3DGodzik%26aufirst%3DA.%26aulast%3DMichalska%26aufirst%3DK.%26aulast%3DJoachimiak%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520Nsp15%2520endoribonuclease%2520NendoU%2520from%2520SARS-CoV-2%26jtitle%3DProtein%2520Sci.%26date%3D2020%26doi%3D10.1002%2Fpro.3873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putics, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissbrich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabenau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerr, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbalenya, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziebuhr, J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms and enzymes involved in SARS coronavirus genome expression</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2305</span>– <span class="NLM_lpage">2315</span>, <span class="refDoi"> DOI: 10.1099/vir.0.19424-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.19424-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=12917450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFaqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=2305-2315&issue=9&author=V.+Thielauthor=K.+A.+Ivanovauthor=A.+Puticsauthor=T.+Hertzigauthor=B.+Schelleauthor=S.+Bayerauthor=B.+Weissbrichauthor=E.+J.+Snijderauthor=H.+Rabenauauthor=H.+W.+Doerrauthor=A.+E.+Gorbalenyaauthor=J.+Ziebuhr&title=Mechanisms+and+enzymes+involved+in+SARS+coronavirus+genome+expression&doi=10.1099%2Fvir.0.19424-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms and enzymes involved in SARS coronavirus genome expression</span></div><div class="casAuthors">Thiel, Volker; Ivanov, Konstantin A.; Putics, Akos; Hertzig, Tobias; Schelle, Barbara; Bayer, Sonja; Weissbrich, Benedikt; Snijder, Eric J.; Rabenau, Holger; Doerr, Hans Wilhelm; Gorbalenya, Alexander E.; Ziebuhr, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2305-2315</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A novel coronavirus is the causative agent of the current epidemic of severe acute respiratory syndrome (SARS).  Coronaviruses are exceptionally large RNA viruses and employ complex regulatory mechanisms to express their genomes.  Here, we detd. the sequence of SARS coronavirus (SARS-CoV), isolate Frankfurt 1, and characterized key RNA elements and protein functions involved in viral genome expression.  Important regulatory mechanisms, such as the (discontinuous) synthesis of eight subgenomic mRNAs, ribosomal frameshifting and post-translational proteolytic processing, were addressed.  Activities of three SARS coronavirus enzymes, the helicase and two cysteine proteinases, which are known to be critically involved in replication, transcription and/or post-translational polyprotein processing, were characterized.  The availability of recombinant forms of key replicative enzymes of SARS coronavirus should pave the way for high-throughput screening approaches to identify candidate inhibitors in compd. libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwV_DQUJ6EFbVg90H21EOLACvtfcHk0ljF7L_KTOH9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFaqsb4%253D&md5=c0e344cdde7ce697dee5a6aaeea9feb7</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.19424-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.19424-0%26sid%3Dliteratum%253Aachs%26aulast%3DThiel%26aufirst%3DV.%26aulast%3DIvanov%26aufirst%3DK.%2BA.%26aulast%3DPutics%26aufirst%3DA.%26aulast%3DHertzig%26aufirst%3DT.%26aulast%3DSchelle%26aufirst%3DB.%26aulast%3DBayer%26aufirst%3DS.%26aulast%3DWeissbrich%26aufirst%3DB.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DRabenau%26aufirst%3DH.%26aulast%3DDoerr%26aufirst%3DH.%2BW.%26aulast%3DGorbalenya%26aufirst%3DA.%2BE.%26aulast%3DZiebuhr%26aufirst%3DJ.%26atitle%3DMechanisms%2520and%2520enzymes%2520involved%2520in%2520SARS%2520coronavirus%2520genome%2520expression%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2003%26volume%3D84%26issue%3D9%26spage%3D2305%26epage%3D2315%26doi%3D10.1099%2Fvir.0.19424-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4085</span>– <span class="NLM_lpage">4096</span>, <span class="refDoi"> DOI: 10.1111/febs.12936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1111%2Ffebs.12936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25039866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2014&pages=4085-4096&issue=18&author=R.+Hilgenfeld&title=From+SARS+to+MERS%3A+crystallographic+studies+on+coronaviral+proteases+enable+antiviral+drug+design&doi=10.1111%2Ffebs.12936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design</span></div><div class="casAuthors">Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4085-4096</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Here, the author focuses on the important contributions that macromol. crystallog. has made over the past 12 yr to elucidating structures and mechanisms of the essential proteases of coronaviruses, the main protease (Mpro) and the papain-like protease (PLpro).  The role of x-ray crystallog. in structure-assisted drug discovery against these targets is discussed.  Aspects dealt with in this review include the emergence of the SARS coronavirus in 2002-2003 and of the MERS coronavirus 10 yr later and the origins of these viruses.  The crystal structure of the free SARS coronavirus Mpro and its dependence on pH is discussed, as are efforts to design inhibitors on the basis of these structures.  The mechanism of maturation of the enzyme from the viral polyprotein is still a matter of debate.  The crystal structure of the SARS coronavirus PLpro and its complex with ubiquitin is also discussed, as is its ortholog from MERS coronavirus.  Efforts at predictive structure-based inhibitor development for bat coronavirus Mpros to increase the preparedness against zoonotic transmission to man are described as well.  The paper closes with a brief discussion of structure-based discovery of antivirals in an academic setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_Y5ir6KZ8LVg90H21EOLACvtfcHk0ljF7L_KTOH9iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsbbI&md5=6a9330976a5c3a13dd4bf7bed14665ce</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12936%26sid%3Dliteratum%253Aachs%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DFrom%2520SARS%2520to%2520MERS%253A%2520crystallographic%2520studies%2520on%2520coronaviral%2520proteases%2520enable%2520antiviral%2520drug%2520design%26jtitle%3DFEBS%2520J.%26date%3D2014%26volume%3D281%26issue%3D18%26spage%3D4085%26epage%3D4096%26doi%3D10.1111%2Ffebs.12936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huitema, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltis, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. N.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jmb.2005.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16219322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKms7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=1137-1151&issue=5&author=T.+W.+Leeauthor=M.+M.+Cherneyauthor=C.+Huitemaauthor=J.+Liuauthor=K.+E.+Jamesauthor=J.+C.+Powersauthor=L.+D.+Eltisauthor=M.+N.+James&title=Crystal+structures+of+the+main+peptidase+from+the+SARS+coronavirus+inhibited+by+a+substrate-like+aza-peptide+epoxide&doi=10.1016%2Fj.jmb.2005.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate-like Aza-peptide Epoxide</span></div><div class="casAuthors">Lee, Ting-Wai; Cherney, Maia M.; Huitema, Carly; Liu, Jie; James, Karen Ellis; Powers, James C.; Eltis, Lindsay D.; James, Michael N. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1137-1151</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The main peptidase (Mpro) from the coronavirus (CoV) causing severe acute respiratory syndrome (SARS) is one of the most attractive mol. targets for the development of anti-SARS agents.  We report the irreversible inhibition of SARS-CoV Mpro by an aza-peptide epoxide (APE; kinact/Ki=1900(±400) M-1 s-1).  The crystal structures of the Mpro:APE complex in the space groups C2 and P212121 revealed the formation of a covalent bond between the catalytic Cys145 Sγ atom of the peptidase and the epoxide C3 atom of the inhibitor, substantiating the mode of action of this class of cysteine-peptidase inhibitors.  The aza-peptide component of APE binds in the substrate-binding regions of Mpro in a substrate-like manner, with excellent structural and chem. complementarity.  In addn., the crystal structure of unbound Mpro in the space group C2 revealed that the "N-fingers" (N-terminal residues 1 to 7) of both protomers of Mpro are well defined and the substrate-binding regions of both protomers are in the catalytically competent conformation at the crystn. pH of 6.5, contrary to the previously detd. crystal structures of unbound Mpro in the space group P21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzcP9A4-DKErVg90H21EOLACvtfcHk0ljvk9p4fAJfhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKms7nL&md5=ba0e5fbad36bfc3d259c9221d451ef60</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%2BW.%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DHuitema%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJames%26aufirst%3DK.%2BE.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DEltis%26aufirst%3DL.%2BD.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DCrystal%2520structures%2520of%2520the%2520main%2520peptidase%2520from%2520the%2520SARS%2520coronavirus%2520inhibited%2520by%2520a%2520substrate-like%2520aza-peptide%2520epoxide%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26issue%3D5%26spage%3D1137%26epage%3D1151%26doi%3D10.1016%2Fj.jmb.2005.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevener, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatuz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. E.</span></span> <span> </span><span class="NLM_article-title">Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1361</span>– <span class="NLM_lpage">1372</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.201300134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23788528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1361-1372&issue=8&author=H.+Leeauthor=S.+Caoauthor=K.+E.+Hevenerauthor=L.+Truongauthor=J.+L.+Gatuzauthor=K.+Patelauthor=A.+K.+Ghoshauthor=M.+E.+Johnson&title=Synergistic+inhibitor+binding+to+the+papain-like+protease+of+human+SARS+coronavirus%3A+mechanistic+and+inhibitor+design+implications&doi=10.1002%2Fcmdc.201300134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic Inhibitor Binding to the Papain-Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications</span></div><div class="casAuthors">Lee, Hyun; Cao, Shuyi; Hevener, Kirk E.; Truong, Lena; Gatuz, Joseph L.; Patel, Kavankumar; Ghosh, Arun K.; Johnson, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1361-1372</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We previously developed two potent chem. classes that inhibit the essential papain-like protease (PLpro) of severe acute respiratory syndrome coronavirus.  In this study, we applied a novel approach to identify small fragments that act synergistically with these inhibitors.  A fragment library was screened in combination with four previously developed lead inhibitors by fluorescence-based enzymic assays.  Several fragment compds. synergistically enhanced the inhibitory activity of the lead inhibitors by approx. an order of magnitude.  Surface plasmon resonance measurements showed that three fragments bind specifically to the PLpro enzyme.  Mode of inhibition, computational solvent mapping, and mol. docking studies suggest that these fragments bind adjacent to the binding site of the lead inhibitors and further stabilize the inhibitor-bound state.  We propose potential next-generation compds. based on a computational fragment-merging approach.  This approach provides an alternative strategy for lead optimization for cases in which direct co-crystn. is difficult.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgKin5O32Y97Vg90H21EOLACvtfcHk0ljvk9p4fAJfhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslGjtbw%253D&md5=4596fa56fd5d679ffbcc0c10ddf2123e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300134%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DHevener%26aufirst%3DK.%2BE.%26aulast%3DTruong%26aufirst%3DL.%26aulast%3DGatuz%26aufirst%3DJ.%2BL.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DJohnson%26aufirst%3DM.%2BE.%26atitle%3DSynergistic%2520inhibitor%2520binding%2520to%2520the%2520papain-like%2520protease%2520of%2520human%2520SARS%2520coronavirus%253A%2520mechanistic%2520and%2520inhibitor%2520design%2520implications%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3D1361%26epage%3D1372%26doi%3D10.1002%2Fcmdc.201300134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahabi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span> <span> </span><span class="NLM_article-title">Drug development and medicinal chemistry efforts toward SARS-coronavirus and Covid-19 therapeutics</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">907</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.202000223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32324951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXos1GmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=907&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=D.+Shahabiauthor=M.+E.+Chapmanauthor=A.+D.+Mesecar&title=Drug+development+and+medicinal+chemistry+efforts+toward+SARS-coronavirus+and+Covid-19+therapeutics&doi=10.1002%2Fcmdc.202000223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Shahabi, Dana; Chapman, Mackenzie E.; Mesecar, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">907-932</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The COVID-19 pandemic caused by SARS-CoV-2 infection is spreading at an alarming rate and has created an unprecedented health emergency around the globe.  There is no effective vaccine or approved drug treatment against COVID-19 and other pathogenic coronaviruses.  The development of antiviral agents is an urgent priority.  Biochem. events crit. to the coronavirus replication cycle provided a no. of attractive targets for drug development.  These include, spike protein for binding to host cell-surface receptors, proteolytic enzymes that are essential for processing polyproteins into mature viruses, and RNA-dependent RNA polymerase for RNA replication.  There has been a lot of ground work for drug discovery and development against these targets.  Also, high-throughput screening efforts have led to the identification of diverse lead structures, including natural product-derived mols.  This review highlights past and present drug discovery and medicinal-chem. approaches against SARS-CoV, MERS-CoV and COVID-19 targets.  The review hopes to stimulate further research and will be a useful guide to the development of effective therapies against COVID-19 and other pathogenic coronaviruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcgVQF9N3zf7Vg90H21EOLACvtfcHk0ljvk9p4fAJfhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXos1GmsL4%253D&md5=8b4c3c83c05a7b64f39ba7d803ea1709</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000223%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DShahabi%26aufirst%3DD.%26aulast%3DChapman%26aufirst%3DM.%2BE.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26atitle%3DDrug%2520development%2520and%2520medicinal%2520chemistry%2520efforts%2520toward%2520SARS-coronavirus%2520and%2520Covid-19%2520therapeutics%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D907%26doi%3D10.1002%2Fcmdc.202000223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedantham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agudelo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrion, R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunneley, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, G.</span></span> <span> </span><span class="NLM_article-title">Protease inhibitors targeting coronavirus and filovirus entry</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2015.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2015.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25666761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVOrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=76-84&author=Y.+Zhouauthor=P.+Vedanthamauthor=K.+Luauthor=J.+Agudeloauthor=R.+Carrionauthor=J.+W.+Nunneleyauthor=D.+Barnardauthor=S.+Pohlmannauthor=J.+H.+McKerrowauthor=A.+R.+Rensloauthor=G.+Simmons&title=Protease+inhibitors+targeting+coronavirus+and+filovirus+entry&doi=10.1016%2Fj.antiviral.2015.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Protease inhibitors targeting coronavirus and filovirus entry</span></div><div class="casAuthors">Zhou, Yanchen; Vedantham, Punitha; Lu, Kai; Agudelo, Juliet; Carrion, Ricardo; Nunneley, Jerritt W.; Barnard, Dale; Pohlmann, Stefan; McKerrow, James H.; Renslo, Adam R.; Simmons, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-84</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to gain entry into cells, diverse viruses, including Ebola virus, SARS-coronavirus and the emerging MERS-coronavirus, depend on activation of their envelope glycoproteins by host cell proteases.  The resp. enzymes are thus excellent targets for antiviral intervention.  In cell culture, activation of Ebola virus, as well as SARS- and MERS-coronavirus can be accomplished by the endosomal cysteine proteases, cathepsin L (CTSL) and cathepsin B (CTSB).  In addn., SARS- and MERS-coronavirus can use serine proteases localized at the cell surface, for their activation.  However, it is currently unclear which protease(s) facilitate viral spread in the infected host.  We report here that the cysteine protease inhibitor K11777, ((2S)-N-[(1E,3S)-1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-{[(E)-4-methylpiperazine-1-carbonyl]amino}-3-phenylpropanamide) and closely-related vinylsulfones act as broad-spectrum antivirals by targeting cathepsin-mediated cell entry.  K11777 is already in advanced stages of development for a no. of parasitic diseases, such as Chagas disease, and has proven to be safe and effective in a range of animal models.  K11777 inhibition of SARS-CoV and Ebola virus entry was obsd. in the sub-nanomolar range.  In order to assess whether cysteine or serine proteases promote viral spread in the host, we compared the antiviral activity of an optimized K11777-deriv. with that of camostat, an inhibitor of TMPRSS2 and related serine proteases.  Employing a pathogenic animal model of SARS-CoV infection, we demonstrated that viral spread and pathogenesis of SARS-CoV is driven by serine rather than cysteine proteases and can be effectively prevented by camostat.  Camostat has been clin. used to treat chronic pancreatitis, and thus represents an exciting potential therapeutic for respiratory coronavirus infections.  Our results indicate that camostat, or similar serine protease inhibitors, might be an effective option for treatment of SARS and potentially MERS, while vinyl sulfone-based inhibitors are excellent lead candidates for Ebola virus therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgkBpEfAc5bVg90H21EOLACvtfcHk0lhN4m4ZhJknRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVOrs7Y%253D&md5=5dc38edb19ade6920ba6ca860699b8cf</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DVedantham%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DAgudelo%26aufirst%3DJ.%26aulast%3DCarrion%26aufirst%3DR.%26aulast%3DNunneley%26aufirst%3DJ.%2BW.%26aulast%3DBarnard%26aufirst%3DD.%26aulast%3DPohlmann%26aufirst%3DS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DSimmons%26aufirst%3DG.%26atitle%3DProtease%2520inhibitors%2520targeting%2520coronavirus%2520and%2520filovirus%2520entry%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D116%26spage%3D76%26epage%3D84%26doi%3D10.1016%2Fj.antiviral.2015.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Structure of M(pro) from COVID-19 virus and discovery of its inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>582</i></span>,  <span class="NLM_fpage">289</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2223-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2223-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32272481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVyhsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2020&pages=289&author=Z.+Jinauthor=X.+Duauthor=Y.+Xuauthor=Y.+Dengauthor=M.+Liuauthor=Y.+Zhaoauthor=B.+Zhangauthor=X.+Liauthor=L.+Zhangauthor=C.+Pengauthor=Y.+Duanauthor=J.+Yuauthor=L.+Wangauthor=K.+Yangauthor=F.+Liuauthor=R.+Jiangauthor=X.+Yangauthor=T.+Youauthor=X.+Liuauthor=X.+Yangauthor=F.+Baiauthor=H.+Liuauthor=X.+Liuauthor=L.+W.+Guddatauthor=W.+Xuauthor=G.+Xiaoauthor=C.+Qinauthor=Z.+Shiauthor=H.+Jiangauthor=Z.+Raoauthor=H.+Yang&title=Structure+of+M%28pro%29+from+COVID-19+virus+and+discovery+of+its+inhibitors&doi=10.1038%2Fs41586-020-2223-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors</span></div><div class="casAuthors">Jin, Zhenming; Du, Xiaoyu; Xu, Yechun; Deng, Yongqiang; Liu, Meiqin; Zhao, Yao; Zhang, Bing; Li, Xiaofeng; Zhang, Leike; Peng, Chao; Duan, Yinkai; Yu, Jing; Wang, Lin; Yang, Kailin; Liu, Fengjiang; Jiang, Rendi; Yang, Xinglou; You, Tian; Liu, Xiaoce; Yang, Xiuna; Bai, Fang; Liu, Hong; Liu, Xiang; Guddat, Luke W.; Xu, Wenqing; Xiao, Gengfu; Qin, Chengfeng; Shi, Zhengli; Jiang, Hualiang; Rao, Zihe; Yang, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">7811</span>),
    <span class="NLM_cas:pages">289-293</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the etiol. agent responsible for the 2019-2020 viral pneumonia outbreak of coronavirus disease 2019 (COVID-19).  Currently, there are no targeted therapeutic agents for the treatment of this disease, and effective treatment options remain very limited.  Here, we describe the results of a program that aimed to rapidly discover lead compds. for clin. use, by combining structure-assisted drug design, virtual drug screening and high-throughput screening.  This program focused on identifying drug leads that target main protease (Mpro) of SARS-CoV-2: Mpro is a key enzyme of coronaviruses and has a pivotal role in mediating viral replication and transcription, making it an attractive drug target for SARS-CoV-2.  We identified a mechanism-based inhibitor (N3) by computer-aided drug design, and then detd. the crystal structure of Mpro of SARS-CoV-2 in complex with this compd.  Through a combination of structure-based virtual and high-throughput screening, we assayed more than 10,000 compds.-including approved drugs, drug candidates in clin. trials and other pharmacol. active compds.-as inhibitors of Mpro.  Six of these compds. inhibited Mpro, showing half-maximal inhibitory concn. values that ranged from 0.67 to 21.4μM.  One of these compds. (ebselen) also exhibited promising antiviral activity in cell-based assays.  Our results demonstrate the efficacy of our screening strategy, which can lead to the rapid discovery of drug leads with clin. potential in response to new infectious diseases for which no specific drugs or vaccines are available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFupuh6WIyW7Vg90H21EOLACvtfcHk0lhN4m4ZhJknRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVyhsrrO&md5=b84f350fe9ce1109485df6caf814ba82</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2223-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2223-y%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DRao%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DH.%26atitle%3DStructure%2520of%2520M%2528pro%2529%2520from%2520COVID-19%2520virus%2520and%2520discovery%2520of%2520its%2520inhibitors%26jtitle%3DNature%26date%3D2020%26volume%3D582%26spage%3D289%26doi%3D10.1038%2Fs41586-020-2223-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Brunn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyssen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wilde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">alpha-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4562</span>– <span class="NLM_lpage">4578</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivValt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4562-4578&issue=9&author=L.+Zhangauthor=D.+Linauthor=Y.+Kusovauthor=Y.+Nianauthor=Q.+Maauthor=J.+Wangauthor=A.+von+Brunnauthor=P.+Leyssenauthor=K.+Lankoauthor=J.+Neytsauthor=A.+de+Wildeauthor=E.+J.+Snijderauthor=H.+Liuauthor=R.+Hilgenfeld&title=alpha-Ketoamides+as+broad-spectrum+inhibitors+of+coronavirus+and+enterovirus+replication%3A+structure-based+design%2C+synthesis%2C+and+activity+assessment&doi=10.1021%2Facs.jmedchem.9b01828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment</span></div><div class="casAuthors">Zhang, Linlin; Lin, Daizong; Kusov, Yuri; Nian, Yong; Ma, Qingjun; Wang, Jiang; von Brunn, Albrecht; Leyssen, Pieter; Lanko, Kristina; Neyts, Johan; de Wilde, Adriaan; Snijder, Eric J.; Liu, Hong; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4562-4578</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The main protease of coronaviruses and the 3C protease of enteroviruses share a similar active-site architecture and a unique requirement for glutamine in the P1 position of the substrate.  Because of their unique specificity and essential role in viral polyprotein processing, these proteases are suitable targets for the development of antiviral drugs.  In order to obtain near-equipotent, broad-spectrum antivirals against alphacoronaviruses, betacoronaviruses, and enteroviruses, we pursued structure-based design of peptidomimetic α-ketoamides as inhibitors of main and 3C proteases.  Six crystal structures of protease:inhibitor complexes were detd. as part of this study.  Compds. synthesized were tested against the recombinant proteases as well as in viral replicons and virus-infected cell cultures; most of them were not cell-toxic.  Optimization of the P2 substituent of the α-ketoamides proved crucial for achieving near-equipotency against the three virus genera.  The best near-equipotent inhibitors, (I) [R1 = cyclopentylmethyl (P2) and R1 = cyclohexylmethyl (P2)], display low-micromolar EC50 values against enteroviruses, alphacoronaviruses, and betacoronaviruses in cell cultures.  In Huh7 cells, I [R1 = cyclohexylmethyl (P2)] exhibits three-digit picomolar activity against Middle East Respiratory Syndrome coronavirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWpcfl4wTRLLVg90H21EOLACvtfcHk0lhN4m4ZhJknRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivValt7o%253D&md5=60d91a8ecf916856a844d835ecf84d5f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01828%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DKusov%26aufirst%3DY.%26aulast%3DNian%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3Dvon%2BBrunn%26aufirst%3DA.%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DLanko%26aufirst%3DK.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3Dde%2BWilde%26aufirst%3DA.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3Dalpha-Ketoamides%2520as%2520broad-spectrum%2520inhibitors%2520of%2520coronavirus%2520and%2520enterovirus%2520replication%253A%2520structure-based%2520design%252C%2520synthesis%252C%2520and%2520activity%2520assessment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D9%26spage%3D4562%26epage%3D4578%26doi%3D10.1021%2Facs.jmedchem.9b01828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nutho, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalapbutr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengphasatporn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattaranggoon, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simanon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannongbua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rungrotmongkol, T.</span></span> <span> </span><span class="NLM_article-title">Why Are Lopinavir and Ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">1769</span>– <span class="NLM_lpage">1779</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.0c00160</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.0c00160" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntVKltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=1769-1779&issue=18&author=B.+Nuthoauthor=P.+Mahalapbutrauthor=K.+Hengphasatpornauthor=N.+C.+Pattaranggoonauthor=N.+Simanonauthor=Y.+Shigetaauthor=S.+Hannongbuaauthor=T.+Rungrotmongkol&title=Why+Are+Lopinavir+and+Ritonavir+effective+against+the+newly+emerged+coronavirus+2019%3F+Atomistic+insights+into+the+inhibitory+mechanisms&doi=10.1021%2Facs.biochem.0c00160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms</span></div><div class="casAuthors">Nutho, Bodee; Mahalapbutr, Panupong; Hengphasatporn, Kowit; Pattaranggoon, Nawanwat Chainuwong; Simanon, Nattapon; Shigeta, Yasuteru; Hannongbua, Supot; Rungrotmongkol, Thanyada</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1769-1779</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since the emergence of a novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported from Wuhan, China, neither a specific vaccine nor an antiviral drug against SARS-CoV-2 has become available.  However, a combination of two HIV-1 protease inhibitors, lopinavir and ritonavir, has been found to be effective against SARS-CoV, and both drugs could bind well to the SARS-CoV 3C-like protease (SARS-CoV 3CLpro).  In this work, mol. complexation between each inhibitor and SARS-CoV-2 3CLpro was studied using all-atom mol. dynamics simulations, free energy calcns., and pair interaction energy analyses based on MM/PB(GB)SA and FMO-MP2/PCM/6-31G* methods.  Both anti-HIV drugs interacted well with the residues at the active site of SARS-CoV-2 3CLpro.  Ritonavir showed a somewhat higher no. at. contacts, a somewhat higher binding efficiency, and a somewhat higher no. of key binding residues compared to lopinavir, which correspond with the slightly lower water accessibility at the 3CLpro active site.  In addn., only ritonavir could interact with the oxyanion hole residues N142 and G143 via the formation of two hydrogen bonds.  The interactions in terms of electrostatics, dispersion, and charge transfer played an important role in the drug binding.  The obtained results demonstrated how repurposed anti-HIV drugs could be used to combat COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro03-EVm8c4LVg90H21EOLACvtfcHk0lhxzn2LawnWfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntVKltr8%253D&md5=86b235b2c4f618c9cbd0aadb25c81e97</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.0c00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.0c00160%26sid%3Dliteratum%253Aachs%26aulast%3DNutho%26aufirst%3DB.%26aulast%3DMahalapbutr%26aufirst%3DP.%26aulast%3DHengphasatporn%26aufirst%3DK.%26aulast%3DPattaranggoon%26aufirst%3DN.%2BC.%26aulast%3DSimanon%26aufirst%3DN.%26aulast%3DShigeta%26aufirst%3DY.%26aulast%3DHannongbua%26aufirst%3DS.%26aulast%3DRungrotmongkol%26aufirst%3DT.%26atitle%3DWhy%2520Are%2520Lopinavir%2520and%2520Ritonavir%2520effective%2520against%2520the%2520newly%2520emerged%2520coronavirus%25202019%253F%2520Atomistic%2520insights%2520into%2520the%2520inhibitory%2520mechanisms%26jtitle%3DBiochemistry%26date%3D2020%26volume%3D59%26issue%3D18%26spage%3D1769%26epage%3D1779%26doi%3D10.1021%2Facs.biochem.0c00160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, S. M.</span></span> <span> </span><span class="NLM_article-title">RNA synthetic mechanisms employed by diverse families of RNA viruses</span>. <i>WIREs RNA</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1002/wrna.1164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fwrna.1164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23606593" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=351-367&issue=4&author=S.+M.+McDonald&title=RNA+synthetic+mechanisms+employed+by+diverse+families+of+RNA+viruses&doi=10.1002%2Fwrna.1164"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fwrna.1164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fwrna.1164%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DS.%2BM.%26atitle%3DRNA%2520synthetic%2520mechanisms%2520employed%2520by%2520diverse%2520families%2520of%2520RNA%2520viruses%26jtitle%3DWIREs%2520RNA%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D351%26epage%3D367%26doi%3D10.1002%2Fwrna.1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span> <span> </span><span class="NLM_article-title">Approved antiviral drugs over the past 50 years</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1128/CMR.00102-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FCMR.00102-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27281742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fos12htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=695-747&issue=3&author=E.+De%0AClercqauthor=G.+Li&title=Approved+antiviral+drugs+over+the+past+50+years&doi=10.1128%2FCMR.00102-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Approved Antiviral Drugs over the Past 50 Years</span></div><div class="casAuthors">De Clercq Erik; Li Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">695-747</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs categorized into 13 functional groups have been formally approved for the treatment of the following 9 human infectious diseases: (i) HIV infections (protease inhibitors, integrase inhibitors, entry inhibitors, nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and acyclic nucleoside phosphonate analogues), (ii) hepatitis B virus (HBV) infections (lamivudine, interferons, nucleoside analogues, and acyclic nucleoside phosphonate analogues), (iii) hepatitis C virus (HCV) infections (ribavirin, interferons, NS3/4A protease inhibitors, NS5A inhibitors, and NS5B polymerase inhibitors), (iv) herpesvirus infections (5-substituted 2'-deoxyuridine analogues, entry inhibitors, nucleoside analogues, pyrophosphate analogues, and acyclic guanosine analogues), (v) influenza virus infections (ribavirin, matrix 2 protein inhibitors, RNA polymerase inhibitors, and neuraminidase inhibitors), (vi) human cytomegalovirus infections (acyclic guanosine analogues, acyclic nucleoside phosphonate analogues, pyrophosphate analogues, and oligonucleotides), (vii) varicella-zoster virus infections (acyclic guanosine analogues, nucleoside analogues, 5-substituted 2'-deoxyuridine analogues, and antibodies), (viii) respiratory syncytial virus infections (ribavirin and antibodies), and (ix) external anogenital warts caused by human papillomavirus infections (imiquimod, sinecatechins, and podofilox).  Here, we present for the first time a comprehensive overview of antiviral drugs approved over the past 50 years, shedding light on the development of effective antiviral treatments against current and emerging infectious diseases worldwide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbPpNpCY_qYTEC-75aqa5AfW6udTcc2ebHoKLkekftRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fos12htA%253D%253D&md5=1d25d961c1c6a72d6bc4634041bbb6fe</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1128%2FCMR.00102-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00102-15%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DG.%26atitle%3DApproved%2520antiviral%2520drugs%2520over%2520the%2520past%252050%2520years%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2016%26volume%3D29%26issue%3D3%26spage%3D695%26epage%3D747%26doi%3D10.1128%2FCMR.00102-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subissi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posthuma, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zevenhoven-Dobbe, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbalenya, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbert, I.</span></span> <span> </span><span class="NLM_article-title">One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">E3900</span>– <span class="NLM_lpage">E3909</span>, <span class="refDoi"> DOI: 10.1073/pnas.1323705111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1323705111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25197083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGntb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E3900-E3909&issue=37&author=L.+Subissiauthor=C.+C.+Posthumaauthor=A.+Colletauthor=J.+C.+Zevenhoven-Dobbeauthor=A.+E.+Gorbalenyaauthor=E.+Decrolyauthor=E.+J.+Snijderauthor=B.+Canardauthor=I.+Imbert&title=One+severe+acute+respiratory+syndrome+coronavirus+protein+complex+integrates+processive+RNA+polymerase+and+exonuclease+activities&doi=10.1073%2Fpnas.1323705111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities</span></div><div class="casAuthors">Subissi, Lorenzo; Posthuma, Clara C.; Collet, Axelle; Zevenhoven-Dobbe, Jessika C.; Gorbalenya, Alexander E.; Decroly, Etienne; Snijder, Eric J.; Canard, Bruno; Imbert, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">E3900-E3909</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In addn. to members causing milder human infections, the Coronaviridae family includes potentially lethal zoonotic agents causing severe acute respiratory syndrome (SARS) and the recently emerged Middle East respiratory syndrome.  The ∼30-kb pos.-stranded RNA genome of coronaviruses encodes a replication/transcription machinery that is unusually complex and composed of 16 nonstructural proteins (nsps).  SARS-CoV nsp12, the canonical RNA-dependent RNA polymerase (RdRp), exhibits poorly processive RNA synthesis in vitro, at odds with the efficient replication of a very large RNA genome in vivo.  Here, we report that SARS-CoV nsp7 and nsp8 activate and confer processivity to the RNA-synthesizing activity of nsp12.  Using biochem. assays and reverse genetics, the importance of conserved nsp7 and nsp8 residues was probed.  Whereas several nsp7 mutations affected virus replication to a limited extent, the replacement of two nsp8 residues (P183 and R190) essential for interaction with nsp12 and a third (K58) crit. for the interaction of the polymerase complex with RNA were all lethal to the virus.  Without a loss of processivity, the nsp7/nsp8/nsp12 complex can assoc. with nsp14, a bifunctional enzyme bearing 3'-5' exoribonuclease and RNA cap N7-guanine methyltransferase activities involved in replication fidelity and 5'-RNA capping, resp.  The identification of this tripartite polymerase complex that in turn assocs. with the nsp14 proofreading enzyme sheds light on how coronaviruses assemble an RNA-synthesizing machinery to replicate the largest known RNA genomes.  This protein complex is a fascinating example of the functional integration of RNA polymerase, capping, and proofreading activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodG7yPmFowK7Vg90H21EOLACvtfcHk0lhyCXrbLTmgHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGntb3M&md5=ed2d7e8787ddd0d8a5e4565932cc54ef</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1323705111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1323705111%26sid%3Dliteratum%253Aachs%26aulast%3DSubissi%26aufirst%3DL.%26aulast%3DPosthuma%26aufirst%3DC.%2BC.%26aulast%3DCollet%26aufirst%3DA.%26aulast%3DZevenhoven-Dobbe%26aufirst%3DJ.%2BC.%26aulast%3DGorbalenya%26aufirst%3DA.%2BE.%26aulast%3DDecroly%26aufirst%3DE.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DCanard%26aufirst%3DB.%26aulast%3DImbert%26aufirst%3DI.%26atitle%3DOne%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520protein%2520complex%2520integrates%2520processive%2520RNA%2520polymerase%2520and%2520exonuclease%2520activities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D37%26spage%3DE3900%26epage%3DE3909%26doi%3D10.1073%2Fpnas.1323705111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debarnot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbert, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluais, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papageorgiou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Lombardia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span> <span> </span><span class="NLM_article-title">Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2′-O-methyltransferase nsp10/nsp16 complex</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e1002059</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.ppat.1002059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21637813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&issue=5&author=E.+Decrolyauthor=C.+Debarnotauthor=F.+Ferronauthor=M.+Bouvetauthor=B.+Coutardauthor=I.+Imbertauthor=L.+Gluaisauthor=N.+Papageorgiouauthor=A.+Sharffauthor=G.+Bricogneauthor=M.+Ortiz-Lombardiaauthor=J.+Lescarauthor=B.+Canard&title=Crystal+structure+and+functional+analysis+of+the+SARS-coronavirus+RNA+cap+2%E2%80%B2-O-methyltransferase+nsp10%2Fnsp16+complex&doi=10.1371%2Fjournal.ppat.1002059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure and functional analysis of the SARS-Coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex</span></div><div class="casAuthors">Decroly, Etienne; Debarnot, Claire; Ferron, Francois; Bouvet, Mickael; Coutard, Bruno; Imbert, Isabelle; Gluais, Laure; Papageorgiou, Nicolas; Sharff, Andrew; Bricogne, Gerard; Ortiz-Lombardia, Miguel; Lescar, Julien; Canard, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e1002059</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cellular and viral S-adenosylmethionine (SAM)-dependent methyltransferases are involved in many regulated processes such as metab., detoxification, signal transduction, chromatin remodeling, nucleic acid processing, and mRNA capping.  The severe acute respiratory syndrome coronavirus (SARS-CoV) nsp16 protein is a S-adenosylmethionine-dependent (nucleoside-2'-O)-methyltransferase (2'-O-MTase) only active in the presence of its activating partner nsp10.  We report the nsp10/nsp16 complex structure at 2.0 Å resoln., which shows nsp10 bound to nsp16 through a ∼930 Å2 surface area in nsp10.  Functional assays identify key residues involved in nsp10/nsp16 assocn., and in RNA binding or catalysis, the latter likely through a SN2-like mechanism.  We present two other crystal structures, the inhibitor sinefungin bound in the S-adenosylmethionine binding pocket and the tighter complex nsp10(Y96F)/nsp16, providing the first structural insight into the regulation of RNA capping enzymes in (+)RNA viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj9FGUC_LGErVg90H21EOLACvtfcHk0lhyCXrbLTmgHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVajsrY%253D&md5=292e743ef82e8084a4678d6ccfe2729a</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002059%26sid%3Dliteratum%253Aachs%26aulast%3DDecroly%26aufirst%3DE.%26aulast%3DDebarnot%26aufirst%3DC.%26aulast%3DFerron%26aufirst%3DF.%26aulast%3DBouvet%26aufirst%3DM.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DImbert%26aufirst%3DI.%26aulast%3DGluais%26aufirst%3DL.%26aulast%3DPapageorgiou%26aufirst%3DN.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DBricogne%26aufirst%3DG.%26aulast%3DOrtiz-Lombardia%26aufirst%3DM.%26aulast%3DLescar%26aufirst%3DJ.%26aulast%3DCanard%26aufirst%3DB.%26atitle%3DCrystal%2520structure%2520and%2520functional%2520analysis%2520of%2520the%2520SARS-coronavirus%2520RNA%2520cap%25202%25E2%2580%25B2-O-methyltransferase%2520nsp10%252Fnsp16%2520complex%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26issue%3D5%26doi%3D10.1371%2Fjournal.ppat.1002059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span> <span> </span><span class="NLM_article-title">Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">9436</span>– <span class="NLM_lpage">9441</span>, <span class="refDoi"> DOI: 10.1073/pnas.1508686112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1508686112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26159422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGkt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=9436-9441&issue=30&author=Y.+Maauthor=L.+Wuauthor=N.+Shawauthor=Y.+Gaoauthor=J.+Wangauthor=Y.+Sunauthor=Z.+Louauthor=L.+Yanauthor=R.+Zhangauthor=Z.+Rao&title=Structural+basis+and+functional+analysis+of+the+SARS+coronavirus+nsp14-nsp10+complex&doi=10.1073%2Fpnas.1508686112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex</span></div><div class="casAuthors">Ma, Yuanyuan; Wu, Lijie; Shaw, Neil; Gao, Yan; Wang, Jin; Sun, Yuna; Lou, Zhiyong; Yan, Liming; Zhang, Rongguang; Rao, Zihe</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9436-9441</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Nonstructural protein 14 (nsp14) of coronaviruses (CoV) is important for viral replication and transcription.  The N-terminal exoribonuclease (ExoN) domain plays a proofreading role for prevention of lethal mutagenesis, and the C-terminal domain functions as a (guanine-N7) Me transferase (N7-MTase) for mRNA capping.  The mol. basis of both these functions is unknown.  Here, we describe crystal structures of severe acute respiratory syndrome (SARS)-CoV nsp14 in complex with its activator nonstructural protein 10 (nsp10) and functional ligands.  One mol. of nsp10 interacts with ExoN of nsp14 to stabilize it and stimulate its activity.  Although the catalytic core of nsp14 ExoN is reminiscent of proofreading exonucleases, the presence of two zinc fingers sets it apart from homologs.  Mutagenesis studies indicate that both these zinc fingers are essential for the function of nsp14.  We show that a DEEDh (the five catalytic amino acids) motif drives nucleotide excision.  The N7-MTase domain exhibits a noncanonical MTase fold with a rare β-sheet insertion and a peripheral zinc finger.  The cap-precursor guanosine-P3-adenosine-5',5'-triphosphate (GpppA) and S-adenosyl methionine (SAM) bind in proximity in a highly constricted pocket between two β-sheets to accomplish Me transfer.  Our studies provide the first glimpses, to our knowledge, into the architecture of the nsp14-nsp10 complex involved in RNA viral proofreading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4g1b9tJjK_rVg90H21EOLACvtfcHk0lh75IN_NX4YoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGkt7vJ&md5=f19a48e43faff6c92632a108d87641c1</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1508686112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1508686112%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DShaw%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DZ.%26atitle%3DStructural%2520basis%2520and%2520functional%2520analysis%2520of%2520the%2520SARS%2520coronavirus%2520nsp14-nsp10%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D30%26spage%3D9436%26epage%3D9441%26doi%3D10.1073%2Fpnas.1508686112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirchdoerfer, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span> <span> </span><span class="NLM_article-title">Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">2342</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-10280-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41467-019-10280-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31138817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB3M3gslGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2342&issue=1&author=R.+N.+Kirchdoerferauthor=A.+B.+Ward&title=Structure+of+the+SARS-CoV+nsp12+polymerase+bound+to+nsp7+and+nsp8+co-factors&doi=10.1038%2Fs41467-019-10280-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors</span></div><div class="casAuthors">Kirchdoerfer Robert N; Ward Andrew B</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2342</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent history is punctuated by the emergence of highly pathogenic coronaviruses such as SARS- and MERS-CoV into human circulation.  Upon infecting host cells, coronaviruses assemble a multi-subunit RNA-synthesis complex of viral non-structural proteins (nsp) responsible for the replication and transcription of the viral genome.  Here, we present the 3.1 ÅA resolution structure of the SARS-CoV nsp12 polymerase bound to its essential co-factors, nsp7 and nsp8, using single particle cryo-electron microscopy. nsp12 possesses an architecture common to all viral polymerases as well as a large N-terminal extension containing a kinase-like fold and is bound by two nsp8 co-factors.  This structure illuminates the assembly of the coronavirus core RNA-synthesis machinery, provides key insights into nsp12 polymerase catalysis and fidelity and acts as a template for the design of novel antiviral therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHhQTFTUGoc7HHuJhbyicZfW6udTcc2ebFQcYoHf4j9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3gslGnsg%253D%253D&md5=71c144c86c8cef5df8bd02905d93d6dc</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-10280-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-10280-3%26sid%3Dliteratum%253Aachs%26aulast%3DKirchdoerfer%26aufirst%3DR.%2BN.%26aulast%3DWard%26aufirst%3DA.%2BB.%26atitle%3DStructure%2520of%2520the%2520SARS-CoV%2520nsp12%2520polymerase%2520bound%2520to%2520nsp7%2520and%2520nsp8%2520co-factors%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D2342%26doi%3D10.1038%2Fs41467-019-10280-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Therapeutic options for the 2019 novel coronavirus (2019-nCoV)</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/d41573-020-00016-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fd41573-020-00016-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32127666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkt1GksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2020&pages=149-150&issue=3&author=G.+Liauthor=E.+De+Clercq&title=Therapeutic+options+for+the+2019+novel+coronavirus+%282019-nCoV%29&doi=10.1038%2Fd41573-020-00016-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic options for the 2019 novel coronavirus (2019-nCoV)</span></div><div class="casAuthors">Li, Guangdi; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-150</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Therapeutic options in response to the 2019-nCoV outbreak are urgently needed.  Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCBg8QqE24YbVg90H21EOLACvtfcHk0lh75IN_NX4YoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkt1GksLo%253D&md5=60d91d88e6a0279829eecb74990c9d03</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fd41573-020-00016-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fd41573-020-00016-0%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DTherapeutic%2520options%2520for%2520the%25202019%2520novel%2520coronavirus%2520%25282019-nCoV%2529%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2020%26volume%3D19%26issue%3D3%26spage%3D149%26epage%3D150%26doi%3D10.1038%2Fd41573-020-00016-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elfiky, A. A.</span></span> <span> </span><span class="NLM_article-title">Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">117592</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2020.117592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.lfs.2020.117592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32222463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvFemurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=2020&pages=117592&author=A.+A.+Elfiky&title=Ribavirin%2C+Remdesivir%2C+Sofosbuvir%2C+Galidesivir%2C+and+Tenofovir+against+SARS-CoV-2+RNA+dependent+RNA+polymerase+%28RdRp%29%3A+A+molecular+docking+study&doi=10.1016%2Fj.lfs.2020.117592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study</span></div><div class="casAuthors">Elfiky, Abdo A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117592</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new human coronavirus (HCoV), which has been designated SARS-CoV-2, began spreading in Dec. 2019 in Wuhan City, China causing pneumonia called COVID-19.  The spread of SARS-CoV-2 has been faster than any other coronaviruses that have succeeded in crossing the animal-human barrier.  There is concern that this new virus will spread around the world as did the previous two HCoVs-Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)-each of which caused approx. 800 deaths in the years 2002 and 2012, resp.  Thus far, 11,268 deaths have been reported from the 258,842 confirmed infections in 168 countries.  In this study, the RNA-dependent RNA polymerase (RdRp) of the newly emerged coronavirus is modeled, validated, and then targeted using different anti-polymerase drugs currently on the market that have been approved for use against various viruses.  The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp.  In addn., the results suggest guanosine deriv. (IDX-184), Setrobuvir, and YAK as top seeds for antiviral treatments with high potential to fight the SARS-CoV-2 strain specifically.  The availability of FDA-approved anti-RdRp drugs can help treat patients and reduce the danger of the mysterious new viral infection COVID-19.  The drugs mentioned above can tightly bind to the RdRp of the SARS-CoV-2 strain and thus may be used to treat the disease.  No toxicity measurements are required for these drugs since they were previously tested prior to their approval by the FDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUsdjkpK0gpbVg90H21EOLACvtfcHk0ljq02NSXR-Niw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvFemurw%253D&md5=9f464ee51fef4510c659f03f996110fb</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2020.117592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2020.117592%26sid%3Dliteratum%253Aachs%26aulast%3DElfiky%26aufirst%3DA.%2BA.%26atitle%3DRibavirin%252C%2520Remdesivir%252C%2520Sofosbuvir%252C%2520Galidesivir%252C%2520and%2520Tenofovir%2520against%2520SARS-CoV-2%2520RNA%2520dependent%2520RNA%2520polymerase%2520%2528RdRp%2529%253A%2520A%2520molecular%2520docking%2520study%26jtitle%3DLife%2520Sci.%26date%3D2020%26volume%3D253%26spage%3D117592%26doi%3D10.1016%2Fj.lfs.2020.117592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span> <span> </span><span class="NLM_article-title">Expression, purification, and characterization of SARS coronavirus RNA polymerase</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>335</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2005.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2005.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15840516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlaisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2005&pages=165-176&issue=2&author=A.+Chengauthor=W.+Zhangauthor=Y.+Xieauthor=W.+Jiangauthor=E.+Arnoldauthor=S.+G.+Sarafianosauthor=J.+Ding&title=Expression%2C+purification%2C+and+characterization+of+SARS+coronavirus+RNA+polymerase&doi=10.1016%2Fj.virol.2005.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, purification, and characterization of SARS coronavirus RNA polymerase</span></div><div class="casAuthors">Cheng, Ao; Zhang, Wei; Xie, Youhua; Jiang, Weihong; Arnold, Eddy; Sarafianos, Stefan G.; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The RNA-dependent RNA polymerase (RdRp) of SARS coronavirus (SARS-CoV) is essential for viral replication and a potential target for anti-SARS drugs.  Here, the authors report the cloning, expression, and purifn. of N-terminal GST-fused SARS-CoV RdRp and its polymerase catalytic domain in Escherichia coli.  During purifn., the full-length GST-RdRp was found to cleave into 3 main fragments: an N-terminal p12 fragment, a middle p30 fragment, and a C-terminal p64 fragment comprising the catalytic domain, presumably due to bacterial proteases.  Biochem. assays showed that full-length GST-RdRp had RdRp activity and that the p64 and p12 fragments formed a complex that exhibited comparable RdRp activity, whereas the GST-p64 protein had no activity, suggesting that the p12 domain is required for polymerase activity possibly via involvement in template-primer binding.  Non-nucleoside HIV-1 RT inhibitors were shown to have no evident inhibitory effect on SARS-CoV RdRp activity.  This work provides a basis for biochem. and structural studies of SARS-CoV RdRp and for the development of anti-SARS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkqaXvp-3xvLVg90H21EOLACvtfcHk0ljq02NSXR-Niw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlaisb0%253D&md5=cdaf95f961394d5668bd4a27fd1a5b6a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2005.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2005.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DExpression%252C%2520purification%252C%2520and%2520characterization%2520of%2520SARS%2520coronavirus%2520RNA%2520polymerase%26jtitle%3DVirology%26date%3D2005%26volume%3D335%26issue%3D2%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.virol.2005.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheahan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menachery, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gralinski, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyrc, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trantcheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spahn, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmiotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span> <span> </span><span class="NLM_article-title">Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">396</span>), <span class="NLM_elocation-id">eaal3653</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aal3653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscitranslmed.aal3653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28659436" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&issue=396&author=T.+P.+Sheahanauthor=A.+C.+Simsauthor=R.+L.+Grahamauthor=V.+D.+Menacheryauthor=L.+E.+Gralinskiauthor=J.+B.+Caseauthor=S.+R.+Leistauthor=K.+Pyrcauthor=J.+Y.+Fengauthor=I.+Trantchevaauthor=R.+Bannisterauthor=Y.+Parkauthor=D.+Babusisauthor=M.+O.+Clarkeauthor=R.+L.+Mackmanauthor=J.+E.+Spahnauthor=C.+A.+Palmiottiauthor=D.+Siegelauthor=A.+S.+Rayauthor=T.+Cihlarauthor=R.+Jordanauthor=M.+R.+Denisonauthor=R.+S.+Baric&title=Broad-spectrum+antiviral+GS-5734+inhibits+both+epidemic+and+zoonotic+coronaviruses&doi=10.1126%2Fscitranslmed.aal3653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aal3653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aal3653%26sid%3Dliteratum%253Aachs%26aulast%3DSheahan%26aufirst%3DT.%2BP.%26aulast%3DSims%26aufirst%3DA.%2BC.%26aulast%3DGraham%26aufirst%3DR.%2BL.%26aulast%3DMenachery%26aufirst%3DV.%2BD.%26aulast%3DGralinski%26aufirst%3DL.%2BE.%26aulast%3DCase%26aufirst%3DJ.%2BB.%26aulast%3DLeist%26aufirst%3DS.%2BR.%26aulast%3DPyrc%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DTrantcheva%26aufirst%3DI.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSpahn%26aufirst%3DJ.%2BE.%26aulast%3DPalmiotti%26aufirst%3DC.%2BA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26atitle%3DBroad-spectrum%2520antiviral%2520GS-5734%2520inhibits%2520both%2520epidemic%2520and%2520zoonotic%2520coronaviruses%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26issue%3D396%26doi%3D10.1126%2Fscitranslmed.aal3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span> <span> </span><span class="NLM_article-title">Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1038/s41422-020-0282-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41422-020-0282-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32020029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkt1Ciu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=269-271&issue=3&author=M.+Wangauthor=R.+Caoauthor=L.+Zhangauthor=X.+Yangauthor=J.+Liuauthor=M.+Xuauthor=Z.+Shiauthor=Z.+Huauthor=W.+Zhongauthor=G.+Xiao&title=Remdesivir+and+chloroquine+effectively+inhibit+the+recently+emerged+novel+coronavirus+%282019-nCoV%29+in+vitro&doi=10.1038%2Fs41422-020-0282-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</span></div><div class="casAuthors">Wang, Manli; Cao, Ruiyuan; Zhang, Leike; Yang, Xinglou; Liu, Jia; Xu, Mingyue; Shi, Zhengli; Hu, Zhihong; Zhong, Wu; Xiao, Gengfu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-271</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">In Dec. 2019, a novel pneumonia caused by a previously unknown pathogen emerged in Wuhan, a city of 11 million people in central China.  The initial cases were linked to exposures in a seafood market in Wuhan.  The pathogen was soon identified as a novel coronavirus (2019-nCoV), which is closely related to severe acute respiratory syndrome CoV (SARS-CoV).  Currently, there is no specific treatment against the new virus.  Therefore, identifying effective antiviral agents to combat the disease is urgently needed.  In this study, we evaluated the antiviral efficiency of FAD-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine and two well-known broad-spectrum antiviral drugs remdesivir (GS-5734) and favipiravir (T-705) against a clin. isolate of 2019-nCoV in vitro.  Our findings reveal that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro.  Since these compds. have been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnj2tW4TeD7Vg90H21EOLACvtfcHk0lhCc22Z_N9t-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkt1Ciu7k%253D&md5=bdf16b352ebc06bc148ed5c513b7d414</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1038%2Fs41422-020-0282-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-020-0282-0%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DG.%26atitle%3DRemdesivir%2520and%2520chloroquine%2520effectively%2520inhibit%2520the%2520recently%2520emerged%2520novel%2520coronavirus%2520%25282019-nCoV%2529%2520in%2520vitro%26jtitle%3DCell%2520Res.%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D269%26epage%3D271%26doi%3D10.1038%2Fs41422-020-0282-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1126/science.abc1560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abc1560" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=W.+Yinauthor=C.+Maoauthor=X.+Luanauthor=D.+D.+Shenauthor=Q.+Shenauthor=H.+Suauthor=X.+Wangauthor=F.+Zhouauthor=W.+Zhaoauthor=M.+Gaoauthor=S.+Changauthor=Y.+C.+Xieauthor=G.+Tianauthor=H.+W.+Jiangauthor=S.+C.+Taoauthor=J.+Shenauthor=Y.+Jiangauthor=H.+Jiangauthor=Y.+Xuauthor=S.+Zhangauthor=Y.+Zhangauthor=H.+E.+Xu&title=Structural+basis+for+inhibition+of+the+RNA-dependent+RNA+polymerase+from+SARS-CoV-2+by+remdesivir&doi=10.1126%2Fscience.abc1560"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1126%2Fscience.abc1560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abc1560%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DLuan%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DY.%2BC.%26aulast%3DTian%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DH.%2BW.%26aulast%3DTao%26aufirst%3DS.%2BC.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520SARS-CoV-2%2520by%2520remdesivir%26jtitle%3DScience%26date%3D2020%26doi%3D10.1126%2Fscience.abc1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupferschmidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, J.</span></span> <span> </span><span class="NLM_article-title">Race to find COVID-19 treatments accelerates</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">6485</span>),  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1413</span>, <span class="refDoi"> DOI: 10.1126/science.367.6485.1412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.367.6485.1412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32217705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslyms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2020&pages=1412-1413&issue=6485&author=K.+Kupferschmidtauthor=J.+Cohen&title=Race+to+find+COVID-19+treatments+accelerates&doi=10.1126%2Fscience.367.6485.1412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Race to find COVID-19 treatments accelerates</span></div><div class="casAuthors">Kupferschmidt, Kai; Cohen, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6485</span>),
    <span class="NLM_cas:pages">1412-1413</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">As the race to find treatments for coronavirus disease 2019 (COVID-19) accelerates, the World Health Organization (WHO) last week announced a major study to compare treatment strategies in a streamlined clin. trial design that doctors around the world can join.  SOLIDARITY-an unprecedented, coordinated push to collect robust scientific data rapidly during a pandemic, could include many thousands of patients in dozens of countries and has emphasized simplicity so that even hospitals overwhelmed by an onslaught of COVID-19 patients can participate.  The study will examine an exptl. antiviral compd. called remdesivir; the malaria medication chloroquine (or its chem. cousin hydroxychloroquine); a combination of the HIV drugs lopinavir and ritonavir; and that combination plus interferon-beta, an immune system messenger that can help cripple viruses.  WHO hopes to start to enroll patients as early as this week.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh0Ms8vLr3QLVg90H21EOLACvtfcHk0lhCc22Z_N9t-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslyms7g%253D&md5=6daa35af38dc238a33c14e24af1035c3</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1126%2Fscience.367.6485.1412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.367.6485.1412%26sid%3Dliteratum%253Aachs%26aulast%3DKupferschmidt%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DRace%2520to%2520find%2520COVID-19%2520treatments%2520accelerates%26jtitle%3DScience%26date%3D2020%26volume%3D367%26issue%3D6485%26spage%3D1412%26epage%3D1413%26doi%3D10.1126%2Fscience.367.6485.1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horby, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span> (<span class="NLM_issue">10236</span>),  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1578</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)31022-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2931022-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32423584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXosVWlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=1569-1578&issue=10236&author=Y.+Wangauthor=D.+Zhangauthor=G.+Duauthor=R.+Duauthor=J.+Zhaoauthor=Y.+Jinauthor=S.+Fuauthor=L.+Gaoauthor=Z.+Chengauthor=Q.+Luauthor=Y.+Huauthor=G.+Luoauthor=K.+Wangauthor=Y.+Luauthor=H.+Liauthor=S.+Wangauthor=S.+Ruanauthor=C.+Yangauthor=C.+Meiauthor=Y.+Wangauthor=D.+Dingauthor=F.+Wuauthor=X.+Tangauthor=X.+Yeauthor=Y.+Yeauthor=B.+Liuauthor=J.+Yangauthor=W.+Yinauthor=A.+Wangauthor=G.+Fanauthor=F.+Zhouauthor=Z.+Liuauthor=X.+Guauthor=J.+Xuauthor=L.+Shangauthor=Y.+Zhangauthor=L.+Caoauthor=T.+Guoauthor=Y.+Wanauthor=H.+Qinauthor=Y.+Jiangauthor=T.+Jakiauthor=F.+G.+Haydenauthor=P.+W.+Horbyauthor=B.+Caoauthor=C.+Wang&title=Remdesivir+in+adults+with+severe+COVID-19%3A+a+randomised%2C+double-blind%2C+placebo-controlled%2C+multicentre+trial&doi=10.1016%2FS0140-6736%2820%2931022-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial</span></div><div class="casAuthors">Wang, Yeming; Zhang, Dingyu; Du, Guanhua; Du, Ronghui; Zhao, Jianping; Jin, Yang; Fu, Shouzhi; Gao, Ling; Cheng, Zhenshun; Lu, Qiaofa; Hu, Yi; Luo, Guangwei; Wang, Ke; Lu, Yang; Li, Huadong; Wang, Shuzhen; Ruan, Shunan; Yang, Chengqing; Mei, Chunlin; Wang, Yi; Ding, Dan; Wu, Feng; Tang, Xin; Ye, Xianzhi; Ye, Yingchun; Liu, Bing; Yang, Jie; Yin, Wen; Wang, Aili; Fan, Guohui; Zhou, Fei; Liu, Zhibo; Gu, Xiaoying; Xu, Jiuyang; Shang, Lianhan; Zhang, Yi; Cao, Lianjun; Guo, Tingting; Wan, Yan; Qin, Hong; Jiang, Yushen; Jaki, Thomas; Hayden, Frederick G.; Horby, Peter W.; Cao, Bin; Wang, Chen</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10236</span>),
    <span class="NLM_cas:pages">1569-1578</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19).  Remdesivir (GS-5734), a nucleoside analog prodrug, has inhibitory effects on pathogenic animal and human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro, and inhibits Middle East respiratory syndrome coronavirus, SARS-CoV-1, and SARS-CoV-2 replication in animal models.  We did a randomized, double-blind, placebo-controlled, multicenter trial at ten hospitals in Hubei, China.  Eligible patients were adults (aged ≥18 years) admitted to hospital with lab.-confirmed SARS-CoV-2 infection, with an interval from symptom onset to enrollment of 12 days or less, oxygen satn. of 94% or less on room air or a ratio of arterial oxygen partial pressure to fractional inspired oxygen of 300 mm Hg or less, and radiol. confirmed pneumonia.  Patients were randomly assigned in a 2:1 ratio to i.v. remdesivir (200 mg on day 1 followed by 100 mg on days 2-10 in single daily infusions) or the same vol. of placebo infusions for 10 days.  Patients were permitted concomitant use of lopinavir-ritonavir, interferons, and corticosteroids.  The primary endpoint was time to clin. improvement up to day 28, defined as the time (in days) from randomization to the point of a decline of two levels on a six-point ordinal scale of clin. status (from 1=discharged to 6=death) or discharged alive from hospital, whichever came first.  Primary anal. was done in the intention-to-treat (ITT) population and safety anal. was done in all patients who started their assigned treatment.  This trial is registered with ClinicalTrials.gov, NCT04257656.  Between Feb 6, 2020, and March 12, 2020, 237 patients were enrolled and randomly assigned to a treatment group (158 to remdesivir and 79 to placebo); one patient in the placebo group who withdrew after randomization was not included in the ITT population.  Remdesivir use was not assocd. with a difference in time to clin. improvement (hazard ratio 1·23 [95% CI 0·87-1·75]).  Although not statistically significant, patients receiving remdesivir had a numerically faster time to clin. improvement than those receiving placebo among patients with symptom duration of 10 days or less (hazard ratio 1·52 [0·95-2·43]).  Adverse events were reported in 102 (66%) of 155 remdesivir recipients vs. 50 (64%) of 78 placebo recipients.  Remdesivir was stopped early because of adverse events in 18 (12%) patients vs. four (5%) patients who stopped placebo early.  In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not assocd. with statistically significant clin. benefits.  However, the numerical redn. in time to clin. improvement in those treated earlier requires confirmation in larger studies.  Chinese Academy of Medical Sciences Emergency Project of COVID-19, National Key Research and Development Program of China, the Beijing Science and Technol. Project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmNUsjDSS-z7Vg90H21EOLACvtfcHk0lhkaZivq-ouWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXosVWlurc%253D&md5=160af7f665ed7fe089e9c07b3bec1acd</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2931022-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252931022-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DDu%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMei%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DShang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJaki%26aufirst%3DT.%26aulast%3DHayden%26aufirst%3DF.%2BG.%26aulast%3DHorby%26aufirst%3DP.%2BW.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DRemdesivir%2520in%2520adults%2520with%2520severe%2520COVID-19%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%252C%2520multicentre%2520trial%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26issue%3D10236%26spage%3D1569%26epage%3D1578%26doi%3D10.1016%2FS0140-6736%2820%2931022-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">U.S. Food & Drug Administration</span>, <span> </span><span class="NLM_article-title">Coronavirus (COVID-19) Update: FDA
Issues Emergency
Use Authorization for Potential COVID-19 Treatment</span>, FDA News Release, May 1, 2020; <a href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment" class="extLink">https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment</a> (accessed <span class="NLM_year">2020</span>-05-29).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=U.S.+Food+%26+Drug+Administration&title=Coronavirus+%28COVID-19%29+Update%3A+FDA%0AIssues+Emergency%0AUse+Authorization+for+Potential+COVID-19+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCoronavirus%2520%2528COVID-19%2529%2520Update%253A%2520FDA%250AIssues%2520Emergency%250AUse%2520Authorization%2520for%2520Potential%2520COVID-19%2520Treatment%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulangu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tshiani Mbaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukadi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusakibanza Manzo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nzolo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tshomba Oloma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulibaly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muyembe-Tamfum, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">the PALM Writing Group</span></span> <span> </span><span class="NLM_article-title">A randomized, controlled trial of Ebola virus disease therapeutics</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>381</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2303</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1910993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa1910993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31774950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVylsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2019&pages=2293-2303&issue=24&author=S.+Mulanguauthor=L.+E.+Doddauthor=R.+T.+Daveyauthor=O.+Tshiani+Mbayaauthor=M.+Proschanauthor=D.+Mukadiauthor=M.+Lusakibanza+Manzoauthor=D.+Nzoloauthor=A.+Tshomba+Olomaauthor=A.+Ibandaauthor=R.+Aliauthor=S.+Coulibalyauthor=A.+C.+Levineauthor=R.+Graisauthor=J.+Diazauthor=H.+C.+Laneauthor=J.-J.+Muyembe-Tamfumauthor=+the+PALM+Writing+Group&title=A+randomized%2C+controlled+trial+of+Ebola+virus+disease+therapeutics&doi=10.1056%2FNEJMoa1910993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, controlled trial of ebola virus disease therapeutics</span></div><div class="casAuthors">Mulangu, Sabue; Dodd, Lori E.; Davey, Richard T., Jr.; Mbaya, Olivier Tshiani; Proschan, Michael; Mukadi, Daniel; Manzo, Mariano Lusakibanza; Nzolo, Didier; Oloma, Antoine Tshomba; Ibanda, Augustin; Ali, Rosine; Coulibaly, Sinare; Levine, Adam C.; Grais, Rebecca; Diaz, Janet; Lane, H. Clifford; Muyembe-Tamfum, Jean-Jacques</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2293-2303</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Although several exptl. therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial. methods We conducted a trial of four investigational therapies for EVD in the Democratic Republic of Congo, where an outbreak began in August 2018.  Patients of any age who had a pos. result for Ebola virus RNA on reverse-transcriptase-polymerase-chain-reaction assay were enrolled.  All patients received std. care and were randomly assigned in a 1:1:1:1 ratio to i.v. administration of the triple monoclonal antibody ZMapp (the control group), the antiviral agent remdesivir, the single monoclonal antibody MAb114, or the triple monoclonal antibody REGN-EB3.  The REGN-EB3 group was added in a later version of the protocol, so data from these patients were compared with those of patients in the ZMapp group who were enrolled at or after the time the REGN-EB3 group was added (the ZMapp subgroup).  The primary end point was death at 28 days. results A total of 681 patients were enrolled from Nov. 20, 2018, to August 9, 2019, at which time the data and safety monitoring board recommended that patients be assigned only to the MAb114 and REGN-EB3 groups for the remainder of the trial; the recommendation was based on the results of an interim anal. that showed superiority of these groups to ZMapp and remdesivir with respect to mortality.  At 28 days, death had occurred in 61 of 174 patients (35.1%) in the MAb114 group, as compared with 84 of 169 (49.7%) in the ZMapp group (P = 0.007), and in 52 of 155 (33.5%) in the REGN-EB3 group, as compared with 79 of 154 (51.3%) in the ZMapp subgroup (P = 0.002).  A shorter duration of symptoms before admission and lower baseline values for viral load and for serum creatinine and aminotransferase levels each correlated with improved survival.  Four serious adverse events were judged to be potentially related to the trial drugs. conclusions Both MAb114 and REGN-EB3 were superior to ZMapp in reducing mortality from EVD.  Scientifically and ethically sound clin. research can be conducted during disease outbreaks and can help inform the outbreak response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsF31fomvTPrVg90H21EOLACvtfcHk0lhkaZivq-ouWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVylsLzP&md5=ace616255b8372f99aef8dee4864d38f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1910993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1910993%26sid%3Dliteratum%253Aachs%26aulast%3DMulangu%26aufirst%3DS.%26aulast%3DDodd%26aufirst%3DL.%2BE.%26aulast%3DDavey%26aufirst%3DR.%2BT.%26aulast%3DTshiani%2BMbaya%26aufirst%3DO.%26aulast%3DProschan%26aufirst%3DM.%26aulast%3DMukadi%26aufirst%3DD.%26aulast%3DLusakibanza%2BManzo%26aufirst%3DM.%26aulast%3DNzolo%26aufirst%3DD.%26aulast%3DTshomba%2BOloma%26aufirst%3DA.%26aulast%3DIbanda%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DR.%26aulast%3DCoulibaly%26aufirst%3DS.%26aulast%3DLevine%26aufirst%3DA.%2BC.%26aulast%3DGrais%26aufirst%3DR.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DH.%2BC.%26aulast%3DMuyembe-Tamfum%26aufirst%3DJ.-J.%26aulast%3Dthe%2BPALM%2BWriting%2BGroup%26atitle%3DA%2520randomized%252C%2520controlled%2520trial%2520of%2520Ebola%2520virus%2520disease%2520therapeutics%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D381%26issue%3D24%26spage%3D2293%26epage%3D2303%26doi%3D10.1056%2FNEJMoa1910993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agostini, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheahan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span> <span> </span><span class="NLM_article-title">Coronavirus susceptibility to the antiviral Remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>), <span class="NLM_elocation-id">e00221-18</span> <span class="refDoi"> DOI: 10.1128/mBio.00221-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FmBio.00221-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29511076" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&issue=2&author=M.+L.+Agostiniauthor=E.+L.+Andresauthor=A.+C.+Simsauthor=R.+L.+Grahamauthor=T.+P.+Sheahanauthor=X.+Luauthor=E.+C.+Smithauthor=J.+B.+Caseauthor=J.+Y.+Fengauthor=R.+Jordanauthor=A.+S.+Rayauthor=T.+Cihlarauthor=D.+Siegelauthor=R.+L.+Mackmanauthor=M.+O.+Clarkeauthor=R.+S.+Baricauthor=M.+R.+Denison&title=Coronavirus+susceptibility+to+the+antiviral+Remdesivir+%28GS-5734%29+is+mediated+by+the+viral+polymerase+and+the+proofreading+exoribonuclease&doi=10.1128%2FmBio.00221-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1128%2FmBio.00221-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00221-18%26sid%3Dliteratum%253Aachs%26aulast%3DAgostini%26aufirst%3DM.%2BL.%26aulast%3DAndres%26aufirst%3DE.%2BL.%26aulast%3DSims%26aufirst%3DA.%2BC.%26aulast%3DGraham%26aufirst%3DR.%2BL.%26aulast%3DSheahan%26aufirst%3DT.%2BP.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DE.%2BC.%26aulast%3DCase%26aufirst%3DJ.%2BB.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26atitle%3DCoronavirus%2520susceptibility%2520to%2520the%2520antiviral%2520Remdesivir%2520%2528GS-5734%2529%2520is%2520mediated%2520by%2520the%2520viral%2520polymerase%2520and%2520the%2520proofreading%2520exoribonuclease%26jtitle%3DmBio%26date%3D2018%26volume%3D9%26issue%3D2%26doi%3D10.1128%2FmBio.00221-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minskaia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbalenya, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanacci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambillau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziebuhr, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of an RNA virus 3′->5′ exoribonuclease that is critically involved in coronavirus RNA synthesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5108</span>– <span class="NLM_lpage">5113</span>, <span class="refDoi"> DOI: 10.1073/pnas.0508200103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.0508200103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16549795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVGltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=5108-5113&issue=13&author=E.+Minskaiaauthor=T.+Hertzigauthor=A.+E.+Gorbalenyaauthor=V.+Campanacciauthor=C.+Cambillauauthor=B.+Canardauthor=J.+Ziebuhr&title=Discovery+of+an+RNA+virus+3%E2%80%B2-%3E5%E2%80%B2+exoribonuclease+that+is+critically+involved+in+coronavirus+RNA+synthesis&doi=10.1073%2Fpnas.0508200103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an RNA virus 3'→5' exoribonuclease that is critically involved in coronavirus RNA synthesis</span></div><div class="casAuthors">Minskaia, Ekaterina; Hertzig, Tobias; Gorbalenya, Alexander E.; Campanacci, Valerie; Cambillau, Christian; Canard, Bruno; Ziebuhr, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5108-5113</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Replication of the giant RNA genome of severe acute respiratory syndrome (SARS) coronavirus (CoV) and synthesis of as many as eight subgenomic (sg) mRNAs are mediated by a viral replicase-transcriptase of outstanding complexity that includes an essential endoribonuclease activity.  Here, we show that the CoV replicative machinery, unlike that of other RNA viruses, also uses an exoribonuclease (ExoN) activity, which is assocd. with nonstructural protein (nsp) 14.  Bacterially expressed forms of SARS-CoV nsp14 were shown to act on both ssRNAs and dsRNAs in a 3'→5' direction.  The activity depended on residues that are conserved in the DEDD exonuclease superfamily.  The protein did not hydrolyze DNA or ribose-2'-O-methylated RNA substrates and required divalent metal ions for activity.  A range of 5'-labeled ssRNA substrates were processed to final products of ≈8-12 nucleotides.  When part of dsRNA or in the presence of nonlabeled dsRNA, the 5'-labeled RNA substrates were processed to significantly smaller products, indicating that binding to dsRNA in cis or trans modulates the exonucleolytic activity of nsp14.  Characterization of human CoV 229E ExoN active-site mutants revealed severe defects in viral RNA synthesis, and no viable virus could be recovered.  Besides strongly reduced genome replication, specific defects in sg RNA synthesis, such as aberrant sizes of specific sg RNAs and changes in the molar ratios between individual sg RNA species, were obsd.  Taken together, the study identifies an RNA virus ExoN activity that is involved in the synthesis of multiple RNAs from the exceptionally large genomic RNA templates of CoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6SF6y0gH--rVg90H21EOLACvtfcHk0lg95ojP6COYjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVGltr0%253D&md5=bdf193d90a45d6b9433dbdd4d74d4a4f</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508200103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508200103%26sid%3Dliteratum%253Aachs%26aulast%3DMinskaia%26aufirst%3DE.%26aulast%3DHertzig%26aufirst%3DT.%26aulast%3DGorbalenya%26aufirst%3DA.%2BE.%26aulast%3DCampanacci%26aufirst%3DV.%26aulast%3DCambillau%26aufirst%3DC.%26aulast%3DCanard%26aufirst%3DB.%26aulast%3DZiebuhr%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520RNA%2520virus%25203%25E2%2580%25B2-%253E5%25E2%2580%25B2%2520exoribonuclease%2520that%2520is%2520critically%2520involved%2520in%2520coronavirus%2520RNA%2520synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D13%26spage%3D5108%26epage%3D5113%26doi%3D10.1073%2Fpnas.0508200103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span> <span> </span><span class="NLM_article-title">Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>), <span class="NLM_elocation-id">e1003565</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1003565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.ppat.1003565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23966862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVChs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&issue=8&author=E.+C.+Smithauthor=H.+Blancauthor=M.+Vignuzziauthor=M.+R.+Denison&title=Coronaviruses+lacking+exoribonuclease+activity+are+susceptible+to+lethal+mutagenesis%3A+evidence+for+proofreading+and+potential+therapeutics&doi=10.1371%2Fjournal.ppat.1003565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics</span></div><div class="casAuthors">Smith, Everett Clinton; Blanc, Herve; Surdel, Matthew C.; Vignuzzi, Marco; Denison, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e1003565</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">No therapeutics or vaccines currently exist for human coronaviruses (HCoVs).  The severe acute respiratory syndrome-assocd. coronavirus (SARS-CoV) epidemic in 2002-2003, and the recent emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in Apr. 2012, emphasize the high probability of future zoonotic HCoV emergence causing severe and lethal human disease.  Addnl., the resistance of SARS-CoV to ribavirin (RBV) demonstrates the need to define new targets for inhibition of CoV replication.  CoVs express a 3'-to-5' exoribonuclease in nonstructural protein 14 (nsp14-ExoN) that is required for high-fidelity replication and is conserved across the CoV family.  All genetic and biochem. data support the hypothesis that nsp14-ExoN has an RNA proofreading function.  Thus, we hypothesized that ExoN is responsible for CoV resistance to RNA mutagens.  We demonstrate that while wild-type (ExoN+) CoVs were resistant to RBV and 5-fluorouracil (5-FU), CoVs lacking ExoN activity (ExoN-) were up to 300-fold more sensitive.  While the primary antiviral activity of RBV against CoVs was not mutagenesis, ExoN- CoVs treated with 5-FU demonstrated both enhanced sensitivity during multi-cycle replication, as well as decreased specific infectivity, consistent with 5-FU functioning as a mutagen.  Comparison of full-genome next-generation sequencing of 5-FU treated SARS-CoV populations revealed a 16-fold increase in the no. of mutations within the ExoN- population as compared to ExoN+.  Ninety percent of these mutations represented A:G and U:C transitions, consistent with 5-FU incorporation during RNA synthesis.  Together our results constitute direct evidence that CoV ExoN activity provides a crit. proofreading function during virus replication.  Furthermore, these studies identify ExoN as the first viral protein distinct from the RdRp that dets. the sensitivity of RNA viruses to mutagens.  Finally, our results show the importance of ExoN as a target for inhibition, and suggest that small-mol. inhibitors of ExoN activity could be potential pan-CoV therapeutics in combination with RBV or RNA mutagens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgCfuqrEG6y7Vg90H21EOLACvtfcHk0lhmrJdXcKQndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVChs73K&md5=8ac64b4a35096342d4a879be0226e455</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003565%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DE.%2BC.%26aulast%3DBlanc%26aufirst%3DH.%26aulast%3DVignuzzi%26aufirst%3DM.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26atitle%3DCoronaviruses%2520lacking%2520exoribonuclease%2520activity%2520are%2520susceptible%2520to%2520lethal%2520mutagenesis%253A%2520evidence%2520for%2520proofreading%2520and%2520potential%2520therapeutics%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26issue%3D8%26doi%3D10.1371%2Fjournal.ppat.1003565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. P.</span></span> <span> </span><span class="NLM_article-title">Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/cpt.1844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcpt.1844" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+X.+Duauthor=X.+P.+Chen&title=Favipiravir%3A+pharmacokinetics+and+concerns+about+clinical+trials+for+2019-nCoV+infection&doi=10.1002%2Fcpt.1844"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fcpt.1844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt.1844%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%2BX.%26aulast%3DChen%26aufirst%3DX.%2BP.%26atitle%3DFavipiravir%253A%2520pharmacokinetics%2520and%2520concerns%2520about%2520clinical%2520trials%2520for%25202019-nCoV%2520infection%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2020%26doi%3D10.1002%2Fcpt.1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posthuma, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbalenya, A. E.</span></span> <span> </span><span class="NLM_article-title">What we know but do not understand about nidovirus helicases</span>. <i>Virus Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.virusres.2014.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virusres.2014.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25497126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVygs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2015&pages=12-32&author=K.+C.+Lehmannauthor=E.+J.+Snijderauthor=C.+C.+Posthumaauthor=A.+E.+Gorbalenya&title=What+we+know+but+do+not+understand+about+nidovirus+helicases&doi=10.1016%2Fj.virusres.2014.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">What we know but do not understand about nidovirus helicases</span></div><div class="casAuthors">Lehmann, Kathleen C.; Snijder, Eric J.; Posthuma, Clara C.; Gorbalenya, Alexander E.</div><div class="citationInfo"><span class="NLM_cas:title">Virus Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12-32</span>CODEN:
                <span class="NLM_cas:coden">VIREDF</span>;
        ISSN:<span class="NLM_cas:issn">0168-1702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Helicases are versatile NTP-dependent motor proteins of monophyletic origin that are found in all kingdoms of life.  Their functions range from nucleic acid duplex unwinding to protein displacement and double-strand translocation.  This explains their participation in virtually every metabolic process that involves nucleic acids, including DNA replication, recombination and repair, transcription, translation, as well as RNA processing.  Helicases are encoded by all plant and animal viruses with a pos.-sense RNA genome that is larger than 7 kb, indicating a link to genome size evolution in this virus class.  Viral helicases belong to three out of the six currently recognized superfamilies, SF1, SF2, and SF3.  Despite being omnipresent, highly conserved and essential, only a few viral helicases, mostly from SF2, have been studied extensively.  In general, their specific roles in the viral replication cycle remain poorly understood at present.  The SF1 helicase protein of viruses classified in the order Nidovirales is encoded in replicase open reading frame 1b (ORF1b), which is translated to give rise to a large polyprotein following a ribosomal frameshift from the upstream ORF1a.  Proteolytic processing of the replicase polyprotein yields a dozen or so mature proteins, one of which includes a helicase.  Its hallmark is the presence of an N-terminal multi-nuclear zinc-binding domain, the nidoviral genetic marker and one of the most conserved domains across members of the order.  This review summarizes biochem., structural, and genetic data, including drug development studies, obtained using helicases originating from several mammalian nidoviruses, along with the results of the genomics characterization of a much larger no. of (putative) helicases of vertebrate and invertebrate nidoviruses.  In the context of our knowledge of related helicases of cellular and viral origin, it discusses the implications of these results for the protein's emerging crit. function(s) in nidovirus evolution, genome replication and expression, virion biogenesis, and possibly also post-transcriptional processing of viral RNAs.  Using our accumulated knowledge and highlighting gaps in our data, concepts and approaches, it concludes with a perspective on future research aimed at elucidating the role of helicases in the nidovirus replication cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqikWVbm4gKHrVg90H21EOLACvtfcHk0lhmrJdXcKQndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVygs7rO&md5=aeabad49055088b872719df294545d52</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.virusres.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virusres.2014.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DK.%2BC.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DPosthuma%26aufirst%3DC.%2BC.%26aulast%3DGorbalenya%26aufirst%3DA.%2BE.%26atitle%3DWhat%2520we%2520know%2520but%2520do%2520not%2520understand%2520about%2520nidovirus%2520helicases%26jtitle%3DVirus%2520Res.%26date%3D2015%26volume%3D202%26spage%3D12%26epage%3D32%26doi%3D10.1016%2Fj.virusres.2014.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesel, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. D.</span></span> <span> </span><span class="NLM_article-title">The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2005.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.chembiol.2005.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15797214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Knu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=303-311&issue=3&author=J.+A.+Tannerauthor=B.+J.+Zhengauthor=J.+Zhouauthor=R.+M.+Wattauthor=J.+Q.+Jiangauthor=K.+L.+Wongauthor=Y.+P.+Linauthor=L.+Y.+Luauthor=M.+L.+Heauthor=H.+F.+Kungauthor=A.+J.+Keselauthor=J.+D.+Huang&title=The+adamantane-derived+bananins+are+potent+inhibitors+of+the+helicase+activities+and+replication+of+SARS+coronavirus&doi=10.1016%2Fj.chembiol.2005.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS Coronavirus</span></div><div class="casAuthors">Tanner, Julian A.; Zheng, Bo-Jian; Zhou, Jie; Watt, Rory M.; Jiang, Jie-Qing; Wong, Kin-Ling; Lin, Yong-Ping; Lu, Lin-Yu; He, Ming-Liang; Kung, Hsiang-Fu; Kesel, Andreas J.; Huang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-311</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Bananins are a class of antiviral compds. with a unique structural signature incorporating a trioxa-adamantane moiety covalently bound to a pyridoxal deriv.  Six members of this class of compds.: bananin, iodobananin, vanillinbananin, ansabananin, eubananin, and adeninobananin were synthesized and tested as inhibitors of the SARS Coronavirus (SCV) helicase.  Bananin, iodobananin, vanillinbananin, and eubananin were effective inhibitors of the ATPase activity of the SCV helicase with IC50 values in the range 0.5-3 μM.  A similar trend, though at slightly higher inhibitor concns., was obsd. for inhibition of the helicase activities, using a FRET-based fluorescent assay.  In a cell culture system of SCV, bananin exhibited an EC50 of less than 10 μM and a CC50 of over 300 μM.  Kinetics of inhibition are consistent with bananin inhibiting an intracellular process or processes involved in SCV replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo73PymkPDSmLVg90H21EOLACvtfcHk0li24aZxtNezjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Knu7c%253D&md5=829a6c9c03429f144b55be0ee7cd37ee</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DTanner%26aufirst%3DJ.%2BA.%26aulast%3DZheng%26aufirst%3DB.%2BJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DWatt%26aufirst%3DR.%2BM.%26aulast%3DJiang%26aufirst%3DJ.%2BQ.%26aulast%3DWong%26aufirst%3DK.%2BL.%26aulast%3DLin%26aufirst%3DY.%2BP.%26aulast%3DLu%26aufirst%3DL.%2BY.%26aulast%3DHe%26aufirst%3DM.%2BL.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DKesel%26aufirst%3DA.%2BJ.%26aulast%3DHuang%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520adamantane-derived%2520bananins%2520are%2520potent%2520inhibitors%2520of%2520the%2520helicase%2520activities%2520and%2520replication%2520of%2520SARS%2520coronavirus%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D3%26spage%3D303%26epage%3D311%26doi%3D10.1016%2Fj.chembiol.2005.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y.</span></span> <span> </span><span class="NLM_article-title">2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5698</span>– <span class="NLM_lpage">5704</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.ejmech.2011.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21925774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKkurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=5698-5704&issue=11&author=M.+K.+Kimauthor=M.+S.+Yuauthor=H.+R.+Parkauthor=K.+B.+Kimauthor=C.+Leeauthor=S.+Y.+Choauthor=J.+Kangauthor=H.+Yoonauthor=D.+E.+Kimauthor=H.+Chooauthor=Y.+J.+Jeongauthor=Y.+Chong&title=2%2C6-Bis-arylmethyloxy-5-hydroxychromones+with+antiviral+activity+against+both+hepatitis+C+virus+%28HCV%29+and+SARS-associated+coronavirus+%28SCV%29&doi=10.1016%2Fj.ejmech.2011.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)</span></div><div class="casAuthors">Kim, Mi Kyoung; Yu, Mi-Sun; Park, Hye Ri; Kim, Kyung Bo; Lee, Chaewoon; Cho, Suh Young; Kang, Jihoon; Yoon, Hyunjun; Kim, Dong-Eun; Choo, Hyunah; Jeong, Yong-Joo; Chong, Youhoon</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5698-5704</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In this study, as a bioisosteric alternative scaffold of the antiviral aryl diketoacids (ADKs), we used 5-hydroxychromone on which two arylmethyloxy substituents were installed.  The 5-hydroxychromones (5b-5g) thus prepd. showed anti-HCV activity and, depending on the arom. substituents on the 2-arylmethyloxy moiety, some of the derivs. (5b-5f) were also active against SCV.  In addn., unlike the ADKs which showed selective inhibition against the helicase activity of the SCV NTPase/helicase, the 5-hydroxychromones (5b-5f) were active against both NTPase and helicase activities of the target enzyme.  Among those, 3-iodobenzyloxy-substituted deriv. 5e showed the most potent activity against HCV (EC50 = 4 μM) as well as SCV (IC50 = 4 μM for ATPase activity, 11 μM for helicase activity) and this might be used as a platform structure for future development of the multi-target or broad-spectrum antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT6c44qsYeWLVg90H21EOLACvtfcHk0li24aZxtNezjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKkurjJ&md5=8e47e57e238d48afa61cecb1aa86af83</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DYu%26aufirst%3DM.%2BS.%26aulast%3DPark%26aufirst%3DH.%2BR.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%2BE.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DJeong%26aufirst%3DY.%2BJ.%26aulast%3DChong%26aufirst%3DY.%26atitle%3D2%252C6-Bis-arylmethyloxy-5-hydroxychromones%2520with%2520antiviral%2520activity%2520against%2520both%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520and%2520SARS-associated%2520coronavirus%2520%2528SCV%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26issue%3D11%26spage%3D5698%26epage%3D5704%26doi%3D10.1016%2Fj.ejmech.2011.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y.</span></span> <span> </span><span class="NLM_article-title">Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1636</span>– <span class="NLM_lpage">1638</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bmcl.2009.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19233643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1636-1638&issue=6&author=C.+Leeauthor=J.+M.+Leeauthor=N.+R.+Leeauthor=B.+S.+Jinauthor=K.+J.+Jangauthor=D.+E.+Kimauthor=Y.+J.+Jeongauthor=Y.+Chong&title=Aryl+diketoacids+%28ADK%29+selectively+inhibit+duplex+DNA-unwinding+activity+of+SARS+coronavirus+NTPase%2Fhelicase&doi=10.1016%2Fj.bmcl.2009.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase</span></div><div class="casAuthors">Lee, Chaewoon; Lee, Jin Moo; Lee, Na-Ra; Jin, Bong-Suk; Jang, Kyoung Jin; Kim, Dong-Eun; Jeong, Yong-Joo; Chong, Youhoon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1636-1638</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As anti-HCV aryl diketoacids (ADK) are good metal chelators, we anticipated that ADKs might serve as potential inhibitors of SARS CoV (SCV) NTPase/helicase (Hel) by mimicking the binding modes of the bismuth complexes which effectively competes for the Zn2+ ion binding sites in SCV Hel thereby disrupting and inhibiting both the NTPase and helicase activities.  Phosphate release assay and FRET-based assay of the ADK analogs showed that the ADKs selectively inhibit the duplex DNA-unwinding activity without significant impact on the helicase ATPase activity.  Also, antiviral activities of the ADKs were shown dependent upon the substituent.  Taken together, these results suggest that there might be ADK-specific binding site in the SCV Hel, which warrants further investigations with diverse ADKs to provide valuable insights into rational design of specific SCV Hel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvSD2WIZmbqrVg90H21EOLACvtfcHk0lgEdhPm-lfrAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSlsb0%253D&md5=768b511fde674d1d05a0e820e412119a</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DN.%2BR.%26aulast%3DJin%26aufirst%3DB.%2BS.%26aulast%3DJang%26aufirst%3DK.%2BJ.%26aulast%3DKim%26aufirst%3DD.%2BE.%26aulast%3DJeong%26aufirst%3DY.%2BJ.%26aulast%3DChong%26aufirst%3DY.%26atitle%3DAryl%2520diketoacids%2520%2528ADK%2529%2520selectively%2520inhibit%2520duplex%2520DNA-unwinding%2520activity%2520of%2520SARS%2520coronavirus%2520NTPase%252Fhelicase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D6%26spage%3D1636%26epage%3D1638%26doi%3D10.1016%2Fj.bmcl.2009.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adedeji, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calcaterra, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeDiego, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4718</span>– <span class="NLM_lpage">4728</span>, <span class="refDoi"> DOI: 10.1128/AAC.00957-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.00957-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22733076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12mtrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=4718-4728&issue=9&author=A.+O.+Adedejiauthor=K.+Singhauthor=N.+E.+Calcaterraauthor=M.+L.+DeDiegoauthor=L.+Enjuanesauthor=S.+Weissauthor=S.+G.+Sarafianos&title=Severe+acute+respiratory+syndrome+coronavirus+replication+inhibitor+that+interferes+with+the+nucleic+acid+unwinding+of+the+viral+helicase&doi=10.1128%2FAAC.00957-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase</span></div><div class="casAuthors">Adedeji, Adeyemi O.; Singh, Kamalendra; Calcaterra, Nicholas E.; DeDiego, Marta L.; Enjuanes, Luis; Weiss, Susan; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4718-4728</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome (SARS) is a highly contagious disease, caused by SARS coronavirus (SARS-CoV), for which there are no approved treatments.  We report the discovery of a potent inhibitor of SARS-CoV that blocks replication by inhibiting the unwinding activity of the SARS-CoV helicase (nsp13).  We used a Forster resonance energy transfer (FRET)-based helicase assay to screen the Maybridge Hitfinder chem. library.  We identified and validated a compd. (SSYA10-001) that specifically blocks the double-stranded RNA (dsRNA) and dsDNA unwinding activities of nsp13, with 50% inhibitory concns. (IC50s) of 5.70 and 5.30 μM, resp.  This compd. also has inhibitory activity (50% effective concn. [EC50] = 8.95 μM) in a SARS-CoV replicon assay, with low cytotoxicity (50% cytotoxic concn. [CC50] = >250 μM), suggesting that the helicase plays a still unidentified crit. role in the SARS-CoV life cycle.  Enzyme kinetic studies on the mechanism of nsp13 inhibition revealed that SSYA10-001 acts as a noncompetitive inhibitor of nsp13 with respect to nucleic acid and ATP substrates.  Moreover, SSYA10-001 does not affect ATP hydrolysis or nsp13 binding to the nucleic acid substrate.  SSYA10-001 did not inhibit hepatitis C virus (HCV) helicase, other bacterial and viral RNA-dependent RNA polymerases, or reverse transcriptase.  These results suggest that SSYA10-001 specifically blocks nsp13 through a novel mechanism and is less likely to interfere with the functions of cellular enzymes that process nucleic acids or ATP.  Hence, it is possible that SSYA10-001 inhibits unwinding by nsp13 by affecting conformational changes during the course of the reaction or translocation on the nucleic acid.  SSYA10-001 will be a valuable tool for studying the specific role of nsp13 in the SARS-CoV life cycle, which could be a model for other nidoviruses and also a candidate for further development as a SARS antiviral target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzmNPIMRXGXrVg90H21EOLACvtfcHk0lgEdhPm-lfrAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12mtrfM&md5=6effa02a0e9a4dbfe85bced0eb585a1d</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1128%2FAAC.00957-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00957-12%26sid%3Dliteratum%253Aachs%26aulast%3DAdedeji%26aufirst%3DA.%2BO.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DCalcaterra%26aufirst%3DN.%2BE.%26aulast%3DDeDiego%26aufirst%3DM.%2BL.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DWeiss%26aufirst%3DS.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520replication%2520inhibitor%2520that%2520interferes%2520with%2520the%2520nucleic%2520acid%2520unwinding%2520of%2520the%2520viral%2520helicase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26issue%3D9%26spage%3D4718%26epage%3D4728%26doi%3D10.1128%2FAAC.00957-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adedeji, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of SSYA10–001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4894</span>– <span class="NLM_lpage">4898</span>, <span class="refDoi"> DOI: 10.1128/AAC.02994-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.02994-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24841268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ajurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4894-4898&issue=8&author=A.+O.+Adedejiauthor=K.+Singhauthor=A.+Kassimauthor=C.+M.+Colemanauthor=R.+Elliottauthor=S.+R.+Weissauthor=M.+B.+Friemanauthor=S.+G.+Sarafianos&title=Evaluation+of+SSYA10%E2%80%93001+as+a+replication+inhibitor+of+severe+acute+respiratory+syndrome%2C+mouse+hepatitis%2C+and+Middle+East+respiratory+syndrome+coronaviruses&doi=10.1128%2FAAC.02994-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and middle east respiratory syndrome coronaviruses</span></div><div class="casAuthors">Adedeji, Adeyemi O.; Singh, Kamalendra; Kassim, Ademola; Coleman, Christopher M.; Elliott, Ruth; Weiss, Susan R.; Frieman, Matthew B.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4894-4898, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We have previously shown that SSYA10-001 blocks severe acute respiratory syndrome coronavirus (SARS-CoV) replication by inhibiting SARS-CoV helicase (nsp13).  Here, we show that SSYA10-001 also inhibits replication of two other coronaviruses, mouse hepatitis virus (MHV) and Middle Eastern respiratory syndrome coronavirus (MERS-CoV).  A putative binding pocket for SSYA10-001 was identified and shown to be similar in SARS-CoV, MERS-CoV, and MHV helicases.  These studies show that it is possible to target multiple coronaviruses through broad-spectrum inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Gi0xnfYsGLVg90H21EOLACvtfcHk0ljMyZWzqfmB7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ajurvM&md5=2cf5662f8617c429799c35c6ceb2fe97</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1128%2FAAC.02994-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02994-14%26sid%3Dliteratum%253Aachs%26aulast%3DAdedeji%26aufirst%3DA.%2BO.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DKassim%26aufirst%3DA.%26aulast%3DColeman%26aufirst%3DC.%2BM.%26aulast%3DElliott%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DS.%2BR.%26aulast%3DFrieman%26aufirst%3DM.%2BB.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DEvaluation%2520of%2520SSYA10%25E2%2580%2593001%2520as%2520a%2520replication%2520inhibitor%2520of%2520severe%2520acute%2520respiratory%2520syndrome%252C%2520mouse%2520hepatitis%252C%2520and%2520Middle%2520East%2520respiratory%2520syndrome%2520coronaviruses%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4894%26epage%3D4898%26doi%3D10.1128%2FAAC.02994-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span> <span> </span><span class="NLM_article-title">Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">6538</span>– <span class="NLM_lpage">6550</span>, <span class="refDoi"> DOI: 10.1093/nar/gkz409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1093%2Fnar%2Fgkz409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31131400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=6538-6550&issue=12&author=Z.+Jiaauthor=L.+Yanauthor=Z.+Renauthor=L.+Wuauthor=J.+Wangauthor=J.+Guoauthor=L.+Zhengauthor=Z.+Mingauthor=L.+Zhangauthor=Z.+Louauthor=Z.+Rao&title=Delicate+structural+coordination+of+the+Severe+Acute+Respiratory+Syndrome+coronavirus+Nsp13+upon+ATP+hydrolysis&doi=10.1093%2Fnar%2Fgkz409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis</span></div><div class="casAuthors">Jia, Zhihui; Yan, Liming; Ren, Zhilin; Wu, Lijie; Wang, Jin; Guo, Jing; Zheng, Litao; Ming, Zhenhua; Zhang, Lianqi; Lou, Zhiyong; Rao, Zihe</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6538-6550</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">To date, an effective therapeutic treatment that confers strong attenuation toward coronaviruses (CoVs) remains elusive.  Of all the potential drug targets, the helicase of CoVs is considered to be one of the most important.  Here, we first present the structure of the full-length Nsp13 helicase of SARS-CoV (SARS-Nsp13) and investigate the structural coordination of its five domains and how these contribute to its translocation and unwinding activity.  A translocation model is proposed for the Upf1-like helicase members according to three different structural conditions in soln. characterized through H/D exchange assay, including substrate state (SARS-Nsp13-dsDNA bound with AMPPNP), transition state (bound with ADP-AlF4-) and product state (bound with ADP).  We obsd. that the β19-β20 loop on the 1A domain is involved in unwinding process directly.  Furthermore, we have shown that the RNA dependent RNA polymerase (RdRp), SARS-Nsp12, can enhance the helicase activity of SARS-Nsp13 through interacting with it directly.  The interacting regions were identified and can be considered common across CoVs, which provides new insights into the Replication and Transcription Complex (RTC) of CoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohBmwhTskMz7Vg90H21EOLACvtfcHk0ljMyZWzqfmB7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVCqtr4%253D&md5=dbc8758bb3d0c416dd5edebb555b128a</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkz409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkz409%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DMing%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DRao%26aufirst%3DZ.%26atitle%3DDelicate%2520structural%2520coordination%2520of%2520the%2520Severe%2520Acute%2520Respiratory%2520Syndrome%2520coronavirus%2520Nsp13%2520upon%2520ATP%2520hydrolysis%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2019%26volume%3D47%26issue%3D12%26spage%3D6538%26epage%3D6550%26doi%3D10.1093%2Fnar%2Fgkz409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slutsky, A. S.</span></span> <span> </span><span class="NLM_article-title">Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target</span>. <i>Intensive Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1007/s00134-020-05985-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs00134-020-05985-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32125455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkt1erurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2020&pages=586-590&issue=4&author=H.+Zhangauthor=J.+M.+Penningerauthor=Y.+Liauthor=N.+Zhongauthor=A.+S.+Slutsky&title=Angiotensin-converting+enzyme+2+%28ACE2%29+as+a+SARS-CoV-2+receptor%3A+molecular+mechanisms+and+potential+therapeutic+target&doi=10.1007%2Fs00134-020-05985-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target</span></div><div class="casAuthors">Zhang, Haibo; Penninger, Josef M.; Li, Yimin; Zhong, Nanshan; Slutsky, Arthur S.</div><div class="citationInfo"><span class="NLM_cas:title">Intensive Care Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">586-590</span>CODEN:
                <span class="NLM_cas:coden">ICMED9</span>;
        ISSN:<span class="NLM_cas:issn">0342-4642</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A novel infectious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in Wuhan, China, in Dec. 2019.  The disease (COVID-19) spread rapidly, reaching epidemic proportions in China, and has been found in 27 other countries.  As of Feb. 27, 2020, over 82,000 cases of COVID-19 were reported, with > 2800 deaths.  No specific therapeutics are available, and current management includes travel restrictions, patient isolation, and supportive medical care.  There are a no. of pharmaceuticals already being tested, but a better understanding of the underlying pathobiol. is required.  In this context, this article will brief review the rationale for angiotensin-converting enzyme 2 (ACE2) receptor as a specific target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBiI5Ku63FLrVg90H21EOLACvtfcHk0lgBeW0x9JliIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkt1erurY%253D&md5=705f72887420f24bdc15084bb6fdf193</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1007%2Fs00134-020-05985-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00134-020-05985-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DN.%26aulast%3DSlutsky%26aufirst%3DA.%2BS.%26atitle%3DAngiotensin-converting%2520enzyme%25202%2520%2528ACE2%2529%2520as%2520a%2520SARS-CoV-2%2520receptor%253A%2520molecular%2520mechanisms%2520and%2520potential%2520therapeutic%2520target%26jtitle%3DIntensive%2520Care%2520Med.%26date%3D2020%26volume%3D46%26issue%3D4%26spage%3D586%26epage%3D590%26doi%3D10.1007%2Fs00134-020-05985-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto-Nakanishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span> <span> </span><span class="NLM_article-title">Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2010.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.pharmthera.2010.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=20599443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGjtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2010&pages=119-128&issue=1&author=K.+Kubaauthor=Y.+Imaiauthor=T.+Ohto-Nakanishiauthor=J.+M.+Penninger&title=Trilogy+of+ACE2%3A+a+peptidase+in+the+renin-angiotensin+system%2C+a+SARS+receptor%2C+and+a+partner+for+amino+acid+transporters&doi=10.1016%2Fj.pharmthera.2010.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters</span></div><div class="casAuthors">Kuba, Keiji; Imai, Yumiko; Ohto-Nakanishi, Takayo; Penninger, Josef M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Angiotensin-converting enzyme (ACE) 2 is a homolog to the carboxypeptidase ACE, which generates angiotensin II, the main active peptide of renin-angiotensin system (RAS).  After the cloning of ACE2 in 2000, three major ACE2 functions have been described so far.  First ACE2 has emerged as a potent neg. regulator of the RAS counterbalancing the multiple functions of ACE.  By targeting angiotensin II ACE2 exhibits a protective role in the cardiovascular system and many other organs.  Second ACE2 was identified as an essential receptor for the SARS coronavirus that causes severe acute lung failure.  Downregulation of ACE2 strongly contributes to the pathogenesis of severe lung failure.  Third, both ACE2 and its homolog Collectrin can assoc. with amino acid transporters and play essential role in the absorption of amino acids in the kidney and gut.  In this review, we will discuss the multiple biol. functions of ACE2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2-r-spyoTBbVg90H21EOLACvtfcHk0lgBeW0x9JliIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGjtrrP&md5=1fa86a4ffe78ca408b178ad25cc46c0a</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DKuba%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DOhto-Nakanishi%26aufirst%3DT.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26atitle%3DTrilogy%2520of%2520ACE2%253A%2520a%2520peptidase%2520in%2520the%2520renin-angiotensin%2520system%252C%2520a%2520SARS%2520receptor%252C%2520and%2520a%2520partner%2520for%2520amino%2520acid%2520transporters%26jtitle%3DPharmacol.%2520Ther.%26date%3D2010%26volume%3D128%26issue%3D1%26spage%3D119%26epage%3D128%26doi%3D10.1016%2Fj.pharmthera.2010.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, S.</span></span> <span> </span><span class="NLM_article-title">Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1254/jphs.CPJ06008X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1254%2Fjphs.CPJ06008X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16799256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVWqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2006&pages=391-397&issue=5&author=M.+Miyazakiauthor=S.+Takai&title=Tissue+angiotensin+II+generating+system+by+angiotensin-converting+enzyme+and+chymase&doi=10.1254%2Fjphs.CPJ06008X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase</span></div><div class="casAuthors">Miyazaki, Mizuo; Takai, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-397</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review.  It had been believed that angiotensin II (Ang II) was produced by the renin-angiotensin system (RAS), which was established in the 1950's.  After a while, people realized that the multiple functions of Ang II could not be explained by the conventional RAS.  We have tried to det. the existence of the tissue Ang II generating system.  At first, we found that vascular angiotensin-converting enzyme (ACE) was increased to generate local Ang II in the vessels of hypertension and was enhanced in lipid-loaded atherosclerosis, to respond to ACE inhibitor or Ang II antagonist (ARB).  In both cases, Ang II prodn. in vessels was independent from the systemic RAS that was estd. by the plasma renin activity.  On the way to clarifying the roles of the vascular ACE, we noticed that vascular Ang II prodn. was not completely suppressed by ACE inhibitor alone.  This evidence led us to discover different types of chymase as a new Ang II producing enzyme.  Now, we have obtained a strategy to distinguish the Ang II one by one, i.e., circulating RAS derived, tissue ACE derived, and chymase derived.  It is essential to understand not only the intracellular mechanisms of Ang II but also the process of Ang II productions in each disease to show accurate indications of the effectiveness of ACE inhibitor, ARB, and chymase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvMGqbjQZs2rVg90H21EOLACvtfcHk0lhI9aJEbCPe1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVWqu7k%253D&md5=e23357871ac213e2eb53825711683e12</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1254%2Fjphs.CPJ06008X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.CPJ06008X%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DTakai%26aufirst%3DS.%26atitle%3DTissue%2520angiotensin%2520II%2520generating%2520system%2520by%2520angiotensin-converting%2520enzyme%2520and%2520chymase%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D100%26issue%3D5%26spage%3D391%26epage%3D397%26doi%3D10.1254%2Fjphs.CPJ06008X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span> <span> </span><span class="NLM_article-title">Single-cell RNA expression profiling shows that ACE2, the putative receptor of Wuhan 2019-nCoV, has significant expression in the nasal, mouth, lung and colon tissues, and tends to be co-expressed with HLA-DRB1 in the four tissues</span>. <i>Preprints</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">2020020247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=2020020247&author=C.+Wuauthor=M.+Zheng&title=Single-cell+RNA+expression+profiling+shows+that+ACE2%2C+the+putative+receptor+of+Wuhan+2019-nCoV%2C+has+significant+expression+in+the+nasal%2C+mouth%2C+lung+and+colon+tissues%2C+and+tends+to+be+co-expressed+with+HLA-DRB1+in+the+four+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DM.%26atitle%3DSingle-cell%2520RNA%2520expression%2520profiling%2520shows%2520that%2520ACE2%252C%2520the%2520putative%2520receptor%2520of%2520Wuhan%25202019-nCoV%252C%2520has%2520significant%2520expression%2520in%2520the%2520nasal%252C%2520mouth%252C%2520lung%2520and%2520colon%2520tissues%252C%2520and%2520tends%2520to%2520be%2520co-expressed%2520with%2520HLA-DRB1%2520in%2520the%2520four%2520tissues%26jtitle%3DPreprints%26date%3D2020%26spage%3D2020020247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2: virus dynamics and host response</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(20)30235-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS1473-3099%2820%2930235-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32213336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXls1Ggsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=515-516&issue=5&author=Y.+Chenauthor=L.+Li&title=SARS-CoV-2%3A+virus+dynamics+and+host+response&doi=10.1016%2FS1473-3099%2820%2930235-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-CoV-2: virus dynamics and host response</span></div><div class="casAuthors">Chen, Yu; Li, Lanjuan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">515-516</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  A commentary of Kelvin To et al. (2020).  Since Dec., 2019, coronavirus disease 2019 (COVID-19) has affected more than 100,000 patients globally.  COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has a case-fatality rate of 23%, with higher rates among elderly patients and patients with comorbidities.  Person-to-person transmission is efficient, with multiple clusters reported.  Clin., patients with COVID-19 present with respiratory symptoms, which is very similar to the presentation of other respiratory virus infections.  Radiol., COVID-19 is characterized by multifocal ground-glass opacities, even for patients with mild disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4yrWwqI1n3LVg90H21EOLACvtfcHk0lhI9aJEbCPe1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXls1Ggsrc%253D&md5=4b1353982030da09ad08cb38351c9007</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2820%2930235-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252820%252930235-8%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DSARS-CoV-2%253A%2520virus%2520dynamics%2520and%2520host%2520response%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2020%26volume%3D20%26issue%3D5%26spage%3D515%26epage%3D516%26doi%3D10.1016%2FS1473-3099%2820%2930235-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, N.</span></span> <span> </span><span class="NLM_article-title">ACE2: The key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: Demon or Angel?</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">E491</span>, <span class="refDoi"> DOI: 10.3390/v12050491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv12050491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32354022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtF2gtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=E491&issue=5&author=L.+Xiaoauthor=H.+Sakagamiauthor=N.+Miwa&title=ACE2%3A+The+key+molecule+for+understanding+the+pathophysiology+of+severe+and+critical+conditions+of+COVID-19%3A+Demon+or+Angel%3F&doi=10.3390%2Fv12050491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">ACE2: the key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel?</span></div><div class="casAuthors">Xiao, Li; Sakagami, Hiroshi; Miwa, Nobuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review with commentary.  Recently, the SARS-CoV-2 induced disease COVID-19 has spread all over the world.  Nearly 20% of the patients have severe or crit. conditions.  SARS-CoV-2 exploits ACE2 for host cell entry.  ACE2 plays an essential role in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance.  ACE2 also protects organs from inflammatory injuries and regulates intestinal functions.  ACE2 can be shed by two proteases, ADAM17 and TMPRSS2.  TMPRSS2-cleaved ACE2 allows SARS-CoV-2 cell entry, whereas ADAM17-cleaved ACE2 offers protection to organs.  SARS-CoV-2 infection-caused ACE2 dysfunction worsens COVID-19 and could initiate multi-organ failure.  Here, we will explain the role of ACE2 in the pathogenesis of severe and crit. conditions of COVID-19 and discuss auspicious strategies for controlling the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFaezZMD4FMLVg90H21EOLACvtfcHk0lhRgjtji1MVHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtF2gtLbJ&md5=06423b648ebc9ddfa6504b9009430d69</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.3390%2Fv12050491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv12050491%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DSakagami%26aufirst%3DH.%26aulast%3DMiwa%26aufirst%3DN.%26atitle%3DACE2%253A%2520The%2520key%2520molecule%2520for%2520understanding%2520the%2520pathophysiology%2520of%2520severe%2520and%2520critical%2520conditions%2520of%2520COVID-19%253A%2520Demon%2520or%2520Angel%253F%26jtitle%3DViruses%26date%3D2020%26volume%3D12%26issue%3D5%26spage%3DE491%26doi%3D10.3390%2Fv12050491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilieva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somasundaran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzuriaga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenough, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span> <span> </span><span class="NLM_article-title">Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>426</i></span> (<span class="NLM_issue">6965</span>),  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1038/nature02145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnature02145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=14647384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1GlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=450-454&issue=6965&author=W.+Liauthor=M.+J.+Mooreauthor=N.+Vasilievaauthor=J.+Suiauthor=S.+K.+Wongauthor=M.+A.+Berneauthor=M.+Somasundaranauthor=J.+L.+Sullivanauthor=K.+Luzuriagaauthor=T.+C.+Greenoughauthor=H.+Choeauthor=M.+Farzan&title=Angiotensin-converting+enzyme+2+is+a+functional+receptor+for+the+SARS+coronavirus&doi=10.1038%2Fnature02145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus</span></div><div class="casAuthors">Li, Wenhui; Moore, Michael J.; Vasilieva, Natalya; Sui, Jianhua; Wong, Swee Kee; Berne, Michael A.; Somasundaran, Mohan; Sullivan, John L.; Luzuriaga, Katherine; Greenough, Thomas C.; Choe, Hyeryun; Farzan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6965</span>),
    <span class="NLM_cas:pages">450-454</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), assoc. with cellular receptors to mediate infection of their target cells.  Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein.  We found that a sol. form of ACE2, but not of the related enzyme ACE1, blocked assocn. of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein.  Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells.  Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells.  Together our data indicate that ACE2 is a functional receptor for SARS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqK17Cf3rQS7Vg90H21EOLACvtfcHk0lhRgjtji1MVHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1GlsLs%253D&md5=884851c53d0f77cbdd6520aaa79efbed</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnature02145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02145%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26aulast%3DVasilieva%26aufirst%3DN.%26aulast%3DSui%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%2BK.%26aulast%3DBerne%26aufirst%3DM.%2BA.%26aulast%3DSomasundaran%26aufirst%3DM.%26aulast%3DSullivan%26aufirst%3DJ.%2BL.%26aulast%3DLuzuriaga%26aufirst%3DK.%26aulast%3DGreenough%26aufirst%3DT.%2BC.%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DFarzan%26aufirst%3DM.%26atitle%3DAngiotensin-converting%2520enzyme%25202%2520is%2520a%2520functional%2520receptor%2520for%2520the%2520SARS%2520coronavirus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26issue%3D6965%26spage%3D450%26epage%3D454%26doi%3D10.1038%2Fnature02145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span> <span> </span><span class="NLM_article-title">Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface</span>. <i>ChemRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">11871402.v4</span>, (accessed 2020-05-30) <span class="refDoi"> DOI: 10.26434/chemrxiv.11871402.v4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.26434%2Fchemrxiv.11871402.v4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=11871402.v4&author=M.+Smithauthor=J.+C.+Smith&title=Repurposing+therapeutics+for+COVID-19%3A+Supercomputer-based+docking+to+the+SARS-CoV-2+viral+spike+protein+and+viral+spike+protein-human+ACE2+interface&doi=10.26434%2Fchemrxiv.11871402.v4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.26434%2Fchemrxiv.11871402.v4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26434%252Fchemrxiv.11871402.v4%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26atitle%3DRepurposing%2520therapeutics%2520for%2520COVID-19%253A%2520Supercomputer-based%2520docking%2520to%2520the%2520SARS-CoV-2%2520viral%2520spike%2520protein%2520and%2520viral%2520spike%2520protein-human%2520ACE2%2520interface%26jtitle%3DChemRxiv%2520Preprint%26date%3D2020%26spage%3D11871402.v4%26doi%3D10.26434%2Fchemrxiv.11871402.v4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batra, R.</span>; <span class="NLM_string-name">Chan, H.</span>; <span class="NLM_string-name">Kamath, G.</span>; <span class="NLM_string-name">Ramprasad, R.</span>; <span class="NLM_string-name">Cherukara, M. J.</span>; <span class="NLM_string-name">Sankaranarayanan, S.</span></span>, <span> </span><span class="NLM_article-title">Screening of therapeutic agents for COVID-19 using machine learning and ensemble docking simulations</span>.  <i>arXiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2004.03766 [q-bio.BM]</span> (accessed 2020-05-30). <a href="https://arxiv.org/abs/2004.03766" class="extLink">https://arxiv.org/abs/2004.03766</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=R.+Batra&author=H.+Chan&author=G.+Kamath&author=R.+Ramprasad&author=M.+J.+Cherukara&author=S.+Sankaranarayanan&title=Screening+of+therapeutic+agents+for+COVID-19+using+machine+learning+and+ensemble+docking+simulations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBatra%26aufirst%3DR.%26atitle%3DScreening%2520of%2520therapeutic%2520agents%2520for%2520COVID-19%2520using%2520machine%2520learning%2520and%2520ensemble%2520docking%2520simulations%26jtitle%3DarXiv%2520Preprint%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rothlin, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetulli, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelorosso, F. G.</span></span> <span> </span><span class="NLM_article-title">Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/ddr.21679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fddr.21679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32356926" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=R.+P.+Rothlinauthor=H.+M.+Vetulliauthor=M.+Duarteauthor=F.+G.+Pelorosso&title=Telmisartan+as+tentative+angiotensin+receptor+blocker+therapeutic+for+COVID-19&doi=10.1002%2Fddr.21679"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2Fddr.21679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.21679%26sid%3Dliteratum%253Aachs%26aulast%3DRothlin%26aufirst%3DR.%2BP.%26aulast%3DVetulli%26aufirst%3DH.%2BM.%26aulast%3DDuarte%26aufirst%3DM.%26aulast%3DPelorosso%26aufirst%3DF.%2BG.%26atitle%3DTelmisartan%2520as%2520tentative%2520angiotensin%2520receptor%2520blocker%2520therapeutic%2520for%2520COVID-19%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2020%26doi%3D10.1002%2Fddr.21679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J. H.</span></span> <span> </span><span class="NLM_article-title">Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19</span>. <i>J. Travel Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">3</span>), <span class="NLM_elocation-id">taaa041</span> <span class="refDoi"> DOI: 10.1093/jtm/taaa041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1093%2Fjtm%2Ftaaa041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32186711" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&issue=3&author=J.+H.+Diaz&title=Hypothesis%3A+angiotensin-converting+enzyme+inhibitors+and+angiotensin+receptor+blockers+may+increase+the+risk+of+severe+COVID-19&doi=10.1093%2Fjtm%2Ftaaa041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1093%2Fjtm%2Ftaaa041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjtm%252Ftaaa041%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DJ.%2BH.%26atitle%3DHypothesis%253A%2520angiotensin-converting%2520enzyme%2520inhibitors%2520and%2520angiotensin%2520receptor%2520blockers%2520may%2520increase%2520the%2520risk%2520of%2520severe%2520COVID-19%26jtitle%3DJ.%2520Travel%2520Med.%26date%3D2020%26volume%3D27%26issue%3D3%26doi%3D10.1093%2Fjtm%2Ftaaa041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chary, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbuto, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. M.</span></span> <span> </span><span class="NLM_article-title">COVID-19: Therapeutics and their toxicities</span>. <i>J. Med. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1007/s13181-020-00777-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs13181-020-00777-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=M.+A.+Charyauthor=A.+F.+Barbutoauthor=S.+Izadmehrauthor=B.+D.+Hayesauthor=M.+M.+Burns&title=COVID-19%3A+Therapeutics+and+their+toxicities&doi=10.1007%2Fs13181-020-00777-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1007%2Fs13181-020-00777-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13181-020-00777-5%26sid%3Dliteratum%253Aachs%26aulast%3DChary%26aufirst%3DM.%2BA.%26aulast%3DBarbuto%26aufirst%3DA.%2BF.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DHayes%26aufirst%3DB.%2BD.%26aulast%3DBurns%26aufirst%3DM.%2BM.%26atitle%3DCOVID-19%253A%2520Therapeutics%2520and%2520their%2520toxicities%26jtitle%3DJ.%2520Med.%2520Toxicol.%26date%3D2020%26doi%3D10.1007%2Fs13181-020-00777-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wösten-Van Asperen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specht, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Woensel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Loos, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Goor, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamilic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florquin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, A. P.</span></span> <span> </span><span class="NLM_article-title">Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1–7) or an angiotensin II receptor antagonist</span>. <i>J. Pathol</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>225</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1002/path.2987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fpath.2987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22009550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC3MbjslWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2011&pages=618-627&issue=4&author=R.+M.+W%C3%B6sten-Van+Asperenauthor=R.+Lutterauthor=P.+A.+Spechtauthor=G.+N.+Mollauthor=J.+B.+van+Woenselauthor=C.+M.+van+der+Loosauthor=H.+van+Goorauthor=J.+Kamilicauthor=S.+Florquinauthor=A.+P.+Bos&title=Acute+respiratory+distress+syndrome+leads+to+reduced+ratio+of+ACE%2FACE2+activities+and+is+prevented+by+angiotensin-%281%E2%80%937%29+or+an+angiotensin+II+receptor+antagonist&doi=10.1002%2Fpath.2987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist</span></div><div class="casAuthors">Wosten-van Asperen Roelie M; Lutter Rene; Specht Patricia A; Moll Gert N; van Woensel Job B; van der Loos Chris M; van Goor Harry; Kamilic Jelena; Florquin Sandrine; Bos Albert P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">618-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acute respiratory distress syndrome (ARDS) is a devastating clinical syndrome.  Angiotensin-converting enzyme (ACE) and its effector peptide angiotensin (Ang) II have been implicated in the pathogenesis of ARDS.  A counter-regulatory enzyme of ACE, ie ACE2 that degrades Ang II to Ang-(1-7), offers a promising novel treatment modality for this syndrome.  As the involvement of ACE and ACE2 in ARDS is still unclear, this study investigated the role of these two enzymes in an animal model of ARDS.  ARDS was induced in rats by intratracheal administration of LPS followed by mechanical ventilation.  During ventilation, animals were treated with saline (placebo), losartan (Ang II receptor antagonist), or with a protease-resistant, cyclic form of Ang-(1-7) [cAng-(1-7)].  In bronchoalveolar lavage fluid (BALF) of ventilated LPS-exposed animals, ACE activity was enhanced, whereas ACE2 activity was reduced.  This was matched by enhanced BALF levels of Ang II and reduced levels of Ang-(1-7).  Therapeutic intervention with cAng-(1-7) attenuated the inflammatory mediator response, markedly decreased lung injury scores, and improved lung function, as evidenced by increased oxygenation.  These data indicate that ARDS develops, in part, due to reduced pulmonary levels of Ang-(1-7) and that repletion of this peptide halts the development of ARDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4PqrQm3be8VUIs6wFK5xJfW6udTcc2ebMHRC7h9eAp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbjslWgsg%253D%253D&md5=00a78b7627e754aa408327ac4dfb30df</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fpath.2987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2987%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B6sten-Van%2BAsperen%26aufirst%3DR.%2BM.%26aulast%3DLutter%26aufirst%3DR.%26aulast%3DSpecht%26aufirst%3DP.%2BA.%26aulast%3DMoll%26aufirst%3DG.%2BN.%26aulast%3Dvan%2BWoensel%26aufirst%3DJ.%2BB.%26aulast%3Dvan%2Bder%2BLoos%26aufirst%3DC.%2BM.%26aulast%3Dvan%2BGoor%26aufirst%3DH.%26aulast%3DKamilic%26aufirst%3DJ.%26aulast%3DFlorquin%26aufirst%3DS.%26aulast%3DBos%26aufirst%3DA.%2BP.%26atitle%3DAcute%2520respiratory%2520distress%2520syndrome%2520leads%2520to%2520reduced%2520ratio%2520of%2520ACE%252FACE2%2520activities%2520and%2520is%2520prevented%2520by%2520angiotensin-%25281%25E2%2580%25937%2529%2520or%2520an%2520angiotensin%2520II%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pathol%26date%3D2011%26volume%3D225%26issue%3D4%26spage%3D618%26epage%3D627%26doi%3D10.1002%2Fpath.2987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poglitsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loibner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggisser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krahenbuhl, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1007/s40262-013-0072-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs40262-013-0072-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23681967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=783-792&issue=9&author=M.+Haschkeauthor=M.+Schusterauthor=M.+Poglitschauthor=H.+Loibnerauthor=M.+Salzbergauthor=M.+Bruggisserauthor=J.+Penningerauthor=S.+Krahenbuhl&title=Pharmacokinetics+and+pharmacodynamics+of+recombinant+human+angiotensin-converting+enzyme+2+in+healthy+human+subjects&doi=10.1007%2Fs40262-013-0072-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects</span></div><div class="casAuthors">Haschke, Manuel; Schuster, Manfred; Poglitsch, Marko; Loibner, Hans; Salzberg, Marc; Bruggisser, Marcel; Penninger, Joseph; Kraehenbuehl, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">783-792</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background and Objectives Angiotensin-converting enzyme 2 (ACE2) converts angiotensin II (Ang1-8) to angiotensin 1-7 (Ang1-7), a functional antagonist of Ang1-8, with vasodilatory, antiproliferative, antiangiogenic, and anti-inflammatory properties.  In conditions with an unbalanced renin-angiotensin-aldosterone system with elevated Ang1-8, administration of ACE2 has shown promising effects in a variety of animal models.  Enhancing ACE2 activity by exogenous administration of ACE2 might also be beneficial in human diseases with pathol. elevated Ang1-8.  As a first step we performed a first-in-man study to det. pharmacokinetics, pharmacodynamics, safety, and tolerability of recombinant ACE2 in healthy volunteers.  Methods Recombinant human ACE2 (rhACE2) was administered i.v. to healthy human subjects in a randomized, double-blind, placebo-controlled, single-dose, dose-escalation study followed by an open-label multiple-dose study.  ACE2 concns. were detd. by quantifying ACE2 activity and ACE2 content in plasma samples.  Concns. of the angiotensin system effector peptides Ang1-8, Ang1-7, and Ang1-5 were detd. using a liq. chromatog.-tandem mass spectrometry method.  Results Single rhACE2 doses of 100-1,200 μg/kg caused a dose-dependent increase of systemic exposure with biphasic elimination and a dose-independent terminal half-life of 10 h.  In all single-dose cohorts, Ang1-8 decreased within 30 min postinfusion, angiotensin 1-7 (Ang1-7) either increased (100 and 200 μg/kg doses), decreased, or remained unchanged (400-1,200 μg/kg doses), whereas angiotensin 1-5 (Ang1-5) transiently increased for all doses investigated.  With the exception of the lowest rhACE2 dose, the decrease in Ang1-8 levels lasted for at least 24 h.  Repeated dosing (400 μg/kg for 3 or 6 days) caused only minimal accumulation of ACE2, and Ang1-8 levels were suppressed over the whole application period.  Conclusions Administration of rhACE2 was well tolerated by healthy human subjects.  Exposure was dose dependent with a dose-independent terminal elimination half-life in the range of 10 h.  Despite marked changes in angiotensin system peptide concns., cardiovascular effects were absent, suggesting the presence of effective compensatory mechanisms in healthy volunteers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonBawSLKLjO7Vg90H21EOLACvtfcHk0lh-VOEvgsbhMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmtLvF&md5=f3a6b30b22ce2a41e5d7989a6dc1242d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1007%2Fs40262-013-0072-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-013-0072-7%26sid%3Dliteratum%253Aachs%26aulast%3DHaschke%26aufirst%3DM.%26aulast%3DSchuster%26aufirst%3DM.%26aulast%3DPoglitsch%26aufirst%3DM.%26aulast%3DLoibner%26aufirst%3DH.%26aulast%3DSalzberg%26aufirst%3DM.%26aulast%3DBruggisser%26aufirst%3DM.%26aulast%3DPenninger%26aufirst%3DJ.%26aulast%3DKrahenbuhl%26aufirst%3DS.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520recombinant%2520human%2520angiotensin-converting%2520enzyme%25202%2520in%2520healthy%2520human%2520subjects%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2013%26volume%3D52%26issue%3D9%26spage%3D783%26epage%3D792%26doi%3D10.1007%2Fs40262-013-0072-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monteil, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prado, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagelkrüys, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopoldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garreta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurtado del Pozo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosper, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirnsberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slutsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montserrat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirazimi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cell.2020.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32333836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotVCnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=905-913&issue=4&author=V.+Monteilauthor=Y.+Kwonauthor=P.+Pradoauthor=A.+Hagelkr%C3%BCysauthor=R.+Wimmerauthor=M.+Stahlauthor=A.+Leopoldiauthor=E.+Garretaauthor=C.+Hurtado+del+Pozoauthor=F.+Prosperauthor=J.+Romeroauthor=G.+Wirnsbergerauthor=H.+Zhangauthor=A.+Slutskyauthor=R.+Conderauthor=N.+Montserratauthor=A.+Mirazimiauthor=J.+Penninger&title=Inhibition+of+SARS-CoV-2+infections+in+engineered+human+tissues+using+clinical-grade+soluble+human+ACE2&doi=10.1016%2Fj.cell.2020.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2</span></div><div class="casAuthors">Monteil, Vanessa; Kwon, Hyesoo; Prado, Patricia; Hagelkruys, Astrid; Wimmer, Reiner A.; Stahl, Martin; Leopoldi, Alexandra; Garreta, Elena; Hurtado del Pozo, Carmen; Prosper, Felipe; Romero, Juan Pablo; Wirnsberger, Gerald; Zhang, Haibo; Slutsky, Arthur S.; Conder, Ryan; Montserrat, Nuria; Mirazimi, Ali; Penninger, Josef M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">905-913.e7</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously provided the 1st genetic evidence that angiotensin converting enzyme 2 (ACE2) is the crit. receptor for severe acute respiratory syndrome coronavirus (SARS-CoV), and ACE2 protects the lung from injury, providing a mol. explanation for the severe lung failure and death due to SARS-CoV infections.  ACE2 has now also been identified as a key receptor for SARS-CoV-2 infections, and it has been proposed that inhibiting this interaction might be used in treating patients with COVID-19.  However, it is not known whether human recombinant sol. ACE2 (hrsACE2) blocks growth of SARS-CoV-2.  Here, we show that clin. grade hrsACE2 reduced SARS-CoV-2 recovery from Vero cells by a factor of 1000-5000.  An equivalent mouse rsACE2 had no effect.  SARS-CoV-2 can directly infect engineered human blood vessel organoids and human kidney organoids, which can be inhibited by hrsACE2.  These data demonstrate that hrsACE2 can significantly block early stages of SARS-CoV-2 infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5eOzP0qWiVLVg90H21EOLACvtfcHk0lhup_ptrt_t_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotVCnsLY%253D&md5=c0d71bb0fb61ba1c1037ed7ecaea6f5a</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMonteil%26aufirst%3DV.%26aulast%3DKwon%26aufirst%3DY.%26aulast%3DPrado%26aufirst%3DP.%26aulast%3DHagelkr%25C3%25BCys%26aufirst%3DA.%26aulast%3DWimmer%26aufirst%3DR.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DLeopoldi%26aufirst%3DA.%26aulast%3DGarreta%26aufirst%3DE.%26aulast%3DHurtado%2Bdel%2BPozo%26aufirst%3DC.%26aulast%3DProsper%26aufirst%3DF.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DWirnsberger%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSlutsky%26aufirst%3DA.%26aulast%3DConder%26aufirst%3DR.%26aulast%3DMontserrat%26aufirst%3DN.%26aulast%3DMirazimi%26aufirst%3DA.%26aulast%3DPenninger%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520SARS-CoV-2%2520infections%2520in%2520engineered%2520human%2520tissues%2520using%2520clinical-grade%2520soluble%2520human%2520ACE2%26jtitle%3DCell%26date%3D2020%26volume%3D181%26issue%3D4%26spage%3D905%26epage%3D913%26doi%3D10.1016%2Fj.cell.2020.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwata-Yoshikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, N.</span></span> <span> </span><span class="NLM_article-title">TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">6</span>), <span class="NLM_elocation-id">e01815-18</span> <span class="refDoi"> DOI: 10.1128/JVI.01815-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.01815-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30626688" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2019&issue=6&author=N.+Iwata-Yoshikawaauthor=T.+Okamuraauthor=Y.+Shimizuauthor=H.+Hasegawaauthor=M.+Takedaauthor=N.+Nagata&title=TMPRSS2+contributes+to+virus+spread+and+immunopathology+in+the+airways+of+murine+models+after+coronavirus+infection&doi=10.1128%2FJVI.01815-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1128%2FJVI.01815-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01815-18%26sid%3Dliteratum%253Aachs%26aulast%3DIwata-Yoshikawa%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DHasegawa%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DN.%26atitle%3DTMPRSS2%2520contributes%2520to%2520virus%2520spread%2520and%2520immunopathology%2520in%2520the%2520airways%2520of%2520murine%2520models%2520after%2520coronavirus%2520infection%26jtitle%3DJ.%2520Virol.%26date%3D2019%26volume%3D93%26issue%3D6%26doi%3D10.1128%2FJVI.01815-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaarala, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porvari, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellokumpu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyllonen, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vihko, P. T.</span></span> <span> </span><span class="NLM_article-title">Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH743%3E3.0.CO%3B2-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=11169526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVemtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2001&pages=134-140&issue=1&author=M.+H.+Vaaralaauthor=K.+S.+Porvariauthor=S.+Kellokumpuauthor=A.+P.+Kyllonenauthor=P.+T.+Vihko&title=Expression+of+transmembrane+serine+protease+TMPRSS2+in+mouse+and+human+tissues&doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH743%3E3.0.CO%3B2-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues</span></div><div class="casAuthors">Vaarala, Markku H.; Porvari, Katja S.; Kellokumpu, Sakari; Kyllonen, Atte P.; Vihko, Pirkko T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-140</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The purpose of this study was to clarify the expression of TMPRSS2 in mice during development and to compare the tissue distribution of the transcripts in adult mouse and human tissues.  Mouse TMPRSS2 cDNA was cloned; the predicted amino acid sequence contains 490 residues sharing 81.4% similarity with human TMPRSS2.  According to northern blots, mouse TMPRSS2 is expressed mainly in the prostate and kidney, while human TMPRSS2 is expressed in the prostate, colon, stomach, and salivary gland.  In situ hybridization analyses of mouse embryos and adult tissues revealed that TMPRSS2 was expressed in the epithelia of the gastrointestinal, urogenital, and respiratory tracts.  Expression was very selective and const. after the gene was turned on during development.  Expression of TMPRSS2 was localized in the luminal epithelial cells of the mouse and human prostate.  The information presented here will be useful in further studies regarding the function and physiol. significance of TMPRSS2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7_ssoyHuvCrVg90H21EOLACvtfcHk0lhup_ptrt_t_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVemtQ%253D%253D&md5=c124567922c2432f4213d6875805a49c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH743%3E3.0.CO%3B2-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-9896%25282000%25299999%253A9999%253C%253A%253AAID-PATH743%253E3.0.CO%253B2-T%26sid%3Dliteratum%253Aachs%26aulast%3DVaarala%26aufirst%3DM.%2BH.%26aulast%3DPorvari%26aufirst%3DK.%2BS.%26aulast%3DKellokumpu%26aufirst%3DS.%26aulast%3DKyllonen%26aufirst%3DA.%2BP.%26aulast%3DVihko%26aufirst%3DP.%2BT.%26atitle%3DExpression%2520of%2520transmembrane%2520serine%2520protease%2520TMPRSS2%2520in%2520mouse%2520and%2520human%2520tissues%26jtitle%3DJ.%2520Pathol.%26date%3D2001%26volume%3D193%26issue%3D1%26spage%3D134%26epage%3D140%26doi%3D10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH743%3E3.0.CO%3B2-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuyama, S.</span></span> <span> </span><span class="NLM_article-title">Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>517</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2017.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2017.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29217279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWmtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2018&pages=9-15&author=K.+Shiratoauthor=M.+Kawaseauthor=S.+Matsuyama&title=Wild-type+human+coronaviruses+prefer+cell-surface+TMPRSS2+to+endosomal+cathepsins+for+cell+entry&doi=10.1016%2Fj.virol.2017.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry</span></div><div class="casAuthors">Shirato, Kazuya; Kawase, Miyuki; Matsuyama, Shutoku</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">517</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human coronaviruses (HCoVs) enter cells via two distinct pathways: the endosomal pathway using cathepsins to activate spike protein and the cell-surface or early endosome pathway using extracellular proteases such as transmembrane protease serine 2 (TMPRSS2).  We previously reported that clin. isolates of HCoV-229E preferred cell-surface TMPRSS2 to endosomal cathepsin for cell entry, and that they acquired the ability to use cathepsin L by repeated passage in cultured cells and were then able to enter cells via the endosomal pathway.  Here, we show that clin. isolates of HCoV-OC43 and -HKU1 preferred the cell-surface TMRRSS2 to endosomal cathepsins for cell entry, similar to HCoV-229E.  In addn., the cell-culture-adapted HCoV-OC43 lost the ability to infect and replicate in air-liq. interface cultures of human bronchial tracheal epithelial cells.  These results suggest that circulating HCoVs in the field generally use cell-surface TMPRSS2 for cell entry, not endosomal cathepsins, in human airway epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUMxI7pVE547Vg90H21EOLACvtfcHk0lgUj4zxOPAk1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWmtb3M&md5=db5fb4930c4ab42874f8c20580630d27</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2017.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2017.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DShirato%26aufirst%3DK.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DMatsuyama%26aufirst%3DS.%26atitle%3DWild-type%2520human%2520coronaviruses%2520prefer%2520cell-surface%2520TMPRSS2%2520to%2520endosomal%2520cathepsins%2520for%2520cell%2520entry%26jtitle%3DVirology%26date%3D2018%26volume%3D517%26spage%3D9%26epage%3D15%26doi%3D10.1016%2Fj.virol.2017.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lukassen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boots, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eils, R.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">10</span>), <span class="NLM_elocation-id">e105114</span> <span class="refDoi"> DOI: 10.15252/embj.20105114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.15252%2Fembj.2020105114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32246845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlaqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2020&issue=10&author=S.+Lukassenauthor=R.+L.+Chuaauthor=T.+Trefzerauthor=N.+C.+Kahnauthor=M.+A.+Schneiderauthor=T.+Muleyauthor=H.+Winterauthor=M.+Meisterauthor=C.+Veithauthor=A.+W.+Bootsauthor=B.+P.+Hennigauthor=M.+Kreuterauthor=C.+Conradauthor=R.+Eils&title=SARS-CoV-2+receptor+ACE2+and+TMPRSS2+are+primarily+expressed+in+bronchial+transient+secretory+cells&doi=10.15252%2Fembj.20105114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells</span></div><div class="casAuthors">Lukassen, Soeren; Chua, Robert Lorenz; Trefzer, Timo; Kahn, Nicolas C.; Schneider, Marc A.; Muley, Thomas; Winter, Hauke; Meister, Michael; Veith, Carmen; Boots, Agnes W.; Hennig, Bianca P.; Kreuter, Michael; Conrad, Christian; Eils, Roland</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e105114</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The SARS-CoV-2 pandemic affecting the human respiratory system severely challenges public health and urgently demands for increasing our understanding of COVID-19 pathogenesis, esp. host factors facilitating virus infection and replication.  SARS-CoV-2 was reported to enter cells via binding to ACE2, followed by its priming by TMPRSS2.  Here, we investigate ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue (twelve donors, 39,778 cells) and in cells derived from subsegmental bronchial branches (four donors, 17,521 cells) by single nuclei and single cell RNA sequencing, resp.  While TMPRSS2 is strongly expressed in both tissues, in the subsegmental bronchial branches ACE2 is predominantly expressed in a transient secretory cell type.  Interestingly, these transiently differentiating cells show an enrichment for pathways related to RHO GTPase function and viral processes suggesting increased vulnerability for SARS-CoV-2 infection.  Our data provide a rich resource for future investigations of COVID-19 infection and pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofOK-TEcosALVg90H21EOLACvtfcHk0lgUj4zxOPAk1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlaqsL4%253D&md5=3695fb3220d55a715e38088d118151b1</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.15252%2Fembj.2020105114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.2020105114%26sid%3Dliteratum%253Aachs%26aulast%3DLukassen%26aufirst%3DS.%26aulast%3DChua%26aufirst%3DR.%2BL.%26aulast%3DTrefzer%26aufirst%3DT.%26aulast%3DKahn%26aufirst%3DN.%2BC.%26aulast%3DSchneider%26aufirst%3DM.%2BA.%26aulast%3DMuley%26aufirst%3DT.%26aulast%3DWinter%26aufirst%3DH.%26aulast%3DMeister%26aufirst%3DM.%26aulast%3DVeith%26aufirst%3DC.%26aulast%3DBoots%26aufirst%3DA.%2BW.%26aulast%3DHennig%26aufirst%3DB.%2BP.%26aulast%3DKreuter%26aufirst%3DM.%26aulast%3DConrad%26aufirst%3DC.%26aulast%3DEils%26aufirst%3DR.%26atitle%3DSARS-CoV-2%2520receptor%2520ACE2%2520and%2520TMPRSS2%2520are%2520primarily%2520expressed%2520in%2520bronchial%2520transient%2520secretory%2520cells%26jtitle%3DEMBO%2520J.%26date%3D2020%26volume%3D39%26issue%3D10%26doi%3D10.15252%2Fembj.20105114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2017.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.biochi.2017.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28778717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yrtrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2017&pages=1&author=L.+W.+Shenauthor=H.+J.+Maoauthor=Y.+L.+Wuauthor=Y.+Tanakaauthor=W.+Zhang&title=TMPRSS2%3A+A+potential+target+for+treatment+of+influenza+virus+and+coronavirus+infections&doi=10.1016%2Fj.biochi.2017.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections</span></div><div class="casAuthors">Shen, Li Wen; Mao, Hui Juan; Wu, Yan Ling; Tanaka, Yoshimasa; Zhang, Wen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Influenza virus and coronavirus epidemics or pandemics have occurred in succession worldwide throughout the early 21st century.  These epidemics or pandemics pose a major threat to human health.  Here, we outline a crit. role of the host cell protease TMPRSS2 in influenza virus and coronavirus infections and highlight an antiviral therapeutic strategy targeting TMPRSS2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHg-Ucbn3p7Vg90H21EOLACvtfcHk0ljB_BljswZfmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yrtrbJ&md5=f327e6e390b675cb99e2301c639acbf1</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2017.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2017.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%2BW.%26aulast%3DMao%26aufirst%3DH.%2BJ.%26aulast%3DWu%26aufirst%3DY.%2BL.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DTMPRSS2%253A%2520A%2520potential%2520target%2520for%2520treatment%2520of%2520influenza%2520virus%2520and%2520coronavirus%2520infections%26jtitle%3DBiochimie%26date%3D2017%26volume%3D142%26spage%3D1%26doi%3D10.1016%2Fj.biochi.2017.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maggio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsini, G. U.</span></span> <span> </span><span class="NLM_article-title">Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">104837</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2020.104837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.phrs.2020.104837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32334052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovFKmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2020&pages=104837&author=R.+Maggioauthor=G.+U.+Corsini&title=Repurposing+the+mucolytic+cough+suppressant+and+TMPRSS2+protease+inhibitor+bromhexine+for+the+prevention+and+management+of+SARS-CoV-2+infection&doi=10.1016%2Fj.phrs.2020.104837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection</span></div><div class="casAuthors">Maggio, Roberto; Corsini, Giovanni U.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104837</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The spread of the COVID-19 coronavirus pandemic is a major crisis of public health and has stimulated intensive efforts to find treatments active against the SARS-CoV-2 virus.  The interaction of bromhexine with the TMPRSS2 enzyme together with its widespread clin. use and safety strongly support its evaluation inpatients with SARS-CoV-2 infection, esp. since the use of camostatmesylate is much less well established and very expensive.  Bromhexine hydrochloride is already in the pipeline for COVID-19 treatment, as a mucolytic medication for chest congestion and cough in patients with suspected and mild novel coronavirus pneumonia in China (ClinicalTrials.gov Identifier: NCT04273763).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjxuo_l3ao8bVg90H21EOLACvtfcHk0ljB_BljswZfmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovFKmt7s%253D&md5=0b8dcd8c431fb53f4dd1981b716ffdfc</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2020.104837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2020.104837%26sid%3Dliteratum%253Aachs%26aulast%3DMaggio%26aufirst%3DR.%26aulast%3DCorsini%26aufirst%3DG.%2BU.%26atitle%3DRepurposing%2520the%2520mucolytic%2520cough%2520suppressant%2520and%2520TMPRSS2%2520protease%2520inhibitor%2520bromhexine%2520for%2520the%2520prevention%2520and%2520management%2520of%2520SARS-CoV-2%2520infection%26jtitle%3DPharmacol.%2520Res.%26date%3D2020%26volume%3D157%26spage%3D104837%26doi%3D10.1016%2Fj.phrs.2020.104837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhindsa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povysil, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motelow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D.</span></span> <span> </span><span class="NLM_article-title">Transcriptional inhibition of host viral entry proteins as a therapeutic strategy for SARS-CoV-2</span>. <i>Preprints</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">2020030360</span>, <span class="refDoi"> DOI: 10.20944/preprints202003.0360.v1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.20944%2Fpreprints202003.0360.v1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=2020030360&author=X.+Wangauthor=R.+Dhindsaauthor=G.+Povysilauthor=A.+Zoghbiauthor=J.+Motelowauthor=J.+Hostykauthor=D.+Goldstein&title=Transcriptional+inhibition+of+host+viral+entry+proteins+as+a+therapeutic+strategy+for+SARS-CoV-2&doi=10.20944%2Fpreprints202003.0360.v1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.20944%2Fpreprints202003.0360.v1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.20944%252Fpreprints202003.0360.v1%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDhindsa%26aufirst%3DR.%26aulast%3DPovysil%26aufirst%3DG.%26aulast%3DZoghbi%26aufirst%3DA.%26aulast%3DMotelow%26aufirst%3DJ.%26aulast%3DHostyk%26aufirst%3DJ.%26aulast%3DGoldstein%26aufirst%3DD.%26atitle%3DTranscriptional%2520inhibition%2520of%2520host%2520viral%2520entry%2520proteins%2520as%2520a%2520therapeutic%2520strategy%2520for%2520SARS-CoV-2%26jtitle%3DPreprints%26date%3D2020%26spage%3D2020030360%26doi%3D10.20944%2Fpreprints202003.0360.v1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopsack, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucci, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonarakis, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantoff, P. W.</span></span> <span> </span><span class="NLM_article-title">TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">779</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-20-0451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1158%2F2159-8290.CD-20-0451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32276929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1antbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=779&author=K.+H.+Stopsackauthor=L.+A.+Mucciauthor=E.+S.+Antonarakisauthor=P.+S.+Nelsonauthor=P.+W.+Kantoff&title=TMPRSS2+and+COVID-19%3A+Serendipity+or+opportunity+for+intervention%3F&doi=10.1158%2F2159-8290.CD-20-0451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">TMPRSS2 and COVID-19: serendipity or opportunity for intervention?</span></div><div class="casAuthors">Stopsack, Konrad H.; Mucci, Lorelei A.; Antonarakis, Emmanuel S.; Nelson, Peter S.; Kantoff, Philip W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">779-782</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">TMPRSS2 is both the most frequently altered gene in primary prostate cancer and a crit. factor enabling cellular infection by coronaviruses, including SARS-CoV-2.  The modulation of its expression by sex steroids could contribute to the male predominance of severe infections, and given that TMPRSS2 has no known indispensable functions, and inhibitors are available, it is an appealing target for prevention or treatment of respiratory viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcm_SvWqdanrVg90H21EOLACvtfcHk0ljnRSiqyQg6GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1antbnE&md5=1781aef77259c9787167efed373440d5</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-20-0451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-20-0451%26sid%3Dliteratum%253Aachs%26aulast%3DStopsack%26aufirst%3DK.%2BH.%26aulast%3DMucci%26aufirst%3DL.%2BA.%26aulast%3DAntonarakis%26aufirst%3DE.%2BS.%26aulast%3DNelson%26aufirst%3DP.%2BS.%26aulast%3DKantoff%26aufirst%3DP.%2BW.%26atitle%3DTMPRSS2%2520and%2520COVID-19%253A%2520Serendipity%2520or%2520opportunity%2520for%2520intervention%253F%26jtitle%3DCancer%2520Discovery%26date%3D2020%26volume%3D10%26spage%3D779%26doi%3D10.1158%2F2159-8290.CD-20-0451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleine-Weber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2020.04.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.molcel.2020.04.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32362314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovVCgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2020&pages=779-784&issue=4&author=M.+Hoffmannauthor=H.+Kleine-Weberauthor=S.+Pohlmann&title=A+multibasic+cleavage+site+in+the+spike+protein+of+SARS-CoV-2+is+essential+for+infection+of+human+lung+cells&doi=10.1016%2Fj.molcel.2020.04.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells</span></div><div class="casAuthors">Hoffmann, Markus; Kleine-Weber, Hannah; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">779-784.e5</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The pandemic coronavirus SARS-CoV-2 threatens public health worldwide.  The viral spike protein mediates SARS-CoV-2 entry into host cells and harbors a S1/S2 cleavage site contg. multiple arginine residues (multibasic) not found in closely related animal coronaviruses.  However, the role of this multibasic cleavage site in SARS-CoV-2 infection is unknown.  Here, we report that the cellular protease furin cleaves the spike protein at the S1/S2 site and that cleavage is essential for S-protein-mediated cell-cell fusion and entry into human lung cells.  Moreover, optimizing the S1/S2 site increased cell-cell, but not virus-cell, fusion, suggesting that the corresponding viral variants might exhibit increased cell-cell spread and potentially altered virulence.  Our results suggest that acquisition of a S1/S2 multibasic cleavage site was essential for SARS-CoV-2 infection of humans and identify furin as a potential target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvFjzWN78Da7Vg90H21EOLACvtfcHk0ljnRSiqyQg6GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovVCgs7o%253D&md5=18c626bd22d3d9c280d8b5e19c116db8</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2020.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2020.04.022%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DKleine-Weber%26aufirst%3DH.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DA%2520multibasic%2520cleavage%2520site%2520in%2520the%2520spike%2520protein%2520of%2520SARS-CoV-2%2520is%2520essential%2520for%2520infection%2520of%2520human%2520lung%2520cells%26jtitle%3DMol.%2520Cell%26date%3D2020%26volume%3D78%26issue%3D4%26spage%3D779%26epage%3D784%26doi%3D10.1016%2Fj.molcel.2020.04.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of neurotropism</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">972</span>, <span class="refDoi"> DOI: 10.3390/v11100972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv11100972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFehtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=972&issue=10&author=J.+Chengauthor=Y.+Zhaoauthor=G.+Xuauthor=K.+Zhangauthor=W.+Jiaauthor=Y.+Sunauthor=J.+Zhaoauthor=J.+Xueauthor=Y.+Huauthor=G.+Zhang&title=The+S2+subunit+of+QX-type+infectious+bronchitis+coronavirus+spike+protein+is+an+essential+determinant+of+neurotropism&doi=10.3390%2Fv11100972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of neurotropism</span></div><div class="casAuthors">Cheng, Jinlong; Zhao, Ye; Xu, Gang; Zhang, Keran; Jia, Wenfeng; Sun, Yali; Zhao, Jing; Xue, Jia; Hu, Yanxin; Zhang, Guozhong</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">972</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Some coronaviruses (CoVs) have an extra furin cleavage site (RRKR/S, furin-S2' site) upstream of the fusion peptide in the spike protein, which plays roles in virion adsorption and fusion.  Mutation of the S2' site of QX genotype (QX-type) infectious bronchitis virus (IBV) spike protein (S) in a recombinant virus background results in higher pathogenicity, pronounced neural symptoms and neurotropism when compared with conditions in wild-type IBV (WT-IBV) infected chickens.  In this study, we present evidence suggesting that recombinant IBV with a mutant S2' site (furin-S2' site) leads to higher mortality.  Infection with mutant IBV induces severe encephalitis and breaks the blood-brain barrier.  The results of a neutralization test and immunoprotection expt. show that an original serum and vaccine can still provide effective protection in vivo and in vitro.  This is the first demonstration of IBV-induced neural symptoms in chickens with encephalitis and the furin-S2' site as a determinant of neurotropism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg4yRAHYjIwbVg90H21EOLACvtfcHk0ljwN8OdnorLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFehtLw%253D&md5=239734d51586388fc02d8bf46c33a253</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.3390%2Fv11100972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv11100972%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DThe%2520S2%2520subunit%2520of%2520QX-type%2520infectious%2520bronchitis%2520coronavirus%2520spike%2520protein%2520is%2520an%2520essential%2520determinant%2520of%2520neurotropism%26jtitle%3DViruses%26date%3D2019%26volume%3D11%26issue%3D10%26spage%3D972%26doi%3D10.3390%2Fv11100972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Virus strain of a mild COVID-19 patient in Hangzhou representing a new trend in SARS-CoV-2 evolution related to Furin cleavage site</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1080/22221751.2020.1781551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F22221751.2020.1781551" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=X.+Jinauthor=K.+Xuauthor=P.+Jiangauthor=J.+Lianauthor=S.+Haoauthor=H.+Yaoauthor=H.+Jiaauthor=Y.+Zhangauthor=L.+Zhengauthor=N.+Zhengauthor=D.+Chenauthor=J.+Yaoauthor=J.+Huauthor=J.+Gaoauthor=L.+Wenauthor=J.+Shenauthor=Y.+Renauthor=G.+Yuauthor=X.+Wangauthor=Y.+Luauthor=X.+Yuauthor=L.+Yuauthor=D.+Xiangauthor=N.+Wuauthor=X.+Luauthor=L.+Chengauthor=F.+Liuauthor=H.+Wuauthor=C.+Jinauthor=X.+Yangauthor=P.+Qianauthor=Y.+Qiuauthor=J.+Shengauthor=T.+Liangauthor=L.+Liauthor=Y.+Yang&title=Virus+strain+of+a+mild+COVID-19+patient+in+Hangzhou+representing+a+new+trend+in+SARS-CoV-2+evolution+related+to+Furin+cleavage+site&doi=10.1080%2F22221751.2020.1781551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1080%2F22221751.2020.1781551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F22221751.2020.1781551%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DLian%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DS.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DP.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DVirus%2520strain%2520of%2520a%2520mild%2520COVID-19%2520patient%2520in%2520Hangzhou%2520representing%2520a%2520new%2520trend%2520in%2520SARS-CoV-2%2520evolution%2520related%2520to%2520Furin%2520cleavage%2520site%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2020%26doi%3D10.1080%2F22221751.2020.1781551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paray, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qadir, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aziz, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharifi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derakhshankhah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehrabi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahpasand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saboury, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falahati, M.</span></span> <span> </span><span class="NLM_article-title">A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1080/07391102.2020.1754293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F07391102.2020.1754293" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=A.+Hasanauthor=B.+A.+Parayauthor=A.+Hussainauthor=F.+A.+Qadirauthor=F.+Attarauthor=F.+M.+Azizauthor=M.+Sharifiauthor=H.+Derakhshankhahauthor=B.+Rastiauthor=M.+Mehrabiauthor=K.+Shahpasandauthor=A.+A.+Sabouryauthor=M.+Falahati&title=A+review+on+the+cleavage+priming+of+the+spike+protein+on+coronavirus+by+angiotensin-converting+enzyme-2+and+furin&doi=10.1080%2F07391102.2020.1754293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1080%2F07391102.2020.1754293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2020.1754293%26sid%3Dliteratum%253Aachs%26aulast%3DHasan%26aufirst%3DA.%26aulast%3DParay%26aufirst%3DB.%2BA.%26aulast%3DHussain%26aufirst%3DA.%26aulast%3DQadir%26aufirst%3DF.%2BA.%26aulast%3DAttar%26aufirst%3DF.%26aulast%3DAziz%26aufirst%3DF.%2BM.%26aulast%3DSharifi%26aufirst%3DM.%26aulast%3DDerakhshankhah%26aufirst%3DH.%26aulast%3DRasti%26aufirst%3DB.%26aulast%3DMehrabi%26aufirst%3DM.%26aulast%3DShahpasand%26aufirst%3DK.%26aulast%3DSaboury%26aufirst%3DA.%2BA.%26aulast%3DFalahati%26aufirst%3DM.%26atitle%3DA%2520review%2520on%2520the%2520cleavage%2520priming%2520of%2520the%2520spike%2520protein%2520on%2520coronavirus%2520by%2520angiotensin-converting%2520enzyme-2%2520and%2520furin%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2020%26doi%3D10.1080%2F07391102.2020.1754293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usul Afsar, C.</span></span> <span> </span><span class="NLM_article-title">2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of Furin and relevance with cancer</span>. <i>Med. Hypotheses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">109770</span>, <span class="refDoi"> DOI: 10.1016/j.mehy.2020.109770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.mehy.2020.109770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32344311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFChu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2020&pages=109770&author=C.+Usul+Afsar&title=2019-nCoV-SARS-CoV-2+%28COVID-19%29+infection%3A+Cruciality+of+Furin+and+relevance+with+cancer&doi=10.1016%2Fj.mehy.2020.109770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of furin and relevance with cancer</span></div><div class="casAuthors">Usul Afsar, Cigdem</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109770</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review on relationship between furin activities of different populations and the different clin. scenarios of the 2019-nCoV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryNaEQ-4GUV7Vg90H21EOLACvtfcHk0ljxjRBBeUFXJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFChu7k%253D&md5=5c349dc1b0c512fc4ea561637a895d05</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2020.109770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2020.109770%26sid%3Dliteratum%253Aachs%26aulast%3DUsul%2BAfsar%26aufirst%3DC.%26atitle%3D2019-nCoV-SARS-CoV-2%2520%2528COVID-19%2529%2520infection%253A%2520Cruciality%2520of%2520Furin%2520and%2520relevance%2520with%2520cancer%26jtitle%3DMed.%2520Hypotheses%26date%3D2020%26volume%3D140%26spage%3D109770%26doi%3D10.1016%2Fj.mehy.2020.109770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couture, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dory, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic uses of furin and its inhibitors: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.1000303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1517%2F13543776.2014.1000303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25563687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktlKks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=379-396&issue=4&author=F.+Coutureauthor=A.+Kwiatkowskaauthor=Y.+L.+Doryauthor=R.+Day&title=Therapeutic+uses+of+furin+and+its+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2014.1000303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic uses of furin and its inhibitors: a patent review</span></div><div class="casAuthors">Couture, Frederic; Kwiatkowska, Anna; Dory, Yves L.; Day, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-396</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Since the discovery of furin, numerous reports have studied its role in health and diseases, including cancer, inflammatory and infectious diseases.  This interest has led to the development of both large protein- and peptide-based inhibitors aiming to control furin activity to treat these disorders.  The most recent advances include the development of potent peptidomimetic furin inhibitors, considerably expanding the field of therapeutic applications.  Area covered: In this review, the use of furin or its inhibitors for therapeutic conditions is described through the patent literature since 1994.  Only compds. with biol. efficacy or augmented properties demonstrated within the patent literature or the assocd. publications concerning their claimed uses are discussed.  Expert opinion: Considering the diseases that may benefit from furin inhibition, several patents detail the use of the restricted no. of furin inhibitors.  However, there have been recent reports of new scaffolds, and even the use of furin itself, as a therapeutic agent.  Despite considerable evidence of in vivo efficacy, limited confirmation from clin. trials supports or refutes the further use of these compds. in a therapeutic context.  The most advanced application is the use of furin knockdown in the generation of an autologous cancer vaccine, which has initiated clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJX_XQ0ERUbVg90H21EOLACvtfcHk0ljxjRBBeUFXJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktlKks7w%253D&md5=59b351831debdf983beba1571fd395c2</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.1000303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.1000303%26sid%3Dliteratum%253Aachs%26aulast%3DCouture%26aufirst%3DF.%26aulast%3DKwiatkowska%26aufirst%3DA.%26aulast%3DDory%26aufirst%3DY.%2BL.%26aulast%3DDay%26aufirst%3DR.%26atitle%3DTherapeutic%2520uses%2520of%2520furin%2520and%2520its%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D379%26epage%3D396%26doi%3D10.1517%2F13543776.2014.1000303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottcher-Friebertshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartenschlager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span> <span> </span><span class="NLM_article-title">Optimization of substrate-analogue Furin inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">1953</span>– <span class="NLM_lpage">1968</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.201700596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29059503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWms7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1953-1968&issue=23&author=T.+Ivanovaauthor=K.+Hardesauthor=S.+Kallisauthor=S.+O.+Dahmsauthor=M.+E.+Thanauthor=S.+Kunzelauthor=E.+Bottcher-Friebertshauserauthor=I.+Lindbergauthor=G.+S.+Jiaoauthor=R.+Bartenschlagerauthor=T.+Steinmetzer&title=Optimization+of+substrate-analogue+Furin+inhibitors&doi=10.1002%2Fcmdc.201700596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Substrate-Analogue Furin Inhibitors</span></div><div class="casAuthors">Ivanova, Teodora; Hardes, Kornelia; Kallis, Stephanie; Dahms, Sven O.; Than, Manuel E.; Kuenzel, Sebastian; Boettcher-Friebertshaeuser, Eva; Lindberg, Iris; Jiao, Guan-Sheng; Bartenschlager, Ralf; Steinmetzer, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1953-1968</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The proprotein convertase furin is a potential target for drug design, esp. for the inhibition of furin-dependent virus replication.  All effective synthetic furin inhibitors identified thus far are multibasic compds.; the highest potency was found for our previously developed inhibitor 4-(guanidinomethyl)phenylacetyl-Arg-Tle-Arg-4-amidinobenzylamide (MI-1148).  An initial study in mice revealed a narrow therapeutic range for this tetrabasic compd., while significantly reduced toxicity was obsd. for some tribasic analogs.  This suggests that the toxicity depends at least to some extent on the overall multibasic character of this inhibitor.  Therefore, in a first approach, the C-terminal benzamidine of MI-1148 was replaced by less basic P1 residues.  Despite decreased potency, a few compds. still inhibit furin in the low nanomolar range, but display negligible efficacy in cells.  In a second approach, the P2 arginine was replaced by lysine; compared to MI-1148, this furin inhibitor has slightly decreased potency, but exhibits similar antiviral activity against West Nile and Dengue virus in cell culture and decreased toxicity in mice.  These results provide a promising starting point for the development of efficacious and well-tolerated furin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYo9s8FeFdOLVg90H21EOLACvtfcHk0lga4F_rc5qbhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWms7vJ&md5=623b9176f4ba36292f2c30dd6f05f4f8</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700596%26sid%3Dliteratum%253Aachs%26aulast%3DIvanova%26aufirst%3DT.%26aulast%3DHardes%26aufirst%3DK.%26aulast%3DKallis%26aufirst%3DS.%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DThan%26aufirst%3DM.%2BE.%26aulast%3DKunzel%26aufirst%3DS.%26aulast%3DBottcher-Friebertshauser%26aufirst%3DE.%26aulast%3DLindberg%26aufirst%3DI.%26aulast%3DJiao%26aufirst%3DG.%2BS.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DSteinmetzer%26aufirst%3DT.%26atitle%3DOptimization%2520of%2520substrate-analogue%2520Furin%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26issue%3D23%26spage%3D1953%26epage%3D1968%26doi%3D10.1002%2Fcmdc.201700596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span> <span> </span><span class="NLM_article-title">Structural studies revealed active site distortions of human Furin by a small molecule inhibitor</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2474</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00633</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00633" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OrsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2474&issue=9&author=S.+O.+Dahmsauthor=G.+S.+Jiaoauthor=M.+E.+Than&title=Structural+studies+revealed+active+site+distortions+of+human+Furin+by+a+small+molecule+inhibitor&doi=10.1021%2Facschembio.7b00633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor [Erratum to document cited in CA166:530543]</span></div><div class="casAuthors">Dahms, Sven O.; Jiao, Guan-Sheng; Than, Manuel E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2474</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On page 1215 the author information for Guan-Sheng Jiao was not included in the original article; the author information is given here.  On page 1214 Figure 2b is mislabeled; the correct labeling is provided for Figure 2b is given.  Figure 1a in the Supportinging Information is mislabeled; the correct labeling is give here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPyl_FXSG_hrVg90H21EOLACvtfcHk0lga4F_rc5qbhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OrsbzF&md5=a96ab6cdcd28e1fe17ff2be4d83b423c</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00633%26sid%3Dliteratum%253Aachs%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DJiao%26aufirst%3DG.%2BS.%26aulast%3DThan%26aufirst%3DM.%2BE.%26atitle%3DStructural%2520studies%2520revealed%2520active%2520site%2520distortions%2520of%2520human%2520Furin%2520by%2520a%2520small%2520molecule%2520inhibitor%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26issue%3D9%26spage%3D2474%26doi%3D10.1021%2Facschembio.7b00633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandstetter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span> <span> </span><span class="NLM_article-title">X-ray structures of human furin in complex with competitive inhibitors</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1113</span>– <span class="NLM_lpage">1118</span>, <span class="refDoi"> DOI: 10.1021/cb500087x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500087x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslChu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1113-1118&issue=5&author=S.+O.+Dahmsauthor=K.+Hardesauthor=G.+L.+Beckerauthor=T.+Steinmetzerauthor=H.+Brandstetterauthor=M.+E.+Than&title=X-ray+structures+of+human+furin+in+complex+with+competitive+inhibitors&doi=10.1021%2Fcb500087x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Structures of Human Furin in Complex with Competitive Inhibitors</span></div><div class="casAuthors">Dahms, Sven O.; Hardes, Kornelia; Becker, Gero L.; Steinmetzer, Torsten; Brandstetter, Hans; Than, Manuel E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1113-1118</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Furin inhibitors are promising therapeutics for the treatment of cancer and numerous infections caused by bacteria and viruses, including the highly lethal Bacillus anthracis or the pandemic influenza virus.  Development and improvement of inhibitors for pharmacol. use require a detailed knowledge of the protease's substrate and inhibitor binding properties.  Here we present a novel prepn. of human furin and the first crystal structures of this enzyme in complex with noncovalent inhibitors.  We show the inhibitor exchange by soaking, allowing the investigation of addnl. inhibitors and substrate analogs.  Thus, our work provides a basis for the rational design of furin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbro7cw_PVjrVg90H21EOLACvtfcHk0lj7qH4h9bGqcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslChu7c%253D&md5=a46cdfddbc0e1c9209d869ee067696de</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fcb500087x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500087x%26sid%3Dliteratum%253Aachs%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DHardes%26aufirst%3DK.%26aulast%3DBecker%26aufirst%3DG.%2BL.%26aulast%3DSteinmetzer%26aufirst%3DT.%26aulast%3DBrandstetter%26aufirst%3DH.%26aulast%3DThan%26aufirst%3DM.%2BE.%26atitle%3DX-ray%2520structures%2520of%2520human%2520furin%2520in%2520complex%2520with%2520competitive%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26issue%3D5%26spage%3D1113%26epage%3D1118%26doi%3D10.1021%2Fcb500087x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arciniega, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span> <span> </span><span class="NLM_article-title">Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">11196</span>– <span class="NLM_lpage">11201</span>, <span class="refDoi"> DOI: 10.1073/pnas.1613630113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1613630113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27647913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFarsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=11196-11201&issue=40&author=S.+O.+Dahmsauthor=M.+Arciniegaauthor=T.+Steinmetzerauthor=R.+Huberauthor=M.+E.+Than&title=Structure+of+the+unliganded+form+of+the+proprotein+convertase+furin+suggests+activation+by+a+substrate-induced+mechanism&doi=10.1073%2Fpnas.1613630113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism</span></div><div class="casAuthors">Dahms, Sven O.; Arciniega, Marcelino; Steinmetzer, Torsten; Huber, Robert; Than, Manuel E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">11196-11201</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proprotein convertases (PCs) are highly specific proteases required for the proteolytic modification of many secreted proteins.  An unbalanced activity of these enzymes is connected to pathologies like cancer, atherosclerosis, hypercholesterolemia, and infectious diseases.  Novel protein crystallog. structures of the prototypical PC family member furin in different functional states were detd. to 1.8-2.0 Å.  These, together with biochem. data and modeling by mol. dynamics calcns., suggest essential elements underlying its unusually high substrate specificity.  Furin shows a complex activation mechanism and exists in at least four defined states: (i) the "off state," incompatible with substrate binding as seen in the unliganded enzyme; (ii) the active "on state" seen in inhibitor-bound furin; and the resp. (iii) calcium-free and (iv) calcium-bound forms.  The transition from the off to the on state is triggered by ligand binding at subsites S1 to S4 and appears to underlie the preferential recognition of the four-residue sequence motif of furin.  The mol. dynamics simulations of the four structural states reflect the exptl. observations in general and provide approxns. of the resp. stabilities.  Ligation by calcium at the PC-specific binding site II influences the active-site geometry and dets. the rotamer state of the oxyanion hole-forming Asn295, and thus adds a second level of the activity modulation of furin.  The described crystal forms and the observations of different defined functional states may foster the development of new tools and strategies for pharmacol. intervention targeting furin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4ggTLvcRpCrVg90H21EOLACvtfcHk0lj7qH4h9bGqcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFarsLjE&md5=dfdb26447c366f1c928b10fd1252e767</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1613630113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1613630113%26sid%3Dliteratum%253Aachs%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DArciniega%26aufirst%3DM.%26aulast%3DSteinmetzer%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DThan%26aufirst%3DM.%2BE.%26atitle%3DStructure%2520of%2520the%2520unliganded%2520form%2520of%2520the%2520proprotein%2520convertase%2520furin%2520suggests%2520activation%2520by%2520a%2520substrate-induced%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D40%26spage%3D11196%26epage%3D11201%26doi%3D10.1073%2Fpnas.1613630113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span> <span> </span><span class="NLM_article-title">X-ray structures of the proprotein convertase Furin bound with substrate analogue inhibitors reveal substrate specificity determinants beyond the S4 pocket</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b01124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b01124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvFahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=925-934&issue=6&author=S.+O.+Dahmsauthor=K.+Hardesauthor=T.+Steinmetzerauthor=M.+E.+Than&title=X-ray+structures+of+the+proprotein+convertase+Furin+bound+with+substrate+analogue+inhibitors+reveal+substrate+specificity+determinants+beyond+the+S4+pocket&doi=10.1021%2Facs.biochem.7b01124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Structures of the Proprotein Convertase Furin Bound with Substrate Analogue Inhibitors Reveal Substrate Specificity Determinants beyond the S4 Pocket</span></div><div class="casAuthors">Dahms, Sven O.; Hardes, Kornelia; Steinmetzer, Torsten; Than, Manuel E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">925-934</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The proprotein convertase furin is a highly specific serine protease modifying and thereby activating proteins in the secretory pathway by proteolytic cleavage.  Its substrates are involved in many diseases, including cancer and infections caused by bacteria and viruses.  Understanding furin's substrate specificity is crucially important for the development of pharmacol. applicable inhibitors.  Using protein X-ray crystallog., we investigated the extended substrate binding site of furin in complex with three peptide-derived inhibitors at up to 1.9 Å resoln.  The structure of the protease bound with a hexapeptide inhibitor revealed mol. details of its S6 pocket, which remained completely unknown so far.  The arginine residue at P6 induced an unexpected turnlike conformation of the inhibitor backbone, which is stabilized by intra- and intermol. H-bonds.  In addn., we confirmed the binding of arginine to the previously proposed S5 pocket (S51).  An alternative S5 site (S52) could be utilized by shorter side chains as demonstrated for a 4-aminomethyl-phenylacetyl residue, which shows steric properties similar to those of a lysine side chain.  Interestingly, we also obsd. binding of a peptide with citrulline at P4 substituting for the highly conserved arginine.  The structural data might indicate an unusual protonation state of Asp264 maintaining the interaction with uncharged citrulline.  The herein identified mol. interaction sites at P5 and P6 can be utilized to improve next-generation furin inhibitors.  Our data will also help to predict furin substrates more precisely on the basis of the addnl. specificity determinants obsd. for P5 and P6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFa98y-uFMQLVg90H21EOLACvtfcHk0ljvQNRayGPx9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvFahtA%253D%253D&md5=df6eb3676e8f0c196763fb6b83a41cd2</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b01124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b01124%26sid%3Dliteratum%253Aachs%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DHardes%26aufirst%3DK.%26aulast%3DSteinmetzer%26aufirst%3DT.%26aulast%3DThan%26aufirst%3DM.%2BE.%26atitle%3DX-ray%2520structures%2520of%2520the%2520proprotein%2520convertase%2520Furin%2520bound%2520with%2520substrate%2520analogue%2520inhibitors%2520reveal%2520substrate%2520specificity%2520determinants%2520beyond%2520the%2520S4%2520pocket%26jtitle%3DBiochemistry%26date%3D2018%26volume%3D57%26issue%3D6%26spage%3D925%26epage%3D934%26doi%3D10.1021%2Facs.biochem.7b01124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, E.</span></span> <span> </span><span class="NLM_article-title">A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">103417</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bioorg.2019.103417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31744600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitF2msLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2020&pages=103417&author=L.+Yuanauthor=C.+Zouauthor=W.+Geauthor=Y.+Liuauthor=B.+Huauthor=J.+Wangauthor=B.+Linauthor=Y.+Liauthor=E.+Ma&title=A+novel+cathepsin+L+inhibitor+prevents+the+progression+of+idiopathic+pulmonary+fibrosis&doi=10.1016%2Fj.bioorg.2019.103417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Yuan, Lei; Zou, Chunyang; Ge, Wentao; Liu, Yutong; Hu, Baichun; Wang, Jian; Lin, Bin; Li, Yanchun; Ma, Enlong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103417</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In previous work, the target of asperphenamate as a natural product was successfully detd. as cathepsin by the natural product consensus pharmacophore strategy.  In order to develop accurate SAR (structure-activity relationship) of asperphenamate-type cathepsin inhibitor, we chose several novel analogs with heterocyclic moiety to perform further study.  The mol. simulation showed that 4-pyridyl deriv. 3 (I) with the greatest cathepsin inhibitory activity presented new interaction modes with protein utilizing its B-ring moiety.  And then mol. dynamics (MD) simulation further revealed that I and cathepsin kept stable interaction in the binding site, which validated the mol. docking results.  In view that cathepsins play an important role in fibrosis and some cathepsin inhibitors display the therapeutic ability for fibrosis, we investigated the anti-fibrotic effect of I in vitro and in vivo.  The results indicated that I displayed the strongest inhibitory effect on the formation of α-SMA and collagen I as the protein markers of fibrosis among all tested derivs.  Further in vivo assay confirmed that Ι indeed showed significant inhibitory ability against pulmonary fibrosis by the method of H&E and Masson staining as well as immunohistochem. staining for characteristic α-SMA proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo_6vEOunQq7Vg90H21EOLACvtfcHk0ljvQNRayGPx9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitF2msLjK&md5=aa63e00504254cbe28839056c1c69a2b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103417%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DGe%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DE.%26atitle%3DA%2520novel%2520cathepsin%2520L%2520inhibitor%2520prevents%2520the%2520progression%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D94%26spage%3D103417%26doi%3D10.1016%2Fj.bioorg.2019.103417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padmanabhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desikan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, N. M.</span></span> <span> </span><span class="NLM_article-title">Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection</span>. <i>ChemRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">12213125.v2</span>, (accessed 2020-05-30) <span class="refDoi"> DOI: 10.26434/chemrxiv.12213125.v2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.26434%2Fchemrxiv.12213125.v2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=12213125.v2&author=P.+Padmanabhanauthor=R.+Desikanauthor=N.+M.+Dixit&title=Targeting+TMPRSS2+and+Cathepsin+B%2FL+together+may+be+synergistic+against+SARS-CoV-2+infection&doi=10.26434%2Fchemrxiv.12213125.v2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.26434%2Fchemrxiv.12213125.v2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26434%252Fchemrxiv.12213125.v2%26sid%3Dliteratum%253Aachs%26aulast%3DPadmanabhan%26aufirst%3DP.%26aulast%3DDesikan%26aufirst%3DR.%26aulast%3DDixit%26aufirst%3DN.%2BM.%26atitle%3DTargeting%2520TMPRSS2%2520and%2520Cathepsin%2520B%252FL%2520together%2520may%2520be%2520synergistic%2520against%2520SARS-CoV-2%2520infection%26jtitle%3DChemRxiv%2520Preprint%26date%3D2020%26spage%3D12213125.v2%26doi%3D10.26434%2Fchemrxiv.12213125.v2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, C. A.</span></span> <span> </span><span class="NLM_article-title">Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">12</span>), <span class="NLM_elocation-id">e0222055</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0222055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0222055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31856175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFSjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&issue=12&author=G.+R.+Sartoriauthor=A.+Leitaoauthor=C.+A.+Montanariauthor=C.+A.+Laughton&title=Ligand-induced+conformational+selection+predicts+the+selectivity+of+cysteine+protease+inhibitors&doi=10.1371%2Fjournal.pone.0222055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors</span></div><div class="casAuthors">Sartori, Geraldo Rodrigues; Leitao, Andrei; Montanari, Carlos A.; Laughton, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e0222055</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cruzain, a cysteine protease of Trypanosoma cruzi, is a validated target for the treatment of Chagas disease.  Due to its high similarity in three-dimensional structure with human cathepsins and their sequence identity above 70% in the active site regions, identifying potent but selective cruzain inhibitors with low side effects on the host organism represents a significant challenge.  Here a panel of nitrile ligands with varying potencies against cathepsin K, cathepsin L and cruzain, are studied by mol. dynamics simulations as both non-covalent and covalent complexes.  Principal component anal. (PCA), identifies and quantifies patterns of ligand-induced conformational selection that enable the construction of a decision tree which can predict with high confidence a low-nanomolar inhibitor of each of three proteins, and det. the selectivity for one against others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsCHQnQabhQLVg90H21EOLACvtfcHk0lgPsluge51_CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFSjtbk%253D&md5=11e180ee1673141ec0f180f7e0187133</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0222055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0222055%26sid%3Dliteratum%253Aachs%26aulast%3DSartori%26aufirst%3DG.%2BR.%26aulast%3DLeitao%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26atitle%3DLigand-induced%2520conformational%2520selection%2520predicts%2520the%2520selectivity%2520of%2520cysteine%2520protease%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2019%26volume%3D14%26issue%3D12%26doi%3D10.1371%2Fjournal.pone.0222055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehmke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freymond, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmeister, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.201300112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23658062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlSru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=967-975&issue=6&author=V.+Ehmkeauthor=E.+Winklerauthor=D.+W.+Bannerauthor=W.+Haapauthor=W.+B.+Schweizerauthor=M.+Rottmannauthor=M.+Kaiserauthor=C.+Freymondauthor=T.+Schirmeisterauthor=F.+Diederich&title=Optimization+of+triazine+nitriles+as+rhodesain+inhibitors%3A+structure-activity+relationships%2C+bioisosteric+imidazopyridine+nitriles%2C+and+X-ray+crystal+structure+analysis+with+human+cathepsin+L&doi=10.1002%2Fcmdc.201300112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Triazine Nitriles as Rhodesain Inhibitors: Structure-Activity Relationships, Bioisosteric Imidazopyridine Nitriles, and X-ray Crystal Structure Analysis with Human Cathepsin L</span></div><div class="casAuthors">Ehmke, Veronika; Winkler, Edwin; Banner, David W.; Haap, Wolfgang; Schweizer, W. Bernd; Rottmann, Matthias; Kaiser, Marcel; Freymond, Celine; Schirmeister, Tanja; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">967-975</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The cysteine protease rhodesain of Trypanosoma brucei parasites causing African sleeping sickness has emerged as a target for the development of new drug candidates.  Based on a triazine nitrile moiety as electrophilic headgroup, optimization studies on the substituents for the S1, S2, and S3 pockets of the enzyme were performed using structure-based design and resulted in inhibitors with inhibition consts. in the single-digit nanomolar range.  Comprehensive structure-activity relationships clarified the binding preferences of the individual pockets of the active site.  The S1 pocket tolerates various substituents with a preference for flexible and basic side chains.  Variation of the S2 substituent led to high-affinity ligands with inhibition consts. down to 2 nM for compds. bearing cyclohexyl substituents.  Systematic investigations on the S3 pocket revealed its potential to achieve high activities with arom. vectors that undergo stacking interactions with the planar peptide backbone forming part of the pocket.  X-ray crystal structure anal. with the structurally related enzyme human cathepsin L confirmed the binding mode of the triazine ligand series as proposed by mol. modeling.  Sub-micromolar inhibition of the proliferation of cultured parasites was achieved for ligands decorated with the best substituents identified through the optimization cycles.  In cell-based assays, the introduction of a basic side chain on the inhibitors resulted in a 35-fold increase in antitrypanosomal activity.  Finally, bioisosteric imidazopyridine nitriles were studied to prevent off-target effects with unselective nucleophiles by decreasing the inherent electrophilicity of the triazine nitrile headgroup.  Using this ligand, the stabilization by intramol. hydrogen bonding of the thioimidate intermediate, formed upon attack of the catalytic cysteine residue, compensates for the lower reactivity of the headgroup.  The imidazopyridine nitrile ligand showed excellent stability toward the thiol nucleophile glutathione in a quant. in vitro assay and fourfold lower cytotoxicity than the parent triazine nitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGwTj6sYRPi7Vg90H21EOLACvtfcHk0lgPsluge51_CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlSru7k%253D&md5=0db889bf80bc6ea9fa3c16bfed80f614</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300112%26sid%3Dliteratum%253Aachs%26aulast%3DEhmke%26aufirst%3DV.%26aulast%3DWinkler%26aufirst%3DE.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DFreymond%26aufirst%3DC.%26aulast%3DSchirmeister%26aufirst%3DT.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DOptimization%2520of%2520triazine%2520nitriles%2520as%2520rhodesain%2520inhibitors%253A%2520structure-activity%2520relationships%252C%2520bioisosteric%2520imidazopyridine%2520nitriles%252C%2520and%2520X-ray%2520crystal%2520structure%2520analysis%2520with%2520human%2520cathepsin%2520L%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D967%26epage%3D975%26doi%3D10.1002%2Fcmdc.201300112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardegger, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinnler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anselm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecabert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plancher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isshiki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2048</span>– <span class="NLM_lpage">2054</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.201100353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21898833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFajtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=2048-2054&issue=11&author=L.+A.+Hardeggerauthor=B.+Kuhnauthor=B.+Spinnlerauthor=L.+Anselmauthor=R.+Ecabertauthor=M.+Stihleauthor=B.+Gsellauthor=R.+Thomaauthor=J.+Diezauthor=J.+Benzauthor=J.+M.+Plancherauthor=G.+Hartmannauthor=Y.+Isshikiauthor=K.+Morikamiauthor=N.+Shimmaauthor=W.+Haapauthor=D.+W.+Bannerauthor=F.+Diederich&title=Halogen+bonding+at+the+active+sites+of+human+cathepsin+L+and+MEK1+kinase%3A+efficient+interactions+in+different+environments&doi=10.1002%2Fcmdc.201100353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments</span></div><div class="casAuthors">Hardegger, Leo A.; Kuhn, Bernd; Spinnler, Beat; Anselm, Lilli; Ecabert, Robert; Stihle, Martine; Gsell, Bernard; Thoma, Ralf; Diez, Joachim; Benz, Joerg; Plancher, Jean-Marc; Hartmann, Guido; Isshiki, Yoshiaki; Morikami, Kenji; Shimma, Nobuo; Haap, Wolfgang; Banner, David W.; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2048-2054</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In two series of small-mol. ligands, one inhibiting human cathepsin L (hcatL) and the other MEK1 kinase, biol. affinities were found to strongly increase when an aryl ring of the inhibitors is substituted with the larger halogens Cl, Br, and I, but to decrease upon F substitution.  X-ray co-crystal structure analyses revealed that the higher halides engage in halogen bonding (XB) with a backbone C=O in the S3 pocket of hcatL and in a back pocket of MEK1.  While the S3 pocket is located at the surface of the enzyme, which provides a polar environment, the back pocket in MEK1 is deeply buried in the protein and is of pronounced apolar character.  This study analyzes environmental effects on XB in protein-ligand complexes.  It is hypothesized that energetic gains by XB are predominantly not due to water replacements but originate from direct interactions between the XB donor (Caryl-X) and the XB acceptor (C=O) in the correct geometry.  New x-ray co-crystal structures in the same crystal form (space group P212121) were obtained for aryl chloride, bromide, and iodide ligands bound to hcatL.  These high-resoln. structures reveal that the backbone C=O group of Gly61 in most hcatL co-crystal structures maintains water solvation while engaging in XB.  An aryl-CF3-substituted ligand of hcatL with an unexpectedly high affinity was found to adopt the same binding geometry as the aryl halides, with the CF3 group pointing to the C=O group of Gly61 in the S3 pocket.  In this case, a repulsive F2C-F···O=C contact apparently is energetically overcompensated by other favorable protein-ligand contacts established by the CF3 group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnaNYbZ3KJUbVg90H21EOLACvtfcHk0lgMEimUM2pgBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFajtr7E&md5=12c7cc93b65ba017acee37796811309d</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100353%26sid%3Dliteratum%253Aachs%26aulast%3DHardegger%26aufirst%3DL.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DSpinnler%26aufirst%3DB.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DEcabert%26aufirst%3DR.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DDiez%26aufirst%3DJ.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DPlancher%26aufirst%3DJ.%2BM.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DIsshiki%26aufirst%3DY.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DHalogen%2520bonding%2520at%2520the%2520active%2520sites%2520of%2520human%2520cathepsin%2520L%2520and%2520MEK1%2520kinase%253A%2520efficient%2520interactions%2520in%2520different%2520environments%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26issue%3D11%26spage%3D2048%26epage%3D2054%26doi%3D10.1002%2Fcmdc.201100353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardegger, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinnler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anselm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecabert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plancher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Systematic investigation of halogen bonding in protein-ligand interactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1002/anie.201006781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fanie.201006781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1alu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=314-318&issue=1&author=L.+A.+Hardeggerauthor=B.+Kuhnauthor=B.+Spinnlerauthor=L.+Anselmauthor=R.+Ecabertauthor=M.+Stihleauthor=B.+Gsellauthor=R.+Thomaauthor=J.+Diezauthor=J.+Benzauthor=J.+M.+Plancherauthor=G.+Hartmannauthor=D.+W.+Bannerauthor=W.+Haapauthor=F.+Diederich&title=Systematic+investigation+of+halogen+bonding+in+protein-ligand+interactions&doi=10.1002%2Fanie.201006781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions</span></div><div class="casAuthors">Hardegger, Leo A.; Kuhn, Bernd; Spinnler, Beat; Anselm, Lilli; Ecabert, Robert; Stihle, Martine; Gsell, Bernard; Thoma, Ralf; Diez, Joachim; Benz, Joerg; Plancher, Jean-Marc; Hartmann, Guido; Banner, David W.; Haap, Wolfgang; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">314-318, S314/1-S314/145</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Halogen bonding triggers activity.  Increasing binding affinity was obsd. for a series of covalent human Cathepsin L inhibitors by exchanging an aryl ring H atom with Cl, Br, and I, which undergo halogen bonding with the C=O group of Gly61 in the S3 pocket of the enzyme.  Fluorine, in contrast, strongly avoids halogen bonding.  The strong distance and angle dependence of halogen bonding was confirmed for biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsbCNMQhVu7Vg90H21EOLACvtfcHk0lgMEimUM2pgBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1alu73N&md5=1a7f2983a386fd133be0663657fc486b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2Fanie.201006781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201006781%26sid%3Dliteratum%253Aachs%26aulast%3DHardegger%26aufirst%3DL.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DSpinnler%26aufirst%3DB.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DEcabert%26aufirst%3DR.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DDiez%26aufirst%3DJ.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DPlancher%26aufirst%3DJ.%2BM.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DSystematic%2520investigation%2520of%2520halogen%2520bonding%2520in%2520protein-ligand%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26issue%3D1%26spage%3D314%26epage%3D318%26doi%3D10.1002%2Fanie.201006781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bekerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neveu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shulla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barouch-Bentov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakken, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamine, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdewijn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einav, S.</span></span> <span> </span><span class="NLM_article-title">Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1338</span>– <span class="NLM_lpage">1352</span>, <span class="refDoi"> DOI: 10.1172/JCI89857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1172%2FJCI89857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28240606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC1czgvFajtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=1338-1352&issue=4&author=E.+Bekermanauthor=G.+Neveuauthor=A.+Shullaauthor=J.+Brannanauthor=S.+Y.+Puauthor=S.+Wangauthor=F.+Xiaoauthor=R.+Barouch-Bentovauthor=R.+R.+Bakkenauthor=R.+Mateoauthor=J.+Goveroauthor=C.+M.+Nagamineauthor=M.+S.+Diamondauthor=S.+De+Jongheauthor=P.+Herdewijnauthor=J.+M.+Dyeauthor=G.+Randallauthor=S.+Einav&title=Anticancer+kinase+inhibitors+impair+intracellular+viral+trafficking+and+exert+broad-spectrum+antiviral+effects&doi=10.1172%2FJCI89857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects</span></div><div class="casAuthors">Bekerman Elena; Neveu Gregory; Shulla Ana; Brannan Jennifer; Pu Szu-Yuan; Wang Stanley; Xiao Fei; Barouch-Bentov Rina; Bakken Russell R; Mateo Roberto; Govero Jennifer; Nagamine Claude M; Diamond Michael S; De Jonghe Steven; Herdewijn Piet; Dye John M; Randall Glenn; Einav Shirit</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1338-1352</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Global health is threatened by emerging viral infections, which largely lack effective vaccines or therapies.  Targeting host pathways that are exploited by multiple viruses could offer broad-spectrum solutions.  We previously reported that AAK1 and GAK, kinase regulators of the host adaptor proteins AP1 and AP2, are essential for hepatitis C virus (HCV) infection, but the underlying mechanism and relevance to other viruses or in vivo infections remained unknown.  Here, we have discovered that AP1 and AP2 cotraffic with HCV particles in live cells.  Moreover, we found that multiple viruses, including dengue and Ebola, exploit AAK1 and GAK during entry and infectious virus production.  In cultured cells, treatment with sunitinib and erlotinib, approved anticancer drugs that inhibit AAK1 or GAK activity, or with more selective compounds inhibited intracellular trafficking of HCV and multiple unrelated RNA viruses with a high barrier to resistance.  In murine models of dengue and Ebola infection, sunitinib/erlotinib combination protected against morbidity and mortality.  We validated sunitinib- and erlotinib-mediated inhibition of AAK1 and GAK activity as an important mechanism of antiviral action.  Additionally, we revealed potential roles for additional kinase targets.  These findings advance our understanding of virus-host interactions and establish a proof of principle for a repurposed, host-targeted approach to combat emerging viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeR1dYk1i_czQLBVDQn4bCfW6udTcc2ebjkS-qOUAxprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czgvFajtg%253D%253D&md5=2de0a5d7668651f92be3c2e79823ced4</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1172%2FJCI89857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI89857%26sid%3Dliteratum%253Aachs%26aulast%3DBekerman%26aufirst%3DE.%26aulast%3DNeveu%26aufirst%3DG.%26aulast%3DShulla%26aufirst%3DA.%26aulast%3DBrannan%26aufirst%3DJ.%26aulast%3DPu%26aufirst%3DS.%2BY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DF.%26aulast%3DBarouch-Bentov%26aufirst%3DR.%26aulast%3DBakken%26aufirst%3DR.%2BR.%26aulast%3DMateo%26aufirst%3DR.%26aulast%3DGovero%26aufirst%3DJ.%26aulast%3DNagamine%26aufirst%3DC.%2BM.%26aulast%3DDiamond%26aufirst%3DM.%2BS.%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26aulast%3DHerdewijn%26aufirst%3DP.%26aulast%3DDye%26aufirst%3DJ.%2BM.%26aulast%3DRandall%26aufirst%3DG.%26aulast%3DEinav%26aufirst%3DS.%26atitle%3DAnticancer%2520kinase%2520inhibitors%2520impair%2520intracellular%2520viral%2520trafficking%2520and%2520exert%2520broad-spectrum%2520antiviral%2520effects%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2017%26volume%3D127%26issue%3D4%26spage%3D1338%26epage%3D1352%26doi%3D10.1172%2FJCI89857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, Z.</span></span> <span> </span><span class="NLM_article-title">The serine/threonine kinase AP2-associated kinase 1 plays an important role in Rabies virus entry</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">45</span>, <span class="refDoi"> DOI: 10.3390/v12010045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv12010045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVCqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=45&issue=1&author=C.+Wangauthor=J.+Wangauthor=L.+Shuaiauthor=X.+Maauthor=H.+Zhangauthor=R.+Liuauthor=W.+Chenauthor=X.+Wangauthor=J.+Geauthor=Z.+Wenauthor=Z.+Bu&title=The+serine%2Fthreonine+kinase+AP2-associated+kinase+1+plays+an+important+role+in+Rabies+virus+entry&doi=10.3390%2Fv12010045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">The serine/threonine kinase AP2-associated kinase 1 plays an important role in rabies virus entry</span></div><div class="casAuthors">Wang, Chong; Wang, Jinliang; Shuai, Lei; Ma, Xiao; Zhang, Hailin; Liu, Renqiang; Chen, Weiye; Wang, Xijun; Ge, Jinying; Wen, Zhiyuan; Bu, Zhigao</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Rabies virus (RABV) invades the central nervous system and nearly always causes fatal disease in humans.  RABV enters cells via clathrin-mediated endocytosis upon receptor binding.  The detailed mechanism of this process and how it is regulated are not fully understood.  Here, we carried out a high-through-put RNAi anal. and identified AP2-assocd. kinase 1 (AAK1), a serine/threonine kinase, as an important cellular component in regulating the entry of RABV.  AAK1 knock-down greatly inhibits RABV infection of cells, and AAK1-induced phosphorylation of threonine 156 of the μ subunit of adaptor protein 2 (AP2M1) is found to be required for RABV entry.  Inhibition of AAK1 kinase activity by sunitinib blocked AP2M1 phosphorylation, significantly inhibiting RABV infection and preventing RABV from entering early endosomes.  In vivo studies revealed that sunitinib prolongs the survival of mice challenged with RABV street virus.  Our findings indicate that AAK1 is a potential drug target for postexposure prophylaxis against rabies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-BKEcc98NJrVg90H21EOLACvtfcHk0lhxuQ7NGaEwWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVCqsLc%253D&md5=94cf4d4ab31da60e23e50449c9e22830</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.3390%2Fv12010045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv12010045%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShuai%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DBu%26aufirst%3DZ.%26atitle%3DThe%2520serine%252Fthreonine%2520kinase%2520AP2-associated%2520kinase%25201%2520plays%2520an%2520important%2520role%2520in%2520Rabies%2520virus%2520entry%26jtitle%3DViruses%26date%3D2020%26volume%3D12%26issue%3D1%26spage%3D45%26doi%3D10.3390%2Fv12010045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keates, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzos-Skintges, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joachimiak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muyldermans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herberg, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, S.</span></span> <span> </span><span class="NLM_article-title">Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>459</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1042/BJ20131399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1042%2FBJ20131399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24438162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlekt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2014&pages=59-69&issue=1&author=A.+Chaikuadauthor=T.+Keatesauthor=C.+Vinckeauthor=M.+Kaufholzauthor=M.+Zennauthor=B.+Zimmermannauthor=C.+Gutierrezauthor=R.+G.+Zhangauthor=C.+Hatzos-Skintgesauthor=A.+Joachimiakauthor=S.+Muyldermansauthor=F.+W.+Herbergauthor=S.+Knappauthor=S.+Muller&title=Structure+of+cyclin+G-associated+kinase+%28GAK%29+trapped+in+different+conformations+using+nanobodies&doi=10.1042%2FBJ20131399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies</span></div><div class="casAuthors">Chaikuad, Apirat; Keates, Tracy; Vincke, Cecile; Kaufholz, Melanie; Zenn, Michael; Zimmermann, Bastian; Gutierrez, Carlos; Zhang, Rong-guang; Hatzos-Skintges, Catherine; Joachimiak, Andrzej; Muyldermans, Serge; Herberg, Friedrich W.; Knapp, Stefan; Mueller, Susanne</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">GAK (cyclin G-assocd. kinase) is a key regulator of clathrin-coated vesicle trafficking and plays a central role during development.  Addnl., due to the unusually high plasticity of its catalytic domain, it is a frequent 'off-target' of clin. kinase inhibitors assocd. with respiratory side effects of these drugs.  In the present paper, we detd. the crystal structure of the GAK catalytic domain alone and in complex with specific single-chain antibodies (nanobodies).  GAK is constitutively active and weakly assocs. in soln.  The GAK apo structure revealed a dimeric inactive state of the catalytic domain mediated by an unusual activation segment interaction.  Co-crystn. with the nanobody NbGAK4 trapped GAK in a dimeric arrangement similar to the one obsd. in the apo structure, whereas NbGAK1 captured the activation segment of monomeric GAK in a well-ordered conformation, representing features of the active kinase.  The presented structural and biochem. data provide insight into the domain plasticity of GAK and demonstrate the utility of nanobodies to gain insight into conformational changes of dynamic mols.  In addn., we present structural data on the binding mode of ATP mimetic inhibitors and enzyme kinetic data, which will support rational inhibitor design of inhibitors to reduce the off-target effect on GAK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_b7iAn08ebVg90H21EOLACvtfcHk0lioMYfNWkapCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlekt7w%253D&md5=e4f4a4146869d6a78b6b752fe73f7acc</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1042%2FBJ20131399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20131399%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DVincke%26aufirst%3DC.%26aulast%3DKaufholz%26aufirst%3DM.%26aulast%3DZenn%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DB.%26aulast%3DGutierrez%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DR.%2BG.%26aulast%3DHatzos-Skintges%26aufirst%3DC.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DMuyldermans%26aufirst%3DS.%26aulast%3DHerberg%26aufirst%3DF.%2BW.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DS.%26atitle%3DStructure%2520of%2520cyclin%2520G-associated%2520kinase%2520%2528GAK%2529%2520trapped%2520in%2520different%2520conformations%2520using%2520nanobodies%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D459%26issue%3D1%26spage%3D59%26epage%3D69%26doi%3D10.1042%2FBJ20131399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdonck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froeyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prugar, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorosky, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barouch-Bentov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdewijn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einav, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of 3,5-disubstituted-pyrrolo[2,3- b]pyridines as inhibitors of Adaptor-Associated Kinase 1 with antiviral activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5810</span>– <span class="NLM_lpage">5831</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKgtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5810-5831&issue=12&author=S.+Verdonckauthor=S.+Y.+Puauthor=F.+J.+Sorrellauthor=J.+M.+Elkinsauthor=M.+Froeyenauthor=L.+J.+Gaoauthor=L.+I.+Prugarauthor=D.+E.+Doroskyauthor=J.+M.+Brannanauthor=R.+Barouch-Bentovauthor=S.+Knappauthor=J.+M.+Dyeauthor=P.+Herdewijnauthor=S.+Einavauthor=S.+De+Jonghe&title=Synthesis+and+structure-activity+relationships+of+3%2C5-disubstituted-pyrrolo%5B2%2C3-+b%5Dpyridines+as+inhibitors+of+Adaptor-Associated+Kinase+1+with+antiviral+activity&doi=10.1021%2Facs.jmedchem.9b00136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3-b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity</span></div><div class="casAuthors">Verdonck, Sven; Pu, Szu-Yuan; Sorrell, Fiona J.; Elkins, Jon M.; Froeyen, Mathy; Gao, Ling-Jie; Prugar, Laura I.; Dorosky, Danielle E.; Brannan, Jennifer M.; Barouch-Bentov, Rina; Knapp, Stefan; Dye, John M.; Herdewijn, Piet; Einav, Shirit; De Jonghe, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5810-5831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are currently no approved drugs for the treatment of emerging viral infections, such as dengue and Ebola.  Adaptor-assocd. kinase 1 (AAK1) is a cellular serine-threonine protein kinase that functions as a key regulator of the clathrin-assocd. host adaptor proteins and regulates the intracellular trafficking of multiple unrelated RNA viruses.  Moreover, AAK1 is overexpressed specifically in dengue virus-infected but not bystander cells.  Because AAK1 is a promising antiviral drug target, we have embarked on an optimization campaign of a previously identified 7-azaindole analog, yielding novel pyrrolo[2,3-b]pyridines with high AAK1 affinity.  The optimized compds. demonstrate improved activity against dengue virus both in vitro and in human primary dendritic cells and the unrelated Ebola virus.  These findings demonstrate that targeting cellular AAK1 may represent a promising broad-spectrum antiviral strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7SIdwEDKk_bVg90H21EOLACvtfcHk0lioMYfNWkapCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKgtr7P&md5=bdec475534dbe2ad18d1c377f8b4c67d</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00136%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonck%26aufirst%3DS.%26aulast%3DPu%26aufirst%3DS.%2BY.%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFroeyen%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DL.%2BJ.%26aulast%3DPrugar%26aufirst%3DL.%2BI.%26aulast%3DDorosky%26aufirst%3DD.%2BE.%26aulast%3DBrannan%26aufirst%3DJ.%2BM.%26aulast%3DBarouch-Bentov%26aufirst%3DR.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DDye%26aufirst%3DJ.%2BM.%26aulast%3DHerdewijn%26aufirst%3DP.%26aulast%3DEinav%26aufirst%3DS.%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%25203%252C5-disubstituted-pyrrolo%255B2%252C3-%2520b%255Dpyridines%2520as%2520inhibitors%2520of%2520Adaptor-Associated%2520Kinase%25201%2520with%2520antiviral%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D12%26spage%3D5810%26epage%3D5831%26doi%3D10.1021%2Facs.jmedchem.9b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barouch-Bentov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamine, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einav, S.</span></span> <span> </span><span class="NLM_article-title">Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2018.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2018.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29753658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpslaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2018&pages=67-75&author=S.+Y.+Puauthor=F.+Xiaoauthor=S.+Schorauthor=E.+Bekermanauthor=F.+Zaniniauthor=R.+Barouch-Bentovauthor=C.+M.+Nagamineauthor=S.+Einav&title=Feasibility+and+biological+rationale+of+repurposing+sunitinib+and+erlotinib+for+dengue+treatment&doi=10.1016%2Fj.antiviral.2018.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment</span></div><div class="casAuthors">Pu, Szu-Yuan; Xiao, Fei; Schor, Stanford; Bekerman, Elena; Zanini, Fabio; Barouch-Bentov, Rina; Nagamine, Claude M.; Einav, Shirit</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-75</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is an urgent need for strategies to combat dengue virus (DENV) infection; a major global threat.  We reported that the cellular kinases AAK1 and GAK regulate intracellular trafficking of multiple viruses and that sunitinib and erlotinib, approved anticancer drugs with potent activity against these kinases, protect DENV-infected mice from mortality.  Nevertheless, further characterization of the therapeutic potential and underlying mechanism of this approach is required prior to clin. evaluation.  Here, we demonstrate that sunitinib/erlotinib combination achieves sustained suppression of systemic infection at approved dose in DENV-infected IFN-α/β and IFN-γ receptor-deficient mice.  Nevertheless, treatment with these blood-brain barrier impermeable drugs delays, yet does not prevent, late-onset paralysis; a common manifestation in this immunodeficient mouse model but not in humans.  Sunitinib and erlotinib treatment also demonstrates efficacy in human primary monocyte-derived dendritic cells.  Addnl., DENV infection induces expression of AAK1 transcripts, but not GAK, via single-cell transcriptomics, and these kinases are important mol. targets underlying the anti-DENV effect of sunitinib and erlotinib.  Lastly, sunitinib/erlotinib combination alters inflammatory cytokine responses in DENV-infected mice.  These findings support feasibility of repurposing sunitinib/erlotinib combination as a host-targeted antiviral approach and contribute to understanding its mechanism of antiviral action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2cs8UpuoykLVg90H21EOLACvtfcHk0ljbDEpeAeQTgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpslaqtbk%253D&md5=acde697b6e3c6d9f42a2011be6091e83</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2018.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2018.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DPu%26aufirst%3DS.%2BY.%26aulast%3DXiao%26aufirst%3DF.%26aulast%3DSchor%26aufirst%3DS.%26aulast%3DBekerman%26aufirst%3DE.%26aulast%3DZanini%26aufirst%3DF.%26aulast%3DBarouch-Bentov%26aufirst%3DR.%26aulast%3DNagamine%26aufirst%3DC.%2BM.%26aulast%3DEinav%26aufirst%3DS.%26atitle%3DFeasibility%2520and%2520biological%2520rationale%2520of%2520repurposing%2520sunitinib%2520and%2520erlotinib%2520for%2520dengue%2520treatment%26jtitle%3DAntiviral%2520Res.%26date%3D2018%26volume%3D155%26spage%3D67%26epage%3D75%26doi%3D10.1016%2Fj.antiviral.2018.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oechsle, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savory, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbing, J.</span></span> <span> </span><span class="NLM_article-title">Baricitinib as potential treatment for 2019-nCoV acute respiratory disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span> (<span class="NLM_issue">10223</span>),  <span class="NLM_fpage">e30</span>– <span class="NLM_lpage">e31</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)30304-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2930304-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32032529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1Chtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=e30-e31&issue=10223&author=P.+Richardsonauthor=I.+Griffinauthor=C.+Tuckerauthor=D.+Smithauthor=O.+Oechsleauthor=A.+Phelanauthor=M.+Rawlingauthor=E.+Savoryauthor=J.+Stebbing&title=Baricitinib+as+potential+treatment+for+2019-nCoV+acute+respiratory+disease&doi=10.1016%2FS0140-6736%2820%2930304-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Baricitinib as potential treatment for 2019-nCoV acute respiratory disease</span></div><div class="casAuthors">Richardson, Peter; Griffin, Ivan; Tucker, Catherine; Smith, Dan; Oechsle, Olly; Phelan, Anne; Stebbing, Justin</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10223</span>),
    <span class="NLM_cas:pages">e30-e31</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Given the scale and rapid spread of the 2019 novel coronavirus (2019-nCoV) acute respiratory disease, there is an immediate need for medicines that can help before a vaccine can be produced.  Results of rapid sequencing of 2019-nCoV, coupled with mol. modeling based on the genomes of related virus proteins, have suggested a few compds. that are likely to be effective, including the anti-HIV lopinavir plus ritonavir combination.  Most viruses enter cells through receptor-mediated endocytosis.  One of the known regulators of endocytosis is the AP2-assocd. protein kinase 1 (AAK1).  Disruption of AAK1 might, in turn, interrupt the passage of the virus into cells and also the intracellular assembly of virus particles.  One of six high affinity AAK1-binding drugs was the janus kinase inhibitor baricitinib, which also binds the cyclin G-assocd. kinase, another regulator of endocytosis.  Because the plasma concn. of baricitinib on therapeutic dosing (either as 2 mg or 4 mg once daily) is sufficient to inhibit AAK1, we suggest it could be trialled, using an appropriate patient population with 2019-nCoV acute respiratory disease, to reduce both the viral entry and inflammation in patients, using endpoints such as the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT8bDm3HM7aLVg90H21EOLACvtfcHk0ljbDEpeAeQTgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1Chtr4%253D&md5=9e884d046780c8aa5f3a0934bf4a59ed</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2930304-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252930304-4%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DGriffin%26aufirst%3DI.%26aulast%3DTucker%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DOechsle%26aufirst%3DO.%26aulast%3DPhelan%26aufirst%3DA.%26aulast%3DRawling%26aufirst%3DM.%26aulast%3DSavory%26aufirst%3DE.%26aulast%3DStebbing%26aufirst%3DJ.%26atitle%3DBaricitinib%2520as%2520potential%2520treatment%2520for%25202019-nCoV%2520acute%2520respiratory%2520disease%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26issue%3D10223%26spage%3De30%26epage%3De31%26doi%3D10.1016%2FS0140-6736%2820%2930304-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stebbing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oechsle, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span> <span> </span><span class="NLM_article-title">COVID-19: combining antiviral and anti-inflammatory treatments</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(20)30132-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS1473-3099%2820%2930132-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32113509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktFCitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=400-402&issue=4&author=J.+Stebbingauthor=A.+Phelanauthor=I.+Griffinauthor=C.+Tuckerauthor=O.+Oechsleauthor=D.+Smithauthor=P.+Richardson&title=COVID-19%3A+combining+antiviral+and+anti-inflammatory+treatments&doi=10.1016%2FS1473-3099%2820%2930132-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">COVID-19: combining antiviral and anti-inflammatory treatments</span></div><div class="casAuthors">Stebbing, Justin; Phelan, Anne; Griffin, Ivan; Tucker, Catherine; Oechsle, Olly; Smith, Dan; Richardson, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">400-402</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The potential for combination therapy of the anti-inflammatory baricitinib with the direct-acting antivirals (lopinavir or ritonavir and remdesivir) currently being used in the COVID-19 outbreak, since it has a minimal interaction with the relevant CYP drug-metabolizing enzymes.  Combinations of baricitinib with these direct-acting antivirals could reduce viral infectivity, viral replication, and the aberrant host inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcjx8n9u2irVg90H21EOLACvtfcHk0lh53Pm67TCWmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktFCitb4%253D&md5=c311166386f148d130f49b72f3c0b381</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2820%2930132-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252820%252930132-8%26sid%3Dliteratum%253Aachs%26aulast%3DStebbing%26aufirst%3DJ.%26aulast%3DPhelan%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DI.%26aulast%3DTucker%26aufirst%3DC.%26aulast%3DOechsle%26aufirst%3DO.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRichardson%26aufirst%3DP.%26atitle%3DCOVID-19%253A%2520combining%2520antiviral%2520and%2520anti-inflammatory%2520treatments%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2020%26volume%3D20%26issue%3D4%26spage%3D400%26epage%3D402%26doi%3D10.1016%2FS1473-3099%2820%2930132-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Praveen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puvvada, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">M, V. A.</span></span> <span> </span><span class="NLM_article-title">Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">105967</span>, <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2020.105967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.ijantimicag.2020.105967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32259575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsV2rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2020&pages=105967&issue=5&author=D.+Praveenauthor=R.+C.+Puvvadaauthor=V.+A.+M&title=Janus+kinase+inhibitor+baricitinib+is+not+an+ideal+option+for+management+of+COVID-19&doi=10.1016%2Fj.ijantimicag.2020.105967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19</span></div><div class="casAuthors">Praveen, D.; Puvvada, Ranadheer Chowdary; M, Vijey Aanandhi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">105967</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Wuhan outbreak of novel Corona virus infection has been the global focus since Dec. 2019.  This infection has become a global pandemic.  It is highly important to understand the virol. of the pathogen and to explore the therapeutic options for management of this pandemic.  Drug repurposing strategies are being considered for management of COVID 19.  Among the identified drugs, Baricitinib has become a keen interest for researchers because of its ability to inhibit the viral assembly by the prevention of Clarithrin assocd. endocytosis.  We tried to explore the reasons on why Baricitinib is not an ideal option for COVID 19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl3tkQaMBwdbVg90H21EOLACvtfcHk0lh53Pm67TCWmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsV2rtb0%253D&md5=53ee40e8ae424cf392fbf9c7987707c3</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2020.105967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2020.105967%26sid%3Dliteratum%253Aachs%26aulast%3DPraveen%26aufirst%3DD.%26aulast%3DPuvvada%26aufirst%3DR.%2BC.%26aulast%3DM%26aufirst%3DV.%2BA.%26atitle%3DJanus%2520kinase%2520inhibitor%2520baricitinib%2520is%2520not%2520an%2520ideal%2520option%2520for%2520management%2520of%2520COVID-19%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2020%26volume%3D55%26issue%3D5%26spage%3D105967%26doi%3D10.1016%2Fj.ijantimicag.2020.105967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklarz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul Azeez, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Family-wide structural analysis of human Numb-associated protein kinases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1016/j.str.2015.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.str.2015.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26853940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=401-411&issue=3&author=F.+J.+Sorrellauthor=M.+Szklarzauthor=K.+R.+Abdul+Azeezauthor=J.+M.+Elkinsauthor=S.+Knapp&title=Family-wide+structural+analysis+of+human+Numb-associated+protein+kinases&doi=10.1016%2Fj.str.2015.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Family-wide Structural Analysis of Human Numb-Associated Protein Kinases</span></div><div class="casAuthors">Sorrell, Fiona J.; Szklarz, Marta; Abdul Azeez, Kamal R.; Elkins, Jon M.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-411</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The highly diverse Numb-assocd. kinase (NAK) family has been linked to broad cellular functions including receptor-mediated endocytosis, Notch pathway modulation, osteoblast differentiation, and dendrite morphogenesis.  Consequently, NAK kinases play a key role in a diverse range of diseases from Parkinson's and prostate cancer to HIV.  Due to the plasticity of this kinase family, NAK kinases are often inhibited by approved or investigational drugs and have been assocd. with side effects, but they are also potential drug targets.  The presence of cysteine residues in some NAK family members provides the possibility for selective targeting via covalent inhibition.  Here we report the first high-resoln. structures of kinases AAK1 and BIKE in complex with two drug candidates.  The presented data allow a comprehensive structural characterization of the NAK kinase family and provide the basis for rational design of selective NAK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryZi0QmT8YH7Vg90H21EOLACvtfcHk0liEx6P_BSS8FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCktLY%253D&md5=6a353c993ec9f2b7152e459d72bab9d3</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2015.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2015.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DSzklarz%26aufirst%3DM.%26aulast%3DAbdul%2BAzeez%26aufirst%3DK.%2BR.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DFamily-wide%2520structural%2520analysis%2520of%2520human%2520Numb-associated%2520protein%2520kinases%26jtitle%3DStructure%26date%3D2016%26volume%3D24%26issue%3D3%26spage%3D401%26epage%3D411%26doi%3D10.1016%2Fj.str.2015.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohbayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Murayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukimoto-Niino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uejima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohsawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the inhibition of cyclin G-associated kinase by gefitinib</span>. <i>ChemistryOpen</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">713</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1002/open.201800177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fopen.201800177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=713-719&issue=9&author=N.+Ohbayashiauthor=K.+Murayamaauthor=M.+Kato-Murayamaauthor=M.+Kukimoto-Niinoauthor=T.+Uejimaauthor=T.+Matsudaauthor=N.+Ohsawaauthor=S.+Yokoyamaauthor=H.+Nojimaauthor=M.+Shirouzu&title=Structural+basis+for+the+inhibition+of+cyclin+G-associated+kinase+by+gefitinib&doi=10.1002%2Fopen.201800177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Inhibition of Cyclin G-Associated Kinase by Gefitinib</span></div><div class="casAuthors">Ohbayashi, Naomi; Murayama, Kazutaka; Kato-Murayama, Miyuki; Kukimoto-Niino, Mutsuko; Uejima, Tamami; Matsuda, Takayoshi; Ohsawa, Noboru; Yokoyoma, Shigeyuki; Nojima, Hiroshi; Shirouzu, Mikako</div><div class="citationInfo"><span class="NLM_cas:title">ChemistryOpen</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">713-719</span>CODEN:
                <span class="NLM_cas:coden">CHOPCK</span>;
        ISSN:<span class="NLM_cas:issn">2191-1363</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Gefitinib is the mol. target drug for advanced non-small-cell lung cancer.  The primary target of gefitinib is the pos. mutation of epidermal growth factor receptor, but it also inhibits cyclin G-assocd. kinase (GAK).  To reveal the mol. bases of GAK and gefitinib binding, structure analyses were conducted and detd. two forms of the gefitinib-bound nanobody·GAK kinase domain complex structures.  The first form, GAK_1, has one gefitinib at the ATP binding pocket, whereas the second form, GAK_2, binds one each in the ATP binding site and a novel binding site adjacent to the activation segment C-terminal helix, a unique element of the Numb-assocd. kinase family.  In the novel binding site, gefitinib binds in the hydrophobic groove around the activation segment, disrupting the conserved hydrogen bonds for the catalytic activity.  These structures suggest possibilities for the development of selective GAK inhibitors for viral infections, such as the hepatitis C virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZeMIF-4YuzLVg90H21EOLACvtfcHk0liEx6P_BSS8FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqu7nF&md5=644dc1dd71349a0cdc5859838382c824</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1002%2Fopen.201800177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fopen.201800177%26sid%3Dliteratum%253Aachs%26aulast%3DOhbayashi%26aufirst%3DN.%26aulast%3DMurayama%26aufirst%3DK.%26aulast%3DKato-Murayama%26aufirst%3DM.%26aulast%3DKukimoto-Niino%26aufirst%3DM.%26aulast%3DUejima%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DOhsawa%26aufirst%3DN.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DNojima%26aufirst%3DH.%26aulast%3DShirouzu%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520cyclin%2520G-associated%2520kinase%2520by%2520gefitinib%26jtitle%3DChemistryOpen%26date%3D2018%26volume%3D7%26issue%3D9%26spage%3D713%26epage%3D719%26doi%3D10.1002%2Fopen.201800177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurbani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everley, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gondi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berberich, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westover, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorger, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Leveraging compound promiscuity to identify targetable cysteines within the kinome</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.chembiol.2019.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30982749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnt1CksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=818-829&issue=6&author=S.+Raoauthor=D.+Gurbaniauthor=G.+Duauthor=R.+A.+Everleyauthor=C.+M.+Browneauthor=A.+Chaikuadauthor=L.+Tanauthor=M.+Schroderauthor=S.+Gondiauthor=S.+B.+Ficarroauthor=T.+Simauthor=N.+D.+Kimauthor=M.+J.+Berberichauthor=S.+Knappauthor=J.+A.+Martoauthor=K.+D.+Westoverauthor=P.+K.+Sorgerauthor=N.+S.+Gray&title=Leveraging+compound+promiscuity+to+identify+targetable+cysteines+within+the+kinome&doi=10.1016%2Fj.chembiol.2019.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome</span></div><div class="casAuthors">Rao, Suman; Gurbani, Deepak; Du, Guangyan; Everley, Robert A.; Browne, Christopher M.; Chaikuad, Apirat; Li, Tan; Schroder, Martin; Gondi, Sudershan; Ficarro, Scott B.; Sim, Taebo; Kim, Nam Doo; Berberich, Matthew J.; Knapp, Stefan; Marto, Jarrod A.; Westover, Kenneth D.; Sorger, Peter K.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">818-829.e9</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Covalent kinase inhibitors, which typically target cysteine residues, represent an important class of clin. relevant compds.  Approx. 215 kinases are known to have potentially targetable cysteines distributed across 18 spatially distinct locations proximal to the ATP-binding pocket.  However, only 40 kinases have been covalently targeted, with certain cysteine sites being the primary focus.  To address this disparity, we have developed a strategy that combines the use of a multi-targeted acrylamide-modified inhibitor, SM1-71, with a suite of complementary chemoproteomic and cellular approaches to identify addnl. targetable cysteines.  Using this single multi-targeted compd., we successfully identified 23 kinases that are amenable to covalent inhibition including MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1, and RSK2.  The identification of nine of these kinases previously not targeted by a covalent inhibitor increases the no. of targetable kinases and highlights opportunities for covalent kinase inhibitor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUcHJFGWFTTrVg90H21EOLACvtfcHk0lgNkJBW7JGt2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnt1CksL4%253D&md5=6a8656d083fc4d49fa8520b48e05d100</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DS.%26aulast%3DGurbani%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DEverley%26aufirst%3DR.%2BA.%26aulast%3DBrowne%26aufirst%3DC.%2BM.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DSchroder%26aufirst%3DM.%26aulast%3DGondi%26aufirst%3DS.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DBerberich%26aufirst%3DM.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DWestover%26aufirst%3DK.%2BD.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DLeveraging%2520compound%2520promiscuity%2520to%2520identify%2520targetable%2520cysteines%2520within%2520the%2520kinome%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26issue%3D6%26spage%3D818%26epage%3D829%26doi%3D10.1016%2Fj.chembiol.2019.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsland, R.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyayula, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capraro, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillern, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhausen, T.</span></span> <span> </span><span class="NLM_article-title">Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>552</i></span> (<span class="NLM_issue">7685</span>),  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1038/nature25146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnature25146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29236694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOht7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2017&pages=410-414&issue=7685&author=K.+Heauthor=R.+Marslandauthor=S.+Upadhyayulaauthor=E.+Songauthor=S.+Dangauthor=B.+R.+Capraroauthor=W.+Wangauthor=W.+Skillernauthor=R.+Gaudinauthor=M.+Maauthor=T.+Kirchhausen&title=Dynamics+of+phosphoinositide+conversion+in+clathrin-mediated+endocytic+traffic&doi=10.1038%2Fnature25146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic</span></div><div class="casAuthors">He, Kangmin; Marsland, Robert, III; Upadhyayula, Srigokul; Song, Eli; Dang, Song; Capraro, Benjamin R.; Wang, Weiming; Skillern, Wesley; Gaudin, Raphael; Ma, Minghe; Kirchhausen, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">7685</span>),
    <span class="NLM_cas:pages">410-414</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Vesicular carriers transport proteins and lipids from one organelle to another, recognizing specific identifiers for the donor and acceptor membranes.  Two important identifiers are phosphoinositides and GTP-bound GTPases, which provide well-defined but mutable labels.  Phosphatidylinositol (PI) and its phosphorylated derivs. are present on the cytosolic faces of most cellular membranes.  Reversible phosphorylation of its headgroup produces 7 distinct phosphoinositides.  In endocytic traffic, PI 4,5-biphosphate marks the plasma membrane, and PI 3-phosphate and PI 4-phosphate mark distinct endosomal compartments.  It is unknown what sequence of changes in lipid content confers on the vesicles their distinct identity at each intermediate step.  Here, we describe 'coincidence-detecting' sensors that selectively report the phosphoinositide compn. of clathrin-assocd. structures, and the use of these sensors to follow the dynamics of phosphoinositide conversion during endocytosis.  The membrane of an assembling coated pit, in equil. with the surrounding plasma membrane, contains PI 4,5-biphosphate and a smaller amt. of PI 4-phosphate.  Closure of the vesicle interrupts free exchange with the plasma membrane.  A substantial burst of PI 4-phosphate immediately after budding coincides with a burst of PI 3-phosphate, distinct from any later encounter with the PI 3-phosphate pool in early endosomes; PI 3,4-bisphosphate and GTPase Rab5 then appear and remain as the uncoating vesicles mature into Rab5-pos. endocytic intermediates.  These observations show that a cascade of mol. conversions, made possible by the sepn. of a vesicle from its parent membrane, can label membrane-traffic intermediates and det. their destinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzPWqG43V_UrVg90H21EOLACvtfcHk0lgNkJBW7JGt2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOht7rL&md5=1cba4714dd3350c7c074ea8263fcabd9</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fnature25146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25146%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DK.%26aulast%3DMarsland%26aufirst%3DR.%26aulast%3DUpadhyayula%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DE.%26aulast%3DDang%26aufirst%3DS.%26aulast%3DCapraro%26aufirst%3DB.%2BR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSkillern%26aufirst%3DW.%26aulast%3DGaudin%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DM.%26aulast%3DKirchhausen%26aufirst%3DT.%26atitle%3DDynamics%2520of%2520phosphoinositide%2520conversion%2520in%2520clathrin-mediated%2520endocytic%2520traffic%26jtitle%3DNature%26date%3D2017%26volume%3D552%26issue%3D7685%26spage%3D410%26epage%3D414%26doi%3D10.1038%2Fnature25146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shisheva, A.</span></span> <span> </span><span class="NLM_article-title">PIKfyve: Partners, significance, debates and paradoxes</span>. <i>Cell Biol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1016/j.cellbi.2008.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cellbi.2008.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18304842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVSntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=591-604&issue=6&author=A.+Shisheva&title=PIKfyve%3A+Partners%2C+significance%2C+debates+and+paradoxes&doi=10.1016%2Fj.cellbi.2008.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">PIKfyve: Partners, significance, debates and paradoxes</span></div><div class="casAuthors">Shisheva, Assia</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology International</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">591-604</span>CODEN:
                <span class="NLM_cas:coden">CBIIEV</span>;
        ISSN:<span class="NLM_cas:issn">1065-6995</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Key components of membrane trafficking and signaling machinery in eukaryotic cells are proteins that bind or synthesize phosphoinositides.  PIKfyve, a product of an evolutionarily conserved single-copy gene has both these features.  It binds to membrane phosphatidylinositol (PtdIns)3P and synthesizes PtdIns(3,5)P2 and PtdIns5P.  Mol. functions of PIKfyve are elusive but recent advances are consistent with a key role in the course of endosomal transport.  PIKfyve dysfunction induces endosome enlargement and profound cytoplasmic vacuolation, likely as a result of impaired normal endosome processing and membrane exit out of endosomes.  Multicellular organisms with genetically impaired function of PIKfyve or that of the PIKfyve protein partners regulating PtdIns(3,5)P2 homeostasis display severe disorders, including embryonic/perinatal death.  This review describes recent advances on PIKfyve functionality in higher eukaryotes, with particular ref. to biochem. and genetic insights in PIKfyve protein partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOgOq8yvtpALVg90H21EOLACvtfcHk0lgNkJBW7JGt2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVSntLc%253D&md5=54db4172e95de0cb38bcc47d371e7a88</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.cellbi.2008.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellbi.2008.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DShisheva%26aufirst%3DA.%26atitle%3DPIKfyve%253A%2520Partners%252C%2520significance%252C%2520debates%2520and%2520paradoxes%26jtitle%3DCell%2520Biol.%2520Int.%26date%3D2008%26volume%3D32%26issue%3D6%26spage%3D591%26epage%3D604%26doi%3D10.1016%2Fj.cellbi.2008.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Lartigue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooze, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clague, M. J.</span></span> <span> </span><span class="NLM_article-title">PIKfyve regulation of endosome-linked pathways</span>. <i>Traffic</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0854.2009.00915.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1111%2Fj.1600-0854.2009.00915.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19582903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFGrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=883-893&issue=7&author=J.+de+Lartigueauthor=H.+Polsonauthor=M.+Feldmanauthor=K.+Shokatauthor=S.+A.+Toozeauthor=S.+Urbeauthor=M.+J.+Clague&title=PIKfyve+regulation+of+endosome-linked+pathways&doi=10.1111%2Fj.1600-0854.2009.00915.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">PIKfyve regulation of endosome-linked pathways</span></div><div class="casAuthors">de Lartigue, Jane; Polson, Hannah; Feldman, Morri; Shokat, Kevan; Tooze, Sharon A.; Urbe, Sylvie; Clague, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Traffic (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-893</span>CODEN:
                <span class="NLM_cas:coden">TRAFFA</span>;
        ISSN:<span class="NLM_cas:issn">1398-9219</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The phosphoinositide 5-kinase (PIKfyve) is a crit. enzyme for the synthesis of PtdIns(3,5)P2, that was implicated in various trafficking events assocd. with the endocytic pathway.  We have now directly compared the effects of siRNA-mediated knockdown of PIKfyve in HeLa cells with a specific pharmacol. inhibitor of enzyme activity.  Both approaches induce changes in the distribution of cation-independent mannose 6-phosphate receptor (CI-M6PR) and trans-Golgi network (TGN)-46 proteins, which cycles between endosomes and TGN, leading to their accumulation in dispersed punctae, while the TGN marker golgin-245 retains a perinuclear disposition.  Trafficking of CD8-CI-M6PR (retromer-dependent) and CD8-Furin (retromer-independent) chimeras from the cell surface to the TGN is delayed following drug administration, as is the transport of the Shiga toxin B-subunit.  SiRNA knockdown of PIKfyve produced no defect in epidermal growth factor receptor (EGFR) degrdn., unless combined with knockdown of its activator mol. Vac14, suggesting that a low threshold of PtdIns(3,5)P2 is necessary and sufficient for this pathway.  Accordingly pharmacol. inhibition of PIKfyve results in a profound block to the lysosomal degrdn. of activated epidermal growth factor (EGF) and Met receptors.  Immunofluorescence revealed EGF receptors to be trapped in the interior of a swollen endosomal compartment.  In cells starved of amino acids, PIKfyve inhibition leads to the accumulation of the lipidated form of GFP-LC3, a marker of autophagosomal structures, which can be visualized as fluorescent punctae.  We suggest that PIKfyve inhibition may render the late endosome/lysosome compartment refractory to fusion with both autophagosomes and with EGFR-contg. multivesicular bodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjAHcsNBejkbVg90H21EOLACvtfcHk0lijQzLX7XzAng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFGrsb8%253D&md5=5522c9dfb2e576da77e2a6b166f08b51</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0854.2009.00915.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0854.2009.00915.x%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLartigue%26aufirst%3DJ.%26aulast%3DPolson%26aufirst%3DH.%26aulast%3DFeldman%26aufirst%3DM.%26aulast%3DShokat%26aufirst%3DK.%26aulast%3DTooze%26aufirst%3DS.%2BA.%26aulast%3DUrbe%26aufirst%3DS.%26aulast%3DClague%26aufirst%3DM.%2BJ.%26atitle%3DPIKfyve%2520regulation%2520of%2520endosome-linked%2520pathways%26jtitle%3DTraffic%26date%3D2009%26volume%3D10%26issue%3D7%26spage%3D883%26epage%3D893%26doi%3D10.1111%2Fj.1600-0854.2009.00915.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardinale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatcherian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsoum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, J. G.</span></span> <span> </span><span class="NLM_article-title">Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e35069</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0035069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0035069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22493730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVyqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=4&author=Y.+Wadaauthor=I.+Cardinaleauthor=A.+Khatcherianauthor=J.+Chuauthor=A.+B.+Kantorauthor=A.+B.+Gottliebauthor=N.+Tatsutaauthor=E.+Jacobsonauthor=J.+Barsoumauthor=J.+G.+Krueger&title=Apilimod+inhibits+the+production+of+IL-12+and+IL-23+and+reduces+dendritic+cell+infiltration+in+psoriasis&doi=10.1371%2Fjournal.pone.0035069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis</span></div><div class="casAuthors">Wada, Yumiko; Cardinale, Irma; Khatcherian, Artemis; Chu, John; Kantor, Aaron B.; Gottlieb, Alice B.; Tatsuta, Noriaki; Jacobson, Eric; Barsoum, James; Krueger, James G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e35069</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Psoriasis is characterized by hyperplasia of the epidermis and infiltration of leukocytes into both the dermis and epidermis.  IL-23, a key cytokine that induces TH17 cells, has been found to play a crit. role in the pathogenesis of psoriasis.  Apilimod is a small-mol. compd. that selectively suppresses synthesis of IL-12 and IL-23.  An open-label clin. study of oral administration of apilimod was conducted in patients with psoriasis.  Substantial improvements in histol. and clin. measurements were obsd. in patients receiving 70mg QD.  The expression of IL-23p19 and IL-12/IL-23p40 in skin lesions was significantly reduced in this dose group, with a simultaneous increase in IL-10 obsd.  A decrease in the levels of TH1 and TH17 cytokines/chemokines in skin lesions followed these p19 and p40 changes.  In parallel, a redn. in skin-infiltrating CD11c+ dendritic cells and CD3+ T cells was seen, with a greater decrease in the CD11c+ population.  This was accompanied by increases in T and B cells, and decreases in neutrophils and eosinophils in the periphery.  This study demonstrates the immunomodulatory activity of apilimod and provides clin. evidence supporting the inhibition of IL-12/IL-23 synthesis for the treatment of TH1- and TH17-mediated inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxAQtGmEdUGbVg90H21EOLACvtfcHk0lijQzLX7XzAng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVyqu7c%253D&md5=18f569c46e0e86ee9167ceb96cce2b49</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0035069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0035069%26sid%3Dliteratum%253Aachs%26aulast%3DWada%26aufirst%3DY.%26aulast%3DCardinale%26aufirst%3DI.%26aulast%3DKhatcherian%26aufirst%3DA.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DKantor%26aufirst%3DA.%2BB.%26aulast%3DGottlieb%26aufirst%3DA.%2BB.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DE.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DApilimod%2520inhibits%2520the%2520production%2520of%2520IL-12%2520and%2520IL-23%2520and%2520reduces%2520dendritic%2520cell%2520infiltration%2520in%2520psoriasis%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D4%26doi%3D10.1371%2Fjournal.pone.0035069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikonomov, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbrissa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shisheva, A.</span></span> <span> </span><span class="NLM_article-title">YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2009.03.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bbrc.2009.03.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2009&pages=566-570&issue=3&author=O.+C.+Ikonomovauthor=D.+Sbrissaauthor=A.+Shisheva&title=YM201636%2C+an+inhibitor+of+retroviral+budding+and+PIKfyve-catalyzed+PtdIns%283%2C5%29P2+synthesis%2C+halts+glucose+entry+by+insulin+in+adipocytes&doi=10.1016%2Fj.bbrc.2009.03.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes</span></div><div class="casAuthors">Ikonomov, Ognian C.; Sbrissa, Diego; Shisheva, Assia</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">566-570</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Silencing of PIKfyve, the sole enzyme for PtdIns(3,5)P2 biosynthesis that controls proper endosome dynamics, inhibits retroviral replication.  A novel PIKfyve-specific inhibitor YM201636 disrupts retroviral budding at 800 nM, suggesting its potential use as an antiretroviral therapeutic.  Because PIKfyve is also required for optimal insulin activation of GLUT4 surface translocation and glucose influx, we tested the outcome of YM201636 application on insulin responsiveness in 3T3L1 adipocytes.  YM201636 almost completely inhibited basal and insulin-activated 2-deoxyglucose uptake at doses as low as 160 nM, with IC50 = 54 ± 4 nM for the net insulin response.  Insulin-induced GLUT4 translocation was partially inhibited at substantially higher doses, comparable to those required for inhibition of insulin-induced phosphorylation of Akt/PKB.  In addn. to PIKfyve, YM201636 also completely inhibited insulin-dependent activation of class IA PI 3-kinase.  We suggest that apart from PIKfyve, there are at least two addnl. targets for YM201636 in the context of insulin signaling to GLUT4 and glucose uptake: the insulin-activated class IA PI 3-kinase and a here-unidentified high-affinity target responsible for the greater inhibition of glucose entry vs. GLUT4 translocation.  The profound inhibition of the net insulin effect on glucose influx at YM201636 doses markedly lower than those required for efficient retroviral budding disruption warns of severe perturbations in glucose homeostasis assocd. with potential YM201636 use in antiretroviral therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl-6UuJwUK8rVg90H21EOLACvtfcHk0lijQzLX7XzAng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCnurc%253D&md5=98f81b0aac7f16e916af4d847fbeef22</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.03.063%26sid%3Dliteratum%253Aachs%26aulast%3DIkonomov%26aufirst%3DO.%2BC.%26aulast%3DSbrissa%26aufirst%3DD.%26aulast%3DShisheva%26aufirst%3DA.%26atitle%3DYM201636%252C%2520an%2520inhibitor%2520of%2520retroviral%2520budding%2520and%2520PIKfyve-catalyzed%2520PtdIns%25283%252C5%2529P2%2520synthesis%252C%2520halts%2520glucose%2520entry%2520by%2520insulin%2520in%2520adipocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D382%26issue%3D3%26spage%3D566%26epage%3D570%26doi%3D10.1016%2Fj.bbrc.2009.03.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothlauf, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccinotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cureton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whelan, S. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhausen, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2020.04.21.053058</span> (accessed 2020-05-30) <span class="refDoi"> DOI: 10.1101/2020.04.21.053058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.04.21.053058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.-L.+Kangauthor=Y.+Y.+Chouauthor=P.+W.+Rothlaufauthor=Z.+Liuauthor=S.+Piccinottiauthor=T.+K.+Sohauthor=D.+Curetonauthor=J.+B.+Caseauthor=R.+E.+Chenauthor=M.+S.+Diamondauthor=S.+P.+J.+Whelanauthor=T.+Kirchhausen&title=Inhibition+of+PIKfyve+kinase+prevents+infection+by+EBOV+and+SARS-CoV-2&doi=10.1101%2F2020.04.21.053058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1101%2F2020.04.21.053058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.04.21.053058%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DY.-L.%26aulast%3DChou%26aufirst%3DY.%2BY.%26aulast%3DRothlauf%26aufirst%3DP.%2BW.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DPiccinotti%26aufirst%3DS.%26aulast%3DSoh%26aufirst%3DT.%2BK.%26aulast%3DCureton%26aufirst%3DD.%26aulast%3DCase%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DR.%2BE.%26aulast%3DDiamond%26aufirst%3DM.%2BS.%26aulast%3DWhelan%26aufirst%3DS.%2BP.%2BJ.%26aulast%3DKirchhausen%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520PIKfyve%2520kinase%2520prevents%2520infection%2520by%2520EBOV%2520and%2520SARS-CoV-2%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26doi%3D10.1101%2F2020.04.21.053058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl-Schott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span> <span> </span><span class="NLM_article-title">Two-pore channels: Catalyzers of endolysosomal transport and function</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">45</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3389%2Ffphar.2017.00045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28223936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFenu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=45&author=C.+Grimmauthor=C.+C.+Chenauthor=C.+Wahl-Schottauthor=M.+Biel&title=Two-pore+channels%3A+Catalyzers+of+endolysosomal+transport+and+function&doi=10.3389%2Ffphar.2017.00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Two-pore channels: catalyzers of endolysosomal transport and function</span></div><div class="casAuthors">Grimm, Christian; Chen, Cheng-Chang; Wahl-Schott, Christian; Biel, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45/1-45/6</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Two-pore channels (TPCs) have recently emerged as a novel class of non-selective cation channels in the endolysosomal system.  There are two members in the human genome, TPC1 and TPC2.  Studies with TPC knockout and knockdown models have revealed that these channels participate in the regulation of multiple endolysosomal trafficking pathways which when dysregulated can lead to or influence the development of a range of different diseases such as lysosomal storage, metabolic, or infectious diseases.  TPCs have been demonstrated to be activated by different endogenous stimuli, PI(3,5)P♂ and NAADP, and ATP has been found to block TPC activation via mTOR.  Loss of TPCs can lead to obesity and hypercholesterolemia, and to a slowdown of intracellular virus and bacterial toxin trafficking, it can affect VEGF-induced neoangiogenesis, autophagy, human hair pigmentation or the acrosome reaction in sperm.  Moreover, physiol. roles of TPCs in cardiac myocytes and pancreatic b cells have been postulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlRYMGWXTA4rVg90H21EOLACvtfcHk0liPn6rJqHnIbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFenu7k%253D&md5=cd56e3259d160d144bd25609d855a287</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00045%26sid%3Dliteratum%253Aachs%26aulast%3DGrimm%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%2BC.%26aulast%3DWahl-Schott%26aufirst%3DC.%26aulast%3DBiel%26aufirst%3DM.%26atitle%3DTwo-pore%2520channels%253A%2520Catalyzers%2520of%2520endolysosomal%2520transport%2520and%2520function%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D45%26doi%3D10.3389%2Ffphar.2017.00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kintzer, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span> <span> </span><span class="NLM_article-title">On the structure and mechanism of two-pore channels</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1111/febs.14154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1111%2Ffebs.14154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28656706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Wgu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2018&pages=233-243&issue=2&author=A.+F.+Kintzerauthor=R.+M.+Stroud&title=On+the+structure+and+mechanism+of+two-pore+channels&doi=10.1111%2Ffebs.14154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">On the structure and mechanism of two-pore channels</span></div><div class="casAuthors">Kintzer, Alexander F.; Stroud, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-243</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In eukaryotes, two-pore channels 1-3 (TPC1-3) comprise a family of ion channels that regulate the conductance of Na+ and Ca2+ ions across cellular membranes.  TPC1-3 form endolysosomal channels, but TPC3 can also function in the plasma membrane.  TPC1/3 are voltage-gated channels, but TPC2 opens in response to binding the endolysosome-specific lipid, phosphatidylinositol 3,5-diphosphate (PI(3,5)P2).  Filoviruses, such as Ebola virus, exploit TPC-mediated ion release as a means of escape from the endolysosome during infection.  Antagonists that block TPC1/2 channel conductance abrogate filoviral infections.  TPC1/2 form complexes with the mechanistic target of rapamycin complex 1 (mTORC1) at the endolysosomal surface that couple cellular metabolic state and cytosolic nutrient concns. to the control of membrane potential and pH.  We previously detd. the x-ray structure of TPC1 from Arabidopsis thaliana (AtTPC1) to 2.87Å resoln., which is one of the 2 1st reports of TPC channel structure.  Here, we summarize these findings and the implications that the structure may have for understanding endolysosomal control mechanisms and their role in human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvV4yLcwNonbVg90H21EOLACvtfcHk0lgOx1ndWGw73g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Wgu7zN&md5=134e6d1f38a19a0329da866a016e6a6b</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14154%26sid%3Dliteratum%253Aachs%26aulast%3DKintzer%26aufirst%3DA.%2BF.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DOn%2520the%2520structure%2520and%2520mechanism%2520of%2520two-pore%2520channels%26jtitle%3DFEBS%2520J.%26date%3D2018%26volume%3D285%26issue%3D2%26spage%3D233%26epage%3D243%26doi%3D10.1111%2Ffebs.14154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolokoltsov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauta, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klugbauer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl-Schott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, R. A.</span></span> <span> </span><span class="NLM_article-title">Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span> (<span class="NLM_issue">6225</span>),  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1126/science.1258758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.1258758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25722412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtF2qtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=995-998&issue=6225&author=Y.+Sakuraiauthor=A.+A.+Kolokoltsovauthor=C.+C.+Chenauthor=M.+W.+Tidwellauthor=W.+E.+Bautaauthor=N.+Klugbauerauthor=C.+Grimmauthor=C.+Wahl-Schottauthor=M.+Bielauthor=R.+A.+Davey&title=Ebola+virus.+Two-pore+channels+control+Ebola+virus+host+cell+entry+and+are+drug+targets+for+disease+treatment&doi=10.1126%2Fscience.1258758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment</span></div><div class="casAuthors">Sakurai, Yasuteru; Kolokoltsov, Andrey A.; Chen, Cheng-Chang; Tidwell, Michael W.; Bauta, William E.; Klugbauer, Norbert; Grimm, Christian; Wahl-Schott, Christian; Biel, Martin; Davey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6225</span>),
    <span class="NLM_cas:pages">995-998</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Ebola virus causes sporadic outbreaks of lethal hemorrhagic fever in humans, but there is no currently approved therapy.  Cells take up Ebola virus by macropinocytosis, followed by trafficking through endosomal vesicles.  However, few factors controlling endosomal virus movement are known.  Here we find that Ebola virus entry into host cells requires the endosomal calcium channels called two-pore channels (TPCs).  Disrupting TPC function by gene knockout, small interfering RNAs, or small-mol. inhibitors halted virus trafficking and prevented infection.  Tetrandrine, the most potent small mol. that we tested, inhibited infection of human macrophages, the primary target of Ebola virus in vivo, and also showed therapeutic efficacy in mice.  Therefore, TPC proteins play a key role in Ebola virus infection and may be effective targets for antiviral therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJDhOEyzuYirVg90H21EOLACvtfcHk0lgOx1ndWGw73g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtF2qtbk%253D&md5=d5964238acb39481595dba3419222ec2</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1126%2Fscience.1258758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1258758%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DKolokoltsov%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DC.%2BC.%26aulast%3DTidwell%26aufirst%3DM.%2BW.%26aulast%3DBauta%26aufirst%3DW.%2BE.%26aulast%3DKlugbauer%26aufirst%3DN.%26aulast%3DGrimm%26aufirst%3DC.%26aulast%3DWahl-Schott%26aufirst%3DC.%26aulast%3DBiel%26aufirst%3DM.%26aulast%3DDavey%26aufirst%3DR.%2BA.%26atitle%3DEbola%2520virus.%2520Two-pore%2520channels%2520control%2520Ebola%2520virus%2520host%2520cell%2520entry%2520and%2520are%2520drug%2520targets%2520for%2520disease%2520treatment%26jtitle%3DScience%26date%3D2015%26volume%3D347%26issue%3D6225%26spage%3D995%26epage%3D998%26doi%3D10.1126%2Fscience.1258758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">She, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span> <span> </span><span class="NLM_article-title">Structural mechanisms of phospholipid activation of the human TPC2 channel</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e45222</span> <span class="refDoi"> DOI: 10.7554/eLife.45222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.7554%2FeLife.45222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30860481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVegtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=J.+Sheauthor=W.+Zengauthor=J.+Guoauthor=Q.+Chenauthor=X.+C.+Baiauthor=Y.+Jiang&title=Structural+mechanisms+of+phospholipid+activation+of+the+human+TPC2+channel&doi=10.7554%2FeLife.45222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanisms of phospholipid activation of the human TPC2 channel</span></div><div class="casAuthors">She, Ji; Zeng, Weizhong; Guo, Jiangtao; Chen, Qingfeng; Bai, Xiao-Chen; Jiang, Youxing</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45222</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Mammalian two-pore channels (TPCs) regulate the physiol. functions of the endolysosome.  Here we present cryo-EM structures of human TPC2 (HsTPC2), a phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2)-activated, Na+ selective channel, in the ligand- bound and apo states.  The apo structure captures the closed conformation, while the ligand-bound form features the channel in both open and closed conformations.  Combined with functional anal., these structures provide insights into the mechanism of PI(3,5)P2-regulated gating of TPC2, which is distinct from that of TPC1.  Specifically, the endolysosome-specific PI(3,5)P2 binds at the first 6-TM and activates the channel - independently of the membrane potential - by inducing a structural change at the pore-lining inner helix (IS6), which forms a continuous helix in the open state but breaks into two segments at Gly317 in the closed state.  Addnl., structural comparison to the voltage-dependent TPC1 structure allowed us to identify Ile551 as being responsible for the loss of voltage dependence in TPC2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqll32J6e0i6LVg90H21EOLACvtfcHk0lgOx1ndWGw73g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVegtb%252FP&md5=32c8f36f13d357aec53c7c563d4e3095</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.7554%2FeLife.45222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.45222%26sid%3Dliteratum%253Aachs%26aulast%3DShe%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DBai%26aufirst%3DX.%2BC.%26aulast%3DJiang%26aufirst%3DY.%26atitle%3DStructural%2520mechanisms%2520of%2520phospholipid%2520activation%2520of%2520the%2520human%2520TPC2%2520channel%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2FeLife.45222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penny, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassileva, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chee, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muallem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span> <span> </span><span class="NLM_article-title">Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1866</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bbamcr.2018.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30408544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlWnsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1866&publication_year=2019&pages=1151-1161&issue=7&author=C.+J.+Pennyauthor=K.+Vassilevaauthor=A.+Jhaauthor=Y.+Yuanauthor=X.+Cheeauthor=E.+Yatesauthor=M.+Mazzonauthor=B.+S.+Kilpatrickauthor=S.+Muallemauthor=M.+Marshauthor=T.+Rahmanauthor=S.+Patel&title=Mining+of+Ebola+virus+entry+inhibitors+identifies+approved+drugs+as+two-pore+channel+pore+blockers&doi=10.1016%2Fj.bbamcr.2018.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers</span></div><div class="casAuthors">Penny, Christopher J.; Vassileva, Kristin; Jha, Archana; Yuan, Yu; Chee, Xavier; Yates, Elizabeth; Mazzon, Michela; Kilpatrick, Bethan S.; Muallem, Shmuel; Marsh, Mark; Rahman, Taufiq; Patel, Sandip</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1866</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1151-1161</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two-pore channels (TPCs) are Ca2+-permeable ion channels localised to the endo-lysosomal system where they regulate trafficking of various cargoes including viruses.  As a result, TPCs are emerging as important drug targets.  However, their pharmacol. is ill-defined.  There are no approved drugs to target them.  And their mechanism of ligand activation is largely unknown.  Here, we identify a no. of FDA-approved drugs as TPC pore blockers.  Using a model of the pore of human TPC2 based on recent structures of mammalian TPCs, we virtually screened a database of ∼1500 approved drugs.  Because TPCs have recently emerged as novel host factors for Ebola virus entry, we reasoned that Ebola virus entry inhibitors may exert their effects through inhibition of TPCs.  Cross-referencing hits from the TPC virtual screen with two recent high throughput anti-Ebola screens yielded approved drugs targeting dopamine and estrogen receptors as common hits.  These compds. inhibited endogenous NAADP-evoked Ca2+ release from sea urchin egg homogenates, NAADP-mediated channel activity of TPC2 re-routed to the plasma membrane, and PI(3,5)P2-mediated channel activity of TPC2 expressed in enlarged lysosomes.  Mechanistically, single channel analyses showed that the drugs reduced mean open time consistent with a direct action on the pore.  Functionally, drug potency in blocking TPC2 activity correlated with inhibition of Ebola virus-like particle entry.  Our results expand TPC pharmacol. through the identification of approved drugs as novel blockers, support a role for TPCs in Ebola virus entry, and provide insight into the mechanisms underlying channel regulation.  This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeAbsnnebkILVg90H21EOLACvtfcHk0lg92Zam9b7NHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlWnsb%252FI&md5=9cd83d471e0a264fdb5d780427ca62d9</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DPenny%26aufirst%3DC.%2BJ.%26aulast%3DVassileva%26aufirst%3DK.%26aulast%3DJha%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DChee%26aufirst%3DX.%26aulast%3DYates%26aufirst%3DE.%26aulast%3DMazzon%26aufirst%3DM.%26aulast%3DKilpatrick%26aufirst%3DB.%2BS.%26aulast%3DMuallem%26aufirst%3DS.%26aulast%3DMarsh%26aufirst%3DM.%26aulast%3DRahman%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DS.%26atitle%3DMining%2520of%2520Ebola%2520virus%2520entry%2520inhibitors%2520identifies%2520approved%2520drugs%2520as%2520two-pore%2520channel%2520pore%2520blockers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2019%26volume%3D1866%26issue%3D7%26spage%3D1151%26epage%3D1161%26doi%3D10.1016%2Fj.bbamcr.2018.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Coronavirus infections and immune responses</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1002/jmv.25685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fjmv.25685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31981224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntVKntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2020&pages=424-432&issue=4&author=G.+Liauthor=Y.+Fanauthor=Y.+Laiauthor=T.+Hanauthor=Z.+Liauthor=P.+Zhouauthor=P.+Panauthor=W.+Wangauthor=D.+Huauthor=X.+Liuauthor=Q.+Zhangauthor=J.+Wu&title=Coronavirus+infections+and+immune+responses&doi=10.1002%2Fjmv.25685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Coronavirus infections and immune responses</span></div><div class="casAuthors">Li, Geng; Fan, Yaohua; Lai, Yanni; Han, Tiantian; Li, Zonghui; Zhou, Peiwen; Pan, Pan; Wang, Wenbiao; Hu, Dingwen; Liu, Xiaohong; Zhang, Qiwei; Wu, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Virology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">424-432</span>CODEN:
                <span class="NLM_cas:coden">JMVIDB</span>;
        ISSN:<span class="NLM_cas:issn">0146-6615</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Coronaviruses (CoVs) are by far the largest group of known pos.-sense RNA viruses having an extensive range of natural hosts.  In the past few decades, newly evolved Coronaviruses have posed a global threat to public health.  The immune response is essential to control and eliminate CoV infections, however, maladjusted immune responses may result in immunopathol. and impaired pulmonary gas exchange.  Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs.  In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clin. treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV2qgbg4xqk7Vg90H21EOLACvtfcHk0lg92Zam9b7NHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntVKntr4%253D&md5=f2de904af37ab888695f51c9b9222ac0</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1002%2Fjmv.25685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.25685%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DPan%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DCoronavirus%2520infections%2520and%2520immune%2520responses%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2020%26volume%3D92%26issue%3D4%26spage%3D424%26epage%3D432%26doi%3D10.1002%2Fjmv.25685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. X.</span></span> <span> </span><span class="NLM_article-title">Human coronaviruses: A review of virus-host interactions</span>. <i>Diseases</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">26</span>, <span class="refDoi"> DOI: 10.3390/diseases4030026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fdiseases4030026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXms1Ortbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=26&issue=3&author=Y.+X.+Limauthor=Y.+L.+Ngauthor=J.+P.+Tamauthor=D.+X.+Liu&title=Human+coronaviruses%3A+A+review+of+virus-host+interactions&doi=10.3390%2Fdiseases4030026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Human coronaviruses: a review of virus-host interactions</span></div><div class="casAuthors">Lim, Yvonne Xinyi; Ng, Yan Ling; Tam, James P.; Liu, Ding Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">26/1-26/28</span>CODEN:
                <span class="NLM_cas:coden">DISECP</span>;
        ISSN:<span class="NLM_cas:issn">2079-9721</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Human coronaviruses (HCoVs) are known respiratory pathogens assocd. with a range of respiratory outcomes.  In the past 14 years, the onset of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) have thrust HCoVs into spotlight of the research community due to their high pathogenicity in humans.  The study of HCoV-host interactions has contributed extensively to our understanding of HCoV pathogenesis.  In this review, we discuss some of the recent findings of host cell factors that might be exploited by HCoVs to facilitate their own replication cycle.  We also discuss various cellular processes, such as apoptosis, innate immunity, ER stress response, mitogen-activated protein kinase (MAPK) pathway and nuclear factor kappa B (NF-B) pathway that may be modulated by HCoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEr8IbYfvpAbVg90H21EOLACvtfcHk0lgWSkxcv1UgyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXms1Ortbw%253D&md5=5c4c7595bb32f559621c152afe43c153</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.3390%2Fdiseases4030026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fdiseases4030026%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DY.%2BX.%26aulast%3DNg%26aufirst%3DY.%2BL.%26aulast%3DTam%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DD.%2BX.%26atitle%3DHuman%2520coronaviruses%253A%2520A%2520review%2520of%2520virus-host%2520interactions%26jtitle%3DDiseases%26date%3D2016%26volume%3D4%26issue%3D3%26spage%3D26%26doi%3D10.3390%2Fdiseases4030026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, G.</span></span> <span> </span><span class="NLM_article-title">Virology, epidemiology, pathogenesis, and control of COVID-19</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">E372</span>, <span class="refDoi"> DOI: 10.3390/v12040372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv12040372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32230900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1SjtL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=E372&issue=4&author=Y.+Jinauthor=H.+Yangauthor=W.+Jiauthor=W.+Wuauthor=S.+Chenauthor=W.+Zhangauthor=G.+Duan&title=Virology%2C+epidemiology%2C+pathogenesis%2C+and+control+of+COVID-19&doi=10.3390%2Fv12040372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Virology, epidemiology, pathogenesis, and control of COVID-19</span></div><div class="casAuthors">Jin, Yuefei; Yang, Haiyan; Ji, Wangquan; Wu, Weidong; Chen, Shuaiyin; Zhang, Weiguo; Duan, Guangcai</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020.  Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~ 2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiol. and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection.  As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health.  To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvPIi9IdgAu7Vg90H21EOLACvtfcHk0lgWSkxcv1UgyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1SjtL7J&md5=c0d8fb7964b01cf9c52bab3869f36e74</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.3390%2Fv12040372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv12040372%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDuan%26aufirst%3DG.%26atitle%3DVirology%252C%2520epidemiology%252C%2520pathogenesis%252C%2520and%2520control%2520of%2520COVID-19%26jtitle%3DViruses%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3DE372%26doi%3D10.3390%2Fv12040372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prompetchara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketloy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palaga, T.</span></span> <span> </span><span class="NLM_article-title">Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic</span>. <i>Asian Pac. J. Allergy Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">0772</span>, <span class="refDoi"> DOI: 10.12932/AP-200220-0772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.12932%2FAP-200220-0772" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=0772&issue=1&author=E.+Prompetcharaauthor=C.+Ketloyauthor=T.+Palaga&title=Immune+responses+in+COVID-19+and+potential+vaccines%3A+Lessons+learned+from+SARS+and+MERS+epidemic&doi=10.12932%2FAP-200220-0772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.12932%2FAP-200220-0772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12932%252FAP-200220-0772%26sid%3Dliteratum%253Aachs%26aulast%3DPrompetchara%26aufirst%3DE.%26aulast%3DKetloy%26aufirst%3DC.%26aulast%3DPalaga%26aufirst%3DT.%26atitle%3DImmune%2520responses%2520in%2520COVID-19%2520and%2520potential%2520vaccines%253A%2520Lessons%2520learned%2520from%2520SARS%2520and%2520MERS%2520epidemic%26jtitle%3DAsian%2520Pac.%2520J.%2520Allergy%2520Immunol.%26date%3D2020%26volume%3D38%26issue%3D1%26spage%3D0772%26doi%3D10.12932%2FAP-200220-0772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Melo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson-Payant, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoagland, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Møller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">tenOever, B. R.</span></span> <span> </span><span class="NLM_article-title">Imbalanced host response to SARS-CoV-2 drives development of COVID-19</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1036</span>– <span class="NLM_lpage">1045</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cell.2020.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32416070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXps1yjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=1036-1045&issue=5&author=D.+Blanco-Meloauthor=B.+E.+Nilsson-Payantauthor=W.-C.+Liuauthor=S.+Uhlauthor=D.+Hoaglandauthor=R.+M%C3%B8llerauthor=T.+X.+Jordanauthor=K.+Oishiauthor=M.+Panisauthor=D.+Sachsauthor=T.+T.+Wangauthor=R.+E.+Schwartzauthor=J.+K.+Limauthor=R.+A.+Albrechtauthor=B.+R.+tenOever&title=Imbalanced+host+response+to+SARS-CoV-2+drives+development+of+COVID-19&doi=10.1016%2Fj.cell.2020.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19</span></div><div class="casAuthors">Blanco-Melo, Daniel; Nilsson-Payant, Benjamin E.; Liu, Wen-Chun; Uhl, Skyler; Hoagland, Daisy; Moeller, Rasmus; Jordan, Tristan X.; Oishi, Kohei; Panis, Maryline; Sachs, David; Wang, Taia T.; Schwartz, Robert E.; Lim, Jean K.; Albrecht, Randy A.; tenOever, Benjamin R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1036-1045.e9</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity.  Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection.  Here we offer an in-depth anal. of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses.  Cell and animal models of SARS-CoV-2 infection, in addn. to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.  This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6.  We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine prodn. are the defining and driving features of COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMWwpoPQkdl7Vg90H21EOLACvtfcHk0lgWSkxcv1UgyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXps1yjtrk%253D&md5=cd1c1b429265a563ec1625972e3b07f7</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco-Melo%26aufirst%3DD.%26aulast%3DNilsson-Payant%26aufirst%3DB.%2BE.%26aulast%3DLiu%26aufirst%3DW.-C.%26aulast%3DUhl%26aufirst%3DS.%26aulast%3DHoagland%26aufirst%3DD.%26aulast%3DM%25C3%25B8ller%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DT.%2BX.%26aulast%3DOishi%26aufirst%3DK.%26aulast%3DPanis%26aufirst%3DM.%26aulast%3DSachs%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%2BT.%26aulast%3DSchwartz%26aufirst%3DR.%2BE.%26aulast%3DLim%26aufirst%3DJ.%2BK.%26aulast%3DAlbrecht%26aufirst%3DR.%2BA.%26aulast%3DtenOever%26aufirst%3DB.%2BR.%26atitle%3DImbalanced%2520host%2520response%2520to%2520SARS-CoV-2%2520drives%2520development%2520of%2520COVID-19%26jtitle%3DCell%26date%3D2020%26volume%3D181%26issue%3D5%26spage%3D1036%26epage%3D1045%26doi%3D10.1016%2Fj.cell.2020.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sia, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiris, J. S.</span></span> <span> </span><span class="NLM_article-title">Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">7819</span>– <span class="NLM_lpage">7826</span>, <span class="refDoi"> DOI: 10.1128/JVI.79.12.7819-7826.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.79.12.7819-7826.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15919935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=7819-7826&issue=12&author=C.+Y.+Cheungauthor=L.+L.+Poonauthor=I.+H.+Ngauthor=W.+Lukauthor=S.+F.+Siaauthor=M.+H.+Wuauthor=K.+H.+Chanauthor=K.+Y.+Yuenauthor=S.+Gordonauthor=Y.+Guanauthor=J.+S.+Peiris&title=Cytokine+responses+in+severe+acute+respiratory+syndrome+coronavirus-infected+macrophages+in+vitro%3A+possible+relevance+to+pathogenesis&doi=10.1128%2FJVI.79.12.7819-7826.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: Possible relevance to pathogenesis</span></div><div class="casAuthors">Cheung, Chung Y.; Poon, Leo L. M.; Ng, Iris H. Y.; Luk, Winsie; Sia, Sin-Fun; Wu, Mavis H. S.; Chan, Kwok-Hung; Yuen, Kwok-Yung; Gordon, Siamon; Guan, Yi; Peiris, Joseph S. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7819-7826</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The pathogenesis of severe acute respiratory syndrome (SARS) remains unclear.  Macrophages are key sentinel cells in the respiratory system, and it is therefore relevant to compare the responses of human macrophages to infections with the SARS coronavirus (SARS-CoV) and other respiratory viruses.  Primary human monocyte-derived macrophages were infected with SARS-CoV in vitro.  Virus replication was monitored by measuring the levels of pos.- and neg.-strand RNA, by immunofluorescence detection of the SARS-CoV nucleoprotein, and by titrn. of the infectious virus.  The gene expression profiles of macrophages infected with SARS-CoV, human coronavirus 229E, and influenza A (H1N1) virus were compared by using microarrays and real-time quant. reverse transcriptase PCR.  Secreted cytokines were measured with an ELISA.  SARS-CoV initiated viral gene transcription and protein synthesis in macrophages, but replication was abortive and no infectious virus was produced.  In contrast to the case with human coronavirus 229E and influenza A virus, there was little or no induction of beta interferon (IFN-β) in SARS-CoV-infected macrophages.  Furthermore, SARS-CoV induced the expression of chemokines such as CXCL10/IFN-γ-inducible protein 10 and CCL2/monocyte chemotactic protein 1.  The poor induction of IFN-β, a key component of innate immunity, and the ability of the virus to induce chemokines could explain aspects of the pathogenesis of SARS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCZlR8OL6YkrVg90H21EOLACvtfcHk0lj-e2P-AYCwqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFCmsbs%253D&md5=b6a5095ca2f10e6b42ab4bd30127a62e</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.12.7819-7826.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.12.7819-7826.2005%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DC.%2BY.%26aulast%3DPoon%26aufirst%3DL.%2BL.%26aulast%3DNg%26aufirst%3DI.%2BH.%26aulast%3DLuk%26aufirst%3DW.%26aulast%3DSia%26aufirst%3DS.%2BF.%26aulast%3DWu%26aufirst%3DM.%2BH.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26aulast%3DGordon%26aufirst%3DS.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DPeiris%26aufirst%3DJ.%2BS.%26atitle%3DCytokine%2520responses%2520in%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus-infected%2520macrophages%2520in%2520vitro%253A%2520possible%2520relevance%2520to%2520pathogenesis%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26issue%3D12%26spage%3D7819%26epage%3D7826%26doi%3D10.1128%2FJVI.79.12.7819-7826.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heise, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R.</span></span> <span> </span><span class="NLM_article-title">SARS coronavirus and innate immunity</span>. <i>Virus Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.virusres.2007.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virusres.2007.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=17451827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlWksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2008&pages=101-112&issue=1&author=M.+Friemanauthor=M.+Heiseauthor=R.+Baric&title=SARS+coronavirus+and+innate+immunity&doi=10.1016%2Fj.virusres.2007.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">SARS coronavirus and innate immunity</span></div><div class="casAuthors">Frieman, Matthew; Heise, Mark; Baric, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Virus Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">VIREDF</span>;
        ISSN:<span class="NLM_cas:issn">0168-1702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The emergence of the highly pathogenic SARS coronavirus (SARS-CoV) has re-ignited interest in coronavirus biol. and pathogenesis.  An emerging theme in coronavirus pathogenesis is that the interaction between specific viral genes and the host immune system, specifically the innate immune system, functions as a key determinant in regulating virulence and disease outcomes.  Using SARS-CoV as a model, the authors will review the current knowledge of the interplay between coronavirus infection and the host innate immune system in vivo, and then discuss the mechanisms by which specific gene products antagonize the host innate immune response in cell culture models.  The data suggests that the SARS-CoV uses specific strategies to evade and antagonize the sensing and signaling arms of the interferon pathway.  The authors summarize by identifying future points of consideration that will contribute greatly to understanding of the mol. mechanisms governing coronavirus pathogenesis and virulence, and the development of severe disease in humans and animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUGUtu2pZpfbVg90H21EOLACvtfcHk0lj-e2P-AYCwqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlWksLo%253D&md5=1088f342138eb126db5681a516e6fd36</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.virusres.2007.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virusres.2007.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DFrieman%26aufirst%3DM.%26aulast%3DHeise%26aufirst%3DM.%26aulast%3DBaric%26aufirst%3DR.%26atitle%3DSARS%2520coronavirus%2520and%2520innate%2520immunity%26jtitle%3DVirus%2520Res.%26date%3D2008%26volume%3D133%26issue%3D1%26spage%3D101%26epage%3D112%26doi%3D10.1016%2Fj.virusres.2007.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Randall, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodbourn, S.</span></span> <span> </span><span class="NLM_article-title">Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1099/vir.0.83391-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.83391-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18089727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Wiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2008&pages=1-47&issue=1&author=R.+E.+Randallauthor=S.+Goodbourn&title=Interferons+and+viruses%3A+an+interplay+between+induction%2C+signalling%2C+antiviral+responses+and+virus+countermeasures&doi=10.1099%2Fvir.0.83391-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures</span></div><div class="casAuthors">Randall, Richard E.; Goodbourn, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-47</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review.  The interferon (IFN) system is an extremely powerful antiviral response that is capable of controlling most, if not all, virus infections in the absence of adaptive immunity.  However, viruses can still replicate and cause disease in vivo, because they have some strategy for at least partially circumventing the IFN response.  We reviewed this topic in 2000 but, since then, a great deal has been discovered about the mol. mechanisms of the IFN response and how different viruses circumvent it.  This information is of fundamental interest, but may also have practical application in the design and manuf. of attenuated virus vaccines and the development of novel antiviral drugs.  In the first part of this review, we describe how viruses activate the IFN system, how IFNs induce transcription of their target genes and the mechanism of action of IFN-induced proteins with antiviral action.  In the second part, we describe how viruses circumvent the IFN response.  Here, we reflect upon possible consequences for both the virus and host of the different strategies that viruses have evolved and discuss whether certain viruses have exploited the IFN response to modulate their life cycle (e.g. to establish and maintain persistent/latent infections), whether perturbation of the IFN response by persistent infections can lead to chronic disease, and the importance of the IFN system as a species barrier to virus infections.  Lastly, we briefly describe applied aspects that arise from an increase in our knowledge in this area, including vaccine design and manuf., the development of novel antiviral drugs and the use of IFN-sensitive oncolytic viruses in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKY95HYaAoirVg90H21EOLACvtfcHk0lj-e2P-AYCwqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Wiug%253D%253D&md5=14603d812131ca5552562623bcbf8811</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.83391-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.83391-0%26sid%3Dliteratum%253Aachs%26aulast%3DRandall%26aufirst%3DR.%2BE.%26aulast%3DGoodbourn%26aufirst%3DS.%26atitle%3DInterferons%2520and%2520viruses%253A%2520an%2520interplay%2520between%2520induction%252C%2520signalling%252C%2520antiviral%2520responses%2520and%2520virus%2520countermeasures%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2008%26volume%3D89%26issue%3D1%26spage%3D1%26epage%3D47%26doi%3D10.1099%2Fvir.0.83391-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kok, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D. Y.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">16202</span>– <span class="NLM_lpage">16209</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.008227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M109.008227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19380580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFSjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16202-16209&issue=24&author=K.+L.+Siuauthor=K.+H.+Kokauthor=M.+H.+Ngauthor=V.+K.+Poonauthor=K.+Y.+Yuenauthor=B.+J.+Zhengauthor=D.+Y.+Jin&title=Severe+acute+respiratory+syndrome+coronavirus+M+protein+inhibits+type+I+interferon+production+by+impeding+the+formation+of+TRAF3.TANK.TBK1%2FIKKepsilon+complex&doi=10.1074%2Fjbc.M109.008227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKε Complex</span></div><div class="casAuthors">Siu, Kam-Leung; Kok, Kin-Hang; Ng, Ming-Him James; Poon, Vincent K. M.; Yuen, Kwok-Yung; Zheng, Bo-Jian; Jin, Dong-Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">16202-16209</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome (SARS) coronavirus is highly pathogenic in humans and evades innate immunity at multiple levels.  It has evolved various strategies to counteract the prodn. and action of type I interferons, which mobilize the front-line defense against viral infection.  Here, the authors demonstrate that SARS coronavirus M protein inhibits gene transcription of type I interferons.  M protein potently antagonizes the activation of interferon-stimulated response element-dependent transcription by double-stranded RNA, RIG-I, MDA5, TBK1, IKKε, and virus-induced signaling adaptor (VISA) but has no influence on the transcriptional activity of this element when IRF3 or IRF7 is overexpressed.  M protein phys. assocs. with RIG-I, TBK1, IKKε, and TRAF3 and likely sequesters some of them in membrane-assocd. cytoplasmic compartments.  Consequently, the expression of M protein prevents the formation of TRAF3·TANK·TBK1/IKKε complex and thereby inhibits TBK1/IKKε-dependent activation of IRF3/IRF7 transcription factors.  The authors' findings thus reveal a new mechanism by which SARS coronavirus circumvents the prodn. of type I interferons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEmqnN6kjIbVg90H21EOLACvtfcHk0lhRiyygPy4PSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFSjtr8%253D&md5=c6510323dd5985b014ee72808d8a44db</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.008227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.008227%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DK.%2BL.%26aulast%3DKok%26aufirst%3DK.%2BH.%26aulast%3DNg%26aufirst%3DM.%2BH.%26aulast%3DPoon%26aufirst%3DV.%2BK.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26aulast%3DZheng%26aufirst%3DB.%2BJ.%26aulast%3DJin%26aufirst%3DD.%2BY.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520M%2520protein%2520inhibits%2520type%2520I%2520interferon%2520production%2520by%2520impeding%2520the%2520formation%2520of%2520TRAF3.TANK.TBK1%252FIKKepsilon%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26issue%3D24%26spage%3D16202%26epage%3D16209%26doi%3D10.1074%2Fjbc.M109.008227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span> <span> </span><span class="NLM_article-title">The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists</span>. <i>Protein Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">951</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1007/s13238-013-3096-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs13238-013-3096-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24318862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKgtbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=951-961&issue=12&author=Y.+Yangauthor=L.+Zhangauthor=H.+Gengauthor=Y.+Dengauthor=B.+Huangauthor=Y.+Guoauthor=Z.+Zhaoauthor=W.+Tan&title=The+structural+and+accessory+proteins+M%2C+ORF+4a%2C+ORF+4b%2C+and+ORF+5+of+Middle+East+respiratory+syndrome+coronavirus+%28MERS-CoV%29+are+potent+interferon+antagonists&doi=10.1007%2Fs13238-013-3096-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists</span></div><div class="casAuthors">Yang, Yang; Zhang, Ling; Geng, Heyuan; Deng, Yao; Huang, Baoying; Guo, Yin; Zhao, Zhengdong; Tan, Wenjie</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">951-961</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic respiratory virus with pathogenic mechanisms that may be driven by innate immune pathways.  The goal of this study is to characterize the expression of the structural (S, E, M, N) and accessory (ORF 3, ORF 4a, ORF 4b, ORF 5) proteins of MERS-CoV and to det. whether any of these proteins acts as an interferon antagonist.  Individual structural and accessory protein-coding plasmids with an N-terminal HA tag were constructed and transiently transfected into cells, and their native expression and subcellular localization were assessed using Wes tern blotting and indirect immunofluorescence.  While ORF 4b demonstrated majorly nuclear localization, all of the other proteins demonstrated cytoplasmic localization.  In addn., for the first time, our expts. revealed that the M, ORF 4a, ORF 4b, and ORF 5 proteins are potent interferon antagonists.  Further examn. revealed that the ORF 4a protein of MERS-CoV has the most potential to counteract the antiviral effects of IFN via the inhibition of both the interferon prodn. (IFN-β promoter activity, IRF-3/7 and NF-κB activation) and ISRE promoter element signaling pathways.  Together, our results provide new insights into the function and pathogenic role of the structural and accessory proteins of MERS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvWEJgFShHYLVg90H21EOLACvtfcHk0lhRiyygPy4PSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKgtbjN&md5=4ba698ca16113333a8f6a65813bbe95c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1007%2Fs13238-013-3096-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-013-3096-8%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DW.%26atitle%3DThe%2520structural%2520and%2520accessory%2520proteins%2520M%252C%2520ORF%25204a%252C%2520ORF%25204b%252C%2520and%2520ORF%25205%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520%2528MERS-CoV%2529%2520are%2520potent%2520interferon%2520antagonists%26jtitle%3DProtein%2520Cell%26date%3D2013%26volume%3D4%26issue%3D12%26spage%3D951%26epage%3D961%26doi%3D10.1007%2Fs13238-013-3096-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopecky-Bromberg, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Sobrido, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palese, P.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">557</span>, <span class="refDoi"> DOI: 10.1128/JVI.01782-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.01782-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=17108024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1ShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=548-557&issue=2&author=S.+A.+Kopecky-Brombergauthor=L.+Martinez-Sobridoauthor=M.+Friemanauthor=R.+A.+Baricauthor=P.+Palese&title=Severe+acute+respiratory+syndrome+coronavirus+open+reading+frame+%28ORF%29+3b%2C+ORF+6%2C+and+nucleocapsid+proteins+function+as+interferon+antagonists&doi=10.1128%2FJVI.01782-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists</span></div><div class="casAuthors">Kopecky-Bromberg, Sarah A.; Martinez-Sobrido, Luis; Frieman, Matthew; Baric, Ralph A.; Palese, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">548-557</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The severe acute respiratory syndrome coronavirus (SARS-CoV) is highly pathogenic in humans, with a death rate near 10%.  This high pathogenicity suggests that SARS-CoV has developed mechanisms to overcome the host innate immune response.  It has now been detd. that SARS-CoV open reading frame (ORF) 3b, ORF 6, and N proteins antagonize interferon, a key component of the innate immune response.  All 3 proteins inhibit the expression of β interferon (IFN-β), and further examn. revealed that these SARS-CoV proteins inhibit a key protein necessary for the expression of IFN-β, IRF-3.  N protein dramatically inhibited expression of an NF-κB-responsive promoter.  All 3 proteins were able to inhibit expression of an interferon-stimulated response element (ISRE) promoter after infection with Sendai virus, while only ORF 3b and ORF 6 proteins were able to inhibit expression of the ISRE promoter after treatment with interferon.  This indicates that N protein inhibits only the synthesis of interferon, while ORF 3b and ORF 6 proteins inhibit both interferon synthesis and signaling.  ORF 6 protein, but not ORF 3b or N protein, inhibited nuclear translocation but not phosphorylation of STAT1.  Thus, these 3 interferon antagonists of SARS-CoV inhibit the interferon response by different mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOBL2P61aFJbVg90H21EOLACvtfcHk0lhRiyygPy4PSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1ShtA%253D%253D&md5=44d12f784cd5c9ded5cb51686394ad95</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1128%2FJVI.01782-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01782-06%26sid%3Dliteratum%253Aachs%26aulast%3DKopecky-Bromberg%26aufirst%3DS.%2BA.%26aulast%3DMartinez-Sobrido%26aufirst%3DL.%26aulast%3DFrieman%26aufirst%3DM.%26aulast%3DBaric%26aufirst%3DR.%2BA.%26aulast%3DPalese%26aufirst%3DP.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520open%2520reading%2520frame%2520%2528ORF%2529%25203b%252C%2520ORF%25206%252C%2520and%2520nucleocapsid%2520proteins%2520function%2520as%2520interferon%2520antagonists%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26issue%3D2%26spage%3D548%26epage%3D557%26doi%3D10.1128%2FJVI.01782-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism</span>. <i>Virus Genes</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1007/s11262-010-0544-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs11262-010-0544-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=20976535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFartbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2011&pages=37-45&issue=1&author=X.+Luauthor=J.+Panauthor=J.+Taoauthor=D.+Guo&title=SARS-CoV+nucleocapsid+protein+antagonizes+IFN-beta+response+by+targeting+initial+step+of+IFN-beta+induction+pathway%2C+and+its+C-terminal+region+is+critical+for+the+antagonism&doi=10.1007%2Fs11262-010-0544-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism</span></div><div class="casAuthors">Lu, Xiaolu; Pan, Ji'an; Tao, Jiali; Guo, Deyin</div><div class="citationInfo"><span class="NLM_cas:title">Virus Genes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-45</span>CODEN:
                <span class="NLM_cas:coden">VIGEET</span>;
        ISSN:<span class="NLM_cas:issn">0920-8569</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) encodes a highly basic nucleocapsid (N) protein which can inhibit the synthesis of type I interferon (IFN), but the mol. mechanism of this antagonism remains to be identified.  In this study, we demonstrated that the N protein of SARS-CoV could inhibit IFN-beta (IFN-β) induced by poly(I:C) or Sendai virus.  However, we found that N protein could not inhibit IFN-β prodn. induced by overexpression of downstream signaling mols. of two important IFN-β induction pathways, toll-like receptor 3 (TLR3)- and RIG-I-like receptors (RLR)-dependent pathways.  These results indicate that SARS-CoV N protein targets the initial step, probably the cellular PRRs (pattern recognition receptors)-RNAs-recognition step in the innate immune pathways, to suppress IFN expression responses.  In addn., co-immunopptn. assays revealed that N protein did not interact with RIG-I or MDA5.  Further, an assay using truncated mutants revealed that the C-terminal domain of N protein was crit. for its antagonism of IFN induction, and the N deletion mutant impaired for RNA-binding almost completely lost the IFN-β antagonist activity.  These results contribute to our further understanding of the pathogenesis of SARS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwPrJTNDUxy7Vg90H21EOLACvtfcHk0lgCoY6o-J4FxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFartbk%253D&md5=e5d3ecff3da8a58183e8819dea18c793</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1007%2Fs11262-010-0544-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11262-010-0544-x%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DSARS-CoV%2520nucleocapsid%2520protein%2520antagonizes%2520IFN-beta%2520response%2520by%2520targeting%2520initial%2520step%2520of%2520IFN-beta%2520induction%2520pathway%252C%2520and%2520its%2520C-terminal%2520region%2520is%2520critical%2520for%2520the%2520antagonism%26jtitle%3DVirus%2520Genes%26date%3D2011%26volume%3D42%26issue%3D1%26spage%3D37%26epage%3D45%26doi%3D10.1007%2Fs11262-010-0544-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span> <span> </span><span class="NLM_article-title">The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I Interferon production by interfering with TRIM25-mediated RIG-I ubiquitination</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">8</span>), <span class="NLM_elocation-id">e02143-16</span> <span class="refDoi"> DOI: 10.1128/JVI.02143-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.02143-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28148787" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&issue=8&author=Y.+Huauthor=W.+Liauthor=T.+Gaoauthor=Y.+Cuiauthor=Y.+Jinauthor=P.+Liauthor=Q.+Maauthor=X.+Liuauthor=C.+Cao&title=The+severe+acute+respiratory+syndrome+coronavirus+nucleocapsid+inhibits+type+I+Interferon+production+by+interfering+with+TRIM25-mediated+RIG-I+ubiquitination&doi=10.1128%2FJVI.02143-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1128%2FJVI.02143-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02143-16%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DC.%26atitle%3DThe%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520nucleocapsid%2520inhibits%2520type%2520I%2520Interferon%2520production%2520by%2520interfering%2520with%2520TRIM25-mediated%2520RIG-I%2520ubiquitination%26jtitle%3DJ.%2520Virol.%26date%3D2017%26volume%3D91%26issue%3D8%26doi%3D10.1128%2FJVI.02143-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dosch, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. R.</span></span> <span> </span><span class="NLM_article-title">SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro</span>. <i>Virus Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.virusres.2009.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virusres.2009.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19185596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlKqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2009&pages=19-27&issue=1%E2%80%932&author=S.+F.+Doschauthor=S.+D.+Mahajanauthor=A.+R.+Collins&title=SARS+coronavirus+spike+protein-induced+innate+immune+response+occurs+via+activation+of+the+NF-kappaB+pathway+in+human+monocyte+macrophages+in+vitro&doi=10.1016%2Fj.virusres.2009.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro</span></div><div class="casAuthors">Dosch, Susan F.; Mahajan, Supriya D.; Collins, Arlene R.</div><div class="citationInfo"><span class="NLM_cas:title">Virus Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">19-27</span>CODEN:
                <span class="NLM_cas:coden">VIREDF</span>;
        ISSN:<span class="NLM_cas:issn">0168-1702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A purified recombinant spike (S) protein was studied for its effect on stimulating human peripheral blood monocyte macrophages (PBMC).  The authors examd. inflammatory gene mRNA levels found in S protein-treated PBMC using gene arrays.  They identified differential mRNA levels of genes with functional properties assocd. with antiviral (CXCL10) and inflammatory (IL-6 and IL-8) responses.  They confirmed cytokine mRNA increases by real-time quant. RT-PCR or ELISA.  They further analyzed the sensitivity and specificity of the prominent IL-8 response.  By real-time qRT-PCR, S protein was shown to stimulate IL-8 mRNA accumulation in a dose dependent manner while treatment with E protein did not.  Also, titrn. of S protein-specific prodn. and secretion of IL-8 by ELISA showed that the dose of 5.6 nM of S produced an increase in IL-8 compared to mock-treated controls.  The increase in IL-8 stimulated by a concn. of 5.6 nM of S was comparable to concns. seen for S protein binding to ACE2 or to neutralizing monoclonal antibody suggesting a physiol. relevance.  An NF-κB inhibitor, TPCK (N-tosyl-L-phenylalanine chloromethyl ketone) could suppress IL-8 prodn. and secretion in response to S protein in PBMC and THP-1 cells and in HCoV-229E virus-infected PBMC.  Activation and translocation of NF-κB was shown to occur rapidly following exposure of PBMC or THP-1 cells to S protein using a highly sensitive assay for active nuclear NF-κB p65 transcription factor.  The results further suggested that released or secreted S protein could activate blood monocytes via recognition by toll-like receptor (TLR)2 ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHsbRwdZ_Dx7Vg90H21EOLACvtfcHk0lgCoY6o-J4FxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlKqtbw%253D&md5=8ea269e400b3922901ba05eca8787689</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.virusres.2009.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virusres.2009.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DDosch%26aufirst%3DS.%2BF.%26aulast%3DMahajan%26aufirst%3DS.%2BD.%26aulast%3DCollins%26aufirst%3DA.%2BR.%26atitle%3DSARS%2520coronavirus%2520spike%2520protein-induced%2520innate%2520immune%2520response%2520occurs%2520via%2520activation%2520of%2520the%2520NF-kappaB%2520pathway%2520in%2520human%2520monocyte%2520macrophages%2520in%2520vitro%26jtitle%3DVirus%2520Res.%26date%3D2009%26volume%3D142%26issue%3D1%25E2%2580%25932%26spage%3D19%26epage%3D27%26doi%3D10.1016%2Fj.virusres.2009.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieto-Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdia-Baguena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Guardeno, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regla-Nava, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castano-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Delgado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilella, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2015.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2015.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26331680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyls7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2015&pages=330-339&author=J.+L.+Nieto-Torresauthor=C.+Verdia-Baguenaauthor=J.+M.+Jimenez-Guardenoauthor=J.+A.+Regla-Navaauthor=C.+Castano-Rodriguezauthor=R.+Fernandez-Delgadoauthor=J.+Torresauthor=V.+M.+Aguilellaauthor=L.+Enjuanes&title=Severe+acute+respiratory+syndrome+coronavirus+E+protein+transports+calcium+ions+and+activates+the+NLRP3+inflammasome&doi=10.1016%2Fj.virol.2015.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome</span></div><div class="casAuthors">Nieto-Torres, Jose L.; Verdia-Baguena, Carmina; Jimenez-Guardeno, Jose M.; Regla-Nava, Jose A.; Castano-Rodriguez, Carlos; Fernandez-Delgado, Raul; Torres, Jaume; Aguilella, Vicente M.; Enjuanes, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">330-339</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) envelope (E) protein is a viroporin involved in virulence.  E protein ion channel (IC) activity is specifically correlated with enhanced pulmonary damage, edema accumulation and death.  IL-1β driven proinflammation is assocd. with those pathol. signatures, however its link to IC activity remains unknown.  In this report, we demonstrate that SARS-CoV E protein forms protein-lipid channels in ERGIC/Golgi membranes that are permeable to calcium ions, a highly relevant feature never reported before.  Calcium ions together with pH modulated E protein pore charge and selectivity.  Interestingly, E protein IC activity boosted the activation of the NLRP3 inflammasome, leading to IL-1β overprodn.  Calcium transport through the E protein IC was the main trigger of this process.  These findings strikingly link SARS-CoV E protein IC induced ionic disturbances at the cell level to immunopathol. consequences and disease worsening in the infected organism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF2C4rAutetbVg90H21EOLACvtfcHk0lgCoY6o-J4FxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyls7fP&md5=27d428b5b025c92e4c62721935903fd3</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2015.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2015.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DNieto-Torres%26aufirst%3DJ.%2BL.%26aulast%3DVerdia-Baguena%26aufirst%3DC.%26aulast%3DJimenez-Guardeno%26aufirst%3DJ.%2BM.%26aulast%3DRegla-Nava%26aufirst%3DJ.%2BA.%26aulast%3DCastano-Rodriguez%26aufirst%3DC.%26aulast%3DFernandez-Delgado%26aufirst%3DR.%26aulast%3DTorres%26aufirst%3DJ.%26aulast%3DAguilella%26aufirst%3DV.%2BM.%26aulast%3DEnjuanes%26aufirst%3DL.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520E%2520protein%2520transports%2520calcium%2520ions%2520and%2520activates%2520the%2520NLRP3%2520inflammasome%26jtitle%3DVirology%26date%3D2015%26volume%3D485%26spage%3D330%26epage%3D339%26doi%3D10.1016%2Fj.virol.2015.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ru, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span> <span> </span><span class="NLM_article-title">G3BP1 inhibits RNA virus replication by positively regulating RIG-I-mediated cellular antiviral response</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">946</span>, <span class="refDoi"> DOI: 10.1038/s41419-019-2178-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41419-019-2178-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31827077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVykurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=946&issue=12&author=W.+Yangauthor=Y.+Ruauthor=J.+Renauthor=J.+Baiauthor=J.+Weiauthor=S.+Fuauthor=X.+Liuauthor=D.+Liauthor=H.+Zheng&title=G3BP1+inhibits+RNA+virus+replication+by+positively+regulating+RIG-I-mediated+cellular+antiviral+response&doi=10.1038%2Fs41419-019-2178-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">G3BP1 inhibits RNA virus replication by positively regulating RIG-I-mediated cellular antiviral response</span></div><div class="casAuthors">Yang, Wenping; Ru, Yi; Ren, Jingjing; Bai, Juncui; Wei, Junshu; Fu, Shaozu; Liu, Xiangtao; Li, Dan; Zheng, Haixue</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">946</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Retinoic acid-inducible gene I (RIG-I) is a pattern recognition receptor and is involved in the innate immune response against RNA viruses infection.  Here, we demonstrate that the Ras-GTPase-activating protein SH3-domain-binding protein 1 (G3BP1) serves as a pos. regulator of the RIG-I-mediated signaling pathway.  G3BP1-deficient cells inhibited RNA virus-triggered induction of downstream antiviral genes.  Furthermore, we found that G3BP1 inhibited the replication of Sendai virus and vesicular stomatitis virus, indicating a pos. regulation of G3BP1 to cellular antiviral responses.  Mechanistically, G3BP1 formed a complex with RNF125 and RIG-I, leading to decreased RNF125 via its auto-ubiquitination; thus, promoting expression of RIG-I.  Overall, the results suggest a novel mechanism for G3BP1 in the pos. regulation of antiviral signaling mediated by RIG-I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8P89UWLRK0LVg90H21EOLACvtfcHk0lhoVx3L5RwFzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVykurzI&md5=78d2007816d4c146c595ad6b0f462384</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-2178-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-2178-9%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DRu%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DG3BP1%2520inhibits%2520RNA%2520virus%2520replication%2520by%2520positively%2520regulating%2520RIG-I-mediated%2520cellular%2520antiviral%2520response%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26issue%3D12%26spage%3D946%26doi%3D10.1038%2Fs41419-019-2178-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhaddou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obernier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezelj, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huettenhain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaake, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutuncuoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foussard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polacco, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabius, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucheray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cakir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Kain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miorin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, Z. Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorba, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrio-Hernandez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Armenta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathy, C. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perica, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilla, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltzberg, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calviello, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataramanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liboy-Lugo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wankowicz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugur, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savar, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shengjuler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neal, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadhurst, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klippsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzuoglu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavero, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiatt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathore, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verba, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agard, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Enfert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ideker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floor, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortemme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltrao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Sastre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogan, N. J.</span></span> <span> </span><span class="NLM_article-title">A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2286-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2286-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32353859" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=D.+E.+Gordonauthor=G.+M.+Jangauthor=M.+Bouhaddouauthor=J.+Xuauthor=K.+Obernierauthor=K.+M.+Whiteauthor=M.+J.+O%E2%80%99Mearaauthor=V.+V.+Rezeljauthor=J.+Z.+Guoauthor=D.+L.+Swaneyauthor=T.+A.+Tumminoauthor=R.+Huettenhainauthor=R.+M.+Kaakeauthor=A.+L.+Richardsauthor=B.+Tutuncuogluauthor=H.+Foussardauthor=J.+Batraauthor=K.+Haasauthor=M.+Modakauthor=M.+Kimauthor=P.+Haasauthor=B.+J.+Polaccoauthor=H.+Brabergauthor=J.+M.+Fabiusauthor=M.+Eckhardtauthor=M.+Soucherayauthor=M.+J.+Bennettauthor=M.+Cakirauthor=M.+J.+McGregorauthor=Q.+Liauthor=B.+Meyerauthor=F.+Roeschauthor=T.+Valletauthor=A.+Mac+Kainauthor=L.+Miorinauthor=E.+Morenoauthor=Z.+Z.+C.+Naingauthor=Y.+Zhouauthor=S.+Pengauthor=Y.+Shiauthor=Z.+Zhangauthor=W.+Shenauthor=I.+T.+Kirbyauthor=J.+E.+Melnykauthor=J.+S.+Chorbaauthor=K.+Louauthor=S.+A.+Daiauthor=I.+Barrio-Hernandezauthor=D.+Memonauthor=C.+Hernandez-Armentaauthor=J.+Lyuauthor=C.+J.+P.+Mathyauthor=T.+Pericaauthor=K.+B.+Pillaauthor=S.+J.+Ganesanauthor=D.+J.+Saltzbergauthor=R.+Rakeshauthor=X.+Liuauthor=S.+B.+Rosenthalauthor=L.+Calvielloauthor=S.+Venkataramananauthor=J.+Liboy-Lugoauthor=Y.+Linauthor=X.+P.+Huangauthor=Y.+Liuauthor=S.+A.+Wankowiczauthor=M.+Bohnauthor=M.+Safariauthor=F.+S.+Ugurauthor=C.+Kohauthor=N.+S.+Savarauthor=Q.+D.+Tranauthor=D.+Shengjulerauthor=S.+J.+Fletcherauthor=M.+C.+O%E2%80%99Nealauthor=Y.+Caiauthor=J.+C.+J.+Changauthor=D.+J.+Broadhurstauthor=S.+Klippstenauthor=P.+P.+Sharpauthor=N.+A.+Wenzellauthor=D.+Kuzuogluauthor=H.+Y.+Wangauthor=R.+Trenkerauthor=J.+M.+Youngauthor=D.+A.+Caveroauthor=J.+Hiattauthor=T.+L.+Rothauthor=U.+Rathoreauthor=A.+Subramanianauthor=J.+Noackauthor=M.+Hubertauthor=R.+M.+Stroudauthor=A.+D.+Frankelauthor=O.+S.+Rosenbergauthor=K.+A.+Verbaauthor=D.+A.+Agardauthor=M.+Ottauthor=M.+Emermanauthor=N.+Juraauthor=M.+von+Zastrowauthor=E.+Verdinauthor=A.+Ashworthauthor=O.+Schwartzauthor=C.+d%E2%80%99Enfertauthor=S.+Mukherjeeauthor=M.+Jacobsonauthor=H.+S.+Malikauthor=D.+G.+Fujimoriauthor=T.+Idekerauthor=C.+S.+Craikauthor=S.+N.+Floorauthor=J.+S.+Fraserauthor=J.+D.+Grossauthor=A.+Saliauthor=B.+L.+Rothauthor=D.+Ruggeroauthor=J.+Tauntonauthor=T.+Kortemmeauthor=P.+Beltraoauthor=M.+Vignuzziauthor=A.+Garcia-Sastreauthor=K.+M.+Shokatauthor=B.+K.+Shoichetauthor=N.+J.+Krogan&title=A+SARS-CoV-2+protein+interaction+map+reveals+targets+for+drug+repurposing&doi=10.1038%2Fs41586-020-2286-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2286-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2286-9%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BE.%26aulast%3DJang%26aufirst%3DG.%2BM.%26aulast%3DBouhaddou%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DObernier%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BJ.%26aulast%3DRezelj%26aufirst%3DV.%2BV.%26aulast%3DGuo%26aufirst%3DJ.%2BZ.%26aulast%3DSwaney%26aufirst%3DD.%2BL.%26aulast%3DTummino%26aufirst%3DT.%2BA.%26aulast%3DHuettenhain%26aufirst%3DR.%26aulast%3DKaake%26aufirst%3DR.%2BM.%26aulast%3DRichards%26aufirst%3DA.%2BL.%26aulast%3DTutuncuoglu%26aufirst%3DB.%26aulast%3DFoussard%26aufirst%3DH.%26aulast%3DBatra%26aufirst%3DJ.%26aulast%3DHaas%26aufirst%3DK.%26aulast%3DModak%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DHaas%26aufirst%3DP.%26aulast%3DPolacco%26aufirst%3DB.%2BJ.%26aulast%3DBraberg%26aufirst%3DH.%26aulast%3DFabius%26aufirst%3DJ.%2BM.%26aulast%3DEckhardt%26aufirst%3DM.%26aulast%3DSoucheray%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26aulast%3DCakir%26aufirst%3DM.%26aulast%3DMcGregor%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DRoesch%26aufirst%3DF.%26aulast%3DVallet%26aufirst%3DT.%26aulast%3DMac%2BKain%26aufirst%3DA.%26aulast%3DMiorin%26aufirst%3DL.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DZ.%2BZ.%2BC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DKirby%26aufirst%3DI.%2BT.%26aulast%3DMelnyk%26aufirst%3DJ.%2BE.%26aulast%3DChorba%26aufirst%3DJ.%2BS.%26aulast%3DLou%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DS.%2BA.%26aulast%3DBarrio-Hernandez%26aufirst%3DI.%26aulast%3DMemon%26aufirst%3DD.%26aulast%3DHernandez-Armenta%26aufirst%3DC.%26aulast%3DLyu%26aufirst%3DJ.%26aulast%3DMathy%26aufirst%3DC.%2BJ.%2BP.%26aulast%3DPerica%26aufirst%3DT.%26aulast%3DPilla%26aufirst%3DK.%2BB.%26aulast%3DGanesan%26aufirst%3DS.%2BJ.%26aulast%3DSaltzberg%26aufirst%3DD.%2BJ.%26aulast%3DRakesh%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DRosenthal%26aufirst%3DS.%2BB.%26aulast%3DCalviello%26aufirst%3DL.%26aulast%3DVenkataramanan%26aufirst%3DS.%26aulast%3DLiboy-Lugo%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWankowicz%26aufirst%3DS.%2BA.%26aulast%3DBohn%26aufirst%3DM.%26aulast%3DSafari%26aufirst%3DM.%26aulast%3DUgur%26aufirst%3DF.%2BS.%26aulast%3DKoh%26aufirst%3DC.%26aulast%3DSavar%26aufirst%3DN.%2BS.%26aulast%3DTran%26aufirst%3DQ.%2BD.%26aulast%3DShengjuler%26aufirst%3DD.%26aulast%3DFletcher%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DM.%2BC.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DJ.%2BC.%2BJ.%26aulast%3DBroadhurst%26aufirst%3DD.%2BJ.%26aulast%3DKlippsten%26aufirst%3DS.%26aulast%3DSharp%26aufirst%3DP.%2BP.%26aulast%3DWenzell%26aufirst%3DN.%2BA.%26aulast%3DKuzuoglu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DTrenker%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DCavero%26aufirst%3DD.%2BA.%26aulast%3DHiatt%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DT.%2BL.%26aulast%3DRathore%26aufirst%3DU.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DNoack%26aufirst%3DJ.%26aulast%3DHubert%26aufirst%3DM.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26aulast%3DFrankel%26aufirst%3DA.%2BD.%26aulast%3DRosenberg%26aufirst%3DO.%2BS.%26aulast%3DVerba%26aufirst%3DK.%2BA.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DEmerman%26aufirst%3DM.%26aulast%3DJura%26aufirst%3DN.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DO.%26aulast%3Dd%25E2%2580%2599Enfert%26aufirst%3DC.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DMalik%26aufirst%3DH.%2BS.%26aulast%3DFujimori%26aufirst%3DD.%2BG.%26aulast%3DIdeker%26aufirst%3DT.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DFloor%26aufirst%3DS.%2BN.%26aulast%3DFraser%26aufirst%3DJ.%2BS.%26aulast%3DGross%26aufirst%3DJ.%2BD.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DKortemme%26aufirst%3DT.%26aulast%3DBeltrao%26aufirst%3DP.%26aulast%3DVignuzzi%26aufirst%3DM.%26aulast%3DGarcia-Sastre%26aufirst%3DA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DKrogan%26aufirst%3DN.%2BJ.%26atitle%3DA%2520SARS-CoV-2%2520protein%2520interaction%2520map%2520reveals%2520targets%2520for%2520drug%2520repurposing%26jtitle%3DNature%26date%3D2020%26doi%3D10.1038%2Fs41586-020-2286-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jauregui, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savalia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowry, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wathelet, M. G.</span></span> <span> </span><span class="NLM_article-title">Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e62416</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0062416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0062416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23658627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlCrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=4&author=A.+R.+Jaureguiauthor=D.+Savaliaauthor=V.+K.+Lowryauthor=C.+M.+Farrellauthor=M.+G.+Wathelet&title=Identification+of+residues+of+SARS-CoV+nsp1+that+differentially+affect+inhibition+of+gene+expression+and+antiviral+signaling&doi=10.1371%2Fjournal.pone.0062416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling</span></div><div class="casAuthors">Jauregui, Andrew R.; Savalia, Dhruti; Lowry, Virginia K.; Farrell, Cara M.; Wathelet, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e62416</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">An epidemic of severe acute respiratory syndrome (SARS) led to the identification of an assocd. coronavirus, SARS-CoV.  This virus evades the host innate immune response in part through the expression of its non-structural protein (nsp) 1, which inhibits both host gene expression and virus- and interferon (IFN)-dependent signaling.  Thus, nsp1 is a promising target for drugs, as inhibition of nsp1 would make SARS-CoV more susceptible to the host antiviral defenses.  To gain a better understanding of nsp1 mode of action, we generated and analyzed 38 mutants of the SARS-CoV nsp1, targeting 62 solvent-exposed residues out of the 180 amino acid protein.  From this work, we identified six classes of mutants that abolished, attenuated or increased nsp1 inhibition of host gene expression and/or antiviral signaling.  Each class of mutants clustered on SARS-CoV nsp1 surface and suggested nsp1 interacts with distinct host factors to exert its inhibitory activities.  Identification of the nsp1 residues crit. for its activities and the pathways involved in these activities should help in the design of drugs targeting nsp1.  Significantly, several point mutants increased the inhibitory activity of nsp1, suggesting that coronaviruses could evolve a greater ability to evade the host response through mutations of such residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz0ex8tf9VbLVg90H21EOLACvtfcHk0lh1JOof1WO40A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlCrtr0%253D&md5=94c9a53c22276d9b894e947cd4ee50f5</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0062416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0062416%26sid%3Dliteratum%253Aachs%26aulast%3DJauregui%26aufirst%3DA.%2BR.%26aulast%3DSavalia%26aufirst%3DD.%26aulast%3DLowry%26aufirst%3DV.%2BK.%26aulast%3DFarrell%26aufirst%3DC.%2BM.%26aulast%3DWathelet%26aufirst%3DM.%2BG.%26atitle%3DIdentification%2520of%2520residues%2520of%2520SARS-CoV%2520nsp1%2520that%2520differentially%2520affect%2520inhibition%2520of%2520gene%2520expression%2520and%2520antiviral%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D4%26doi%3D10.1371%2Fjournal.pone.0062416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devaraj, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barretto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span> <span> </span><span class="NLM_article-title">Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">32208</span>– <span class="NLM_lpage">32221</span>, <span class="refDoi"> DOI: 10.1074/jbc.M704870200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M704870200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=17761676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Wls7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=32208-32221&issue=44&author=S.+G.+Devarajauthor=N.+Wangauthor=Z.+Chenauthor=Z.+Chenauthor=M.+Tsengauthor=N.+Barrettoauthor=R.+Linauthor=C.+J.+Petersauthor=C.+T.+Tsengauthor=S.+C.+Bakerauthor=K.+Li&title=Regulation+of+IRF-3-dependent+innate+immunity+by+the+papain-like+protease+domain+of+the+severe+acute+respiratory+syndrome+coronavirus&doi=10.1074%2Fjbc.M704870200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus</span></div><div class="casAuthors">Devaraj, Santhana G.; Wang, Nan; Chen, Zhongbin; Chen, Zihong; Tseng, Monica; Barretto, Naina; Lin, Rongtuan; Peters, Clarence J.; Tseng, Chien-Te K.; Baker, Susan C.; Li, Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">32208-32221</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) is a novel coronavirus that causes a highly contagious respiratory disease, SARS, with significant mortality.  Although factors contributing to the highly pathogenic nature of SARS-CoV remain poorly understood, it has been reported that SARS-CoV infection does not induce type I interferons (IFNs) in cell culture.  However, it is uncertain whether SARS-CoV evades host detection or has evolved mechanisms to counteract innate host defenses.  The authors show here that infection of SARS-CoV triggers a weak IFN response in cultured human lung/bronchial epithelial cells without inducing the phosphorylation of IFN-regulatory factor 3 (IRF-3), a latent cellular transcription factor that is pivotal for type I IFN synthesis.  Furthermore, SARS-CoV infection blocked the induction of IFN antiviral activity and the up-regulation of protein expression of a subset of IFN-stimulated genes triggered by double-stranded RNA or an unrelated paramyxovirus.  In searching for a SARS-CoV protein capable of counteracting innate immunity, the authors identified the papain-like protease (PLpro) domain as a potent IFN antagonist.  The inhibition of the IFN response does not require the protease activity of PLpro.  Rather, PLpro interacts with IRF-3 and inhibits the phosphorylation and nuclear translocation of IRF-3, thereby disrupting the activation of type I IFN responses through either Toll-like receptor 3 or retinoic acid-inducible gene I/melanoma differentiation-assocd. gene 5 pathways.  The authors' data suggest that regulation of IRF-3-dependent innate antiviral defenses by PLpro may contribute to the establishment of SARS-CoV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCaHrUo-VWzrVg90H21EOLACvtfcHk0lh1JOof1WO40A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Wls7zE&md5=7358d227da9cdd535ec2d13ac771786c</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M704870200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M704870200%26sid%3Dliteratum%253Aachs%26aulast%3DDevaraj%26aufirst%3DS.%2BG.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DTseng%26aufirst%3DM.%26aulast%3DBarretto%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DC.%2BJ.%26aulast%3DTseng%26aufirst%3DC.%2BT.%26aulast%3DBaker%26aufirst%3DS.%2BC.%26aulast%3DLi%26aufirst%3DK.%26atitle%3DRegulation%2520of%2520IRF-3-dependent%2520innate%2520immunity%2520by%2520the%2520papain-like%2520protease%2520domain%2520of%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D44%26spage%3D32208%26epage%3D32221%26doi%3D10.1074%2Fjbc.M704870200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotouhi-Ardakani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lytvyn, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulea, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, R.</span></span> <span> </span><span class="NLM_article-title">The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">15199</span>– <span class="NLM_lpage">15208</span>, <span class="refDoi"> DOI: 10.1128/JVI.79.24.15199-15208.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.79.24.15199-15208.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16306591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslOitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=15199-15208&issue=24&author=H.+A.+Lindnerauthor=N.+Fotouhi-Ardakaniauthor=V.+Lytvynauthor=P.+Lachanceauthor=T.+Suleaauthor=R.+Menard&title=The+papain-like+protease+from+the+severe+acute+respiratory+syndrome+coronavirus+is+a+deubiquitinating+enzyme&doi=10.1128%2FJVI.79.24.15199-15208.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme</span></div><div class="casAuthors">Lindner, Holger A.; Fotouhi-Ardakani, Nasser; Lytvyn, Viktoria; Lachance, Paule; Sulea, Traian; Menard, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15199-15208</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The severe acute respiratory syndrome coronavirus papain-like protease (SARS-CoV PLpro) is involved in the processing of the viral polyprotein and, thereby, contributes to the biogenesis of the virus replication complex.  Structural bioinformatics has revealed a relationship for the SARS-CoV PLpro to herpesvirus-assocd. ubiquitin-specific protease (HAUSP), a ubiquitin-specific protease, indicating potential deubiquitinating activity in addn. to its function in polyprotein processing.  In order to confirm this prediction, we overexpressed and purified SARS-CoV PLpro (amino acids [aa]1507 to 1858) from Escherichia coli.  The purified enzyme hydrolyzed ubiquitin-7-amino-4-methylcoumarin (Ub-AMC), a general deubiquitinating enzyme substrate, with a catalytic efficiency of 13,100 M-1 s-1, 220-fold more efficiently than the small synthetic peptide substrate Z-LRGG-AMC, which incorporates the C-terminal four residues of ubiquitin.  In addn., SARS-CoV PLpro was inhibited by the specific deubiquitinating enzyme inhibitor ubiquitin aldehyde, with an inhibition const. of 210 nM.  The purified SARS-CoV PLpro disassembles branched polyubiquitin chains with lengths of two to seven (Ub2-7) or four (Ub4) units, which involves isopeptide bond cleavage.  SARS-CoV PLpro processing activity was also detected against a protein fused to the C terminus of the ubiquitin-like modifier ISG15, both in vitro using the purified enzyme and in HeLa cells by coexpression with SARS-CoV PLpro (aa 1198 to 2009).  These results clearly establish that SARS-CoV PLpro is a deubiquitinating enzyme, thereby confirming our earlier prediction.  This unexpected activity for a coronavirus papain-like protease suggests a novel viral strategy to modulate the host cell ubiquitination machinery to its advantage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1m1bqW9GpybVg90H21EOLACvtfcHk0lh0tzvzMplAug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslOitw%253D%253D&md5=dff5e5e3d3b2fc8838413a8551480383</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.24.15199-15208.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.24.15199-15208.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLindner%26aufirst%3DH.%2BA.%26aulast%3DFotouhi-Ardakani%26aufirst%3DN.%26aulast%3DLytvyn%26aufirst%3DV.%26aulast%3DLachance%26aufirst%3DP.%26aulast%3DSulea%26aufirst%3DT.%26aulast%3DMenard%26aufirst%3DR.%26atitle%3DThe%2520papain-like%2520protease%2520from%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520is%2520a%2520deubiquitinating%2520enzyme%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26issue%3D24%26spage%3D15199%26epage%3D15208%26doi%3D10.1128%2FJVI.79.24.15199-15208.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1099/vir.0.059014-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.059014-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24362959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyms7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2014&pages=614-626&issue=3&author=X.+Yangauthor=X.+Chenauthor=G.+Bianauthor=J.+Tuauthor=Y.+Xingauthor=Y.+Wangauthor=Z.+Chen&title=Proteolytic+processing%2C+deubiquitinase+and+interferon+antagonist+activities+of+Middle+East+respiratory+syndrome+coronavirus+papain-like+protease&doi=10.1099%2Fvir.0.059014-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease</span></div><div class="casAuthors">Yang, Xingxing; Chen, Xiaojuan; Bian, Guangxing; Tu, Jian; Xing, Yaling; Wang, Yayun; Chen, Zhongbin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-626</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">The emerging Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe pulmonary disease in humans and represents the second example of a highly pathogenic coronavirus (CoV) following severe acute respiratory syndrome coronavirus (SARS-CoV).  Genomic studies revealed that two viral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), process the polyproteins encoded by the MERS-CoV genomic RNA.  We previously reported that SARS-CoV PLpro acts as both deubiquitinase (DUB) and IFN antagonist, but the function of the MERS-CoV PLpro was poorly understood.  In this study, we characterized MERS-CoV PLpro, which is a protease and can recognize and process the cleavage sites (CS) of nsp1-2, nsp2-3 and nsp3-4.  The LXGG consensus cleavage sites in the N terminus of pp1a/1ab, which is generally essential for CoV PLpro-mediated processing, were also characterized in MERS-CoV.  MERS-CoV PLpro, like human SARS-CoV PLpro and NL63-CoV PLP2, is a viral deubiquitinating enzyme.  It acts on both K48- and K63-linked ubiquitination and ISG15-linked ISGylation.  We confirmed that MERS-CoV PLpro acts as an IFN antagonist through blocking the phosphorylation and nuclear translocation of IFN regulatory factor 3 (IRF3).  These findings indicate that MERS-CoV PLpro acts as a viral DUB and suppresses prodn. of IFN-β by an interfering IRF3-mediated signalling pathway, in addn. to recognizing and processing the CS at the N terminus of replicase polyprotein to release the non-structural proteins.  The characterization of proteolytic processing, DUB and IFN antagonist activities of MERS-CoV PLpro would reveal the interactions between MERS-CoV and its host, and be applicable to develop strategies targeting PLpro for the effective control of MERS-CoV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKNBrp1z7PFrVg90H21EOLACvtfcHk0lh0tzvzMplAug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyms7zN&md5=6681725064519d5fc1a743ebd912c07f</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.059014-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.059014-0%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DG.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DProteolytic%2520processing%252C%2520deubiquitinase%2520and%2520interferon%2520antagonist%2520activities%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520papain-like%2520protease%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2014%26volume%3D95%26issue%3D3%26spage%3D614%26epage%3D626%26doi%3D10.1099%2Fvir.0.059014-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. W.</span></span> <span> </span><span class="NLM_article-title">SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">678</span>, <span class="refDoi"> DOI: 10.3390/ijms17050678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fijms17050678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslCktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=678&issue=5&author=S.+W.+Liauthor=C.+Y.+Wangauthor=Y.+J.+Jouauthor=S.+H.+Huangauthor=L.+H.+Hsiaoauthor=L.+Wanauthor=Y.+J.+Linauthor=S.+H.+Kungauthor=C.+W.+Lin&title=SARS+coronavirus+papain-like+protease+inhibits+the+TLR7+signaling+pathway+through+removing+Lys63-linked+polyubiquitination+of+TRAF3+and+TRAF6&doi=10.3390%2Fijms17050678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6</span></div><div class="casAuthors">Li, Shih-Wen; Wang, Ching-Ying; Jou, Yu-Jen; Huang, Su-Hua; Hsiao, Li-Hsin; Wan, Lei; Lin, Ying-Ju; Kung, Szu-Hao; Lin, Cheng-Wen</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">678/1-678/10</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) papain-like protease (PLPro) reportedly inhibits the prodn. of type I interferons (IFNs) and pro-inflammatory cytokines in Toll-like receptor 3 (TLR3) and retinoic acid-inducible gene 1 (RIG-I) pathways.  The study investigated the inhibitory effect and its antagonistic mechanism of SARS-CoV PLPro on TLR7-mediated cytokine prodn.  TLR7 agonist (imiquimod (IMQ)) concn.-dependently induced activation of ISRE-, NF-κB- and AP-1-luciferase reporters, as well as the prodn. of IFN-α, IFN-β, TNF-α, IL-6 and IL-8 in human promonocyte cells.  However, SARS-CoV PLPro significantly inhibited IMQ-induced cytokine prodn. through suppressing the activation of transcription factors IRF-3, NF-κB and AP-1.  Western blot anal. with anti-Lys48 and anti-Lys63 ubiquitin antibodies indicated the SARS-CoV PLPro removed Lys63-linked ubiquitin chains of TRAF3 and TRAF6, but not Lys48-linked ubiquitin chains in un-treated and treated cells.  The decrease in the activated state of TRAF3 and TRAF6 correlated with the inactivation of TBK1 in response to IMQ by PLPro.  The results revealed that the antagonism of SARS-CoV PLPro on TLR7-mediated innate immunity was assocd. with the neg. regulation of TRAF3/6-TBK1-IRF3/NF-κB/AP1 signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogHrXOidYFQLVg90H21EOLACvtfcHk0lgwkNhUFXMSFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslCktbY%253D&md5=46328304cb29f501e142ac46c3865bde</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.3390%2Fijms17050678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17050678%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DJou%26aufirst%3DY.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%2BH.%26aulast%3DHsiao%26aufirst%3DL.%2BH.%26aulast%3DWan%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DY.%2BJ.%26aulast%3DKung%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BW.%26atitle%3DSARS%2520coronavirus%2520papain-like%2520protease%2520inhibits%2520the%2520TLR7%2520signaling%2520pathway%2520through%2520removing%2520Lys63-linked%2520polyubiquitination%2520of%2520TRAF3%2520and%2520TRAF6%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26issue%3D5%26spage%3D678%26doi%3D10.3390%2Fijms17050678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mielech, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilianski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baez-Santos, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. C.</span></span> <span> </span><span class="NLM_article-title">MERS-CoV papain-like protease has deISGylating and deubiquitinating activities</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>450–451</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2013.11.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2013.11.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24503068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450%E2%80%93451&publication_year=2014&pages=64-70&author=A.+M.+Mielechauthor=A.+Kilianskiauthor=Y.+M.+Baez-Santosauthor=A.+D.+Mesecarauthor=S.+C.+Baker&title=MERS-CoV+papain-like+protease+has+deISGylating+and+deubiquitinating+activities&doi=10.1016%2Fj.virol.2013.11.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">MERS-CoV papain-like protease has deISGylating and deubiquitinating activities</span></div><div class="casAuthors">Mielech, Anna M.; Kilianski, Andy; Baez-Santos, Yahira M.; Mesecar, Andrew D.; Baker, Susan C.</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">450-451</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-70</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Coronaviruses encode papain-like proteases (PLpro) that are often multifunctional enzymes with protease activity to process the viral replicase polyprotein and deubiquitinating (DUB)/deISGylating activity, which is hypothesized to modify the innate immune response to infection.  Here, we investigate the predicted DUB activity of the PLpro domain of the recently described Middle East Respiratory Syndrome Coronavirus (MERS-CoV).  We found that expression of MERS-CoV PLpro reduces the levels of ubiquitinated and ISGylated host cell proteins; consistent with multifunctional PLpro activity.  Further, we compared the ability of MERS-CoV PLpro and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) PLpro to block innate immune signaling of proinflammatory cytokines.  We show that expression of SARS-CoV and MERS-CoV PLpros blocks upregulation of cytokines CCL5, IFN-β and CXCL10 in stimulated cells.  Overall these results indicate that the PLpro domains of MERS-CoV and SARS-CoV have the potential to modify the innate immune response to viral infection and contribute to viral pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOR-nvL34lf7Vg90H21EOLACvtfcHk0lgwkNhUFXMSFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGlsLY%253D&md5=ff468bc8c6b5d1e18247a999f6e64555</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2013.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2013.11.040%26sid%3Dliteratum%253Aachs%26aulast%3DMielech%26aufirst%3DA.%2BM.%26aulast%3DKilianski%26aufirst%3DA.%26aulast%3DBaez-Santos%26aufirst%3DY.%2BM.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DBaker%26aufirst%3DS.%2BC.%26atitle%3DMERS-CoV%2520papain-like%2520protease%2520has%2520deISGylating%2520and%2520deubiquitinating%2520activities%26jtitle%3DVirology%26date%3D2014%26volume%3D450%25E2%2580%2593451%26spage%3D64%26epage%3D70%26doi%3D10.1016%2Fj.virol.2013.11.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuri, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putics, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddell, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziebuhr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, F.</span></span> <span> </span><span class="NLM_article-title">The ADP-ribose-1′’-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1899</span>– <span class="NLM_lpage">1905</span>, <span class="refDoi"> DOI: 10.1099/vir.0.031856-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.031856-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21525212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFektbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2011&pages=1899-1905&issue=8&author=T.+Kuriauthor=K.+K.+Erikssonauthor=A.+Puticsauthor=R.+Zustauthor=E.+J.+Snijderauthor=A.+D.+Davidsonauthor=S.+G.+Siddellauthor=V.+Thielauthor=J.+Ziebuhrauthor=F.+Weber&title=The+ADP-ribose-1%E2%80%B2%E2%80%99-monophosphatase+domains+of+severe+acute+respiratory+syndrome+coronavirus+and+human+coronavirus+229E+mediate+resistance+to+antiviral+interferon+responses&doi=10.1099%2Fvir.0.031856-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">The ADP-ribose-1-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses</span></div><div class="casAuthors">Kuri, Thomas; Eriksson, Klara K.; Putics, Akos; Zuest, Roland; Snijder, Eric J.; Davidson, Andrew D.; Siddell, Stuart G.; Thiel, Volker; Ziebuhr, John; Weber, Friedemann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1899-1905</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Several plus-strand RNA viruses encode proteins contg. macrodomains.  These domains possess ADP-ribose-1''-phosphatase (ADRP) activity and/or bind poly(ADP-ribose), poly(A) or poly(G).  The relevance of these activities in the viral life cycle has not yet been resolved.  Here, the authors report that genetically engineered mutants of severe acute respiratory syndrome coronavirus (SARS-CoV) and human coronavirus 229E (HCoV-229E) expressing ADRP-deficient macrodomains displayed an increased sensitivity to the antiviral effect of alpha interferon compared with their wild-type counterparts.  The data suggest that macrodomain-assocd. ADRP activities may have a role in viral escape from the innate immune responses of the host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn6DyERvUW47Vg90H21EOLACvtfcHk0lgwkNhUFXMSFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFektbc%253D&md5=b5ff6bf8e1f5f13db6b296de60f18497</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.031856-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.031856-0%26sid%3Dliteratum%253Aachs%26aulast%3DKuri%26aufirst%3DT.%26aulast%3DEriksson%26aufirst%3DK.%2BK.%26aulast%3DPutics%26aufirst%3DA.%26aulast%3DZust%26aufirst%3DR.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DDavidson%26aufirst%3DA.%2BD.%26aulast%3DSiddell%26aufirst%3DS.%2BG.%26aulast%3DThiel%26aufirst%3DV.%26aulast%3DZiebuhr%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DF.%26atitle%3DThe%2520ADP-ribose-1%25E2%2580%25B2%25E2%2580%2599-monophosphatase%2520domains%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520and%2520human%2520coronavirus%2520229E%2520mediate%2520resistance%2520to%2520antiviral%2520interferon%2520responses%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2011%26volume%3D92%26issue%3D8%26spage%3D1899%26epage%3D1905%26doi%3D10.1099%2Fvir.0.031856-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma-Lauer, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo-Lozoya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Brunn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bairad, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermeking, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonhardt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Brunn, A.</span></span> <span> </span><span class="NLM_article-title">p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">E5192</span>– <span class="NLM_lpage">E5201</span>, <span class="refDoi"> DOI: 10.1073/pnas.1603435113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1603435113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27519799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlChsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E5192-E5201&issue=35&author=Y.+Ma-Lauerauthor=J.+Carbajo-Lozoyaauthor=M.+Y.+Heinauthor=M.+A.+Mullerauthor=W.+Dengauthor=J.+Leiauthor=B.+Meyerauthor=Y.+Kusovauthor=B.+von+Brunnauthor=D.+R.+Bairadauthor=S.+Huntenauthor=C.+Drostenauthor=H.+Hermekingauthor=H.+Leonhardtauthor=M.+Mannauthor=R.+Hilgenfeldauthor=A.+von+Brunn&title=p53+down-regulates+SARS+coronavirus+replication+and+is+targeted+by+the+SARS-unique+domain+and+PLpro+via+E3+ubiquitin+ligase+RCHY1&doi=10.1073%2Fpnas.1603435113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1</span></div><div class="casAuthors">Ma-Lauer, Yue; Carbajo-Lozoya, Javier; Hein, Marco Y.; Mueller, Marcel A.; Deng, Wen; Lei, Jian; Meyer, Benjamin; Kusov, Yuri; von Brunn, Brigitte; Bairad, Dev Raj; Huenten, Sabine; Drosten, Christian; Hermeking, Heiko; Leonhardt, Heinrich; Mann, Matthias; Hilgenfeld, Rolf; von Brunn, Albrecht</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">E5192-E5201</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV) has developed strategies to inhibit host immune recognition.  We identify cellular E3 ubiquitin ligase ring-finger and CHY zinc-finger domain-contg. 1 (RCHY1) as an interacting partner of the viral SARS-unique domain (SUD) and papain-like protease (PLpro), and, as a consequence, the involvement of cellular p53 as antagonist of coronaviral replication.  Residues 95-144 of RCHY1 and 389-652 of SUD (SUD-NM) subdomains are crucial for interaction.  Assocn. with SUD increases the stability of RCHY1 and augments RCHY1-mediated ubiquitination as well as degrdn. of p53.  The calcium/calmodulin-dependent protein kinase II delta (CAMK2D), which normally influences RCHY1 stability by phosphorylation, also binds to SUD.  In vivo phosphorylation shows that SUD does not regulate phosphorylation of RCHY1 via CAMK2D.  Similarly to SUD, the PLpros from SARS-CoV, MERS-CoV, and HCoV-NL63 phys. interact with and stabilize RCHY1, and thus trigger degrdn. of endogenous p53.  The SARS-CoV papain-like protease is encoded next to SUD within nonstructural protein 3.  A SUD-PLpro fusion interacts with RCHY1 more intensively and causes stronger p53 degrdn. than SARS-CoV PLpro alone.  We show that p53 inhibits replication of infectious SARS-CoV as well as of replicons and human coronavirus NL63.  Hence, human coronaviruses antagonize the viral inhibitor p53 via stabilizing RCHY1 and promoting RCHY1-mediated p53 degrdn.  SUD functions as an enhancer to strengthen interaction between RCHY1 and nonstructural protein 3, leading to a further increase in in p53 degrdn.  The significance of these findings is that down-regulation of p53 as a major player in antiviral innate immunity provides a long-sought explanation for delayed activities of resp. genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyOwBYxS8GJ7Vg90H21EOLACvtfcHk0li19iBcO3gSJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlChsLnL&md5=e31c8dfbb5f7ca89b7e7fa337a8daf0d</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1603435113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1603435113%26sid%3Dliteratum%253Aachs%26aulast%3DMa-Lauer%26aufirst%3DY.%26aulast%3DCarbajo-Lozoya%26aufirst%3DJ.%26aulast%3DHein%26aufirst%3DM.%2BY.%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DKusov%26aufirst%3DY.%26aulast%3Dvon%2BBrunn%26aufirst%3DB.%26aulast%3DBairad%26aufirst%3DD.%2BR.%26aulast%3DHunten%26aufirst%3DS.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DHermeking%26aufirst%3DH.%26aulast%3DLeonhardt%26aufirst%3DH.%26aulast%3DMann%26aufirst%3DM.%26aulast%3DHilgenfeld%26aufirst%3DR.%26aulast%3Dvon%2BBrunn%26aufirst%3DA.%26atitle%3Dp53%2520down-regulates%2520SARS%2520coronavirus%2520replication%2520and%2520is%2520targeted%2520by%2520the%2520SARS-unique%2520domain%2520and%2520PLpro%2520via%2520E3%2520ubiquitin%2520ligase%2520RCHY1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D35%26spage%3DE5192%26epage%3DE5201%26doi%3D10.1073%2Fpnas.1603435113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Cruz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spanier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabouw, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">V’Kovski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habjan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervantes-Barragan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaughan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludewig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziebuhr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span> <span> </span><span class="NLM_article-title">Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>), <span class="NLM_elocation-id">e1006195</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1006195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.ppat.1006195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28158275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&issue=2&author=E.+Kindlerauthor=C.+Gil-Cruzauthor=J.+Spanierauthor=Y.+Liauthor=J.+Wilhelmauthor=H.+H.+Rabouwauthor=R.+Zustauthor=M.+Hwangauthor=P.+V%E2%80%99Kovskiauthor=H.+Stalderauthor=S.+Martiauthor=M.+Habjanauthor=L.+Cervantes-Barraganauthor=R.+Elliotauthor=N.+Karlauthor=C.+Gaughanauthor=F.+J.+van+Kuppeveldauthor=R.+H.+Silvermanauthor=M.+Kellerauthor=B.+Ludewigauthor=C.+C.+Bergmannauthor=J.+Ziebuhrauthor=S.+R.+Weissauthor=U.+Kalinkeauthor=V.+Thiel&title=Early+endonuclease-mediated+evasion+of+RNA+sensing+ensures+efficient+coronavirus+replication&doi=10.1371%2Fjournal.ppat.1006195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication</span></div><div class="casAuthors">Kindler, Eveline; Gil-Cruz, Cristina; Spanier, Julia; Li, Yize; Wilhelm, Jochen; Rabouw, Huib H.; Zust, Roland; Hwang, Mihyun; V'kovski, Philip; Stalder, Hanspeter; Marti, Sabrina; Habjan, Matthias; Cervantes-Barragan, Luisa; Elliot, Ruth; Karl, Nadja; Gaughan, Christina; van Kuppeveld, Frank J. M.; Silverman, Robert H.; Keller, Markus; Ludewig, Burkhard; Bergmann, Cornelia C.; Ziebuhr, John; Weiss, Susan R.; Kalinke, Ulrich; Thiel, Volker</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1006195/1-e1006195/26</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Coronaviruses are of veterinary and medical importance and include highly pathogenic zoonotic viruses, such as SARS-CoV and MERS-CoV.  They are known to efficiently evade early innate immune responses, manifesting in almost negligible expression of type-I interferons (IFN-I).  This evasion strategy suggests an evolutionary conserved viral function that has evolved to prevent RNA-based sensing of infection in vertebrate hosts.  Here we show that the coronavirus endonuclease (EndoU) activity is key to prevent early induction of double-stranded RNA (dsRNA) host cell responses.  Replication of EndoU-deficient coronaviruses is greatly attenuated in vivo and severely restricted in primary cells even during the early phase of the infection.  In macrophages we found immediate induction of IFN-I expression and RNase L-mediated breakdown of rRNA.  Accordingly, EndoU-deficient viruses can retain replication only in cells that are deficient in IFN-I expression or sensing, and in cells lacking both RNase L and PKR.  Collectively our results demonstrate that the coronavirus EndoU efficiently prevents simultaneous activation of host cell dsRNA sensors, such as Mda5, OAS and PKR.  The localization of the EndoU activity at the site of viral RNA synthesis-within the replicase complex-suggests that coronaviruses have evolved a viral RNA decay pathway to evade early innate and intrinsic antiviral host cell responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJihv7-Ahq6rVg90H21EOLACvtfcHk0liMJ18TzM7EuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCqtrvP&md5=12cd5c885b2b147fe10fe55fc5ccd19c</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1006195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1006195%26sid%3Dliteratum%253Aachs%26aulast%3DKindler%26aufirst%3DE.%26aulast%3DGil-Cruz%26aufirst%3DC.%26aulast%3DSpanier%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWilhelm%26aufirst%3DJ.%26aulast%3DRabouw%26aufirst%3DH.%2BH.%26aulast%3DZust%26aufirst%3DR.%26aulast%3DHwang%26aufirst%3DM.%26aulast%3DV%25E2%2580%2599Kovski%26aufirst%3DP.%26aulast%3DStalder%26aufirst%3DH.%26aulast%3DMarti%26aufirst%3DS.%26aulast%3DHabjan%26aufirst%3DM.%26aulast%3DCervantes-Barragan%26aufirst%3DL.%26aulast%3DElliot%26aufirst%3DR.%26aulast%3DKarl%26aufirst%3DN.%26aulast%3DGaughan%26aufirst%3DC.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BH.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DLudewig%26aufirst%3DB.%26aulast%3DBergmann%26aufirst%3DC.%2BC.%26aulast%3DZiebuhr%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DS.%2BR.%26aulast%3DKalinke%26aufirst%3DU.%26aulast%3DThiel%26aufirst%3DV.%26atitle%3DEarly%2520endonuclease-mediated%2520evasion%2520of%2520RNA%2520sensing%2520ensures%2520efficient%2520coronavirus%2520replication%26jtitle%3DPLoS%2520Pathog.%26date%3D2017%26volume%3D13%26issue%3D2%26doi%3D10.1371%2Fjournal.ppat.1006195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual-Iglesias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuniga, S.</span></span> <span> </span><span class="NLM_article-title">Mutagenesis of coronavirus nsp14 reveals its potential role in modulation of the innate immune response</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5399</span>– <span class="NLM_lpage">5414</span>, <span class="refDoi"> DOI: 10.1128/JVI.03259-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.03259-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27009949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFejsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=5399-5414&issue=11&author=M.+Becaresauthor=A.+Pascual-Iglesiasauthor=A.+Nogalesauthor=I.+Solaauthor=L.+Enjuanesauthor=S.+Zuniga&title=Mutagenesis+of+coronavirus+nsp14+reveals+its+potential+role+in+modulation+of+the+innate+immune+response&doi=10.1128%2FJVI.03259-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenesis of coronavirus nsp14 reveals its potential role in modulation of the innate immune response</span></div><div class="casAuthors">Becares, Martina; Pascual-Iglesias, Alejandro; Nogales, Aitor; Sola, Isabel; Enjuanes, Luis; Zuniga, Sonia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5399-5414</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Coronavirus (CoV) nonstructural protein 14 (nsp14) is a 60-kDa protein encoded by the replicase gene that is part of the replication-transcription complex.  It is a bifunctional enzyme bearing 3'-to-5' exoribonuclease (ExoN) and guanine-N7-methyltransferase (N7-MTase) activities.  ExoN hydrolyzes single-stranded RNAs and double-stranded RNAs (dsRNAs) and is part of a proofreading system responsible for the high fidelity of CoV replication.  Nsp14 N7-MTase activity is required for viral mRNA cap synthesis and prevents the recognition of viral mRNAs as non-self by the host cell.  In this work, a set of point mutants affecting different motifs within the ExoN domain of nsp14 was generated, using transmissible gastroenteritis virus as a model of Alphacoronavirus.  Mutants lacking ExoN activity were nonviable despite being competent in both viral RNA and protein synthesis.  A specific mutation within zinc finger 1 (ZF-C) led to prodn. of a viable virus with growth and viral RNA synthesis kinetics similar to that of the parental virus.  Mutant recombinant transmissible gastroenteritis virus (TGEV) ZF-C (rTGEV-ZF-C) caused decreased cytopathic effect and apoptosis compared with the wild-type virus and reduced levels of dsRNA accumulation at late times postinfection.  Consequently, the mutant triggered a reduced antiviral response, which was confirmed by evaluating different stages of the dsRNA-induced antiviral pathway.  The expression of β-interferon (IFN-β), tumor necrosis factor (TNF), and interferon-stimulated genes in cells infected with mutant rTGEV-ZF-C was reduced compared to the levels seen with the parental virus.  Overall, our data revealed a potential role for CoV nsp14 in modulation of the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGB3-IxTwnM7Vg90H21EOLACvtfcHk0liMJ18TzM7EuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFejsbvI&md5=919e9bf908e45df16ca2861e59b252c5</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1128%2FJVI.03259-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.03259-15%26sid%3Dliteratum%253Aachs%26aulast%3DBecares%26aufirst%3DM.%26aulast%3DPascual-Iglesias%26aufirst%3DA.%26aulast%3DNogales%26aufirst%3DA.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DZuniga%26aufirst%3DS.%26atitle%3DMutagenesis%2520of%2520coronavirus%2520nsp14%2520reveals%2520its%2520potential%2520role%2520in%2520modulation%2520of%2520the%2520innate%2520immune%2520response%26jtitle%3DJ.%2520Virol.%26date%3D2016%26volume%3D90%26issue%3D11%26spage%3D5399%26epage%3D5414%26doi%3D10.1128%2FJVI.03259-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">Accessory proteins of SARS-CoV and other coronaviruses</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2014.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2014.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24995382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Klsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2014&pages=97-109&author=D.+X.+Liuauthor=T.+S.+Fungauthor=K.+K.+Chongauthor=A.+Shuklaauthor=R.+Hilgenfeld&title=Accessory+proteins+of+SARS-CoV+and+other+coronaviruses&doi=10.1016%2Fj.antiviral.2014.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Accessory proteins of SARS-CoV and other coronaviruses</span></div><div class="casAuthors">Liu, Ding Xiang; Fung, To Sing; Chong, Kelvin Kian-Long; Shukla, Aditi; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">97-109</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The huge RNA genome of SARS coronavirus comprises a no. of open reading frames that code for a total of eight accessory proteins.  Although none of these are essential for virus replication, some appear to have a role in virus pathogenesis.  Notably, some SARS-CoV accessory proteins have been shown to modulate the interferon signaling pathways and the prodn. of pro-inflammatory cytokines.  The structural information on these proteins is also limited, with only two (p7a and p9b) having their structures detd. by X-ray crystallog.  This review makes an attempt to summarize the published knowledge on SARS-CoV accessory proteins, with an emphasis on their involvement in virus-host interaction.  The accessory proteins of other coronaviruses are also briefly discussed.  This paper forms part of a series of invited articles in Antiviral Research on "From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses" (see Introduction by Hilgenfeld and Peiris (2013)).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9B_fwxwUQULVg90H21EOLACvtfcHk0liMJ18TzM7EuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Klsr3M&md5=7e44f77c8b47f5d41e466b7813774c0d</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2014.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2014.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%2BX.%26aulast%3DFung%26aufirst%3DT.%2BS.%26aulast%3DChong%26aufirst%3DK.%2BK.%26aulast%3DShukla%26aufirst%3DA.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DAccessory%2520proteins%2520of%2520SARS-CoV%2520and%2520other%2520coronaviruses%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D109%26spage%3D97%26epage%3D109%26doi%3D10.1016%2Fj.antiviral.2014.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castano-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D. Y.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">8865</span>– <span class="NLM_lpage">8877</span>, <span class="refDoi"> DOI: 10.1096/fj.201802418R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1096%2Ffj.201802418R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31034780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVWnsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=8865-8877&issue=8&author=K.+L.+Siuauthor=K.+S.+Yuenauthor=C.+Castano-Rodriguezauthor=Z.+W.+Yeauthor=M.+L.+Yeungauthor=S.+Y.+Fungauthor=S.+Yuanauthor=C.+P.+Chanauthor=K.+Y.+Yuenauthor=L.+Enjuanesauthor=D.+Y.+Jin&title=Severe+acute+respiratory+syndrome+coronavirus+ORF3a+protein+activates+the+NLRP3+inflammasome+by+promoting+TRAF3-dependent+ubiquitination+of+ASC&doi=10.1096%2Ffj.201802418R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC</span></div><div class="casAuthors">Siu, Kam-Leung; Yuen, Kit-San; Castano-Rodriguez, Carlos; Ye, Zi-Wei; Yeung, Man-Lung; Fung, Sin-Yee; Yuan, Shuofeng; Chan, Chi-Ping; Yuen, Kwok-Yung; Enjuanes, Luis; Jin, Dong-Yan</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">8865-8877</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) is capable of inducing a storm of proinflammatory cytokines.  In this study, we show that the SARS-CoV open reading frame 3a (ORF3a) accessory protein activates the NLRP3 inflammasome by promoting TNF receptor-assocd. factor 3 (TRAF3)-mediated ubiquitination of apoptosis-assocd. speck-like protein contg. a caspase recruitment domain (ASC).  SARS-CoV and its ORF3a protein were found to be potent activators of pro-IL-1b gene transcription and protein maturation, the 2 signals required for activation of the NLRP3 inflammasome.  ORF3a induced pro-IL-1b transcription through activation of NF-kB, which was mediated by TRAF3-dependent ubiquitination and processing of p105.  ORF3a induced elevation of IL-1b secretion was independent of its ion channel activity or absent in melanoma 2 but required NLRP3, ASC, and TRAF3.  ORF3a interacted with TRAF3 and ASC, colocalized with them in discrete punctate structures in the cytoplasm, and facilitated ASC speck formation.  TRAF3-dependent K63-linked ubiquitination of ASC was more pronounced in SARS-CoV-infected cells or when ORF3a was expressed.  Taken together, our findings reveal a new mechanism by which SARS-CoV ORF3a protein activates NF-kB and the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of p105 and ASC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9PzhM5DkKdLVg90H21EOLACvtfcHk0ljNVdJg702wGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVWnsLrP&md5=f5b36378f985b3e16047b00a0e5e5bde</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1096%2Ffj.201802418R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201802418R%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DK.%2BL.%26aulast%3DYuen%26aufirst%3DK.%2BS.%26aulast%3DCastano-Rodriguez%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DZ.%2BW.%26aulast%3DYeung%26aufirst%3DM.%2BL.%26aulast%3DFung%26aufirst%3DS.%2BY.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DC.%2BP.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DD.%2BY.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520ORF3a%2520protein%2520activates%2520the%2520NLRP3%2520inflammasome%2520by%2520promoting%2520TRAF3-dependent%2520ubiquitination%2520of%2520ASC%26jtitle%3DFASEB%2520J.%26date%3D2019%26volume%3D33%26issue%3D8%26spage%3D8865%26epage%3D8877%26doi%3D10.1096%2Ffj.201802418R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. W.</span></span> <span> </span><span class="NLM_article-title">Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism</span>. <i>J. Microbiol Immunol Infect</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.1016/j.jmii.2015.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jmii.2015.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26320399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCru7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2017&pages=277-285&issue=3&author=S.+H.+Huangauthor=T.+Y.+Leeauthor=Y.+J.+Linauthor=L.+Wanauthor=C.+H.+Laiauthor=C.+W.+Lin&title=Phage+display+technique+identifies+the+interaction+of+severe+acute+respiratory+syndrome+coronavirus+open+reading+frame+6+protein+with+nuclear+pore+complex+interacting+protein+NPIPB3+in+modulating+Type+I+interferon+antagonism&doi=10.1016%2Fj.jmii.2015.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism</span></div><div class="casAuthors">Huang, Su-Hua; Lee, Tzu-Ying; Lin, Ying-Ju; Wan, Lei; Lai, Chih-Ho; Lin, Cheng-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Microbiology, Immunology and Infection</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">JMIIFG</span>;
        ISSN:<span class="NLM_cas:issn">1995-9133</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Taiwan LLC</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) proteins including ORF6 inhibit type I interferon (IFN) signaling.  This study identified SARS-CoV ORF6-interacting proteins using the phage displayed human lung cDNA libraries, and examd. the assocn. of ORF6-host factor interaction with type I IFN antagonism.  After the fifth round of biopanning with Escherichia coli-synthesized ORF6-His tagged protein, the relative binding affinity of phage clones to ORF6 was detd. using direct ELISA.  The highest affinity clone to ORF6 displayed the C-terminal domain of NPIPB3 (nuclear pore complex interacting protein family member B3, also named as phosphatidylinositol-3-kinase-related kinase SMG-1 isoform 1 homolog).  The coimmunopptn. assay demonstrated the direct binding of ORF6 to the C-terminal domain of NPIPB3 in vitro.  Confocal imaging revealed a close colocalization of SARS-CoV ORF6 protein with NPIPB3 in human promonocytes.  The dual luciferase reporter assay showed that the C-terminal domain of NPIPB3 attenuated the antagonistic activity of SARS-CoV ORF6 on IFN-β-induced ISRE (IFN-stimulated response element)-responsive firefly luciferase activity.  In addn., confocal imaging and Western blotting assays revealed that the increases in STAT-1 nuclear translocation and phosphorylation occurred in the transfected cells expressing both genes of ORF6 and NPIPB3, but not in the ORF6-expressing cells in response to IFN-β.  The overexpression of NPIPB3 restored the IFN-β responses in SARS-CoV ORF6 expressing cells, indicating that the interaction of SARS CoV ORF6 and NPIPB3 reduced type I IFN antagonism by SARS-CoV ORF6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogwBju9yFTQbVg90H21EOLACvtfcHk0ljNVdJg702wGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCru7nP&md5=3cd9ce0635d2402fa9bf97467f236f99</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.jmii.2015.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmii.2015.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BY.%26aulast%3DLin%26aufirst%3DY.%2BJ.%26aulast%3DWan%26aufirst%3DL.%26aulast%3DLai%26aufirst%3DC.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BW.%26atitle%3DPhage%2520display%2520technique%2520identifies%2520the%2520interaction%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520open%2520reading%2520frame%25206%2520protein%2520with%2520nuclear%2520pore%2520complex%2520interacting%2520protein%2520NPIPB3%2520in%2520modulating%2520Type%2520I%2520interferon%2520antagonism%26jtitle%3DJ.%2520Microbiol%2520Immunol%2520Infect%26date%3D2017%26volume%3D50%26issue%3D3%26spage%3D277%26epage%3D285%26doi%3D10.1016%2Fj.jmii.2015.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabouw, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langereis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaap, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalebout, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bredenbeek, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikkert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J.</span></span> <span> </span><span class="NLM_article-title">Middle East respiratory coronavirus accessory protein 4a inhibits PKR-mediated antiviral stress responses</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">10</span>), <span class="NLM_elocation-id">e1005982</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1005982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.ppat.1005982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27783669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&issue=10&author=H.+H.+Rabouwauthor=M.+A.+Langereisauthor=R.+C.+Knaapauthor=T.+J.+Daleboutauthor=J.+Cantonauthor=I.+Solaauthor=L.+Enjuanesauthor=P.+J.+Bredenbeekauthor=M.+Kikkertauthor=R.+J.+de+Grootauthor=F.+J.+van+Kuppeveld&title=Middle+East+respiratory+coronavirus+accessory+protein+4a+inhibits+PKR-mediated+antiviral+stress+responses&doi=10.1371%2Fjournal.ppat.1005982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Middle East respiratory coronavirus accessory protein 4a inhibits PKR-mediated antiviral stress responses</span></div><div class="casAuthors">Rabouw, Huib H.; Langereis, Martijn A.; Knaap, Robert C. M.; Dalebout, Tim J.; Canton, Javier; Sola, Isabel; Enjuanes, Luis; Bredenbeek, Peter J.; Kikkert, Marjolein; de Groot, Raoul J.; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1005982/1-e1005982/26</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory infections that can be life-threatening.  To establish an infection and spread, MERS-CoV, like most other viruses, must navigate through an intricate network of antiviral host responses.  Besides the well-known type I interferon (IFN-α/β) response, the protein kinase R (PKR)-mediated stress response is being recognized as an important innate response pathway.  Upon detecting viral dsRNA, PKR phosphorylates eIF2α, leading to the inhibition of cellular and viral translation and the formation of stress granules (SGs), which are increasingly recognized as platforms for antiviral signaling pathways.  It is unknown whether cellular infection by MERS-CoV activates the stress response pathway or whether the virus has evolved strategies to suppress this infection-limiting pathway.  Here, we show that cellular infection with MERS-CoV does not lead to the formation of SGs.  By transiently expressing the MERS-CoV accessory proteins individually, we identified a role of protein 4a (p4a) in preventing activation of the stress response pathway.  Expression of MERS-CoV p4a impeded dsRNA-mediated PKR activation, thereby rescuing translation inhibition and preventing SG formation.  In contrast, p4a failed to suppress stress response pathway activation that is independent of PKR and dsRNA.  MERS-CoV p4a is a dsRNA binding protein.  Mutation of the dsRNA binding motif in p4a disrupted its PKR antagonistic activity.  By inserting p4a in a picornavirus lacking its natural PKR antagonist, we showed that p4a exerts PKR antagonistic activity also under infection conditions.  However, a recombinant MERS-CoV deficient in p4a expression still suppressed SG formation, indicating the expression of at least one other stress response antagonist.  This virus also suppressed the dsRNA-independent stress response pathway.  Thus, MERS-CoV interferes with antiviral stress responses using at least two different mechanisms, with p4a suppressing the PKRPLOS dependent stress response pathway, probably by sequestering dsRNA.  MERS-CoV p4a represents the first coronavirus stress response antagonist described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgh_AxI7g1gLVg90H21EOLACvtfcHk0ljNVdJg702wGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCmsLg%253D&md5=735e048c05d79a88f9e4a96ae9be8f98</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1005982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1005982%26sid%3Dliteratum%253Aachs%26aulast%3DRabouw%26aufirst%3DH.%2BH.%26aulast%3DLangereis%26aufirst%3DM.%2BA.%26aulast%3DKnaap%26aufirst%3DR.%2BC.%26aulast%3DDalebout%26aufirst%3DT.%2BJ.%26aulast%3DCanton%26aufirst%3DJ.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DBredenbeek%26aufirst%3DP.%2BJ.%26aulast%3DKikkert%26aufirst%3DM.%26aulast%3Dde%2BGroot%26aufirst%3DR.%2BJ.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%26atitle%3DMiddle%2520East%2520respiratory%2520coronavirus%2520accessory%2520protein%25204a%2520inhibits%2520PKR-mediated%2520antiviral%2520stress%2520responses%26jtitle%3DPLoS%2520Pathog.%26date%3D2016%26volume%3D12%26issue%3D10%26doi%3D10.1371%2Fjournal.ppat.1005982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boularan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Asab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelhamer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehrl, J. H.</span></span> <span> </span><span class="NLM_article-title">SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3080</span>– <span class="NLM_lpage">3089</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1303196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.4049%2Fjimmunol.1303196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25135833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2qur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2014&pages=3080-3089&issue=6&author=C.+S.+Shiauthor=H.+Y.+Qiauthor=C.+Boularanauthor=N.+N.+Huangauthor=M.+Abu-Asabauthor=J.+H.+Shelhamerauthor=J.+H.+Kehrl&title=SARS-coronavirus+open+reading+frame-9b+suppresses+innate+immunity+by+targeting+mitochondria+and+the+MAVS%2FTRAF3%2FTRAF6+signalosome&doi=10.4049%2Fjimmunol.1303196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-Coronavirus Open Reading Frame-9b Suppresses Innate Immunity by Targeting Mitochondria and the MAVS/TRAF3/TRAF6 Signalosome</span></div><div class="casAuthors">Shi, Chong-Shan; Qi, Hai-Yan; Boularan, Cedric; Huang, Ning-Na; Abu-Asab, Mones; Shelhamer, James H.; Kehrl, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3080-3089</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Coronaviruses (CoV) have recently emerged as potentially serious pathogens that can cause significant human morbidity and death.  The severe acute respiratory syndrome (SARS)-CoV was identified as the etiol. agent of the 2002-2003 international SARS outbreak.  Yet, how SARS evades innate immune responses to cause human disease remains poorly understood.  In this study, we show that a protein encoded by SARS-CoV designated as open reading frame-9b (ORF-9b) localizes to mitochondria and causes mitochondrial elongation by triggering ubiquitination and proteasomal degrdn. of dynamin-like protein 1, a host protein involved in mitochondrial fission.  Also, acting on mitochondria, ORF-9b targets the mitochondrial-assocd. adaptor mol. MAVS signalosome by usurping PCBP2 and the HECT domain E3 ligase AIP4 to trigger the degrdn. of MAVS, TRAF3, and TRAF 6.  This severely limits host cell IFN responses.  Reducing either PCBP2 or AIP4 expression substantially reversed the ORF-9b-mediated redn. of MAVS and the suppression of antiviral transcriptional responses.  Finally, transient ORF-9b expression led to a strong induction of autophagy in cells.  The induction of autophagy depended upon ATG5, a crit. autophagy regulator, but the inhibition of MAVS signaling did not.  These results indicate that SARS-CoV ORF-9b manipulates host cell mitochondria and mitochondrial function to help evade host innate immunity.  This study has uncovered an important clue to the pathogenesis of SARS-CoV infection and illustrates the havoc that a small ORF can cause in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEFurKcfqnO7Vg90H21EOLACvtfcHk0liI5K5pPuXpog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2qur3E&md5=aaac5ff549aa06a3ea33b419bfaec921</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1303196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1303196%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%2BS.%26aulast%3DQi%26aufirst%3DH.%2BY.%26aulast%3DBoularan%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DN.%2BN.%26aulast%3DAbu-Asab%26aufirst%3DM.%26aulast%3DShelhamer%26aufirst%3DJ.%2BH.%26aulast%3DKehrl%26aufirst%3DJ.%2BH.%26atitle%3DSARS-coronavirus%2520open%2520reading%2520frame-9b%2520suppresses%2520innate%2520immunity%2520by%2520targeting%2520mitochondria%2520and%2520the%2520MAVS%252FTRAF3%252FTRAF6%2520signalosome%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D193%26issue%3D6%26spage%3D3080%26epage%3D3089%26doi%3D10.4049%2Fjimmunol.1303196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor</span>. <i>Virol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1007/s12250-015-3581-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs12250-015-3581-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25907116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsVamtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=153-161&issue=2&author=W.+Chengauthor=S.+Chenauthor=R.+Liauthor=Y.+Chenauthor=M.+Wangauthor=D.+Guo&title=Severe+acute+respiratory+syndrome+coronavirus+protein+6+mediates+ubiquitin-dependent+proteosomal+degradation+of+N-Myc+%28and+STAT%29+interactor&doi=10.1007%2Fs12250-015-3581-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor</span></div><div class="casAuthors">Cheng, Weijia; Chen, Shiyou; Li, Ruiling; Chen, Yu; Wang, Min; Guo, Deyin</div><div class="citationInfo"><span class="NLM_cas:title">Virologica Sinica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-161</span>CODEN:
                <span class="NLM_cas:coden">VSIICH</span>;
        ISSN:<span class="NLM_cas:issn">1674-0769</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) encodes eight accessory proteins, the functions of which are not yet fully understood.  SARS-CoV protein 6 (P6) is one of the previously studied accessory proteins that have been documented to enhance viral replication and suppress host interferon (IFN) signaling pathways.  Through yeast two-hybrid screening, we identified eight potential cellular P6-interacting proteins from a human spleen cDNA library.  For further investigation, we targeted the IFN signaling pathway-mediating protein, N-Myc (and STAT) interactor (Nmi).  Its interaction with P6 was confirmed within cells.  The results showed that P6 can promote the ubiquitin-dependent proteosomal degrdn. of Nmi.  This study revealed a new mechanism of SARS-CoV P6 in limiting the IFN signaling to promote SARS-CoV survival in host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDht5aAI4QWLVg90H21EOLACvtfcHk0liI5K5pPuXpog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsVamtL4%253D&md5=c06c5fdd1d599ddb49b35f99fee71050</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1007%2Fs12250-015-3581-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12250-015-3581-8%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520protein%25206%2520mediates%2520ubiquitin-dependent%2520proteosomal%2520degradation%2520of%2520N-Myc%2520%2528and%2520STAT%2529%2520interactor%26jtitle%3DVirol.%2520Sin.%26date%3D2015%26volume%3D30%26issue%3D2%26spage%3D153%26epage%3D161%26doi%3D10.1007%2Fs12250-015-3581-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span> <span> </span><span class="NLM_article-title">NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">483</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1448-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1186%2Fs13046-019-1448-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31805977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitl2ltrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=483&issue=1&author=P.+Xuauthor=S.+Yeauthor=K.+Liauthor=M.+Huangauthor=Q.+Wangauthor=S.+Zengauthor=X.+Chenauthor=W.+Gaoauthor=J.+Chenauthor=Q.+Zhangauthor=Z.+Zhongauthor=Y.+Linauthor=Z.+Rongauthor=Y.+Xuauthor=B.+Haoauthor=A.+Pengauthor=M.+Ouyangauthor=Q.+Liu&title=NOS1+inhibits+the+interferon+response+of+cancer+cells+by+S-nitrosylation+of+HDAC2&doi=10.1186%2Fs13046-019-1448-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2</span></div><div class="casAuthors">Xu, Pengfei; Ye, Shuangyan; Li, Keyi; Huang, Mengqiu; Wang, Qianli; Zeng, Sisi; Chen, Xi; Gao, Wenwen; Chen, Jianping; Zhang, Qianbing; Zhong, Zhuo; Lin, Ying; Rong, Zhili; Xu, Yang; Hao, Bingtao; Peng, Anghui; Ouyang, Manzhao; Liu, Qiuzhen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">483</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">In this study, we investigated the regulation of NOS1 on the interferon response and clarified the relevant mol. mechanisms.  After stable transfection of A375 cells with NOS1 expression plasmids, the transcription and expression of IFNα-stimulated genes (ISGs) were assessed using pISRE luciferase reporter gene anal., RT-PCR, and western blotting, resp.  A biotin-switch assay was performed to detect the S-nitrosylation of HDAC2 by NOS1.  This effect was further evaluated by altering the expression level of HDAC2 or by transfecting the HDAC2-C262A/C274A site mutant plasmids into cells.  The coimmunopptn. assay was performed to detect the interaction of HDAC2 with STAT1 and STAT2.  Overexpression of NOS1 in melanoma cells decreases IFNα-responsiveness and induces the S-nitrosylation of HDAC2-C262/C274.  This modification decreases the binding of HDAC2 with STAT1, thereby reducing the recruitment of HDAC2 to the ISG promoter and the deacetylation of H4K16.  Moreover, expression of a mutant form of HDAC2, which cannot be nitrosylated, reverses the inhibition of ISG expression by NOS1 in vitro and decreases NOS1-induced lung metastasis and inhibition of tumor infiltrating lymphocytes in a melanoma mouse model.  This study provides evidence that NOS1 induces dysfunctional IFN signaling to promote lung metastasis in melanoma, highlighting NOS1-induced S-nitrosylation of HDAC2 in the regulation of IFN signaling via histone modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCu4FXuJSFN7Vg90H21EOLACvtfcHk0liI5K5pPuXpog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitl2ltrzM&md5=2da754594c5f1bd75d20d1b5967a1bfc</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1448-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1448-9%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DRong%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DA.%26aulast%3DOuyang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DQ.%26atitle%3DNOS1%2520inhibits%2520the%2520interferon%2520response%2520of%2520cancer%2520cells%2520by%2520S-nitrosylation%2520of%2520HDAC2%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26issue%3D1%26spage%3D483%26doi%3D10.1186%2Fs13046-019-1448-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span> <span> </span><span class="NLM_article-title">The E3 ubiquitin ligase Nrdp1 ‘preferentially’ promotes TLR-mediated production of type I interferon</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">744</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1038/ni.1742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fni.1742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19483718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1alt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=744-752&issue=7&author=C.+Wangauthor=T.+Chenauthor=J.+Zhangauthor=M.+Yangauthor=N.+Liauthor=X.+Xuauthor=X.+Cao&title=The+E3+ubiquitin+ligase+Nrdp1+%E2%80%98preferentially%E2%80%99+promotes+TLR-mediated+production+of+type+I+interferon&doi=10.1038%2Fni.1742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">The E3 ubiquitin ligase Nrdp1 "preferentially" promotes TLR-mediated production of type I interferon</span></div><div class="casAuthors">Wang, Chen; Chen, Taoyong; Zhang, Jia; Yang, Mingjin; Li, Nan; Xu, Xiongfei; Cao, Xuetao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">744-752</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases are important in both innate and adaptive immunity.  Here the authors report that Nrdp1, an E3 ubiquitin ligase, inhibited the prodn. of proinflammatory cytokines but increased interferon-β prodn. in Toll-like receptor-triggered macrophages by suppressing adaptor MyD88-dependent activation of transcription factors NF-κB and AP-1 while promoting activation of the kinase TBK1 and transcription factor IRF3.  Nrdp1 directly bound and polyubiquitinated MyD88 and TBK1, which led to degrdn. of MyD88 and activation of TBK1.  Knockdown of Nrdp1 inhibited the degrdn. of MyD88 and the activation of TBK1 and IRF3.  Nrdp1-transgenic mice showed resistance to lipopolysaccharide-induced endotoxin shock and to infection with vesicular stomatitis virus.  Apparently, Nrdp1 functions as both an adaptor protein and an E3 ubiquitin ligase to regulate TLR responses in different ways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgPSbpA3sf0rVg90H21EOLACvtfcHk0lhhjT9YniC93g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1alt7s%253D&md5=4721e0bf029130f74cd8909082d77a54</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1038%2Fni.1742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1742%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DX.%26atitle%3DThe%2520E3%2520ubiquitin%2520ligase%2520Nrdp1%2520%25E2%2580%2598preferentially%25E2%2580%2599%2520promotes%2520TLR-mediated%2520production%2520of%2520type%2520I%2520interferon%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D10%26issue%3D7%26spage%3D744%26epage%3D752%26doi%3D10.1038%2Fni.1742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittet, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scadden, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweetser, D. A.</span></span> <span> </span><span class="NLM_article-title">Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-kappaB inflammatory pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1871</span>– <span class="NLM_lpage">1876</span>, <span class="refDoi"> DOI: 10.1073/pnas.1511380113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1511380113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26831087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=1871-1876&issue=7&author=S.+Ramasamyauthor=B.+Saezauthor=S.+Mukhopadhyayauthor=D.+Dingauthor=A.+M.+Ahmedauthor=X.+Chenauthor=F.+Pucciauthor=R.+Yaminauthor=J.+Wangauthor=M.+J.+Pittetauthor=C.+M.+Kelleherauthor=D.+T.+Scaddenauthor=D.+A.+Sweetser&title=Tle1+tumor+suppressor+negatively+regulates+inflammation+in+vivo+and+modulates+NF-kappaB+inflammatory+pathway&doi=10.1073%2Fpnas.1511380113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway</span></div><div class="casAuthors">Ramasamy, Selvi; Saez, Borja; Mukhopadhyay, Subhankar; Ding, Daching; Ahmed, Alwiya M.; Chen, Xi; Pucci, Ferdinando; Yamin, Rae'e; Wang, Jianfeng; Pittet, Mikael J.; Kelleher, Cassandra M.; Scadden, David T.; Sweetser, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1871-1876</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tle1 (transducin-like enhancer of split 1) is a corepressor that interacts with a variety of DNA-binding transcription factors and has been implicated in many cellular functions; however, physiol. studies are limited.  Tle1-deficient Tle1Δ/Δ mice, although grossly normal at birth, exhibit skin defects, lung hypoplasia, severe runting, poor body condition, and early mortality.  Tle1-deficient mice display a chronic inflammatory phenotype with increased expression of inflammatory cytokines and chemokines in the skin, lung, and intestine and increased circulatory IL-6 and G-CSF, along with a hematopoietic shift toward granulocyte macrophage progenitor and myeloid cells.  Tle1-deficient macrophages produce increased inflammatory cytokines in response to Toll-like receptor (TLR) agonists and lipopolysaccharides (LPS), and Tle1-deficient mice display an enhanced inflammatory response to ear skin 12-O-tetradecanoylphorbol-13-acetate treatment.  Loss of Tle1 not only results in increased phosphorylation and activation of proinflammatory NF-κB but also results in decreased Hes1 (hairy and enhancer of split-1), a neg. regulator of inflammation in macrophages.  Furthermore, Tle1-deficient mice exhibit accelerated growth of B6-F10 melanoma xenografts.  The authors' work provides the first in vivo evidence, to the authors' knowledge, that TLE1 is a major counterregulator of inflammation with potential roles in a variety of inflammatory diseases and in cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV9MGdYFsuArVg90H21EOLACvtfcHk0lhhjT9YniC93g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWhu78%253D&md5=80639dceed8fd33bfd0907be9ad0cff0</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1511380113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1511380113%26sid%3Dliteratum%253Aachs%26aulast%3DRamasamy%26aufirst%3DS.%26aulast%3DSaez%26aufirst%3DB.%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPucci%26aufirst%3DF.%26aulast%3DYamin%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPittet%26aufirst%3DM.%2BJ.%26aulast%3DKelleher%26aufirst%3DC.%2BM.%26aulast%3DScadden%26aufirst%3DD.%2BT.%26aulast%3DSweetser%26aufirst%3DD.%2BA.%26atitle%3DTle1%2520tumor%2520suppressor%2520negatively%2520regulates%2520inflammation%2520in%2520vivo%2520and%2520modulates%2520NF-kappaB%2520inflammatory%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D7%26spage%3D1871%26epage%3D1876%26doi%3D10.1073%2Fpnas.1511380113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lokugamage, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hage, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindewolf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajsbaum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menachery, V. D.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 is sensitive to type I interferon pretreatment</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2020.03.07.982264</span> (accessed 2020-05-31) <span class="refDoi"> DOI: 10.1101/2020.03.07.982264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.03.07.982264" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=K.+G.+Lokugamageauthor=A.+Hageauthor=C.+Schindewolfauthor=R.+Rajsbaumauthor=V.+D.+Menachery&title=SARS-CoV-2+is+sensitive+to+type+I+interferon+pretreatment&doi=10.1101%2F2020.03.07.982264"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1101%2F2020.03.07.982264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.03.07.982264%26sid%3Dliteratum%253Aachs%26aulast%3DLokugamage%26aufirst%3DK.%2BG.%26aulast%3DHage%26aufirst%3DA.%26aulast%3DSchindewolf%26aufirst%3DC.%26aulast%3DRajsbaum%26aufirst%3DR.%26aulast%3DMenachery%26aufirst%3DV.%2BD.%26atitle%3DSARS-CoV-2%2520is%2520sensitive%2520to%2520type%2520I%2520interferon%2520pretreatment%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26doi%3D10.1101%2F2020.03.07.982264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyanagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2020.05.11.088179</span> (accessed 2020-05-31) <span class="refDoi"> DOI: 10.1101/2020.05.11.088179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.05.11.088179" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+Konnoauthor=I.+Kimuraauthor=K.+Uriuauthor=M.+Fukushiauthor=T.+Irieauthor=Y.+Koyanagiauthor=S.+Nakagawaauthor=K.+Sato&title=SARS-CoV-2+ORF3b+is+a+potent+interferon+antagonist+whose+activity+is+further+increased+by+a+naturally+occurring+elongation+variant&doi=10.1101%2F2020.05.11.088179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1101%2F2020.05.11.088179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.05.11.088179%26sid%3Dliteratum%253Aachs%26aulast%3DKonno%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DI.%26aulast%3DUriu%26aufirst%3DK.%26aulast%3DFukushi%26aufirst%3DM.%26aulast%3DIrie%26aufirst%3DT.%26aulast%3DKoyanagi%26aufirst%3DY.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DK.%26atitle%3DSARS-CoV-2%2520ORF3b%2520is%2520a%2520potent%2520interferon%2520antagonist%2520whose%2520activity%2520is%2520further%2520increased%2520by%2520a%2520naturally%2520occurring%2520elongation%2520variant%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26doi%3D10.1101%2F2020.05.11.088179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Channappanavar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span> <span> </span><span class="NLM_article-title">Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology</span>. <i>Semin. Immunopathol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1007/s00281-017-0629-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs00281-017-0629-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28466096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntVGquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2017&pages=529-539&issue=5&author=R.+Channappanavarauthor=S.+Perlman&title=Pathogenic+human+coronavirus+infections%3A+causes+and+consequences+of+cytokine+storm+and+immunopathology&doi=10.1007%2Fs00281-017-0629-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology</span></div><div class="casAuthors">Channappanavar, Rudragouda; Perlman, Stanley</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunopathology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">529-539</span>CODEN:
                <span class="NLM_cas:coden">SIEMB7</span>;
        ISSN:<span class="NLM_cas:issn">1863-2297</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Human coronaviruses (hCoVs) can be divided into low pathogenic and highly pathogenic coronaviruses.  The low pathogenic CoVs infect the upper respiratory tract and cause mild, cold-like respiratory illness.  In contrast, highly pathogenic hCoVs such as severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV) predominantly infect lower airways and cause fatal pneumonia.  Severe pneumonia caused by pathogenic hCoVs is often assocd. with rapid virus replication, massive inflammatory cell infiltration and elevated pro-inflammatory cytokine/chemokine responses resulting in acute lung injury (ALI), and acute respiratory distress syndrome (ARDS).  Recent studies in exptl. infected animal strongly suggest a crucial role for virus-induced immunopathol. events in causing fatal pneumonia after hCoV infections.  Here we review the current understanding of how a dysregulated immune response may cause lung immunopathol. leading to deleterious clin. manifestations after pathogenic hCoV infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirTei_9NOcbVg90H21EOLACvtfcHk0liSAcPgb48fnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntVGquro%253D&md5=0a03e70c30c8d2f39db0a359f9e2e362</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1007%2Fs00281-017-0629-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00281-017-0629-x%26sid%3Dliteratum%253Aachs%26aulast%3DChannappanavar%26aufirst%3DR.%26aulast%3DPerlman%26aufirst%3DS.%26atitle%3DPathogenic%2520human%2520coronavirus%2520infections%253A%2520causes%2520and%2520consequences%2520of%2520cytokine%2520storm%2520and%2520immunopathology%26jtitle%3DSemin.%2520Immunopathol.%26date%3D2017%26volume%3D39%26issue%3D5%26spage%3D529%26epage%3D539%26doi%3D10.1007%2Fs00281-017-0629-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span> <span> </span><span class="NLM_article-title">Pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection</span>. <i>SSRN</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.2139/ssrn.3527420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.2139%2Fssrn.3527420" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=M.+Yang&title=Pyroptosis%2C+a+potential+pathogenic+mechanism+of+2019-nCoV+infection&doi=10.2139%2Fssrn.3527420"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.2139%2Fssrn.3527420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2139%252Fssrn.3527420%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26atitle%3DPyroptosis%252C%2520a%2520potential%2520pathogenic%2520mechanism%2520of%25202019-nCoV%2520infection%26jtitle%3DSSRN%26date%3D2020%26doi%3D10.2139%2Fssrn.3527420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, R.Y.T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, V.C.C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, W.H.W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I.F.N</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.S.W</span></span> <span> </span><span class="NLM_article-title">In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds</span>. <i>J. Clin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.jcv.2004.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jcv.2004.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15288617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Onurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=69-75&issue=1&author=F+Chenauthor=K.H+Chanauthor=Y+Jiangauthor=R.Y.T+Kaoauthor=H.T+Luauthor=K.W+Fanauthor=V.C.C+Chengauthor=W.H.W+Tsuiauthor=I.F.N+Hungauthor=T.S.W+Lee&title=In+vitro+susceptibility+of+10+clinical+isolates+of+SARS+coronavirus+to+selected+antiviral+compounds&doi=10.1016%2Fj.jcv.2004.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds</span></div><div class="casAuthors">Chen, F.; Chan, K. H.; Jiang, Y.; Kao, R. Y. T.; Lu, H. T.; Fan, K. W.; Cheng, V. C. C.; Tsui, W. H. W.; Hung, I. F. N.; Lee, T. S. W.; Guan, Y.; Peiris, J. S. M.; Yuen, K. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-75</span>CODEN:
                <span class="NLM_cas:coden">JCVIFB</span>;
        ISSN:<span class="NLM_cas:issn">1386-6532</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Effective antiviral agents are urgently needed to combat the possible return of severe acute respiratory syndrome (SARS).  Com. antiviral agents and pure chem. compds. extd. from traditional Chinese medicinal herbs were screened against 10 clin. isolates of SARS coronavirus by neutralization tests with confirmation by plaque redn. assays.  Interferon-beta-1a, leukocytic interferon-alpha, ribavirin, lopinavir, rimantadine, baicalin and glycyrrhizin showed antiviral activity.  The two interferons were only active if the cell lines were pre-incubated with the drugs 16 h before viral inoculation.  Results were confirmed by plaque redn. assays.  Antiviral activity varied with the use of different cell lines.  Checkerboard assays for synergy were performed showing combinations of interferon beta-1a or leukocytic interferon-alpha with ribavirin are synergistic.  Since the clin. and toxicity profiles of these agents are well known, they should be considered either singly or in combination for prophylaxis or treatment of SARS in randomized placebo controlled trials in future epidemics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx0935yAiE4LVg90H21EOLACvtfcHk0liSAcPgb48fnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Onurg%253D&md5=157e8ed46e0290359ba28a7211eca170</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.jcv.2004.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcv.2004.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF%26aulast%3DChan%26aufirst%3DK.H%26aulast%3DJiang%26aufirst%3DY%26aulast%3DKao%26aufirst%3DR.Y.T%26aulast%3DLu%26aufirst%3DH.T%26aulast%3DFan%26aufirst%3DK.W%26aulast%3DCheng%26aufirst%3DV.C.C%26aulast%3DTsui%26aufirst%3DW.H.W%26aulast%3DHung%26aufirst%3DI.F.N%26aulast%3DLee%26aufirst%3DT.S.W%26atitle%3DIn%2520vitro%2520susceptibility%2520of%252010%2520clinical%2520isolates%2520of%2520SARS%2520coronavirus%2520to%2520selected%2520antiviral%2520compounds%26jtitle%3DJ.%2520Clin.%2520Virol.%26date%3D2004%26volume%3D31%26issue%3D1%26spage%3D69%26epage%3D75%26doi%3D10.1016%2Fj.jcv.2004.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenstern, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerr, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinatl, J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>326</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">908</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.11.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bbrc.2004.11.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15607755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVykurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2005&pages=905-908&issue=4&author=B.+Morgensternauthor=M.+Michaelisauthor=P.+C.+Baerauthor=H.+W.+Doerrauthor=J.+Cinatl&title=Ribavirin+and+interferon-beta+synergistically+inhibit+SARS-associated+coronavirus+replication+in+animal+and+human+cell+lines&doi=10.1016%2Fj.bbrc.2004.11.128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines</span></div><div class="casAuthors">Morgenstern, Birgit; Michaelis, Martin; Baer, Patrick C.; Doerr, Hans W.; Cinatl, Jindrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">905-908</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Initial in vitro investigations demonstrated type I interferons (IFNs: IFN-α, IFN-β) to inhibit replication of SARS coronavirus (SARS-CoV), but found the nucleoside analog ribavirin ineffective in Vero cells.  In this report, ribavirin was shown to inhibit SARS-CoV replication in five different cell types of animal or human origin at therapeutically achievable concns.  Since clin. anti-SARS-CoV activity of type I interferons or ribavirin is limited, we investigated the combination of IFN-β and ribavirin.  Detn. of the virus yield indicated highly synergistic anti-SARS-CoV action of the combination suggesting the consideration of ribavirin plus IFN-β for the treatment of SARS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptUzigPDhnprVg90H21EOLACvtfcHk0liSAcPgb48fnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVykurzK&md5=938eb92c0e021aea3cb999bb60f5ba6a</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.11.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.11.128%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenstern%26aufirst%3DB.%26aulast%3DMichaelis%26aufirst%3DM.%26aulast%3DBaer%26aufirst%3DP.%2BC.%26aulast%3DDoerr%26aufirst%3DH.%2BW.%26aulast%3DCinatl%26aufirst%3DJ.%26atitle%3DRibavirin%2520and%2520interferon-beta%2520synergistically%2520inhibit%2520SARS-associated%2520coronavirus%2520replication%2520in%2520animal%2520and%2520human%2520cell%2520lines%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D326%26issue%3D4%26spage%3D905%26epage%3D908%26doi%3D10.1016%2Fj.bbrc.2004.11.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falzarano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brining, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushmaker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martellaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baseler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benecke, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katze, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munster, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, H.</span></span> <span> </span><span class="NLM_article-title">Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1038/nm.3362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnm.3362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24013700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2ktr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1313-1317&issue=10&author=D.+Falzaranoauthor=E.+de+Witauthor=A.+L.+Rasmussenauthor=F.+Feldmannauthor=A.+Okumuraauthor=D.+P.+Scottauthor=D.+Briningauthor=T.+Bushmakerauthor=C.+Martellaroauthor=L.+Baselerauthor=A.+G.+Beneckeauthor=M.+G.+Katzeauthor=V.+J.+Munsterauthor=H.+Feldmann&title=Treatment+with+interferon-alpha2b+and+ribavirin+improves+outcome+in+MERS-CoV-infected+rhesus+macaques&doi=10.1038%2Fnm.3362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques</span></div><div class="casAuthors">Falzarano, Darryl; de Wit, Emmie; Rasmussen, Angela L.; Feldmann, Friederike; Okumura, Atsushi; Scott, Dana P.; Brining, Doug; Bushmaker, Trenton; Martellaro, Cynthia; Baseler, Laura; Benecke, Arndt G.; Katze, Michael G.; Munster, Vincent J.; Feldmann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1313-1317</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) is of global concern: the virus has caused severe respiratory illness, with 111 confirmed cases and 52 deaths at the time of this article's publication.  Therapeutic interventions have not been evaluated in vivo; thus, patient management relies exclusively on supportive care, which, given the high case-fatality rate, is not highly effective.  The rhesus macaque is the only known model organism for MERS-CoV infection, developing an acute localized to widespread pneumonia with transient clin. disease that recapitulates mild to moderate human MERS-CoV cases.  The combination of interferon-α2b and ribavirin was effective in reducing MERS-CoV replication in vitro; therefore, we initiated this treatment 8 h after inoculation of rhesus macaques.  In contrast to untreated, infected macaques, treated animals did not develop breathing abnormalities and showed no or very mild radiog. evidence of pneumonia.  Moreover, treated animals showed lower levels of systemic (serum) and local (lung) proinflammatory markers, in addn. to fewer viral genome copies, distinct gene expression and less severe histopathol. changes in the lungs.  Taken together, these data suggest that treatment of MERS-CoV infected rhesus macaques with IFN-α2b and ribavirin reduces virus replication, moderates the host response and improves clin. outcome.  As these two drugs are already used in combination in the clinic for other infections, IFN-α2b and ribavirin should be considered for the management of MERS-CoV cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7KRGZlqCpC7Vg90H21EOLACvtfcHk0lj8VZekiN6GPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2ktr3J&md5=fa75c7f4bef47ddd13487708188ccb34</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1038%2Fnm.3362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3362%26sid%3Dliteratum%253Aachs%26aulast%3DFalzarano%26aufirst%3DD.%26aulast%3Dde%2BWit%26aufirst%3DE.%26aulast%3DRasmussen%26aufirst%3DA.%2BL.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DOkumura%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DD.%2BP.%26aulast%3DBrining%26aufirst%3DD.%26aulast%3DBushmaker%26aufirst%3DT.%26aulast%3DMartellaro%26aufirst%3DC.%26aulast%3DBaseler%26aufirst%3DL.%26aulast%3DBenecke%26aufirst%3DA.%2BG.%26aulast%3DKatze%26aufirst%3DM.%2BG.%26aulast%3DMunster%26aufirst%3DV.%2BJ.%26aulast%3DFeldmann%26aufirst%3DH.%26atitle%3DTreatment%2520with%2520interferon-alpha2b%2520and%2520ribavirin%2520improves%2520outcome%2520in%2520MERS-CoV-infected%2520rhesus%2520macaques%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26issue%3D10%26spage%3D1313%26epage%3D1317%26doi%3D10.1038%2Fnm.3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span> <span> </span><span class="NLM_article-title">Treatment with Lopinavir/Ritonavir or Interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>212</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1904</span>– <span class="NLM_lpage">1913</span>, <span class="refDoi"> DOI: 10.1093/infdis/jiv392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1093%2Finfdis%2Fjiv392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26198719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVOqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=1904-1913&issue=12&author=J.+F.+Chanauthor=Y.+Yaoauthor=M.+L.+Yeungauthor=W.+Dengauthor=L.+Baoauthor=L.+Jiaauthor=F.+Liauthor=C.+Xiaoauthor=H.+Gaoauthor=P.+Yuauthor=J.+P.+Caiauthor=H.+Chuauthor=J.+Zhouauthor=H.+Chenauthor=C.+Qinauthor=K.+Y.+Yuen&title=Treatment+with+Lopinavir%2FRitonavir+or+Interferon-beta1b+improves+outcome+of+MERS-CoV+infection+in+a+nonhuman+primate+model+of+common+marmoset&doi=10.1093%2Finfdis%2Fjiv392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERSCoV infection in a nonhuman primate model of common marmoset</span></div><div class="casAuthors">Chan, Jasper Fuk-Woo; Yao, Yanfeng; Yeung, Man-Lung; Deng, Wei; Bao, Linlin; Jia, Lilong; Li, Fengdi; Xiao, Chong; Gao, Hong; Yu, Pin; Cai, Jian-Piao; Chu, Hin; Zhou, Jie; Chen, Honglin; Qin, Chuan; Yuen, Kwok-Yung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1904-1913</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe disease in human with an overall case-fatality rate of >35%.  Effective antivirals are crucial for improving the clin. outcome of MERS.  Although a no. of repurposed drugs, convalescent-phase plasma, antiviral peptides, and neutralizing antibodies exhibit anti-MERS-CoV activity in vitro, most are not readily available or have not been evaluated in nonhuman primates.  We assessed 3 repurposed drugs with potent in vitro anti-MERS-CoV activity (mycophenolate mofetil [MMF], lopinavir/ritonavir, and interferon-β1b) in common marmosets with severe disease resembling MERS in humans.  The lopinavir/ritonavir-treated and interferon-β1b-treated animals had better outcome than the untreated animals, with improved clin. (mean clin. scores ↓50.9%-95.0% and ↓wt. loss than the untreated animals), radiol. (minimal pulmonary infiltrates), and pathol. (mild bronchointerstitial pneumonia) findings, and lower mean viral loads in necropsied lung (↓0.59-1.06 log10 copies/glyceraldehyde 3-phosphate dehydrogenase [GAPDH]; P < .050) and extrapulmonary (↓0.11-1.29 log10 copies/GAPDH; P < .050 in kidney) tissues.  In contrast, all MMF-treated animals developed severe and/or fatal disease with higher mean viral loads (↑0.15-0.54 log10 copies/GAPDH) than the untreated animals.  The mortality rate at 36 h postinoculation was 67% (untreated and MMF-treated) vs. 0-33% (lopinavir/ritonavir-treated and interferon-β1b-treated).  Lopinavir/ritonavir and interferon-β1b alone or in combination should be evaluated in clin. trials.  MMF alone may worsen MERS and should not be used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5dKSKmz6KkLVg90H21EOLACvtfcHk0lj8VZekiN6GPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVOqtQ%253D%253D&md5=3a46776e71712f1779b3680c890b882d</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiv392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiv392%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DYeung%26aufirst%3DM.%2BL.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DCai%26aufirst%3DJ.%2BP.%26aulast%3DChu%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26atitle%3DTreatment%2520with%2520Lopinavir%252FRitonavir%2520or%2520Interferon-beta1b%2520improves%2520outcome%2520of%2520MERS-CoV%2520infection%2520in%2520a%2520nonhuman%2520primate%2520model%2520of%2520common%2520marmoset%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D212%26issue%3D12%26spage%3D1904%26epage%3D1913%26doi%3D10.1093%2Finfdis%2Fjiv392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lung, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tso, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shum, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lung, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lie, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span> <span> </span><span class="NLM_article-title">Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span>,  <span class="NLM_fpage">1695</span>– <span class="NLM_lpage">1704</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)31042-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2931042-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32401715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovFOjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=1695-1704&author=I.+F.+Hungauthor=K.+C.+Lungauthor=E.+Y.+Tsoauthor=R.+Liuauthor=T.+W.+Chungauthor=M.+Y.+Chuauthor=Y.+Y.+Ngauthor=J.+Loauthor=J.+Chanauthor=A.+R.+Tamauthor=H.+P.+Shumauthor=V.+Chanauthor=A.+K.+Wuauthor=K.+M.+Sinauthor=W.+S.+Leungauthor=W.+L.+Lawauthor=D.+C.+Lungauthor=S.+Sinauthor=P.+Yeungauthor=C.+C.+Yipauthor=R.+R.+Zhangauthor=A.+Y.+Fungauthor=E.+Y.+Yanauthor=K.+H.+Leungauthor=J.+D.+Ipauthor=A.+W.+Chuauthor=W.+M.+Chanauthor=A.+C.+Ngauthor=R.+Leeauthor=K.+Fungauthor=A.+Yeungauthor=T.+C.+Wuauthor=J.+W.+Chanauthor=W.+W.+Yanauthor=W.+M.+Chanauthor=J.+F.+Chanauthor=A.+K.+Lieauthor=O.+T.+Tsangauthor=V.+C.+Chengauthor=T.+L.+Queauthor=C.+S.+Lauauthor=K.+H.+Chanauthor=K.+K.+Toauthor=K.+Y.+Yuen&title=Triple+combination+of+interferon+beta-1b%2C+lopinavir-ritonavir%2C+and+ribavirin+in+the+treatment+of+patients+admitted+to+hospital+with+COVID-19%3A+an+open-label%2C+randomised%2C+phase+2+trial&doi=10.1016%2FS0140-6736%2820%2931042-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial</span></div><div class="casAuthors">Hung, Ivan Fan-Ngai; Lung, Kwok-Cheung; Tso, Eugene Yuk-Keung; Liu, Raymond; Chung, Tom Wai-Hin; Chu, Man-Yee; Ng, Yuk-Yung; Lo, Jenny; Chan, Jacky; Tam, Anthony Raymond; Shum, Hoi-Ping; Chan, Veronica; Wu, Alan Ka-Lun; Sin, Kit-Man; Leung, Wai-Shing; Law, Wai-Lam; Lung, David Christopher; Sin, Simon; Yeung, Pauline; Yip, Cyril Chik-Yan; Zhang, Ricky Ruiqi; Fung, Agnes Yim-Fong; Yan, Erica Yuen-Wing; Leung, Kit-Hang; Ip, Jonathan Daniel; Chu, Allen Wing-Ho; Chan, Wan-Mui; Ng, Anthony Chin-Ki; Lee, Rodney; Fung, Kitty; Yeung, Alwin; Wu, Tak-Chiu; Chan, Johnny Wai-Man; Yan, Wing-Wah; Chan, Wai-Ming; Chan, Jasper Fuk-Woo; Lie, Albert Kwok-Wai; Tsang, Owen Tak-Yin; Cheng, Vincent Chi-Chung; Que, Tak-Lun; Lau, Chak-Sing; Chan, Kwok-Hung; To, Kelvin Kai-Wang; Yuen, Kwok-Yung</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10238</span>),
    <span class="NLM_cas:pages">1695-1704</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic.  We assessed the efficacy and safety of combined interferon beta-1b, lopinavir-ritonavir, and ribavirin for treating patients with COVID-19.  This was a multicenter, prospective, open-label, randomized, phase 2 trial in adults with COVID-19 who were admitted to six hospitals in Hong Kong.  Patients were randomly assigned (2:1) to a 14-day combination of lopinavir 400 mg and ritonavir 100 mg every 12 h, ribavirin 400 mg every 12 h, and three doses of 8 million IU of interferon beta-1b on alternate days (combination group) or to 14 days of lopinavir 400 mg and ritonavir 100 mg every 12 h (control group).  The primary endpoint was the time to providing a nasopharyngeal swab neg. for severe acute respiratory syndrome coronavirus 2 RT-PCR, and was done in the intention-to-treat population.  The study is registered with ClinicalTrials.gov, NCT04276688.  Between Feb 10 and March 20, 2020, 127 patients were recruited; 86 were randomly assigned to the combination group and 41 were assigned to the control group.  The median no. of days from symptom onset to start of study treatment was 5 days (IQR 3-7).  The combination group had a significantly shorter median time from start of study treatment to neg. nasopharyngeal swab (7 days [IQR 5-11]) than the control group (12 days [8-15]; hazard ratio 4·37 [95% CI 1·86-10·24], p=0·0010).  Adverse events included self-limited nausea and diarrhea with no difference between the two groups.  One patient in the control group discontinued lopinavir-ritonavir because of biochem. hepatitis.  No patients died during the study.  Early triple antiviral therapy was safe and superior to lopinavir-ritonavir alone in alleviating symptoms and shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19.  Future clin. study of a double antiviral therapy with interferon beta-1b as a backbone is warranted.  The Shaw-Foundation, Richard and Carol Yu, May Tam Mak Mei Yin, and Sanming Project of Medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriJEGOjYCdy7Vg90H21EOLACvtfcHk0ljIGKdQjiXmfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovFOjsr0%253D&md5=3729ea5b5e707167e9c26296e4ce2dbb</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2931042-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252931042-4%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DI.%2BF.%26aulast%3DLung%26aufirst%3DK.%2BC.%26aulast%3DTso%26aufirst%3DE.%2BY.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DChu%26aufirst%3DM.%2BY.%26aulast%3DNg%26aufirst%3DY.%2BY.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DA.%2BR.%26aulast%3DShum%26aufirst%3DH.%2BP.%26aulast%3DChan%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DA.%2BK.%26aulast%3DSin%26aufirst%3DK.%2BM.%26aulast%3DLeung%26aufirst%3DW.%2BS.%26aulast%3DLaw%26aufirst%3DW.%2BL.%26aulast%3DLung%26aufirst%3DD.%2BC.%26aulast%3DSin%26aufirst%3DS.%26aulast%3DYeung%26aufirst%3DP.%26aulast%3DYip%26aufirst%3DC.%2BC.%26aulast%3DZhang%26aufirst%3DR.%2BR.%26aulast%3DFung%26aufirst%3DA.%2BY.%26aulast%3DYan%26aufirst%3DE.%2BY.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DIp%26aufirst%3DJ.%2BD.%26aulast%3DChu%26aufirst%3DA.%2BW.%26aulast%3DChan%26aufirst%3DW.%2BM.%26aulast%3DNg%26aufirst%3DA.%2BC.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DFung%26aufirst%3DK.%26aulast%3DYeung%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DT.%2BC.%26aulast%3DChan%26aufirst%3DJ.%2BW.%26aulast%3DYan%26aufirst%3DW.%2BW.%26aulast%3DChan%26aufirst%3DW.%2BM.%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DLie%26aufirst%3DA.%2BK.%26aulast%3DTsang%26aufirst%3DO.%2BT.%26aulast%3DCheng%26aufirst%3DV.%2BC.%26aulast%3DQue%26aufirst%3DT.%2BL.%26aulast%3DLau%26aufirst%3DC.%2BS.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DTo%26aufirst%3DK.%2BK.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26atitle%3DTriple%2520combination%2520of%2520interferon%2520beta-1b%252C%2520lopinavir-ritonavir%252C%2520and%2520ribavirin%2520in%2520the%2520treatment%2520of%2520patients%2520admitted%2520to%2520hospital%2520with%2520COVID-19%253A%2520an%2520open-label%252C%2520randomised%252C%2520phase%25202%2520trial%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26spage%3D1695%26epage%3D1704%26doi%3D10.1016%2FS0140-6736%2820%2931042-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mordstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neugebauer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditt, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorgeloos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwemmle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staeheli, P.</span></span> <span> </span><span class="NLM_article-title">Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5670</span>– <span class="NLM_lpage">5677</span>, <span class="refDoi"> DOI: 10.1128/JVI.00272-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.00272-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=20335250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3cXms1aktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=5670-5677&issue=11&author=M.+Mordsteinauthor=E.+Neugebauerauthor=V.+Dittauthor=B.+Jessenauthor=T.+Riegerauthor=V.+Falconeauthor=F.+Sorgeloosauthor=S.+Ehlauthor=D.+Mayerauthor=G.+Kochsauthor=M.+Schwemmleauthor=S.+Guntherauthor=C.+Drostenauthor=T.+Michielsauthor=P.+Staeheli&title=Lambda+interferon+renders+epithelial+cells+of+the+respiratory+and+gastrointestinal+tracts+resistant+to+viral+infections&doi=10.1128%2FJVI.00272-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections</span></div><div class="casAuthors">Mordstein, Markus; Neugebauer, Eva; Ditt, Vanessa; Jessen, Birthe; Rieger, Toni; Falcone, Valeria; Sorgeloos, Frederic; Ehl, Stephan; Mayer, Daniel; Kochs, Georg; Schwemmle, Martin; Guenther, Stephan; Drosten, Christian; Michiels, Thomas; Staeheli, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5670-5677</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Virus-infected cells secrete a broad range of interferons (IFN) which confer resistance to yet uninfected cells by triggering the synthesis of antiviral factors.  The relative contributions of the various IFN subtypes to innate immunity against virus infections remain elusive.  IFN-α, IFN-β, and other type I IFN mols. signal through a common, universally expressed cell surface receptor, whereas type III IFN (IFN-λ) uses a distinct cell-type-specific receptor complex for signaling.  Using mice lacking functional receptors for type I IFN, type III IFN, or both, we found that IFN-λ plays an important role in the defense against several human pathogens that infect the respiratory tract, such as influenza A virus, influenza B virus, respiratory syncytial virus, human metapneumovirus, and severe acute respiratory syndrome (SARS) coronavirus.  These viruses were more pathogenic and replicated to higher titers in the lungs of mice lacking both IFN receptors than in mice with single IFN receptor defects.  In contrast, Lassa fever virus, which infects via the respiratory tract but primarily replicates in the liver, was not influenced by the IFN-λ receptor defect.  Careful anal. revealed that expression of functional IFN-λ receptor complexes in the lung and intestinal tract is restricted to epithelial cells and a few other, undefined cell types.  Interestingly, we found that SARS coronavirus was present in feces from infected mice lacking receptors for both type I and type III IFN but not in those from mice lacking single receptors, supporting the view that IFN-λ contributes to the control of viral infections in epithelial cells of both respiratory and gastrointestinal tracts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojNv3xmJUl_LVg90H21EOLACvtfcHk0ljIGKdQjiXmfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXms1aktLc%253D&md5=8ac1aae5fb35c311008df99440eb0441</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1128%2FJVI.00272-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00272-10%26sid%3Dliteratum%253Aachs%26aulast%3DMordstein%26aufirst%3DM.%26aulast%3DNeugebauer%26aufirst%3DE.%26aulast%3DDitt%26aufirst%3DV.%26aulast%3DJessen%26aufirst%3DB.%26aulast%3DRieger%26aufirst%3DT.%26aulast%3DFalcone%26aufirst%3DV.%26aulast%3DSorgeloos%26aufirst%3DF.%26aulast%3DEhl%26aufirst%3DS.%26aulast%3DMayer%26aufirst%3DD.%26aulast%3DKochs%26aufirst%3DG.%26aulast%3DSchwemmle%26aufirst%3DM.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DMichiels%26aufirst%3DT.%26aulast%3DStaeheli%26aufirst%3DP.%26atitle%3DLambda%2520interferon%2520renders%2520epithelial%2520cells%2520of%2520the%2520respiratory%2520and%2520gastrointestinal%2520tracts%2520resistant%2520to%2520viral%2520infections%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26issue%3D11%26spage%3D5670%26epage%3D5677%26doi%3D10.1128%2FJVI.00272-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahlakoiv, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeDiego, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staeheli, P.</span></span> <span> </span><span class="NLM_article-title">Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2601</span>– <span class="NLM_lpage">2605</span>, <span class="refDoi"> DOI: 10.1099/vir.0.046284-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.046284-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22956738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVWisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2012&pages=2601-2605&issue=12&author=T.+Mahlakoivauthor=D.+Ritzauthor=M.+Mordsteinauthor=M.+L.+DeDiegoauthor=L.+Enjuanesauthor=M.+A.+Mullerauthor=C.+Drostenauthor=P.+Staeheli&title=Combined+action+of+type+I+and+type+III+interferon+restricts+initial+replication+of+severe+acute+respiratory+syndrome+coronavirus+in+the+lung+but+fails+to+inhibit+systemic+virus+spread&doi=10.1099%2Fvir.0.046284-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread</span></div><div class="casAuthors">Mahlakoiv, Tanel; Ritz, Daniel; Mordstein, Markus; DeDiego, Marta L.; Enjuanes, Luis; Mueller, Marcel A.; Drosten, Christian; Staeheli, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2601-2605</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">STAT1-deficient mice are more susceptible to infection with severe acute respiratory syndrome coronavirus (SARS-CoV) than type I interferon (IFN) receptor-deficient mice.  We used mice lacking functional receptors for both type I and type III IFN (double knockout, dKO) to evaluate the possibility that type III IFN plays a decisive role in SARS-CoV protection.  We found that viral peak titers in lungs of dKO and STAT1-deficient mice were similar, but significantly higher than in wild-type mice.  The kinetics of viral clearance from the lung were also comparable in dKO and STAT1-deficient mice.  Surprisingly, however, infected dKO mice remained healthy, whereas infected STAT1-deficient mice developed liver pathol. and eventually succumbed to neurol. disease.  Our data suggest that the failure of STAT1-deficient mice to control initial SARS-CoV replication efficiently in the lung is due to impaired type I and type III IFN signalling, whereas the failure to control subsequent systemic viral spread is due to unrelated defects in STAT1-deficient mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVs0kbieLFibVg90H21EOLACvtfcHk0ljIGKdQjiXmfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVWisg%253D%253D&md5=7ca5ee98b8d50b328f8a25ad86dc3970</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.046284-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.046284-0%26sid%3Dliteratum%253Aachs%26aulast%3DMahlakoiv%26aufirst%3DT.%26aulast%3DRitz%26aufirst%3DD.%26aulast%3DMordstein%26aufirst%3DM.%26aulast%3DDeDiego%26aufirst%3DM.%2BL.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DStaeheli%26aufirst%3DP.%26atitle%3DCombined%2520action%2520of%2520type%2520I%2520and%2520type%2520III%2520interferon%2520restricts%2520initial%2520replication%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520in%2520the%2520lung%2520but%2520fails%2520to%2520inhibit%2520systemic%2520virus%2520spread%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2012%26volume%3D93%26issue%3D12%26spage%3D2601%26epage%3D2605%26doi%3D10.1099%2Fvir.0.046284-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span> <span> </span><span class="NLM_article-title">Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia</span>. <i>Signal Transduct Target Ther</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.1038/s41392-020-0127-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41392-020-0127-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32296012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB38zlsl2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=18&issue=1&author=W.+Zhouauthor=Y.+Liuauthor=D.+Tianauthor=C.+Wangauthor=S.+Wangauthor=J.+Chengauthor=M.+Huauthor=M.+Fangauthor=Y.+Gao&title=Potential+benefits+of+precise+corticosteroids+therapy+for+severe+2019-nCoV+pneumonia&doi=10.1038%2Fs41392-020-0127-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia</span></div><div class="casAuthors">Zhou Wei; Gao Yue; Liu Yisi; Tian Dongdong; Wang Cheng; Wang Sa; Cheng Jing; Hu Ming; Fang Minghao</div><div class="citationInfo"><span class="NLM_cas:title">Signal transduction and targeted therapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJP91n08onw_6AExegM5LLfW6udTcc2eapm6tnXyJfobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38zlsl2itw%253D%253D&md5=44f46586d789976a4c059526e9030037</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1038%2Fs41392-020-0127-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41392-020-0127-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DY.%26atitle%3DPotential%2520benefits%2520of%2520precise%2520corticosteroids%2520therapy%2520for%2520severe%25202019-nCoV%2520pneumonia%26jtitle%3DSignal%2520Transduct%2520Target%2520Ther%26date%3D2020%26volume%3D5%26issue%3D1%26spage%3D18%26doi%3D10.1038%2Fs41392-020-0127-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span> <span> </span><span class="NLM_article-title">On the use of corticosteroids for 2019-nCoV pneumonia</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span> (<span class="NLM_issue">10225</span>),  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)30361-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2930361-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32122468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtVarsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=683-684&issue=10225&author=L.+Shangauthor=J.+Zhaoauthor=Y.+Huauthor=R.+Duauthor=B.+Cao&title=On+the+use+of+corticosteroids+for+2019-nCoV+pneumonia&doi=10.1016%2FS0140-6736%2820%2930361-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">On the use of corticosteroids for 2019-nCoV pneumonia</span></div><div class="casAuthors">Shang, Lianhan; Zhao, Jianping; Hu, Yi; Du, Ronghui; Cao, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10225</span>),
    <span class="NLM_cas:pages">683-684</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review discussing use of corticosteroids for 2019-nCoV pneumonia.  It also discusses liberal use of corticosteroids is not recommend but low dose is advisable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq02_7GcA2c8bVg90H21EOLACvtfcHk0lgbMjkc1LWkqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtVarsbY%253D&md5=de66bbea0c31e3985b7c241bf87288ad</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2930361-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252930361-5%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DB.%26atitle%3DOn%2520the%2520use%2520of%2520corticosteroids%2520for%25202019-nCoV%2520pneumonia%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26issue%3D10225%26spage%3D683%26epage%3D684%26doi%3D10.1016%2FS0140-6736%2820%2930361-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, K.</span></span> <span> </span><span class="NLM_article-title">Tocilizumab treatment in severe COVID-19 patients attenuates the inflammatory storm incited by monocyte centric immune interactions revealed by single-cell analysis</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2020.04.08.029769</span> (accessed 2020-05-30) <span class="refDoi"> DOI: 10.1101/2020.04.08.029769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.04.08.029769" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=C.+Guoauthor=B.+Liauthor=H.+Maauthor=X.+Wangauthor=P.+Caiauthor=Q.+Yuauthor=L.+Zhuauthor=L.+Jinauthor=C.+Jiangauthor=J.+Fangauthor=Q.+Liuauthor=D.+Zongauthor=W.+Zhangauthor=Y.+Luauthor=K.+Liauthor=X.+Gaoauthor=B.+Fuauthor=L.+Liuauthor=X.+Maauthor=J.+Wengauthor=H.+Weiauthor=T.+Jinauthor=J.+Linauthor=K.+Qu&title=Tocilizumab+treatment+in+severe+COVID-19+patients+attenuates+the+inflammatory+storm+incited+by+monocyte+centric+immune+interactions+revealed+by+single-cell+analysis&doi=10.1101%2F2020.04.08.029769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1101%2F2020.04.08.029769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.04.08.029769%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZong%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DK.%26atitle%3DTocilizumab%2520treatment%2520in%2520severe%2520COVID-19%2520patients%2520attenuates%2520the%2520inflammatory%2520storm%2520incited%2520by%2520monocyte%2520centric%2520immune%2520interactions%2520revealed%2520by%2520single-cell%2520analysis%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26doi%3D10.1101%2F2020.04.08.029769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koretzky, G. A.</span></span> <span> </span><span class="NLM_article-title">Review: Cytokine storm syndrome: Looking toward the precision medicine era</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1135</span>– <span class="NLM_lpage">1143</span>, <span class="refDoi"> DOI: 10.1002/art.40071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fart.40071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28217930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC1c3os1Gmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2017&pages=1135-1143&issue=6&author=E.+M.+Behrensauthor=G.+A.+Koretzky&title=Review%3A+Cytokine+storm+syndrome%3A+Looking+toward+the+precision+medicine+era&doi=10.1002%2Fart.40071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era</span></div><div class="casAuthors">Behrens Edward M; Koretzky Gary A</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & rheumatology (Hoboken, N.J.)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1135-1143</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlE2jpru5mMnRxY89Cm6SyfW6udTcc2ebwFIB1qXw3Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3os1Gmtg%253D%253D&md5=956cf037eb1f6804f6c9fe70e66c4401</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1002%2Fart.40071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.40071%26sid%3Dliteratum%253Aachs%26aulast%3DBehrens%26aufirst%3DE.%2BM.%26aulast%3DKoretzky%26aufirst%3DG.%2BA.%26atitle%3DReview%253A%2520Cytokine%2520storm%2520syndrome%253A%2520Looking%2520toward%2520the%2520precision%2520medicine%2520era%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2017%26volume%3D69%26issue%3D6%26spage%3D1135%26epage%3D1143%26doi%3D10.1002%2Fart.40071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimabukuro-Vornhagen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subklewe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemmler, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlosser, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlaak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochanek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boll, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Bergwelt-Baildon, M. S.</span></span> <span> </span><span class="NLM_article-title">Cytokine release syndrome</span>. <i>J. Immunother. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">56</span>, <span class="refDoi"> DOI: 10.1186/s40425-018-0343-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1186%2Fs40425-018-0343-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29907163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC1Mbnslylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=56&issue=1&author=A.+Shimabukuro-Vornhagenauthor=P.+Godelauthor=M.+Subkleweauthor=H.+J.+Stemmlerauthor=H.+A.+Schlosserauthor=M.+Schlaakauthor=M.+Kochanekauthor=B.+Bollauthor=M.+S.+von+Bergwelt-Baildon&title=Cytokine+release+syndrome&doi=10.1186%2Fs40425-018-0343-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine release syndrome</span></div><div class="casAuthors">Shimabukuro-Vornhagen Alexander; Godel Philipp; Schlosser Hans Anton; von Bergwelt-Baildon Michael S; Shimabukuro-Vornhagen Alexander; Godel Philipp; Kochanek Matthias; Boll Boris; Shimabukuro-Vornhagen Alexander; Godel Philipp; Kochanek Matthias; Boll Boris; Shimabukuro-Vornhagen Alexander; Kochanek Matthias; Boll Boris; von Bergwelt-Baildon Michael S; Subklewe Marion; Stemmler Hans Joachim; von Bergwelt-Baildon Michael S; Subklewe Marion; Subklewe Marion; von Bergwelt-Baildon Michael S; Subklewe Marion; Stemmler Hans Joachim; von Bergwelt-Baildon Michael S; Schlosser Hans Anton; Schlaak Max</div><div class="citationInfo"><span class="NLM_cas:title">Journal for immunotherapy of cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the last decade the field of cancer immunotherapy has witnessed impressive progress.  Highly effective immunotherapies such as immune checkpoint inhibition, and T-cell engaging therapies like bispecific T-cell engaging (BiTE) single-chain antibody constructs and chimeric antigen receptor (CAR) T cells have shown remarkable efficacy in clinical trials and some of these agents have already received regulatory approval.  However, along with growing experience in the clinical application of these potent immunotherapeutic agents comes the increasing awareness of their inherent and potentially fatal adverse effects, most notably the cytokine release syndrome (CRS).  This review provides a comprehensive overview of the mechanisms underlying CRS pathophysiology, risk factors, clinical presentation, differential diagnoses, and prognostic factors.  In addition, based on the current evidence we give practical guidance to the management of the cytokine release syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRG6qqRA8_CemlSCSgBhwJFfW6udTcc2ebwFIB1qXw3Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mbnslylsg%253D%253D&md5=84052edc102063547e56efa00969765b</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1186%2Fs40425-018-0343-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40425-018-0343-9%26sid%3Dliteratum%253Aachs%26aulast%3DShimabukuro-Vornhagen%26aufirst%3DA.%26aulast%3DGodel%26aufirst%3DP.%26aulast%3DSubklewe%26aufirst%3DM.%26aulast%3DStemmler%26aufirst%3DH.%2BJ.%26aulast%3DSchlosser%26aufirst%3DH.%2BA.%26aulast%3DSchlaak%26aufirst%3DM.%26aulast%3DKochanek%26aufirst%3DM.%26aulast%3DBoll%26aufirst%3DB.%26aulast%3Dvon%2BBergwelt-Baildon%26aufirst%3DM.%2BS.%26atitle%3DCytokine%2520release%2520syndrome%26jtitle%3DJ.%2520Immunother.%2520Cancer%26date%3D2018%26volume%3D6%26issue%3D1%26spage%3D56%26doi%3D10.1186%2Fs40425-018-0343-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todorov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandeel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span> <span> </span><span class="NLM_article-title">HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4796</span>– <span class="NLM_lpage">4801</span>, <span class="refDoi"> DOI: 10.1073/pnas.0712051105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.0712051105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18347343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlSrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=4796-4801&issue=12&author=N.+Liauthor=D.+Zhaoauthor=M.+Kirschbaumauthor=C.+Zhangauthor=C.+L.+Linauthor=I.+Todorovauthor=F.+Kandeelauthor=S.+Formanauthor=D.+Zeng&title=HDAC+inhibitor+reduces+cytokine+storm+and+facilitates+induction+of+chimerism+that+reverses+lupus+in+anti-CD3+conditioning+regimen&doi=10.1073%2Fpnas.0712051105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen</span></div><div class="casAuthors">Li, Nainong; Zhao, Dongchang; Kirschbaum, Mark; Zhang, Chunyan; Lin, Chia-Lei; Todorov, Ivan; Kandeel, Fouad; Forman, Stephen; Zeng, Defu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4796-4801</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In allogeneic hematopoietic cell transplantation (HCT), donor T cell-mediated graft vs. host leukemia (GVL) and graft vs. autoimmune (GVA) activity play crit. roles in treatment of hematol. malignancies and refractory autoimmune diseases.  However, graft vs. host disease (GVHD), which sometimes can be fatal, remains a major obstacle in classical HCT, where recipients are conditioned with total body irradn. or high-dose chemotherapy.  We previously reported that anti-CD3 conditioning allows donor CD8+ T cells to facilitate engraftment and mediate GVL without causing GVHD.  However, the clin. application of this radiation-free and GVHD preventative conditioning regimen is hindered by the cytokine storm syndrome triggered by anti-CD3 and the high-dose donor bone marrow (BM) cells required for induction of chimerism.  Histone deacetylase (HDAC) inhibitors such as suberoylanilide hydroxamic acid (SAHA) are known to induce apoptosis of cancer cells and reduce prodn. of proinflammatory cytokines by nonmalignant cells.  Here, we report that SAHA inhibits the proliferative and cytotoxic activity of anti-CD3-activated T cells.  Administration of low-dose SAHA reduces cytokine prodn. and ameliorates the cytokine storm syndrome triggered by anti-CD3.  Conditioning with anti-CD3 and SAHA allows induction of chimerism with lower doses of donor BM cells in old nonautoimmune and autoimmune lupus mice.  In addn., conditioning with anti-CD3 and SAHA allows donor CD8+ T cell-mediated GVA activity to reverse lupus glomerulonephritis without causing GVHD.  These results indicate that conditioning with anti-CD3 and HDAC inhibitors represent a radiation-free and GVHD-preventative regimen with clin. application potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqamfEM1QBw77Vg90H21EOLACvtfcHk0li57zCa3SJ45A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlSrt70%253D&md5=5323fe693943d494e4d3775b9477469a</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0712051105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0712051105%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DKirschbaum%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DTodorov%26aufirst%3DI.%26aulast%3DKandeel%26aufirst%3DF.%26aulast%3DForman%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DD.%26atitle%3DHDAC%2520inhibitor%2520reduces%2520cytokine%2520storm%2520and%2520facilitates%2520induction%2520of%2520chimerism%2520that%2520reverses%2520lupus%2520in%2520anti-CD3%2520conditioning%2520regimen%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D12%26spage%3D4796%26epage%3D4801%26doi%3D10.1073%2Fpnas.0712051105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlford-Lenane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnihothram, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, M. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCray, P. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span> <span> </span><span class="NLM_article-title">Rapid generation of a mouse model for Middle East respiratory syndrome</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4970</span>– <span class="NLM_lpage">4975</span>, <span class="refDoi"> DOI: 10.1073/pnas.1323279111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1323279111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24599590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsFGrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=4970-4975&issue=13&author=J.+Zhaoauthor=K.+Liauthor=C.+Wohlford-Lenaneauthor=S.+S.+Agnihothramauthor=C.+Fettauthor=J.+Zhaoauthor=M.+J.+Galeauthor=R.+S.+Baricauthor=L.+Enjuanesauthor=T.+Gallagherauthor=P.+B.+McCrayauthor=S.+Perlman&title=Rapid+generation+of+a+mouse+model+for+Middle+East+respiratory+syndrome&doi=10.1073%2Fpnas.1323279111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid generation of a mouse model for Middle East respiratory syndrome</span></div><div class="casAuthors">Zhao, Jincun; Li, Kun; Wohlford-Lenane, Christine; Agnihothram, Sudhakar S.; Fett, Craig; Zhao, Jingxian; Gale, Michael J., Jr.; Baric, Ralph S.; Enjuanes, Luis; Gallagher, Tom; McCray, Paul B., Jr.; Perlman, Stanley</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4970-4975</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In this era of continued emergence of zoonotic virus infections, the rapid development of rodent models represents a crit. barrier to public health preparedness, including the testing of antivirus therapy and vaccines.  The Middle East respiratory syndrome coronavirus (MERS-CoV) was recently identified as the causative agent of a severe pneumonia.  Given the ability of coronavirus to rapidly adapt to new hosts, a major public health concern is that MERS-CoV will further adapt to replication in humans, triggering a pandemic.  No small-animal model for this infection is currently available, but studies suggest that virus entry factors can confer virus susceptibility.  Here, we show that mice were sensitized to MERS-CoV infection by prior transduction with adenoviral vectors expressing the human host-cell receptor dipeptidyl peptidase 4.  Mice developed a pneumonia characterized by extensive inflammatory-cell infiltration with virus clearance occurring 6-8 d after infection.  Clin. disease and histopathol. changes were more severe in the absence of type-I IFN signaling whereas the T-cell response was required for virus clearance.  Using these mice, we demonstrated the efficacy of a therapeutic intervention (poly I:C) and a potential vaccine [Venezuelan equine encephalitis replicon particles expressing MERS-CoV spike protein].  We also found little protective cross-reactivity between MERS-CoV and the severe acute respiratory syndrome-CoV.  Our results demonstrate that this system will be useful for MERS-CoV studies and for the rapid development of relevant animal models for emerging respiratory viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfnfP41n0L7Vg90H21EOLACvtfcHk0ljkoNlEki2l9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsFGrsb4%253D&md5=ad32a7a980d59b20056f45e569d5b1d5</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1323279111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1323279111%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DWohlford-Lenane%26aufirst%3DC.%26aulast%3DAgnihothram%26aufirst%3DS.%2BS.%26aulast%3DFett%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DGale%26aufirst%3DM.%2BJ.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DGallagher%26aufirst%3DT.%26aulast%3DMcCray%26aufirst%3DP.%2BB.%26aulast%3DPerlman%26aufirst%3DS.%26atitle%3DRapid%2520generation%2520of%2520a%2520mouse%2520model%2520for%2520Middle%2520East%2520respiratory%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D13%26spage%3D4970%26epage%3D4975%26doi%3D10.1073%2Fpnas.1323279111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, J. F.</span></span> <span> </span><span class="NLM_article-title">Nitazoxanide: a first-in-class broad-spectrum antiviral agent</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2014.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2014.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25108173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleisL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2014&pages=94-103&author=J.+F.+Rossignol&title=Nitazoxanide%3A+a+first-in-class+broad-spectrum+antiviral+agent&doi=10.1016%2Fj.antiviral.2014.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Nitazoxanide: A first-in-class broad-spectrum antiviral agent</span></div><div class="casAuthors">Rossignol, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-103</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza.  A Phase 2b/3 clin. trial recently published in The Lancet Infectious Diseases found that oral administration of nitazoxanide 600 mg twice daily for five days reduced the duration of clin. symptoms and reduced viral shedding compared to placebo in persons with lab.-confirmed influenza.  The same study also suggested a potential benefit for subjects with influenza-like illness who did not have influenza or other documented respiratory viral infection.  From a chem. perspective, nitazoxanide is the scaffold for a new class of drugs called thiazolides.  These small-mol. drugs target host-regulated processes involved in viral replication.  Nitazoxanide is orally bioavailable and safe with extensive post-marketing experience involving more than 75 million adults and children.  A new dosage formulation of nitazoxanide is presently undergoing global Phase 3 clin. development for the treatment of influenza.  Nitazoxanide inhibits a broad range of influenza A and B viruses including influenza A(pH1N1) and the avian A(H7N9) as well as viruses that are resistant to neuraminidase inhibitors.  It is synergistic with neuraminidase inhibitors, and combination therapy with oseltamivir is being studied in humans as part of ongoing Phase 3 clin. development.  Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, coronavirus, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, Japanese encephalitis virus and human immunodeficiency virus in cell culture assays.  Clin. trials have indicated a potential role for thiazolides in treating rotavirus and norovirus gastroenteritis and chronic hepatitis B and chronic hepatitis C.  Ongoing and future clin. development is focused on viral respiratory infections, viral gastroenteritis and emerging infections such as dengue fever.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_XyG4B6HlO7Vg90H21EOLACvtfcHk0ljkoNlEki2l9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleisL%252FK&md5=12dd8a143876626fc31303da2c5f24c4</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2014.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2014.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRossignol%26aufirst%3DJ.%2BF.%26atitle%3DNitazoxanide%253A%2520a%2520first-in-class%2520broad-spectrum%2520antiviral%2520agent%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D110%26spage%3D94%26epage%3D103%26doi%3D10.1016%2Fj.antiviral.2014.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haffizulla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resnick, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samudrala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginocchio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, J.-F.</span></span> <span> </span><span class="NLM_article-title">Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(14)70717-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS1473-3099%2814%2970717-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24852376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFamsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=609-618&issue=7&author=J.+Haffizullaauthor=A.+Hartmanauthor=M.+Hoppersauthor=H.+Resnickauthor=S.+Samudralaauthor=C.+Ginocchioauthor=M.+Bardinauthor=J.-F.+Rossignol&title=Effect+of+nitazoxanide+in+adults+and+adolescents+with+acute+uncomplicated+influenza%3A+a+double-blind%2C+randomised%2C+placebo-controlled%2C+phase+2b%2F3+trial&doi=10.1016%2FS1473-3099%2814%2970717-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial</span></div><div class="casAuthors">Haffizulla, Jason; Hartman, Aaron; Hoppers, Melanie; Resnick, Harvey; Samudrala, Steve; Ginocchio, Christine; Bardin, Matthew; Rossignol, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">609-618</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Influenza is an important cause of morbidity and mortality worldwide.  Treatment options are scarce, and new drugs with novel mechanisms of action are needed.  We aimed to assess the efficacy and safety of nitazoxanide, a thiazolide anti-infective, for treatment of acute uncomplicated influenza.  We did a double-blind, randomised, placebo-controlled, phase 2b/3 trial in 74 primary care clinics in the USA between Dec 27, 2010, and Apr. 30, 2011.  We enrolled participants aged 12-65 years with fever, at least one respiratory symptom, and one constitutional symptom of influenza within 48 h of symptom onset.  We randomly assigned participants to receive either nitazoxanide 600 mg, nitazoxanide 300 mg, or placebo twice daily for 5 days, (ratio 1:1:1) and followed them up for 28 days.  Randomisation lists were computer generated and done in blocks of three.  Sponsor, investigators, study monitors, patients, and lab. personnel were all masked to treatment allocation in the study.  The primary endpoint was the time from first dose to alleviation of symptoms.  The primary anal. was by intention-to-treat for participants with influenza infection confirmed by RT-PCR or culture at baseline.  This trial is registered with ClinicalTrials.gov, no. NCT01227421.Of 650 participants screened, 624 (96%) were enrolled.  Of these, 212 were randomly assigned to receive placebo twice a day, 201 to receive nitazoxanide 300 mg twice a day, and 211 to receive nitazoxanide 600 mg a day.  The median duration of symptoms for participants receiving placebo was 116·7 h (95% CI 108·1-122·1) compared with 95·5 h (84·0-108·0; p=0·0084) for those receiving 600 mg nitazoxanide and 109·1 h (96·1-129·5, p=0·52) for those receiving 300 mg nitazoxanide.  Adverse events were similar between the three groups, the most common being headache reported by 24 (11%) of 212 patients enrolled in placebo group, 12 (6%) of 201 patients in the low-dose group, and 17 (8%) of 211 patients in the high-dose group, or diarrhoea, reported by seven (3%) patients in the placebo group, four (2%) patients enrolled in the low-dose group, and 17 (8%) patients in the high-dose group.  Treatment with nitazoxanide 600 mg twice daily for 5 days was assocd. with a redn. of the duration of symptoms in participants with acute uncomplicated influenza.  Further studies are warranted to confirm these findings and to assess efficacy of the drug alone or in combination with existing drugs in seriously ill patients and those at risk of influenza complications.  Romark Labs. LC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZqUjE_Nmo_7Vg90H21EOLACvtfcHk0ljkoNlEki2l9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFamsLs%253D&md5=fa49c09ee5706e17ca6c92dc3f15bead</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2814%2970717-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252814%252970717-0%26sid%3Dliteratum%253Aachs%26aulast%3DHaffizulla%26aufirst%3DJ.%26aulast%3DHartman%26aufirst%3DA.%26aulast%3DHoppers%26aufirst%3DM.%26aulast%3DResnick%26aufirst%3DH.%26aulast%3DSamudrala%26aufirst%3DS.%26aulast%3DGinocchio%26aufirst%3DC.%26aulast%3DBardin%26aufirst%3DM.%26aulast%3DRossignol%26aufirst%3DJ.-F.%26atitle%3DEffect%2520of%2520nitazoxanide%2520in%2520adults%2520and%2520adolescents%2520with%2520acute%2520uncomplicated%2520influenza%253A%2520a%2520double-blind%252C%2520randomised%252C%2520placebo-controlled%252C%2520phase%25202b%252F3%2520trial%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2014%26volume%3D14%26issue%3D7%26spage%3D609%26epage%3D618%26doi%3D10.1016%2FS1473-3099%2814%2970717-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabil, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Gohary, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elfert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeffe, E. B.</span></span> <span> </span><span class="NLM_article-title">Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2036.2008.03781.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1111%2Fj.1365-2036.2008.03781.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18616643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWms7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=574-580&issue=5&author=J.+F.+Rossignolauthor=S.+M.+Kabilauthor=Y.+El-Goharyauthor=A.+Elfertauthor=E.+B.+Keeffe&title=Clinical+trial%3A+randomized%2C+double-blind%2C+placebo-controlled+study+of+nitazoxanide+monotherapy+for+the+treatment+of+patients+with+chronic+hepatitis+C+genotype+4&doi=10.1111%2Fj.1365-2036.2008.03781.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4</span></div><div class="casAuthors">Rossignol, J. F.; Kabil, S. M.; El-Gohary, Y.; Elfert, A.; Keeffe, E. B.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">574-580</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Nitazoxanide, licensed in the US for treatment of Cryptosporidium parvum and Giardia lamblia, inhibits hepatitis C virus replication in replicon systems.  Aim: To evaluate the safety and efficacy of nitazoxanide monotherapy for the treatment of chronic hepatitis C.  Methods: This multicentre, randomized, double-blind, placebo-controlled study randomized 50 adult patients with chronic hepatitis C genotype 4 at three centers in Egypt to nitazoxanide 500 mg tablet or placebo twice daily for 24 wk.  Patients were followed up every 4 wk during treatment and for 24 wk after therapy.  Results: Seven of 23 patients (30.4%) in the nitazoxanide group achieved undetectable serum HCV RNA compared to 0 of 24 in the placebo group during therapy (P = 0.004).  Each of the seven responders had baseline HCV RNA levels ≤400 000 IU/mL.  Six of the seven virol. responders were followed up for 24 wk after the end of treatment, and four patients (17.4% of 23 treated) had a sustained virol. response.  Adverse events were similar in the nitazoxanide and placebo groups.  Conclusion: Nitazoxanide monotherapy is safe and effective in achieving sustained virol. response in a modest no. of patients with chronic hepatitis C genotype 4, particularly in patients with low baseline serum HCV RNA levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3c5PPbFXpc7Vg90H21EOLACvtfcHk0ljHkosMEXKVZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWms7nI&md5=b890e1b4d0f03b0af6d2926d956cfed7</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2008.03781.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2008.03781.x%26sid%3Dliteratum%253Aachs%26aulast%3DRossignol%26aufirst%3DJ.%2BF.%26aulast%3DKabil%26aufirst%3DS.%2BM.%26aulast%3DEl-Gohary%26aufirst%3DY.%26aulast%3DElfert%26aufirst%3DA.%26aulast%3DKeeffe%26aufirst%3DE.%2BB.%26atitle%3DClinical%2520trial%253A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520nitazoxanide%2520monotherapy%2520for%2520the%2520treatment%2520of%2520patients%2520with%2520chronic%2520hepatitis%2520C%2520genotype%25204%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D28%26issue%3D5%26spage%3D574%26epage%3D580%26doi%3D10.1111%2Fj.1365-2036.2008.03781.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, J. F.</span></span> <span> </span><span class="NLM_article-title">Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus</span>. <i>J. Infect Public Health</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1016/j.jiph.2016.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jiph.2016.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27095301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC28bhsFamsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=227-230&issue=3&author=J.+F.+Rossignol&title=Nitazoxanide%2C+a+new+drug+candidate+for+the+treatment+of+Middle+East+respiratory+syndrome+coronavirus&doi=10.1016%2Fj.jiph.2016.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus</span></div><div class="casAuthors">Rossignol Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of infection and public health</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nitazoxanide is a broad-spectrum antiviral agent undergoing clinical development for treatment of influenza and other viral respiratory infections.  Nitazoxanide exhibits in vitro activity against Middle East respiratory syndrome coronavirus (MERS-CoV) and other coronaviruses, inhibiting expression of the viral N protein.  Nitazoxanide also suppresses production of pro-inflammatory cytokines in peripheral blood mononuclear cells and suppresses interleukin 6 production in mice.  Having been used extensively in clinical trials and in post-marketing experience, nitazoxanide is an attractive drug candidate for treatment of Middle East respiratory syndrome.  Future research should include in vitro mechanism studies, animal models of MERS-CoV infection, clinical trials, including dose-ranging trials, and evaluation of combination therapy with other potential MERS-CoV antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSL6Iq5eC6xumPgL4LrC-0VfW6udTcc2eYuiuyietSy27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bhsFamsw%253D%253D&md5=375ed45c28b8797a4eec4aa24dc67d02</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1016%2Fj.jiph.2016.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jiph.2016.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DRossignol%26aufirst%3DJ.%2BF.%26atitle%3DNitazoxanide%252C%2520a%2520new%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%26jtitle%3DJ.%2520Infect%2520Public%2520Health%26date%3D2016%26volume%3D9%26issue%3D3%26spage%3D227%26epage%3D230%26doi%3D10.1016%2Fj.jiph.2016.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asl, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseinzadeh, H.</span></span> <span> </span><span class="NLM_article-title">Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1002/ptr.2362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fptr.2362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18446848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVCqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=709-724&issue=6&author=M.+N.+Aslauthor=H.+Hosseinzadeh&title=Review+of+pharmacological+effects+of+Glycyrrhiza+sp.+and+its+bioactive+compounds&doi=10.1002%2Fptr.2362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds</span></div><div class="casAuthors">Asl, Marjan Nassiri; Hosseinzadeh, Hossein</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">709-724</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The roots and rhizomes of licorice (Glycyrrhiza) species have long been used worldwide as a herbal medicine and natural sweetener.  Licorice root is a traditional medicine used mainly for the treatment of peptic ulcer, hepatitis C, and pulmonary and skin diseases, although clin. and exptl. studies suggest that it has several other useful pharmacol. properties such as antiinflammatory, antiviral, antimicrobial, antioxidative, anticancer activities, immunomodulatory, hepatoprotective and cardioprotective effects.  A large no. of components have been isolated from licorice, including triterpene saponins, flavonoids, isoflavonoids and chalcones, with glycyrrhizic acid normally being considered to be the main biol. active component.  This review summarizes the phytochem., pharmacol. and pharmacokinetics data, together with the clin. and adverse effects of licorice and its bioactive components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc76W9fK7UIbVg90H21EOLACvtfcHk0ljHkosMEXKVZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVCqu7s%253D&md5=b81eeec27c70653e91e49b961822d006</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1002%2Fptr.2362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.2362%26sid%3Dliteratum%253Aachs%26aulast%3DAsl%26aufirst%3DM.%2BN.%26aulast%3DHosseinzadeh%26aufirst%3DH.%26atitle%3DReview%2520of%2520pharmacological%2520effects%2520of%2520Glycyrrhiza%2520sp.%2520and%2520its%2520bioactive%2520compounds%26jtitle%3DPhytother.%2520Res.%26date%3D2008%26volume%3D22%26issue%3D6%26spage%3D709%26epage%3D724%26doi%3D10.1002%2Fptr.2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolkerstorfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachhofner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szolar, O. H.</span></span> <span> </span><span class="NLM_article-title">Glycyrrhizin inhibits influenza A virus uptake into the cell</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2009.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2009.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19416738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=171-178&issue=2&author=A.+Wolkerstorferauthor=H.+Kurzauthor=N.+Bachhofnerauthor=O.+H.+Szolar&title=Glycyrrhizin+inhibits+influenza+A+virus+uptake+into+the+cell&doi=10.1016%2Fj.antiviral.2009.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhizin inhibits influenza A virus uptake into the cell</span></div><div class="casAuthors">Wolkerstorfer, Andrea; Kurz, Harald; Bachhofner, Nicole; Szolar, Oliver H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-178</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated the mechanism by which glycyrrhizin (GL), the main active component of licorice roots, protects cells from infection with influenza A virus (IAV).  We found that GL treatment leads to a clear redn. in the no. of IAV-infected human lung cells as well as a redn. in the CCID50 titer by 90%.  The antiviral effect, however, was limited to one or two virus replication cycles.  Anal. of different GL treatment protocols suggested that the antiviral effect of GL was limited to an early step in the virus replication cycle.  A direct inhibitory action of GL on IAV particles could be excluded and GL did not interact with virus receptor binding either.  The antiviral effect of GL was abolished by treatment 1 h after virus infection, whereas pre-treatment and treatment during and after virus adsorption led to a redn. in the cytopathic effect, reduced viral RNA within the cells and in the cell supernatants, and reduced viral hemagglutination titers.  Detailed virus uptake analyses unambiguously demonstrated reduced virus uptake in various GL-treated cells.  These observations lead to the conclusion, that the antiviral activity of GL is mediated by an interaction with the cell membrane which most likely results in reduced endocytic activity and hence reduced virus uptake.  These insights might help in the design of structurally related compds. leading to potent anti-influenza therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbK5YVUB9067Vg90H21EOLACvtfcHk0ljHkosMEXKVZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKnurg%253D&md5=692658ff3129046df8b19885768b433c</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2009.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2009.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DWolkerstorfer%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DH.%26aulast%3DBachhofner%26aufirst%3DN.%26aulast%3DSzolar%26aufirst%3DO.%2BH.%26atitle%3DGlycyrrhizin%2520inhibits%2520influenza%2520A%2520virus%2520uptake%2520into%2520the%2520cell%26jtitle%3DAntiviral%2520Res.%26date%3D2009%26volume%3D83%26issue%3D2%26spage%3D171%26epage%3D178%26doi%3D10.1016%2Fj.antiviral.2009.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michaelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naczk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sithisarn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leutz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerr, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinatl, J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e19705</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0019705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0019705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21611183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&issue=5&author=M.+Michaelisauthor=J.+Geilerauthor=P.+Naczkauthor=P.+Sithisarnauthor=A.+Leutzauthor=H.+W.+Doerrauthor=J.+Cinatl&title=Glycyrrhizin+exerts+antioxidative+effects+in+H5N1+influenza+A+virus-infected+cells+and+inhibits+virus+replication+and+pro-inflammatory+gene+expression&doi=10.1371%2Fjournal.pone.0019705"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression</span></div><div class="casAuthors">Michaelis, Martin; Geiler, Janina; Naczk, Patrizia; Sithisarn, Patchima; Leutz, Anke; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19705</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Glycyrrhizin is known to exert antiviral and anti-inflammatory effects.  Here, the effects of an approved parenteral glycyrrhizin prepn. (Stronger Neo-Minophafen C) were investigated on highly pathogenic influenza A H5N1 virus replication, H5N1-induced apoptosis, and H5N1-induced pro-inflammatory responses in lung epithelial (A549) cells.  Therapeutic glycyrrhizin concns. substantially inhibited H5N1-induced expression of the pro-inflammatory mols. CXCL10, interleukin 6, CCL2, and CCL5 (effective glycyrrhizin concns. 25 to 50 μg/mL) but interfered with H5N1 replication and H5N1-induced apoptosis to a lesser extent (effective glycyrrhizin concns. 100 μg/mL or higher).  Glycyrrhizin also diminished monocyte migration towards supernatants of H5N1-infected A549 cells.  The mechanism by which glycyrrhizin interferes with H5N1 replication and H5N1-induced pro-inflammatory gene expression includes inhibition of H5N1-induced formation of reactive oxygen species and (in turn) reduced activation of NFκB, JNK, and p38, redox-sensitive signalling events known to be relevant for influenza A virus replication.  Therefore, glycyrrhizin may complement the arsenal of potential drugs for the treatment of H5N1 disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQDXOxpPtb7Vg90H21EOLACvtfcHk0lgy8E-8jlJuPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGqsbw%253D&md5=207f17b0a280b6f5f703c0a024bf8f88</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019705%26sid%3Dliteratum%253Aachs%26aulast%3DMichaelis%26aufirst%3DM.%26aulast%3DGeiler%26aufirst%3DJ.%26aulast%3DNaczk%26aufirst%3DP.%26aulast%3DSithisarn%26aufirst%3DP.%26aulast%3DLeutz%26aufirst%3DA.%26aulast%3DDoerr%26aufirst%3DH.%2BW.%26aulast%3DCinatl%26aufirst%3DJ.%26atitle%3DGlycyrrhizin%2520exerts%2520antioxidative%2520effects%2520in%2520H5N1%2520influenza%2520A%2520virus-infected%2520cells%2520and%2520inhibits%2520virus%2520replication%2520and%2520pro-inflammatory%2520gene%2520expression%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D5%26doi%3D10.1371%2Fjournal.pone.0019705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suebsasana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pongnaratorn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattayasai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkaravichien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiamkao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aromdee, C.</span></span> <span> </span><span class="NLM_article-title">Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1191</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1007/s12272-009-1902-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs12272-009-1902-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19784573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOrtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=1191-1200&issue=9&author=S.+Suebsasanaauthor=P.+Pongnaratornauthor=J.+Sattayasaiauthor=T.+Arkaravichienauthor=S.+Tiamkaoauthor=C.+Aromdee&title=Analgesic%2C+antipyretic%2C+anti-inflammatory+and+toxic+effects+of+andrographolide+derivatives+in+experimental+animals&doi=10.1007%2Fs12272-009-1902-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals</span></div><div class="casAuthors">Suebsasana, Supawadee; Pongnaratorn, Panicha; Sattayasai, Jintana; Arkaravichien, Tarinee; Tiamkao, Siriporn; Aromdee, Chantana</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1191-1200</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Andrographolide (1) and 14-deoxy-11,12-didehydroandrographolide (2) are active constituents of Andrographis paniculata (Burm. f.), family Acanthaceae.  A. paniculata exts. are reported to have antiviral, antipyretic, immunostimulant and anticancer activities.  In this study, 1 and its 14-acetyl- (4) and 3,19-isopropylidenyl- (3) derivs., as well as 2 and its 3,19-dipalmitoyl-deriv. (5), were i.p. tested for their analgesic, antipyretic, anti-inflammatory and acute toxicity effects in animal models.  Analgesic effects were tested in mice using hot plate and writhing tests to distinguish the central and peripheral effects, resp.  The results showed that, at 4 mg/kg, all tested substances have significant analgesic effects, and the highest potency was seen with 3, 4 and 5.  Increasing the dose of 3 and 5 to 8 mg/kg did not increase the analgesic effect.  In the writhing test, 3 and 5, but not 1, showed significant results.  In a baker's yeast-induced fever model, 3 and 5 significantly reduced rats' rectal temp. (p < 0.05).  In a carrageenan-induced inflammation model, 1, 3 and 5 significantly reduced rats' paw vol.  Doses of 3 and 5 up to 100 mg/kg did not show any serious toxic effects.  From this study, 3 and 5 are the most interesting derivs., showing much greater potency than their parent compds.  These could be further developed as analgesic, antipyretic and anti-inflammatory agents, without any serious toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplWGAe_XzEkrVg90H21EOLACvtfcHk0lgy8E-8jlJuPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOrtbrE&md5=8cc629c3ff6154e6863da3d382bcbb48</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1007%2Fs12272-009-1902-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-009-1902-x%26sid%3Dliteratum%253Aachs%26aulast%3DSuebsasana%26aufirst%3DS.%26aulast%3DPongnaratorn%26aufirst%3DP.%26aulast%3DSattayasai%26aufirst%3DJ.%26aulast%3DArkaravichien%26aufirst%3DT.%26aulast%3DTiamkao%26aufirst%3DS.%26aulast%3DAromdee%26aufirst%3DC.%26atitle%3DAnalgesic%252C%2520antipyretic%252C%2520anti-inflammatory%2520and%2520toxic%2520effects%2520of%2520andrographolide%2520derivatives%2520in%2520experimental%2520animals%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2009%26volume%3D32%26issue%3D9%26spage%3D1191%26epage%3D1200%26doi%3D10.1007%2Fs12272-009-1902-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M.</span></span> <span> </span><span class="NLM_article-title">14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2015.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2015.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25800824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVWkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2015&pages=82-92&author=W.+Caiauthor=Y.+Liauthor=S.+Chenauthor=M.+Wangauthor=A.+Zhangauthor=H.+Zhouauthor=H.+Chenauthor=M.+Jin&title=14-Deoxy-11%2C12-dehydroandrographolide+exerts+anti-influenza+A+virus+activity+and+inhibits+replication+of+H5N1+virus+by+restraining+nuclear+export+of+viral+ribonucleoprotein+complexes&doi=10.1016%2Fj.antiviral.2015.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes</span></div><div class="casAuthors">Cai, Wentao; Li, Yongtao; Chen, Sunrui; Wang, Mengli; Zhang, Anding; Zhou, Hongbo; Chen, Huanchun; Jin, Meilin</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-92</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The highly pathogenic avian influenza H5N1 virus has become a worldwide public health threat, and current antiviral therapies have limited activity against the emerging, resistant influenza viruses.  Therefore, effective drugs with novel targets against influenza A viruses, H5N1 strains in particular, should be developed.  In the present study, 14-deoxy-11,12-dehydroandrographolide (DAP), a major component of the traditional Chinese medicine Andrographis paniculata, exerted potent anti-influenza A virus activity against A/chicken/Hubei/327/2004 (H5N1), A/duck/Hubei/XN/2007 (H5N1), A/PR/8/34 (H1N1), A/NanChang/08/2010 (H1N1) and A/HuNan/01/2014 (H3N2) in vitro.  To elucidate the underlying mechanisms, a series of expts. was conducted using A/chicken/Hubei/327/2004 (H5N1) as an example.  Our results demonstrated that DAP strongly inhibited H5N1 replication by reducing the prodn. of viral nucleoprotein (NP) mRNA, NP and NS1proteins, whereas DAP had no effect on the absorption and release of H5N1 towards/from A549 cells.  DAP also effectively restrained the nuclear export of viral ribonucleoprotein (vRNP) complexes.  This inhibitory effect ought to be an important anti-H5N1 mechanism of DAP.  Meanwhile, DAP significantly reduced the upregulated expression of all the tested proinflammatory cytokines (TNF-α, IL-6, IL-8, IFN-α, IL-1β and IFN-β) and chemokines (CXCL-10 and CCL-2) stimulated by H5N1.  Overall results suggest that DAP impairs H5N1 replication at least in part by restraining nuclear export of vRNP complexes, and the inhibition of viral replication leads to a subsequent decrease of the intense proinflammatory cytokine/chemokine expression.  In turn, the effect of modification of the host excessive immune response may contribute to overcoming H5N1.  To our knowledge, this study is the first to reveal the antiviral and anti-inflammatory activities of DAP in vitro against H5N1 influenza A virus infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXT0VtoHWVrVg90H21EOLACvtfcHk0lhwqw_ca5w1Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVWkur0%253D&md5=86a7a31793fcdf2f32e2f098d5db8b8b</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DM.%26atitle%3D14-Deoxy-11%252C12-dehydroandrographolide%2520exerts%2520anti-influenza%2520A%2520virus%2520activity%2520and%2520inhibits%2520replication%2520of%2520H5N1%2520virus%2520by%2520restraining%2520nuclear%2520export%2520of%2520viral%2520ribonucleoprotein%2520complexes%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D118%26spage%3D82%26epage%3D92%26doi%3D10.1016%2Fj.antiviral.2015.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassaganya-Riera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubau-Juni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoccoli-Rodriguez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godfrey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hontecillas, R.</span></span> <span> </span><span class="NLM_article-title">Lanthionine synthetase C-like 2 modulates immune responses to Influenza virus infection</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">178</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.00178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3389%2Ffimmu.2017.00178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28270815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFegt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=178&author=A.+Leberauthor=J.+Bassaganya-Rieraauthor=N.+Tubau-Juniauthor=V.+Zoccoli-Rodriguezauthor=P.+Luauthor=V.+Godfreyauthor=S.+Kaleauthor=R.+Hontecillas&title=Lanthionine+synthetase+C-like+2+modulates+immune+responses+to+Influenza+virus+infection&doi=10.3389%2Ffimmu.2017.00178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Lanthionine synthetase C-like 2 modulates immune responses to influenza virus infection</span></div><div class="casAuthors">Leber, Andrew; Bassaganya-Riera, Josep; Tubau-Juni, Nuria; Zoccoli-Rodriguez, Victoria; Lu, Pinyi; Godfrey, Victoria; Kale, Shiv; Hontecillas, Raquel</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178/1-178/14</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Broad-based, host-targeted therapeutics have the potential to ameliorate viral infections without inducing antiviral resistance.  We identified lanthionine synthetase C-like 2 (LANCL2) as a new therapeutic target for immunoinflammatory diseases.  To examine the therapeutic efficacy of oral NSC61610 administration on influenza, we infected C57BL/6 mice with influenza A H1N1pdm virus and evaluated influenza-related mortality, lung inflammatory profiles, and pulmonary histopathol.  Oral treatment with NSC61610 ameliorates influenza virus infection by down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and redn. in the infiltration of neutrophils.  NSC61610 treatment increases IL10-producing CD8+ T cells and macrophages in the lungs during the resoln. phase of disease.  The loss of LANCL2 or neutralization of IL-10 in mice infected with influenza virus abrogates the ability of NSC61610 to accelerate recovery and induce IL-10-mediated regulatory responses.  These studies validate that oral treatment with NSC61610 ameliorates morbidity and mortality and accelerates recovery during influenza virus infection through a mechanism mediated by activation of LANCL2 and subsequent induction of IL-10 responses by CD8+ T cells and macrophages in the lungs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOC-09yPF_qrVg90H21EOLACvtfcHk0lhwqw_ca5w1Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFegt78%253D&md5=3bd15a369d2bc8757b64514dde3ec423</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00178%26sid%3Dliteratum%253Aachs%26aulast%3DLeber%26aufirst%3DA.%26aulast%3DBassaganya-Riera%26aufirst%3DJ.%26aulast%3DTubau-Juni%26aufirst%3DN.%26aulast%3DZoccoli-Rodriguez%26aufirst%3DV.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DGodfrey%26aufirst%3DV.%26aulast%3DKale%26aufirst%3DS.%26aulast%3DHontecillas%26aufirst%3DR.%26atitle%3DLanthionine%2520synthetase%2520C-like%25202%2520modulates%2520immune%2520responses%2520to%2520Influenza%2520virus%2520infection%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D178%26doi%3D10.3389%2Ffimmu.2017.00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z. D.</span></span> <span> </span><span class="NLM_article-title">Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-gamma</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2015.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jep.2015.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26190352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFWntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2016&pages=128-136&author=X.+P.+Huauthor=M.+M.+Shaoauthor=X.+Songauthor=X.+L.+Wuauthor=L.+Qiauthor=K.+Zhengauthor=L.+Fanauthor=C.+H.+Liaoauthor=C.+Y.+Liauthor=J.+Heauthor=Y.+J.+Huauthor=H.+Q.+Wuauthor=S.+H.+Liauthor=J.+Zhangauthor=F.+X.+Zhangauthor=Z.+D.+He&title=Anti-influenza+virus+effects+of+crude+phenylethanoid+glycosides+isolated+from+ligustrum+purpurascens+via+inducing+endogenous+interferon-gamma&doi=10.1016%2Fj.jep.2015.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γ</span></div><div class="casAuthors">Hu, Xiao-peng; Shao, Min-ming; Song, Xun; Wu, Xu-li; Qi, Ling; Zheng, Kai; Fan, Long; Liao, Cheng-hui; Li, Chen-yang; He, Jiang; Hu, Ying-jie; Wu, Hai-qiang; Li, Shi-he; Zhang, Jian; Zhang, Feng-xue; He, Zhen-dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">128-136</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Ligustrum purpurascens Y.  C. Yang (Oleaceae) is traditionally recorded as "Ku Ding Cha", a kind of functional tea in southern China for about two thousand years, which has been reported with sore throat alleviating and pathogenic heat expelling effects.  However, there are no scientific studies demonstrating its antiviral activity.  This study is aimed at investigating the anti-influenza virus effects of phenylethanoid glycosides isolated from L. purpurascens (LPG) as well as its corresponding mechanisms.  In vitro, hemagglutination assay was employed to detect the influenza virus titer; In vivo, C57BL/6J mice were given oral administration of LPG (100 mg/kg, 300 mg/kg, 900 mg/kg) or ribavirin (100 mg/kg) once daily for 5 successive days.  Meanwhile, on the second day, mice were infected intranasally (i.n.) with A/FM/1/47 H1N1 virus.  Mice survival rate and other clin. index were monitored for 15 days.  Infected mice were sacrificed to measure the lung lesion and stained with hematoxylin-eosin.  Flow cytometry analyses spleen lymphocytes and interferon-γ (IFN-γ) level.  The IFN-γ knockout mice (IFN-γ-/- mice, C57BL/6J) which had been verified lacking IFN-γ through Western Blot, were applied in the death-protection test to identify the role of IFN-γ played in LPG antiviral effect.In vitro, LPG at 0.5 mg/mL inhibited Influenza A Virus H1N1 type (H1N1) infection of MDCK cells.  In vivo, LPG at 300 and 900 mg/kg significantly decreased the mouse lung index (p<0.05), alleviated influenza-induced lethality and clin. symptoms, and therefore enhanced mouse survival (p<0.05).  More detailed expts. demonstrated that antiviral cytokine IFN-γ was involved in the antiviral effect of LPG.  Flow cytometric anal. revealed that LPG (900 mg/kg) significantly induced secretion of IFN-γ by splenic CD4+ and CD8+ cells (p<0.05).  Moreover, LPG (900 mg/kg) protected wild-type C57BL/6J mice from H1N1 injury, whereas LPG-mediated survival protection disappeared in IFN-γ-/- mice.  These results suggest that up-regulating endogenous IFN-γ by LPG may represent a novel therapeutic approach for H1N1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo865uUzhg6e7Vg90H21EOLACvtfcHk0lg9K0Gbjz4L6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFWntA%253D%253D&md5=1b7649906cf0de80d8f17ee064a1a2f7</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2015.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2015.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%2BP.%26aulast%3DShao%26aufirst%3DM.%2BM.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%2BL.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DC.%2BH.%26aulast%3DLi%26aufirst%3DC.%2BY.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%2BJ.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DLi%26aufirst%3DS.%2BH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DF.%2BX.%26aulast%3DHe%26aufirst%3DZ.%2BD.%26atitle%3DAnti-influenza%2520virus%2520effects%2520of%2520crude%2520phenylethanoid%2520glycosides%2520isolated%2520from%2520ligustrum%2520purpurascens%2520via%2520inducing%2520endogenous%2520interferon-gamma%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2016%26volume%3D179%26spage%3D128%26epage%3D136%26doi%3D10.1016%2Fj.jep.2015.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felsenstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbert, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrich, C. M.</span></span> <span> </span><span class="NLM_article-title">COVID-19: Immunology and treatment options</span>. <i>Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">108448</span>, <span class="refDoi"> DOI: 10.1016/j.clim.2020.108448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.clim.2020.108448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32353634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1aqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2020&pages=108448&author=S.+Felsensteinauthor=J.+A.+Herbertauthor=P.+S.+McNamaraauthor=C.+M.+Hedrich&title=COVID-19%3A+Immunology+and+treatment+options&doi=10.1016%2Fj.clim.2020.108448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">COVID-19: Immunology and treatment options</span></div><div class="casAuthors">Felsenstein, Susanna; Herbert, Jenny A.; McNamara, Paul S.; Hedrich, Christian M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108448</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions.  As protective immunity does not exist in humans and the virus is capable of escaping innate immune responses, it can proliferate, unhindered, in primarily infected tissues.  Subsequent cell death results in the release of virus particles and intracellular components to the extracellular space, which result in immune cell recruitment, the generation of immune complexes and assocd. damage.  Infection of monocytes/macrophages and/or recruitment of uninfected immune cells can result in massive inflammatory responses later in the disease.  Uncontrolled prodn. of pro-inflammatory mediators contributes to ARDS and cytokine storm syndrome.  Antiviral agents and immune modulating treatments are currently being trialled.  Understanding immune evasion strategies of SARS-CoV2 and the resulting delayed massive immune response will result in the identification of biomarkers that predict outcomes as well as phenotype and disease stage specific treatments that will likely include both antiviral and immune modulating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCEfmBuJUQ_bVg90H21EOLACvtfcHk0lg9K0Gbjz4L6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1aqsbs%253D&md5=9d9b3b983b60f625bcedf058c9cecb8b</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2020.108448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2020.108448%26sid%3Dliteratum%253Aachs%26aulast%3DFelsenstein%26aufirst%3DS.%26aulast%3DHerbert%26aufirst%3DJ.%2BA.%26aulast%3DMcNamara%26aufirst%3DP.%2BS.%26aulast%3DHedrich%26aufirst%3DC.%2BM.%26atitle%3DCOVID-19%253A%2520Immunology%2520and%2520treatment%2520options%26jtitle%3DClin.%2520Immunol.%26date%3D2020%26volume%3D215%26spage%3D108448%26doi%3D10.1016%2Fj.clim.2020.108448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, P. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span> <span> </span><span class="NLM_article-title">Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>191</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1086/427811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1086%2F427811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15688292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVentrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2005&pages=755-760&issue=5&author=Z.+Chenauthor=L.+Miauthor=J.+Xuauthor=J.+Yuauthor=X.+Wangauthor=J.+Jiangauthor=J.+Xingauthor=P.+Shangauthor=A.+Qianauthor=Y.+Liauthor=P.+X.+Shawauthor=J.+Wangauthor=S.+Duanauthor=J.+Dingauthor=C.+Fanauthor=Y.+Zhangauthor=Y.+Yangauthor=X.+Yuauthor=Q.+Fengauthor=B.+Liauthor=X.+Yaoauthor=Z.+Zhangauthor=L.+Liauthor=X.+Xueauthor=P.+Zhu&title=Function+of+HAb18G%2FCD147+in+invasion+of+host+cells+by+severe+acute+respiratory+syndrome+coronavirus&doi=10.1086%2F427811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus</span></div><div class="casAuthors">Chen, Zhinan; Mi, Li; Xu, Jing; Yu, Jiyun; Wang, Xianhui; Jiang, Jianli; Xing, Jinliang; Shang, Peng; Qian, Airong; Li, Yu; Shaw, Peter X.; Wang, Jianwei; Duan, Shumin; Ding, Jin; Fan, Chunmei; Zhang, Yang; Yang, Yong; Yu, Xiaoling; Feng, Qiang; Li, Biehu; Yao, Xiying; Zhang, Zheng; Li, Ling; Xue, Xiaoping; Zhu, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">755-760</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">To identify the function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome (SARS) coronavirus (CoV), we analyzed the protein-protein interaction among HAb18G/CD147, cyclophilin A (CyPA), and SARS-CoV structural proteins by coimmunopptn. and surface plasmon resonance anal.  Although none of the SARS-CoV proteins was found to be directly bound to HAb18G/CD147, the nucleocapsid (N) protein of SARS-CoV was bound to CyPA, which interacted with HAb18G/CD147.  Further research showed that HAb18G/CD147, a transmembrane mol., was highly expressed on 293 cells and that CyPA was integrated with SARS-CoV.  HAb18G/CD147-antagonistic peptide (AP)-9, an AP of HAb18G/CD147, had a high rate of binding to 293 cells and an inhibitory effect on SARS-CoV.  These results show that HAb18G/CD147, mediated by CyPA bound to SARS-CoV N protein, plays a functional role in facilitating invasion of host cells by SARS-CoV.  Our findings provide some evidence for the cytol. mechanism of invasion by SARS-CoV and provide a mol. basis for screening anti-SARS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokFLnbxoWjlbVg90H21EOLACvtfcHk0liWfC0poTKXlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVentrw%253D&md5=be73edfebb2c293880f6c3367dec028d</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1086%2F427811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F427811%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DShang%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShaw%26aufirst%3DP.%2BX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DP.%26atitle%3DFunction%2520of%2520HAb18G%252FCD147%2520in%2520invasion%2520of%2520host%2520cells%2520by%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D191%26issue%3D5%26spage%3D755%26epage%3D760%26doi%3D10.1086%2F427811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillat, M. M.</span></span> <span> </span><span class="NLM_article-title">CD147 as a target for COVID-19 treatment: Suggested effects of Azithromycin and stem cell engagement</span>. <i>Stem Cell Rev. Rep</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1007/s12015-020-09976-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs12015-020-09976-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32307653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsV2mtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=434-440&issue=3&author=H.+Ulrichauthor=M.+M.+Pillat&title=CD147+as+a+target+for+COVID-19+treatment%3A+Suggested+effects+of+Azithromycin+and+stem+cell+engagement&doi=10.1007%2Fs12015-020-09976-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement</span></div><div class="casAuthors">Ulrich, Henning; Pillat, Micheli M.</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Reviews and Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">SCRREE</span>;
        ISSN:<span class="NLM_cas:issn">2629-3277</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Abstr.: The expressive no. of deaths and confirmed cases of SARS-CoV-2 call for an urgent demand of effective and available drugs for COVID-19 treatment.  CD147, a receptor on host cells, is a novel route for SARS-CoV-2 invasion.  Thus, drugs that interfere in the spike protein/CD147 interaction or CD147 expression may inhibit viral invasion and dissemination among other cells, including in progenitor/stem cells.  Studies suggest beneficial effects of azithromycin in reducing viral load of hospitalized patients, possibly interfering with ligand/CD147 receptor interactions; however, its possible effects on SARS-CoV-2 invasion has not yet been evaluated.  In addn. to the possible effect in invasion, azithromycin decreases the expression of some metalloproteinases (downstream to CD147), induces anti-viral responses in primary human bronchial epithelial infected with rhinovirus, decreasing viral replication and release.  Moreover, resident lung progenitor/stem are extensively differentiated into myofibroblasts during pulmonary fibrosis, a complication obsd. in COVID-19 patients.  This process, and the possible direct viral invasion of progenitor/stem cells via CD147 or ACE2, could result in the decline of these cellular stocks and failing lung repair.  Clin. tests with allogeneic MSCs from healthy individuals are underway to enhance endogenous lung repair and suppress inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEpbHkoVQGHLVg90H21EOLACvtfcHk0liWfC0poTKXlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsV2mtLY%253D&md5=383e7dd8417a9cc29238d9f942a58dcc</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1007%2Fs12015-020-09976-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12015-020-09976-7%26sid%3Dliteratum%253Aachs%26aulast%3DUlrich%26aufirst%3DH.%26aulast%3DPillat%26aufirst%3DM.%2BM.%26atitle%3DCD147%2520as%2520a%2520target%2520for%2520COVID-19%2520treatment%253A%2520Suggested%2520effects%2520of%2520Azithromycin%2520and%2520stem%2520cell%2520engagement%26jtitle%3DStem%2520Cell%2520Rev.%2520Rep%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D434%26epage%3D440%26doi%3D10.1007%2Fs12015-020-09976-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindrachuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrling, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laidlaw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lear-Rooney, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M. B.</span></span> <span> </span><span class="NLM_article-title">Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4885</span>– <span class="NLM_lpage">4893</span>, <span class="refDoi"> DOI: 10.1128/AAC.03036-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.03036-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24841273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1art73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4885-4893&issue=8&author=J.+Dyallauthor=C.+M.+Colemanauthor=B.+J.+Hartauthor=T.+Venkataramanauthor=M.+R.+Holbrookauthor=J.+Kindrachukauthor=R.+F.+Johnsonauthor=G.+G.+Olingerauthor=P.+B.+Jahrlingauthor=M.+Laidlawauthor=L.+M.+Johansenauthor=C.+M.+Lear-Rooneyauthor=P.+J.+Glassauthor=L.+E.+Hensleyauthor=M.+B.+Frieman&title=Repurposing+of+clinically+developed+drugs+for+treatment+of+Middle+East+respiratory+syndrome+coronavirus+infection&doi=10.1128%2FAAC.03036-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection</span></div><div class="casAuthors">Dyall, Julie; Coleman, Christopher M.; Hart, Brit J.; Venkataraman, Thiagarajan; Holbrook, Michael R.; Kindrachuk, Jason; Johnson, Reed F.; Olinger, Gene G.; Jahrling, Peter B.; Laidlaw, Monique; Johansen, Lisa M.; Lear-Rooney, Calli M.; Glass, Pamela J.; Hensley, Lisa E.; Frieman, Matthew B.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4885-4893, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Outbreaks of emerging infections present health professionals with the unique challenge of trying to select appropriate pharmacol. treatments in the clinic with little time available for drug testing and development.  Typically, clinicians are left with general supportive care and often untested convalescent-phase plasma as available treatment options.  Repurposing of approved pharmaceutical drugs for new indications presents an attractive alternative to clinicians, researchers, public health agencies, drug developers and funding agencies.  Given the development times and manufg. requirements for new products, repurposing of existing drugs is likely the only soln. for outbreaks due to emerging viruses.  In the studies described here, a library of 290 compds. was screened for antiviral activity against Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV).  Selection of compds. for inclusion in the library was dependent on current or previous FDA approval or advanced clin. development.  Some drugs that had a well-defined cellular pathway as target were included.  In total, 27 compds. with activity against both MERS-CoV and SARS-CoV were identified.  The compds. belong to 13 different classes of pharmaceuticals, including inhibitors of estrogen receptors used for cancer treatment and inhibitors of dopamine receptor used as antipsychotics.  The drugs identified in these screens provide new targets for in vivo studies as well as incorporation into ongoing clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE_PH7j54pPrVg90H21EOLACvtfcHk0lhjgDyjfzchnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1art73L&md5=4cd7f71c09de4c1965b7c6f42f3ae2ce</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1128%2FAAC.03036-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03036-14%26sid%3Dliteratum%253Aachs%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DC.%2BM.%26aulast%3DHart%26aufirst%3DB.%2BJ.%26aulast%3DVenkataraman%26aufirst%3DT.%26aulast%3DHolbrook%26aufirst%3DM.%2BR.%26aulast%3DKindrachuk%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BF.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DJahrling%26aufirst%3DP.%2BB.%26aulast%3DLaidlaw%26aufirst%3DM.%26aulast%3DJohansen%26aufirst%3DL.%2BM.%26aulast%3DLear-Rooney%26aufirst%3DC.%2BM.%26aulast%3DGlass%26aufirst%3DP.%2BJ.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DFrieman%26aufirst%3DM.%2BB.%26atitle%3DRepurposing%2520of%2520clinically%2520developed%2520drugs%2520for%2520treatment%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4885%26epage%3D4893%26doi%3D10.1128%2FAAC.03036-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindrachuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ork, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrling, P. B.</span></span> <span> </span><span class="NLM_article-title">Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1088</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.1128/AAC.03659-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.03659-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25487801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVagsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=1088-1099&issue=2&author=J.+Kindrachukauthor=B.+Orkauthor=B.+J.+Hartauthor=S.+Mazurauthor=M.+R.+Holbrookauthor=M.+B.+Friemanauthor=D.+Traynorauthor=R.+F.+Johnsonauthor=J.+Dyallauthor=J.+H.+Kuhnauthor=G.+G.+Olingerauthor=L.+E.+Hensleyauthor=P.+B.+Jahrling&title=Antiviral+potential+of+ERK%2FMAPK+and+PI3K%2FAKT%2FmTOR+signaling+modulation+for+Middle+East+respiratory+syndrome+coronavirus+infection+as+identified+by+temporal+kinome+analysis&doi=10.1128%2FAAC.03659-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for middle east respiratory syndrome coronavirus infection as identified by temporal kinome analysis</span></div><div class="casAuthors">Kindrachuk, Jason; Ork, Britini; Hart, Brit J.; Mazur, Steven; Holbrook, Michael R.; Frieman, Matthew B.; Traynor, Dawn; Johnson, Reed F.; Dyall, Julie; Kuhn, Jens H.; Olinger, Gene G.; Hensley, Lisa E.; Jahrling, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1088-1099/1-1088-1099/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus, and infections with this virus can result in acute respiratory syndrome with renal failure.  Globally, MERS-CoV has been responsible for 877 lab.-confirmed infections, including 317 deaths, since Sept. 2012.  As there is a paucity of information regarding the mol. pathogenesis assocd. with this virus or the identities of novel antiviral drug targets, we performed temporal kinome anal. on human hepatocytes infected with the Erasmus isolate of MERS-CoV with peptide kinome arrays. bioinformatics anal. of our kinome data, including pathway overrepresentation anal. (ORA) and functional network anal., suggested that extracellular signalregulated kinase (ERK)/mitogen-activated protein kinase (MAPK) and phosphoinositol 3-kinase (PI3K)/serine-threonine kinase (AKT)/mammalian target of rapamycin (mTOR) signaling responses were specifically modulated in response to MERS-CoV infection in vitro throughout the course of infection.  The overrepresentation of specific intermediates within these pathways detd. by pathway and functional network anal. of our kinome data correlated with similar patterns of phosphorylation detd. through Western blot array anal.  In addn., anal. of the effects of specific kinase inhibitors on MERS-CoV infection in tissue culture models confirmed these cellular response observations.  Further, we have demonstrated that a subset of licensed kinase inhibitors targeting the ERK/MAPK and PI3K/AKT/mTOR pathways significantly inhibited MERS-CoV replication in vitro whether they were added before or after viral infection.  Taken together, our data suggest that ERK/MAPK and PI3K/AKT/mTOR signaling responses play important roles in MERS-CoV infection and may represent novel drug targets for therapeutic intervention strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwo9H9W_zXg7Vg90H21EOLACvtfcHk0lhjgDyjfzchnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVagsbw%253D&md5=1fef3dd7bccc643cec0762fdfbee27bb</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1128%2FAAC.03659-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03659-14%26sid%3Dliteratum%253Aachs%26aulast%3DKindrachuk%26aufirst%3DJ.%26aulast%3DOrk%26aufirst%3DB.%26aulast%3DHart%26aufirst%3DB.%2BJ.%26aulast%3DMazur%26aufirst%3DS.%26aulast%3DHolbrook%26aufirst%3DM.%2BR.%26aulast%3DFrieman%26aufirst%3DM.%2BB.%26aulast%3DTraynor%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DR.%2BF.%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DKuhn%26aufirst%3DJ.%2BH.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DJahrling%26aufirst%3DP.%2BB.%26atitle%3DAntiviral%2520potential%2520of%2520ERK%252FMAPK%2520and%2520PI3K%252FAKT%252FmTOR%2520signaling%2520modulation%2520for%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520infection%2520as%2520identified%2520by%2520temporal%2520kinome%2520analysis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26issue%3D2%26spage%3D1088%26epage%3D1099%26doi%3D10.1128%2FAAC.03659-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postnikova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindrachuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrling, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L.</span></span> <span> </span><span class="NLM_article-title">Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1099/vir.0.061911-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.061911-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24323636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyms7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2014&pages=571-577&issue=3&author=B.+J.+Hartauthor=J.+Dyallauthor=E.+Postnikovaauthor=H.+Zhouauthor=J.+Kindrachukauthor=R.+F.+Johnsonauthor=G.+G.+Olingerauthor=M.+B.+Friemanauthor=M.+R.+Holbrookauthor=P.+B.+Jahrlingauthor=L.+Hensley&title=Interferon-beta+and+mycophenolic+acid+are+potent+inhibitors+of+Middle+East+respiratory+syndrome+coronavirus+in+cell-based+assays&doi=10.1099%2Fvir.0.061911-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays</span></div><div class="casAuthors">Hart, Brit J.; Dyall, Julie; Postnikova, Elena; Zhou, Huanying; Kindrachuk, Jason; Johnson, Reed F.; Olinger, Gene G., Jr.; Frieman, Matthew B.; Holbrook, Michael R.; Jahrling, Peter B.; Hensley, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">571-577</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">The Middle East respiratory syndrome coronavirus (MERS-CoV) presents a novel emerging threat to public health worldwide.  Several treatments for infected individuals have been suggested including IFN, ribavirin and passive immunotherapy with convalescent plasma.  Administration of IFN-α2b and ribavirin has improved outcomes of MERS-CoV infection in rhesus macaques when administered within 8 h post-challenge.  However, detailed and systematic evidence on the activity of other clin. available drugs is limited.  Here we compared the susceptibility of MERS-CoV with different IFN products (IFN-α2b, IFN-γ, IFN-universal, IFN-α2a and IFN-β), as well as with two antivirals, ribavirin and mycophenolic acid (MPA), against MERS-CoV (Hu/Jordan-N3/2012) in vitro.  Of all the IFNs tested, IFN-β showed the strongst inhibition of MERS-CoV in vitro, with an IC50 of 1.37 U ml-1, 41 times lower than the previously reported IC50 (56.08 U ml-1) of IFN-α2b.  IFN-β inhibition was confirmed in the virus yield redn. assay, with an IC90 of 38.8 U ml-1.  Ribavirin did not inhibit viral replication in vitro at a dose that would be applicable to current treatment protocols in humans.  In contrast, MPA showed strong inhibition, with an IC50 of 2.87 μM.  This drug has not been previously tested against MERS-CoV and may provide an alternative to ribavirin for treatment of MERS-CoV.  In conclusion, IFN-β, MPA or a combination of the two may be beneficial in the treatment of MERS-CoV or as a post-exposure intervention in high-risk patients with known exposures to MERS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wny_RT-Vi7Vg90H21EOLACvtfcHk0lh4dFP_Dzthjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyms7%252FL&md5=1c222918737c4960fcc70b107c7e148b</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.061911-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.061911-0%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DB.%2BJ.%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DPostnikova%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKindrachuk%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BF.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DFrieman%26aufirst%3DM.%2BB.%26aulast%3DHolbrook%26aufirst%3DM.%2BR.%26aulast%3DJahrling%26aufirst%3DP.%2BB.%26aulast%3DHensley%26aufirst%3DL.%26atitle%3DInterferon-beta%2520and%2520mycophenolic%2520acid%2520are%2520potent%2520inhibitors%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520in%2520cell-based%2520assays%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2014%26volume%3D95%26issue%3D3%26spage%3D571%26epage%3D577%26doi%3D10.1099%2Fvir.0.061911-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horby, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1787</span>– <span class="NLM_lpage">1799</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa2001282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa2001282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32187464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB383kvFOjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2020&pages=1787-1799&issue=19&author=B.+Caoauthor=Y.+Wangauthor=D.+Wenauthor=W.+Liuauthor=J.+Wangauthor=G.+Fanauthor=L.+Ruanauthor=B.+Songauthor=Y.+Caiauthor=M.+Weiauthor=X.+Liauthor=J.+Xiaauthor=N.+Chenauthor=J.+Xiangauthor=T.+Yuauthor=T.+Baiauthor=X.+Xieauthor=L.+Zhangauthor=C.+Liauthor=Y.+Yuanauthor=H.+Chenauthor=H.+Liauthor=H.+Huangauthor=S.+Tuauthor=F.+Gongauthor=Y.+Liuauthor=Y.+Weiauthor=C.+Dongauthor=F.+Zhouauthor=X.+Guauthor=J.+Xuauthor=Z.+Liuauthor=Y.+Zhangauthor=H.+Liauthor=L.+Shangauthor=K.+Wangauthor=K.+Liauthor=X.+Zhouauthor=X.+Dongauthor=Z.+Quauthor=S.+Luauthor=X.+Huauthor=S.+Ruanauthor=S.+Luoauthor=J.+Wuauthor=L.+Pengauthor=F.+Chengauthor=L.+Panauthor=J.+Zouauthor=C.+Jiaauthor=J.+Wangauthor=X.+Liuauthor=S.+Wangauthor=X.+Wuauthor=Q.+Geauthor=J.+Heauthor=H.+Zhanauthor=F.+Qiuauthor=L.+Guoauthor=C.+Huangauthor=T.+Jakiauthor=F.+G.+Haydenauthor=P.+W.+Horbyauthor=D.+Zhangauthor=C.+Wang&title=A+trial+of+Lopinavir-Ritonavir+in+adults+hospitalized+with+severe+Covid-19&doi=10.1056%2FNEJMoa2001282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19</span></div><div class="casAuthors">Cao Bin; Wang Yeming; Wen Danning; Liu Wen; Wang Jingli; Fan Guohui; Ruan Lianguo; Song Bin; Cai Yanping; Wei Ming; Li Xingwang; Xia Jiaan; Chen Nanshan; Xiang Jie; Yu Ting; Bai Tao; Xie Xuelei; Zhang Li; Li Caihong; Yuan Ye; Chen Hua; Li Huadong; Huang Hanping; Tu Shengjing; Gong Fengyun; Liu Ying; Wei Yuan; Dong Chongya; Zhou Fei; Gu Xiaoying; Xu Jiuyang; Liu Zhibo; Zhang Yi; Li Hui; Shang Lianhan; Wang Ke; Li Kunxia; Zhou Xia; Dong Xuan; Qu Zhaohui; Lu Sixia; Hu Xujuan; Ruan Shunan; Luo Shanshan; Wu Jing; Peng Lu; Cheng Fang; Pan Lihong; Zou Jun; Jia Chunmin; Wang Juan; Liu Xia; Wang Shuzhen; Wu Xudong; Ge Qin; He Jing; Zhan Haiyan; Qiu Fang; Guo Li; Huang Chaolin; Jaki Thomas; Hayden Frederick G; Horby Peter W; Zhang Dingyu; Wang Chen</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1787-1799</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.  METHODS:  We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao2) to the fraction of inspired oxygen (Fio2) of less than 300 mm Hg.  Patients were randomly assigned in a 1:1 ratio to receive either lopinavir-ritonavir (400 mg and 100 mg, respectively) twice a day for 14 days, in addition to standard care, or standard care alone.  The primary end point was the time to clinical improvement, defined as the time from randomization to either an improvement of two points on a seven-category ordinal scale or discharge from the hospital, whichever came first.  RESULTS:  A total of 199 patients with laboratory-confirmed SARS-CoV-2 infection underwent randomization; 99 were assigned to the lopinavir-ritonavir group, and 100 to the standard-care group.  Treatment with lopinavir-ritonavir was not associated with a difference from standard care in the time to clinical improvement (hazard ratio for clinical improvement, 1.31; 95% confidence interval [CI], 0.95 to 1.80).  Mortality at 28 days was similar in the lopinavir-ritonavir group and the standard-care group (19.2% vs. 25.0%; difference, -5.8 percentage points; 95% CI, -17.3 to 5.7).  The percentages of patients with detectable viral RNA at various time points were similar.  In a modified intention-to-treat analysis, lopinavir-ritonavir led to a median time to clinical improvement that was shorter by 1 day than that observed with standard care (hazard ratio, 1.39; 95% CI, 1.00 to 1.91).  Gastrointestinal adverse events were more common in the lopinavir-ritonavir group, but serious adverse events were more common in the standard-care group.  Lopinavir-ritonavir treatment was stopped early in 13 patients (13.8%) because of adverse events.  CONCLUSIONS:  In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir-ritonavir treatment beyond standard care.  Future trials in patients with severe illness may help to confirm or exclude the possibility of a treatment benefit. (Funded by Major Projects of National Science and Technology on New Drug Creation and Development and others; Chinese Clinical Trial Register number, ChiCTR2000029308.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLXU2_2H1oIv6BottYdIAWfW6udTcc2eZNLlAnsivQF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383kvFOjtQ%253D%253D&md5=affdbe91481a3ada1a2fed29e2ad17f9</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa2001282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa2001282%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DRuan%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DB.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DBai%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DTu%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DShang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DQu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DZhan%26aufirst%3DH.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJaki%26aufirst%3DT.%26aulast%3DHayden%26aufirst%3DF.%2BG.%26aulast%3DHorby%26aufirst%3DP.%2BW.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DA%2520trial%2520of%2520Lopinavir-Ritonavir%2520in%2520adults%2520hospitalized%2520with%2520severe%2520Covid-19%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D382%26issue%3D19%26spage%3D1787%26epage%3D1799%26doi%3D10.1056%2FNEJMoa2001282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holshue, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBolt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lofy, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkerson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tural, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallansch, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weldon, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyeki, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, S. K.</span></span> <span> </span><span class="NLM_article-title">Washington State -nCo, V. C. I. T. First case of 2019 novel coronavirus in the United States</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa2001191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa2001191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32004427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvVKrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2020&pages=929-936&issue=10&author=M.+L.+Holshueauthor=C.+DeBoltauthor=S.+Lindquistauthor=K.+H.+Lofyauthor=J.+Wiesmanauthor=H.+Bruceauthor=C.+Spittersauthor=K.+Ericsonauthor=S.+Wilkersonauthor=A.+Turalauthor=G.+Diazauthor=A.+Cohnauthor=L.+Foxauthor=A.+Patelauthor=S.+I.+Gerberauthor=L.+Kimauthor=S.+Tongauthor=X.+Luauthor=S.+Lindstromauthor=M.+A.+Pallanschauthor=W.+C.+Weldonauthor=H.+M.+Biggsauthor=T.+M.+Uyekiauthor=S.+K.+Pillai&title=Washington+State+-nCo%2C+V.+C.+I.+T.+First+case+of+2019+novel+coronavirus+in+the+United+States&doi=10.1056%2FNEJMoa2001191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">First case of 2019 novel coronavirus in the United States</span></div><div class="casAuthors">Holshue, Michelle L.; DeBolt, Chas; Lindquist, Scott; Lofy, Kathy H.; Wiesman, John; Bruce, Hollianne; Spitters, Christopher; Ericson, Keith; Wilkerson, Sara; Tural, Ahmet; Diaz, George; Cohn, Amanda; Fox, LeAnne; Patel, Anita; Gerber, Susan I.; Kim, Lindsay; Tong, Suxiang; Lu, Xiaoyan; Lindstrom, Steve; Pallansch, Mark A.; Weldon, William C.; Biggs, Holly M.; Uyeki, Timothy M.; Pillai, Satish K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">929-936</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries.  We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clin. course, and management of the case, including the patient's initial mild symptoms at presentation with progression to pneumonia on day 9 of illness.  This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clin. information related to the care of patients with this emerging infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrthESVAgZg7LVg90H21EOLACvtfcHk0ljLV1mInBoutg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvVKrsbo%253D&md5=bbd55e08e80c31c36bf686f09a5a797c</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa2001191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa2001191%26sid%3Dliteratum%253Aachs%26aulast%3DHolshue%26aufirst%3DM.%2BL.%26aulast%3DDeBolt%26aufirst%3DC.%26aulast%3DLindquist%26aufirst%3DS.%26aulast%3DLofy%26aufirst%3DK.%2BH.%26aulast%3DWiesman%26aufirst%3DJ.%26aulast%3DBruce%26aufirst%3DH.%26aulast%3DSpitters%26aufirst%3DC.%26aulast%3DEricson%26aufirst%3DK.%26aulast%3DWilkerson%26aufirst%3DS.%26aulast%3DTural%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DG.%26aulast%3DCohn%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DGerber%26aufirst%3DS.%2BI.%26aulast%3DKim%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DLindstrom%26aufirst%3DS.%26aulast%3DPallansch%26aufirst%3DM.%2BA.%26aulast%3DWeldon%26aufirst%3DW.%2BC.%26aulast%3DBiggs%26aufirst%3DH.%2BM.%26aulast%3DUyeki%26aufirst%3DT.%2BM.%26aulast%3DPillai%26aufirst%3DS.%2BK.%26atitle%3DWashington%2520State%2520-nCo%252C%2520V.%2520C.%2520I.%2520T.%2520First%2520case%2520of%25202019%2520novel%2520coronavirus%2520in%2520the%2520United%2520States%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D382%26issue%3D10%26spage%3D929%26epage%3D936%26doi%3D10.1056%2FNEJMoa2001191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref245"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref245'); return false;" data-citation="" class="refNumLink">245</a></strong><div class="NLM_citation" id="cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span> <span> </span><span class="NLM_article-title">Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study</span>. <i>J. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">e1</span>– <span class="NLM_lpage">e5</span>, <span class="refDoi"> DOI: 10.1016/j.jinf.2020.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jinf.2020.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32171872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCjtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2020&pages=e1-e5&author=L.+Dengauthor=C.+Liauthor=Q.+Zengauthor=X.+Liuauthor=X.+Liauthor=H.+Zhangauthor=Z.+Hongauthor=J.+Xia&title=Arbidol+combined+with+LPV%2Fr+versus+LPV%2Fr+alone+against+Corona+Virus+Disease+2019%3A+A+retrospective+cohort+study&doi=10.1016%2Fj.jinf.2020.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study</span></div><div class="casAuthors">Deng, Lisi; Li, Chunna; Zeng, Qi; Liu, Xi; Li, Xinghua; Zhang, Haitang; Hong, Zhongsi; Xia, Jinyu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infection</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1-e5</span>CODEN:
                <span class="NLM_cas:coden">JINFD2</span>;
        ISSN:<span class="NLM_cas:issn">1532-2742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Corona Virus Disease 2019 (COVID-19) due to the 2019 novel coronavirus (SARS-CoV-2) emerged in Wuhan city and rapidly spread throughout China.  We aimed to compare arbidol and lopinavir/ritonavir(LPV/r) treatment for patients with COVID-19 with LPV/r only.  In this retrospective cohort study, we included adults (age≥18years) with lab.-confirmed COVID-19 without Invasive ventilation, diagnosed between Jan 17, 2020, and Feb 13, 2020.  Patients, diagnosed after Jan 17, 2020, were given oral arbidol and LPV/r in the combination group and oral LPV/r only in the monotherapy group for 5-21 days.  The primary endpoint was a neg. conversion rate of coronavirus from the date of COVID-19 diagnosis(day7, day14), and assessed whether the pneumonia was progressing or improving by chest CT (day7).  We analyzed 16 patients who received oral arbidol and LPV/r in the combination group and 17 who oral LPV/r only in the monotherapy group, and both initiated after diagnosis.  Baseline clin., lab., and chest CT characteristics were similar between groups.  The SARS-CoV-2 could not be detected for 12(75%) of 16 patients' nasopharyngeal specimens in the combination group after seven days, compared with 6 (35%) of 17 in the monotherapy group (p < 0·05).  After 14 days, 15 (94%) of 16 and 9 (52·9%) of 17, resp., SARS-CoV-2 could not be detected (p < 0·05).  The chest CT scans were improving for 11(69%) of 16 patients in the combination group after seven days, compared with 5(29%) of 17 in the monotherapy group (p < 0·05).  In patients with COVID-19, the apparent favorable clin. response with arbidol and LPV/r supports further LPV/r only.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopNN5US_y047Vg90H21EOLACvtfcHk0liT0H-re1-Pmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCjtLbL&md5=cb21ca380cca48db5f317bf82ddd25b6</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1016%2Fj.jinf.2020.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinf.2020.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DXia%26aufirst%3DJ.%26atitle%3DArbidol%2520combined%2520with%2520LPV%252Fr%2520versus%2520LPV%252Fr%2520alone%2520against%2520Corona%2520Virus%2520Disease%25202019%253A%2520A%2520retrospective%2520cohort%2520study%26jtitle%3DJ.%2520Infect.%26date%3D2020%26volume%3D81%26spage%3De1%26epage%3De5%26doi%3D10.1016%2Fj.jinf.2020.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref246"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref246'); return false;" data-citation="" class="refNumLink">246</a></strong><div class="NLM_citation" id="cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span> <span> </span><span class="NLM_article-title">Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19</span>. <i>J. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">e21</span>– <span class="NLM_lpage">e23</span>, <span class="refDoi"> DOI: 10.1016/j.jinf.2020.03.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jinf.2020.03.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32283143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCjtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2020&pages=e21-e23&author=Z.+Zhuauthor=Z.+Luauthor=T.+Xuauthor=C.+Chenauthor=G.+Yangauthor=T.+Zhaauthor=J.+Luauthor=Y.+Xue&title=Arbidol+monotherapy+is+superior+to+lopinavir%2Fritonavir+in+treating+COVID-19&doi=10.1016%2Fj.jinf.2020.03.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19</span></div><div class="casAuthors">Zhu, Zhen; Lu, Zhaohui; Xu, Tianmin; Chen, Cong; Yang, Gang; Zha, Tao; Lu, Jianchun; Xue, Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infection</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e21-e23</span>CODEN:
                <span class="NLM_cas:coden">JINFD2</span>;
        ISSN:<span class="NLM_cas:issn">1532-2742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lopinavir/ritonavir and arbidol have been previously used to treat acute respiratory syndrome- coronavirus 2 (SARS-CoV-2) replication in clin. practice; nevertheless, their effectiveness remains controversial.  In this study, we evaluated the antiviral effects and safety of lopinavir/ritonavir and arbidol in patients with the 2019-nCoV disease (COVID-19).  Fifty patients with lab.-confirmed COVID-19 were divided into two groups: including lopinavir/ritonavir group (34 cases) and arbidol group (16 cases).  Lopinavir/ritonavir group received 400 mg/100mg of Lopinavir/ritonavir, twice a day for a week, while the arbidol group was given 0.2 g arbidol, three times a day.  Data from these patients were retrospectively analyzed.  The cycle threshold values of open reading frame 1ab and nucleocapsid genes by RT-PCR assay were monitored during antiviral therapy.  None of the patients developed severe pneumonia or ARDS.  There was no difference in fever duration between the two groups (P=0.61).  On day 14 after the admission, no viral load was detected in arbidol group, but the viral load was found in 15(44.1%) patients treated with lopinavir/ritonavir.  Patients in the arbidol group had a shorter duration of pos. RNA test compared to those in the lopinavir/ritonavir group (P<0.01).  Moreover, no apparent side effects were found in both groups.  In conclusion, our data indicate that arbidol monotherapy may be superior to lopinavir/ritonavir in treating COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpusZ0NCuBeZrVg90H21EOLACvtfcHk0liT0H-re1-Pmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCjtLfO&md5=0d8722f018affa4c2ee6e3086bef446c</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.jinf.2020.03.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinf.2020.03.060%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZha%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DY.%26atitle%3DArbidol%2520monotherapy%2520is%2520superior%2520to%2520lopinavir%252Fritonavir%2520in%2520treating%2520COVID-19%26jtitle%3DJ.%2520Infect.%26date%3D2020%26volume%3D81%26spage%3De21%26epage%3De23%26doi%3D10.1016%2Fj.jinf.2020.03.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref247"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref247'); return false;" data-citation="" class="refNumLink">247</a></strong><div class="NLM_citation" id="cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arabi, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalhoub, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandourah, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Hameed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Omari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Qasim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alraddadi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almotairi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Khatib, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulmomen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qushmaq, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solaiman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Raddadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maghrabi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Mekhlafi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balkhy, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Harthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharaba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gramish, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Aithan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Dawood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, R.</span></span> <span> </span><span class="NLM_article-title">Ribavirin and interferon therapy for critically Ill patients with Middle East respiratory syndrome: A multicenter observational study</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1837</span>– <span class="NLM_lpage">1844</span>, <span class="refDoi"> DOI: 10.1093/cid/ciz544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1093%2Fcid%2Fciz544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31925415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsFGlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2020&pages=1837-1844&issue=9&author=Y.+M.+Arabiauthor=S.+Shalhoubauthor=Y.+Mandourahauthor=F.+Al-Hameedauthor=A.+Al-Omariauthor=E.+Al+Qasimauthor=J.+Joseauthor=B.+Alraddadiauthor=A.+Almotairiauthor=K.+Al+Khatibauthor=A.+Abdulmomenauthor=I.+Qushmaqauthor=A.+A.+Sindiauthor=A.+Madyauthor=O.+Solaimanauthor=R.+Al-Raddadiauthor=K.+Maghrabiauthor=A.+Ragabauthor=G.+A.+Al+Mekhlafiauthor=H.+H.+Balkhyauthor=A.+Al+Harthyauthor=A.+Kharabaauthor=J.+A.+Gramishauthor=A.+M.+Al-Aithanauthor=A.+Al-Dawoodauthor=L.+Mersonauthor=F.+G.+Haydenauthor=R.+Fowler&title=Ribavirin+and+interferon+therapy+for+critically+Ill+patients+with+Middle+East+respiratory+syndrome%3A+A+multicenter+observational+study&doi=10.1093%2Fcid%2Fciz544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin and interferon therapy for critically ill patients with middle east respiratory syndrome: a multicenter observational study</span></div><div class="casAuthors">Arabi, Yaseen M.; Shalhoub, Sarah; Mandourah, Yasser; Al-Hameed, Fahad; Al-Omari, Awad; Al Qasim, Eman; Jose, Jesna; Alraddadi, Basem; Almotairi, Abdullah; Al Khatib, Kasim; Abdulmomen, Ahmed; Qushmaq, Ismael; Sindi, Anees A.; Mady, Ahmed; Solaiman, Othman; Al-Raddadi, Rajaa; Maghrabi, Khalid; Ragab, Ahmed; Al Mekhlafi, Ghaleb A.; Balkhy, Hanan H.; Al Harthy, Abdulrahman; Kharaba, Ayman; Gramish, Jawaher A.; Al-Aithan, Abdulsalam M.; Al-Dawood, Abdulaziz; Merson, Laura; Hayden, Frederick G.; Fowler, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1837-1844</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1537-6591</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The objective of this study was to evaluate the effect of ribavirin and recombinant interferon (RBV/rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syndrome (MERS), accounting for time-varying confounders.  This is a retrospective cohort study of critically ill patients with lab.-confirmed MERS from 14 hospitals in Saudi Arabia diagnosed between Sept. 2012 and Jan. 2018.  We evaluated the assocn. of RBV/rIFN with 90-day mortality and MERS coronavirus (MERS-CoV) RNA clearance using marginal structural modeling to account for baseline and time-varying confounders.  Of 349 MERS patients, 144 (41.3%) patients received RBV/rIFN (RBV and/or rIFN-α2a, rIFN-α2b, or rIFN-β1a; none received rIFN-β1b).  RBV/rIFN was initiated at a median of 2 days (Q1, Q3: 1, 3 days) from intensive care unit admission.  Crude 90-day mortality was higher in patients with RBV/rIFN compared to no RBV/rIFN (106/144 [73.6%] vs 126/205 [61.5%]; P = .02).  After adjusting for baseline and time-varying confounders using a marginal structural model, RBV/rIFN was not assocd. with changes in 90-day mortality (adjusted odds ratio, 1.03 [95% confidence interval {CI}, .73-1.44]; P = .87) or with more rapid MERS-CoV RNA clearance (adjusted hazard ratio, 0.65 [95% CI, .30-1.44]; P = .29).  In this observational study, RBV/rIFN (RBV and/or rIFN-α2a, rIFN-α2b, or rIFN-β1a) therapy was commonly used in critically ill MERS patients but was not assocd. with redn. in 90-day mortality or in faster MERS-CoV RNA clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohyYIFPQwdTrVg90H21EOLACvtfcHk0lirWVKgeo_LbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsFGlsLs%253D&md5=98356465247f1acf47c8dc6ba3b09d2d</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciz544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciz544%26sid%3Dliteratum%253Aachs%26aulast%3DArabi%26aufirst%3DY.%2BM.%26aulast%3DShalhoub%26aufirst%3DS.%26aulast%3DMandourah%26aufirst%3DY.%26aulast%3DAl-Hameed%26aufirst%3DF.%26aulast%3DAl-Omari%26aufirst%3DA.%26aulast%3DAl%2BQasim%26aufirst%3DE.%26aulast%3DJose%26aufirst%3DJ.%26aulast%3DAlraddadi%26aufirst%3DB.%26aulast%3DAlmotairi%26aufirst%3DA.%26aulast%3DAl%2BKhatib%26aufirst%3DK.%26aulast%3DAbdulmomen%26aufirst%3DA.%26aulast%3DQushmaq%26aufirst%3DI.%26aulast%3DSindi%26aufirst%3DA.%2BA.%26aulast%3DMady%26aufirst%3DA.%26aulast%3DSolaiman%26aufirst%3DO.%26aulast%3DAl-Raddadi%26aufirst%3DR.%26aulast%3DMaghrabi%26aufirst%3DK.%26aulast%3DRagab%26aufirst%3DA.%26aulast%3DAl%2BMekhlafi%26aufirst%3DG.%2BA.%26aulast%3DBalkhy%26aufirst%3DH.%2BH.%26aulast%3DAl%2BHarthy%26aufirst%3DA.%26aulast%3DKharaba%26aufirst%3DA.%26aulast%3DGramish%26aufirst%3DJ.%2BA.%26aulast%3DAl-Aithan%26aufirst%3DA.%2BM.%26aulast%3DAl-Dawood%26aufirst%3DA.%26aulast%3DMerson%26aufirst%3DL.%26aulast%3DHayden%26aufirst%3DF.%2BG.%26aulast%3DFowler%26aufirst%3DR.%26atitle%3DRibavirin%2520and%2520interferon%2520therapy%2520for%2520critically%2520Ill%2520patients%2520with%2520Middle%2520East%2520respiratory%2520syndrome%253A%2520A%2520multicenter%2520observational%2520study%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2020%26volume%3D70%26issue%3D9%26spage%3D1837%26epage%3D1844%26doi%3D10.1093%2Fcid%2Fciz544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref248"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref248'); return false;" data-citation="" class="refNumLink">248</a></strong><div class="NLM_citation" id="cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuthman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tongeren, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retterer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegoraro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honnold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taubenheim, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minning, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>508</i></span> (<span class="NLM_issue">7496</span>),  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1038/nature13027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnature13027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24590073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=508&publication_year=2014&pages=402-405&issue=7496&author=T.+K.+Warrenauthor=J.+Wellsauthor=R.+G.+Panchalauthor=K.+S.+Stuthmanauthor=N.+L.+Garzaauthor=S.+A.+Van+Tongerenauthor=L.+Dongauthor=C.+J.+Rettererauthor=B.+P.+Eatonauthor=G.+Pegoraroauthor=S.+Honnoldauthor=S.+Bantiaauthor=P.+Kotianauthor=X.+Chenauthor=B.+R.+Taubenheimauthor=L.+S.+Welchauthor=D.+M.+Minningauthor=Y.+S.+Babuauthor=W.+P.+Sheridanauthor=S.+Bavari&title=Protection+against+filovirus+diseases+by+a+novel+broad-spectrum+nucleoside+analogue+BCX4430&doi=10.1038%2Fnature13027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430</span></div><div class="casAuthors">Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Welch, Lisa S.; Minning, Dena M.; Babu, Yarlagadda S.; Sheridan, William P.; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">508</span>
        (<span class="NLM_cas:issue">7496</span>),
    <span class="NLM_cas:pages">402-405</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever.  Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen, exceeding 90% (ref. 1).  Licensed therapeutic or vaccine products are not available to treat filovirus diseases.  Candidate therapeutics previously shown to be efficacious in non-human primate disease models are based on virus-specific designs and have limited broad-spectrum antiviral potential.  Here we show that BCX4430, a novel synthetic adenosine analog, inhibits infection of distinct filoviruses in human cells.  Biochem., reporter-based and primer-extension assays indicate that BCX4430 inhibits viral RNA polymerase function, acting as a non-obligate RNA chain terminator.  Post-exposure i.m. administration of BCX4430 protects against Ebola virus and Marburg virus disease in rodent models.  Most importantly, BCX4430 completely protects cynomolgus macaques from Marburg virus infection when administered as late as 48 h after infection.  In addn., BCX4430 exhibits broad-spectrum antiviral activity against numerous viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses.  This is the first report, to our knowledge, of non-human primate protection from filovirus disease by a synthetic drug-like small mol.  We provide addnl. pharmacol. characterizations supporting the potential development of BCX4430 as a countermeasure against human filovirus diseases and other viral diseases representing major public health threats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpev8c7g-X43rVg90H21EOLACvtfcHk0lirWVKgeo_LbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWhu7w%253D&md5=dc7d390055ecf253e4b21c95b4e9e1a2</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1038%2Fnature13027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13027%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DWells%26aufirst%3DJ.%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DStuthman%26aufirst%3DK.%2BS.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DVan%2BTongeren%26aufirst%3DS.%2BA.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DRetterer%26aufirst%3DC.%2BJ.%26aulast%3DEaton%26aufirst%3DB.%2BP.%26aulast%3DPegoraro%26aufirst%3DG.%26aulast%3DHonnold%26aufirst%3DS.%26aulast%3DBantia%26aufirst%3DS.%26aulast%3DKotian%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTaubenheim%26aufirst%3DB.%2BR.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DMinning%26aufirst%3DD.%2BM.%26aulast%3DBabu%26aufirst%3DY.%2BS.%26aulast%3DSheridan%26aufirst%3DW.%2BP.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DProtection%2520against%2520filovirus%2520diseases%2520by%2520a%2520novel%2520broad-spectrum%2520nucleoside%2520analogue%2520BCX4430%26jtitle%3DNature%26date%3D2014%26volume%3D508%26issue%3D7496%26spage%3D402%26epage%3D405%26doi%3D10.1038%2Fnature13027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref249"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref249'); return false;" data-citation="" class="refNumLink">249</a></strong><div class="NLM_citation" id="cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. Y.</span></span> <span> </span><span class="NLM_article-title">Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2017.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2017.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29289665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis12rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=155-163&author=M.+H.+Linauthor=D.+C.+Mosesauthor=C.+H.+Hsiehauthor=S.+C.+Chengauthor=Y.+H.+Chenauthor=C.+Y.+Sunauthor=C.+Y.+Chou&title=Disulfiram+can+inhibit+MERS+and+SARS+coronavirus+papain-like+proteases+via+different+modes&doi=10.1016%2Fj.antiviral.2017.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes</span></div><div class="casAuthors">Lin, Min-Han; Moses, David C.; Hsieh, Chih-Hua; Cheng, Shu-Chun; Chen, Yau-Hung; Sun, Chiao-Yin; Chou, Chi-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in southern China in late 2002 and caused a global outbreak with a fatality rate around 10% in 2003.  Ten years later, a second highly pathogenic human CoV, MERS-CoV, emerged in the Middle East and has spread to other countries in Europe, North Africa, North America and Asia.  As of Nov. 2017, MERS-CoV had infected at least 2102 people with a fatality rate of about 35% globally, and hence there is an urgent need to identify antiviral drugs that are active against MERS-CoV.  Here we show that a clin. available alc.-aversive drug, disulfiram, can inhibit the papain-like proteases (PLpros) of MERS-CoV and SARS-CoV.  Our findings suggest that disulfiram acts as an allosteric inhibitor of MERS-CoV PLpro but as a competitive (or mixed) inhibitor of SARS-CoV PLpro.  The phenomenon of slow-binding inhibition and the irrecoverability of enzyme activity after removing unbound disulfiram indicate covalent inactivation of SARS-CoV PLpro by disulfiram, while synergistic inhibition of MERS-CoV PLpro by disulfiram and 6-thioguanine or mycophenolic acid implies the potential for combination treatments using these three clin. available drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO7GTDzTmBF7Vg90H21EOLACvtfcHk0liRVBDnlM5Svw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis12rsg%253D%253D&md5=623c128a81c27178b6c5d58fa7e6a8e7</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2017.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2017.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DMoses%26aufirst%3DD.%2BC.%26aulast%3DHsieh%26aufirst%3DC.%2BH.%26aulast%3DCheng%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BH.%26aulast%3DSun%26aufirst%3DC.%2BY.%26aulast%3DChou%26aufirst%3DC.%2BY.%26atitle%3DDisulfiram%2520can%2520inhibit%2520MERS%2520and%2520SARS%2520coronavirus%2520papain-like%2520proteases%2520via%2520different%2520modes%26jtitle%3DAntiviral%2520Res.%26date%3D2018%26volume%3D150%26spage%3D155%26epage%3D163%26doi%3D10.1016%2Fj.antiviral.2017.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref250"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref250'); return false;" data-citation="" class="refNumLink">250</a></strong><div class="NLM_citation" id="cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouokam, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasnik, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foreman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojdani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, K. E.</span></span> <span> </span><span class="NLM_article-title">Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1128/AAC.01407-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.01407-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24145548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=120-127&issue=1&author=C.+Bartonauthor=J.+C.+Kouokamauthor=A.+B.+Lasnikauthor=O.+Foremanauthor=A.+Cambonauthor=G.+Brockauthor=D.+C.+Montefioriauthor=F.+Vojdaniauthor=A.+A.+McCormickauthor=B.+R.+O%E2%80%99Keefeauthor=K.+E.+Palmer&title=Activity+of+and+effect+of+subcutaneous+treatment+with+the+broad-spectrum+antiviral+lectin+griffithsin+in+two+laboratory+rodent+models&doi=10.1128%2FAAC.01407-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models</span></div><div class="casAuthors">Barton, Christopher; Kouokam, J. Calvin; Lasnik, Amanda B.; Foreman, Oded; Cambon, Alexander; Brock, Guy; Montefiori, David C.; Vojdani, Fakhrieh; McCormick, Alison A.; O'Keefe, Barry R.; Palmer, Kenneth E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-127, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Griffithsin (GRFT) is a red-alga-derived lectin that binds the terminal mannose residues of N-linked glycans found on the surface of human immunodeficiency virus type 1 (HIV-1), HIV-2, and other enveloped viruses, including hepatitis C virus (HCV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Ebola virus.  GRFT displays no human T-cell mitogenic activity and does not induce prodn. of proinflammatory cytokines in treated human cell lines.  However, despite the growing evidence showing the broad-spectrum nanomolar or better antiviral activity of GRFT, no study has reported a comprehensive assessment of GRFT safety as a potential systemic antiviral treatment.  The results presented in this work show that minimal toxicity was induced by a range of single and repeated daily s.c. doses of GRFT in two rodent species, although we noted treatment-assocd. increases in spleen and liver mass suggestive of an antidrug immune response.  The drug is systemically distributed, accumulating to high levels in the serum and plasma after s.c. delivery.  Further, we showed that serum from GRFT-treated animals retained antiviral activity against HIV-1-enveloped pseudoviruses in a cell-based neutralization assay.  Overall, our data presented here show that GRFT accumulates to relevant therapeutic concns. which are tolerated with minimal toxicity.  These studies support further development of GRFT as a systemic antiviral therapeutic agent against enveloped viruses, although deimmunizing the mol. may be necessary if it is to be used in long-term treatment of chronic viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNS7hlCTdbMbVg90H21EOLACvtfcHk0liRVBDnlM5Svw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCiu7o%253D&md5=a901e479ffbce75f45a84ada5081e0d7</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1128%2FAAC.01407-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01407-13%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DC.%26aulast%3DKouokam%26aufirst%3DJ.%2BC.%26aulast%3DLasnik%26aufirst%3DA.%2BB.%26aulast%3DForeman%26aufirst%3DO.%26aulast%3DCambon%26aufirst%3DA.%26aulast%3DBrock%26aufirst%3DG.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DVojdani%26aufirst%3DF.%26aulast%3DMcCormick%26aufirst%3DA.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DB.%2BR.%26aulast%3DPalmer%26aufirst%3DK.%2BE.%26atitle%3DActivity%2520of%2520and%2520effect%2520of%2520subcutaneous%2520treatment%2520with%2520the%2520broad-spectrum%2520antiviral%2520lectin%2520griffithsin%2520in%2520two%2520laboratory%2520rodent%2520models%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D1%26spage%3D120%26epage%3D127%26doi%3D10.1128%2FAAC.01407-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref251"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref251'); return false;" data-citation="" class="refNumLink">251</a></strong><div class="NLM_citation" id="cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuo, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. C.</span></span> <span> </span><span class="NLM_article-title">Effective inhibition of MERS-CoV infection by resveratrol</span>. <i>BMC Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">144</span>, <span class="refDoi"> DOI: 10.1186/s12879-017-2253-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1186%2Fs12879-017-2253-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28193191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVWitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=144&issue=1&author=S.+C.+Linauthor=C.+T.+Hoauthor=W.+H.+Chuoauthor=S.+Liauthor=T.+T.+Wangauthor=C.+C.+Lin&title=Effective+inhibition+of+MERS-CoV+infection+by+resveratrol&doi=10.1186%2Fs12879-017-2253-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Effective inhibition of MERS-CoV infection by resveratrol</span></div><div class="casAuthors">Lin, Shih-Chao; Ho, Chi-Tang; Chuo, Wen-Ho; Li, Shiming; Wang, Tony T.; Lin, Chi-Chen</div><div class="citationInfo"><span class="NLM_cas:title">BMC Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144/1-144/10</span>CODEN:
                <span class="NLM_cas:coden">BIDMBJ</span>;
        ISSN:<span class="NLM_cas:issn">1471-2334</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging viral pathogen that causes severe morbidity and mortality.  Up to date, there is no approved or licensed vaccine or antiviral medicines can be used to treat MERS-CoV-infected patients.  Here, we analyzed the antiviral activities of resveratrol, a natural compd. found in grape seeds and skin and in red wine, against MERS-CoV infection.  We performed MTT and neutral red uptake assays to assess the survival rates of MERS-infected Vero E6 cells.  In addn., quant. PCR, western blotting, and immunofluorescent assays detd. the intracellular viral RNA and protein expression.  For viral productivity, we utilized plaque assays to confirm the antiviral properties of resveratrol against MERS-CoV.  Resveratrol significantly inhibited MERS-CoV infection and prolonged cellular survival after virus infection.  We also found that the expression of nucleocapsid (N) protein essential for MERS-CoV replication was decreased after resveratrol treatment.  Furthermore, resveratrol down-regulated the apoptosis induced by MERS-CoV in vitro.  By consecutive administration of resveratrol, we were able to reduce the concn. of resveratrol while achieving inhibitory effectiveness against MERS-CoV.  In this study, we first demonstrated that resveratrol is a potent anti-MERS agent in vitro.  We perceive that resveratrol can be a potential antiviral agent against MERS-CoV infection in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIbNu3h_xCX7Vg90H21EOLACvtfcHk0ljLq_Ba9lh01g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVWitro%253D&md5=f6709c845629205c7f3498d0a6ae4990</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1186%2Fs12879-017-2253-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12879-017-2253-8%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DHo%26aufirst%3DC.%2BT.%26aulast%3DChuo%26aufirst%3DW.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%2BT.%26aulast%3DLin%26aufirst%3DC.%2BC.%26atitle%3DEffective%2520inhibition%2520of%2520MERS-CoV%2520infection%2520by%2520resveratrol%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2017%26volume%3D17%26issue%3D1%26spage%3D144%26doi%3D10.1186%2Fs12879-017-2253-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref252"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref252'); return false;" data-citation="" class="refNumLink">252</a></strong><div class="NLM_citation" id="cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Wilde, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochmans, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posthuma, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zevenhoven-Dobbe, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Nieuwkoop, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestebroer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Hoogen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span> <span> </span><span class="NLM_article-title">Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4875</span>– <span class="NLM_lpage">4884</span>, <span class="refDoi"> DOI: 10.1128/AAC.03011-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.03011-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24841269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1artrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4875-4884&issue=8&author=A.+H.+de+Wildeauthor=D.+Jochmansauthor=C.+C.+Posthumaauthor=J.+C.+Zevenhoven-Dobbeauthor=S.+van+Nieuwkoopauthor=T.+M.+Bestebroerauthor=B.+G.+van+den+Hoogenauthor=J.+Neytsauthor=E.+J.+Snijder&title=Screening+of+an+FDA-approved+compound+library+identifies+four+small-molecule+inhibitors+of+Middle+East+respiratory+syndrome+coronavirus+replication+in+cell+culture&doi=10.1128%2FAAC.03011-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture</span></div><div class="casAuthors">de Wilde, Adriaan H.; Jochmans, Dirk; Posthuma, Clara C.; Zevenhoven-Dobbe, Jessika C.; van Nieuwkoop, Stefan; Bestebroer, Theo M.; van den Hoogen, Bernadette G.; Neyts, Johan; Snijder, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4875-4884, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Coronaviruses can cause respiratory and enteric disease in a wide variety of human and animal hosts.  The 2003 outbreak of severe acute respiratory syndrome (SARS) first demonstrated the potentially lethal consequences of zoonotic coronavirus infections in humans.  In 2012, a similar previously unknown coronavirus emerged, Middle East respiratory syndrome coronavirus (MERS-CoV), thus far causing over 650 lab.-confirmed infections, with an unexplained steep rise in the no. of cases being recorded over recent months.  The human MERS fatality rate of ∼30% is alarmingly high, even though many deaths were assocd. with underlying medical conditions.  Registered therapeutics for the treatment of coronavirus infections are not available.  Moreover, the pace of drug development and registration for human use is generally incompatible with strategies to combat emerging infectious diseases.  Therefore, we have screened a library of 348 FDA-approved drugs for anti-MERS-CoV activity in cell culture.  If such compds. proved sufficiently potent, their efficacy might be directly assessed in MERS patients.  We identified four compds. (chloroquine, chlorpromazine, loperamide, and lopinavir) inhibiting MERS-CoV replication in the low-micromolar range (50% effective concns. [EC50s], 3 to 8 μM).  Moreover, these compds. also inhibit the replication of SARS coronavirus and human coronavirus 229E.  Although their protective activity (alone or in combination) remains to be assessed in animal models, our findings may offer a starting point for treatment of patients infected with zoonotic coronaviruses like MERS-CoV.  Although they may not necessarily reduce viral replication to very low levels, a moderate viral load redn. may create a window during which to mount a protective immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5b8wPhhGmhbVg90H21EOLACvtfcHk0ljLq_Ba9lh01g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1artrfJ&md5=3fac7c18295ca0aca41632cbb9bd1280</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1128%2FAAC.03011-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03011-14%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BWilde%26aufirst%3DA.%2BH.%26aulast%3DJochmans%26aufirst%3DD.%26aulast%3DPosthuma%26aufirst%3DC.%2BC.%26aulast%3DZevenhoven-Dobbe%26aufirst%3DJ.%2BC.%26aulast%3Dvan%2BNieuwkoop%26aufirst%3DS.%26aulast%3DBestebroer%26aufirst%3DT.%2BM.%26aulast%3Dvan%2Bden%2BHoogen%26aufirst%3DB.%2BG.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26atitle%3DScreening%2520of%2520an%2520FDA-approved%2520compound%2520library%2520identifies%2520four%2520small-molecule%2520inhibitors%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520replication%2520in%2520cell%2520culture%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4875%26epage%3D4884%26doi%3D10.1128%2FAAC.03011-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref253"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref253'); return false;" data-citation="" class="refNumLink">253</a></strong><div class="NLM_citation" id="cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caly, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druce, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catton, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jans, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagstaff, K. M.</span></span> <span> </span><span class="NLM_article-title">The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">104787</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2020.104787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2020.104787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32251768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsFalsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2020&pages=104787&author=L.+Calyauthor=J.+D.+Druceauthor=M.+G.+Cattonauthor=D.+A.+Jansauthor=K.+M.+Wagstaff&title=The+FDA-approved+drug+Ivermectin+inhibits+the+replication+of+SARS-CoV-2+in+vitro&doi=10.1016%2Fj.antiviral.2020.104787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro</span></div><div class="casAuthors">Caly, Leon; Druce, Julian D.; Catton, Mike G.; Jans, David A.; Wagstaff, Kylie M.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104787</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Although several clin. trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment.  We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addn. to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ∼5000-fold redn. in viral RNA at 48 h.  Ivermectin therefore warrants further investigation for possible benefits in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHJsrOxupqz7Vg90H21EOLACvtfcHk0ljLq_Ba9lh01g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsFalsL8%253D&md5=d5bac8cb28292f4dc5a2feac22ce6824</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2020.104787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2020.104787%26sid%3Dliteratum%253Aachs%26aulast%3DCaly%26aufirst%3DL.%26aulast%3DDruce%26aufirst%3DJ.%2BD.%26aulast%3DCatton%26aufirst%3DM.%2BG.%26aulast%3DJans%26aufirst%3DD.%2BA.%26aulast%3DWagstaff%26aufirst%3DK.%2BM.%26atitle%3DThe%2520FDA-approved%2520drug%2520Ivermectin%2520inhibits%2520the%2520replication%2520of%2520SARS-CoV-2%2520in%2520vitro%26jtitle%3DAntiviral%2520Res.%26date%3D2020%26volume%3D178%26spage%3D104787%26doi%3D10.1016%2Fj.antiviral.2020.104787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref254"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref254'); return false;" data-citation="" class="refNumLink">254</a></strong><div class="NLM_citation" id="cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smoot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jervey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaiu, D.</span></span> <span> </span><span class="NLM_article-title">Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.0c00272</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.0c00272" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkslWrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=315-331&issue=3&author=C.+Liuauthor=Q.+Zhouauthor=Y.+Liauthor=L.+V.+Garnerauthor=S.+P.+Watkinsauthor=L.+J.+Carterauthor=J.+Smootauthor=A.+C.+Greggauthor=A.+D.+Danielsauthor=S.+Jerveyauthor=D.+Albaiu&title=Research+and+development+on+therapeutic+agents+and+vaccines+for+COVID-19+and+related+human+coronavirus+diseases&doi=10.1021%2Facscentsci.0c00272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases</span></div><div class="casAuthors">Liu, Cynthia; Zhou, Qiongqiong; Li, Yingzhu; Garner, Linda V.; Watkins, Steve P.; Carter, Linda J.; Smoot, Jeffrey; Gregg, Anne C.; Daniels, Angela D.; Jervey, Susan; Albaiu, Dana</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-331</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Since the outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus, this disease has spread rapidly around the globe.  Considering the potential threat of a pandemic, scientists and physicians have been racing to understand this new virus and the pathophysiol. of this disease to uncover possible treatment regimens and discover effective therapeutic agents and vaccines.  To support the current research and development, CAS has produced a special report to provide an overview of published scientific information with an emphasis on patents in the CAS content collection.  It highlights antiviral strategies involving small mols. and biologics targeting complex mol. interactions involved in coronavirus infection and replication.  The drug-repurposing effort documented herein focuses primarily on agents known to be effective against other RNA viruses including SARS-CoV and MERS-CoV.  The patent anal. of coronavirus-related biologics includes therapeutic antibodies, cytokines, and nucleic acid-based therapies targeting virus gene expression as well as various types of vaccines.  More than 500 patents disclose methodologies of these four biologics with the potential for treating and preventing coronavirus infections, which may be applicable to COVID-19.  The information included in this report provides a strong intellectual groundwork for the ongoing development of therapeutic agents and vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAA030tIyfebVg90H21EOLACvtfcHk0lggL0zjOTY6sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkslWrsbo%253D&md5=fa29fb4cc3353a140e3a6a74059a99b1</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.0c00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.0c00272%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGarner%26aufirst%3DL.%2BV.%26aulast%3DWatkins%26aufirst%3DS.%2BP.%26aulast%3DCarter%26aufirst%3DL.%2BJ.%26aulast%3DSmoot%26aufirst%3DJ.%26aulast%3DGregg%26aufirst%3DA.%2BC.%26aulast%3DDaniels%26aufirst%3DA.%2BD.%26aulast%3DJervey%26aufirst%3DS.%26aulast%3DAlbaiu%26aufirst%3DD.%26atitle%3DResearch%2520and%2520development%2520on%2520therapeutic%2520agents%2520and%2520vaccines%2520for%2520COVID-19%2520and%2520related%2520human%2520coronavirus%2520diseases%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2020%26volume%3D6%26issue%3D3%26spage%3D315%26epage%3D331%26doi%3D10.1021%2Facscentsci.0c00272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244'],'ref245':['cit245'],'ref246':['cit246'],'ref247':['cit247'],'ref248':['cit248'],'ref249':['cit249'],'ref250':['cit250'],'ref251':['cit251'],'ref252':['cit252'],'ref253':['cit253'],'ref254':['cit254']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 90 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chamandi S. Dampalla, Yunjeong Kim, Naemi Bickmeier, Athri D. Rathnayake, Harry Nhat Nguyen, Jian Zheng, Maithri M. Kashipathy, Matthew A. Baird, Kevin P. Battaile, Scott Lovell, Stanley Perlman, Kyeong-Ok Chang, <span class="NLM_string-name hlFld-ContribAuthor">William C. Groutas</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10047-10058. <a href="https://doi.org/10.1021/acs.jmedchem.1c00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDesign%252Bof%252BConformationally%252BConstrained%252BCyclohexane%252BInhibitors%252Bof%252BSevere%252BAcute%252BRespiratory%252BSyndrome%252BCoronavirus-2%252B3CL%252BProtease%26aulast%3DDampalla%26aufirst%3DChamandi%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D20022021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D10047%26epage%3D10058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bing Bai, Alexandr Belovodskiy, Mostofa Hena, Appan Srinivas Kandadai, Michael A. Joyce, Holly A. Saffran, Justin A. Shields, Muhammad Bashir Khan, Elena Arutyunova, Jimmy Lu, Sardeev K. Bajwa, Darren Hockman, Conrad Fischer, Tess Lamer, Wayne Vuong, Marco J. van Belkum, Zhengxian Gu, Fusen Lin, Yanhua Du, Jia Xu, Mohammad Rahim, Howard S. Young, John C. Vederas, D. Lorne Tyrrell, M. Joanne Lemieux, <span class="NLM_string-name hlFld-ContribAuthor">James A. Nieman</span>. </span><span class="cited-content_cbyCitation_article-title">Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00616%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPeptidomimetic%252B%2525CE%2525B1-Acyloxymethylketone%252BWarheads%252Bwith%252BSix-Membered%252BLactam%252BP1%252BGlutamine%252BMimic%25253A%252BSARS-CoV-2%252B3CL%252BProtease%252BInhibition%25252C%252BCoronavirus%252BAntiviral%252BActivity%25252C%252Band%252Bin%252BVitro%252BBiological%252BStability%26aulast%3DBai%26aufirst%3DBing%26date%3D2021%26date%3D2021%26date%3D04042021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Damir Bojadzic, Oscar Alcazar, Jinshui Chen, Sung-Ting Chuang, Jose M. Condor Capcha, Lina A. Shehadeh, <span class="NLM_string-name hlFld-ContribAuthor">Peter Buchwald</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , 1519-1534. <a href="https://doi.org/10.1021/acsinfecdis.1c00070" title="DOI URL">https://doi.org/10.1021/acsinfecdis.1c00070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.1c00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.1c00070%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252Bthe%252BCoronavirus%252BSpike%25253A%252BACE2%252BProtein%2525E2%252580%252593Protein%252BInteraction%252Bas%252BBlockers%252Bof%252BViral%252BAttachment%252Band%252BEntry%252Bfor%252BSARS-CoV-2%26aulast%3DBojadzic%26aufirst%3DDamir%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08022021%26date%3D12052021%26volume%3D7%26issue%3D6%26spage%3D1519%26epage%3D1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annelies Stevaert, Besir Krasniqi, Benjamin Van Loy, Tien Nguyen, Joice Thomas, Julie Vandeput, Dirk Jochmans, Volker Thiel, Ronald Dijkman, Wim Dehaen, Arnout Voet, <span class="NLM_string-name hlFld-ContribAuthor">Lieve Naesens</span>. </span><span class="cited-content_cbyCitation_article-title">Betulonic Acid Derivatives Interfering with Human Coronavirus 229E Replication via the nsp15 Endoribonuclease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5632-5644. <a href="https://doi.org/10.1021/acs.jmedchem.0c02124" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02124%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBetulonic%252BAcid%252BDerivatives%252BInterfering%252Bwith%252BHuman%252BCoronavirus%252B229E%252BReplication%252Bvia%252Bthe%252Bnsp15%252BEndoribonuclease%26aulast%3DStevaert%26aufirst%3DAnnelies%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09122020%26date%3D20042021%26volume%3D64%26issue%3D9%26spage%3D5632%26epage%3D5644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Naoya Kitamura, Michael Dominic Sacco, Chunlong Ma, Yanmei Hu, Julia Alma Townsend, Xiangzhi Meng, Fushun Zhang, Xiujun Zhang, Mandy Ba, Tommy Szeto, Adis Kukuljac, Michael Thomas Marty, David Schultz, Sara Cherry, Yan Xiang, Yu Chen, <span class="NLM_string-name hlFld-ContribAuthor">Jun Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00509%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExpedited%252BApproach%252Btoward%252Bthe%252BRational%252BDesign%252Bof%252BNoncovalent%252BSARS-CoV-2%252BMain%252BProtease%252BInhibitors%26aulast%3DKitamura%26aufirst%3DNaoya%26date%3D2021%26date%3D2021%26date%3D19032021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel W. Kneller, Gwyndalyn Phillips, Kevin L. Weiss, Qiu Zhang, Leighton Coates, <span class="NLM_string-name hlFld-ContribAuthor">Andrey Kovalevsky</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4991-5000. <a href="https://doi.org/10.1021/acs.jmedchem.1c00058" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00058%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDirect%252BObservation%252Bof%252BProtonation%252BState%252BModulation%252Bin%252BSARS-CoV-2%252BMain%252BProtease%252Bupon%252BInhibitor%252BBinding%252Bwith%252BNeutron%252BCrystallography%26aulast%3DKneller%26aufirst%3DDaniel%2BW.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D13012021%26date%3D23032021%26volume%3D64%26issue%3D8%26spage%3D4991%26epage%3D5000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mohamed Hamdi, Hend Mohamed Abdel-Bar, Enas Elmowafy, Ahmed El-khouly, Mai Mansour, <span class="NLM_string-name hlFld-ContribAuthor">Gehanne A.S. Awad</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating the Internalization and COVID-19 Antiviral Computational Analysis of Optimized Nanoscale Zinc Oxide. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (10)
                                     , 6848-6860. <a href="https://doi.org/10.1021/acsomega.0c06046" title="DOI URL">https://doi.org/10.1021/acsomega.0c06046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c06046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c06046%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DInvestigating%252Bthe%252BInternalization%252Band%252BCOVID-19%252BAntiviral%252BComputational%252BAnalysis%252Bof%252BOptimized%252BNanoscale%252BZinc%252BOxide%26aulast%3DHamdi%26aufirst%3DMohamed%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D11122020%26date%3D24022021%26date%3D04032021%26volume%3D6%26issue%3D10%26spage%3D6848%26epage%3D6860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kartikay Prasad, Shahzaib Ahamad, Hema Kanipakam, Dinesh Gupta, <span class="NLM_string-name hlFld-ContribAuthor">Vijay Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 930-944. <a href="https://doi.org/10.1021/acschemneuro.1c00019" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00019%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSimultaneous%252BInhibition%252Bof%252BSARS-CoV-2%252BEntry%252BPathways%252Bby%252BCyclosporine%26aulast%3DPrasad%26aufirst%3DKartikay%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12012021%26date%3D10022021%26date%3D19022021%26volume%3D12%26issue%3D5%26spage%3D930%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ayushee, Monika Patel, Priyanka Meena, Kousar Jahan, Prasad V. Bharatam, <span class="NLM_string-name hlFld-ContribAuthor">Akhilesh K. Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Base-Mediated Anti-Markovnikov Hydroamidation of Vinyl Arenes with Arylamides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (2)
                                     , 565-570. <a href="https://doi.org/10.1021/acs.orglett.0c04084" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04084%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DBase-Mediated%252BAnti-Markovnikov%252BHydroamidation%252Bof%252BVinyl%252BArenes%252Bwith%252BArylamides%26aulast%3DAyushee%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D10122020%26date%3D04012021%26volume%3D23%26issue%3D2%26spage%3D565%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hong Liu,  (<span class="NLM_role">Associate Editor, <i>Journal of Medicinal Chemistry</i></span>)Nouri Neamati,  (<span class="NLM_role">Associate Editor, <i>Journal of Medicinal Chemistry</i></span>)Nicholas Meanwell,  (<span class="NLM_role">Perspectives Editor, <i>Journal of Medicinal Chemistry</i></span>)Wendy Young,  (<span class="NLM_role">Drug Annotations Editor, <i>Journal of Medicinal Chemistry</i></span>)Gunda I. Georg,  (<span class="NLM_role">Editor-in-Chief, <i>Journal of Medicinal Chemistry</i></span>)<span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span> (<span class="NLM_role">Editor-in-Chief, <i>Journal of Medicinal Chemistry</i></span>). </span><span class="cited-content_cbyCitation_article-title">Advances toward COVID-19 Therapies Special Issue Call for Papers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15073-15074. <a href="https://doi.org/10.1021/acs.jmedchem.0c01963" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01963%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Btoward%252BCOVID-19%252BTherapies%252BSpecial%252BIssue%252BCall%252Bfor%252BPapers%26aulast%3DLiu%26aufirst%3DHong%26date%3D2020%26date%3D2020%26date%3D02122020%26volume%3D63%26issue%3D24%26spage%3D15073%26epage%3D15074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rolando Cannalire, Carmen Cerchia, Andrea R. Beccari, Francesco Saverio Di Leva, <span class="NLM_string-name hlFld-ContribAuthor">Vincenzo Summa</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01140%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BSARS-CoV-2%252BProteases%252Band%252BPolymerase%252Bfor%252BCOVID-19%252BTreatment%25253A%252BState%252Bof%252Bthe%252BArt%252Band%252BFuture%252BOpportunities%26aulast%3DCannalire%26aufirst%3DRolando%26date%3D2020%26date%3D2020%26date%3D02072020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miroslava  Cuperlovic-Culf</span>, <span class="hlFld-ContribAuthor ">Emma L.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Hossen  Teimoorinia</span>, <span class="hlFld-ContribAuthor ">Anuradha  Surendra</span>, <span class="hlFld-ContribAuthor ">Xiaobei  Pan</span>, <span class="hlFld-ContribAuthor ">Steffany A. L.  Bennett</span>, <span class="hlFld-ContribAuthor ">Mijin  Jung</span>, <span class="hlFld-ContribAuthor ">Bernadette  McGuiness</span>, <span class="hlFld-ContribAuthor ">Anthony Peter  Passmore</span>, <span class="hlFld-ContribAuthor ">David  Beverland</span>, <span class="hlFld-ContribAuthor ">Brian D.  Green</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-90243-1" title="DOI URL">https://doi.org/10.1038/s41598-021-90243-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-90243-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-90243-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DMetabolomics%252Band%252Bcomputational%252Banalysis%252Bof%252Bthe%252Brole%252Bof%252Bmonoamine%252Boxidase%252Bactivity%252Bin%252Bdelirium%252Band%252BSARS-COV-2%252Binfection%26aulast%3DCuperlovic-Culf%26aufirst%3DMiroslava%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marwa  Elsbaey</span>, <span class="hlFld-ContribAuthor ">Mahmoud A.A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Fatma Abdel  Bar</span>, <span class="hlFld-ContribAuthor ">Abdullah A.  Elgazar</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical constituents from coconut waste and their in silico evaluation as potential antiviral agents against SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">South African Journal of Botany</span><span> <strong>2021,</strong> <em>141 </em>, 278-289. <a href="https://doi.org/10.1016/j.sajb.2021.05.018" title="DOI URL">https://doi.org/10.1016/j.sajb.2021.05.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.sajb.2021.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.sajb.2021.05.018%26sid%3Dliteratum%253Aachs%26jtitle%3DSouth%2520African%2520Journal%2520of%2520Botany%26atitle%3DChemical%252Bconstituents%252Bfrom%252Bcoconut%252Bwaste%252Band%252Btheir%252Bin%252Bsilico%252Bevaluation%252Bas%252Bpotential%252Bantiviral%252Bagents%252Bagainst%252BSARS-CoV-2%26aulast%3DElsbaey%26aufirst%3DMarwa%26date%3D2021%26volume%3D141%26spage%3D278%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shibi  Muralidar</span>, <span class="hlFld-ContribAuthor ">Gayathri  Gopal</span>, <span class="hlFld-ContribAuthor ">Senthil  Visaga Ambi</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medical Virology</span><span> <strong>2021,</strong> <em>93 </em>
                                    (9)
                                     , 5260-5276. <a href="https://doi.org/10.1002/jmv.27019" title="DOI URL">https://doi.org/10.1002/jmv.27019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmv.27019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmv.27019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medical%2520Virology%26atitle%3DTargeting%252Bthe%252Bviral%2525E2%252580%252590entry%252Bfacilitators%252Bof%252BSARS%2525E2%252580%252590CoV%2525E2%252580%2525902%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bin%252BCOVID%2525E2%252580%25259019%26aulast%3DMuralidar%26aufirst%3DShibi%26date%3D2021%26date%3D2021%26volume%3D93%26issue%3D9%26spage%3D5260%26epage%3D5276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akeberegn Gorems  Ayele</span>, <span class="hlFld-ContribAuthor ">Engidaw Fentahun  Enyew</span>, <span class="hlFld-ContribAuthor ">Zemene Demelash  Kifle</span>. </span><span class="cited-content_cbyCitation_article-title">Roles of existing drug and drug targets for COVID-19 management. </span><span class="cited-content_cbyCitation_journal-name">Metabolism Open</span><span> <strong>2021,</strong> <em>11 </em>, 100103. <a href="https://doi.org/10.1016/j.metop.2021.100103" title="DOI URL">https://doi.org/10.1016/j.metop.2021.100103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.metop.2021.100103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.metop.2021.100103%26sid%3Dliteratum%253Aachs%26jtitle%3DMetabolism%2520Open%26atitle%3DRoles%252Bof%252Bexisting%252Bdrug%252Band%252Bdrug%252Btargets%252Bfor%252BCOVID-19%252Bmanagement%26aulast%3DAyele%26aufirst%3DAkeberegn%2BGorems%26date%3D2021%26volume%3D11%26spage%3D100103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia  Martín</span>, <span class="hlFld-ContribAuthor ">Noelia  Tena</span>, <span class="hlFld-ContribAuthor ">Agustin G.  Asuero</span>. </span><span class="cited-content_cbyCitation_article-title">Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view. </span><span class="cited-content_cbyCitation_journal-name">Microchemical Journal</span><span> <strong>2021,</strong> <em>167 </em>, 106305. <a href="https://doi.org/10.1016/j.microc.2021.106305" title="DOI URL">https://doi.org/10.1016/j.microc.2021.106305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.microc.2021.106305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.microc.2021.106305%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrochemical%2520Journal%26atitle%3DCurrent%252Bstate%252Bof%252Bdiagnostic%25252C%252Bscreening%252Band%252Bsurveillance%252Btesting%252Bmethods%252Bfor%252BCOVID-19%252Bfrom%252Ban%252Banalytical%252Bchemistry%252Bpoint%252Bof%252Bview%26aulast%3DMart%25C3%25ADn%26aufirst%3DJulia%26date%3D2021%26volume%3D167%26spage%3D106305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sujan  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Snehasis  Mishra</span>, <span class="hlFld-ContribAuthor ">Kaustav Dutta  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Chandan Kumar  Ghosh</span>, <span class="hlFld-ContribAuthor ">Krishna Das  Saha</span>. </span><span class="cited-content_cbyCitation_article-title">Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2021,</strong> <em>278 </em>, 119580. <a href="https://doi.org/10.1016/j.lfs.2021.119580" title="DOI URL">https://doi.org/10.1016/j.lfs.2021.119580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2021.119580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2021.119580%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DVarious%252Btheranostics%252Band%252Bimmunization%252Bstrategies%252Bbased%252Bon%252Bnanotechnology%252Bagainst%252BCovid-19%252Bpandemic%25253A%252BAn%252Binterdisciplinary%252Bview%26aulast%3DChatterjee%26aufirst%3DSujan%26date%3D2021%26volume%3D278%26spage%3D119580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdi E. A.  Zaki</span>, <span class="hlFld-ContribAuthor ">Sami A.  Al-Hussain</span>, <span class="hlFld-ContribAuthor ">Vijay H.  Masand</span>, <span class="hlFld-ContribAuthor ">Manoj K.  Sabnani</span>, <span class="hlFld-ContribAuthor ">Abdul  Samad</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (15)
                                     , 8352. <a href="https://doi.org/10.3390/ijms22158352" title="DOI URL">https://doi.org/10.3390/ijms22158352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22158352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22158352%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMechanistic%252Band%252BPredictive%252BQSAR%252BAnalysis%252Bof%252BDiverse%252BMolecules%252Bto%252BCapture%252BSalient%252Band%252BHidden%252BPharmacophores%252Bfor%252BAnti-Thrombotic%252BActivity%26aulast%3DZaki%26aufirst%3DMagdi%2BE.%2BA.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D15%26spage%3D8352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. Mahaboob  Basha</span>, <span class="hlFld-ContribAuthor ">Rishikesh S.  Parulekar</span>, <span class="hlFld-ContribAuthor ">Abdullah G.  Al-Sehemi</span>, <span class="hlFld-ContribAuthor ">Mehboobali  Pannipara</span>, <span class="hlFld-ContribAuthor ">Vidavalur  Siddaiah</span>, <span class="hlFld-ContribAuthor ">Sunanda  Kumari</span>, <span class="hlFld-ContribAuthor ">Prafulla B.  Choudhari</span>, <span class="hlFld-ContribAuthor ">Yasinalli  Tamboli</span>. </span><span class="cited-content_cbyCitation_article-title">Design and
              in silico
              investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 M
              pro. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>12 </em>, 1-16. <a href="https://doi.org/10.1080/07391102.2021.1955742" title="DOI URL">https://doi.org/10.1080/07391102.2021.1955742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1955742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1955742%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDesign%252Band%252Bin%252Bsilico%252Binvestigation%252Bof%252Bnovel%252BMaraviroc%252Banalogues%252Bas%252Bdual%252Binhibition%252Bof%252BCCR-5%25252FSARS-CoV-2%252BM%252Bpro%26aulast%3DBasha%26aufirst%3DG.%2BMahaboob%26date%3D2021%26date%3D2021%26volume%3D12%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saravanan  Subramaniam</span>, <span class="hlFld-ContribAuthor ">Wolfram  Ruf</span>, <span class="hlFld-ContribAuthor ">Markus  Bosmann</span>. </span><span class="cited-content_cbyCitation_article-title">Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>183 </em><a href="https://doi.org/10.1111/bph.15587" title="DOI URL">https://doi.org/10.1111/bph.15587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15587%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DAdvocacy%252Bof%252Btargeting%252Bprotease%2525E2%252580%252590activated%252Breceptors%252Bin%252Bsevere%252Bcoronavirus%252Bdisease%252B2019%26aulast%3DSubramaniam%26aufirst%3DSaravanan%26date%3D2021%26date%3D2021%26volume%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sajjad  Ahmad</span>, <span class="hlFld-ContribAuthor ">Yasir  Waheed</span>, <span class="hlFld-ContribAuthor ">Asma  Abro</span>, <span class="hlFld-ContribAuthor ">Sumra Wajid  Abbasi</span>, <span class="hlFld-ContribAuthor ">Saba  Ismail</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2021,</strong> <em>27 </em>
                                    (7)
                                     <a href="https://doi.org/10.1007/s00894-021-04816-y" title="DOI URL">https://doi.org/10.1007/s00894-021-04816-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-021-04816-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-021-04816-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DMolecular%252Bscreening%252Bof%252Bglycyrrhizin-based%252Binhibitors%252Bagainst%252BACE2%252Bhost%252Breceptor%252Bof%252BSARS-CoV-2%26aulast%3DAhmad%26aufirst%3DSajjad%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fulvio  Perrella</span>, <span class="hlFld-ContribAuthor ">Federico  Coppola</span>, <span class="hlFld-ContribAuthor ">Alessio  Petrone</span>, <span class="hlFld-ContribAuthor ">Chiara  Platella</span>, <span class="hlFld-ContribAuthor ">Daniela  Montesarchio</span>, <span class="hlFld-ContribAuthor ">Annarita  Stringaro</span>, <span class="hlFld-ContribAuthor ">Giampietro  Ravagnan</span>, <span class="hlFld-ContribAuthor ">Maria Pia  Fuggetta</span>, <span class="hlFld-ContribAuthor ">Nadia  Rega</span>, <span class="hlFld-ContribAuthor ">Domenica  Musumeci</span>. </span><span class="cited-content_cbyCitation_article-title">Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 1048. <a href="https://doi.org/10.3390/biom11071048" title="DOI URL">https://doi.org/10.3390/biom11071048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11071048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11071048%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DInterference%252Bof%252BPolydatin%25252FResveratrol%252Bin%252Bthe%252BACE2%25253ASpike%252BRecognition%252Bduring%252BCOVID-19%252BInfection.%252BA%252BFocus%252Bon%252BTheir%252BPotential%252BMechanism%252Bof%252BAction%252Bthrough%252BComputational%252Band%252BBiochemical%252BAssays%26aulast%3DPerrella%26aufirst%3DFulvio%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uttpal  Anand</span>, <span class="hlFld-ContribAuthor ">Shweta  Jakhmola</span>, <span class="hlFld-ContribAuthor ">Omkar  Indari</span>, <span class="hlFld-ContribAuthor ">Hem Chandra  Jha</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Vijay  Tripathi</span>, <span class="hlFld-ContribAuthor ">José M.  Pérez de la Lastra</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fimmu.2021.658519" title="DOI URL">https://doi.org/10.3389/fimmu.2021.658519</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2021.658519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2021.658519%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DPotential%252BTherapeutic%252BTargets%252Band%252BVaccine%252BDevelopment%252Bfor%252BSARS-CoV-2%25252FCOVID-19%252BPandemic%252BManagement%25253A%252BA%252BReview%252Bon%252Bthe%252BRecent%252BUpdate%26aulast%3DAnand%26aufirst%3DUttpal%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun Bahadur  Gurung</span>, <span class="hlFld-ContribAuthor ">Mohammad Ajmal  Ali</span>, <span class="hlFld-ContribAuthor ">Joongku  Lee</span>, <span class="hlFld-ContribAuthor ">Mohammad Abul  Farah</span>, <span class="hlFld-ContribAuthor ">Khalid Mashay  Al-Anazi</span>, . </span><span class="cited-content_cbyCitation_article-title">An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2021,</strong> <em>2021 </em>, 1-18. <a href="https://doi.org/10.1155/2021/8853056" title="DOI URL">https://doi.org/10.1155/2021/8853056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2021/8853056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2021%2F8853056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DAn%252BUpdated%252BReview%252Bof%252BComputer-Aided%252BDrug%252BDesign%252Band%252BIts%252BApplication%252Bto%252BCOVID-19%26aulast%3DGurung%26aufirst%3DArun%2BBahadur%26date%3D2021%26volume%3D2021%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belmina  Saric</span>, <span class="hlFld-ContribAuthor ">Nikolina  Tomic</span>, <span class="hlFld-ContribAuthor ">Abdurahim  Kalajdzic</span>, <span class="hlFld-ContribAuthor ">Naris  Pojskic</span>, <span class="hlFld-ContribAuthor ">Lejla  Pojskic</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              analysis of selected components of grapefruit seed extract against SARS-CoV-2 main protease. </span><span class="cited-content_cbyCitation_journal-name">The EuroBiotech Journal</span><span> <strong>2021,</strong> <em>5 </em>
                                    (s1)
                                     , 5-12. <a href="https://doi.org/10.2478/ebtj-2021-0015" title="DOI URL">https://doi.org/10.2478/ebtj-2021-0015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2478/ebtj-2021-0015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2478%2Febtj-2021-0015%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520EuroBiotech%2520Journal%26atitle%3DIn%252Bsilico%252Banalysis%252Bof%252Bselected%252Bcomponents%252Bof%252Bgrapefruit%252Bseed%252Bextract%252Bagainst%252BSARS-CoV-2%252Bmain%252Bprotease%26aulast%3DSaric%26aufirst%3DBelmina%26date%3D2021%26date%3D2021%26volume%3D5%26issue%3Ds1%26spage%3D5%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kelly  Bugatti</span>. </span><span class="cited-content_cbyCitation_article-title">α
              V
              β
              6
              Integrin: An Intriguing Target for COVID‐19 and Related Diseases. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>26 </em><a href="https://doi.org/10.1002/cbic.202100209" title="DOI URL">https://doi.org/10.1002/cbic.202100209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202100209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202100209%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3D%2525CE%2525B1%252BV%252B%2525CE%2525B2%252B6%252BIntegrin%25253A%252BAn%252BIntriguing%252BTarget%252Bfor%252BCOVID%2525E2%252580%25259019%252Band%252BRelated%252BDiseases%26aulast%3DBugatti%26aufirst%3DKelly%26date%3D2021%26date%3D2021%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shobana  Sundar</span>, <span class="hlFld-ContribAuthor ">Lokesh  Thangamani</span>, <span class="hlFld-ContribAuthor ">Shanmughavel  Piramanayagam</span>, <span class="hlFld-ContribAuthor ">Chandrasekar Narayanan  Rahul</span>, <span class="hlFld-ContribAuthor ">Natarajan  Aiswarya</span>, <span class="hlFld-ContribAuthor ">Kanagaraj  Sekar</span>, <span class="hlFld-ContribAuthor ">Jeyakumar  Natarajan</span>. </span><span class="cited-content_cbyCitation_article-title">Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteins and Proteomics</span><span> <strong>2021,</strong> <em>1 </em><a href="https://doi.org/10.1007/s42485-021-00067-w" title="DOI URL">https://doi.org/10.1007/s42485-021-00067-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s42485-021-00067-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs42485-021-00067-w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteins%2520and%2520Proteomics%26atitle%3DScreening%252Bof%252BFDA-approved%252Bcompound%252Blibrary%252Bidentifies%252Bpotential%252Bsmall-molecule%252Binhibitors%252Bof%252BSARS-CoV-2%252Bnon-structural%252Bproteins%252BNSP1%25252C%252BNSP4%25252C%252BNSP6%252Band%252BNSP13%25253A%252Bmolecular%252Bmodeling%252Band%252Bmolecular%252Bdynamics%252Bstudies%26aulast%3DSundar%26aufirst%3DShobana%26date%3D2021%26date%3D2021%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-an  Zhang</span>, <span class="hlFld-ContribAuthor ">Cui-Min  Yan</span>, <span class="hlFld-ContribAuthor ">Bai-Wang  Sun</span>, <span class="hlFld-ContribAuthor ">Lin-Xuan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Bromhexine and its fumarate salt: Crystal structures, Hirshfeld surfaces and dissolution study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1233 </em>, 130154. <a href="https://doi.org/10.1016/j.molstruc.2021.130154" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130154%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DBromhexine%252Band%252Bits%252Bfumarate%252Bsalt%25253A%252BCrystal%252Bstructures%25252C%252BHirshfeld%252Bsurfaces%252Band%252Bdissolution%252Bstudy%26aulast%3DZhang%26aufirst%3DYa-an%26date%3D2021%26volume%3D1233%26spage%3D130154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikola  Hudakova</span>, <span class="hlFld-ContribAuthor ">Simona  Hricikova</span>, <span class="hlFld-ContribAuthor ">Amod  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Mangesh  Bhide</span>, <span class="hlFld-ContribAuthor ">Eva  Kontsekova</span>, <span class="hlFld-ContribAuthor ">Dasa  Cizkova</span>. </span><span class="cited-content_cbyCitation_article-title">Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">Pathogens</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 636. <a href="https://doi.org/10.3390/pathogens10060636" title="DOI URL">https://doi.org/10.3390/pathogens10060636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pathogens10060636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpathogens10060636%26sid%3Dliteratum%253Aachs%26jtitle%3DPathogens%26atitle%3DFundamental%252Band%252BAdvanced%252BTherapies%25252C%252BVaccine%252BDevelopment%252Bagainst%252BSARS-CoV-2%26aulast%3DHudakova%26aufirst%3DNikola%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diletta  Onorato</span>, <span class="hlFld-ContribAuthor ">Mairi  Pucci</span>, <span class="hlFld-ContribAuthor ">Giovanni  Carpene</span>, <span class="hlFld-ContribAuthor ">Brandon Michael  Henry</span>, <span class="hlFld-ContribAuthor ">Fabian  Sanchis-Gomar</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Lippi</span>. </span><span class="cited-content_cbyCitation_article-title">Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Thrombosis and Hemostasis</span><span> <strong>2021,</strong> <em>47 </em>
                                    (04)
                                     , 392-399. <a href="https://doi.org/10.1055/s-0040-1722307" title="DOI URL">https://doi.org/10.1055/s-0040-1722307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1722307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1722307%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Thrombosis%2520and%2520Hemostasis%26atitle%3DProtective%252BEffects%252Bof%252BStatins%252BAdministration%252Bin%252BEuropean%252Band%252BNorth%252BAmerican%252BPatients%252BInfected%252Bwith%252BCOVID-19%25253A%252BA%252BMeta-Analysis%26aulast%3DOnorato%26aufirst%3DDiletta%26date%3D2021%26date%3D2021%26volume%3D47%26issue%3D04%26spage%3D392%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas  Hanan</span>, <span class="hlFld-ContribAuthor ">Ronnie L.  Doud</span>, <span class="hlFld-ContribAuthor ">In-Woo  Park</span>, <span class="hlFld-ContribAuthor ">Harlan P.  Jones</span>, <span class="hlFld-ContribAuthor ">Stephen O.  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">The Many Faces of Innate Immunity in SARS-CoV-2 Infection. </span><span class="cited-content_cbyCitation_journal-name">Vaccines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (6)
                                     , 596. <a href="https://doi.org/10.3390/vaccines9060596" title="DOI URL">https://doi.org/10.3390/vaccines9060596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/vaccines9060596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fvaccines9060596%26sid%3Dliteratum%253Aachs%26jtitle%3DVaccines%26atitle%3DThe%252BMany%252BFaces%252Bof%252BInnate%252BImmunity%252Bin%252BSARS-CoV-2%252BInfection%26aulast%3DHanan%26aufirst%3DNicholas%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D6%26spage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Pradeep</span>, <span class="hlFld-ContribAuthor ">Umme  Najma</span>, <span class="hlFld-ContribAuthor ">H. S.  Aparna</span>. </span><span class="cited-content_cbyCitation_article-title">Milk Peptides as Novel Multi‐Targeted Therapeutic Candidates for SARS-CoV2. </span><span class="cited-content_cbyCitation_journal-name">The Protein Journal</span><span> <strong>2021,</strong> <em>40 </em>
                                    (3)
                                     , 310-327. <a href="https://doi.org/10.1007/s10930-021-09983-8" title="DOI URL">https://doi.org/10.1007/s10930-021-09983-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10930-021-09983-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10930-021-09983-8%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Protein%2520Journal%26atitle%3DMilk%252BPeptides%252Bas%252BNovel%252BMulti%2525E2%252580%252590Targeted%252BTherapeutic%252BCandidates%252Bfor%252BSARS-CoV2%26aulast%3DPradeep%26aufirst%3DH.%26date%3D2021%26date%3D2021%26volume%3D40%26issue%3D3%26spage%3D310%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nouman  Rasool</span>, <span class="hlFld-ContribAuthor ">Farkhanda  Yasmin</span>, <span class="hlFld-ContribAuthor ">Shalini  Sahai</span>, <span class="hlFld-ContribAuthor ">Waqar  Hussain</span>, <span class="hlFld-ContribAuthor ">Hadiqa  Inam</span>, <span class="hlFld-ContribAuthor ">Arooj  Arshad</span>. </span><span class="cited-content_cbyCitation_article-title">Biological perspective of thiazolide derivatives against Mpro and MTase of SARS-CoV-2: Molecular docking, DFT and MD simulation investigations. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2021,</strong> <em>771 </em>, 138463. <a href="https://doi.org/10.1016/j.cplett.2021.138463" title="DOI URL">https://doi.org/10.1016/j.cplett.2021.138463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2021.138463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2021.138463%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3DBiological%252Bperspective%252Bof%252Bthiazolide%252Bderivatives%252Bagainst%252BMpro%252Band%252BMTase%252Bof%252BSARS-CoV-2%25253A%252BMolecular%252Bdocking%25252C%252BDFT%252Band%252BMD%252Bsimulation%252Binvestigations%26aulast%3DRasool%26aufirst%3DNouman%26date%3D2021%26volume%3D771%26spage%3D138463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hani A.  Alhadrami</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Sayed</span>, <span class="hlFld-ContribAuthor ">Hossam M.  Hassan</span>, <span class="hlFld-ContribAuthor ">Khayrya A.  Youssif</span>, <span class="hlFld-ContribAuthor ">Yasser  Gaber</span>, <span class="hlFld-ContribAuthor ">Yassmin  Moatasim</span>, <span class="hlFld-ContribAuthor ">Omnia  Kutkat</span>, <span class="hlFld-ContribAuthor ">Ahmed  Mostafa</span>, <span class="hlFld-ContribAuthor ">Mohamed Ahmed  Ali</span>, <span class="hlFld-ContribAuthor ">Mostafa E.  Rateb</span>, <span class="hlFld-ContribAuthor ">Usama Ramadan  Abdelmohsen</span>, <span class="hlFld-ContribAuthor ">Noha M.  Gamaleldin</span>. </span><span class="cited-content_cbyCitation_article-title">Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 542. <a href="https://doi.org/10.3390/antibiotics10050542" title="DOI URL">https://doi.org/10.3390/antibiotics10050542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics10050542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics10050542%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3DCnicin%252Bas%252Ban%252BAnti-SARS-CoV-2%25253A%252BAn%252BIntegrated%252BIn%252BSilico%252Band%252BIn%252BVitro%252BApproach%252Bfor%252Bthe%252BRapid%252BIdentification%252Bof%252BPotential%252BCOVID-19%252BTherapeutics%26aulast%3DAlhadrami%26aufirst%3DHani%2BA.%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun Young  Lee</span>, <span class="hlFld-ContribAuthor ">Young Sup  Shin</span>, <span class="hlFld-ContribAuthor ">Sangeun  Jeon</span>, <span class="hlFld-ContribAuthor ">Se In  Lee</span>, <span class="hlFld-ContribAuthor ">Soojin  Noh</span>, <span class="hlFld-ContribAuthor ">Jung-Eun  Cho</span>, <span class="hlFld-ContribAuthor ">Min Seong  Jang</span>, <span class="hlFld-ContribAuthor ">Seungtaek  Kim</span>, <span class="hlFld-ContribAuthor ">Jong Hwan  Song</span>, <span class="hlFld-ContribAuthor ">Hyoung Rae  Kim</span>, <span class="hlFld-ContribAuthor ">Chul Min  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>39 </em>, 127885. <a href="https://doi.org/10.1016/j.bmcl.2021.127885" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127885%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-aminoquinazolin-4%2525283H%252529-one%252Bderivatives%252Bas%252Bpotential%252BSARS-CoV-2%252Band%252BMERS-CoV%252Btreatments%26aulast%3DLee%26aufirst%3DJun%2BYoung%26date%3D2021%26volume%3D39%26spage%3D127885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debarati  Paul</span>, <span class="hlFld-ContribAuthor ">Debadrita  Basu</span>, <span class="hlFld-ContribAuthor ">Shubhra  Ghosh Dastidar</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-conformation representation of Mpro identifies promising candidates for drug repurposing against COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2021,</strong> <em>27 </em>
                                    (5)
                                     <a href="https://doi.org/10.1007/s00894-021-04732-1" title="DOI URL">https://doi.org/10.1007/s00894-021-04732-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-021-04732-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-021-04732-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DMulti-conformation%252Brepresentation%252Bof%252BMpro%252Bidentifies%252Bpromising%252Bcandidates%252Bfor%252Bdrug%252Brepurposing%252Bagainst%252BCOVID-19%26aulast%3DPaul%26aufirst%3DDebarati%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimin  Xu</span>, <span class="hlFld-ContribAuthor ">Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Richard  Zhou</span>, <span class="hlFld-ContribAuthor ">Pei‐Yong  Shi</span>, <span class="hlFld-ContribAuthor ">Hongmin  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Drug repurposing approach to combating coronavirus: Potential drugs and drug targets. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (3)
                                     , 1375-1426. <a href="https://doi.org/10.1002/med.21763" title="DOI URL">https://doi.org/10.1002/med.21763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21763%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDrug%252Brepurposing%252Bapproach%252Bto%252Bcombating%252Bcoronavirus%25253A%252BPotential%252Bdrugs%252Band%252Bdrug%252Btargets%26aulast%3DXu%26aufirst%3DJimin%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D3%26spage%3D1375%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Claudiu T  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Protease inhibitors targeting the main protease and papain-like protease of coronaviruses. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (4)
                                     , 309-324. <a href="https://doi.org/10.1080/13543776.2021.1857726" title="DOI URL">https://doi.org/10.1080/13543776.2021.1857726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1857726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1857726%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DProtease%252Binhibitors%252Btargeting%252Bthe%252Bmain%252Bprotease%252Band%252Bpapain-like%252Bprotease%252Bof%252Bcoronaviruses%26aulast%3DCapasso%26aufirst%3DClemente%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D4%26spage%3D309%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiziana  Ginex</span>, <span class="hlFld-ContribAuthor ">Urtzi  Garaigorta</span>, <span class="hlFld-ContribAuthor ">David  Ramírez</span>, <span class="hlFld-ContribAuthor ">Victoria  Castro</span>, <span class="hlFld-ContribAuthor ">Vanesa  Nozal</span>, <span class="hlFld-ContribAuthor ">Inés  Maestro</span>, <span class="hlFld-ContribAuthor ">Javier  García-Cárceles</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>, <span class="hlFld-ContribAuthor ">Pablo  Gastaminza</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>. </span><span class="cited-content_cbyCitation_article-title">Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (4)
                                     , 332. <a href="https://doi.org/10.3390/ph14040332" title="DOI URL">https://doi.org/10.3390/ph14040332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14040332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14040332%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DHost-Directed%252BFDA-Approved%252BDrugs%252Bwith%252BAntiviral%252BActivity%252Bagainst%252BSARS-CoV-2%252BIdentified%252Bby%252BHierarchical%252BIn%252BSilico%25252FIn%252BVitro%252BScreening%252BMethods%26aulast%3DGinex%26aufirst%3DTiziana%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D4%26spage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imran  Maqbool</span>, <span class="hlFld-ContribAuthor ">Faisal  Rehman</span>, <span class="hlFld-ContribAuthor ">Faheeda  Soomro</span>, <span class="hlFld-ContribAuthor ">Zubeda  Bhatti</span>, <span class="hlFld-ContribAuthor ">Umeed  Ali</span>, <span class="hlFld-ContribAuthor ">Ashique Hussain  Jatoi</span>, <span class="hlFld-ContribAuthor ">Bhajan  Lal</span>, <span class="hlFld-ContribAuthor ">Muzaffar  Iqbal</span>, <span class="hlFld-ContribAuthor ">Shahnawaz  Phulpoto</span>, <span class="hlFld-ContribAuthor ">Akbar  Ali</span>, <span class="hlFld-ContribAuthor ">Khalid Hussain  Thebo</span>. </span><span class="cited-content_cbyCitation_article-title">Graphene‐based Materials for Fighting Coronavirus Disease 2019: Challenges and Opportunities. </span><span class="cited-content_cbyCitation_journal-name">ChemBioEng Reviews</span><span> <strong>2021,</strong> <em>8 </em>
                                    (2)
                                     , 67-77. <a href="https://doi.org/10.1002/cben.202000039" title="DOI URL">https://doi.org/10.1002/cben.202000039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cben.202000039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcben.202000039%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioEng%2520Reviews%26atitle%3DGraphene%2525E2%252580%252590based%252BMaterials%252Bfor%252BFighting%252BCoronavirus%252BDisease%252B2019%25253A%252BChallenges%252Band%252BOpportunities%26aulast%3DMaqbool%26aufirst%3DImran%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D2%26spage%3D67%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdi E. A.  Zaki</span>, <span class="hlFld-ContribAuthor ">Sami A.  Al-Hussain</span>, <span class="hlFld-ContribAuthor ">Vijay H.  Masand</span>, <span class="hlFld-ContribAuthor ">Siddhartha  Akasapu</span>, <span class="hlFld-ContribAuthor ">Sumit O.  Bajaj</span>, <span class="hlFld-ContribAuthor ">Nahed N. E.  El-Sayed</span>, <span class="hlFld-ContribAuthor ">Arabinda  Ghosh</span>, <span class="hlFld-ContribAuthor ">Israa  Lewaa</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (4)
                                     , 357. <a href="https://doi.org/10.3390/ph14040357" title="DOI URL">https://doi.org/10.3390/ph14040357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14040357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14040357%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DIdentification%252Bof%252BAnti-SARS-CoV-2%252BCompounds%252Bfrom%252BFood%252BUsing%252BQSAR-Based%252BVirtual%252BScreening%25252C%252BMolecular%252BDocking%25252C%252Band%252BMolecular%252BDynamics%252BSimulation%252BAnalysis%26aulast%3DZaki%26aufirst%3DMagdi%2BE.%2BA.%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D4%26spage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anas  Shamsi</span>, <span class="hlFld-ContribAuthor ">Taj  Mohammad</span>, <span class="hlFld-ContribAuthor ">Saleha  Anwar</span>, <span class="hlFld-ContribAuthor ">Samreen  Amani</span>, <span class="hlFld-ContribAuthor ">Mohd Shahnawaz  Khan</span>, <span class="hlFld-ContribAuthor ">Fohad Mabood  Husain</span>, <span class="hlFld-ContribAuthor ">Md. Tabish  Rehman</span>, <span class="hlFld-ContribAuthor ">Asimul  Islam</span>, <span class="hlFld-ContribAuthor ">Md Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Potential drug targets of SARS-CoV-2: From genomics to therapeutics. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>177 </em>, 1-9. <a href="https://doi.org/10.1016/j.ijbiomac.2021.02.071" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2021.02.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2021.02.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2021.02.071%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DPotential%252Bdrug%252Btargets%252Bof%252BSARS-CoV-2%25253A%252BFrom%252Bgenomics%252Bto%252Btherapeutics%26aulast%3DShamsi%26aufirst%3DAnas%26date%3D2021%26volume%3D177%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M.  Sayed</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Khalaf</span>, <span class="hlFld-ContribAuthor ">Mohamed E. A.  Abdelrahim</span>, <span class="hlFld-ContribAuthor ">Marwa O.  Elgendy</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing of some anti‐infective drugs for COVID‐19 treatment: A surveillance study supported by an in silico investigation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Clinical Practice</span><span> <strong>2021,</strong> <em>75 </em>
                                    (4)
                                     <a href="https://doi.org/10.1111/ijcp.13877" title="DOI URL">https://doi.org/10.1111/ijcp.13877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ijcp.13877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fijcp.13877%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Clinical%2520Practice%26atitle%3DRepurposing%252Bof%252Bsome%252Banti%2525E2%252580%252590infective%252Bdrugs%252Bfor%252BCOVID%2525E2%252580%25259019%252Btreatment%25253A%252BA%252Bsurveillance%252Bstudy%252Bsupported%252Bby%252Ban%252Bin%252Bsilico%252Binvestigation%26aulast%3DSayed%26aufirst%3DAhmed%2BM.%26date%3D2021%26date%3D2020%26volume%3D75%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sudhanshu  Saxena</span>, <span class="hlFld-ContribAuthor ">Sanjeev  Kumar</span>, <span class="hlFld-ContribAuthor ">Sachin N.  Hajare</span>, <span class="hlFld-ContribAuthor ">Sumit  Gupta</span>, <span class="hlFld-ContribAuthor ">Satyendra  Gautam</span>, <span class="hlFld-ContribAuthor ">Sunil K.  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">‘BhAVI-23’-A spice-herb based dietary infusion possessing in-vitro anti-viral potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ayurveda and Integrative Medicine</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 312-319. <a href="https://doi.org/10.1016/j.jaim.2020.11.005" title="DOI URL">https://doi.org/10.1016/j.jaim.2020.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jaim.2020.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jaim.2020.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ayurveda%2520and%2520Integrative%2520Medicine%26atitle%3D%2525E2%252580%252598BhAVI-23%2525E2%252580%252599-A%252Bspice-herb%252Bbased%252Bdietary%252Binfusion%252Bpossessing%252Bin-vitro%252Banti-viral%252Bpotential%26aulast%3DSaxena%26aufirst%3DSudhanshu%26date%3D2021%26volume%3D12%26issue%3D2%26spage%3D312%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen‐Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Kun  Li</span>, <span class="hlFld-ContribAuthor ">Anish R.  Maskey</span>, <span class="hlFld-ContribAuthor ">Weihua  Huang</span>, <span class="hlFld-ContribAuthor ">Anton A.  Toutov</span>, <span class="hlFld-ContribAuthor ">Nan  Yang</span>, <span class="hlFld-ContribAuthor ">Kamal  Srivastava</span>, <span class="hlFld-ContribAuthor ">Jan  Geliebter</span>, <span class="hlFld-ContribAuthor ">Raj  Tiwari</span>, <span class="hlFld-ContribAuthor ">Mingsan  Miao</span>, <span class="hlFld-ContribAuthor ">Xiu‐Min  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2021,</strong> <em>35 </em>
                                    (4)
                                     <a href="https://doi.org/10.1096/fj.202001792R" title="DOI URL">https://doi.org/10.1096/fj.202001792R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.202001792R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.202001792R%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DA%252Bsmall%252Bmolecule%252Bcompound%252Bberberine%252Bas%252Ban%252Borally%252Bactive%252Btherapeutic%252Bcandidate%252Bagainst%252BCOVID%2525E2%252580%25259019%252Band%252BSARS%25253A%252BA%252Bcomputational%252Band%252Bmechanistic%252Bstudy%26aulast%3DWang%26aufirst%3DZhen%25E2%2580%2590Zhen%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie J.  Stroever</span>, <span class="hlFld-ContribAuthor ">Daniel  Ostapenko</span>, <span class="hlFld-ContribAuthor ">Robyn  Scatena</span>, <span class="hlFld-ContribAuthor ">Daniel  Pusztai</span>, <span class="hlFld-ContribAuthor ">Lauren  Coritt</span>, <span class="hlFld-ContribAuthor ">Akua A.  Frimpong</span>, <span class="hlFld-ContribAuthor ">Paul  Nee</span>. </span><span class="cited-content_cbyCitation_article-title">Medication Use Among Patients With COVID‐19 in a Large, National Dataset: Cerner Real‐World Data™. </span><span class="cited-content_cbyCitation_journal-name">Clinical Therapeutics</span><span> <strong>2021,</strong> <em>382 </em><a href="https://doi.org/10.1016/j.clinthera.2021.03.024" title="DOI URL">https://doi.org/10.1016/j.clinthera.2021.03.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clinthera.2021.03.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clinthera.2021.03.024%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Therapeutics%26atitle%3DMedication%252BUse%252BAmong%252BPatients%252BWith%252BCOVID%2525E2%252580%25259019%252Bin%252Ba%252BLarge%25252C%252BNational%252BDataset%25253A%252BCerner%252BReal%2525E2%252580%252590World%252BData%2525E2%252584%2525A2%26aulast%3DStroever%26aufirst%3DStephanie%2BJ.%26date%3D2021%26volume%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine S.  Adamson</span>, <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>, <span class="hlFld-ContribAuthor ">Rebecca J. M.  Goss</span>, <span class="hlFld-ContribAuthor ">Marcel  Jaspars</span>, <span class="hlFld-ContribAuthor ">David J.  Newman</span>, <span class="hlFld-ContribAuthor ">Rosemary A.  Dorrington</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral drug discovery: preparing for the next pandemic. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (6)
                                     , 3647-3655. <a href="https://doi.org/10.1039/D0CS01118E" title="DOI URL">https://doi.org/10.1039/D0CS01118E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS01118E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS01118E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAntiviral%252Bdrug%252Bdiscovery%25253A%252Bpreparing%252Bfor%252Bthe%252Bnext%252Bpandemic%26aulast%3DAdamson%26aufirst%3DCatherine%2BS.%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D6%26spage%3D3647%26epage%3D3655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vaishali P  Waman</span>, <span class="hlFld-ContribAuthor ">Neeladri  Sen</span>, <span class="hlFld-ContribAuthor ">Mihaly  Varadi</span>, <span class="hlFld-ContribAuthor ">Antoine  Daina</span>, <span class="hlFld-ContribAuthor ">Shoshana J  Wodak</span>, <span class="hlFld-ContribAuthor ">Vincent  Zoete</span>, <span class="hlFld-ContribAuthor ">Sameer  Velankar</span>, <span class="hlFld-ContribAuthor ">Christine  Orengo</span>. </span><span class="cited-content_cbyCitation_article-title">The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Briefings in Bioinformatics</span><span> <strong>2021,</strong> <em>22 </em>
                                    (2)
                                     , 742-768. <a href="https://doi.org/10.1093/bib/bbaa362" title="DOI URL">https://doi.org/10.1093/bib/bbaa362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bib/bbaa362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbib%2Fbbaa362%26sid%3Dliteratum%253Aachs%26jtitle%3DBriefings%2520in%2520Bioinformatics%26atitle%3DThe%252Bimpact%252Bof%252Bstructural%252Bbioinformatics%252Btools%252Band%252Bresources%252Bon%252BSARS-CoV-2%252Bresearch%252Band%252Btherapeutic%252Bstrategies%26aulast%3DWaman%26aufirst%3DVaishali%2BP%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D2%26spage%3D742%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ali F  Alsulami</span>, <span class="hlFld-ContribAuthor ">Sherine E  Thomas</span>, <span class="hlFld-ContribAuthor ">Arian R  Jamasb</span>, <span class="hlFld-ContribAuthor ">Christopher A  Beaudoin</span>, <span class="hlFld-ContribAuthor ">Ismail  Moghul</span>, <span class="hlFld-ContribAuthor ">Bridget  Bannerman</span>, <span class="hlFld-ContribAuthor ">Liviu  Copoiu</span>, <span class="hlFld-ContribAuthor ">Sundeep Chaitanya  Vedithi</span>, <span class="hlFld-ContribAuthor ">Pedro  Torres</span>, <span class="hlFld-ContribAuthor ">Tom L  Blundell</span>. </span><span class="cited-content_cbyCitation_article-title">SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets. </span><span class="cited-content_cbyCitation_journal-name">Briefings in Bioinformatics</span><span> <strong>2021,</strong> <em>22 </em>
                                    (2)
                                     , 769-780. <a href="https://doi.org/10.1093/bib/bbaa404" title="DOI URL">https://doi.org/10.1093/bib/bbaa404</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bib/bbaa404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbib%2Fbbaa404%26sid%3Dliteratum%253Aachs%26jtitle%3DBriefings%2520in%2520Bioinformatics%26atitle%3DSARS-CoV-2%252B3D%252Bdatabase%25253A%252Bunderstanding%252Bthe%252Bcoronavirus%252Bproteome%252Band%252Bevaluating%252Bpossible%252Bdrug%252Btargets%26aulast%3DAlsulami%26aufirst%3DAli%2BF%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D2%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Rakib</span>, <span class="hlFld-ContribAuthor ">Zulkar  Nain</span>, <span class="hlFld-ContribAuthor ">Saad Ahmed  Sami</span>, <span class="hlFld-ContribAuthor ">Shafi  Mahmud</span>, <span class="hlFld-ContribAuthor ">Ashiqul  Islam</span>, <span class="hlFld-ContribAuthor ">Shahriar  Ahmed</span>, <span class="hlFld-ContribAuthor ">Adnan Bin Faisul  Siddiqui</span>, <span class="hlFld-ContribAuthor ">S M Omar Faruque  Babu</span>, <span class="hlFld-ContribAuthor ">Payar  Hossain</span>, <span class="hlFld-ContribAuthor ">Asif  Shahriar</span>, <span class="hlFld-ContribAuthor ">Firzan  Nainu</span>, <span class="hlFld-ContribAuthor ">Talha Bin  Emran</span>, <span class="hlFld-ContribAuthor ">Jesus  Simal-Gandara</span>. </span><span class="cited-content_cbyCitation_article-title">A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an
              in silico
              investigation. </span><span class="cited-content_cbyCitation_journal-name">Briefings in Bioinformatics</span><span> <strong>2021,</strong> <em>22 </em>
                                    (2)
                                     , 1476-1498. <a href="https://doi.org/10.1093/bib/bbab045" title="DOI URL">https://doi.org/10.1093/bib/bbab045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bib/bbab045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbib%2Fbbab045%26sid%3Dliteratum%253Aachs%26jtitle%3DBriefings%2520in%2520Bioinformatics%26atitle%3DA%252Bmolecular%252Bmodelling%252Bapproach%252Bfor%252Bidentifying%252Bantiviral%252Bselenium-containing%252Bheterocyclic%252Bcompounds%252Bthat%252Binhibit%252Bthe%252Bmain%252Bprotease%252Bof%252BSARS-CoV-2%25253A%252Ban%252Bin%252Bsilico%252Binvestigation%26aulast%3DRakib%26aufirst%3DAhmed%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D2%26spage%3D1476%26epage%3D1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bimalendu  Adhikari</span>, <span class="hlFld-ContribAuthor ">Nihar  Sahu</span>. </span><span class="cited-content_cbyCitation_article-title">COVID‐19 into Chemical Science Perspective: Chemical Preventive Measures and Drug Development. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (9)
                                     , 2010-2028. <a href="https://doi.org/10.1002/slct.202100127" title="DOI URL">https://doi.org/10.1002/slct.202100127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100127%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCOVID%2525E2%252580%25259019%252Binto%252BChemical%252BScience%252BPerspective%25253A%252BChemical%252BPreventive%252BMeasures%252Band%252BDrug%252BDevelopment%26aulast%3DAdhikari%26aufirst%3DBimalendu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D9%26spage%3D2010%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shagufta</span>, <span class="hlFld-ContribAuthor ">Irshad  Ahmad</span>. </span><span class="cited-content_cbyCitation_article-title">The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113157. <a href="https://doi.org/10.1016/j.ejmech.2021.113157" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113157%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Brace%252Bto%252Btreat%252BCOVID-19%25253A%252BPotential%252Btherapeutic%252Bagents%252Bfor%252Bthe%252Bprevention%252Band%252Btreatment%252Bof%252BSARS-CoV-2%26aulast%3DShagufta%26date%3D2021%26volume%3D213%26spage%3D113157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd  Saeed</span>, <span class="hlFld-ContribAuthor ">Amir  Saeed</span>, <span class="hlFld-ContribAuthor ">Md Jahoor  Alam</span>, <span class="hlFld-ContribAuthor ">Mousa  Alreshidi</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 Mpro. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1549. <a href="https://doi.org/10.3390/molecules26061549" title="DOI URL">https://doi.org/10.3390/molecules26061549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061549%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DReceptor-Based%252BPharmacophore%252BModeling%252Bin%252Bthe%252BSearch%252Bfor%252BNatural%252BProducts%252Bfor%252BCOVID-19%252BMpro%26aulast%3DSaeed%26aufirst%3DMohd%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed E.  Abouelela</span>, <span class="hlFld-ContribAuthor ">Hamdy K.  Assaf</span>, <span class="hlFld-ContribAuthor ">Reda A.  Abdelhamid</span>, <span class="hlFld-ContribAuthor ">Ehab S.  Elkhyat</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Sayed</span>, <span class="hlFld-ContribAuthor ">Tomasz  Oszako</span>, <span class="hlFld-ContribAuthor ">Lassaad  Belbahri</span>, <span class="hlFld-ContribAuthor ">Ahmed E.  El Zowalaty</span>, <span class="hlFld-ContribAuthor ">Mohamed Salaheldin A.  Abdelkader</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1767. <a href="https://doi.org/10.3390/molecules26061767" title="DOI URL">https://doi.org/10.3390/molecules26061767</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061767%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIdentification%252Bof%252BPotential%252BSARS-CoV-2%252BMain%252BProtease%252Band%252BSpike%252BProtein%252BInhibitors%252Bfrom%252Bthe%252BGenus%252BAloe%25253A%252BAn%252BIn%252BSilico%252BStudy%252Bfor%252BDrug%252BDevelopment%26aulast%3DAbouelela%26aufirst%3DMohamed%2BE.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biswa Mohan  Sahoo</span>, <span class="hlFld-ContribAuthor ">B. V. V.  Ravi Kumar</span>, <span class="hlFld-ContribAuthor ">J.  Sruti</span>, <span class="hlFld-ContribAuthor ">Manoj Kumar  Mahapatra</span>, <span class="hlFld-ContribAuthor ">Bimal K.  Banik</span>, <span class="hlFld-ContribAuthor ">Preetismita  Borah</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmolb.2021.628144" title="DOI URL">https://doi.org/10.3389/fmolb.2021.628144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2021.628144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2021.628144%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DDrug%252BRepurposing%252BStrategy%252B%252528DRS%252529%25253A%252BEmerging%252BApproach%252Bto%252BIdentify%252BPotential%252BTherapeutics%252Bfor%252BTreatment%252Bof%252BNovel%252BCoronavirus%252BInfection%26aulast%3DSahoo%26aufirst%3DBiswa%2BMohan%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucas S.  Franco</span>, <span class="hlFld-ContribAuthor ">Rodolfo C.  Maia</span>, <span class="hlFld-ContribAuthor ">Eliezer J.  Barreiro</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (M
              PRO
              ) through
              in silico
              screening supported by molecular docking and a fragment-based pharmacophore model. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 110-119. <a href="https://doi.org/10.1039/D0MD00282H" title="DOI URL">https://doi.org/10.1039/D0MD00282H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00282H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00282H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BLASSBio-1945%252Bas%252Ban%252Binhibitor%252Bof%252BSARS-CoV-2%252Bmain%252Bprotease%252B%252528M%252BPRO%252B%252529%252Bthrough%252Bin%252Bsilico%252Bscreening%252Bsupported%252Bby%252Bmolecular%252Bdocking%252Band%252Ba%252Bfragment-based%252Bpharmacophore%252Bmodel%26aulast%3DFranco%26aufirst%3DLucas%2BS.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D110%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hesam Saghaei  Bagheri</span>, <span class="hlFld-ContribAuthor ">Mohammad  Karimipour</span>, <span class="hlFld-ContribAuthor ">Morteza  Heidarzadeh</span>, <span class="hlFld-ContribAuthor ">Hadi  Rajabi</span>, <span class="hlFld-ContribAuthor ">Emel  Sokullu</span>, <span class="hlFld-ContribAuthor ">Reza  Rahbarghazi</span>. </span><span class="cited-content_cbyCitation_article-title">Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body?. </span><span class="cited-content_cbyCitation_journal-name">Stem Cell Reviews and Reports</span><span> <strong>2021,</strong> <em>17 </em>
                                    (1)
                                     , 214-230. <a href="https://doi.org/10.1007/s12015-020-10108-4" title="DOI URL">https://doi.org/10.1007/s12015-020-10108-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12015-020-10108-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12015-020-10108-4%26sid%3Dliteratum%253Aachs%26jtitle%3DStem%2520Cell%2520Reviews%2520and%2520Reports%26atitle%3DDoes%252Bthe%252BGlobal%252BOutbreak%252Bof%252BCOVID-19%252Bor%252BOther%252BViral%252BDiseases%252BThreaten%252Bthe%252BStem%252BCell%252BReservoir%252BInside%252Bthe%252BBody%25253F%26aulast%3DBagheri%26aufirst%3DHesam%2BSaghaei%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D1%26spage%3D214%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hardeep Singh  Tuli</span>, <span class="hlFld-ContribAuthor ">Shivani  Sood</span>, <span class="hlFld-ContribAuthor ">Jagjit  Kaur</span>, <span class="hlFld-ContribAuthor ">Pawan  Kumar</span>, <span class="hlFld-ContribAuthor ">Prachi  Seth</span>, <span class="hlFld-ContribAuthor ">Sandeep  Punia</span>, <span class="hlFld-ContribAuthor ">Priya  Yadav</span>, <span class="hlFld-ContribAuthor ">Anil Kumar  Sharma</span>, <span class="hlFld-ContribAuthor ">Diwakar  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Katrin  Sak</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements. </span><span class="cited-content_cbyCitation_journal-name">3 Biotech</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s13205-021-02644-8" title="DOI URL">https://doi.org/10.1007/s13205-021-02644-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13205-021-02644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13205-021-02644-8%26sid%3Dliteratum%253Aachs%26jtitle%3D3%2520Biotech%26atitle%3DMechanistic%252Binsight%252Binto%252Banti-COVID-19%252Bdrugs%25253A%252Brecent%252Btrends%252Band%252Badvancements%26aulast%3DTuli%26aufirst%3DHardeep%2BSingh%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.  Galindo</span>, <span class="hlFld-ContribAuthor ">U.  Garaigorta</span>, <span class="hlFld-ContribAuthor ">F.  Lasala</span>, <span class="hlFld-ContribAuthor ">M.A.  Cuesta-Geijo</span>, <span class="hlFld-ContribAuthor ">P.  Bueno</span>, <span class="hlFld-ContribAuthor ">C.  Gil</span>, <span class="hlFld-ContribAuthor ">R.  Delgado</span>, <span class="hlFld-ContribAuthor ">P.  Gastaminza</span>, <span class="hlFld-ContribAuthor ">C.  Alonso</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2021,</strong> <em>186 </em>, 104990. <a href="https://doi.org/10.1016/j.antiviral.2020.104990" title="DOI URL">https://doi.org/10.1016/j.antiviral.2020.104990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2020.104990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2020.104990%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DAntiviral%252Bdrugs%252Btargeting%252Bendosomal%252Bmembrane%252Bproteins%252Binhibit%252Bdistant%252Banimal%252Band%252Bhuman%252Bpathogenic%252Bviruses%26aulast%3DGalindo%26aufirst%3DI.%26date%3D2021%26volume%3D186%26spage%3D104990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sajjad  Ahmad</span>, <span class="hlFld-ContribAuthor ">Yasir  Waheed</span>, <span class="hlFld-ContribAuthor ">Saba  Ismail</span>, <span class="hlFld-ContribAuthor ">Sumra Wajid  Abbasi</span>, <span class="hlFld-ContribAuthor ">Muzammil Hasan  Najmi</span>. </span><span class="cited-content_cbyCitation_article-title">A computational study to disclose potential drugs and vaccine ensemble for COVID-19 conundrum. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Liquids</span><span> <strong>2021,</strong> <em>324 </em>, 114734. <a href="https://doi.org/10.1016/j.molliq.2020.114734" title="DOI URL">https://doi.org/10.1016/j.molliq.2020.114734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molliq.2020.114734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molliq.2020.114734%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Liquids%26atitle%3DA%252Bcomputational%252Bstudy%252Bto%252Bdisclose%252Bpotential%252Bdrugs%252Band%252Bvaccine%252Bensemble%252Bfor%252BCOVID-19%252Bconundrum%26aulast%3DAhmad%26aufirst%3DSajjad%26date%3D2021%26volume%3D324%26spage%3D114734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastián A.  Cuesta</span>, <span class="hlFld-ContribAuthor ">José R.  Mora</span>, <span class="hlFld-ContribAuthor ">Edgar A.  Márquez</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1100. <a href="https://doi.org/10.3390/molecules26041100" title="DOI URL">https://doi.org/10.3390/molecules26041100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041100%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIn%252BSilico%252BScreening%252Bof%252Bthe%252BDrugBank%252BDatabase%252Bto%252BSearch%252Bfor%252BPossible%252BDrugs%252Bagainst%252BSARS-CoV-2%26aulast%3DCuesta%26aufirst%3DSebasti%25C3%25A1n%2BA.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiranjib  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Manojit  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Bidyut  Mallick</span>, <span class="hlFld-ContribAuthor ">Ashish Ranjan  Sharma</span>, <span class="hlFld-ContribAuthor ">Sang-Soo  Lee</span>, <span class="hlFld-ContribAuthor ">Govindasamy  Agoramoorthy</span>. </span><span class="cited-content_cbyCitation_article-title">SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (2)
                                     , 225-237. <a href="https://doi.org/10.1080/17512433.2021.1874348" title="DOI URL">https://doi.org/10.1080/17512433.2021.1874348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17512433.2021.1874348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17512433.2021.1874348%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DSARS-CoV-2%252Bprotein%252Bdrug%252Btargets%252Blandscape%25253A%252Ba%252Bpotential%252Bpharmacological%252Binsight%252Bview%252Bfor%252Bthe%252Bnew%252Bdrug%252Bdevelopment%26aulast%3DChakraborty%26aufirst%3DChiranjib%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D2%26spage%3D225%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuki  Akisawa</span>, <span class="hlFld-ContribAuthor ">Ryo  Hatada</span>, <span class="hlFld-ContribAuthor ">Koji  Okuwaki</span>, <span class="hlFld-ContribAuthor ">Yuji  Mochizuki</span>, <span class="hlFld-ContribAuthor ">Kaori  Fukuzawa</span>, <span class="hlFld-ContribAuthor ">Yuto  Komeiji</span>, <span class="hlFld-ContribAuthor ">Shigenori  Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 3272-3279. <a href="https://doi.org/10.1039/D0RA09555A" title="DOI URL">https://doi.org/10.1039/D0RA09555A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA09555A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA09555A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DInteraction%252Banalyses%252Bof%252BSARS-CoV-2%252Bspike%252Bprotein%252Bbased%252Bon%252Bfragment%252Bmolecular%252Borbital%252Bcalculations%26aulast%3DAkisawa%26aufirst%3DKazuki%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D3272%26epage%3D3279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrabose  Selvaraj</span>, <span class="hlFld-ContribAuthor ">Umesh  Panwar</span>, <span class="hlFld-ContribAuthor ">Dhurvas Chandrasekaran  Dinesh</span>, <span class="hlFld-ContribAuthor ">Evzen  Boura</span>, <span class="hlFld-ContribAuthor ">Poonam  Singh</span>, <span class="hlFld-ContribAuthor ">Vikash Kumar  Dubey</span>, <span class="hlFld-ContribAuthor ">Sanjeev Kumar  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.595273" title="DOI URL">https://doi.org/10.3389/fchem.2020.595273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.595273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.595273%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DMicrosecond%252BMD%252BSimulation%252Band%252BMultiple-Conformation%252BVirtual%252BScreening%252Bto%252BIdentify%252BPotential%252BAnti-COVID-19%252BInhibitors%252BAgainst%252BSARS-CoV-2%252BMain%252BProtease%26aulast%3DSelvaraj%26aufirst%3DChandrabose%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Suvankar  Banerjee</span>, <span class="hlFld-ContribAuthor ">Samayaditya  Singh</span>, <span class="hlFld-ContribAuthor ">Insaf Ahmed  Qureshi</span>, <span class="hlFld-ContribAuthor ">Shovanlal  Gayen</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>20 </em><a href="https://doi.org/10.1007/s11030-020-10166-3" title="DOI URL">https://doi.org/10.1007/s11030-020-10166-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10166-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10166-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DFirst%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Banalysis%252Bof%252BSARS-CoV-2%252Bvirus%252Bmain%252Bprotease%252B%252528Mpro%252529%252Binhibitors%25253A%252Ban%252Bendeavor%252Bon%252BCOVID-19%252Bdrug%252Bdiscovery%26aulast%3DAmin%26aufirst%3DSk.%2BAbdul%26date%3D2021%26date%3D2021%26volume%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Suvankar  Banerjee</span>, <span class="hlFld-ContribAuthor ">Kalyan  Ghosh</span>, <span class="hlFld-ContribAuthor ">Shovanlal  Gayen</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115860. <a href="https://doi.org/10.1016/j.bmc.2020.115860" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115860</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115860%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DProtease%252Btargeted%252BCOVID-19%252Bdrug%252Bdiscovery%252Band%252Bits%252Bchallenges%25253A%252BInsight%252Binto%252Bviral%252Bmain%252Bprotease%252B%252528Mpro%252529%252Band%252Bpapain-like%252Bprotease%252B%252528PLpro%252529%252Binhibitors%26aulast%3DAmin%26aufirst%3DSk.%2BAbdul%26date%3D2021%26volume%3D29%26spage%3D115860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit S.  Lokhande</span>, <span class="hlFld-ContribAuthor ">Padma V.  Devarajan</span>. </span><span class="cited-content_cbyCitation_article-title">A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2021,</strong> <em>891 </em>, 173748. <a href="https://doi.org/10.1016/j.ejphar.2020.173748" title="DOI URL">https://doi.org/10.1016/j.ejphar.2020.173748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2020.173748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2020.173748%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Breview%252Bon%252Bpossible%252Bmechanistic%252Binsights%252Bof%252BNitazoxanide%252Bfor%252Brepurposing%252Bin%252BCOVID-19%26aulast%3DLokhande%26aufirst%3DAmit%2BS.%26date%3D2021%26volume%3D891%26spage%3D173748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rimanshee  Arya</span>, <span class="hlFld-ContribAuthor ">Shweta  Kumari</span>, <span class="hlFld-ContribAuthor ">Bharati  Pandey</span>, <span class="hlFld-ContribAuthor ">Hiral  Mistry</span>, <span class="hlFld-ContribAuthor ">Subhash C.  Bihani</span>, <span class="hlFld-ContribAuthor ">Amit  Das</span>, <span class="hlFld-ContribAuthor ">Vishal  Prashar</span>, <span class="hlFld-ContribAuthor ">Gagan D.  Gupta</span>, <span class="hlFld-ContribAuthor ">Lata  Panicker</span>, <span class="hlFld-ContribAuthor ">Mukesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights into SARS-CoV-2 proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2021,</strong> <em>433 </em>
                                    (2)
                                     , 166725. <a href="https://doi.org/10.1016/j.jmb.2020.11.024" title="DOI URL">https://doi.org/10.1016/j.jmb.2020.11.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2020.11.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2020.11.024%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DStructural%252Binsights%252Binto%252BSARS-CoV-2%252Bproteins%26aulast%3DArya%26aufirst%3DRimanshee%26date%3D2021%26volume%3D433%26issue%3D2%26spage%3D166725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Yameen</span>, <span class="hlFld-ContribAuthor ">Sara  Sattar</span>, <span class="hlFld-ContribAuthor ">Ayesha  Khalid</span>, <span class="hlFld-ContribAuthor ">Muhammad Aamir  Aslam</span>, <span class="hlFld-ContribAuthor ">Nishat  Zafar</span>, <span class="hlFld-ContribAuthor ">Muhammad Hassan  Saeed</span>, <span class="hlFld-ContribAuthor ">Muhammad Haseeb  Arif</span>, <span class="hlFld-ContribAuthor ">Muhammad  Jahangeer</span>, <span class="hlFld-ContribAuthor ">Azka  Qadeer</span>, <span class="hlFld-ContribAuthor ">Shoukat  Hussain</span>, <span class="hlFld-ContribAuthor ">Muhammad  Aamir</span>, <span class="hlFld-ContribAuthor ">Sania  Mukhtar</span>, <span class="hlFld-ContribAuthor ">Huma  Nasir</span>, <span class="hlFld-ContribAuthor ">Asif  Shahzad</span>. </span><span class="cited-content_cbyCitation_article-title">NOVEL SARS-COV-2 PANDEMIC TRANSMISSION WITH ONGOING ANTIVIRAL THERAPIES AND VACCINE DESIGN. </span><span class="cited-content_cbyCitation_journal-name">Postępy Mikrobiologii - Advancements of Microbiology</span><span> <strong>2021,</strong> <em>60 </em>
                                    (1)
                                     , 13-20. <a href="https://doi.org/10.21307/PM-2021.60.1.02" title="DOI URL">https://doi.org/10.21307/PM-2021.60.1.02</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.21307/PM-2021.60.1.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.21307%2FPM-2021.60.1.02%26sid%3Dliteratum%253Aachs%26jtitle%3DPost%25C4%2599py%2520Mikrobiologii%2520-%2520Advancements%2520of%2520Microbiology%26atitle%3DNOVEL%252BSARS-COV-2%252BPANDEMIC%252BTRANSMISSION%252BWITH%252BONGOING%252BANTIVIRAL%252BTHERAPIES%252BAND%252BVACCINE%252BDESIGN%26aulast%3DYameen%26aufirst%3DMuhammad%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D1%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  Gomez-Gutierrez</span>, <span class="hlFld-ContribAuthor ">Juan J.  Perez</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (1)
                                     , 257. <a href="https://doi.org/10.3390/ijms22010257" title="DOI URL">https://doi.org/10.3390/ijms22010257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22010257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22010257%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252Ba%252BBradykinin%252BB2%252BPartial%252BAgonist%252BProfile%252Bof%252BRaloxifene%252Bin%252Ba%252BDrug%252BRepurposing%252BCampaign%26aulast%3DGomez-Gutierrez%26aufirst%3DPatricia%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D1%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nourhan  Hisham Shady</span>, <span class="hlFld-ContribAuthor ">Khayrya A.  Youssif</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Sayed</span>, <span class="hlFld-ContribAuthor ">Lassaad  Belbahri</span>, <span class="hlFld-ContribAuthor ">Tomasz  Oszako</span>, <span class="hlFld-ContribAuthor ">Hossam M.  Hassan</span>, <span class="hlFld-ContribAuthor ">Usama Ramadan  Abdelmohsen</span>. </span><span class="cited-content_cbyCitation_article-title">Sterols and Triterpenes: Antiviral     Potential Supported by In-Silico Analysis. </span><span class="cited-content_cbyCitation_journal-name">Plants</span><span> <strong>2021,</strong> <em>10 </em>
                                    (1)
                                     , 41. <a href="https://doi.org/10.3390/plants10010041" title="DOI URL">https://doi.org/10.3390/plants10010041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/plants10010041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fplants10010041%26sid%3Dliteratum%253Aachs%26jtitle%3DPlants%26atitle%3DSterols%252Band%252BTriterpenes%25253A%252BAntiviral%252B%2525C2%2525A0%2525C2%2525A0%2525C2%2525A0%252BPotential%252BSupported%252Bby%252BIn-Silico%252BAnalysis%26aulast%3DHisham%2BShady%26aufirst%3DNourhan%26date%3D2021%26date%3D2020%26volume%3D10%26issue%3D1%26spage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sako  Mirzaie</span>, <span class="hlFld-ContribAuthor ">Fatemeh  Abdi</span>, <span class="hlFld-ContribAuthor ">Amin  GhavamiNejad</span>, <span class="hlFld-ContribAuthor ">Brian  Lu</span>, <span class="hlFld-ContribAuthor ">Xiao Yu  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Antiviral Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 285-312. <a href="https://doi.org/10.1007/978-981-16-0267-2_11" title="DOI URL">https://doi.org/10.1007/978-981-16-0267-2_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-16-0267-2_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-16-0267-2_11%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BAntiviral%252BAgents%26aulast%3DMirzaie%26aufirst%3DSako%26date%3D2021%26date%3D2021%26spage%3D285%26epage%3D312%26pub%3DSpringer%2520Singapore%26atitle%3DAntiviral%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DLiu%26aufirst%3DXinyong%26date%3D2021%26volume%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianguang  Huang</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez-Arias</span>. </span><span class="cited-content_cbyCitation_article-title">Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 219-260. <a href="https://doi.org/10.1007/978-981-16-0267-2_9" title="DOI URL">https://doi.org/10.1007/978-981-16-0267-2_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-16-0267-2_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-16-0267-2_9%26sid%3Dliteratum%253Aachs%26atitle%3DSearch%25252C%252BIdentification%25252C%252Band%252BDesign%252Bof%252BEffective%252BAntiviral%252BDrugs%252BAgainst%252BPandemic%252BHuman%252BCoronaviruses%26aulast%3DHuang%26aufirst%3DTianguang%26date%3D2021%26date%3D2021%26spage%3D219%26epage%3D260%26pub%3DSpringer%2520Singapore%26atitle%3DAntiviral%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DLiu%26aufirst%3DXinyong%26date%3D2021%26volume%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hoang Anh T.  Phan</span>, <span class="hlFld-ContribAuthor ">Sam G.  Giannakoulias</span>, <span class="hlFld-ContribAuthor ">Taylor M.  Barrett</span>, <span class="hlFld-ContribAuthor ">Chunxiao  Liu</span>, <span class="hlFld-ContribAuthor ">E. James  Petersson</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of thioamide peptides as selective inhibitors of cysteine protease cathepsin L. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>20 </em><a href="https://doi.org/10.1039/D1SC00785H" title="DOI URL">https://doi.org/10.1039/D1SC00785H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC00785H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC00785H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DRational%252Bdesign%252Bof%252Bthioamide%252Bpeptides%252Bas%252Bselective%252Binhibitors%252Bof%252Bcysteine%252Bprotease%252Bcathepsin%252BL%26aulast%3DPhan%26aufirst%3DHoang%2BAnh%2BT.%26date%3D2021%26date%3D2021%26volume%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chung-ke  Chang</span>, <span class="hlFld-ContribAuthor ">Shan-Meng  Lin</span>, <span class="hlFld-ContribAuthor ">Roshan  Satange</span>, <span class="hlFld-ContribAuthor ">Shih-Chao  Lin</span>, <span class="hlFld-ContribAuthor ">Sin-Cih  Sun</span>, <span class="hlFld-ContribAuthor ">Hung-Yi  Wu</span>, <span class="hlFld-ContribAuthor ">Kylene  Kehn-Hall</span>, <span class="hlFld-ContribAuthor ">Ming-Hon  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting protein-protein interaction interfaces in COVID-19 drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2021,</strong> <em>19 </em>, 2246-2255. <a href="https://doi.org/10.1016/j.csbj.2021.04.003" title="DOI URL">https://doi.org/10.1016/j.csbj.2021.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2021.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2021.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DTargeting%252Bprotein-protein%252Binteraction%252Binterfaces%252Bin%252BCOVID-19%252Bdrug%252Bdiscovery%26aulast%3DChang%26aufirst%3DChung-ke%26date%3D2021%26volume%3D19%26spage%3D2246%26epage%3D2255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sugandh  Kumar</span>, <span class="hlFld-ContribAuthor ">Bharati  Singh</span>, <span class="hlFld-ContribAuthor ">Pratima  Kumari</span>, <span class="hlFld-ContribAuthor ">Preethy V.  Kumar</span>, <span class="hlFld-ContribAuthor ">Geetanjali  Agnihotri</span>, <span class="hlFld-ContribAuthor ">Shaheerah  Khan</span>, <span class="hlFld-ContribAuthor ">Tushar  Kant Beuria</span>, <span class="hlFld-ContribAuthor ">Gulam Hussain  Syed</span>, <span class="hlFld-ContribAuthor ">Anshuman  Dixit</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2021,</strong> <em>19 </em>, 1998-2017. <a href="https://doi.org/10.1016/j.csbj.2021.04.014" title="DOI URL">https://doi.org/10.1016/j.csbj.2021.04.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2021.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2021.04.014%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DIdentification%252Bof%252Bmultipotent%252Bdrugs%252Bfor%252BCOVID-19%252Btherapeutics%252Bwith%252Bthe%252Bevaluation%252Bof%252Btheir%252BSARS-CoV2%252Binhibitory%252Bactivity%26aulast%3DKumar%26aufirst%3DSugandh%26date%3D2021%26volume%3D19%26spage%3D1998%26epage%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natesh  Singh</span>, <span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>. </span><span class="cited-content_cbyCitation_article-title">Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2021,</strong> <em>19 </em>, 2537-2548. <a href="https://doi.org/10.1016/j.csbj.2021.04.059" title="DOI URL">https://doi.org/10.1016/j.csbj.2021.04.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2021.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2021.04.059%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DResources%252Band%252Bcomputational%252Bstrategies%252Bto%252Badvance%252Bsmall%252Bmolecule%252BSARS-CoV-2%252Bdiscovery%25253A%252BLessons%252Bfrom%252Bthe%252Bpandemic%252Band%252Bpreparing%252Bfor%252Bfuture%252Bhealth%252Bcrises%26aulast%3DSingh%26aufirst%3DNatesh%26date%3D2021%26volume%3D19%26spage%3D2537%26epage%3D2548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaykumar  Jani</span>, <span class="hlFld-ContribAuthor ">Anju  Pappachan</span>. </span><span class="cited-content_cbyCitation_article-title">Protein Analysis: From Sequence to Structure. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 59-82. <a href="https://doi.org/10.1007/978-981-33-6191-1_4" title="DOI URL">https://doi.org/10.1007/978-981-33-6191-1_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-33-6191-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-33-6191-1_4%26sid%3Dliteratum%253Aachs%26atitle%3DProtein%252BAnalysis%25253A%252BFrom%252BSequence%252Bto%252BStructure%26aulast%3DJani%26aufirst%3DJaykumar%26date%3D2021%26date%3D2021%26spage%3D59%26epage%3D82%26pub%3DSpringer%2520Singapore%26atitle%3DAdvances%252Bin%252BBioinformatics%26aulast%3DSingh%26aufirst%3DVijai%26date%3D2021%26volume%3D1%25E2%2580%25932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankit Kumar  Dubey</span>, <span class="hlFld-ContribAuthor ">Aakansha  Singh</span>, <span class="hlFld-ContribAuthor ">Shardendu  Prakash</span>, <span class="hlFld-ContribAuthor ">Manoj  Kumar</span>, <span class="hlFld-ContribAuthor ">Ashok K  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Race to arsenal COVID-19 therapeutics: Current alarming status and future directions. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2020,</strong> <em>332 </em>, 109298. <a href="https://doi.org/10.1016/j.cbi.2020.109298" title="DOI URL">https://doi.org/10.1016/j.cbi.2020.109298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2020.109298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2020.109298%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DRace%252Bto%252Barsenal%252BCOVID-19%252Btherapeutics%25253A%252BCurrent%252Balarming%252Bstatus%252Band%252Bfuture%252Bdirections%26aulast%3DDubey%26aufirst%3DAnkit%2BKumar%26date%3D2020%26volume%3D332%26spage%3D109298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manisha  Yadav</span>, <span class="hlFld-ContribAuthor ">Swasti  Dhagat</span>, <span class="hlFld-ContribAuthor ">J. Satya  Eswari</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging strategies on in silico drug development against COVID-19: challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>155 </em>, 105522. <a href="https://doi.org/10.1016/j.ejps.2020.105522" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105522%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DEmerging%252Bstrategies%252Bon%252Bin%252Bsilico%252Bdrug%252Bdevelopment%252Bagainst%252BCOVID-19%25253A%252Bchallenges%252Band%252Bopportunities%26aulast%3DYadav%26aufirst%3DManisha%26date%3D2020%26volume%3D155%26spage%3D105522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nidhi  Singh</span>, <span class="hlFld-ContribAuthor ">Sachchida Nand  Rai</span>, <span class="hlFld-ContribAuthor ">Veer  Singh</span>, <span class="hlFld-ContribAuthor ">Mohan P.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Neuroanatomy</span><span> <strong>2020,</strong> <em>110 </em>, 101874. <a href="https://doi.org/10.1016/j.jchemneu.2020.101874" title="DOI URL">https://doi.org/10.1016/j.jchemneu.2020.101874</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchemneu.2020.101874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchemneu.2020.101874%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Neuroanatomy%26atitle%3DMolecular%252Bcharacterization%25252C%252Bpathogen-host%252Binteraction%252Bpathway%252Band%252Bin%252Bsilico%252Bapproaches%252Bfor%252Bvaccine%252Bdesign%252Bagainst%252BCOVID-19%26aulast%3DSingh%26aufirst%3DNidhi%26date%3D2020%26volume%3D110%26spage%3D101874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Flavio A.  Cadegiani</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing existing drugs for COVID-19: an endocrinology perspective. </span><span class="cited-content_cbyCitation_journal-name">BMC Endocrine Disorders</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12902-020-00626-0" title="DOI URL">https://doi.org/10.1186/s12902-020-00626-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12902-020-00626-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12902-020-00626-0%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Endocrine%2520Disorders%26atitle%3DRepurposing%252Bexisting%252Bdrugs%252Bfor%252BCOVID-19%25253A%252Ban%252Bendocrinology%252Bperspective%26aulast%3DCadegiani%26aufirst%3DFlavio%2BA.%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel W.  Kneller</span>, <span class="hlFld-ContribAuthor ">Gwyndalyn  Phillips</span>, <span class="hlFld-ContribAuthor ">Kevin L.  Weiss</span>, <span class="hlFld-ContribAuthor ">Swati  Pant</span>, <span class="hlFld-ContribAuthor ">Qiu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hugh M.  O'Neill</span>, <span class="hlFld-ContribAuthor ">Leighton  Coates</span>, <span class="hlFld-ContribAuthor ">Andrey  Kovalevsky</span>. </span><span class="cited-content_cbyCitation_article-title">Unusual zwitterionic catalytic site of SARS–CoV-2 main protease revealed by neutron crystallography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2020,</strong> <em>295 </em>
                                    (50)
                                     , 17365-17373. <a href="https://doi.org/10.1074/jbc.AC120.016154" title="DOI URL">https://doi.org/10.1074/jbc.AC120.016154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.AC120.016154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.AC120.016154%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DUnusual%252Bzwitterionic%252Bcatalytic%252Bsite%252Bof%252BSARS%2525E2%252580%252593CoV-2%252Bmain%252Bprotease%252Brevealed%252Bby%252Bneutron%252Bcrystallography%26aulast%3DKneller%26aufirst%3DDaniel%2BW.%26date%3D2020%26volume%3D295%26issue%3D50%26spage%3D17365%26epage%3D17373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahzaib  Ahamad</span>, <span class="hlFld-ContribAuthor ">Dinesh  Gupta</span>, <span class="hlFld-ContribAuthor ">Vijay  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em> </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2020.1839563" title="DOI URL">https://doi.org/10.1080/07391102.2020.1839563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1839563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1839563%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DTargeting%252BSARS-CoV-2%252Bnucleocapsid%252Boligomerization%25253A%252BInsights%252Bfrom%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DAhamad%26aufirst%3DShahzaib%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debmalya  Barh</span>, <span class="hlFld-ContribAuthor ">Sandeep  Tiwari</span>, <span class="hlFld-ContribAuthor ">Marianna E.  Weener</span>, <span class="hlFld-ContribAuthor ">Vasco  Azevedo</span>, <span class="hlFld-ContribAuthor ">Aristóteles  Góes-Neto</span>, <span class="hlFld-ContribAuthor ">M. Michael  Gromiha</span>, <span class="hlFld-ContribAuthor ">Preetam  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19. </span><span class="cited-content_cbyCitation_journal-name">Computers in Biology and Medicine</span><span> <strong>2020,</strong> <em>126 </em>, 104051. <a href="https://doi.org/10.1016/j.compbiomed.2020.104051" title="DOI URL">https://doi.org/10.1016/j.compbiomed.2020.104051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiomed.2020.104051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiomed.2020.104051%26sid%3Dliteratum%253Aachs%26jtitle%3DComputers%2520in%2520Biology%2520and%2520Medicine%26atitle%3DMulti-omics-based%252Bidentification%252Bof%252BSARS-CoV-2%252Binfection%252Bbiology%252Band%252Bcandidate%252Bdrugs%252Bagainst%252BCOVID-19%26aulast%3DBarh%26aufirst%3DDebmalya%26date%3D2020%26volume%3D126%26spage%3D104051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haidi  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Ren</span>, <span class="hlFld-ContribAuthor ">Junyou  Li</span>, <span class="hlFld-ContribAuthor ">Zixin  Zhang</span>, <span class="hlFld-ContribAuthor ">Ninghui  Chang</span>, <span class="hlFld-ContribAuthor ">Chuanguang  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Greener liquid-phase synthesis and the ACE inhibitory structure–activity relationship of an anti-SARS octapeptide. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (41)
                                     , 8433-8442. <a href="https://doi.org/10.1039/D0OB01948H" title="DOI URL">https://doi.org/10.1039/D0OB01948H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01948H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01948H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DGreener%252Bliquid-phase%252Bsynthesis%252Band%252Bthe%252BACE%252Binhibitory%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Ban%252Banti-SARS%252Boctapeptide%26aulast%3DLi%26aufirst%3DHaidi%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D41%26spage%3D8433%26epage%3D8442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rinki  Minakshi</span>, <span class="hlFld-ContribAuthor ">Arif Tasleem  Jan</span>, <span class="hlFld-ContribAuthor ">Safikur  Rahman</span>, <span class="hlFld-ContribAuthor ">Jihoe  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular and Infection Microbiology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fcimb.2020.575404" title="DOI URL">https://doi.org/10.3389/fcimb.2020.575404</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcimb.2020.575404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcimb.2020.575404%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520and%2520Infection%2520Microbiology%26atitle%3DA%252BTestimony%252Bof%252Bthe%252BSurgent%252BSARS-CoV-2%252Bin%252Bthe%252BImmunological%252BPanorama%252Bof%252Bthe%252BHuman%252BHost%26aulast%3DMinakshi%26aufirst%3DRinki%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir V.  Kouznetsov</span>. </span><span class="cited-content_cbyCitation_article-title">COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112647. <a href="https://doi.org/10.1016/j.ejmech.2020.112647" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112647%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCOVID-19%252Btreatment%25253A%252BMuch%252Bresearch%252Band%252Btesting%25252C%252Bbut%252Bfar%25252C%252Bfew%252Bmagic%252Bbullets%252Bagainst%252BSARS-CoV-2%252Bcoronavirus%26aulast%3DKouznetsov%26aufirst%3DVladimir%2BV.%26date%3D2020%26volume%3D203%26spage%3D112647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Beziau</span>, <span class="hlFld-ContribAuthor ">Denys  Brand</span>, <span class="hlFld-ContribAuthor ">Eric  Piver</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Phosphatidylinositol Phosphate Kinases during Viral Infection. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 1124. <a href="https://doi.org/10.3390/v12101124" title="DOI URL">https://doi.org/10.3390/v12101124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v12101124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv12101124%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DThe%252BRole%252Bof%252BPhosphatidylinositol%252BPhosphate%252BKinases%252Bduring%252BViral%252BInfection%26aulast%3DBeziau%26aufirst%3DAnne%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Culletta</span>, <span class="hlFld-ContribAuthor ">Maria Rita  Gulotta</span>, <span class="hlFld-ContribAuthor ">Ugo  Perricone</span>, <span class="hlFld-ContribAuthor ">Maria  Zappalà</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Almerico</span>, <span class="hlFld-ContribAuthor ">Marco  Tutone</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the SARS-CoV-2 Proteome in the Search of Potential Inhibitors via Structure-Based Pharmacophore Modeling/Docking Approach. </span><span class="cited-content_cbyCitation_journal-name">Computation</span><span> <strong>2020,</strong> <em>8 </em>
                                    (3)
                                     , 77. <a href="https://doi.org/10.3390/computation8030077" title="DOI URL">https://doi.org/10.3390/computation8030077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/computation8030077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcomputation8030077%26sid%3Dliteratum%253Aachs%26jtitle%3DComputation%26atitle%3DExploring%252Bthe%252BSARS-CoV-2%252BProteome%252Bin%252Bthe%252BSearch%252Bof%252BPotential%252BInhibitors%252Bvia%252BStructure-Based%252BPharmacophore%252BModeling%25252FDocking%252BApproach%26aulast%3DCulletta%26aufirst%3DGiulia%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D3%26spage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SARS-CoV-2 infection cycle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of SARS-CoV-2 and its structural proteins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structural diagrams of spike glycoproteins of SARS-CoV-2. The spike protein contains an S1 subunit and an S2 subunit, which are divided by the S cleavage sites. Abbreviations: FP, fusion peptide; HR, heptad repeat 1 and heptad repeat 2, RBD, receptor-binding domain, containing the core binding motif in the external subdomain; SP, signal peptide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Schematic diagram of SARS-CoV S2-mediated membrane fusion. In the receptor-binding stage, S protein, which exists as a trimer, binds to the cellular receptor ACE2 via S1-RBD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representation of the open “up” (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VSB">6VSB</a>) and closed “down” (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VXX">6VXX</a>) states for the pre-fusion S1/S2 glycoprotein of SARS-CoV-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Polar contacts between the S-RBM (in violet) of S-RBD and ACE2 (in green) for SARS-CoV-2 (A) and SARS-CoV (B) and electrostatic potential map for the S-RBD. Some additional polar contacts (Q493-E35 and K417-D30) are visible in the central region of the contact surface for SARS-CoV-2 and ACE2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compounds and peptides directed to S protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative CoV protease inhibitors: (A) SARS 3CLpro inhibitors, (B) SARS and MERS 3CLpro inhibitor, and (C) SARS dual 3CLpro and PLpro inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative SARS-CoV-2 3CLpro inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. RdRp inhibitors active against SARS-CoV-2 and under clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Representative SARS-CoV helicase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (Right) Cryo-EM structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M17">6M17</a>) of full-length human ACE2 with the transporter (B<sup>0</sup>AT1) and the receptor-binding domain of the spike glycoprotein (S1-RBD). (Left) S1-RBD–ACE2 interaction interface for SARS-CoV-2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M0J">6M0J</a>), front and back views. Relevant ACE2 residues involved in direct polar interaction with S1-RBD (in particular, D30, K31, and D35) are represented in yellow sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. TMPRSS2 modulators: (A) chemical structure of TMPRSS2 inhibitors and (B) some transcriptional inhibitors of TMPRSS2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Chemical probes targeting cathepsin L with inhibitory activity against SARS-CoV-2 and SARS-CoV infection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. AAK1 and GAK inhibitors with therapeutic potential for COVID-19.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. PIKfyve inhibitors active on SARS-CoV-2 infection in cell culture.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Clinically used drugs to block TPC2: (A) dopamine antagonists and (B) SERMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Schematic representation of the main pathways of the innate immune response to HCoV. These pathways lead to the activation of nuclear factor kappa B (NF-kB), AP-1, and interferon (IFN), resulting in the secretion of pro-inflammatory cytokines and interferons and the activation of a cellular immune response. Like most viruses, HCoVs have evolved mechanisms to evade the innate immune response. Most of their proteins have been found to be inhibitory (depicted in red) toward several arms of the innate immune response. Remarkably, SARS-CoV-2 ORF9b and nsp15 activate (in green) the IFN route, while other HCoVs proteins have the opposite effect, leading to destruction of both the cell and the virus. Also, SARS-CoV-2 activates PKR, while MERS—and several other viruses—typically inhibit this enzyme for recovery from ER stress and viral protein synthesis shut-off.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Potential immunosuppression treatments: (A) antiviral used in combination with IFNα and IFNβ, (B) JAK inhibitors, and (C) HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Anti-IFV-A agents with potential therapeutic effects on SARS-CoV-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Antivirals used in clinics as potential COVID-19 treatments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/medium/jm0c00606_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Approved drugs in clinical trials for COVID-19: (A) inhibitors of viral RNA polymerase, (B) antipsychotics effective in clathrin-mediated endocytosis, and (C) miscellaneous drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-21/acs.jmedchem.0c00606/20201113-01/images/large/jm0c00606_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00606&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 254 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z. L.</span></span> <span> </span><span class="NLM_article-title">A pneumonia outbreak associated with a new coronavirus of probable bat origin</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>579</i></span> (<span class="NLM_issue">7798</span>),  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2012-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2012-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32015507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFKlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2020&pages=270-273&issue=7798&author=P.+Zhouauthor=X.+L.+Yangauthor=X.+G.+Wangauthor=B.+Huauthor=L.+Zhangauthor=W.+Zhangauthor=H.+R.+Siauthor=Y.+Zhuauthor=B.+Liauthor=C.+L.+Huangauthor=H.+D.+Chenauthor=J.+Chenauthor=Y.+Luoauthor=H.+Guoauthor=R.+D.+Jiangauthor=M.+Q.+Liuauthor=Y.+Chenauthor=X.+R.+Shenauthor=X.+Wangauthor=X.+S.+Zhengauthor=K.+Zhaoauthor=Q.+J.+Chenauthor=F.+Dengauthor=L.+L.+Liuauthor=B.+Yanauthor=F.+X.+Zhanauthor=Y.+Y.+Wangauthor=G.+F.+Xiaoauthor=Z.+L.+Shi&title=A+pneumonia+outbreak+associated+with+a+new+coronavirus+of+probable+bat+origin&doi=10.1038%2Fs41586-020-2012-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A pneumonia outbreak associated with a new coronavirus of probable bat origin</span></div><div class="casAuthors">Zhou, Peng; Yang, Xing-Lou; Wang, Xian-Guang; Hu, Ben; Zhang, Lei; Zhang, Wei; Si, Hao-Rui; Zhu, Yan; Li, Bei; Huang, Chao-Lin; Chen, Hui-Dong; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai; Chen, Quan-Jiao; Deng, Fei; Liu, Lin-Lin; Yan, Bing; Zhan, Fa-Xian; Wang, Yan-Yi; Xiao, Geng-Fu; Shi, Zheng-Li</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">7798</span>),
    <span class="NLM_cas:pages">270-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large no. of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats1-4.  Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans5-7.  Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China.  The epidemic, which started on 12 Dec. 2019, had caused 2,794 lab.-confirmed infections including 80 deaths by 26 Jan. 2020.  Full-length genome sequences were obtained from five patients at an early stage of the outbreak.  The sequences are almost identical and share 79.6% sequence identity to SARS-CoV.  Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus.  Pairwise protein sequence anal. of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV.  In addn., 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients.  Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV_Wb_iUsbFrVg90H21EOLACvtfcHk0liBWwrr0Gxi0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFKlsLg%253D&md5=236f17d4d3c7978d72513e5e0258f1b3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2012-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2012-7%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DX.%2BL.%26aulast%3DWang%26aufirst%3DX.%2BG.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSi%26aufirst%3DH.%2BR.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DC.%2BL.%26aulast%3DChen%26aufirst%3DH.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DR.%2BD.%26aulast%3DLiu%26aufirst%3DM.%2BQ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DX.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DX.%2BS.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DQ.%2BJ.%26aulast%3DDeng%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DL.%2BL.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DZhan%26aufirst%3DF.%2BX.%26aulast%3DWang%26aufirst%3DY.%2BY.%26aulast%3DXiao%26aufirst%3DG.%2BF.%26aulast%3DShi%26aufirst%3DZ.%2BL.%26atitle%3DA%2520pneumonia%2520outbreak%2520associated%2520with%2520a%2520new%2520coronavirus%2520of%2520probable%2520bat%2520origin%26jtitle%3DNature%26date%3D2020%26volume%3D579%26issue%3D7798%26spage%3D270%26epage%3D273%26doi%3D10.1038%2Fs41586-020-2012-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z. L.</span></span> <span> </span><span class="NLM_article-title">Origin and evolution of pathogenic coronaviruses</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1038/s41579-018-0118-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41579-018-0118-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30531947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=181-192&issue=3&author=J.+Cuiauthor=F.+Liauthor=Z.+L.+Shi&title=Origin+and+evolution+of+pathogenic+coronaviruses&doi=10.1038%2Fs41579-018-0118-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Origin and evolution of pathogenic coronaviruses</span></div><div class="casAuthors">Cui, Jie; Li, Fang; Shi, Zheng-Li</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-192</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are two highly transmissible and pathogenic viruses that emerged in humans at the beginning of the 21st century.  Both viruses likely originated in bats, and genetically diverse coronaviruses that are related to SARS-CoV and MERS-CoV were discovered in bats worldwide.  In this Review, we summarize the current knowledge on the origin and evolution of these two pathogenic coronaviruses and discuss their receptor usage; we also highlight the diversity and potential of spillover of bat-borne coronaviruses, as evidenced by the recent spillover of swine acute diarrhoea syndrome coronavirus (SADS-CoV) to pigs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosxL8lhv4N5rVg90H21EOLACvtfcHk0liBioMCveIUzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhtbnL&md5=b2b2c40c0cdf30107d8c70f482fc4f63</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fs41579-018-0118-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41579-018-0118-9%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DZ.%2BL.%26atitle%3DOrigin%2520and%2520evolution%2520of%2520pathogenic%2520coronaviruses%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2019%26volume%3D17%26issue%3D3%26spage%3D181%26epage%3D192%26doi%3D10.1038%2Fs41579-018-0118-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stadler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masignani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eickmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrignani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappuoli, R.</span></span> <span> </span><span class="NLM_article-title">SARS--beginning to understand a new virus</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1038/nrmicro775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnrmicro775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15035025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsVaqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=209-218&issue=3&author=K.+Stadlerauthor=V.+Masignaniauthor=M.+Eickmannauthor=S.+Beckerauthor=S.+Abrignaniauthor=H.+D.+Klenkauthor=R.+Rappuoli&title=SARS%2D%2Dbeginning+to+understand+a+new+virus&doi=10.1038%2Fnrmicro775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-beginning to understand a new virus</span></div><div class="casAuthors">Stadler, Konrad; Masignani, Vega; Eickmann, Markus; Becker, Stephan; Abrignani, Sergio; Klenk, Hans-Dieter; Rappuoli, Rino</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">209-218</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The 114-day epidemic of the severe acute respiratory syndrome (SARS) swept 29 countries, affected a report 8,098 people, left 774 patients dead and almost paralyzed the Asian economy.  Aggressive quarantine measures, possibly aided by rising summer temps., successfully terminated the first eruption of SARS and provided at least a temporal break, which allows us to consolidate what we have learned so far and plan for the future.  Here, we review the genomics of the SARS coronavirus (SARS-CoV), its phylogeny, antigenic structure, immune response and potential therapeutic interventions should the SARS epidemic flare up again.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu0Swc3sbe-LVg90H21EOLACvtfcHk0liBioMCveIUzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsVaqsb0%253D&md5=07a3280a917df5f1727e964c534f78ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro775%26sid%3Dliteratum%253Aachs%26aulast%3DStadler%26aufirst%3DK.%26aulast%3DMasignani%26aufirst%3DV.%26aulast%3DEickmann%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DAbrignani%26aufirst%3DS.%26aulast%3DKlenk%26aufirst%3DH.%2BD.%26aulast%3DRappuoli%26aufirst%3DR.%26atitle%3DSARS--beginning%2520to%2520understand%2520a%2520new%2520virus%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2003%26volume%3D1%26issue%3D3%26spage%3D209%26epage%3D218%26doi%3D10.1038%2Fnrmicro775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span> <span> </span><span class="NLM_article-title">Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">E60</span>, <span class="refDoi"> DOI: 10.3390/v11010060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv11010060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30646569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlOrtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=E60&issue=1&author=Y.+Zhouauthor=Y.+Yangauthor=J.+Huangauthor=S.+Jiangauthor=L.+Du&title=Advances+in+MERS-CoV+vaccines+and+therapeutics+based+on+the+receptor-binding+domain&doi=10.3390%2Fv11010060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain</span></div><div class="casAuthors">Zhou, Yusen; Yang, Yang; Huang, Jingwei; Jiang, Shibo; Du, Lanying</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is an infectious virus that was first reported in 2012.  The MERS-CoV genome encodes four major structural proteins, among which the spike (S) protein has a key role in viral infection and pathogenesis.  The receptor-binding domain (RBD) of the S protein contains a crit. neutralizing domain and is an important target for development of MERS vaccines and therapeutics.  In this review, we describe the relevant features of the MERS-CoV S-protein RBD, summarize recent advances in the development of MERS-CoV RBD-based vaccines and therapeutic antibodies, and illustrate potential challenges and strategies to further improve their efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7AGx4ZFaf1LVg90H21EOLACvtfcHk0liBioMCveIUzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlOrtL3E&md5=e9fd9f33003eafdc7e71b1b1061a75d8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3390%2Fv11010060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv11010060%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DL.%26atitle%3DAdvances%2520in%2520MERS-CoV%2520vaccines%2520and%2520therapeutics%2520based%2520on%2520the%2520receptor-binding%2520domain%26jtitle%3DViruses%26date%3D2019%26volume%3D11%26issue%3D1%26spage%3DE60%26doi%3D10.3390%2Fv11010060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Z.</span></span> <span> </span><span class="NLM_article-title">A new coronavirus associated with human respiratory disease in China</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>579</i></span> (<span class="NLM_issue">7798</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2008-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2008-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32015508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksFKlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2020&pages=265-269&issue=7798&author=F.+Wuauthor=S.+Zhaoauthor=B.+Yuauthor=Y.+M.+Chenauthor=W.+Wangauthor=Z.+G.+Songauthor=Y.+Huauthor=Z.+W.+Taoauthor=J.+H.+Tianauthor=Y.+Y.+Peiauthor=M.+L.+Yuanauthor=Y.+L.+Zhangauthor=F.+H.+Daiauthor=Y.+Liuauthor=Q.+M.+Wangauthor=J.+J.+Zhengauthor=L.+Xuauthor=E.+C.+Holmesauthor=Y.+Z.+Zhang&title=A+new+coronavirus+associated+with+human+respiratory+disease+in+China&doi=10.1038%2Fs41586-020-2008-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A new coronavirus associated with human respiratory disease in China</span></div><div class="casAuthors">Wu, Fan; Zhao, Su; Yu, Bin; Chen, Yan-Mei; Wang, Wen; Song, Zhi-Gang; Hu, Yi; Tao, Zhao-Wu; Tian, Jun-Hua; Pei, Yuan-Yuan; Yuan, Ming-Li; Zhang, Yu-Ling; Dai, Fa-Hui; Liu, Yi; Wang, Qi-Min; Zheng, Jiao-Jiao; Xu, Lin; Holmes, Edward C.; Zhang, Yong-Zhen</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">7798</span>),
    <span class="NLM_cas:pages">265-269</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health.  Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty.  A severe respiratory disease was recently reported in Wuhan, Hubei province, China.  As of 25 Jan. 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 Dec. 2019.  Epidemiol. investigations have suggested that the outbreak was assocd. with a seafood market in Wuhan.  Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 Dec. 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough.  Metagenomic RNA sequencing of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here 'WH-Human 1' coronavirus (and has also been referred to as '2019-nCoV').  Phylogenetic anal. of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China.  This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5h_VHfuDuTbVg90H21EOLACvtfcHk0lgKZJwEtrM5QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksFKlsLc%253D&md5=0163a684829e880a0c3347e19f0ce52a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2008-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2008-3%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DY.%2BM.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DZ.%2BG.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DTao%26aufirst%3DZ.%2BW.%26aulast%3DTian%26aufirst%3DJ.%2BH.%26aulast%3DPei%26aufirst%3DY.%2BY.%26aulast%3DYuan%26aufirst%3DM.%2BL.%26aulast%3DZhang%26aufirst%3DY.%2BL.%26aulast%3DDai%26aufirst%3DF.%2BH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DHolmes%26aufirst%3DE.%2BC.%26aulast%3DZhang%26aufirst%3DY.%2BZ.%26atitle%3DA%2520new%2520coronavirus%2520associated%2520with%2520human%2520respiratory%2520disease%2520in%2520China%26jtitle%3DNature%26date%3D2020%26volume%3D579%26issue%3D7798%26spage%3D265%26epage%3D269%26doi%3D10.1038%2Fs41586-020-2008-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kok, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span> <span> </span><span class="NLM_article-title">Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1080/22221751.2020.1719902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F22221751.2020.1719902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31987001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFOktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=221-236&issue=1&author=J.+F.+Chanauthor=K.+H.+Kokauthor=Z.+Zhuauthor=H.+Chuauthor=K.+K.+Toauthor=S.+Yuanauthor=K.+Y.+Yuen&title=Genomic+characterization+of+the+2019+novel+human-pathogenic+coronavirus+isolated+from+a+patient+with+atypical+pneumonia+after+visiting+Wuhan&doi=10.1080%2F22221751.2020.1719902"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</span></div><div class="casAuthors">Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Zhu, Zheng; Chu, Hin; To, Kelvin Kai-Wang; Yuan, Shuofeng; Yuen, Kwok-Yung</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Microbes & Infections</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">221-236</span>CODEN:
                <span class="NLM_cas:coden">EMIMC4</span>;
        ISSN:<span class="NLM_cas:issn">2222-1751</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China.  Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health Organization.  We performed bioinformatics anal. on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes.  Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV.  The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses.  However, the external subdomain of Spike's receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses.  Remarkably, its orf3b encodes a completely novel short protein.  Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet(s) contg. six strands.  Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus.  These findings provide the basis for starting further studies on the pathogenesis, and optimizing the design of diagnostic, antiviral and vaccination strategies for this emerging infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2BxE9eKNpaLVg90H21EOLACvtfcHk0lgKZJwEtrM5QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFOktLg%253D&md5=1ff0b451da73344406c7485aa5018a45</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F22221751.2020.1719902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F22221751.2020.1719902%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DKok%26aufirst%3DK.%2BH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChu%26aufirst%3DH.%26aulast%3DTo%26aufirst%3DK.%2BK.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26atitle%3DGenomic%2520characterization%2520of%2520the%25202019%2520novel%2520human-pathogenic%2520coronavirus%2520isolated%2520from%2520a%2520patient%2520with%2520atypical%2520pneumonia%2520after%2520visiting%2520Wuhan%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2020%26volume%3D9%26issue%3D1%26spage%3D221%26epage%3D236%26doi%3D10.1080%2F22221751.2020.1719902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morse, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalonde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. R.</span></span> <span> </span><span class="NLM_article-title">Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1002/cbic.202000047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcbic.202000047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32022370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1ans74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=730-738&issue=5&author=J.+S.+Morseauthor=T.+Lalondeauthor=S.+Xuauthor=W.+R.+Liu&title=Learning+from+the+past%3A+Possible+urgent+prevention+and+treatment+options+for+severe+acute+respiratory+infections+caused+by+2019-nCoV&doi=10.1002%2Fcbic.202000047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV</span></div><div class="casAuthors">Morse, Jared S.; Lalonde, Tyler; Xu, Shiqing; Liu, Wenshe Ray</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  With the current trajectory of the 2019-nCoV outbreak unknown, public health and medicinal measures will both be needed to contain spreading of the virus and to optimize patient outcomes.  Although little is known about the virus, an examn. of the genome sequence shows strong homol. with its better-studied cousin, SARS-CoV.  The spike protein used for host cell infection shows key nonsynonymous mutations that might hamper the efficacy of previously developed therapeutics but remains a viable target for the development of biologics and macrocyclic peptides.  Other key drug targets, including RNA-dependent RNA polymerase and coronavirus main proteinase (3CLpro), share a strikingly high (>95 %) homol. to SARS-CoV.  Herein, we suggest four potential drug candidates (an ACE2-based peptide, remdesivir, 3CLpro-1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019-nCoV.  We also summarize previous efforts into drugging these targets and hope to help in the development of broad-spectrum anti-coronaviral agents for future epidemics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQKe18V4rt9rVg90H21EOLACvtfcHk0li60PXdHG8e8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1ans74%253D&md5=57c88df2259222d0a25a545493c66630</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fcbic.202000047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.202000047%26sid%3Dliteratum%253Aachs%26aulast%3DMorse%26aufirst%3DJ.%2BS.%26aulast%3DLalonde%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%2BR.%26atitle%3DLearning%2520from%2520the%2520past%253A%2520Possible%2520urgent%2520prevention%2520and%2520treatment%2520options%2520for%2520severe%2520acute%2520respiratory%2520infections%2520caused%2520by%25202019-nCoV%26jtitle%3DChemBioChem%26date%3D2020%26volume%3D21%26issue%3D5%26spage%3D730%26epage%3D738%26doi%3D10.1002%2Fcbic.202000047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zumla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azhar, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span> <span> </span><span class="NLM_article-title">Coronaviruses - drug discovery and therapeutic options</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1038/nrd.2015.37</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnrd.2015.37" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26868298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVyru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=327-347&issue=5&author=A.+Zumlaauthor=J.+F.+Chanauthor=E.+I.+Azharauthor=D.+S.+Huiauthor=K.+Y.+Yuen&title=Coronaviruses+-+drug+discovery+and+therapeutic+options&doi=10.1038%2Fnrd.2015.37"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Coronaviruses - drug discovery and therapeutic options</span></div><div class="casAuthors">Zumla, Alimuddin; Chan, Jasper F. W.; Azhar, Esam I.; Hui, David S. C.; Yuen, Kwok-Yung</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">327-347</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In humans, infections with the human coronavirus (HCoV) strains HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 usually result in mild, self-limiting upper respiratory tract infections, such as the common cold.  By contrast, the CoVs responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), which were discovered in Hong Kong, China, in 2003, and in Saudi Arabia in 2012, resp., have received global attention over the past 12 years owing to their ability to cause community and health-care-assocd. outbreaks of severe infections in human populations.  These two viruses pose major challenges to clin. management because there are no specific antiviral drugs available.  In this Review, we summarize the epidemiol., virol., clin. features and current treatment strategies of SARS and MERS, and discuss the discovery and development of new virus-based and host-based therapeutic options for CoV infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIRcMBSEE637Vg90H21EOLACvtfcHk0li60PXdHG8e8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVyru70%253D&md5=437159fc2f3885395268bd6d97e34a0b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2015.37&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2015.37%26sid%3Dliteratum%253Aachs%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DAzhar%26aufirst%3DE.%2BI.%26aulast%3DHui%26aufirst%3DD.%2BS.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26atitle%3DCoronaviruses%2520-%2520drug%2520discovery%2520and%2520therapeutic%2520options%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26issue%3D5%26spage%3D327%26epage%3D347%26doi%3D10.1038%2Fnrd.2015.37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleine-Weber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erichsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiergens, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitsche, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cell.2020.02.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32142651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktl2qtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=271-280&issue=2&author=M.+Hoffmannauthor=H.+Kleine-Weberauthor=S.+Schroederauthor=N.+Krugerauthor=T.+Herrlerauthor=S.+Erichsenauthor=T.+S.+Schiergensauthor=G.+Herrlerauthor=N.+H.+Wuauthor=A.+Nitscheauthor=M.+A.+Mullerauthor=C.+Drostenauthor=S.+Pohlmann&title=SARS-CoV-2+cell+entry+depends+on+ACE2+and+TMPRSS2+and+is+blocked+by+a+clinically+proven+protease+inhibitor&doi=10.1016%2Fj.cell.2020.02.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</span></div><div class="casAuthors">Hoffmann, Markus; Kleine-Weber, Hannah; Schroeder, Simon; Krueger, Nadine; Herrler, Tanja; Erichsen, Sandra; Schiergens, Tobias S.; Herrler, Georg; Wu, Nai-Huei; Nitsche, Andreas; Mueller, Marcel A.; Drosten, Christian; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-280.e8</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency.  Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases.  Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets.  Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming.  A TMPRSS2 inhibitor approved for clin. use blocked entry and might constitute a treatment option.  Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry.  Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq92X1lVQaLirVg90H21EOLACvtfcHk0li60PXdHG8e8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktl2qtb8%253D&md5=60aea5c939a2d4df034a91d6198fb3ef</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DKleine-Weber%26aufirst%3DH.%26aulast%3DSchroeder%26aufirst%3DS.%26aulast%3DKruger%26aufirst%3DN.%26aulast%3DHerrler%26aufirst%3DT.%26aulast%3DErichsen%26aufirst%3DS.%26aulast%3DSchiergens%26aufirst%3DT.%2BS.%26aulast%3DHerrler%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DN.%2BH.%26aulast%3DNitsche%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DSARS-CoV-2%2520cell%2520entry%2520depends%2520on%2520ACE2%2520and%2520TMPRSS2%2520and%2520is%2520blocked%2520by%2520a%2520clinically%2520proven%2520protease%2520inhibitor%26jtitle%3DCell%26date%3D2020%26volume%3D181%26issue%3D2%26spage%3D271%26epage%3D280%26doi%3D10.1016%2Fj.cell.2020.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qinfen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinming, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiaojun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huanying, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jicheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunpeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jingqiang, Z.</span></span> <span> </span><span class="NLM_article-title">The life cycle of SARS coronavirus in Vero E6 cells</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1002/jmv.20095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fjmv.20095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15170625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ntFKmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2004&pages=332-337&issue=3&author=Z.+Qinfenauthor=C.+Jinmingauthor=H.+Xiaojunauthor=Z.+Huanyingauthor=H.+Jichengauthor=F.+Lingauthor=L.+Kunpengauthor=Z.+Jingqiang&title=The+life+cycle+of+SARS+coronavirus+in+Vero+E6+cells&doi=10.1002%2Fjmv.20095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The life cycle of SARS coronavirus in Vero E6 cells</span></div><div class="casAuthors">Qinfen Zhang; Jinming Cui; Xiaojun Huang; Huanying Zheng; Jicheng Huang; Ling Fang; Kunpeng Li; Jingqiang Zhang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">332-7</span>
        ISSN:<span class="NLM_cas:issn">0146-6615</span>.
    </div><div class="casAbstract">The aim of the study was to establish the life cycle of severe acute respiratory syndrome-associated coronavirus (SARS CoV) in host cells and determine the pathogenesis of SARS.  Vero E6 cells (African green monkey kidney cells) were inoculated with SARS coronavirus for 3, 7, 24, 48, and 72 hr, respectively, and were observed under electron microscope.  It was found that the SARS coronavirus entered the cells through membrane fusion instead of endocytosis, and then the nucleocapsids assembled in the RER and matured by budding into the smooth vesicles, which were derived from the Golgi apparatus.  The smooth vesicles fused with the cell membrane, and the mature particles were released.  A special phenomenon was that some virus-like particles appeared in the nucleus.  We propose a scheme of the life cycle of SARS coronavirus and discuss the mechanism of its replication in Vero E6 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQe2FWOfRZpaDdblLE_E9PWfW6udTcc2eY9veVHtSJ9ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ntFKmtQ%253D%253D&md5=427a5d7bd75272c572e950e871257e70</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fjmv.20095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.20095%26sid%3Dliteratum%253Aachs%26aulast%3DQinfen%26aufirst%3DZ.%26aulast%3DJinming%26aufirst%3DC.%26aulast%3DXiaojun%26aufirst%3DH.%26aulast%3DHuanying%26aufirst%3DZ.%26aulast%3DJicheng%26aufirst%3DH.%26aulast%3DLing%26aufirst%3DF.%26aulast%3DKunpeng%26aufirst%3DL.%26aulast%3DJingqiang%26aufirst%3DZ.%26atitle%3DThe%2520life%2520cycle%2520of%2520SARS%2520coronavirus%2520in%2520Vero%2520E6%2520cells%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2004%26volume%3D73%26issue%3D3%26spage%3D332%26epage%3D337%26doi%3D10.1002%2Fjmv.20095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooi, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, A. E.</span></span> <span> </span><span class="NLM_article-title">Early events of SARS coronavirus infection in Vero cells</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1002/jmv.10499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fjmv.10499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=12966536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BD3svisFKmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2003&pages=323-331&issue=3&author=M.+L.+Ngauthor=S.+H.+Tanauthor=E.+E.+Seeauthor=E.+E.+Ooiauthor=A.+E.+Ling&title=Early+events+of+SARS+coronavirus+infection+in+Vero+cells&doi=10.1002%2Fjmv.10499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Early events of SARS coronavirus infection in vero cells</span></div><div class="casAuthors">Ng M L; Tan S H; See E E; Ooi E E; Ling A E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medical virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-31</span>
        ISSN:<span class="NLM_cas:issn">0146-6615</span>.
    </div><div class="casAbstract">An isolate from a patient in the recent severe acute respiratory syndrome (SARS) outbreak in Singapore was used to infect Vero E6 cells.  This study concentrated on the first 30 min of infection.  It was discovered that the SARS coronavirus attached, entered, and uncoated the nucleocapsids, all within a 30-min period.  At 5 min after infection, several virus particles lined the Vero cell plasma membrane.  Virus particles were at various stages of fusion at the cell surface, since entry was not a synchronised process.  After entry (10 and 15 min), spherical core particles moved into the cytoplasm within large vacuoles.  Quite surprising at such early stages of infection (20 min), a virus-induced change in the infected cells was evident.  The induction of myelin-like membrane whorls was obvious within the same vacuoles as the core particles.  The significance of this virus-induced change is unknown at this stage.  By 25-30 min postinfection (p.i.), the spherical core particles appeared to be disassociating and, in their place, doughnut-shaped electron-dense structures were observed.  These could be the virus genomes together with the helical nucleocapsids.  They were no longer in large vacuoles but packaged into smaller vacuoles in the cytoplasm, and occasionally in small groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUMb0kI7yUv7JzI8owOhpDfW6udTcc2eZD2QXGFiSXiLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svisFKmtQ%253D%253D&md5=042b91742c8e8925e538172f6c8c2f80</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fjmv.10499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.10499%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DM.%2BL.%26aulast%3DTan%26aufirst%3DS.%2BH.%26aulast%3DSee%26aufirst%3DE.%2BE.%26aulast%3DOoi%26aufirst%3DE.%2BE.%26aulast%3DLing%26aufirst%3DA.%2BE.%26atitle%3DEarly%2520events%2520of%2520SARS%2520coronavirus%2520infection%2520in%2520Vero%2520cells%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2003%26volume%3D71%26issue%3D3%26spage%3D323%26epage%3D331%26doi%3D10.1002%2Fjmv.10499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span> <span> </span><span class="NLM_article-title">SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1038/cr.2008.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fcr.2008.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18227861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1OmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=290-301&issue=2&author=H.+Wangauthor=P.+Yangauthor=K.+Liuauthor=F.+Guoauthor=Y.+Zhangauthor=G.+Zhangauthor=C.+Jiang&title=SARS+coronavirus+entry+into+host+cells+through+a+novel+clathrin-+and+caveolae-independent+endocytic+pathway&doi=10.1038%2Fcr.2008.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway</span></div><div class="casAuthors">Wang, Hongliang; Yang, Peng; Liu, Kangtai; Guo, Feng; Zhang, Yanli; Zhang, Gongyi; Jiang, Chengyu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">290-301</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">While severe acute respiratory syndrome coronavirus (SARS-CoV) was initially thought to enter cells through direct fusion with the plasma membrane, more recent evidence suggests that virus entry may also involve endocytosis.  We have found that SARS-CoV enters cells via pH- and receptor-dependent endocytosis.  Treatment of cells with either SARS-CoV spike protein or spike-bearing pseudoviruses resulted in the translocation of angiotensin-converting enzyme 2 (ACE2), the functional receptor of SARS-CoV, from the cell surface to endosomes.  In addn., the spike-bearing pseudoviruses and early endosome antigen 1 were found to colocalize in endosomes.  Further analyses using specific endocytic pathway inhibitors and dominant-neg. Eps15 as well as caveolin-1 colocalization study suggested that virus entry was mediated by a clathrin- and caveolae-independent mechanism.  Moreover, cholesterol- and sphingolipid-rich lipid raft microdomains in the plasma membrane, which have been shown to act as platforms for many physiol. signaling pathways, were shown to be involved in virus entry.  Endocytic entry of SARS-CoV may expand the cellular range of SARS-CoV infection, and our findings here contribute to the understanding of SARS-CoV pathogenesis, providing new information for anti-viral drug research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSu75e3vYMcLVg90H21EOLACvtfcHk0lhpfWY6FeNyLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1OmtLc%253D&md5=28ce193edc17b23d4b4348e1d400501f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fcr.2008.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2008.15%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DC.%26atitle%3DSARS%2520coronavirus%2520entry%2520into%2520host%2520cells%2520through%2520a%2520novel%2520clathrin-%2520and%2520caveolae-independent%2520endocytic%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2008%26volume%3D18%26issue%3D2%26spage%3D290%26epage%3D301%26doi%3D10.1038%2Fcr.2008.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span> <span> </span><span class="NLM_article-title">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span> (<span class="NLM_issue">10223</span>),  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)30183-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2930183-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31986264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1Kqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=497-506&issue=10223&author=C.+Huangauthor=Y.+Wangauthor=X.+Liauthor=L.+Renauthor=J.+Zhaoauthor=Y.+Huauthor=L.+Zhangauthor=G.+Fanauthor=J.+Xuauthor=X.+Guauthor=Z.+Chengauthor=T.+Yuauthor=J.+Xiaauthor=Y.+Weiauthor=W.+Wuauthor=X.+Xieauthor=W.+Yinauthor=H.+Liauthor=M.+Liuauthor=Y.+Xiaoauthor=H.+Gaoauthor=L.+Guoauthor=J.+Xieauthor=G.+Wangauthor=R.+Jiangauthor=Z.+Gaoauthor=Q.+Jinauthor=J.+Wangauthor=B.+Cao&title=Clinical+features+of+patients+infected+with+2019+novel+coronavirus+in+Wuhan%2C+China&doi=10.1016%2FS0140-6736%2820%2930183-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</span></div><div class="casAuthors">Huang, Chaolin; Wang, Yeming; Li, Xingwang; Ren, Lili; Zhao, Jianping; Hu, Yi; Zhang, Li; Fan, Guohui; Xu, Jiuyang; Gu, Xiaoying; Cheng, Zhenshun; Yu, Ting; Xia, Jiaan; Wei, Yuan; Wu, Wenjuan; Xie, Xuelei; Yin, Wen; Li, Hui; Liu, Min; Xiao, Yan; Gao, Hong; Guo, Li; Xie, Jungang; Wang, Guangfa; Jiang, Rongmeng; Gao, Zhancheng; Jin, Qi; Wang, Jianwei; Cao, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10223</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV).  We report the epidemiol., clin., lab., and radiol. characteristics and treatment and clin. outcomes of these patients.  All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan.  We prospectively collected and analyzed data on patients with lab.-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing.  Data were obtained with standardised data collection forms shared by the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records.  Researchers also directly communicated with patients or their families to ascertain epidemiol. and symptom data.  Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not.  By Jan 2, 2020, 41 admitted hospital patients had been identified as having lab.-confirmed 2019-nCoV infection.  Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]).  Median age was 49·0 years (IQR 41·0-58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market.  One family cluster was found.  Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum prodn. (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38).  Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0-13·0]).  26 (63%) Of 41 patients had lymphopenia.  All 41 patients had pneumonia with abnormal findings on chest CT.  Complications included acute respiratory distress syndrome (12 [29%]), RNAemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died.  Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα.  The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was assocd. with ICU admission and high mortality.  Major gaps in our knowledge of the origin, epidemiol., duration of human transmission, and clin. spectrum of disease need fulfilment by future studies.  Ministry of Science and Technol., Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technol. Commission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1VbprmL3SvLVg90H21EOLACvtfcHk0lj-lWjbg2t0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1Kqu7c%253D&md5=b279b965c1054d99e60f673859c03b49</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2930183-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252930183-5%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DB.%26atitle%3DClinical%2520features%2520of%2520patients%2520infected%2520with%25202019%2520novel%2520coronavirus%2520in%2520Wuhan%252C%2520China%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26issue%3D10223%26spage%3D497%26epage%3D506%26doi%3D10.1016%2FS0140-6736%2820%2930183-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span> <span> </span><span class="NLM_article-title">A novel coronavirus from patients with pneumonia in China, 2019</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa2001017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa2001017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31978945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjslGmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2020&pages=727-733&issue=8&author=N.+Zhuauthor=D.+Zhangauthor=W.+Wangauthor=X.+Liauthor=B.+Yangauthor=J.+Songauthor=X.+Zhaoauthor=B.+Huangauthor=W.+Shiauthor=R.+Luauthor=P.+Niuauthor=F.+Zhanauthor=X.+Maauthor=D.+Wangauthor=W.+Xuauthor=G.+Wuauthor=G.+F.+Gaoauthor=W.+Tan&title=A+novel+coronavirus+from+patients+with+pneumonia+in+China%2C+2019&doi=10.1056%2FNEJMoa2001017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A novel coronavirus from patients with pneumonia in China, 2019</span></div><div class="casAuthors">Zhu, Na; Zhang, Dingyu; Wang, Wenling; Li, Xingwang; Yang, Bo; Song, Jingdong; Zhao, Xiang; Huang, Baoying; Shi, Weifeng; Lu, Roujian; Niu, Peihua; Zhan, Faxian; Ma, Xuejun; Wang, Dayan; Xu, Wenbo; Wu, Guizhen; Gao, George F.; Tan, Wenjie</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">727-733</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">In Dec. 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China.  A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia.  Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily.  Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans.  Enhanced surveillance and further investigation are ongoing.  Complete genome sequences of the three novel coronaviruses were submitted to GISAID (BetaCoV/Wuhan/ IVDC-HB-01/2019, accession ID: EPI_ISL_402119; BetaCoV/Wuhan/IVDC-HB-04/2020, accession ID: EPI_ISL_402120; BetaCoV/Wuhan/IVDC-HB-05/2019, accession ID: EPI_ISL_402121).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoibbAn_VqfXbVg90H21EOLACvtfcHk0lj-lWjbg2t0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjslGmsrc%253D&md5=73cc5c839e1e934da69b39537063b7b3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa2001017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa2001017%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DR.%26aulast%3DNiu%26aufirst%3DP.%26aulast%3DZhan%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DGao%26aufirst%3DG.%2BF.%26aulast%3DTan%26aufirst%3DW.%26atitle%3DA%2520novel%2520coronavirus%2520from%2520patients%2520with%2520pneumonia%2520in%2520China%252C%25202019%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D382%26issue%3D8%26spage%3D727%26epage%3D733%26doi%3D10.1056%2FNEJMoa2001017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preiser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Werf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodt, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabenau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panning, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burguiere, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinatl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eickmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escriou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grywna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramme, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manuguerra, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickerts, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterhaus, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerr, H. W.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel coronavirus in patients with severe acute respiratory syndrome</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">1967</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa030747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa030747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=12690091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslajurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1967-1976&issue=20&author=C.+Drostenauthor=S.+Guntherauthor=W.+Preiserauthor=S.+van+der+Werfauthor=H.+R.+Brodtauthor=S.+Beckerauthor=H.+Rabenauauthor=M.+Panningauthor=L.+Kolesnikovaauthor=R.+A.+Fouchierauthor=A.+Bergerauthor=A.+M.+Burguiereauthor=J.+Cinatlauthor=M.+Eickmannauthor=N.+Escriouauthor=K.+Grywnaauthor=S.+Krammeauthor=J.+C.+Manuguerraauthor=S.+Mullerauthor=V.+Rickertsauthor=M.+Sturmerauthor=S.+Viethauthor=H.+D.+Klenkauthor=A.+D.+Osterhausauthor=H.+Schmitzauthor=H.+W.+Doerr&title=Identification+of+a+novel+coronavirus+in+patients+with+severe+acute+respiratory+syndrome&doi=10.1056%2FNEJMoa030747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a novel coronavirus in patients with severe acute respiratory syndrome</span></div><div class="casAuthors">Drosten, Christian; Guenther, Stephan; Preiser, Wolfgang; van der Werf, Sylvie; Brodt, Hans-Reinhard; Becker, Stephan; Rabenau, Holger; Panning, Marcus; Kolesnikova, Larissa; Fouchier, Ron A. M.; Berger, Annemarie; Burguiere, Ana-Maria; Cinatl, Jindrich; Eickmann, Markus; Escriou, Nicolas; Grywna, Klaus; Kramme, Stefanie; Manuguerra, Jean-Claude; Mueller, Stefanie; Rickerts, Volker; Stuermer, Martin; Vieth, Simon; Klenk, Hans-Dieter; Osterhaus, Albert D. M. E.; Schmitz, Herbert; Doerr, Hans Wilheim</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1967-1976</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The severe acute respiratory syndrome (SARS) has recently been identified as a new clin. entity.  SARS is thought to be caused by an unknown infectious agent.  Clin. specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and mol. techniques.  A novel coronavirus was identified in patients with SARS.  The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a PCR (PCR)-based random-amplification procedure.  Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60% of the nucleotide sequence).  On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established.  Virus was detected in a variety of clin. specimens from patients with SARS but not in controls.  High concns. of viral RNA of up to 100 million mols. per mL were found in sputum.  Viral RNA was also detected at extremely low concns. in plasma during the acute phase and in feces during the late convalescent phase.  Infected patients showed seroconversion on the Vero cells in which the virus was isolated.  The novel coronavirus might have a role in causing SARS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqN8uHpwOG07Vg90H21EOLACvtfcHk0lgQeKixsIGXfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslajurw%253D&md5=3838a7a01273f688e53dc86088bfa9db</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030747%26sid%3Dliteratum%253Aachs%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DPreiser%26aufirst%3DW.%26aulast%3Dvan%2Bder%2BWerf%26aufirst%3DS.%26aulast%3DBrodt%26aufirst%3DH.%2BR.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DRabenau%26aufirst%3DH.%26aulast%3DPanning%26aufirst%3DM.%26aulast%3DKolesnikova%26aufirst%3DL.%26aulast%3DFouchier%26aufirst%3DR.%2BA.%26aulast%3DBerger%26aufirst%3DA.%26aulast%3DBurguiere%26aufirst%3DA.%2BM.%26aulast%3DCinatl%26aufirst%3DJ.%26aulast%3DEickmann%26aufirst%3DM.%26aulast%3DEscriou%26aufirst%3DN.%26aulast%3DGrywna%26aufirst%3DK.%26aulast%3DKramme%26aufirst%3DS.%26aulast%3DManuguerra%26aufirst%3DJ.%2BC.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DRickerts%26aufirst%3DV.%26aulast%3DSturmer%26aufirst%3DM.%26aulast%3DVieth%26aufirst%3DS.%26aulast%3DKlenk%26aufirst%3DH.%2BD.%26aulast%3DOsterhaus%26aufirst%3DA.%2BD.%26aulast%3DSchmitz%26aufirst%3DH.%26aulast%3DDoerr%26aufirst%3DH.%2BW.%26atitle%3DIdentification%2520of%2520a%2520novel%2520coronavirus%2520in%2520patients%2520with%2520severe%2520acute%2520respiratory%2520syndrome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26issue%3D20%26spage%3D1967%26epage%3D1976%26doi%3D10.1056%2FNEJMoa030747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ksiazek, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaki, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peret, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollin, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, A.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guarner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paddock, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rota, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeRisi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeDuc, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellini, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span> <span> </span><span class="NLM_article-title">A novel coronavirus associated with severe acute respiratory syndrome</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>348</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">1953</span>– <span class="NLM_lpage">1966</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa030781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa030781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=12690092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslajtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1953-1966&issue=20&author=T.+G.+Ksiazekauthor=D.+Erdmanauthor=C.+S.+Goldsmithauthor=S.+R.+Zakiauthor=T.+Peretauthor=S.+Emeryauthor=S.+Tongauthor=C.+Urbaniauthor=J.+A.+Comerauthor=W.+Limauthor=P.+E.+Rollinauthor=S.+F.+Dowellauthor=A.-E.+Lingauthor=C.+D.+Humphreyauthor=W.-J.+Shiehauthor=J.+Guarnerauthor=C.+D.+Paddockauthor=P.+Rotaauthor=B.+Fieldsauthor=J.+DeRisiauthor=J.-Y.+Yangauthor=N.+Coxauthor=J.+M.+Hughesauthor=J.+W.+LeDucauthor=W.+J.+Belliniauthor=L.+J.+Anderson&title=A+novel+coronavirus+associated+with+severe+acute+respiratory+syndrome&doi=10.1056%2FNEJMoa030781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel coronavirus associated with severe acute respiratory syndrome</span></div><div class="casAuthors">Ksiazek, Thomas G.; Erdman, Dean; Goldsmith, Cynthia S.; Zaki, Sherif R.; Peret, Teresa; Emery, Shannon; Tong, Suxiang; Urbani, Carlo; Comer, James A.; Lim, Wilina; Rollin, Pierre E.; Dowell, Scott F.; Ling, Ai-Ee; Humphrey, Charles D.; Shieh, Wan-Ju; Guarner, Jeannette; Paddock, Christopher D.; Rota, Paul; Fields, Barry; DeRisi, Joseph; Yang, Jyh-Yuan; Cox, Nancy; Hughes, James M.; LeDuc, James W.; Bellini, William J.; Anderson, Larry J.; Cannon, A. D. L.; Curtis, M.; Farrar, B.; Morgan, L.; Pezzanite, L.; Sanchez, A. J.; Slaughter, K. A.; Stevens, T. L.; Stockton, P. C.; Wagoner, K. D.; Sanchez, A.; Nichol, S.; Vincent, M.; Osborne, J.; Honig, J.; Brickson, B. R.; Holloway, B.; McCaustland, K.; Lingappa, J.; Lowe, L.; Scott, S.; Lu, X.; Villamarzo, Y.; Cook, B.; Chen, Q.; Birge, C.; Shu, B.; Pallansch, M.; Tatti, K. M.; Morken, T.; Smith, C.; Greer, P.; White, E.; McGlothen, T.; Bhatnagar, J.; Patel, M.; Bartlett, J.; Montague, J.; Lee, W.; Packard, M.; Thompson, H. A.; Moen, A.; Fukuda, K.; Uyeki, T.; Harper, S.; Klimov, A.; Lindstrom, S.; Benson, R.; Carlone, G.; Facklam, R.; Fields, P.; Levett, P.; Mayer, L.; Talkington, D.; Thacker, W. L.; Tondella, M. L. C.; Whitney, C.; Robertson, B.; Warnock, D.; Brooks, T.; Schrag, S.; Rosenstein, N.; Arthur, R.; Ganem, D.; Poutanen, S. M.; Chen, T.-J.; Hsiao, C.-H.; Wai-Fu, N. G.; Ho, M.; Keung, T.-K.; Nghiem, K. H.; Nguyen, H. K. L.; Le, M. Q.; Nguyen, H. H. T.; Hoang, L. T.; Vu, T. H.; Vu, H. Q.; Chunsuttiwat, S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1953-1966</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A worldwide outbreak of severe acute respiratory syndrome (SARS) was assocd. with exposures originating from a single ill health care worker from Guangdong Province, China.  We conducted studies to identify the etiol. agent of this outbreak.  We received clin. specimens from patients in 7 countries and tested them, using virus-isolation techniques, electron-microscopical and histol. studies, and mol. and serol. assays, in an attempt to identify a wide range of potential pathogens.  None of the previously described respiratory pathogens were consistently identified.  However, a novel coronavirus was isolated from patients who met the case definition of SARS.  Cytopathol. features were noted in Vero E6 cells inoculated with a throat-swab specimen.  Electron-microscopical examn. revealed ultrastructural features characteristic of coronaviruses.  Immunohistochem. and immunofluorescence staining revealed reactivity with group I coronavirus polyclonal antibodies.  Consensus coronavirus primers designed to amplify a fragment of the polymerase gene by reverse transcription-polymerase chain reaction (RT-PCR) were used to obtain a sequence that clearly identified the isolate as a unique coronavirus only distantly related to previously sequenced coronaviruses.  With specific diagnostic RT-PCR primers the authors identified several identical nucleotide sequences in 12 patients from several locations, a finding consistent with a point-source outbreak.  Indirect fluorescence antibody tests and enzyme-linked immunosorbent assays made with the new isolate were used to demonstrate a virus-specific serol. response.  This virus may never before have circulated in the U.S. population.  Conclusions: A novel coronavirus is assocd. with this outbreak, and the evidence indicates that this virus has an etiol. role in SARS.  Because of the death of Dr. Carlo Urbani, the authors propose that this first isolate be named the Urbani strain of SARS-assocd. coronavirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDbaKH5pboQbVg90H21EOLACvtfcHk0lgQeKixsIGXfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslajtbk%253D&md5=2116912733cd023a05c440dd1e53f174</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030781%26sid%3Dliteratum%253Aachs%26aulast%3DKsiazek%26aufirst%3DT.%2BG.%26aulast%3DErdman%26aufirst%3DD.%26aulast%3DGoldsmith%26aufirst%3DC.%2BS.%26aulast%3DZaki%26aufirst%3DS.%2BR.%26aulast%3DPeret%26aufirst%3DT.%26aulast%3DEmery%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DS.%26aulast%3DUrbani%26aufirst%3DC.%26aulast%3DComer%26aufirst%3DJ.%2BA.%26aulast%3DLim%26aufirst%3DW.%26aulast%3DRollin%26aufirst%3DP.%2BE.%26aulast%3DDowell%26aufirst%3DS.%2BF.%26aulast%3DLing%26aufirst%3DA.-E.%26aulast%3DHumphrey%26aufirst%3DC.%2BD.%26aulast%3DShieh%26aufirst%3DW.-J.%26aulast%3DGuarner%26aufirst%3DJ.%26aulast%3DPaddock%26aufirst%3DC.%2BD.%26aulast%3DRota%26aufirst%3DP.%26aulast%3DFields%26aufirst%3DB.%26aulast%3DDeRisi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.-Y.%26aulast%3DCox%26aufirst%3DN.%26aulast%3DHughes%26aufirst%3DJ.%2BM.%26aulast%3DLeDuc%26aufirst%3DJ.%2BW.%26aulast%3DBellini%26aufirst%3DW.%2BJ.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26atitle%3DA%2520novel%2520coronavirus%2520associated%2520with%2520severe%2520acute%2520respiratory%2520syndrome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26issue%3D20%26spage%3D1953%26epage%3D1966%26doi%3D10.1056%2FNEJMoa030781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaki, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Boheemen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestebroer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osterhaus, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fouchier, R. A.</span></span> <span> </span><span class="NLM_article-title">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1814</span>– <span class="NLM_lpage">1820</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1211721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa1211721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23075143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=1814-1820&issue=19&author=A.+M.+Zakiauthor=S.+van+Boheemenauthor=T.+M.+Bestebroerauthor=A.+D.+Osterhausauthor=R.+A.+Fouchier&title=Isolation+of+a+novel+coronavirus+from+a+man+with+pneumonia+in+Saudi+Arabia&doi=10.1056%2FNEJMoa1211721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</span></div><div class="casAuthors">Zaki, Ali Moh; van Boheemen, Sander; Bestebroer, Theo M.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1814-1820</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A previously unknown coronavirus was isolated from the sputum of a 60-yr-old man who presented with acute pneumonia and subsequent renal failure with a fatal outcome in Saudi Arabia.  The virus (called HCoV-EMC) replicated readily in cell culture, producing cytopathic effects of rounding, detachment, and syncytium formation.  The virus represents a novel betacoronavirus species.  The closest known relatives are bat coronaviruses HKU4 and HKU5.  Here, the clin. data, virus isolation, and mol. identification are presented.  The clin. picture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 2003 and reminds us that animal coronaviruses can cause severe disease in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzvqXZfyam-bVg90H21EOLACvtfcHk0lhT8G0IVU9G2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73P&md5=4fc960f8008c5a4b76a08fbdeb224ac8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1211721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1211721%26sid%3Dliteratum%253Aachs%26aulast%3DZaki%26aufirst%3DA.%2BM.%26aulast%3Dvan%2BBoheemen%26aufirst%3DS.%26aulast%3DBestebroer%26aufirst%3DT.%2BM.%26aulast%3DOsterhaus%26aufirst%3DA.%2BD.%26aulast%3DFouchier%26aufirst%3DR.%2BA.%26atitle%3DIsolation%2520of%2520a%2520novel%2520coronavirus%2520from%2520a%2520man%2520with%2520pneumonia%2520in%2520Saudi%2520Arabia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26issue%3D19%26spage%3D1814%26epage%3D1820%26doi%3D10.1056%2FNEJMoa1211721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millet, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, G. R.</span></span> <span> </span><span class="NLM_article-title">Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">15214</span>– <span class="NLM_lpage">15219</span>, <span class="refDoi"> DOI: 10.1073/pnas.1407087111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1407087111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25288733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yhtb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=15214-15219&issue=42&author=J.+K.+Milletauthor=G.+R.+Whittaker&title=Host+cell+entry+of+Middle+East+respiratory+syndrome+coronavirus+after+two-step%2C+furin-mediated+activation+of+the+spike+protein&doi=10.1073%2Fpnas.1407087111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein</span></div><div class="casAuthors">Millet, Jean Kaoru; Whittaker, Gary R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">15214-15219</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly identified betacoronavirus causing high morbidity and mortality in humans.  The coronavirus spike (S) protein is the main determinant of viral entry, and although it was previously shown that MERS-CoV S can be activated by various proteases, the details of the mechanisms of proteolytic activation of fusion are still incompletely characterized.  Here, we have uncovered distinctive characteristics of MERS-CoV S.  We identify, by bioinformatics and peptide cleavage assays, two cleavage sites for furin, a ubiquitously expressed protease, which are located at the S1/S2 interface and at the S2' position of the S protein.  We show that although the S1/S2 site is proteolytically processed by furin during protein biosynthesis, the S2' site is cleaved upon viral entry.  MERS-CoV pseudovirion infection was shown to be enhanced by elevated levels of furin expression, and entry could be decreased by furin siRNA silencing.  Enhanced furin activity appeared to partially override the low pH-dependent nature of MERS-CoV entry.  Inhibition of furin activity was shown to decrease MERS-CoV S-mediated entry, as well as infection by the virus.  Overall, we show that MERS-CoV has evolved an unusual two-step furin activation for fusion, suggestive of a role during the process of emergence into the human population.  The ability of MERS-CoV to use furin in this manner, along with other proteases, may explain the polytropic nature of the virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs39E8QqNtEbVg90H21EOLACvtfcHk0lhT8G0IVU9G2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yhtb7E&md5=21bea9924d802dd56de1dac9d38bd509</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1407087111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1407087111%26sid%3Dliteratum%253Aachs%26aulast%3DMillet%26aufirst%3DJ.%2BK.%26aulast%3DWhittaker%26aufirst%3DG.%2BR.%26atitle%3DHost%2520cell%2520entry%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520after%2520two-step%252C%2520furin-mediated%2520activation%2520of%2520the%2520spike%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D42%26spage%3D15214%26epage%3D15219%26doi%3D10.1073%2Fpnas.1407087111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habjan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heurich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gierer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glowacka, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann-Winkler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">6150</span>– <span class="NLM_lpage">6160</span>, <span class="refDoi"> DOI: 10.1128/JVI.03372-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.03372-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23536651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFaktrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=6150-6160&issue=11&author=S.+Bertramauthor=R.+Dijkmanauthor=M.+Habjanauthor=A.+Heurichauthor=S.+Giererauthor=I.+Glowackaauthor=K.+Welschauthor=M.+Winklerauthor=H.+Schneiderauthor=H.+Hofmann-Winklerauthor=V.+Thielauthor=S.+Pohlmann&title=TMPRSS2+activates+the+human+coronavirus+229E+for+cathepsin-independent+host+cell+entry+and+is+expressed+in+viral+target+cells+in+the+respiratory+epithelium&doi=10.1128%2FJVI.03372-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium</span></div><div class="casAuthors">Bertram, Stephanie; Dijkman, Ronald; Habjan, Matthias; Heurich, Adeline; Gierer, Stefanie; Glowacka, Ilona; Welsch, Kathrin; Winkler, Michael; Schneider, Heike; Hofmann-Winkler, Heike; Thiel, Volker; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6150-6160</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Infection with human coronavirus 229E (HCoV-229E) is assocd. with the common cold and may result in pneumonia in immunocompromised patients.  The viral spike (S) protein is incorporated into the viral envelope and mediates infectious entry of HCoV-229E into host cells, a process that depends on the activation of the S-protein by host cell proteases.  However, the proteases responsible for HCoV-229E activation are incompletely defined.  Here we show that the type II transmembrane serine proteases TMPRSS2 and HAT cleave the HCoV-229E S-protein (229E-S) and augment 229E-S-driven cell-cell fusion, suggesting that TMPRSS2 and HAT can activate 229E-S.  Indeed, engineered expression of TMPRSS2 and HAT rendered 229E-S-driven virus-cell fusion insensitive to an inhibitor of cathepsin L, a protease previously shown to facilitate HCoV-229E infection.  Inhibition of endogenous cathepsin L or TMPRSS2 demonstrated that both proteases can activate 229E-S for entry into cells that are naturally susceptible to infection.  In addn., evidence was obtained that activation by TMPRSS2 rescues 229E-S-dependent cell entry from inhibition by IFITM proteins.  Finally, immunohistochem. revealed that TMPRSS2 is coexpressed with CD13, the HCoV-229E receptor, in human airway epithelial (HAE) cells, and that CD13+ TMPRSS2+ cells are preferentially targeted by HCoV-229E, suggesting that TMPRSS2 can activate HCoV-229E in infected humans.  In sum, our results indicate that HCoV-229E can employ redundant proteolytic pathways to ensure its activation in host cells.  In addn., our observations and previous work suggest that diverse human respiratory viruses are activated by TMPRSS2, which may constitute a target for antiviral intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvA0mnqiPuHbVg90H21EOLACvtfcHk0lgga4YR_iZumg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFaktrbI&md5=5186c4b9b7eb87684c1034a371dec4cb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FJVI.03372-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.03372-12%26sid%3Dliteratum%253Aachs%26aulast%3DBertram%26aufirst%3DS.%26aulast%3DDijkman%26aufirst%3DR.%26aulast%3DHabjan%26aufirst%3DM.%26aulast%3DHeurich%26aufirst%3DA.%26aulast%3DGierer%26aufirst%3DS.%26aulast%3DGlowacka%26aufirst%3DI.%26aulast%3DWelsch%26aufirst%3DK.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DHofmann-Winkler%26aufirst%3DH.%26aulast%3DThiel%26aufirst%3DV.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DTMPRSS2%2520activates%2520the%2520human%2520coronavirus%2520229E%2520for%2520cathepsin-independent%2520host%2520cell%2520entry%2520and%2520is%2520expressed%2520in%2520viral%2520target%2520cells%2520in%2520the%2520respiratory%2520epithelium%26jtitle%3DJ.%2520Virol%26date%3D2013%26volume%3D87%26issue%3D11%26spage%3D6150%26epage%3D6160%26doi%3D10.1128%2FJVI.03372-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glowacka, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavender, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnirss, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehlmeier, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemeyer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soilleux, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahn, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">13363</span>– <span class="NLM_lpage">13372</span>, <span class="refDoi"> DOI: 10.1128/JVI.05300-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.05300-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21994442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ShsL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=13363-13372&issue=24&author=S.+Bertramauthor=I.+Glowackaauthor=M.+A.+Mullerauthor=H.+Lavenderauthor=K.+Gnirssauthor=I.+Nehlmeierauthor=D.+Niemeyerauthor=Y.+Heauthor=G.+Simmonsauthor=C.+Drostenauthor=E.+J.+Soilleuxauthor=O.+Jahnauthor=I.+Steffenauthor=S.+Pohlmann&title=Cleavage+and+activation+of+the+severe+acute+respiratory+syndrome+coronavirus+spike+protein+by+human+airway+trypsin-like+protease&doi=10.1128%2FJVI.05300-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease</span></div><div class="casAuthors">Bertram, Stephanie; Glowacka, Ilona; Mueller, Marcel A.; Lavender, Hayley; Gnirss, Kerstin; Nehlmeier, Inga; Niemeyer, Daniela; He, Yuxian; Simmons, Graham; Drosten, Christian; Soilleux, Elizabeth J.; Jahn, Olaf; Steffen, Imke; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">13363-13372</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV) poses a const. threat to human health.  The viral spike protein (SARS-S) mediates host cell entry and is a potential target for antiviral intervention.  Activation of SARS-S by host cell proteases is essential for SARS-CoV infectivity but remains incompletely understood.  Here, we analyzed the role of the type II transmembrane serine proteases (TTSPs) human airway trypsin-like protease (HAT) and transmembrane protease, serine 2 (TMPRSS2), in SARS-S activation.  We found that HAT activates SARS-S in the context of surrogate systems and authentic SARS-CoV infection and is coexpressed with the viral receptor angiotensin-converting enzyme 2 (ACE2) in bronchial epithelial cells and pneumocytes.  HAT cleaved SARS-S at R667, as detd. by mutagenesis and mass spectrometry, and activated SARS-S for cell-cell fusion in cis and trans, while the related pulmonary protease TMPRSS2 cleaved SARS-S at multiple sites and activated SARS-S only in trans.  However, TMPRSS2 but not HAT expression rendered SARS-S-driven virus-cell fusion independent of cathepsin activity, indicating that HAT and TMPRSS2 activate SARS-S differentially.  Collectively, our results show that HAT cleaves and activates SARS-S and might support viral spread in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmFYPWOkvPPbVg90H21EOLACvtfcHk0lgquLcA8DfOQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ShsL7M&md5=116e8f1e5869bf52c95d0ed50e2494e2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FJVI.05300-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.05300-11%26sid%3Dliteratum%253Aachs%26aulast%3DBertram%26aufirst%3DS.%26aulast%3DGlowacka%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DLavender%26aufirst%3DH.%26aulast%3DGnirss%26aufirst%3DK.%26aulast%3DNehlmeier%26aufirst%3DI.%26aulast%3DNiemeyer%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DSimmons%26aufirst%3DG.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DSoilleux%26aufirst%3DE.%2BJ.%26aulast%3DJahn%26aufirst%3DO.%26aulast%3DSteffen%26aufirst%3DI.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DCleavage%2520and%2520activation%2520of%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520spike%2520protein%2520by%2520human%2520airway%2520trypsin-like%2520protease%26jtitle%3DJ.%2520Virol%26date%3D2011%26volume%3D85%26issue%3D24%26spage%3D13363%26epage%3D13372%26doi%3D10.1128%2FJVI.05300-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gierer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaup, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrensch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heurich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer-Kuhl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dittmer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Hahn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">5502</span>– <span class="NLM_lpage">5511</span>, <span class="refDoi"> DOI: 10.1128/JVI.00128-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.00128-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23468491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsV2ls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=5502-5511&issue=10&author=S.+Giererauthor=S.+Bertramauthor=F.+Kaupauthor=F.+Wrenschauthor=A.+Heurichauthor=A.+Kramer-Kuhlauthor=K.+Welschauthor=M.+Winklerauthor=B.+Meyerauthor=C.+Drostenauthor=U.+Dittmerauthor=T.+von+Hahnauthor=G.+Simmonsauthor=H.+Hofmannauthor=S.+Pohlmann&title=The+spike+protein+of+the+emerging+betacoronavirus+EMC+uses+a+novel+coronavirus+receptor+for+entry%2C+can+be+activated+by+TMPRSS2%2C+and+is+targeted+by+neutralizing+antibodies&doi=10.1128%2FJVI.00128-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies</span></div><div class="casAuthors">Gierer, Stefanie; Bertram, Stephanie; Kaup, Franziska; Wrensch, Florian; Heurich, Adeline; Kraemer-Kuehl, Annika; Welsch, Kathrin; Winkler, Michael; Meyer, Benjamin; Drosten, Christian; Dittmer, Ulf; von Hahn, Thomas; Simmons, Graham; Hofmann, Heike; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5502-5511</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The novel human coronavirus EMC (hCoV-EMC), which recently emerged in Saudi Arabia, is highly pathogenic and could pose a significant threat to public health.  The elucidation of hCoV-EMC interactions with host cells is crit. to our understanding of the pathogenesis of this virus and to the identification of targets for antiviral intervention.  Here we investigated the viral and cellular determinants governing hCoV-EMC entry into host cells.  We found that the spike protein of hCoV-EMC (EMC-S) is incorporated into lentiviral particles and mediates transduction of human cell lines derived from different organs, including the lungs, kidneys, and colon, as well as primary human macrophages.  Expression of the known coronavirus receptors ACE2, CD13, and CEACAM1 did not facilitate EMC-S-driven transduction, suggesting that hCoV-EMC uses a novel receptor for entry.  Directed protease expression and inhibition analyses revealed that TMPRSS2 and endosomal cathepsins activate EMC-S for virus-cell fusion and constitute potential targets for antiviral intervention.  Finally, EMC-S-driven transduction was abrogated by serum from an hCoV-EMC-infected patient, indicating that EMC-S-specific neutralizing antibodies can be generated in patients.  Collectively, our results indicate that hCoV-EMC uses a novel receptor for protease-activated entry into human cells and might be capable of extrapulmonary spread.  In addn., they define TMPRSS2 and cathepsins B and L as potential targets for intervention and suggest that neutralizing antibodies contribute to the control of hCoV-EMC infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsCFRLU_b5rrVg90H21EOLACvtfcHk0lgquLcA8DfOQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsV2ls7Y%253D&md5=8cc463c255b68c3d41c7cbea7b49607a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FJVI.00128-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00128-13%26sid%3Dliteratum%253Aachs%26aulast%3DGierer%26aufirst%3DS.%26aulast%3DBertram%26aufirst%3DS.%26aulast%3DKaup%26aufirst%3DF.%26aulast%3DWrensch%26aufirst%3DF.%26aulast%3DHeurich%26aufirst%3DA.%26aulast%3DKramer-Kuhl%26aufirst%3DA.%26aulast%3DWelsch%26aufirst%3DK.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DDittmer%26aufirst%3DU.%26aulast%3Dvon%2BHahn%26aufirst%3DT.%26aulast%3DSimmons%26aufirst%3DG.%26aulast%3DHofmann%26aufirst%3DH.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DThe%2520spike%2520protein%2520of%2520the%2520emerging%2520betacoronavirus%2520EMC%2520uses%2520a%2520novel%2520coronavirus%2520receptor%2520for%2520entry%252C%2520can%2520be%2520activated%2520by%2520TMPRSS2%252C%2520and%2520is%2520targeted%2520by%2520neutralizing%2520antibodies%26jtitle%3DJ.%2520Virol%26date%3D2013%26volume%3D87%26issue%3D10%26spage%3D5502%26epage%3D5511%26doi%3D10.1128%2FJVI.00128-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuyama, S.</span></span> <span> </span><span class="NLM_article-title">Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">12552</span>– <span class="NLM_lpage">12561</span>, <span class="refDoi"> DOI: 10.1128/JVI.01890-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.01890-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24027332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVygsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=12552-12561&issue=23&author=K.+Shiratoauthor=M.+Kawaseauthor=S.+Matsuyama&title=Middle+East+respiratory+syndrome+coronavirus+infection+mediated+by+the+transmembrane+serine+protease+TMPRSS2&doi=10.1128%2FJVI.01890-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Middle east respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2</span></div><div class="casAuthors">Shirato, Kazuya; Kawase, Miyuki; Matsuyama, Shutoku</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12552-12561</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Middle East respiratory syndrome coronavirus (MERS-CoV) utilizes host proteases for virus entry into lung cells.  In the current study, Vero cells constitutively expressing type II transmembrane serine protease (Vero-TMPRSS2 cells) showed larger syncytia at 18 h after infection with MERS-CoV than after infection with other coronaviruses.  Furthermore, the susceptibility of Vero-TMPRSS2 cells to MERS-CoV was 100-fold higher than that of non-TMPRSS2-expressing parental Vero cells.  The serine protease inhibitor camostat, which inhibits TMPRSS2 activity, completely blocked syncytium formation but only partially blocked virus entry into Vero-TMPRSS2 cells.  Importantly, the coronavirus is thought to enter cells via two distinct pathways, one mediated by TMPRSS2 at the cell surface and the other mediated by cathepsin L in the endosome.  Simultaneous treatment with inhibitors of cathepsin L and TMPRSS2 completely blocked virus entry into Vero-TMPRSS2 cells, indicating that MERS-CoV employs both the cell surface and the endosomal pathway to infect Vero-TMPRSS2 cells.  In contrast, a single camostat treatment suppressed MERS-CoV entry into human bronchial submucosal gland-derived Calu-3 cells by 10-fold and virus growth by 270-fold, although treatment with both camostat and (23,25)-trans-epoxysuccinyl-L-leucylamindo-3-methylbutane Et ester, a cathepsin inhibitor, or treatment with leupeptin, an inhibitor of cysteine, serine, and threonine peptidases, was no more efficacious than treatment with camostat alone.  Further, these inhibitors were not efficacious against MERS-CoV infection of MRC-5 and WI-38 cells, which were derived from lung, but these characters differed from those of mature pneumocytes.  These results suggest that a single treatment with camostat is sufficient to block MERS-CoV entry into a well-differentiated lung-derived cell line.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUQYSrh_mBe7Vg90H21EOLACvtfcHk0lgkKEMgA16n4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVygsrjM&md5=808a19ec6bbba3b9f0829f82b37bfd89</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FJVI.01890-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01890-13%26sid%3Dliteratum%253Aachs%26aulast%3DShirato%26aufirst%3DK.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DMatsuyama%26aufirst%3DS.%26atitle%3DMiddle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520infection%2520mediated%2520by%2520the%2520transmembrane%2520serine%2520protease%2520TMPRSS2%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26issue%3D23%26spage%3D12552%26epage%3D12561%26doi%3D10.1128%2FJVI.01890-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirogane, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishiguro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagi, Y.</span></span> <span> </span><span class="NLM_article-title">Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">8942</span>– <span class="NLM_lpage">8946</span>, <span class="refDoi"> DOI: 10.1128/JVI.00676-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.00676-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18562527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVClt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=8942-8946&issue=17&author=Y.+Shiroganeauthor=M.+Takedaauthor=M.+Iwasakiauthor=N.+Ishiguroauthor=H.+Takeuchiauthor=Y.+Nakatsuauthor=M.+Taharaauthor=H.+Kikutaauthor=Y.+Yanagi&title=Efficient+multiplication+of+human+metapneumovirus+in+Vero+cells+expressing+the+transmembrane+serine+protease+TMPRSS2&doi=10.1128%2FJVI.00676-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2</span></div><div class="casAuthors">Shirogane, Yuta; Takeda, Makoto; Iwasaki, Masaharu; Ishiguro, Nobuhisa; Takeuchi, Hiroki; Nakatsu, Yuichiro; Tahara, Maino; Kikuta, Hideaki; Yanagi, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8942-8946</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human metapneumovirus (HMPV) is a major causative agent of severe bronchiolitis and pneumonia.  Its fusion (F) protein must be cleaved by host proteases to cause membrane fusion, a crit. step for virus infection.  By generating Vero cells constitutively expressing the transmembrane serine protease TMPRSS2 and green fluorescent protein-expressing recombinant HMPV, we show that TMPRSS2, which is expressed in the human lung epithelium, cleaves the HMPV F protein efficiently and supports HMPV multiplication.  The results indicate that TMPRSS2 is a possible candidate protease involved in the development of lower respiratory tract illness in HMPV-infected patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopIbkVq71hb7Vg90H21EOLACvtfcHk0lgkKEMgA16n4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVClt7rF&md5=b7cf8016a5c7c697f9ed74702c005bba</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FJVI.00676-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00676-08%26sid%3Dliteratum%253Aachs%26aulast%3DShirogane%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DIwasaki%26aufirst%3DM.%26aulast%3DIshiguro%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DH.%26aulast%3DNakatsu%26aufirst%3DY.%26aulast%3DTahara%26aufirst%3DM.%26aulast%3DKikuta%26aufirst%3DH.%26aulast%3DYanagi%26aufirst%3DY.%26atitle%3DEfficient%2520multiplication%2520of%2520human%2520metapneumovirus%2520in%2520Vero%2520cells%2520expressing%2520the%2520transmembrane%2520serine%2520protease%2520TMPRSS2%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26issue%3D17%26spage%3D8942%26epage%3D8946%26doi%3D10.1128%2FJVI.00676-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehr, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCray, P. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T.</span></span> <span> </span><span class="NLM_article-title">Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">12262</span>– <span class="NLM_lpage">12267</span>, <span class="refDoi"> DOI: 10.1073/pnas.1608147113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1608147113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27791014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1elur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=12262-12267&issue=43&author=J.+E.+Parkauthor=K.+Liauthor=A.+Barlanauthor=A.+R.+Fehrauthor=S.+Perlmanauthor=P.+B.+McCrayauthor=T.+Gallagher&title=Proteolytic+processing+of+Middle+East+respiratory+syndrome+coronavirus+spikes+expands+virus+tropism&doi=10.1073%2Fpnas.1608147113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism</span></div><div class="casAuthors">Park, Jung-Eun; Li, Kun; Barlan, Arlene; Fehr, Anthony R.; Perlman, Stanley; McCray, Paul B. Jr.; Gallagher, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">12262-12267</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) infects humans from zoonotic sources and causes severe pulmonary disease.  Virions require spike (S) glycoproteins for binding to cell receptors and for catalyzing virus-cell membrane fusion.  Fusion occurs only after S proteins are cleaved sequentially, first during their secretion through the exocytic organelles of virus-producing cells, and second after virus binding to target-cell receptors.  To more precisely det. how sequential proteolysis contributes to CoV infection, we introduced S mutations obstructing the first cleavages.  These mutations severely compromised MERS-CoV infection into human lung-derived cells, but had little effect on infection into several other cell types.  These cell type-specific requirements for proteolysis correlated with S conformations during cell entry.  Without the first cleavages, S proteins resisted cell receptor-induced conformational changes, which restricted the second, fusion-activating cleavages.  Consistent with these findings, precleaved MERS viruses used receptor-proximal, cell-surface proteases to effect the second fusion-activating cleavages during cell entry, whereas the more rigid uncleaved MERS viruses trafficked past these cell-surface proteases and into endosomes.  Uncleaved viruses were less infectious to human airway epithelial and Calu3 cell cultures because they lacked sufficient endosomal fusion-activating proteases.  Thus, by sensitizing viruses to receptor-induced conformational changes, the first S cleavages expand virus tropism to cell types that are relevant to lung infection, and therefore may be significant determinants of MERS-CoV virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbWppC9-pA2LVg90H21EOLACvtfcHk0lhiX7dACBv1rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1elur3F&md5=25764c2eb9d46c8ab09f70c461f8cb95</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1608147113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1608147113%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DBarlan%26aufirst%3DA.%26aulast%3DFehr%26aufirst%3DA.%2BR.%26aulast%3DPerlman%26aufirst%3DS.%26aulast%3DMcCray%26aufirst%3DP.%2BB.%26aulast%3DGallagher%26aufirst%3DT.%26atitle%3DProteolytic%2520processing%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520spikes%2520expands%2520virus%2520tropism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D43%26spage%3D12262%26epage%3D12267%26doi%3D10.1073%2Fpnas.1608147113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Z.</span></span> <span> </span><span class="NLM_article-title">Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1620</span>, <span class="refDoi"> DOI: 10.1038/s41467-020-15562-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41467-020-15562-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32221306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFyjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1620&issue=1&author=X.+Ouauthor=Y.+Liuauthor=X.+Leiauthor=P.+Liauthor=D.+Miauthor=L.+Renauthor=L.+Guoauthor=R.+Guoauthor=T.+Chenauthor=J.+Huauthor=Z.+Xiangauthor=Z.+Muauthor=X.+Chenauthor=J.+Chenauthor=K.+Huauthor=Q.+Jinauthor=J.+Wangauthor=Z.+Qian&title=Characterization+of+spike+glycoprotein+of+SARS-CoV-2+on+virus+entry+and+its+immune+cross-reactivity+with+SARS-CoV&doi=10.1038%2Fs41467-020-15562-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV</span></div><div class="casAuthors">Ou, Xiuyuan; Liu, Yan; Lei, Xiaobo; Li, Pei; Mi, Dan; Ren, Lili; Guo, Li; Guo, Ruixuan; Chen, Ting; Hu, Jiaxin; Xiang, Zichun; Mu, Zhixia; Chen, Xing; Chen, Jieyong; Hu, Keping; Jin, Qi; Wang, Jianwei; Qian, Zhaohui</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1620</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Since 2002, beta coronaviruses (CoV) have caused three zoonotic outbreaks, SARS-CoV in 2002-2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in late 2019.  However, little is currently known about the biol. of SARS-CoV-2.  Here, using SARS-CoV-2 S protein pseudovirus system, we confirm that human angiotensin converting enzyme 2 (hACE2) is the receptor for SARS-CoV-2, find that SARS-CoV-2 enters 293/hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are crit. for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S.  Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions.  Further studies using recovered SARS and COVID-19 patients' sera show limited cross-neutralization, suggesting that recovery from one infection might not protect against the other.  Our results present potential targets for development of drugs and vaccines for SARS-CoV-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMJdEJrxmpDrVg90H21EOLACvtfcHk0lhiX7dACBv1rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFyjt78%253D&md5=6b0b1ef5a68f4a35da4aabecb0f99544</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-15562-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-15562-9%26sid%3Dliteratum%253Aachs%26aulast%3DOu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMi%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DMu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DZ.%26atitle%3DCharacterization%2520of%2520spike%2520glycoprotein%2520of%2520SARS-CoV-2%2520on%2520virus%2520entry%2520and%2520its%2520immune%2520cross-reactivity%2520with%2520SARS-CoV%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D1620%26doi%3D10.1038%2Fs41467-020-15562-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoenen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelotti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewey, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeWald, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumpp-Thomas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrling, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, J. M.</span></span> <span> </span><span class="NLM_article-title">The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e0005540</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0005540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pntd.0005540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28403145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWrsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&issue=4&author=E.+A.+Nelsonauthor=J.+Dyallauthor=T.+Hoenenauthor=A.+B.+Barnesauthor=H.+Zhouauthor=J.+Y.+Liangauthor=J.+Michelottiauthor=W.+H.+Deweyauthor=L.+E.+DeWaldauthor=R.+S.+Bennettauthor=P.+J.+Morrisauthor=R.+Guhaauthor=C.+Klumpp-Thomasauthor=C.+McKnightauthor=Y.+C.+Chenauthor=X.+Xuauthor=A.+Wangauthor=E.+Hughesauthor=S.+Martinauthor=C.+Thomasauthor=P.+B.+Jahrlingauthor=L.+E.+Hensleyauthor=G.+G.+Olingerauthor=J.+M.+White&title=The+phosphatidylinositol-3-phosphate+5-kinase+inhibitor+apilimod+blocks+filoviral+entry+and+infection&doi=10.1371%2Fjournal.pntd.0005540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection</span></div><div class="casAuthors">Nelson, Elizabeth A.; Dyall, Julie; Hoenen, Thomas; Barnes, Alyson B.; Zhou, Huanying; Liang, Janie Y.; Michelotti, Julia; Dewey, William H.; DeWald, Lisa Evans; Bennett, Richard S.; Morris, Patrick J.; Guha, Rajarshi; Klumpp-Thomas, Carleen; McKnight, Crystal; Chen, Yu-Chi; Xu, Xin; Wang, Amy; Hughes, Emma; Martin, Scott; Thomas, Craig; Jahrling, Peter B.; Hensley, Lisa E.; Olinger, Gene G. Jr.; White, Judith M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0005540/1-e0005540/22</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) is a lipid kinase involved in endosome maturation that emerged from a haploid genetic screen as being required for Ebola virus (EBOV) infection.  Here we analyzed the effects of apilimod, a PIKfyve inhibitor that was reported to be well tolerated in humans in phase 2 clin. trials, for its effects on entry and infection of EBOV and Marburg virus (MARV).  We first found that apilimod blocks infections by EBOV and MARV in Huh 7, Vero E6 and primary human macrophage cells, with notable potency in the macrophages (IC50, 10 nM).  We next obsd. that similar doses of apilimod block EBOV-glycoprotein-virus like particle (VLP) entry and transcription-replication competent VLP infection, suggesting that the primary mode of action of apilimod is as an entry inhibitor, preventing release of the viral genome into the cytoplasm to initiate replication.  After providing evidence that the anti-EBOV action of apilimod is via PIKfyve, we showed that it blocks trafficking of EBOV VLPs to endolysosomes contg. Niemann-Pick C1 (NPC1), the intracellular receptor for EBOV.  Concurrently apilimod caused VLPs to accumulate in early endosome antigen 1-pos. endosomes.  We did not detect any effects of apilimod on bulk endosome acidification, on the activity of cathepsins B and L, or on cholesterol export from endolysosomes.  Hence by antagonizing PIKfyve, apilimod appears to block EBOV trafficking to its site of fusion and entry into the cytoplasm.  Given the drug's obsd. anti-filoviral activity, relatively unexplored mechanism of entry inhibition, and reported tolerability in humans, we propose that apilimod be further explored as part of a therapeutic regimen to treat filoviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlUaAMvLkQT7Vg90H21EOLACvtfcHk0lhiX7dACBv1rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWrsb3O&md5=c2f72fa69b941bcc8c97dcacf0e210bd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0005540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0005540%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DE.%2BA.%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DHoenen%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DA.%2BB.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DJ.%2BY.%26aulast%3DMichelotti%26aufirst%3DJ.%26aulast%3DDewey%26aufirst%3DW.%2BH.%26aulast%3DDeWald%26aufirst%3DL.%2BE.%26aulast%3DBennett%26aufirst%3DR.%2BS.%26aulast%3DMorris%26aufirst%3DP.%2BJ.%26aulast%3DGuha%26aufirst%3DR.%26aulast%3DKlumpp-Thomas%26aufirst%3DC.%26aulast%3DMcKnight%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%2BC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DC.%26aulast%3DJahrling%26aufirst%3DP.%2BB.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520phosphatidylinositol-3-phosphate%25205-kinase%2520inhibitor%2520apilimod%2520blocks%2520filoviral%2520entry%2520and%2520infection%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2017%26volume%3D11%26issue%3D4%26doi%3D10.1371%2Fjournal.pntd.0005540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta-Geijo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galindo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernaez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quetglas, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalmau-Mena, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, C.</span></span> <span> </span><span class="NLM_article-title">Endosomal maturation, Rab7 GTPase and phosphoinositides in African swine fever virus entry</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">11</span>), <span class="NLM_elocation-id">e48853</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0048853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0048853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23133661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslWjsbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=11&author=M.+A.+Cuesta-Geijoauthor=I.+Galindoauthor=B.+Hernaezauthor=J.+I.+Quetglasauthor=I.+Dalmau-Menaauthor=C.+Alonso&title=Endosomal+maturation%2C+Rab7+GTPase+and+phosphoinositides+in+African+swine+fever+virus+entry&doi=10.1371%2Fjournal.pone.0048853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal maturation, Rab7 GTPase and phosphoinositides in African swine fever virus entry</span></div><div class="casAuthors">Cuesta-Geijo, Miguel A.; Galindo, Inmaculada; Hernaez, Bruno; Quetglas, Jose Ignacio; Dalmau-Mena, Inmaculada; Alonso, Covadonga</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e48853</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The authors analyzed the dependence of African swine fever virus (ASFV) infection on the integrity of the endosomal pathway.  Using confocal immunofluorescence with antibodies against viral capsid proteins, we found colocalization of incoming viral particles with early endosomes (EE) during the first minutes of infection.  Conversely, viral capsid protein was not detected in acidic late endosomal compartments, multivesicular bodies (MVBs), late endosomes (LEs) or lysosomes (LY).  Using an antibody against a viral inner core protein, we found colocalization of viral cores with late compartments from 30 to 60 min postinfection.  The absence of capsid protein staining in LEs and LYs suggested that virus desencapsidation would take place at the acid pH of these organelles.  In fact, inhibitors of intraluminal acidification of endosomes caused retention of viral capsid staining virions in Rab7 expressing endosomes and more importantly, severely impaired subsequent viral protein prodn.  Endosomal acidification in the first hour after virus entry was essential for successful infection but not thereafter.  In addn., altering the balance of phosphoinositides (PIs) which are responsible of the maintenance of the endocytic pathway impaired ASFV infection.  Early infection steps were dependent on the prodn. of phosphatidylinositol 3-phosphate (PtdIns3P) which is involved in EE maturation and multivesicular body (MVB) biogenesis and on the interconversion of PtdIns3P to phosphatidylinositol 3,5-biphosphate (PtdIns(3,5)P2).  Likewise, GTPase Rab7 activity should remain intact, as well as processes related to LE compartment physiol., which are crucial during early infection.  The data demonstrate that the EE and LE compartments and the integrity of the endosomal maturation pathway orchestrated by Rab proteins and PIs play a central role during early stages of ASFV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgQBz20LmA_rVg90H21EOLACvtfcHk0lg_G1JeFtx6CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslWjsbzN&md5=256c351c18985dab5f4002e90b263d75</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0048853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0048853%26sid%3Dliteratum%253Aachs%26aulast%3DCuesta-Geijo%26aufirst%3DM.%2BA.%26aulast%3DGalindo%26aufirst%3DI.%26aulast%3DHernaez%26aufirst%3DB.%26aulast%3DQuetglas%26aufirst%3DJ.%2BI.%26aulast%3DDalmau-Mena%26aufirst%3DI.%26aulast%3DAlonso%26aufirst%3DC.%26atitle%3DEndosomal%2520maturation%252C%2520Rab7%2520GTPase%2520and%2520phosphoinositides%2520in%2520African%2520swine%2520fever%2520virus%2520entry%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D11%26doi%3D10.1371%2Fjournal.pone.0048853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozak, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warkentin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salambanga, F. D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobasa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, M.</span></span> <span> </span><span class="NLM_article-title">Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2017.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2017.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29031163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GlsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2018&pages=17-28&author=S.+Qiuauthor=A.+Leungauthor=Y.+Boauthor=R.+A.+Kozakauthor=S.+P.+Anandauthor=C.+Warkentinauthor=F.+D.+R.+Salambangaauthor=J.+Cuiauthor=G.+Kobingerauthor=D.+Kobasaauthor=M.+Cote&title=Ebola+virus+requires+phosphatidylinositol+%283%2C5%29+bisphosphate+production+for+efficient+viral+entry&doi=10.1016%2Fj.virol.2017.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry</span></div><div class="casAuthors">Qiu, Shirley; Leung, Anders; Bo, Yuxia; Kozak, Robert A.; Anand, Sai Priya; Warkentin, Corina; Salambanga, Fabiola D. R.; Cui, Jennifer; Kobinger, Gary; Kobasa, Darwyn; Cote, Marceline</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-28</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">For entry, Ebola virus (EBOV) requires the interaction of its viral glycoprotein with the cellular protein Niemann-Pick C1 (NPC1) which resides in late endosomes and lysosomes.  How EBOV is trafficked and delivered to NPC1 and whether this is pos. regulated during entry remain unclear.  Here, we show that the PIKfyve-ArPIKfyve-Sac3 cellular complex, which is involved in the metab. of phosphatidylinositol (3,5) bisphosphate (PtdIns(3,5)P2), is crit. for EBOV infection.  Although the expression of all subunits of the complex was required for efficient entry, PIKfyve kinase activity was specifically crit. for entry by all pathogenic filoviruses.  Inhibition of PIKfyve prevented colocalization of EBOV with NPC1 and led to virus accumulation in intracellular vesicles with characteristics of early endosomes.  Importantly, genetically-encoded phosphoinositide probes revealed an increase in PtdIns(3,5)P2-pos. vesicles in cells during EBOV entry.  Taken together, our studies suggest that EBOV requires PtdIns(3,5)P2 prodn. in cells to promote efficient delivery to NPC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBj4bGDkDZELVg90H21EOLACvtfcHk0lg_G1JeFtx6CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GlsrbI&md5=1a0bed541a6186ca937abcc2cabc4bb6</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2017.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2017.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DLeung%26aufirst%3DA.%26aulast%3DBo%26aufirst%3DY.%26aulast%3DKozak%26aufirst%3DR.%2BA.%26aulast%3DAnand%26aufirst%3DS.%2BP.%26aulast%3DWarkentin%26aufirst%3DC.%26aulast%3DSalambanga%26aufirst%3DF.%2BD.%2BR.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DKobinger%26aufirst%3DG.%26aulast%3DKobasa%26aufirst%3DD.%26aulast%3DCote%26aufirst%3DM.%26atitle%3DEbola%2520virus%2520requires%2520phosphatidylinositol%2520%25283%252C5%2529%2520bisphosphate%2520production%2520for%2520efficient%2520viral%2520entry%26jtitle%3DVirology%26date%3D2018%26volume%3D513%26spage%3D17%26epage%3D28%26doi%3D10.1016%2Fj.virol.2017.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">V’Kovski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaender, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braga Lagache, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simillion, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaschen, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span> <span> </span><span class="NLM_article-title">Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e42037</span> <span class="refDoi"> DOI: 10.7554/eLife.42037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.7554%2FeLife.42037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30632963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVegtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=P.+V%E2%80%99Kovskiauthor=M.+Gerberauthor=J.+Kellyauthor=S.+Pfaenderauthor=N.+Ebertauthor=S.+Braga+Lagacheauthor=C.+Simillionauthor=J.+Portmannauthor=H.+Stalderauthor=V.+Gaschenauthor=R.+Bruggmannauthor=M.+H.+Stoffelauthor=M.+Hellerauthor=R.+Dijkmanauthor=V.+Thiel&title=Determination+of+host+proteins+composing+the+microenvironment+of+coronavirus+replicase+complexes+by+proximity-labeling&doi=10.7554%2FeLife.42037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling</span></div><div class="casAuthors">V'kovski, Philip; Gerber, Markus; Kelly, Jenna; Pfaender, Stephanie; Ebert, Nadine; Lagache, Sophie Braga; Simillion, Cedric; Portmann, Jasmine; Stalder, Hanspeter; Gaschen, Veronique; Bruggmann, Remy; Stoffel, Michael H.; Heller, Manfred; Dijkman, Ronald; Thiel, Volker</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42037</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Pos.-sense RNA viruses hijack intracellular membranes that provide niches for viral RNA synthesis and a platform for interactions with host proteins.  However, little is known about host factors at the interface between replicase complexes and the host cytoplasm.  We engineered a biotin ligase into a coronaviral replication/transcription complex (RTC) and identified >500 host proteins constituting the RTC microenvironment. siRNA-silencing of each RTC-proximal host factor demonstrated importance of vesicular trafficking pathways, ubiquitin-dependent and autophagy- related processes, and translation initiation factors.  Notably, detection of translation initiation factors at the RTC was instrumental to visualize and demonstrate active translation proximal to replication complexes of several coronaviruses.  Collectively, we establish a spatial link between viral RNA synthesis and diverse host factors of unprecedented breadth.  Our data may serve as a paradigm for other pos.-strand RNA viruses and provide a starting point for a comprehensive anal. of crit. virus-host interactions that represent targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs8nSvGBoVj7Vg90H21EOLACvtfcHk0lg_G1JeFtx6CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVegtLnN&md5=1da3f38802c756d517f0fa8dde8a6d03</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.7554%2FeLife.42037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.42037%26sid%3Dliteratum%253Aachs%26aulast%3DV%25E2%2580%2599Kovski%26aufirst%3DP.%26aulast%3DGerber%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DJ.%26aulast%3DPfaender%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DN.%26aulast%3DBraga%2BLagache%26aufirst%3DS.%26aulast%3DSimillion%26aufirst%3DC.%26aulast%3DPortmann%26aufirst%3DJ.%26aulast%3DStalder%26aufirst%3DH.%26aulast%3DGaschen%26aufirst%3DV.%26aulast%3DBruggmann%26aufirst%3DR.%26aulast%3DStoffel%26aufirst%3DM.%2BH.%26aulast%3DHeller%26aufirst%3DM.%26aulast%3DDijkman%26aufirst%3DR.%26aulast%3DThiel%26aufirst%3DV.%26atitle%3DDetermination%2520of%2520host%2520proteins%2520composing%2520the%2520microenvironment%2520of%2520coronavirus%2520replicase%2520complexes%2520by%2520proximity-labeling%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2FeLife.42037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McBride, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machamer, C. E.</span></span> <span> </span><span class="NLM_article-title">The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2418</span>– <span class="NLM_lpage">2428</span>, <span class="refDoi"> DOI: 10.1128/JVI.02146-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.02146-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=17166901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=2418-2428&issue=5&author=C.+E.+McBrideauthor=J.+Liauthor=C.+E.+Machamer&title=The+cytoplasmic+tail+of+the+severe+acute+respiratory+syndrome+coronavirus+spike+protein+contains+a+novel+endoplasmic+reticulum+retrieval+signal+that+binds+COPI+and+promotes+interaction+with+membrane+protein&doi=10.1128%2FJVI.02146-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein</span></div><div class="casAuthors">McBride, Corrin E.; Li, Jie; Machamer, Carolyn E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2418-2428</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Like other coronaviruses, severe acute respiratory syndrome coronavirus (SARS CoV) assembles at and buds into the lumen of the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC).  Accumulation of the viral envelope proteins at this compartment is a prerequisite for virus assembly.  Previously, we reported the identification of a dibasic motif (KxHxx) in the cytoplasmic tail of the SARS CoV spike (S) protein that was similar to a canonical dilysine ER retrieval signal.  Here we demonstrate that this motif is a novel and functional ER retrieval signal which reduced the rate of traffic of the full-length S protein through the Golgi complex.  The KxHxx motif also partially retained two different reporter proteins in the ERGIC region and reduced their rates of trafficking, although the motif was less potent than the canonical dilysine signal.  The dibasic motif bound the coatomer complex I (COPI) in an in vitro binding assay, suggesting that ER retrieval may contribute to the accumulation of SARS CoV S protein near the virus assembly site for interaction with other viral structural proteins.  In support of this, we found that the dibasic motif on the SARS S protein was required for its localization to the ERGIC/Golgi region when coexpressed with SARS membrane (M) protein.  Thus, the cycling of SARS S through the ER-Golgi system may be required for its incorporation into assembling virions in the ERGIC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtkWd7mTnEFLVg90H21EOLACvtfcHk0lgzII4MwKxvLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOgs7Y%253D&md5=16f33836bbd3a764bb3ef9bf1288a0d3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FJVI.02146-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02146-06%26sid%3Dliteratum%253Aachs%26aulast%3DMcBride%26aufirst%3DC.%2BE.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMachamer%26aufirst%3DC.%2BE.%26atitle%3DThe%2520cytoplasmic%2520tail%2520of%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520spike%2520protein%2520contains%2520a%2520novel%2520endoplasmic%2520reticulum%2520retrieval%2520signal%2520that%2520binds%2520COPI%2520and%2520promotes%2520interaction%2520with%2520membrane%2520protein%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26issue%3D5%26spage%3D2418%26epage%3D2428%26doi%3D10.1128%2FJVI.02146-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmeier, M. J.</span></span> <span> </span><span class="NLM_article-title">Coronavirus spike proteins in viral entry and pathogenesis</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1006/viro.2000.0757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1006%2Fviro.2000.0757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=11162792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2001&pages=371-374&issue=2&author=T.+M.+Gallagherauthor=M.+J.+Buchmeier&title=Coronavirus+spike+proteins+in+viral+entry+and+pathogenesis&doi=10.1006%2Fviro.2000.0757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Coronavirus spike proteins in viral entry and pathogenesis</span></div><div class="casAuthors">Gallagher, Thomas M.; Buchmeier, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">371-374</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 24 refs.  Receptor interactions and membrane fusion properties of spike proteins are discussed.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVxuFZ27QjdbVg90H21EOLACvtfcHk0lgzII4MwKxvLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFOgsA%253D%253D&md5=d35d47926621128c62d9380dfcd68f86</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1006%2Fviro.2000.0757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fviro.2000.0757%26sid%3Dliteratum%253Aachs%26aulast%3DGallagher%26aufirst%3DT.%2BM.%26aulast%3DBuchmeier%26aufirst%3DM.%2BJ.%26atitle%3DCoronavirus%2520spike%2520proteins%2520in%2520viral%2520entry%2520and%2520pathogenesis%26jtitle%3DVirology%26date%3D2001%26volume%3D279%26issue%3D2%26spage%3D371%26epage%3D374%26doi%3D10.1006%2Fviro.2000.0757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castaño-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honrubia, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez-Alvarez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeDiego, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto-Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Guardeno, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regla-Nava, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Delgado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdia-Baguena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queralt-Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilella, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span> <span> </span><span class="NLM_article-title">Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in peplication and pathogenesis</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>), <span class="NLM_elocation-id">e02325-17</span> <span class="refDoi"> DOI: 10.1128/mBio.02325-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FmBio.02325-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29789363" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&issue=3&author=C.+Casta%C3%B1o-Rodriguezauthor=J.+M.+Honrubiaauthor=J.+Gutierrez-Alvarezauthor=M.+L.+DeDiegoauthor=J.+L.+Nieto-Torresauthor=J.+M.+Jimenez-Guardenoauthor=J.+A.+Regla-Navaauthor=R.+Fernandez-Delgadoauthor=C.+Verdia-Baguenaauthor=M.+Queralt-Martinauthor=G.+Kochanauthor=S.+Perlmanauthor=V.+M.+Aguilellaauthor=I.+Solaauthor=L.+Enjuanes&title=Role+of+severe+acute+respiratory+syndrome+coronavirus+viroporins+E%2C+3a%2C+and+8a+in+peplication+and+pathogenesis&doi=10.1128%2FmBio.02325-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FmBio.02325-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.02325-17%26sid%3Dliteratum%253Aachs%26aulast%3DCasta%25C3%25B1o-Rodriguez%26aufirst%3DC.%26aulast%3DHonrubia%26aufirst%3DJ.%2BM.%26aulast%3DGutierrez-Alvarez%26aufirst%3DJ.%26aulast%3DDeDiego%26aufirst%3DM.%2BL.%26aulast%3DNieto-Torres%26aufirst%3DJ.%2BL.%26aulast%3DJimenez-Guardeno%26aufirst%3DJ.%2BM.%26aulast%3DRegla-Nava%26aufirst%3DJ.%2BA.%26aulast%3DFernandez-Delgado%26aufirst%3DR.%26aulast%3DVerdia-Baguena%26aufirst%3DC.%26aulast%3DQueralt-Martin%26aufirst%3DM.%26aulast%3DKochan%26aufirst%3DG.%26aulast%3DPerlman%26aufirst%3DS.%26aulast%3DAguilella%26aufirst%3DV.%2BM.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DEnjuanes%26aufirst%3DL.%26atitle%3DRole%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520viroporins%2520E%252C%25203a%252C%2520and%25208a%2520in%2520peplication%2520and%2520pathogenesis%26jtitle%3DmBio%26date%3D2018%26volume%3D9%26issue%3D3%26doi%3D10.1128%2FmBio.02325-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neuman, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunding, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baksh, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Droese, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawicki, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddell, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamou, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchmeier, M. J.</span></span> <span> </span><span class="NLM_article-title">A structural analysis of M protein in coronavirus assembly and morphology</span>. <i>J. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>174</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.jsb.2010.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jsb.2010.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21130884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFSrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2011&pages=11-22&issue=1&author=B.+W.+Neumanauthor=G.+Kissauthor=A.+H.+Kundingauthor=D.+Bhellaauthor=M.+F.+Bakshauthor=S.+Connellyauthor=B.+Droeseauthor=J.+P.+Klausauthor=S.+Makinoauthor=S.+G.+Sawickiauthor=S.+G.+Siddellauthor=D.+G.+Stamouauthor=I.+A.+Wilsonauthor=P.+Kuhnauthor=M.+J.+Buchmeier&title=A+structural+analysis+of+M+protein+in+coronavirus+assembly+and+morphology&doi=10.1016%2Fj.jsb.2010.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A structural analysis of M protein in coronavirus assembly and morphology</span></div><div class="casAuthors">Neuman, Benjamin W.; Kiss, Gabriella; Kunding, Andreas H.; Bhella, David; Baksh, M. Fazil; Connelly, Stephen; Droese, Ben; Klaus, Joseph P.; Makino, Shinji; Sawicki, Stanley G.; Siddell, Stuart G.; Stamou, Dimitrios G.; Wilson, Ian A.; Kuhn, Peter; Buchmeier, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-22</span>CODEN:
                <span class="NLM_cas:coden">JSBIEM</span>;
        ISSN:<span class="NLM_cas:issn">1047-8477</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The M protein of coronavirus plays a central role in virus assembly, turning cellular membranes into workshops where virus and host factors come together to make new virus particles.  We investigated how M structure and organization is related to virus shape and size using cryo-electron microscopy, tomog. and statistical anal.  We present evidence that suggests M can adopt two conformations and that membrane curvature is regulated by one M conformer.  Elongated M protein is assocd. with rigidity, clusters of spikes and a relatively narrow range of membrane curvature.  In contrast, compact M protein is assocd. with flexibility and low spike d.  Anal. of several types of virus-like particles and virions revealed that S protein, N protein and genomic RNA each help to regulate virion size and variation, presumably through interactions with M. These findings provide insight into how M protein functions to promote virus assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol6PiYyze14rVg90H21EOLACvtfcHk0livy1aUHuEImA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFSrt7w%253D&md5=a86cd24ccfa9d6a3dda1741900dbef60</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jsb.2010.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsb.2010.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DNeuman%26aufirst%3DB.%2BW.%26aulast%3DKiss%26aufirst%3DG.%26aulast%3DKunding%26aufirst%3DA.%2BH.%26aulast%3DBhella%26aufirst%3DD.%26aulast%3DBaksh%26aufirst%3DM.%2BF.%26aulast%3DConnelly%26aufirst%3DS.%26aulast%3DDroese%26aufirst%3DB.%26aulast%3DKlaus%26aufirst%3DJ.%2BP.%26aulast%3DMakino%26aufirst%3DS.%26aulast%3DSawicki%26aufirst%3DS.%2BG.%26aulast%3DSiddell%26aufirst%3DS.%2BG.%26aulast%3DStamou%26aufirst%3DD.%2BG.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DBuchmeier%26aufirst%3DM.%2BJ.%26atitle%3DA%2520structural%2520analysis%2520of%2520M%2520protein%2520in%2520coronavirus%2520assembly%2520and%2520morphology%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D174%26issue%3D1%26spage%3D11%26epage%3D22%26doi%3D10.1016%2Fj.jsb.2010.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McBride, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zyl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fielding, B. C.</span></span> <span> </span><span class="NLM_article-title">The coronavirus nucleocapsid is a multifunctional protein</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2991</span>– <span class="NLM_lpage">3018</span>, <span class="refDoi"> DOI: 10.3390/v6082991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv6082991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25105276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyiu7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=2991-3018&issue=8&author=R.+McBrideauthor=M.+van+Zylauthor=B.+C.+Fielding&title=The+coronavirus+nucleocapsid+is+a+multifunctional+protein&doi=10.3390%2Fv6082991"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The coronavirus nucleocapsid is a multifunctional protein</span></div><div class="casAuthors">McBride, Ruth; van Zyl, Marjorie; Fielding, Burtram C.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2991-3018, 28 pp.</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The coronavirus nucleocapsid (N) is a structural protein that forms complexes with genomic RNA, interacts with the viral membrane protein during virion assembly and plays a crit. role in enhancing the efficiency of virus transcription and assembly.  Recent studies have confirmed that N is a multifunctional protein.  The aim of this review is to highlight the properties and functions of the N protein, with specific ref. to (i) the topol.; (ii) the intracellular localization and (iii) the functions of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqko49yucsC57Vg90H21EOLACvtfcHk0livy1aUHuEImA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyiu7%252FJ&md5=5ed29616bfb0a71386a7b92a33105dd8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fv6082991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv6082991%26sid%3Dliteratum%253Aachs%26aulast%3DMcBride%26aufirst%3DR.%26aulast%3Dvan%2BZyl%26aufirst%3DM.%26aulast%3DFielding%26aufirst%3DB.%2BC.%26atitle%3DThe%2520coronavirus%2520nucleocapsid%2520is%2520a%2520multifunctional%2520protein%26jtitle%3DViruses%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D2991%26epage%3D3018%26doi%3D10.3390%2Fv6082991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemula, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donde, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouda, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadde, R.</span></span> <span> </span><span class="NLM_article-title">In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1080/07391102.2020.1751300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F07391102.2020.1751300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=M.+K.+Guptaauthor=S.+Vemulaauthor=R.+Dondeauthor=G.+Goudaauthor=L.+Beheraauthor=R.+Vadde&title=In-silico+approaches+to+detect+inhibitors+of+the+human+severe+acute+respiratory+syndrome+coronavirus+envelope+protein+ion+channel&doi=10.1080%2F07391102.2020.1751300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1080%2F07391102.2020.1751300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2020.1751300%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DM.%2BK.%26aulast%3DVemula%26aufirst%3DS.%26aulast%3DDonde%26aufirst%3DR.%26aulast%3DGouda%26aufirst%3DG.%26aulast%3DBehera%26aufirst%3DL.%26aulast%3DVadde%26aufirst%3DR.%26atitle%3DIn-silico%2520approaches%2520to%2520detect%2520inhibitors%2520of%2520the%2520human%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520envelope%2520protein%2520ion%2520channel%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2020%26doi%3D10.1080%2F07391102.2020.1751300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV)</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/jmv.25768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fjmv.25768" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=S.+Dongauthor=J.+Sunauthor=Z.+Maoauthor=L.+Wangauthor=Y.+L.+Luauthor=J.+Li&title=A+guideline+for+homology+modeling+of+the+proteins+from+newly+discovered+betacoronavirus%2C+2019+novel+coronavirus+%282019-nCoV%29&doi=10.1002%2Fjmv.25768"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fjmv.25768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.25768%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DA%2520guideline%2520for%2520homology%2520modeling%2520of%2520the%2520proteins%2520from%2520newly%2520discovered%2520betacoronavirus%252C%25202019%2520novel%2520coronavirus%2520%25282019-nCoV%2529%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2020%26doi%3D10.1002%2Fjmv.25768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2020.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.apsb.2020.04.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=S.+Kangauthor=M.+Yangauthor=Z.+Hongauthor=L.+Zhangauthor=Z.+Huangauthor=X.+Chenauthor=S.+Heauthor=Z.+Zhouauthor=Z.+Zhouauthor=Q.+Chenauthor=Y.+Yanauthor=C.+Zhangauthor=H.+Shanauthor=S.+Chen&title=Crystal+structure+of+SARS-CoV-2+nucleocapsid+protein+RNA+binding+domain+reveals+potential+unique+drug+targeting+sites&doi=10.1016%2Fj.apsb.2020.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2020.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2020.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DShan%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520SARS-CoV-2%2520nucleocapsid%2520protein%2520RNA%2520binding%2520domain%2520reveals%2520potential%2520unique%2520drug%2520targeting%2520sites%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2020%26doi%3D10.1016%2Fj.apsb.2020.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wrapp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abiona, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, J. S.</span></span> <span> </span><span class="NLM_article-title">Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">6483</span>),  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1263</span>, <span class="refDoi"> DOI: 10.1126/science.abb2507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abb2507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32075877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvFemt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2020&pages=1260-1263&issue=6483&author=D.+Wrappauthor=N.+Wangauthor=K.+S.+Corbettauthor=J.+A.+Goldsmithauthor=C.+L.+Hsiehauthor=O.+Abionaauthor=B.+S.+Grahamauthor=J.+S.+McLellan&title=Cryo-EM+structure+of+the+2019-nCoV+spike+in+the+prefusion+conformation&doi=10.1126%2Fscience.abb2507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</span></div><div class="casAuthors">Wrapp, Daniel; Wang, Nianshuang; Corbett, Kizzmekia S.; Goldsmith, Jory A.; Hsieh, Ching-Lin; Abiona, Olubukola; Graham, Barney S.; McLellan, Jason S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6483</span>),
    <span class="NLM_cas:pages">1260-1263</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern.  The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics.  To facilitate medical countermeasure development, we detd. a 3.5-angstrom-resoln. cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation.  The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation.  We also provide biophys. and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S.  Addnl., we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs.  The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFmIhnTBqdt7Vg90H21EOLACvtfcHk0lgop0j7dkklUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvFemt70%253D&md5=27d08cbb9a43d1da051a8a92a9f68aa5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb2507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb2507%26sid%3Dliteratum%253Aachs%26aulast%3DWrapp%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCorbett%26aufirst%3DK.%2BS.%26aulast%3DGoldsmith%26aufirst%3DJ.%2BA.%26aulast%3DHsieh%26aufirst%3DC.%2BL.%26aulast%3DAbiona%26aufirst%3DO.%26aulast%3DGraham%26aufirst%3DB.%2BS.%26aulast%3DMcLellan%26aufirst%3DJ.%2BS.%26atitle%3DCryo-EM%2520structure%2520of%2520the%25202019-nCoV%2520spike%2520in%2520the%2520prefusion%2520conformation%26jtitle%3DScience%26date%3D2020%26volume%3D367%26issue%3D6483%26spage%3D1260%26epage%3D1263%26doi%3D10.1126%2Fscience.abb2507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walls, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorici, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veesler, D.</span></span> <span> </span><span class="NLM_article-title">Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.02.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cell.2020.02.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32155444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvVejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=281-292&issue=2&author=A.+C.+Wallsauthor=Y.+J.+Parkauthor=M.+A.+Tortoriciauthor=A.+Wallauthor=A.+T.+McGuireauthor=D.+Veesler&title=Structure%2C+function%2C+and+antigenicity+of+the+SARS-CoV-2+spike+glycoprotein&doi=10.1016%2Fj.cell.2020.02.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein</span></div><div class="casAuthors">Walls, Alexandra C.; Park, Young-Jun; Tortorici, M. Alejandra; Wall, Abigail; McGuire, Andrew T.; Veesler, David</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-292.e6</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The emergence of SARS-CoV-2 has resulted in >90,000 infections and >3000 deaths.  Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies.  We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, correlating with the efficient spread of SARS-CoV-2 among humans.  We found that the SARS-CoV-2 S glycoprotein harbors a furin cleavage site at the boundary between the S1/S2 subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and SARS-related CoVs.  We detd. cryo-EM structures of the SARS-CoV-2 S ectodomain trimer, providing a blueprint for the design of vaccines and inhibitors of viral entry.  Finally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited SARS-CoV-2 S mediated entry into cells, indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpiIU58FB3rVg90H21EOLACvtfcHk0lgop0j7dkklUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvVejsLk%253D&md5=ac8a8a208d9c26f88f702fb7634ab1ab</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.02.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.02.058%26sid%3Dliteratum%253Aachs%26aulast%3DWalls%26aufirst%3DA.%2BC.%26aulast%3DPark%26aufirst%3DY.%2BJ.%26aulast%3DTortorici%26aufirst%3DM.%2BA.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DMcGuire%26aufirst%3DA.%2BT.%26aulast%3DVeesler%26aufirst%3DD.%26atitle%3DStructure%252C%2520function%252C%2520and%2520antigenicity%2520of%2520the%2520SARS-CoV-2%2520spike%2520glycoprotein%26jtitle%3DCell%26date%3D2020%26volume%3D181%26issue%3D2%26spage%3D281%26epage%3D292%26doi%3D10.1016%2Fj.cell.2020.02.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, M. H.</span></span> <span> </span><span class="NLM_article-title">Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">572</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.drudis.2015.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26691874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVemt7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=562-572&issue=4&author=C.+K.+Changauthor=S.+C.+Loauthor=Y.+S.+Wangauthor=M.+H.+Hou&title=Recent+insights+into+the+development+of+therapeutics+against+coronavirus+diseases+by+targeting+N+protein&doi=10.1016%2Fj.drudis.2015.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein</span></div><div class="casAuthors">Chang, Chung-ke; Lo, Shou-Chen; Wang, Yong-Sheng; Hou, Ming-Hon</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">562-572</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The advent of severe acute respiratory syndrome (SARS) in the 21st century and the recent outbreak of Middle-East respiratory syndrome (MERS) highlight the importance of coronaviruses (CoVs) as human pathogens, emphasizing the need for development of novel antiviral strategies to combat acute respiratory infections caused by CoVs.  Recent studies suggest that nucleocapsid (N) proteins from coronaviruses and other viruses can be useful antiviral drug targets against viral infections.  This review aims to provide readers with a concise survey of the structural features of coronavirus N proteins and how these features provide insights into structure-based development of therapeutics against coronaviruses.  We will also present our latest results on MERS-CoV N protein and its potential as an antiviral drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNuHrvMgDnibVg90H21EOLACvtfcHk0ljtlVGGkb0nTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVemt7bF&md5=f6f949b2b3fe7f56e014075f73fb2e2d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DLo%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DHou%26aufirst%3DM.%2BH.%26atitle%3DRecent%2520insights%2520into%2520the%2520development%2520of%2520therapeutics%2520against%2520coronavirus%2520diseases%2520by%2520targeting%2520N%2520protein%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D562%26epage%3D572%26doi%3D10.1016%2Fj.drudis.2015.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sue, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. H.</span></span> <span> </span><span class="NLM_article-title">Modular organization of SARS coronavirus nucleocapsid protein</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1007/s11373-005-9035-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs11373-005-9035-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16228284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XntV2ht7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=59-72&issue=1&author=C.+K.+Changauthor=S.+C.+Sueauthor=T.+H.+Yuauthor=C.+M.+Hsiehauthor=C.+K.+Tsaiauthor=Y.+C.+Chiangauthor=S.+J.+Leeauthor=H.+H.+Hsiaoauthor=W.+J.+Wuauthor=W.+L.+Changauthor=C.+H.+Linauthor=T.+H.+Huang&title=Modular+organization+of+SARS+coronavirus+nucleocapsid+protein&doi=10.1007%2Fs11373-005-9035-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Modular organization of SARS coronavirus nucleocapsid protein</span></div><div class="casAuthors">Chang, Chung-ke; Sue, Shih-Che; Yu, Tsan-hung; Hsieh, Chiu-Min; Tsai, Cheng-Kun; Chiang, Yen-Chieh; Lee, Shin-jye; Hsiao, Hsin-hao; Wu, Wen-Jin; Chang, Wei-Lun; Lin, Chung-Hung; Huang, Tai-huang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Science (Dordrecht, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-72</span>CODEN:
                <span class="NLM_cas:coden">JBCIEA</span>;
        ISSN:<span class="NLM_cas:issn">1021-7770</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The SARS-CoV nucleocapsid (N) protein is a major antigen in severe acute respiratory syndrome.  It binds to the viral RNA genome and forms the ribonucleoprotein core.  The SARS-CoV N protein has also been suggested to be involved in other important functions in the viral life cycle.  Here we show that the N protein consists of two non-interacting structural domains, the N-terminal RNA-binding domain (RBD) (residues 45-181) and the C-terminal dimerization domain (residues 248-365) (DD), surrounded by flexible linkers.  The C-terminal domain exists exclusively as a dimer in soln.  The flexible linkers are intrinsically disordered and represent potential interaction sites with other protein and protein-RNA partners.  Bioinformatics reveal that other coronavirus N proteins could share the same modular organization.  This study provides information on the domain structure partition of SARS-CoV N protein and insights into the differing roles of structured and disordered regions in coronavirus nucleocapsid proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD70v9DrYd_bVg90H21EOLACvtfcHk0ljtlVGGkb0nTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntV2ht7w%253D&md5=6893641b9cc6430fca74a8ea077fbe23</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs11373-005-9035-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11373-005-9035-9%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DSue%26aufirst%3DS.%2BC.%26aulast%3DYu%26aufirst%3DT.%2BH.%26aulast%3DHsieh%26aufirst%3DC.%2BM.%26aulast%3DTsai%26aufirst%3DC.%2BK.%26aulast%3DChiang%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DHsiao%26aufirst%3DH.%2BH.%26aulast%3DWu%26aufirst%3DW.%2BJ.%26aulast%3DChang%26aufirst%3DW.%2BL.%26aulast%3DLin%26aufirst%3DC.%2BH.%26aulast%3DHuang%26aufirst%3DT.%2BH.%26atitle%3DModular%2520organization%2520of%2520SARS%2520coronavirus%2520nucleocapsid%2520protein%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2006%26volume%3D13%26issue%3D1%26spage%3D59%26epage%3D72%26doi%3D10.1007%2Fs11373-005-9035-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldham, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein dimerization domain reveals evolutionary linkage between corona- and arteriviridae</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">17134</span>– <span class="NLM_lpage">17139</span>, <span class="refDoi"> DOI: 10.1074/jbc.M602107200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M602107200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16627473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVGksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=17134-17139&issue=25&author=I.+M.+Yuauthor=M.+L.+Oldhamauthor=J.+Zhangauthor=J.+Chen&title=Crystal+structure+of+the+severe+acute+respiratory+syndrome+%28SARS%29+coronavirus+nucleocapsid+protein+dimerization+domain+reveals+evolutionary+linkage+between+corona-+and+arteriviridae&doi=10.1074%2Fjbc.M602107200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein Dimerization Domain Reveals Evolutionary Linkage between Corona- and Arteriviridae</span></div><div class="casAuthors">Yu, I-Mei; Oldham, Michael L.; Zhang, Jingqiang; Chen, Jue</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">17134-17139</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The causative agent of severe acute respiratory syndrome (SARS) is the SARS-assocd. coronavirus, SARS-CoV.  The nucleocapsid (N) protein plays an essential role in SARS-CoV genome packaging and virion assembly.  We have previously shown that SARS-CoV N protein forms a dimer in soln. through its C-terminal domain.  In this study, the crystal structure of the dimerization domain, consisting of residues 270-370, is detd. to 1.75Å resoln.  The structure shows a dimer with extensive interactions between the two subunits, suggesting that the dimeric form of the N protein is the functional unit in vivo.  Although lacking significant sequence similarity, the dimerization domain of SARS-CoV N protein has a fold similar to that of the nucleocapsid protein of the porcine reproductive and respiratory syndrome virus.  This finding provides structural evidence of the evolutionary link between Coronaviridae and Arteriviridae, suggesting that the N proteins of both viruses have a common origin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobnd_sO534aLVg90H21EOLACvtfcHk0ljtlVGGkb0nTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVGksbw%253D&md5=b546a5d031d2a20cd48abeb2f2da25e9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M602107200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M602107200%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DI.%2BM.%26aulast%3DOldham%26aufirst%3DM.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520%2528SARS%2529%2520coronavirus%2520nucleocapsid%2520protein%2520dimerization%2520domain%2520reveals%2520evolutionary%2520linkage%2520between%2520corona-%2520and%2520arteriviridae%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D25%26spage%3D17134%26epage%3D17139%26doi%3D10.1074%2Fjbc.M602107200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, M. H.</span></span> <span> </span><span class="NLM_article-title">Crystallographic analysis of the N-terminal domain of Middle East respiratory syndrome coronavirus nucleocapsid protein</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">977</span>– <span class="NLM_lpage">980</span>, <span class="refDoi"> DOI: 10.1107/S2053230X15010146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1107%2FS2053230X15010146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26249685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12gs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=977-980&issue=8&author=Y.+S.+Wangauthor=C.+K.+Changauthor=M.+H.+Hou&title=Crystallographic+analysis+of+the+N-terminal+domain+of+Middle+East+respiratory+syndrome+coronavirus+nucleocapsid+protein&doi=10.1107%2FS2053230X15010146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic analysis of the N-terminal domain of Middle East respiratory syndrome coronavirus nucleocapsid protein</span></div><div class="casAuthors">Wang, Yong-Sheng; Chang, Chung-ke; Hou, Ming-Hon</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">977-980</span>CODEN:
                <span class="NLM_cas:coden">ACSFEN</span>;
        ISSN:<span class="NLM_cas:issn">2053-230X</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The N-terminal domain of the nucleocapsid protein from Middle East respiratory syndrome coronavirus (MERS-CoV NP-NTD) contains many pos. charged residues and has been identified to be responsible for RNA binding during ribonucleocapsid formation by the virus.  The crystn. and crystallog. anal. of MERS-CoV NP-NTD (amino acids 39-165), with a mol. wt. of 14.7 kDa, are reported.  MERS-CoV NP-NTD was crystd. at 293 K using PEG 3350 as a precipitant and a 94.5% complete native data set was collected from a cooled crystal at 77 K to 2.63 Å resoln. with an overall R merge of 9.6%.  The crystals were monoclinic and belonged to space group P21, with a 35.60, b 109.64, c 91.99 Å, β 101.22°.  The asym. unit contained four MERS-CoV NP-NTD mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoen0Q4nKqiyLVg90H21EOLACvtfcHk0lj94b3q5jsEYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12gs7bN&md5=e7cd9bb84b6a153faf3164cc440d6290</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS2053230X15010146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053230X15010146%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DHou%26aufirst%3DM.%2BH.%26atitle%3DCrystallographic%2520analysis%2520of%2520the%2520N-terminal%2520domain%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520nucleocapsid%2520protein%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Commun.%26date%3D2015%26volume%3D71%26issue%3D8%26spage%3D977%26epage%3D980%26doi%3D10.1107%2FS2053230X15010146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehn-Hall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, M. H.</span></span> <span> </span><span class="NLM_article-title">Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3141</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01913</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01913" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktlOgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=3131-3141&issue=6&author=S.+M.+Linauthor=S.+C.+Linauthor=J.+N.+Hsuauthor=C.+K.+Changauthor=C.+M.+Chienauthor=Y.+S.+Wangauthor=H.+Y.+Wuauthor=U.+S.+Jengauthor=K.+Kehn-Hallauthor=M.+H.+Hou&title=Structure-based+stabilization+of+non-native+protein-protein+interactions+of+coronavirus+nucleocapsid+proteins+in+antiviral+drug+design&doi=10.1021%2Facs.jmedchem.9b01913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Stabilization of Non-native Protein-Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design</span></div><div class="casAuthors">Lin, Shan-Meng; Lin, Shih-Chao; Hsu, Jia-Ning; Chang, Chung-ke; Chien, Ching-Ming; Wang, Yong-Sheng; Wu, Hung-Yi; Jeng, U-Ser; Kehn-Hall, Kylene; Hou, Ming-Hon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3131-3141</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based stabilization of protein-protein interactions (PPIs) is a promising strategy for drug discovery.  However, this approach has mainly focused on the stabilization of native PPIs, and non-native PPIs have received little consideration.  Here, we identified a non-native interaction interface on the three-dimensional dimeric structure of the N-terminal domain of the MERS-CoV nucleocapsid protein (MERS-CoV N-NTD).  The interface formed a conserved hydrophobic cavity suitable for targeted drug screening.  By considering the hydrophobic complementarity during the virtual screening step, we identified 5-benzyloxygramine as a new N protein PPI orthosteric stabilizer that exhibits both antiviral and N-NTD protein-stabilizing activities.  X-ray crystallog. and small-angle X-ray scattering showed that 5-benzyloxygramine stabilizes the N-NTD dimers through simultaneous hydrophobic interactions with both partners, resulting in abnormal N protein oligomerization that was further confirmed in the cell.  This unique approach based on the identification and stabilization of non-native PPIs of N protein could be applied toward drug discovery against CoV diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVm43csqQD9rVg90H21EOLACvtfcHk0lj94b3q5jsEYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktlOgtro%253D&md5=7a38254192c8fd901ff85ba3d0086259</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01913%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%2BM.%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DHsu%26aufirst%3DJ.%2BN.%26aulast%3DChang%26aufirst%3DC.%2BK.%26aulast%3DChien%26aufirst%3DC.%2BM.%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DJeng%26aufirst%3DU.%2BS.%26aulast%3DKehn-Hall%26aufirst%3DK.%26aulast%3DHou%26aufirst%3DM.%2BH.%26atitle%3DStructure-based%2520stabilization%2520of%2520non-native%2520protein-protein%2520interactions%2520of%2520coronavirus%2520nucleocapsid%2520proteins%2520in%2520antiviral%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D6%26spage%3D3131%26epage%3D3141%26doi%3D10.1021%2Facs.jmedchem.9b01913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quadeer, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, M. R.</span></span> <span> </span><span class="NLM_article-title">Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">254</span>, <span class="refDoi"> DOI: 10.3390/v12030254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv12030254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVKlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=254&issue=3&author=S.+F.+Ahmedauthor=A.+A.+Quadeerauthor=M.+R.+McKay&title=Preliminary+identification+of+potential+vaccine+targets+for+the+COVID-19+coronavirus+%28SARS-CoV-2%29+based+on+SARS-CoV+immunological+studies&doi=10.3390%2Fv12030254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies</span></div><div class="casAuthors">Ahmed, Syed Faraz; Quadeer, Ahmed A.; McKay, Matthew R.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">254</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).  There is an imminent need to better understand this new virus and to develop ways to control its spread.  In this study, we sought to gain insights for vaccine design against SARS-CoV-2 by considering the high genetic similarity between SARS-CoV-2 and SARS-CoV, which caused the outbreak in 2003, and leveraging existing immunol. studies of SARS-CoV.  By screening the exptl.-detd. SARS-CoV-derived B cell and T cell epitopes in the immunogenic structural proteins of SARS-CoV, we identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to SARS-CoV-2 proteins.  As no mutation has been obsd. in these identified epitopes among the 120 available SARS-CoV-2 sequences (as of 21 Feb. 2020), immune targeting of these epitopes may potentially offer protection against this novel virus.  For the T cell epitopes, we performed a population coverage anal. of the assocd. MHC alleles and proposed a set of epitopes that is estd. to provide broad coverage globally, as well as in China.  Our findings provide a screened set of epitopes that can help guide exptl. efforts towards the development of vaccines against SARS-CoV-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLk6VGbroshLVg90H21EOLACvtfcHk0lj94b3q5jsEYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVKlsLk%253D&md5=257427542d56c4b904f0d92562b493fa</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3390%2Fv12030254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv12030254%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BF.%26aulast%3DQuadeer%26aufirst%3DA.%2BA.%26aulast%3DMcKay%26aufirst%3DM.%2BR.%26atitle%3DPreliminary%2520identification%2520of%2520potential%2520vaccine%2520targets%2520for%2520the%2520COVID-19%2520coronavirus%2520%2528SARS-CoV-2%2529%2520based%2520on%2520SARS-CoV%2520immunological%2520studies%26jtitle%3DViruses%26date%3D2020%26volume%3D12%26issue%3D3%26spage%3D254%26doi%3D10.3390%2Fv12030254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span> <span> </span><span class="NLM_article-title">Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">6</span>), <span class="NLM_elocation-id">e00461-20</span> <span class="refDoi"> DOI: 10.1128/JCM.00461-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJCM.00461-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32229605" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2020&issue=6&author=W.+Liuauthor=L.+Liuauthor=G.+Kouauthor=Y.+Zhengauthor=Y.+Dingauthor=W.+Niauthor=Q.+Wangauthor=L.+Tanauthor=W.+Wuauthor=S.+Tangauthor=Z.+Xiongauthor=S.+Zheng&title=Evaluation+of+nucleocapsid+and+spike+protein-based+enzyme-linked+immunosorbent+assays+for+detecting+antibodies+against+SARS-CoV-2&doi=10.1128%2FJCM.00461-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2FJCM.00461-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.00461-20%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKou%26aufirst%3DG.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DS.%26atitle%3DEvaluation%2520of%2520nucleocapsid%2520and%2520spike%2520protein-based%2520enzyme-linked%2520immunosorbent%2520assays%2520for%2520detecting%2520antibodies%2520against%2520SARS-CoV-2%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2020%26volume%3D58%26issue%3D6%26doi%3D10.1128%2FJCM.00461-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belouzard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licitra, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, G. R.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of coronavirus cell entry mediated by the viral spike protein</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.3390/v4061011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv4061011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22816037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFyltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1011-1033&issue=6&author=S.+Belouzardauthor=J.+K.+Milletauthor=B.+N.+Licitraauthor=G.+R.+Whittaker&title=Mechanisms+of+coronavirus+cell+entry+mediated+by+the+viral+spike+protein&doi=10.3390%2Fv4061011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of coronavirus cell entry mediated by the viral spike protein</span></div><div class="casAuthors">Belouzard, Sandrine; Millet, Jean K.; Licitra, Beth N.; Whittaker, Gary R.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1011-1033</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Coronaviruses are enveloped pos.-stranded RNA viruses that replicate in the cytoplasm.  To deliver their nucleocapsid into the host cell, they rely on the fusion of their envelope with the host cell membrane.  The spike glycoprotein (S) mediates virus entry and is a primary determinant of cell tropism and pathogenesis.  It is classified as a class I fusion protein, and is responsible for binding to the receptor on the host cell as well as mediating the fusion of host and viral membranes - A process driven by major conformational changes of the S protein.  This review discusses coronavirus entry mechanisms focusing on the different triggers used by coronaviruses to initiate the conformational change of the S protein: receptor binding, low pH exposure and proteolytic activation.  We also highlight commonalities between coronavirus S proteins and other class I viral fusion proteins, as well as distinctive features that confer distinct tropism, pathogenicity and host interspecies transmission characteristics to coronaviruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCenM_gs7LW7Vg90H21EOLACvtfcHk0lhWUFP_LWWYkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFyltrk%253D&md5=327223944a652c715b0a1550d0e4038a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3390%2Fv4061011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv4061011%26sid%3Dliteratum%253Aachs%26aulast%3DBelouzard%26aufirst%3DS.%26aulast%3DMillet%26aufirst%3DJ.%2BK.%26aulast%3DLicitra%26aufirst%3DB.%2BN.%26aulast%3DWhittaker%26aufirst%3DG.%2BR.%26atitle%3DMechanisms%2520of%2520coronavirus%2520cell%2520entry%2520mediated%2520by%2520the%2520viral%2520spike%2520protein%26jtitle%3DViruses%26date%3D2012%26volume%3D4%26issue%3D6%26spage%3D1011%26epage%3D1033%26doi%3D10.3390%2Fv4061011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lamballerie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span> <span> </span><span class="NLM_article-title">The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">104742</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2020.104742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2020.104742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32057769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFertr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2020&pages=104742&author=B.+Coutardauthor=C.+Valleauthor=X.+de+Lamballerieauthor=B.+Canardauthor=N.+G.+Seidahauthor=E.+Decroly&title=The+spike+glycoprotein+of+the+new+coronavirus+2019-nCoV+contains+a+furin-like+cleavage+site+absent+in+CoV+of+the+same+clade&doi=10.1016%2Fj.antiviral.2020.104742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade</span></div><div class="casAuthors">Coutard, B.; Valle, C.; de Lamballerie, X.; Canard, B.; Seidah, N. G.; Decroly, E.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104742</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In 2019, a new coronavirus (2019-nCoV) infecting Humans has emerged in Wuhan, China.  Its genome has been sequenced and the genomic information promptly released.  Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs.  In this article, we discuss the possible functional consequences of this cleavage site in the viral cycle, pathogenicity and its potential implication in the development of antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplFPbfI9oPe7Vg90H21EOLACvtfcHk0lhI0wF7KpMxWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFertr0%253D&md5=144e90f8ac4dc1a517c899b10c4a7a98</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2020.104742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2020.104742%26sid%3Dliteratum%253Aachs%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DValle%26aufirst%3DC.%26aulast%3Dde%2BLamballerie%26aufirst%3DX.%26aulast%3DCanard%26aufirst%3DB.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DDecroly%26aufirst%3DE.%26atitle%3DThe%2520spike%2520glycoprotein%2520of%2520the%2520new%2520coronavirus%25202019-nCoV%2520contains%2520a%2520furin-like%2520cleavage%2520site%2520absent%2520in%2520CoV%2520of%2520the%2520same%2520clade%26jtitle%3DAntiviral%2520Res.%26date%3D2020%26volume%3D176%26spage%3D104742%26doi%3D10.1016%2Fj.antiviral.2020.104742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirchdoerfer, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallesen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrapp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottrell, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span> <span> </span><span class="NLM_article-title">Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">15701</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-34171-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41598-018-34171-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30356097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB3cvivVWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=15701&issue=1&author=R.+N.+Kirchdoerferauthor=N.+Wangauthor=J.+Pallesenauthor=D.+Wrappauthor=H.+L.+Turnerauthor=C.+A.+Cottrellauthor=K.+S.+Corbettauthor=B.+S.+Grahamauthor=J.+S.+McLellanauthor=A.+B.+Ward&title=Stabilized+coronavirus+spikes+are+resistant+to+conformational+changes+induced+by+receptor+recognition+or+proteolysis&doi=10.1038%2Fs41598-018-34171-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis</span></div><div class="casAuthors">Kirchdoerfer Robert N; Pallesen Jesper; Turner Hannah L; Cottrell Christopher A; Ward Andrew B; Wang Nianshuang; Wrapp Daniel; McLellan Jason S; Wang Nianshuang; Wrapp Daniel; McLellan Jason S; Corbett Kizzmekia S; Graham Barney S</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15701</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 as a highly transmissible pathogenic human betacoronavirus.  The viral spike glycoprotein (S) utilizes angiotensin-converting enzyme 2 (ACE2) as a host protein receptor and mediates fusion of the viral and host membranes, making S essential to viral entry into host cells and host species tropism.  As SARS-CoV enters host cells, the viral S is believed to undergo a number of conformational transitions as it is cleaved by host proteases and binds to host receptors.  We recently developed stabilizing mutations for coronavirus spikes that prevent the transition from the pre-fusion to post-fusion states.  Here, we present cryo-EM analyses of a stabilized trimeric SARS-CoV S, as well as the trypsin-cleaved, stabilized S, and its interactions with ACE2.  Neither binding to ACE2 nor cleavage by trypsin at the S1/S2 cleavage site impart large conformational changes within stabilized SARS-CoV S or expose the secondary cleavage site, S2'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMhgmGs8bVb3O4gDb7JggCfW6udTcc2ea0bxTmiXTIt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvivVWmtw%253D%253D&md5=183ae3b2751cabbb4c132b7d931b3c34</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-34171-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-34171-7%26sid%3Dliteratum%253Aachs%26aulast%3DKirchdoerfer%26aufirst%3DR.%2BN.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DPallesen%26aufirst%3DJ.%26aulast%3DWrapp%26aufirst%3DD.%26aulast%3DTurner%26aufirst%3DH.%2BL.%26aulast%3DCottrell%26aufirst%3DC.%2BA.%26aulast%3DCorbett%26aufirst%3DK.%2BS.%26aulast%3DGraham%26aufirst%3DB.%2BS.%26aulast%3DMcLellan%26aufirst%3DJ.%2BS.%26aulast%3DWard%26aufirst%3DA.%2BB.%26atitle%3DStabilized%2520coronavirus%2520spikes%2520are%2520resistant%2520to%2520conformational%2520changes%2520induced%2520by%2520receptor%2520recognition%2520or%2520proteolysis%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26issue%3D1%26spage%3D15701%26doi%3D10.1038%2Fs41598-018-34171-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takayama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekizuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutsuna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmagari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kageyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span> <span> </span><span class="NLM_article-title">Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">7001</span>– <span class="NLM_lpage">7003</span>, <span class="refDoi"> DOI: 10.1073/pnas.2002589117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.2002589117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32165541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmt1Gju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=7001-7003&issue=13&author=S.+Matsuyamaauthor=N.+Naoauthor=K.+Shiratoauthor=M.+Kawaseauthor=S.+Saitoauthor=I.+Takayamaauthor=N.+Nagataauthor=T.+Sekizukaauthor=H.+Katohauthor=F.+Katoauthor=M.+Sakataauthor=M.+Taharaauthor=S.+Kutsunaauthor=N.+Ohmagariauthor=M.+Kurodaauthor=T.+Suzukiauthor=T.+Kageyamaauthor=M.+Takeda&title=Enhanced+isolation+of+SARS-CoV-2+by+TMPRSS2-expressing+cells&doi=10.1073%2Fpnas.2002589117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells</span></div><div class="casAuthors">Matsuyama, Shutoku; Nao, Naganori; Shirato, Kazuya; Kawase, Miyuki; Saito, Shinji; Takayama, Ikuyo; Nagata, Noriyo; Sekizuka, Tsuyoshi; Katoh, Hiroshi; Kato, Fumihiro; Sakata, Masafumi; Tahara, Maino; Kutsuna, Satoshi; Ohmagari, Norio; Kuroda, Makoto; Suzuki, Tadaki; Kageyama, Tsutomu; Takeda, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">7001-7003</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused a large respiratory outbreak in Wuhan, China in Dec. 2019, is currently spreading across many countries globally.  Here, we show that a TMPRSS2-expressing VeroE6 cell line is highly susceptible to SARS-CoV-2 infection, making it useful for isolating and propagating SARS-CoV-2.  Our results reveal that, in common with SARS- and Middle East respiratory syndrome-CoV, SARS-CoV-2 infection is enhanced by TMPRSS2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq65upK_3RQSLVg90H21EOLACvtfcHk0lg0JhkUf_R_IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmt1Gju7w%253D&md5=e56cdb5c3af49b0a518e291da54deaf6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2002589117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2002589117%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuyama%26aufirst%3DS.%26aulast%3DNao%26aufirst%3DN.%26aulast%3DShirato%26aufirst%3DK.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DTakayama%26aufirst%3DI.%26aulast%3DNagata%26aufirst%3DN.%26aulast%3DSekizuka%26aufirst%3DT.%26aulast%3DKatoh%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DF.%26aulast%3DSakata%26aufirst%3DM.%26aulast%3DTahara%26aufirst%3DM.%26aulast%3DKutsuna%26aufirst%3DS.%26aulast%3DOhmagari%26aufirst%3DN.%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKageyama%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3DEnhanced%2520isolation%2520of%2520SARS-CoV-2%2520by%2520TMPRSS2-expressing%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2020%26volume%3D117%26issue%3D13%26spage%3D7001%26epage%3D7003%26doi%3D10.1073%2Fpnas.2002589117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millet, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, G. R.</span></span> <span> </span><span class="NLM_article-title">Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis</span>. <i>Virus Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.virusres.2014.11.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virusres.2014.11.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25445340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2015&pages=120-134&author=J.+K.+Milletauthor=G.+R.+Whittaker&title=Host+cell+proteases%3A+Critical+determinants+of+coronavirus+tropism+and+pathogenesis&doi=10.1016%2Fj.virusres.2014.11.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis</span></div><div class="casAuthors">Millet, Jean Kaoru; Whittaker, Gary R.</div><div class="citationInfo"><span class="NLM_cas:title">Virus Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-134</span>CODEN:
                <span class="NLM_cas:coden">VIREDF</span>;
        ISSN:<span class="NLM_cas:issn">0168-1702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Coronaviruses are a large group of enveloped, single-stranded pos.-sense RNA viruses that infect a wide range of avian and mammalian species, including humans.  The emergence of deadly human coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) have bolstered research in these viral and often zoonotic pathogens.  While coronavirus cell and tissue tropism, host range, and pathogenesis are initially controlled by interactions between the spike envelope glycoprotein and host cell receptor, it is becoming increasingly apparent that proteolytic activation of spike by host cell proteases also plays a crit. role.  Coronavirus spike proteins are the main determinant of entry as they possess both receptor binding and fusion functions.  Whereas binding to the host cell receptor is an essential 1st step in establishing infection, the proteolytic activation step is often crit. for the fusion function of spike, as it allows for controlled release of the fusion peptide into target cellular membranes.  Coronaviruses have evolved multiple strategies for proteolytic activation of spike, and a large no. of host proteases have been shown to proteolytically process the spike protein.  These include, but are not limited to, endosomal cathepsins, cell surface transmembrane protease/serine (TMPRSS) proteases, furin, and trypsin.  This review focuses on the diversity of strategies coronaviruses have evolved to proteolytically activate their fusion protein during spike protein biosynthesis and the crit. entry step of their life cycle, and highlights important findings on how proteolytic activation of coronavirus spike influences tissue and cell tropism, host range, and pathogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzYtaR7rmObLVg90H21EOLACvtfcHk0lg0JhkUf_R_IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsbjN&md5=1f9248a8886148418b7f7e6109fd6796</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.virusres.2014.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virusres.2014.11.021%26sid%3Dliteratum%253Aachs%26aulast%3DMillet%26aufirst%3DJ.%2BK.%26aulast%3DWhittaker%26aufirst%3DG.%2BR.%26atitle%3DHost%2520cell%2520proteases%253A%2520Critical%2520determinants%2520of%2520coronavirus%2520tropism%2520and%2520pathogenesis%26jtitle%3DVirus%2520Res.%26date%3D2015%26volume%3D202%26spage%3D120%26epage%3D134%26doi%3D10.1016%2Fj.virusres.2014.11.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">6485</span>),  <span class="NLM_fpage">1444</span>– <span class="NLM_lpage">1448</span>, <span class="refDoi"> DOI: 10.1126/science.abb2762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abb2762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32132184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslymsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2020&pages=1444-1448&issue=6485&author=R.+Yanauthor=Y.+Zhangauthor=Y.+Liauthor=L.+Xiaauthor=Y.+Guoauthor=Q.+Zhou&title=Structural+basis+for+the+recognition+of+SARS-CoV-2+by+full-length+human+ACE2&doi=10.1126%2Fscience.abb2762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2</span></div><div class="casAuthors">Yan, Renhong; Zhang, Yuanyuan; Li, Yaning; Xia, Lu; Guo, Yingying; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6485</span>),
    <span class="NLM_cas:pages">1444-1448</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for severe acute respiratory syndrome coronavirus (SARS-CoV) and the new coronavirus (SARS-CoV-2) that is causing the serious coronavirus disease 2019 (COVID-19) epidemic.  Here, we present cryo-electron microscopy structures of full-length human ACE2 in the presence of the neutral amino acid transporter B0AT1 with or without the receptor binding domain (RBD) of the surface spike glycoprotein (S protein) of SARS-CoV-2, both at an overall resoln. of 2.9 angstroms, with a local resoln. of 3.5 angstroms at the ACE2-RBD interface.  The ACE2-B0AT1 complex is assembled as a dimer of heterodimers, with the collectrin-like domain of ACE2 mediating homodimerization.  The RBD is recognized by the extracellular peptidase domain of ACE2 mainly through polar residues.  These findings provide important insights into the mol. basis for coronavirus recognition and infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryg8CJeTxdsrVg90H21EOLACvtfcHk0lhpZbmXS8WZAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslymsLo%253D&md5=ff4dfdfc646ea878cfb325019160e94a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb2762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb2762%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DStructural%2520basis%2520for%2520the%2520recognition%2520of%2520SARS-CoV-2%2520by%2520full-length%2520human%2520ACE2%26jtitle%3DScience%26date%3D2020%26volume%3D367%26issue%3D6485%26spage%3D1444%26epage%3D1448%26doi%3D10.1126%2Fscience.abb2762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>581</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2180-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2180-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32225176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXoslOqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2020&pages=215-220&author=J.+Lanauthor=J.+Geauthor=J.+Yuauthor=S.+Shanauthor=H.+Zhouauthor=S.+Fanauthor=Q.+Zhangauthor=X.+Shiauthor=Q.+Wangauthor=L.+Zhangauthor=X.+Wang&title=Structure+of+the+SARS-CoV-2+spike+receptor-binding+domain+bound+to+the+ACE2+receptor&doi=10.1038%2Fs41586-020-2180-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor</span></div><div class="casAuthors">Lan, Jun; Ge, Jiwan; Yu, Jinfang; Shan, Sisi; Zhou, Huan; Fan, Shilong; Zhang, Qi; Shi, Xuanling; Wang, Qisheng; Zhang, Linqi; Wang, Xinquan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">7807</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A new and highly pathogenic coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) caused an outbreak in Wuhan city, Hubei province, China, starting from Dec. 2019 that quickly spread nationwide and to other countries around the world1-3.  Here, to better understand the initial step of infection at an at. level, we detd. the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2.  The overall ACE2-binding mode of the SARS-CoV-2 RBD is nearly identical to that of the SARS-CoV RBD, which also uses ACE2 as the cell receptor4.  Structural anal. identified residues in the SARS-CoV-2 RBD that are essential for ACE2 binding, the majority of which either are highly conserved or share similar side chain properties with those in the SARS-CoV RBD.  Such similarity in structure and sequence strongly indicate convergent evolution between the SARS-CoV-2 and SARS-CoV RBDs for improved binding to ACE2, although SARS-CoV-2 does not cluster within SARS and SARS-related coronaviruses1-3,5.  The epitopes of two SARS-CoV antibodies that target the RBD are also analyzed for binding to the SARS-CoV-2 RBD, providing insights into the future identification of cross-reactive antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXsiu14u7z5bVg90H21EOLACvtfcHk0lhpZbmXS8WZAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXoslOqtL8%253D&md5=279c60143e8e5eb505457e0778baa8ef</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2180-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2180-5%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DShan%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DStructure%2520of%2520the%2520SARS-CoV-2%2520spike%2520receptor-binding%2520domain%2520bound%2520to%2520the%2520ACE2%2520receptor%26jtitle%3DNature%26date%3D2020%26volume%3D581%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fs41586-020-2180-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aihara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auerbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">Structural basis of receptor recognition by SARS-CoV-2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>581</i></span> (<span class="NLM_issue">7807</span>),  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2179-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2179-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32225175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXoslOqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2020&pages=221-224&issue=7807&author=J.+Shangauthor=G.+Yeauthor=K.+Shiauthor=Y.+Wanauthor=C.+Luoauthor=H.+Aiharaauthor=Q.+Gengauthor=A.+Auerbachauthor=F.+Li&title=Structural+basis+of+receptor+recognition+by+SARS-CoV-2&doi=10.1038%2Fs41586-020-2179-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of receptor recognition by SARS-CoV-2</span></div><div class="casAuthors">Shang, Jian; Ye, Gang; Shi, Ke; Wan, Yushun; Luo, Chuming; Aihara, Hideki; Geng, Qibin; Auerbach, Ashley; Li, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">581</span>
        (<span class="NLM_cas:issue">7807</span>),
    <span class="NLM_cas:pages">221-224</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A novel severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2) recently emerged and is rapidly spreading in humans, causing COVID-191,2.  A key to tackling this pandemic is to understand the receptor recognition mechanism of the virus, which regulates its infectivity, pathogenesis and host range.  SARS-CoV-2 and SARS-CoV recognize the same receptor-angiotensin-converting enzyme 2 (ACE2)-in humans3,4.  Here we detd. the crystal structure of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 (engineered to facilitate crystn.) in complex with ACE2.  In comparison with the SARS-CoV RBD, an ACE2-binding ridge in SARS-CoV-2 RBD has a more compact conformation; moreover, several residue changes in the SARS-CoV-2 RBD stabilize two virus-binding hotspots at the RBD-ACE2 interface.  These structural features of SARS-CoV-2 RBD increase its ACE2-binding affinity.  Addnl., we show that RaTG13, a bat coronavirus that is closely related to SARS-CoV-2, also uses human ACE2 as its receptor.  The differences among SARS-CoV-2, SARS-CoV and RaTG13 in ACE2 recognition shed light on the potential animal-to-human transmission of SARS-CoV-2.  This study provides guidance for intervention strategies that target receptor recognition by SARS-CoV-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWGbLNpR7ZfrVg90H21EOLACvtfcHk0lhpZbmXS8WZAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXoslOqtbs%253D&md5=33bc9151641b2adcfb0dbf446621a1dc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2179-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2179-y%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DK.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DAihara%26aufirst%3DH.%26aulast%3DGeng%26aufirst%3DQ.%26aulast%3DAuerbach%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520of%2520receptor%2520recognition%2520by%2520SARS-CoV-2%26jtitle%3DNature%26date%3D2020%26volume%3D581%26issue%3D7807%26spage%3D221%26epage%3D224%26doi%3D10.1038%2Fs41586-020-2179-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geraghty, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">8904</span>– <span class="NLM_lpage">8911</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.325803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M111.325803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22291007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XjvVehtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=8904-8911&issue=12&author=K.+Wuauthor=G.+Pengauthor=M.+Wilkenauthor=R.+J.+Geraghtyauthor=F.+Li&title=Mechanisms+of+host+receptor+adaptation+by+severe+acute+respiratory+syndrome+coronavirus&doi=10.1074%2Fjbc.M111.325803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus</span></div><div class="casAuthors">Wu, Kailang; Peng, Guiqing; Wilken, Matthew; Geraghty, Robert J.; Li, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8904-8911</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The severe acute respiratory syndrome coronavirus (SARS-CoV) from palm civets has twice evolved the capacity to infect humans by gaining binding affinity for human receptor angiotensin-converting enzyme 2 (ACE2).  Numerous mutations have been identified in the receptor-binding domain (RBD) of different SARS-CoV strains isolated from humans or civets.  Why these mutations were naturally selected or how SARS-CoV evolved to adapt to different host receptors has been poorly understood, presenting evolutionary and epidemic conundrums.  In this study, we investigated the impact of these mutations on receptor recognition, an important determinant of SARS-CoV infection and pathogenesis.  Using a combination of biochem., functional, and crystallog. approaches, we elucidated the mol. and structural mechanisms of each of these naturally selected RBD mutations.  These mutations either strengthen favorable interactions or reduce unfavorable interactions with two virus-binding hot spots on ACE2, and by doing so, they enhance viral interactions with either human (hACE2) or civet (cACE2) ACE2.  Therefore, these mutations were viral adaptations to either hACE2 or cACE2.  To corroborate the above anal., we designed and characterized two optimized RBDs.  The human-optimized RBD contains all of the hACE2-adapted residues (Phe-442, Phe-472, Asn-479, Asp-480, and Thr-487) and possesses exceptionally high affinity for hACE2 but relative low affinity for cACE2.  The civet-optimized RBD contains all of the cACE2-adapted residues (Tyr-442, Pro-472, Arg-479, Gly-480, and Thr-487) and possesses exceptionally high affinity for cACE2 and also substantial affinity for hACE2.  These results not only illustrate the detailed mechanisms of host receptor adaptation by SARS-CoV but also provide a mol. and structural basis for tracking future SARS-CoV evolution in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6_iUt1EsgKLVg90H21EOLACvtfcHk0lhpZbmXS8WZAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjvVehtbs%253D&md5=5ddec3e87883170a6bcb222d7e71b823</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.325803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.325803%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DG.%26aulast%3DWilken%26aufirst%3DM.%26aulast%3DGeraghty%26aufirst%3DR.%2BJ.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DMechanisms%2520of%2520host%2520receptor%2520adaptation%2520by%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D12%26spage%3D8904%26epage%3D8911%26doi%3D10.1074%2Fjbc.M111.325803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Ooij, C.</span></span> <span> </span><span class="NLM_article-title">Parasitology: Basigin opens the door to malaria</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnrmicro2715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeitrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=3&issue=1&author=C.+van%0AOoij&title=Parasitology%3A+Basigin+opens+the+door+to+malaria&doi=10.1038%2Fnrmicro2715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Parasitology: Basigin opens the door to malaria</span></div><div class="casAuthors">van Ooij, Christiaan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The erythrocyte surface protein basigin is identified as the receptor for Rh5 using a large-scale screen, and probably mediates invasion of all Plasmodium falciparum strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRtMzFOIzKQLVg90H21EOLACvtfcHk0lgvfSKIcEEhgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeitrvO&md5=15f6b87aef6b79fd72c947a739a97c20</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2715%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BOoij%26aufirst%3DC.%26atitle%3DParasitology%253A%2520Basigin%2520opens%2520the%2520door%2520to%2520malaria%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2012%26volume%3D10%26issue%3D1%26spage%3D3%26doi%3D10.1038%2Fnrmicro2715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, Z.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-N.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 invades host cells via a novel route: CD147-spike protein</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">2020.03.14.988345</span>, (accessed 2020-05-30) <span class="refDoi"> DOI: 10.1101/2020.03.14.988345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.03.14.988345" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=2020.03.14.988345&author=K.+Wangauthor=W.+Chenauthor=Y.-S.+Zhouauthor=J.-Q.+Lianauthor=Z.+Zhangauthor=P.+Duauthor=L.+Gongauthor=Y.+Zhangauthor=H.-Y.+Cuiauthor=J.-J.+Gengauthor=B.+Wangauthor=X.-X.+Sunauthor=C.-F.+Wangauthor=X.+Yangauthor=P.+Linauthor=Y.-Q.+Dengauthor=D.+Weiauthor=X.-M.+Yangauthor=Y.-M.+Zhuauthor=K.+Zhangauthor=Z.-H.+Hengauthor=J.-L.+Miaoauthor=T.+Guoauthor=Y.+Shiauthor=J.+Zhangauthor=L.+Fuauthor=Q.-Y.+Wangauthor=H.+Bianauthor=P.+Zhuauthor=Z.-N.+Chen&title=SARS-CoV-2+invades+host+cells+via+a+novel+route%3A+CD147-spike+protein&doi=10.1101%2F2020.03.14.988345"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1101%2F2020.03.14.988345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.03.14.988345%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.-S.%26aulast%3DLian%26aufirst%3DJ.-Q.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DP.%26aulast%3DGong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCui%26aufirst%3DH.-Y.%26aulast%3DGeng%26aufirst%3DJ.-J.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DX.-X.%26aulast%3DWang%26aufirst%3DC.-F.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DDeng%26aufirst%3DY.-Q.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DX.-M.%26aulast%3DZhu%26aufirst%3DY.-M.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DHeng%26aufirst%3DZ.-H.%26aulast%3DMiao%26aufirst%3DJ.-L.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.-Y.%26aulast%3DBian%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.-N.%26atitle%3DSARS-CoV-2%2520invades%2520host%2520cells%2520via%2520a%2520novel%2520route%253A%2520CD147-spike%2520protein%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26spage%3D2020.03.14.988345%26doi%3D10.1101%2F2020.03.14.988345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispin, M.</span></span> <span> </span><span class="NLM_article-title">Exploitation of glycosylation in enveloped virus pathobiology</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1863</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">1497</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2019.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bbagen.2019.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31121217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVynsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2019&pages=1480-1497&issue=10&author=Y.+Watanabeauthor=T.+A.+Bowdenauthor=I.+A.+Wilsonauthor=M.+Crispin&title=Exploitation+of+glycosylation+in+enveloped+virus+pathobiology&doi=10.1016%2Fj.bbagen.2019.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Exploitation of glycosylation in enveloped virus pathobiology</span></div><div class="casAuthors">Watanabe, Yasunori; Bowden, Thomas A.; Wilson, Ian A.; Crispin, Max</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1480-1497</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glycosylation is a ubiquitous post-translational modification responsible for a multitude of crucial biol. roles.  As obligate parasites, viruses exploit host-cell machinery to glycosylate their own proteins during replication.  Viral envelope proteins from a variety of human pathogens including HIV-1, influenza virus, Lassa virus, SARS, Zika virus, dengue virus, and Ebola virus have evolved to be extensively glycosylated.  These host-cell derived glycans facilitate diverse structural and functional roles during the viral life-cycle, ranging from immune evasion by glycan shielding to enhancement of immune cell infection.  In this review, we highlight the imperative and auxiliary roles glycans play, and how specific oligosaccharide structures facilitate these functions during viral pathogenesis.  We discuss the growing efforts to exploit viral glycobiol. in the development of anti-viral vaccines and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKbaYVFU4N57Vg90H21EOLACvtfcHk0lgvfSKIcEEhgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVynsbvE&md5=118babe3b318937a35757e0cd5b57521</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2019.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2019.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DBowden%26aufirst%3DT.%2BA.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DCrispin%26aufirst%3DM.%26atitle%3DExploitation%2520of%2520glycosylation%2520in%2520enveloped%2520virus%2520pathobiology%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2019%26volume%3D1863%26issue%3D10%26spage%3D1480%26epage%3D1497%26doi%3D10.1016%2Fj.bbagen.2019.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pauthner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrabi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rantalainen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndsen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diedrich, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastidas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delahunty, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenaga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schief, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. C.</span></span> <span> </span><span class="NLM_article-title">Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3693</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06121-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41467-018-06121-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30209313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB3c3ot1aksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3693&issue=1&author=L.+Caoauthor=M.+Pauthnerauthor=R.+Andrabiauthor=K.+Rantalainenauthor=Z.+Berndsenauthor=J.+K.+Diedrichauthor=S.+Menisauthor=D.+Sokauthor=R.+Bastidasauthor=S.+R.+Parkauthor=C.+M.+Delahuntyauthor=L.+Heauthor=J.+Guenagaauthor=R.+T.+Wyattauthor=W.+R.+Schiefauthor=A.+B.+Wardauthor=J.+R.+Yatesauthor=D.+R.+Burtonauthor=J.+C.+Paulson&title=Differential+processing+of+HIV+envelope+glycans+on+the+virus+and+soluble+recombinant+trimer&doi=10.1038%2Fs41467-018-06121-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer</span></div><div class="casAuthors">Cao Liwei; Diedrich Jolene K; Park Sung-Kyu Robin; Delahunty Claire M; He Lin; Yates John R 3rd; Paulson James C; Cao Liwei; Pauthner Matthias; Andrabi Raiees; Menis Sergey; Sok Devin; Bastidas Raiza; Guenaga Javier; Wyatt Richard T; Schief William R; Burton Dennis R; Paulson James C; Cao Liwei; Pauthner Matthias; Andrabi Raiees; Rantalainen Kimmo; Berndsen Zachary; Menis Sergey; Sok Devin; Bastidas Raiza; Guenaga Javier; Wyatt Richard T; Schief William R; Ward Andrew B; Burton Dennis R; Paulson James C; Rantalainen Kimmo; Berndsen Zachary; Ward Andrew B; Burton Dennis R</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3693</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">As the sole target of broadly neutralizing antibodies (bnAbs) to HIV, the envelope glycoprotein (Env) trimer is the focus of vaccination strategies designed to elicit protective bnAbs in humans.  Because HIV Env is densely glycosylated with 75-90 N-glycans per trimer, most bnAbs use or accommodate them in their binding epitope, making the glycosylation of recombinant Env a key aspect of HIV vaccine design.  Upon analysis of three HIV strains, we here find that site-specific glycosylation of Env from infectious virus closely matches Envs from corresponding recombinant membrane-bound trimers.  However, viral Envs differ significantly from recombinant soluble, cleaved (SOSIP) Env trimers, strongly impacting antigenicity.  These results provide a benchmark for virus Env glycosylation needed for the design of soluble Env trimers as part of an overall HIV vaccine strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzp386o0m1EoNpW7w2tapOfW6udTcc2eZ9gBYlA8OSxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3ot1aksA%253D%253D&md5=d4daee53f36dffe65dff73789b3bf39e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06121-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06121-4%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DL.%26aulast%3DPauthner%26aufirst%3DM.%26aulast%3DAndrabi%26aufirst%3DR.%26aulast%3DRantalainen%26aufirst%3DK.%26aulast%3DBerndsen%26aufirst%3DZ.%26aulast%3DDiedrich%26aufirst%3DJ.%2BK.%26aulast%3DMenis%26aufirst%3DS.%26aulast%3DSok%26aufirst%3DD.%26aulast%3DBastidas%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DS.%2BR.%26aulast%3DDelahunty%26aufirst%3DC.%2BM.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DGuenaga%26aufirst%3DJ.%26aulast%3DWyatt%26aufirst%3DR.%2BT.%26aulast%3DSchief%26aufirst%3DW.%2BR.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DPaulson%26aufirst%3DJ.%2BC.%26atitle%3DDifferential%2520processing%2520of%2520HIV%2520envelope%2520glycans%2520on%2520the%2520virus%2520and%2520soluble%2520recombinant%2520trimer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D3693%26doi%3D10.1038%2Fs41467-018-06121-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frabutt, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. H.</span></span> <span> </span><span class="NLM_article-title">Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5860</span>– <span class="NLM_lpage">5870</span>, <span class="refDoi"> DOI: 10.1074/jbc.M116.768168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M116.768168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28196864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslCrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=5860-5870&issue=14&author=B.+Wangauthor=Y.+Wangauthor=D.+A.+Frabuttauthor=X.+Zhangauthor=X.+Yaoauthor=D.+Huauthor=Z.+Zhangauthor=C.+Liuauthor=S.+Zhengauthor=S.+H.+Xiangauthor=Y.+H.+Zheng&title=Mechanistic+understanding+of+N-glycosylation+in+Ebola+virus+glycoprotein+maturation+and+function&doi=10.1074%2Fjbc.M116.768168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function</span></div><div class="casAuthors">Wang, Bin; Wang, Yujie; Frabutt, Dylan A.; Zhang, Xihe; Yao, Xiaoyu; Hu, Dan; Zhang, Zhuo; Liu, Chaonan; Zheng, Shimin; Xiang, Shi-Hua; Zheng, Yong-Hui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5860-5870</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The Ebola virus (EBOV) trimeric envelope glycoprotein (GP) precursors are cleaved into the receptor-binding GP1 and the fusion-mediating GP2 subunits and incorporated into virions to initiate infection.  GP1 and GP2 form heterodimers that have 15 or 2 N-glycosylation sites (NGSs), resp.  Here we investigated the mechanism of how N-glycosylation contributes to GP expression, maturation, and function.  As reported before, we found that, although GP1 NGSs are not crit., the 2 GP2 NGSs, Asn563 and Asn618, are essential for GP function.  Further anal. uncovered that Asn563 and Asn618 regulate GP processing, demannosylation, oligomerization, and conformation.  Consequently, these 2 NGSs are required for GP incorporation into EBOV-like particles and HIV type 1 (HIV-1) pseudovirions and det. viral transduction efficiency.  Using CRISPR/Cas9 technol., we knocked out the 2 classical endoplasmic reticulum chaperones calnexin (CNX) and/or calreticulin (CRT) and found that both CNX and CRT increase GP expression.  Nevertheless, NGSs are not required for the GP interaction with CNX or CRT.  Together, we conclude that, although Asn563 and Asn618 are not required for EBOV GP expression, they synergistically regulate its maturation, which dets. its functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp07YJsehboBbVg90H21EOLACvtfcHk0lhK7AOlj0AHJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslCrsLw%253D&md5=1ccb977ccf3c9d69176b050baf0d2713</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M116.768168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M116.768168%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFrabutt%26aufirst%3DD.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DXiang%26aufirst%3DS.%2BH.%26aulast%3DZheng%26aufirst%3DY.%2BH.%26atitle%3DMechanistic%2520understanding%2520of%2520N-glycosylation%2520in%2520Ebola%2520virus%2520glycoprotein%2520maturation%2520and%2520function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D14%26spage%3D5860%26epage%3D5870%26doi%3D10.1074%2Fjbc.M116.768168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span> <span> </span><span class="NLM_article-title">Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>86</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3446</span>– <span class="NLM_lpage">3451</span>, <span class="refDoi"> DOI: 10.1128/JVI.06147-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.06147-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22258255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlOkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=3446-3451&issue=7&author=Y.+Kobayashiauthor=Y.+Suzuki&title=Evidence+for+N-glycan+shielding+of+antigenic+sites+during+evolution+of+human+influenza+A+virus+hemagglutinin&doi=10.1128%2FJVI.06147-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin</span></div><div class="casAuthors">Kobayashi, Yuki; Suzuki, Yoshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3446-3451</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">After the emergence of influenza A viruses in the human population, the no. of N-glycosylation sites (NGS) in the globular head region of hemagglutinin (HA) has increased continuously for several decades.  It has been speculated that the addn. of NGS to the globular head region of HA has conferred selective advantages to the virus by preventing the binding of antibodies (Ab) to antigenic sites (AS).  Here, the effect of N-glycosylation on the binding of Ab to AS in human influenza A virus subtype H3N2 (A/H3N2) was examd. by inferring natural selection at AS and other sites (NAS) that are located close to and distantly from the NGS in the three-dimensional structure of HA through a comparison of the rates of synonymous (dS) and nonsynonymous (dN) substitutions.  When positions 63, 122, 126, 133, 144, and 246 in the globular head region of HA were non-NGS, the dN/dS was >1 and pos. selection was detected at the AS located near these positions.  However, the dN/dS value decreased and the evidence of pos. selection disappeared when these positions became NGS.  In contrast, dN/dS at the AS distantly located from the positions mentioned above and at the NAS of any location were generally <1 and did not decrease when these positions changed from non-NGS to NGS.  These results suggest that the attachment of N-glycans to the NGS in the globular head region of HA prevented the binding of Ab to AS in the evolutionary history of human A/H3N2 virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKJBRSlM4_QLVg90H21EOLACvtfcHk0lhK7AOlj0AHJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlOkt7k%253D&md5=4411592534d867a7326821f3ba7fdcaa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1128%2FJVI.06147-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.06147-11%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DY.%26atitle%3DEvidence%2520for%2520N-glycan%2520shielding%2520of%2520antigenic%2520sites%2520during%2520evolution%2520of%2520human%2520influenza%2520A%2520virus%2520hemagglutinin%26jtitle%3DJ.%2520Virol%26date%3D2012%26volume%3D86%26issue%3D7%26spage%3D3446%26epage%3D3451%26doi%3D10.1128%2FJVI.06147-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span> <span> </span><span class="NLM_article-title">Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13473</span>, <span class="refDoi"> DOI: 10.1038/ncomms13473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fncomms13473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27874853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13473&author=L.+Duauthor=W.+Taiauthor=Y.+Yangauthor=G.+Zhaoauthor=Q.+Zhuauthor=S.+Sunauthor=C.+Liuauthor=X.+Taoauthor=C.+K.+Tsengauthor=S.+Perlmanauthor=S.+Jiangauthor=Y.+Zhouauthor=F.+Li&title=Introduction+of+neutralizing+immunogenicity+index+to+the+rational+design+of+MERS+coronavirus+subunit+vaccines&doi=10.1038%2Fncomms13473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines</span></div><div class="casAuthors">Du, Lanying; Tai, Wanbo; Yang, Yang; Zhao, Guangyu; Zhu, Qing; Sun, Shihui; Liu, Chang; Tao, Xinrong; Tseng, Chien-Te K.; Perlman, Stanley; Jiang, Shibo; Zhou, Yusen; Li, Fang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13473</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Viral subunit vaccines often contain immunodominant non-neutralizing epitopes that divert host immune responses.  These epitopes should be eliminated in vaccine design, but there is no reliable method for evaluating an epitope's capacity to elicit neutralizing immune responses.  Here we introduce a new concept 'neutralizing immunogenicity index' (NII) to evaluate an epitope's neutralizing immunogenicity.  To det. the NII, we mask the epitope with a glycan probe and then assess the epitope's contribution to the vaccine's overall neutralizing immunogenicity.  As proof-of-concept, we measure the NII for different epitopes on an immunogen comprised of the receptor-binding domain from MERS coronavirus (MERS-CoV).  Further, we design a variant form of this vaccine by masking an epitope that has a neg. NII score.  This engineered vaccine demonstrates significantly enhanced efficacy in protecting transgenic mice from lethal MERS-CoV challenge.  Our study may guide the rational design of highly effective subunit vaccines to combat MERS-CoV and other life-threatening viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSiUBJWm2vqbVg90H21EOLACvtfcHk0lheNCyDrtBT4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnsrbF&md5=319186420fafe6170d845a6b86d1c80b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fncomms13473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13473%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DL.%26aulast%3DTai%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTseng%26aufirst%3DC.%2BK.%26aulast%3DPerlman%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DF.%26atitle%3DIntroduction%2520of%2520neutralizing%2520immunogenicity%2520index%2520to%2520the%2520rational%2520design%2520of%2520MERS%2520coronavirus%2520subunit%2520vaccines%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13473%26doi%3D10.1038%2Fncomms13473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vankadari, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilce, J. A.</span></span> <span> </span><span class="NLM_article-title">Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1080/22221751.2020.1739565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F22221751.2020.1739565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32178593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovVWmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=601-604&issue=1&author=N.+Vankadariauthor=J.+A.+Wilce&title=Emerging+WuHan+%28COVID-19%29+coronavirus%3A+glycan+shield+and+structure+prediction+of+spike+glycoprotein+and+its+interaction+with+human+CD26&doi=10.1080%2F22221751.2020.1739565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging WuHan COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26</span></div><div class="casAuthors">Vankadari, Naveen; Wilce, Jacqueline A.</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Microbes & Infections</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">601-604</span>CODEN:
                <span class="NLM_cas:coden">EMIMC4</span>;
        ISSN:<span class="NLM_cas:issn">2222-1751</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The recent outbreak of pneumonia-causing COVID-19 in China is an urgent global public health issue with an increase in mortality and morbidity.  Here we report our modeled homo-trimer structure of COVID-19 spike glycoprotein in both closed (ligand-free) and open (ligand-bound) conformation, which is involved in host cell adhesion.  We also predict the unique N- and O-linked glycosylation sites of spike glycoprotein that distinguish it from the SARS and underlines shielding and camouflage of COVID-19 from the host the defense system.  Furthermore, our study also highlights the key finding that the S1 domain of COVID-19 spike glycoprotein potentially interacts with the human CD26, a key immunoregulatory factor for hijacking and virulence.  These findings accentuate the unique features of COVID-19 and assist in the development of new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5tmi4hUkTjbVg90H21EOLACvtfcHk0lheNCyDrtBT4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovVWmtLo%253D&md5=2c2b7e272585e9f5257191bb6e8df4c2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1080%2F22221751.2020.1739565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F22221751.2020.1739565%26sid%3Dliteratum%253Aachs%26aulast%3DVankadari%26aufirst%3DN.%26aulast%3DWilce%26aufirst%3DJ.%2BA.%26atitle%3DEmerging%2520WuHan%2520%2528COVID-19%2529%2520coronavirus%253A%2520glycan%2520shield%2520and%2520structure%2520prediction%2520of%2520spike%2520glycoprotein%2520and%2520its%2520interaction%2520with%2520human%2520CD26%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2020%26volume%3D9%26issue%3D1%26spage%3D601%26epage%3D604%26doi%3D10.1080%2F22221751.2020.1739565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndsen, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghwani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabright, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pybus, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLellan, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowden, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispin, M.</span></span> <span> </span><span class="NLM_article-title">Vulnerabilities in coronavirus glycan shields despite extensive glycosylation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2688</span>, <span class="refDoi"> DOI: 10.1038/s41467-020-16567-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41467-020-16567-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32461612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVCmu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=2688&author=Y.+Watanabeauthor=Z.+T.+Berndsenauthor=J.+Raghwaniauthor=G.+E.+Seabrightauthor=J.+D.+Allenauthor=O.+G.+Pybusauthor=J.+S.+McLellanauthor=I.+A.+Wilsonauthor=T.+A.+Bowdenauthor=A.+B.+Wardauthor=M.+Crispin&title=Vulnerabilities+in+coronavirus+glycan+shields+despite+extensive+glycosylation&doi=10.1038%2Fs41467-020-16567-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Vulnerabilities in coronavirus glycan shields despite extensive glycosylation</span></div><div class="casAuthors">Watanabe, Yasunori; Berndsen, Zachary T.; Raghwani, Jayna; Seabright, Gemma E.; Allen, Joel D.; Pybus, Oliver G.; McLellan, Jason S.; Wilson, Ian A.; Bowden, Thomas A.; Ward, Andrew B.; Crispin, Max</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2688</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential.  Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.  Coronavirus S proteins are extensively glycosylated, encoding around 66-87 N-linked glycosylation sites per trimeric spike.  Here, we reveal a specific area of high glycan d. on MERS S that results in the formation of oligomannose-type glycan clusters, which were absent on SARS and HKU1 CoVs.  We provide a comparison of the global glycan d. of coronavirus spikes with other viral proteins including HIV-1 envelope, Lassa virus glycoprotein complex, and influenza hemagglutinin, where glycosylation plays a known role in shielding immunogenic epitopes.  Overall, our data reveal how organization of glycosylation across class I viral fusion proteins influence not only individual glycan compns. but also the immunol. pressure across the protein surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7yDcmatMh27Vg90H21EOLACvtfcHk0lheNCyDrtBT4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVCmu77L&md5=2c0ce9b10f2a8d10d6889e975e9e09b3</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-16567-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-16567-0%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DBerndsen%26aufirst%3DZ.%2BT.%26aulast%3DRaghwani%26aufirst%3DJ.%26aulast%3DSeabright%26aufirst%3DG.%2BE.%26aulast%3DAllen%26aufirst%3DJ.%2BD.%26aulast%3DPybus%26aufirst%3DO.%2BG.%26aulast%3DMcLellan%26aufirst%3DJ.%2BS.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DBowden%26aufirst%3DT.%2BA.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DCrispin%26aufirst%3DM.%26atitle%3DVulnerabilities%2520in%2520coronavirus%2520glycan%2520shields%2520despite%2520extensive%2520glycosylation%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26spage%3D2688%26doi%3D10.1038%2Fs41467-020-16567-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Potential antivirals and antiviral strategies against SARS coronavirus infections</span>. <i>Expert Rev. Anti-Infect. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1586/14787210.4.2.291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1586%2F14787210.4.2.291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16597209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVSjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=291-302&issue=2&author=E.+De%0AClercq&title=Potential+antivirals+and+antiviral+strategies+against+SARS+coronavirus+infections&doi=10.1586%2F14787210.4.2.291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Potential antivirals and antiviral strategies against SARS coronavirus infections</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-302</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  There are a no. of antivirals as well as antiviral strategies that could be envisaged to prevent or treat severe acute respiratory syndrome (SARS) (or similar) coronavirus (CoV) infections.  Targets for the prophylactic or therapeutic interventions include interaction of the spike (S) glycoprotein (S1 domain) with the host cell receptor, fusion of the S2 domain with the host cell membrane, processing of the replicase polyproteins by the virus-encoded proteases (3C-like cysteine protease (3CLpro) and papain-like cysteine protease) and other virus-encoded enzymes such as the NTPase/helicase and RNA-dependent RNA polymerase.  Human monoclonal antibody blocking S1 may play an important role in the immunoprophylaxis of SARS.  Fusion inhibitors reminiscent of enfuvirtide in the case of HIV may also be developed for SARS-CoV.  Various peptidomimetic and nonpeptidic inhibitors of 3CLpro have been described, the best ones inhibiting SARS-CoV replication with a selectivity index greater than 1000.  Human interferons, in particular α- and β-interferon, as well as short interfering RNAs could further be pursued for the control of SARS.  Various other compds., often with an ill-defined mode of action but selectivity indexes up to 100, have been reported to exhibit in vitro activity against SARS-CoV: valinomycin, glycopeptide antibiotics, plant lectins, hesperetin, glycyrrhizin, aurintricarboxylic acid, chloroquine, niclosamide, nelfinavir and calpain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXOPwb1SdlYrVg90H21EOLACvtfcHk0lgh-DG8cWswaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVSjsbc%253D&md5=cfb032a429ff40c0340c00cca046b617</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1586%2F14787210.4.2.291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14787210.4.2.291%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DPotential%2520antivirals%2520and%2520antiviral%2520strategies%2520against%2520SARS%2520coronavirus%2520infections%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2006%26volume%3D4%26issue%3D2%26spage%3D291%26epage%3D302%26doi%3D10.1586%2F14787210.4.2.291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olurinde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellini, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marasco, W. A.</span></span> <span> </span><span class="NLM_article-title">Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2536</span>– <span class="NLM_lpage">2541</span>, <span class="refDoi"> DOI: 10.1073/pnas.0307140101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.0307140101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=14983044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvVOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=2536-2541&issue=8&author=J.+Suiauthor=W.+Liauthor=A.+Murakamiauthor=A.+Taminauthor=L.+J.+Matthewsauthor=S.+K.+Wongauthor=M.+J.+Mooreauthor=A.+S.+Tallaricoauthor=M.+Olurindeauthor=H.+Choeauthor=L.+J.+Andersonauthor=W.+J.+Belliniauthor=M.+Farzanauthor=W.+A.+Marasco&title=Potent+neutralization+of+severe+acute+respiratory+syndrome+%28SARS%29+coronavirus+by+a+human+mAb+to+S1+protein+that+blocks+receptor+association&doi=10.1073%2Fpnas.0307140101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association</span></div><div class="casAuthors">Sui, Jianhua; Li, Wenhui; Murakami, Akikazu; Tamin, Azaibi; Matthews, Leslie J.; Wong, Swee Kee; Moore, Michael J.; St. Clair Tallarico, Aimee; Olurinde, Mobolaji; Choe, Hyeryun; Anderson, Larry J.; Bellini, William J.; Farzan, Michael; Marasco, Wayne A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2536-2541</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Effective prophylaxis and antiviral therapies are urgently needed in the event of reemergence of the highly contagious and often fatal severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) infection.  We have identified eight recombinant human single-chain variable region fragments (scFvs) against the S1 domain of spike (S) protein of the SARS-CoV from two nonimmune human antibody libraries.  One scFv 80R efficiently neutralized SARS-CoV and inhibited syncytia formation between cells expressing the S protein and those expressing the SARS-CoV receptor angiotensin-converting enzyme 2 (ACE2).  Mapping of the 80R epitope showed it is located within the N-terminal 261-672 amino acids of S protein and is not glycosylation-dependent.  80R scFv competed with sol. ACE2 for assocn. with the S1 domain and bound S1 with high affinity (equil. dissocn. const., Kd = 32.3 nM).  A human IgG1 form of 80R bound S1 with a 20-fold higher affinity of 1.59 nM comparable to that of ACE2 (Kd = 1.70 nM), and neutralized virus 20-fold more efficiently than the 80R scFv.  These data suggest that the 80R human monoclonal antibody may be a useful viral entry inhibitor for the emergency prophylaxis and treatment of SARS, and that the ACE2-binding site of S1 could be an attractive target for subunit vaccine and drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCmGLS2n0GJ7Vg90H21EOLACvtfcHk0lgh-DG8cWswaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvVOit7o%253D&md5=aaad87eb1341be70f4d095cc28206a1d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0307140101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0307140101%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTamin%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DL.%2BJ.%26aulast%3DWong%26aufirst%3DS.%2BK.%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26aulast%3DTallarico%26aufirst%3DA.%2BS.%26aulast%3DOlurinde%26aufirst%3DM.%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DAnderson%26aufirst%3DL.%2BJ.%26aulast%3DBellini%26aufirst%3DW.%2BJ.%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DMarasco%26aufirst%3DW.%2BA.%26atitle%3DPotent%2520neutralization%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520%2528SARS%2529%2520coronavirus%2520by%2520a%2520human%2520mAb%2520to%2520S1%2520protein%2520that%2520blocks%2520receptor%2520association%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D8%26spage%3D2536%26epage%3D2541%26doi%3D10.1073%2Fpnas.0307140101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span> <span> </span><span class="NLM_article-title">The spike protein of SARS-CoV--a target for vaccine and therapeutic development</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">226</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnrmicro2090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19198616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFeqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=226-236&issue=3&author=L.+Duauthor=Y.+Heauthor=Y.+Zhouauthor=S.+Liuauthor=B.+J.+Zhengauthor=S.+Jiang&title=The+spike+protein+of+SARS-CoV%2D%2Da+target+for+vaccine+and+therapeutic+development&doi=10.1038%2Fnrmicro2090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The spike protein of SARS-CoV - a target for vaccine and therapeutic development</span></div><div class="casAuthors">Du, Lanying; He, Yuxian; Zhou, Yusen; Liu, Shuwen; Zheng, Bo-Jian; Jiang, Shibo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">226-236</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused by a novel coronavirus, SARS-coronavirus (SARS-CoV).  The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes.  The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV.  In this Review, we highlight recent advances in the development of vaccines and therapeutics based on the S protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro2X_2acd0E7Vg90H21EOLACvtfcHk0lgh-DG8cWswaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFeqs7Y%253D&md5=610a46a8fed820bf5d0076e7c7d03c13</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2090%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DB.%2BJ.%26aulast%3DJiang%26aufirst%3DS.%26atitle%3DThe%2520spike%2520protein%2520of%2520SARS-CoV--a%2520target%2520for%2520vaccine%2520and%2520therapeutic%2520development%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2009%26volume%3D7%26issue%3D3%26spage%3D226%26epage%3D236%26doi%3D10.1038%2Fnrmicro2090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adedeji, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severson, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms</span>. <i>J. Virol</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">8017</span>– <span class="NLM_lpage">8028</span>, <span class="refDoi"> DOI: 10.1128/JVI.00998-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.00998-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23678171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFWjt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=8017-8028&issue=14&author=A.+O.+Adedejiauthor=W.+Seversonauthor=C.+Jonssonauthor=K.+Singhauthor=S.+R.+Weissauthor=S.+G.+Sarafianos&title=Novel+inhibitors+of+severe+acute+respiratory+syndrome+coronavirus+entry+that+act+by+three+distinct+mechanisms&doi=10.1128%2FJVI.00998-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms</span></div><div class="casAuthors">Adedeji, Adeyemi O.; Severson, William; Jonsson, Colleen; Singh, Kamalendra; Weiss, Susan R.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">8017-8028</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome (SARS) is an infectious and highly contagious disease that is caused by SARS coronavirus (SARS-CoV) and for which there are currently no approved treatments.  We report the discovery and characterization of small-mol. inhibitors of SARS-CoV replication that block viral entry by three different mechanisms.  The compds. were discovered by screening a chem. library of compds. for blocking of entry of HIV-1 pseudotyped with SARS-CoV surface glycoprotein S (SARS-S) but not that of HIV-1 pseudotyped with vesicular stomatitis virus surface glycoprotein G (VSV-G).  Studies on their mechanisms of action revealed that the compds. act by three distinct mechanisms: (i) SSAA09E2 {N-[[4-(4-methyl-piperazin-1-yl)phenyl]methyl]-1,2-oxazole-5-carboxamide} acts through a novel mechanism of action, by blocking early interactions of SARS-S with the receptor for SARS-CoV, angiotensin converting enzyme 2 (ACE2); (ii) SSAA09E1 {[(Z)-1-thiophen-2-ylethylideneamino]thiourea} acts later, by blocking cathepsin L, a host protease required for processing of SARS-S during viral entry; and (iii) SSAA09E3 [N-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide] also acts later and does not affect interactions of SARS-S with ACE2 or the enzymic functions of cathepsin L but prevents fusion of the viral membrane with the host cellular membrane.  Our work demonstrates that there are at least three independent strategies for blocking SARS-CoV entry, validates these mechanisms of inhibition, and introduces promising leads for the development of SARS therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHgZhKpvdh87Vg90H21EOLACvtfcHk0lgh-DG8cWswaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFWjt73N&md5=11a6f72e02435e32c86006993ec4487d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1128%2FJVI.00998-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00998-13%26sid%3Dliteratum%253Aachs%26aulast%3DAdedeji%26aufirst%3DA.%2BO.%26aulast%3DSeverson%26aufirst%3DW.%26aulast%3DJonsson%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DWeiss%26aufirst%3DS.%2BR.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DNovel%2520inhibitors%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520entry%2520that%2520act%2520by%2520three%2520distinct%2520mechanisms%26jtitle%3DJ.%2520Virol%26date%3D2013%26volume%3D87%26issue%3D14%26spage%3D8017%26epage%3D8028%26doi%3D10.1128%2FJVI.00998-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escalante, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tien, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span> <span> </span><span class="NLM_article-title">Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>363</i></span> (<span class="NLM_issue">9413</span>),  <span class="NLM_fpage">938</span>– <span class="NLM_lpage">947</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(04)15788-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2804%2915788-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15043961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVSktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2004&pages=938-947&issue=9413&author=S.+Liuauthor=G.+Xiaoauthor=Y.+Chenauthor=Y.+Heauthor=J.+Niuauthor=C.+R.+Escalanteauthor=H.+Xiongauthor=J.+Farmarauthor=A.+K.+Debnathauthor=P.+Tienauthor=S.+Jiang&title=Interaction+between+heptad+repeat+1+and+2+regions+in+spike+protein+of+SARS-associated+coronavirus%3A+implications+for+virus+fusogenic+mechanism+and+identification+of+fusion+inhibitors&doi=10.1016%2FS0140-6736%2804%2915788-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors</span></div><div class="casAuthors">Liu, Shuwen; Xiao, Gengfu; Chen, Yibang; He, Yuxian; Niu, Jinkui; Escalante, Carlos R.; Xiong, Huabao; Farmar, James; Debnath, Asim K.; Tien, Po; Jiang, Shibo</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9413</span>),
    <span class="NLM_cas:pages">938-947</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Studies on the fusion-inhibitory peptides derived from the heptad repeat 1 and 2 (HR1 and HR2) regions of the HIV-1 envelope glycoprotein gp41 provided crucial information on the viral fusogenic mechanism.  We used a similar approach to study the fusogenic mechanism of severe-acute-respiratory-syndrome-assocd. coronavirus (SARS-CoV).  We tested the inhibitory activity against infection of two sets of peptides corresponding to sequences of SARS-CoV spike protein HR1 and HR2 regions and investigated the interactions between the HR1 and HR2 peptides by surface plasmon resonance, sedimentation equilibration anal., CD, native polyacrylamide-gel electrophoresis, size exclusion high-performance liq. chromatog., and computer-aided homol. modeling and mol. docking anal.  One peptide, CP-1, derived from the HR2 region, inhibited SARS-CoV infection in the micromolar range.  CP-1 bound with high affinity to a peptide from the HR1 region, NP-1.  CP-1 alone had low α-helicity and self-assocd. to form a trimer in phosphate buffer (pH 7.2).  CP-1 and NP-1 mixed in equimolar concns. formed a six-helix bundle, similar to the fusogenic core structure of HIV-1 gp41.  After binding to the target cell, the transmembrane spike protein might change conformation by assocn. between the HR1 and HR2 regions to form an oligomeric structure, leading to fusion between the viral and target-cell membranes.  At the pre-fusion intermediate state, CP-1 could bind to the HR1 region and interfere with the conformational changes, resulting in inhibition of SARS-CoV fusion with the target cells.  CP-1 might be modifiable to increase its anti-SARS-CoV activity and could be further developed as an antiviral agent for treatment or prophylaxis of SARS-CoV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyJ48QTsOnQbVg90H21EOLACvtfcHk0ljIt88E85eaUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVSktbo%253D&md5=578507918c57e2419c24213bea2c978f</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2804%2915788-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252804%252915788-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DJ.%26aulast%3DEscalante%26aufirst%3DC.%2BR.%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DFarmar%26aufirst%3DJ.%26aulast%3DDebnath%26aufirst%3DA.%2BK.%26aulast%3DTien%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DS.%26atitle%3DInteraction%2520between%2520heptad%2520repeat%25201%2520and%25202%2520regions%2520in%2520spike%2520protein%2520of%2520SARS-associated%2520coronavirus%253A%2520implications%2520for%2520virus%2520fusogenic%2520mechanism%2520and%2520identification%2520of%2520fusion%2520inhibitors%26jtitle%3DLancet%26date%3D2004%26volume%3D363%26issue%3D9413%26spage%3D938%26epage%3D947%26doi%3D10.1016%2FS0140-6736%2804%2915788-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1038/s41422-020-0305-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41422-020-0305-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32231345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=343-355&issue=4&author=S.+Xiaauthor=M.+Liuauthor=C.+Wangauthor=W.+Xuauthor=Q.+Lanauthor=S.+Fengauthor=F.+Qiauthor=L.+Baoauthor=L.+Duauthor=S.+Liuauthor=C.+Qinauthor=F.+Sunauthor=Z.+Shiauthor=Y.+Zhuauthor=S.+Jiangauthor=L.+Lu&title=Inhibition+of+SARS-CoV-2+%28previously+2019-nCoV%29+infection+by+a+highly+potent+pan-coronavirus+fusion+inhibitor+targeting+its+spike+protein+that+harbors+a+high+capacity+to+mediate+membrane+fusion&doi=10.1038%2Fs41422-020-0305-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion</span></div><div class="casAuthors">Xia, Shuai; Liu, Meiqin; Wang, Chao; Xu, Wei; Lan, Qiaoshuai; Feng, Siliang; Qi, Feifei; Bao, Linlin; Du, Lanying; Liu, Shuwen; Qin, Chuan; Sun, Fei; Shi, Zhengli; Zhu, Yun; Jiang, Shibo; Lu, Lu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-355</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The recent outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 infection in Wuhan, China has posed a serious threat to global public health.  To develop specific anti-coronavirus therapeutics and prophylactics, the mol. mechanism that underlies viral infection must first be defined.  Therefore, we herein established a SARS-CoV-2 spike (S) protein-mediated cell-cell fusion assay and found that SARS-CoV-2 showed a superior plasma membrane fusion capacity compared to that of SARS-CoV.  We solved the X-ray crystal structure of six-helical bundle (6-HB) core of the HR1 and HR2 domains in the SARS-CoV-2 S protein S2 subunit, revealing that several mutated amino acid residues in the HR1 domain may be assocd. with enhanced interactions with the HR2 domain.  We previously developed a pan-coronavirus fusion inhibitor, EK1, which targeted the HR1 domain and could inhibit infection by divergent human coronaviruses tested, including SARS-CoV and MERS-CoV.  Here we generated a series of lipopeptides derived from EK1 and found that EK1C4 was the most potent fusion inhibitor against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection with IC50s of 1.3 and 15.8 nM, about 241- and 149-fold more potent than the original EK1 peptide, resp.  EK1C4 was also highly effective against membrane fusion and infection of other human coronavirus pseudoviruses tested, including SARS-CoV and MERS-CoV, as well as SARSr-CoVs, and potently inhibited the replication of 5 live human coronaviruses examd., including SARS-CoV-2.  Intranasal application of EK1C4 before or after challenge with HCoV-OC43 protected mice from infection, suggesting that EK1C4 could be used for prevention and treatment of infection by the currently circulating SARS-CoV-2 and other emerging SARSr-CoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojKYayxDdc07Vg90H21EOLACvtfcHk0ljIt88E85eaUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlvFKhtL0%253D&md5=00a4a7fb87b1053fb1033973f3734af3</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fs41422-020-0305-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-020-0305-x%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DQ.%26aulast%3DFeng%26aufirst%3DS.%26aulast%3DQi%26aufirst%3DF.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520SARS-CoV-2%2520%2528previously%25202019-nCoV%2529%2520infection%2520by%2520a%2520highly%2520potent%2520pan-coronavirus%2520fusion%2520inhibitor%2520targeting%2520its%2520spike%2520protein%2520that%2520harbors%2520a%2520high%2520capacity%2520to%2520mediate%2520membrane%2520fusion%26jtitle%3DCell%2520Res.%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D343%26epage%3D355%26doi%3D10.1038%2Fs41422-020-0305-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerhering, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>368</i></span> (<span class="NLM_issue">6489</span>),  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1126/science.abb3405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abb3405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32198291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslKrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2020&pages=409-412&issue=6489&author=L.+Zhangauthor=D.+Linauthor=X.+Sunauthor=U.+Curthauthor=C.+Drostenauthor=L.+Sauerheringauthor=S.+Beckerauthor=K.+Roxauthor=R.+Hilgenfeld&title=Crystal+structure+of+SARS-CoV-2+main+protease+provides+a+basis+for+design+of+improved+alpha-ketoamide+inhibitors&doi=10.1126%2Fscience.abb3405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved   -ketoamide inhibitors</span></div><div class="casAuthors">Zhang, Linlin; Lin, Daizong; Sun, Xinyuanyuan; Curth, Ute; Drosten, Christian; Sauerhering, Lucie; Becker, Stephan; Rox, Katharina; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">6489</span>),
    <span class="NLM_cas:pages">409-412</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome   coronavirus 2 (SARS-CoV-2) is a global health emergency.  An attractive drug target among coronaviruses is the main protease (Mpro, also called 3CLpro) because of its essential role in processing the polyproteins that are translated from the viral RNA.  We report the x-ray structures of the unliganded SARS-CoV-2 Mpro and its complex with an   -ketoamide inhibitor.  This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compd. in plasma.  On the basis of the unliganded structure, we developed the lead compd. into a potent inhibitor of the SARS-CoV-2 Mpro.  The pharmacokinetic characterization of the optimized inhibitor reveals a pronounced lung tropism and suitability for administration by the inhalative route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT531N47m4BbVg90H21EOLACvtfcHk0lgkDq4XvzwCUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslKrtL8%253D&md5=9ac417c20f54c3327f9de9088b512d52</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb3405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb3405%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DCurth%26aufirst%3DU.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DSauerhering%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DRox%26aufirst%3DK.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DCrystal%2520structure%2520of%2520SARS-CoV-2%2520main%2520protease%2520provides%2520a%2520basis%2520for%2520design%2520of%2520improved%2520alpha-ketoamide%2520inhibitors%26jtitle%3DScience%26date%3D2020%26volume%3D368%26issue%3D6489%26spage%3D409%26epage%3D412%26doi%3D10.1126%2Fscience.abb3405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span> <span> </span><span class="NLM_article-title">Structure of the RNA-dependent RNA polymerase from COVID-19 virus</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>368</i></span> (<span class="NLM_issue">6492</span>),  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">782</span>, <span class="refDoi"> DOI: 10.1126/science.abb7498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abb7498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32277040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsVyrsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2020&pages=779-782&issue=6492&author=Y.+Gaoauthor=L.+Yanauthor=Y.+Huangauthor=F.+Liuauthor=Y.+Zhaoauthor=L.+Caoauthor=T.+Wangauthor=Q.+Sunauthor=Z.+Mingauthor=L.+Zhangauthor=J.+Geauthor=L.+Zhengauthor=Y.+Zhangauthor=H.+Wangauthor=Y.+Zhuauthor=C.+Zhuauthor=T.+Huauthor=T.+Huaauthor=B.+Zhangauthor=X.+Yangauthor=J.+Liauthor=H.+Yangauthor=Z.+Liuauthor=W.+Xuauthor=L.+W.+Guddatauthor=Q.+Wangauthor=Z.+Louauthor=Z.+Rao&title=Structure+of+the+RNA-dependent+RNA+polymerase+from+COVID-19+virus&doi=10.1126%2Fscience.abb7498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the RNA-dependent RNA polymerase from COVID-19 virus</span></div><div class="casAuthors">Gao, Yan; Yan, Liming; Huang, Yucen; Liu, Fengjiang; Zhao, Yao; Cao, Lin; Wang, Tao; Sun, Qianqian; Ming, Zhenhua; Zhang, Lianqi; Ge, Ji; Zheng, Litao; Zhang, Ying; Wang, Haofeng; Zhu, Yan; Zhu, Chen; Hu, Tianyu; Hua, Tian; Zhang, Bing; Yang, Xiuna; Li, Jun; Yang, Haitao; Liu, Zhijie; Xu, Wenqing; Guddat, Luke W.; Wang, Quan; Lou, Zhiyong; Rao, Zihe</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">6492</span>),
    <span class="NLM_cas:pages">779-782</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] outbreak has caused a global coronavirus disease 2019 (COVID-19) pandemic, resulting in tens of thousands of infections and thousands of deaths worldwide.  The RNA-dependent RNA polymerase [(RdRp), also named nsp12] is the central component of coronaviral replication and transcription machinery, and it appears to be a primary target for the antiviral drug remdesivir.  We report the cryoelectron microscopy structure of COVID-19 virus full-length nsp12 in complex with cofactors nsp7 and nsp8 at 2.9-angstrom resoln.  In addn. to the conserved architecture of the polymerase core of the viral polymerase family, nsp12 possesses a newly identified β-hairpin domain at its N terminus.  A comparative anal. model shows how remdesivir binds to this polymerase.  The structure provides a basis for the design of new antiviral therapeutics that target viral RdRp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbDgKUj7ZIg7Vg90H21EOLACvtfcHk0lgkDq4XvzwCUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsVyrsr4%253D&md5=07c9ca12ca757e52c2db2e4b4dcbf55b</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1126%2Fscience.abb7498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abb7498%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DMing%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DHua%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DRao%26aufirst%3DZ.%26atitle%3DStructure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520COVID-19%2520virus%26jtitle%3DScience%26date%3D2020%26volume%3D368%26issue%3D6492%26spage%3D779%26epage%3D782%26doi%3D10.1126%2Fscience.abb7498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jedrzejczak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltseva, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilamowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godzik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joachimiak, A.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/pro.3873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fpro.3873" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+Kimauthor=R.+Jedrzejczakauthor=N.+I.+Maltsevaauthor=M.+Wilamowskiauthor=M.+Endresauthor=A.+Godzikauthor=K.+Michalskaauthor=A.+Joachimiak&title=Crystal+structure+of+Nsp15+endoribonuclease+NendoU+from+SARS-CoV-2&doi=10.1002%2Fpro.3873"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fpro.3873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3873%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DJedrzejczak%26aufirst%3DR.%26aulast%3DMaltseva%26aufirst%3DN.%2BI.%26aulast%3DWilamowski%26aufirst%3DM.%26aulast%3DEndres%26aufirst%3DM.%26aulast%3DGodzik%26aufirst%3DA.%26aulast%3DMichalska%26aufirst%3DK.%26aulast%3DJoachimiak%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520Nsp15%2520endoribonuclease%2520NendoU%2520from%2520SARS-CoV-2%26jtitle%3DProtein%2520Sci.%26date%3D2020%26doi%3D10.1002%2Fpro.3873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putics, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissbrich, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabenau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerr, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbalenya, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziebuhr, J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms and enzymes involved in SARS coronavirus genome expression</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2305</span>– <span class="NLM_lpage">2315</span>, <span class="refDoi"> DOI: 10.1099/vir.0.19424-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.19424-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=12917450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFaqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=2305-2315&issue=9&author=V.+Thielauthor=K.+A.+Ivanovauthor=A.+Puticsauthor=T.+Hertzigauthor=B.+Schelleauthor=S.+Bayerauthor=B.+Weissbrichauthor=E.+J.+Snijderauthor=H.+Rabenauauthor=H.+W.+Doerrauthor=A.+E.+Gorbalenyaauthor=J.+Ziebuhr&title=Mechanisms+and+enzymes+involved+in+SARS+coronavirus+genome+expression&doi=10.1099%2Fvir.0.19424-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms and enzymes involved in SARS coronavirus genome expression</span></div><div class="casAuthors">Thiel, Volker; Ivanov, Konstantin A.; Putics, Akos; Hertzig, Tobias; Schelle, Barbara; Bayer, Sonja; Weissbrich, Benedikt; Snijder, Eric J.; Rabenau, Holger; Doerr, Hans Wilhelm; Gorbalenya, Alexander E.; Ziebuhr, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2305-2315</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A novel coronavirus is the causative agent of the current epidemic of severe acute respiratory syndrome (SARS).  Coronaviruses are exceptionally large RNA viruses and employ complex regulatory mechanisms to express their genomes.  Here, we detd. the sequence of SARS coronavirus (SARS-CoV), isolate Frankfurt 1, and characterized key RNA elements and protein functions involved in viral genome expression.  Important regulatory mechanisms, such as the (discontinuous) synthesis of eight subgenomic mRNAs, ribosomal frameshifting and post-translational proteolytic processing, were addressed.  Activities of three SARS coronavirus enzymes, the helicase and two cysteine proteinases, which are known to be critically involved in replication, transcription and/or post-translational polyprotein processing, were characterized.  The availability of recombinant forms of key replicative enzymes of SARS coronavirus should pave the way for high-throughput screening approaches to identify candidate inhibitors in compd. libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwV_DQUJ6EFbVg90H21EOLACvtfcHk0lgbHt2is3uDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFaqsb4%253D&md5=c0e344cdde7ce697dee5a6aaeea9feb7</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.19424-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.19424-0%26sid%3Dliteratum%253Aachs%26aulast%3DThiel%26aufirst%3DV.%26aulast%3DIvanov%26aufirst%3DK.%2BA.%26aulast%3DPutics%26aufirst%3DA.%26aulast%3DHertzig%26aufirst%3DT.%26aulast%3DSchelle%26aufirst%3DB.%26aulast%3DBayer%26aufirst%3DS.%26aulast%3DWeissbrich%26aufirst%3DB.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DRabenau%26aufirst%3DH.%26aulast%3DDoerr%26aufirst%3DH.%2BW.%26aulast%3DGorbalenya%26aufirst%3DA.%2BE.%26aulast%3DZiebuhr%26aufirst%3DJ.%26atitle%3DMechanisms%2520and%2520enzymes%2520involved%2520in%2520SARS%2520coronavirus%2520genome%2520expression%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2003%26volume%3D84%26issue%3D9%26spage%3D2305%26epage%3D2315%26doi%3D10.1099%2Fvir.0.19424-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4085</span>– <span class="NLM_lpage">4096</span>, <span class="refDoi"> DOI: 10.1111/febs.12936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1111%2Ffebs.12936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25039866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2014&pages=4085-4096&issue=18&author=R.+Hilgenfeld&title=From+SARS+to+MERS%3A+crystallographic+studies+on+coronaviral+proteases+enable+antiviral+drug+design&doi=10.1111%2Ffebs.12936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design</span></div><div class="casAuthors">Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4085-4096</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Here, the author focuses on the important contributions that macromol. crystallog. has made over the past 12 yr to elucidating structures and mechanisms of the essential proteases of coronaviruses, the main protease (Mpro) and the papain-like protease (PLpro).  The role of x-ray crystallog. in structure-assisted drug discovery against these targets is discussed.  Aspects dealt with in this review include the emergence of the SARS coronavirus in 2002-2003 and of the MERS coronavirus 10 yr later and the origins of these viruses.  The crystal structure of the free SARS coronavirus Mpro and its dependence on pH is discussed, as are efforts to design inhibitors on the basis of these structures.  The mechanism of maturation of the enzyme from the viral polyprotein is still a matter of debate.  The crystal structure of the SARS coronavirus PLpro and its complex with ubiquitin is also discussed, as is its ortholog from MERS coronavirus.  Efforts at predictive structure-based inhibitor development for bat coronavirus Mpros to increase the preparedness against zoonotic transmission to man are described as well.  The paper closes with a brief discussion of structure-based discovery of antivirals in an academic setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_Y5ir6KZ8LVg90H21EOLACvtfcHk0lgbHt2is3uDLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKnsbbI&md5=6a9330976a5c3a13dd4bf7bed14665ce</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12936%26sid%3Dliteratum%253Aachs%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DFrom%2520SARS%2520to%2520MERS%253A%2520crystallographic%2520studies%2520on%2520coronaviral%2520proteases%2520enable%2520antiviral%2520drug%2520design%26jtitle%3DFEBS%2520J.%26date%3D2014%26volume%3D281%26issue%3D18%26spage%3D4085%26epage%3D4096%26doi%3D10.1111%2Ffebs.12936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huitema, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powers, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltis, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. N.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jmb.2005.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16219322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKms7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=1137-1151&issue=5&author=T.+W.+Leeauthor=M.+M.+Cherneyauthor=C.+Huitemaauthor=J.+Liuauthor=K.+E.+Jamesauthor=J.+C.+Powersauthor=L.+D.+Eltisauthor=M.+N.+James&title=Crystal+structures+of+the+main+peptidase+from+the+SARS+coronavirus+inhibited+by+a+substrate-like+aza-peptide+epoxide&doi=10.1016%2Fj.jmb.2005.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate-like Aza-peptide Epoxide</span></div><div class="casAuthors">Lee, Ting-Wai; Cherney, Maia M.; Huitema, Carly; Liu, Jie; James, Karen Ellis; Powers, James C.; Eltis, Lindsay D.; James, Michael N. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1137-1151</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The main peptidase (Mpro) from the coronavirus (CoV) causing severe acute respiratory syndrome (SARS) is one of the most attractive mol. targets for the development of anti-SARS agents.  We report the irreversible inhibition of SARS-CoV Mpro by an aza-peptide epoxide (APE; kinact/Ki=1900(±400) M-1 s-1).  The crystal structures of the Mpro:APE complex in the space groups C2 and P212121 revealed the formation of a covalent bond between the catalytic Cys145 Sγ atom of the peptidase and the epoxide C3 atom of the inhibitor, substantiating the mode of action of this class of cysteine-peptidase inhibitors.  The aza-peptide component of APE binds in the substrate-binding regions of Mpro in a substrate-like manner, with excellent structural and chem. complementarity.  In addn., the crystal structure of unbound Mpro in the space group C2 revealed that the "N-fingers" (N-terminal residues 1 to 7) of both protomers of Mpro are well defined and the substrate-binding regions of both protomers are in the catalytically competent conformation at the crystn. pH of 6.5, contrary to the previously detd. crystal structures of unbound Mpro in the space group P21.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzcP9A4-DKErVg90H21EOLACvtfcHk0lj8tLDl8L5Qjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKms7nL&md5=ba0e5fbad36bfc3d259c9221d451ef60</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%2BW.%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DHuitema%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJames%26aufirst%3DK.%2BE.%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DEltis%26aufirst%3DL.%2BD.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DCrystal%2520structures%2520of%2520the%2520main%2520peptidase%2520from%2520the%2520SARS%2520coronavirus%2520inhibited%2520by%2520a%2520substrate-like%2520aza-peptide%2520epoxide%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D353%26issue%3D5%26spage%3D1137%26epage%3D1151%26doi%3D10.1016%2Fj.jmb.2005.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hevener, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatuz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. E.</span></span> <span> </span><span class="NLM_article-title">Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1361</span>– <span class="NLM_lpage">1372</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.201300134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23788528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslGjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1361-1372&issue=8&author=H.+Leeauthor=S.+Caoauthor=K.+E.+Hevenerauthor=L.+Truongauthor=J.+L.+Gatuzauthor=K.+Patelauthor=A.+K.+Ghoshauthor=M.+E.+Johnson&title=Synergistic+inhibitor+binding+to+the+papain-like+protease+of+human+SARS+coronavirus%3A+mechanistic+and+inhibitor+design+implications&doi=10.1002%2Fcmdc.201300134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic Inhibitor Binding to the Papain-Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications</span></div><div class="casAuthors">Lee, Hyun; Cao, Shuyi; Hevener, Kirk E.; Truong, Lena; Gatuz, Joseph L.; Patel, Kavankumar; Ghosh, Arun K.; Johnson, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1361-1372</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We previously developed two potent chem. classes that inhibit the essential papain-like protease (PLpro) of severe acute respiratory syndrome coronavirus.  In this study, we applied a novel approach to identify small fragments that act synergistically with these inhibitors.  A fragment library was screened in combination with four previously developed lead inhibitors by fluorescence-based enzymic assays.  Several fragment compds. synergistically enhanced the inhibitory activity of the lead inhibitors by approx. an order of magnitude.  Surface plasmon resonance measurements showed that three fragments bind specifically to the PLpro enzyme.  Mode of inhibition, computational solvent mapping, and mol. docking studies suggest that these fragments bind adjacent to the binding site of the lead inhibitors and further stabilize the inhibitor-bound state.  We propose potential next-generation compds. based on a computational fragment-merging approach.  This approach provides an alternative strategy for lead optimization for cases in which direct co-crystn. is difficult.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgKin5O32Y97Vg90H21EOLACvtfcHk0lj8tLDl8L5Qjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslGjtbw%253D&md5=4596fa56fd5d679ffbcc0c10ddf2123e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300134%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DHevener%26aufirst%3DK.%2BE.%26aulast%3DTruong%26aufirst%3DL.%26aulast%3DGatuz%26aufirst%3DJ.%2BL.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DJohnson%26aufirst%3DM.%2BE.%26atitle%3DSynergistic%2520inhibitor%2520binding%2520to%2520the%2520papain-like%2520protease%2520of%2520human%2520SARS%2520coronavirus%253A%2520mechanistic%2520and%2520inhibitor%2520design%2520implications%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3D1361%26epage%3D1372%26doi%3D10.1002%2Fcmdc.201300134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindisi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahabi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span> <span> </span><span class="NLM_article-title">Drug development and medicinal chemistry efforts toward SARS-coronavirus and Covid-19 therapeutics</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">907</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.202000223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32324951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXos1GmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=907&author=A.+K.+Ghoshauthor=M.+Brindisiauthor=D.+Shahabiauthor=M.+E.+Chapmanauthor=A.+D.+Mesecar&title=Drug+development+and+medicinal+chemistry+efforts+toward+SARS-coronavirus+and+Covid-19+therapeutics&doi=10.1002%2Fcmdc.202000223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics</span></div><div class="casAuthors">Ghosh, Arun K.; Brindisi, Margherita; Shahabi, Dana; Chapman, Mackenzie E.; Mesecar, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">907-932</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The COVID-19 pandemic caused by SARS-CoV-2 infection is spreading at an alarming rate and has created an unprecedented health emergency around the globe.  There is no effective vaccine or approved drug treatment against COVID-19 and other pathogenic coronaviruses.  The development of antiviral agents is an urgent priority.  Biochem. events crit. to the coronavirus replication cycle provided a no. of attractive targets for drug development.  These include, spike protein for binding to host cell-surface receptors, proteolytic enzymes that are essential for processing polyproteins into mature viruses, and RNA-dependent RNA polymerase for RNA replication.  There has been a lot of ground work for drug discovery and development against these targets.  Also, high-throughput screening efforts have led to the identification of diverse lead structures, including natural product-derived mols.  This review highlights past and present drug discovery and medicinal-chem. approaches against SARS-CoV, MERS-CoV and COVID-19 targets.  The review hopes to stimulate further research and will be a useful guide to the development of effective therapies against COVID-19 and other pathogenic coronaviruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcgVQF9N3zf7Vg90H21EOLACvtfcHk0lgvktgs7DRw1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXos1GmsL4%253D&md5=8b4c3c83c05a7b64f39ba7d803ea1709</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000223%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DShahabi%26aufirst%3DD.%26aulast%3DChapman%26aufirst%3DM.%2BE.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26atitle%3DDrug%2520development%2520and%2520medicinal%2520chemistry%2520efforts%2520toward%2520SARS-coronavirus%2520and%2520Covid-19%2520therapeutics%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D907%26doi%3D10.1002%2Fcmdc.202000223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedantham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agudelo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrion, R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunneley, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, G.</span></span> <span> </span><span class="NLM_article-title">Protease inhibitors targeting coronavirus and filovirus entry</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2015.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2015.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25666761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVOrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2015&pages=76-84&author=Y.+Zhouauthor=P.+Vedanthamauthor=K.+Luauthor=J.+Agudeloauthor=R.+Carrionauthor=J.+W.+Nunneleyauthor=D.+Barnardauthor=S.+Pohlmannauthor=J.+H.+McKerrowauthor=A.+R.+Rensloauthor=G.+Simmons&title=Protease+inhibitors+targeting+coronavirus+and+filovirus+entry&doi=10.1016%2Fj.antiviral.2015.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Protease inhibitors targeting coronavirus and filovirus entry</span></div><div class="casAuthors">Zhou, Yanchen; Vedantham, Punitha; Lu, Kai; Agudelo, Juliet; Carrion, Ricardo; Nunneley, Jerritt W.; Barnard, Dale; Pohlmann, Stefan; McKerrow, James H.; Renslo, Adam R.; Simmons, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">76-84</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to gain entry into cells, diverse viruses, including Ebola virus, SARS-coronavirus and the emerging MERS-coronavirus, depend on activation of their envelope glycoproteins by host cell proteases.  The resp. enzymes are thus excellent targets for antiviral intervention.  In cell culture, activation of Ebola virus, as well as SARS- and MERS-coronavirus can be accomplished by the endosomal cysteine proteases, cathepsin L (CTSL) and cathepsin B (CTSB).  In addn., SARS- and MERS-coronavirus can use serine proteases localized at the cell surface, for their activation.  However, it is currently unclear which protease(s) facilitate viral spread in the infected host.  We report here that the cysteine protease inhibitor K11777, ((2S)-N-[(1E,3S)-1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-{[(E)-4-methylpiperazine-1-carbonyl]amino}-3-phenylpropanamide) and closely-related vinylsulfones act as broad-spectrum antivirals by targeting cathepsin-mediated cell entry.  K11777 is already in advanced stages of development for a no. of parasitic diseases, such as Chagas disease, and has proven to be safe and effective in a range of animal models.  K11777 inhibition of SARS-CoV and Ebola virus entry was obsd. in the sub-nanomolar range.  In order to assess whether cysteine or serine proteases promote viral spread in the host, we compared the antiviral activity of an optimized K11777-deriv. with that of camostat, an inhibitor of TMPRSS2 and related serine proteases.  Employing a pathogenic animal model of SARS-CoV infection, we demonstrated that viral spread and pathogenesis of SARS-CoV is driven by serine rather than cysteine proteases and can be effectively prevented by camostat.  Camostat has been clin. used to treat chronic pancreatitis, and thus represents an exciting potential therapeutic for respiratory coronavirus infections.  Our results indicate that camostat, or similar serine protease inhibitors, might be an effective option for treatment of SARS and potentially MERS, while vinyl sulfone-based inhibitors are excellent lead candidates for Ebola virus therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgkBpEfAc5bVg90H21EOLACvtfcHk0lgvktgs7DRw1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVOrs7Y%253D&md5=5dc38edb19ade6920ba6ca860699b8cf</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DVedantham%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DAgudelo%26aufirst%3DJ.%26aulast%3DCarrion%26aufirst%3DR.%26aulast%3DNunneley%26aufirst%3DJ.%2BW.%26aulast%3DBarnard%26aufirst%3DD.%26aulast%3DPohlmann%26aufirst%3DS.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DSimmons%26aufirst%3DG.%26atitle%3DProtease%2520inhibitors%2520targeting%2520coronavirus%2520and%2520filovirus%2520entry%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D116%26spage%3D76%26epage%3D84%26doi%3D10.1016%2Fj.antiviral.2015.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Structure of M(pro) from COVID-19 virus and discovery of its inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>582</i></span>,  <span class="NLM_fpage">289</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2223-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2223-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32272481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVyhsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2020&pages=289&author=Z.+Jinauthor=X.+Duauthor=Y.+Xuauthor=Y.+Dengauthor=M.+Liuauthor=Y.+Zhaoauthor=B.+Zhangauthor=X.+Liauthor=L.+Zhangauthor=C.+Pengauthor=Y.+Duanauthor=J.+Yuauthor=L.+Wangauthor=K.+Yangauthor=F.+Liuauthor=R.+Jiangauthor=X.+Yangauthor=T.+Youauthor=X.+Liuauthor=X.+Yangauthor=F.+Baiauthor=H.+Liuauthor=X.+Liuauthor=L.+W.+Guddatauthor=W.+Xuauthor=G.+Xiaoauthor=C.+Qinauthor=Z.+Shiauthor=H.+Jiangauthor=Z.+Raoauthor=H.+Yang&title=Structure+of+M%28pro%29+from+COVID-19+virus+and+discovery+of+its+inhibitors&doi=10.1038%2Fs41586-020-2223-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors</span></div><div class="casAuthors">Jin, Zhenming; Du, Xiaoyu; Xu, Yechun; Deng, Yongqiang; Liu, Meiqin; Zhao, Yao; Zhang, Bing; Li, Xiaofeng; Zhang, Leike; Peng, Chao; Duan, Yinkai; Yu, Jing; Wang, Lin; Yang, Kailin; Liu, Fengjiang; Jiang, Rendi; Yang, Xinglou; You, Tian; Liu, Xiaoce; Yang, Xiuna; Bai, Fang; Liu, Hong; Liu, Xiang; Guddat, Luke W.; Xu, Wenqing; Xiao, Gengfu; Qin, Chengfeng; Shi, Zhengli; Jiang, Hualiang; Rao, Zihe; Yang, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">7811</span>),
    <span class="NLM_cas:pages">289-293</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the etiol. agent responsible for the 2019-2020 viral pneumonia outbreak of coronavirus disease 2019 (COVID-19).  Currently, there are no targeted therapeutic agents for the treatment of this disease, and effective treatment options remain very limited.  Here, we describe the results of a program that aimed to rapidly discover lead compds. for clin. use, by combining structure-assisted drug design, virtual drug screening and high-throughput screening.  This program focused on identifying drug leads that target main protease (Mpro) of SARS-CoV-2: Mpro is a key enzyme of coronaviruses and has a pivotal role in mediating viral replication and transcription, making it an attractive drug target for SARS-CoV-2.  We identified a mechanism-based inhibitor (N3) by computer-aided drug design, and then detd. the crystal structure of Mpro of SARS-CoV-2 in complex with this compd.  Through a combination of structure-based virtual and high-throughput screening, we assayed more than 10,000 compds.-including approved drugs, drug candidates in clin. trials and other pharmacol. active compds.-as inhibitors of Mpro.  Six of these compds. inhibited Mpro, showing half-maximal inhibitory concn. values that ranged from 0.67 to 21.4μM.  One of these compds. (ebselen) also exhibited promising antiviral activity in cell-based assays.  Our results demonstrate the efficacy of our screening strategy, which can lead to the rapid discovery of drug leads with clin. potential in response to new infectious diseases for which no specific drugs or vaccines are available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFupuh6WIyW7Vg90H21EOLACvtfcHk0ljZRn2STLOInw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVyhsrrO&md5=b84f350fe9ce1109485df6caf814ba82</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2223-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2223-y%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DRao%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DH.%26atitle%3DStructure%2520of%2520M%2528pro%2529%2520from%2520COVID-19%2520virus%2520and%2520discovery%2520of%2520its%2520inhibitors%26jtitle%3DNature%26date%3D2020%26volume%3D582%26spage%3D289%26doi%3D10.1038%2Fs41586-020-2223-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Brunn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyssen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wilde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">alpha-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4562</span>– <span class="NLM_lpage">4578</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXivValt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4562-4578&issue=9&author=L.+Zhangauthor=D.+Linauthor=Y.+Kusovauthor=Y.+Nianauthor=Q.+Maauthor=J.+Wangauthor=A.+von+Brunnauthor=P.+Leyssenauthor=K.+Lankoauthor=J.+Neytsauthor=A.+de+Wildeauthor=E.+J.+Snijderauthor=H.+Liuauthor=R.+Hilgenfeld&title=alpha-Ketoamides+as+broad-spectrum+inhibitors+of+coronavirus+and+enterovirus+replication%3A+structure-based+design%2C+synthesis%2C+and+activity+assessment&doi=10.1021%2Facs.jmedchem.9b01828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment</span></div><div class="casAuthors">Zhang, Linlin; Lin, Daizong; Kusov, Yuri; Nian, Yong; Ma, Qingjun; Wang, Jiang; von Brunn, Albrecht; Leyssen, Pieter; Lanko, Kristina; Neyts, Johan; de Wilde, Adriaan; Snijder, Eric J.; Liu, Hong; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4562-4578</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The main protease of coronaviruses and the 3C protease of enteroviruses share a similar active-site architecture and a unique requirement for glutamine in the P1 position of the substrate.  Because of their unique specificity and essential role in viral polyprotein processing, these proteases are suitable targets for the development of antiviral drugs.  In order to obtain near-equipotent, broad-spectrum antivirals against alphacoronaviruses, betacoronaviruses, and enteroviruses, we pursued structure-based design of peptidomimetic α-ketoamides as inhibitors of main and 3C proteases.  Six crystal structures of protease:inhibitor complexes were detd. as part of this study.  Compds. synthesized were tested against the recombinant proteases as well as in viral replicons and virus-infected cell cultures; most of them were not cell-toxic.  Optimization of the P2 substituent of the α-ketoamides proved crucial for achieving near-equipotency against the three virus genera.  The best near-equipotent inhibitors, (I) [R1 = cyclopentylmethyl (P2) and R1 = cyclohexylmethyl (P2)], display low-micromolar EC50 values against enteroviruses, alphacoronaviruses, and betacoronaviruses in cell cultures.  In Huh7 cells, I [R1 = cyclohexylmethyl (P2)] exhibits three-digit picomolar activity against Middle East Respiratory Syndrome coronavirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWpcfl4wTRLLVg90H21EOLACvtfcHk0ljZRn2STLOInw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXivValt7o%253D&md5=60d91a8ecf916856a844d835ecf84d5f</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01828%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DKusov%26aufirst%3DY.%26aulast%3DNian%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3Dvon%2BBrunn%26aufirst%3DA.%26aulast%3DLeyssen%26aufirst%3DP.%26aulast%3DLanko%26aufirst%3DK.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3Dde%2BWilde%26aufirst%3DA.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3Dalpha-Ketoamides%2520as%2520broad-spectrum%2520inhibitors%2520of%2520coronavirus%2520and%2520enterovirus%2520replication%253A%2520structure-based%2520design%252C%2520synthesis%252C%2520and%2520activity%2520assessment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D9%26spage%3D4562%26epage%3D4578%26doi%3D10.1021%2Facs.jmedchem.9b01828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nutho, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalapbutr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengphasatporn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattaranggoon, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simanon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeta, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannongbua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rungrotmongkol, T.</span></span> <span> </span><span class="NLM_article-title">Why Are Lopinavir and Ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">1769</span>– <span class="NLM_lpage">1779</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.0c00160</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.0c00160" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntVKltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=1769-1779&issue=18&author=B.+Nuthoauthor=P.+Mahalapbutrauthor=K.+Hengphasatpornauthor=N.+C.+Pattaranggoonauthor=N.+Simanonauthor=Y.+Shigetaauthor=S.+Hannongbuaauthor=T.+Rungrotmongkol&title=Why+Are+Lopinavir+and+Ritonavir+effective+against+the+newly+emerged+coronavirus+2019%3F+Atomistic+insights+into+the+inhibitory+mechanisms&doi=10.1021%2Facs.biochem.0c00160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms</span></div><div class="casAuthors">Nutho, Bodee; Mahalapbutr, Panupong; Hengphasatporn, Kowit; Pattaranggoon, Nawanwat Chainuwong; Simanon, Nattapon; Shigeta, Yasuteru; Hannongbua, Supot; Rungrotmongkol, Thanyada</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1769-1779</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since the emergence of a novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported from Wuhan, China, neither a specific vaccine nor an antiviral drug against SARS-CoV-2 has become available.  However, a combination of two HIV-1 protease inhibitors, lopinavir and ritonavir, has been found to be effective against SARS-CoV, and both drugs could bind well to the SARS-CoV 3C-like protease (SARS-CoV 3CLpro).  In this work, mol. complexation between each inhibitor and SARS-CoV-2 3CLpro was studied using all-atom mol. dynamics simulations, free energy calcns., and pair interaction energy analyses based on MM/PB(GB)SA and FMO-MP2/PCM/6-31G* methods.  Both anti-HIV drugs interacted well with the residues at the active site of SARS-CoV-2 3CLpro.  Ritonavir showed a somewhat higher no. at. contacts, a somewhat higher binding efficiency, and a somewhat higher no. of key binding residues compared to lopinavir, which correspond with the slightly lower water accessibility at the 3CLpro active site.  In addn., only ritonavir could interact with the oxyanion hole residues N142 and G143 via the formation of two hydrogen bonds.  The interactions in terms of electrostatics, dispersion, and charge transfer played an important role in the drug binding.  The obtained results demonstrated how repurposed anti-HIV drugs could be used to combat COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro03-EVm8c4LVg90H21EOLACvtfcHk0liyXkxNjRG1rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntVKltr8%253D&md5=86b235b2c4f618c9cbd0aadb25c81e97</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.0c00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.0c00160%26sid%3Dliteratum%253Aachs%26aulast%3DNutho%26aufirst%3DB.%26aulast%3DMahalapbutr%26aufirst%3DP.%26aulast%3DHengphasatporn%26aufirst%3DK.%26aulast%3DPattaranggoon%26aufirst%3DN.%2BC.%26aulast%3DSimanon%26aufirst%3DN.%26aulast%3DShigeta%26aufirst%3DY.%26aulast%3DHannongbua%26aufirst%3DS.%26aulast%3DRungrotmongkol%26aufirst%3DT.%26atitle%3DWhy%2520Are%2520Lopinavir%2520and%2520Ritonavir%2520effective%2520against%2520the%2520newly%2520emerged%2520coronavirus%25202019%253F%2520Atomistic%2520insights%2520into%2520the%2520inhibitory%2520mechanisms%26jtitle%3DBiochemistry%26date%3D2020%26volume%3D59%26issue%3D18%26spage%3D1769%26epage%3D1779%26doi%3D10.1021%2Facs.biochem.0c00160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, S. M.</span></span> <span> </span><span class="NLM_article-title">RNA synthetic mechanisms employed by diverse families of RNA viruses</span>. <i>WIREs RNA</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">351</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1002/wrna.1164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fwrna.1164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23606593" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=351-367&issue=4&author=S.+M.+McDonald&title=RNA+synthetic+mechanisms+employed+by+diverse+families+of+RNA+viruses&doi=10.1002%2Fwrna.1164"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fwrna.1164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fwrna.1164%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DS.%2BM.%26atitle%3DRNA%2520synthetic%2520mechanisms%2520employed%2520by%2520diverse%2520families%2520of%2520RNA%2520viruses%26jtitle%3DWIREs%2520RNA%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D351%26epage%3D367%26doi%3D10.1002%2Fwrna.1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span> <span> </span><span class="NLM_article-title">Approved antiviral drugs over the past 50 years</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1128/CMR.00102-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FCMR.00102-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27281742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fos12htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2016&pages=695-747&issue=3&author=E.+De%0AClercqauthor=G.+Li&title=Approved+antiviral+drugs+over+the+past+50+years&doi=10.1128%2FCMR.00102-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Approved Antiviral Drugs over the Past 50 Years</span></div><div class="casAuthors">De Clercq Erik; Li Guangdi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">695-747</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs categorized into 13 functional groups have been formally approved for the treatment of the following 9 human infectious diseases: (i) HIV infections (protease inhibitors, integrase inhibitors, entry inhibitors, nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and acyclic nucleoside phosphonate analogues), (ii) hepatitis B virus (HBV) infections (lamivudine, interferons, nucleoside analogues, and acyclic nucleoside phosphonate analogues), (iii) hepatitis C virus (HCV) infections (ribavirin, interferons, NS3/4A protease inhibitors, NS5A inhibitors, and NS5B polymerase inhibitors), (iv) herpesvirus infections (5-substituted 2'-deoxyuridine analogues, entry inhibitors, nucleoside analogues, pyrophosphate analogues, and acyclic guanosine analogues), (v) influenza virus infections (ribavirin, matrix 2 protein inhibitors, RNA polymerase inhibitors, and neuraminidase inhibitors), (vi) human cytomegalovirus infections (acyclic guanosine analogues, acyclic nucleoside phosphonate analogues, pyrophosphate analogues, and oligonucleotides), (vii) varicella-zoster virus infections (acyclic guanosine analogues, nucleoside analogues, 5-substituted 2'-deoxyuridine analogues, and antibodies), (viii) respiratory syncytial virus infections (ribavirin and antibodies), and (ix) external anogenital warts caused by human papillomavirus infections (imiquimod, sinecatechins, and podofilox).  Here, we present for the first time a comprehensive overview of antiviral drugs approved over the past 50 years, shedding light on the development of effective antiviral treatments against current and emerging infectious diseases worldwide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbPpNpCY_qYTEC-75aqa5AfW6udTcc2earRYD7Gv-vrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fos12htA%253D%253D&md5=1d25d961c1c6a72d6bc4634041bbb6fe</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1128%2FCMR.00102-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00102-15%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DG.%26atitle%3DApproved%2520antiviral%2520drugs%2520over%2520the%2520past%252050%2520years%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2016%26volume%3D29%26issue%3D3%26spage%3D695%26epage%3D747%26doi%3D10.1128%2FCMR.00102-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subissi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posthuma, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zevenhoven-Dobbe, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbalenya, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbert, I.</span></span> <span> </span><span class="NLM_article-title">One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">E3900</span>– <span class="NLM_lpage">E3909</span>, <span class="refDoi"> DOI: 10.1073/pnas.1323705111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1323705111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25197083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGntb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E3900-E3909&issue=37&author=L.+Subissiauthor=C.+C.+Posthumaauthor=A.+Colletauthor=J.+C.+Zevenhoven-Dobbeauthor=A.+E.+Gorbalenyaauthor=E.+Decrolyauthor=E.+J.+Snijderauthor=B.+Canardauthor=I.+Imbert&title=One+severe+acute+respiratory+syndrome+coronavirus+protein+complex+integrates+processive+RNA+polymerase+and+exonuclease+activities&doi=10.1073%2Fpnas.1323705111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities</span></div><div class="casAuthors">Subissi, Lorenzo; Posthuma, Clara C.; Collet, Axelle; Zevenhoven-Dobbe, Jessika C.; Gorbalenya, Alexander E.; Decroly, Etienne; Snijder, Eric J.; Canard, Bruno; Imbert, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">E3900-E3909</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In addn. to members causing milder human infections, the Coronaviridae family includes potentially lethal zoonotic agents causing severe acute respiratory syndrome (SARS) and the recently emerged Middle East respiratory syndrome.  The ∼30-kb pos.-stranded RNA genome of coronaviruses encodes a replication/transcription machinery that is unusually complex and composed of 16 nonstructural proteins (nsps).  SARS-CoV nsp12, the canonical RNA-dependent RNA polymerase (RdRp), exhibits poorly processive RNA synthesis in vitro, at odds with the efficient replication of a very large RNA genome in vivo.  Here, we report that SARS-CoV nsp7 and nsp8 activate and confer processivity to the RNA-synthesizing activity of nsp12.  Using biochem. assays and reverse genetics, the importance of conserved nsp7 and nsp8 residues was probed.  Whereas several nsp7 mutations affected virus replication to a limited extent, the replacement of two nsp8 residues (P183 and R190) essential for interaction with nsp12 and a third (K58) crit. for the interaction of the polymerase complex with RNA were all lethal to the virus.  Without a loss of processivity, the nsp7/nsp8/nsp12 complex can assoc. with nsp14, a bifunctional enzyme bearing 3'-5' exoribonuclease and RNA cap N7-guanine methyltransferase activities involved in replication fidelity and 5'-RNA capping, resp.  The identification of this tripartite polymerase complex that in turn assocs. with the nsp14 proofreading enzyme sheds light on how coronaviruses assemble an RNA-synthesizing machinery to replicate the largest known RNA genomes.  This protein complex is a fascinating example of the functional integration of RNA polymerase, capping, and proofreading activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodG7yPmFowK7Vg90H21EOLACvtfcHk0lgkT6dtuknd8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGntb3M&md5=ed2d7e8787ddd0d8a5e4565932cc54ef</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1323705111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1323705111%26sid%3Dliteratum%253Aachs%26aulast%3DSubissi%26aufirst%3DL.%26aulast%3DPosthuma%26aufirst%3DC.%2BC.%26aulast%3DCollet%26aufirst%3DA.%26aulast%3DZevenhoven-Dobbe%26aufirst%3DJ.%2BC.%26aulast%3DGorbalenya%26aufirst%3DA.%2BE.%26aulast%3DDecroly%26aufirst%3DE.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DCanard%26aufirst%3DB.%26aulast%3DImbert%26aufirst%3DI.%26atitle%3DOne%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520protein%2520complex%2520integrates%2520processive%2520RNA%2520polymerase%2520and%2520exonuclease%2520activities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D37%26spage%3DE3900%26epage%3DE3909%26doi%3D10.1073%2Fpnas.1323705111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decroly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debarnot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbert, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gluais, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papageorgiou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bricogne, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz-Lombardia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span> <span> </span><span class="NLM_article-title">Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2′-O-methyltransferase nsp10/nsp16 complex</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e1002059</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.ppat.1002059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21637813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&issue=5&author=E.+Decrolyauthor=C.+Debarnotauthor=F.+Ferronauthor=M.+Bouvetauthor=B.+Coutardauthor=I.+Imbertauthor=L.+Gluaisauthor=N.+Papageorgiouauthor=A.+Sharffauthor=G.+Bricogneauthor=M.+Ortiz-Lombardiaauthor=J.+Lescarauthor=B.+Canard&title=Crystal+structure+and+functional+analysis+of+the+SARS-coronavirus+RNA+cap+2%E2%80%B2-O-methyltransferase+nsp10%2Fnsp16+complex&doi=10.1371%2Fjournal.ppat.1002059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure and functional analysis of the SARS-Coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex</span></div><div class="casAuthors">Decroly, Etienne; Debarnot, Claire; Ferron, Francois; Bouvet, Mickael; Coutard, Bruno; Imbert, Isabelle; Gluais, Laure; Papageorgiou, Nicolas; Sharff, Andrew; Bricogne, Gerard; Ortiz-Lombardia, Miguel; Lescar, Julien; Canard, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e1002059</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cellular and viral S-adenosylmethionine (SAM)-dependent methyltransferases are involved in many regulated processes such as metab., detoxification, signal transduction, chromatin remodeling, nucleic acid processing, and mRNA capping.  The severe acute respiratory syndrome coronavirus (SARS-CoV) nsp16 protein is a S-adenosylmethionine-dependent (nucleoside-2'-O)-methyltransferase (2'-O-MTase) only active in the presence of its activating partner nsp10.  We report the nsp10/nsp16 complex structure at 2.0 Å resoln., which shows nsp10 bound to nsp16 through a ∼930 Å2 surface area in nsp10.  Functional assays identify key residues involved in nsp10/nsp16 assocn., and in RNA binding or catalysis, the latter likely through a SN2-like mechanism.  We present two other crystal structures, the inhibitor sinefungin bound in the S-adenosylmethionine binding pocket and the tighter complex nsp10(Y96F)/nsp16, providing the first structural insight into the regulation of RNA capping enzymes in (+)RNA viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj9FGUC_LGErVg90H21EOLACvtfcHk0lgkT6dtuknd8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVajsrY%253D&md5=292e743ef82e8084a4678d6ccfe2729a</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002059%26sid%3Dliteratum%253Aachs%26aulast%3DDecroly%26aufirst%3DE.%26aulast%3DDebarnot%26aufirst%3DC.%26aulast%3DFerron%26aufirst%3DF.%26aulast%3DBouvet%26aufirst%3DM.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DImbert%26aufirst%3DI.%26aulast%3DGluais%26aufirst%3DL.%26aulast%3DPapageorgiou%26aufirst%3DN.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DBricogne%26aufirst%3DG.%26aulast%3DOrtiz-Lombardia%26aufirst%3DM.%26aulast%3DLescar%26aufirst%3DJ.%26aulast%3DCanard%26aufirst%3DB.%26atitle%3DCrystal%2520structure%2520and%2520functional%2520analysis%2520of%2520the%2520SARS-coronavirus%2520RNA%2520cap%25202%25E2%2580%25B2-O-methyltransferase%2520nsp10%252Fnsp16%2520complex%26jtitle%3DPLoS%2520Pathog.%26date%3D2011%26volume%3D7%26issue%3D5%26doi%3D10.1371%2Fjournal.ppat.1002059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span> <span> </span><span class="NLM_article-title">Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">9436</span>– <span class="NLM_lpage">9441</span>, <span class="refDoi"> DOI: 10.1073/pnas.1508686112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1508686112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26159422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGkt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=9436-9441&issue=30&author=Y.+Maauthor=L.+Wuauthor=N.+Shawauthor=Y.+Gaoauthor=J.+Wangauthor=Y.+Sunauthor=Z.+Louauthor=L.+Yanauthor=R.+Zhangauthor=Z.+Rao&title=Structural+basis+and+functional+analysis+of+the+SARS+coronavirus+nsp14-nsp10+complex&doi=10.1073%2Fpnas.1508686112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex</span></div><div class="casAuthors">Ma, Yuanyuan; Wu, Lijie; Shaw, Neil; Gao, Yan; Wang, Jin; Sun, Yuna; Lou, Zhiyong; Yan, Liming; Zhang, Rongguang; Rao, Zihe</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9436-9441</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Nonstructural protein 14 (nsp14) of coronaviruses (CoV) is important for viral replication and transcription.  The N-terminal exoribonuclease (ExoN) domain plays a proofreading role for prevention of lethal mutagenesis, and the C-terminal domain functions as a (guanine-N7) Me transferase (N7-MTase) for mRNA capping.  The mol. basis of both these functions is unknown.  Here, we describe crystal structures of severe acute respiratory syndrome (SARS)-CoV nsp14 in complex with its activator nonstructural protein 10 (nsp10) and functional ligands.  One mol. of nsp10 interacts with ExoN of nsp14 to stabilize it and stimulate its activity.  Although the catalytic core of nsp14 ExoN is reminiscent of proofreading exonucleases, the presence of two zinc fingers sets it apart from homologs.  Mutagenesis studies indicate that both these zinc fingers are essential for the function of nsp14.  We show that a DEEDh (the five catalytic amino acids) motif drives nucleotide excision.  The N7-MTase domain exhibits a noncanonical MTase fold with a rare β-sheet insertion and a peripheral zinc finger.  The cap-precursor guanosine-P3-adenosine-5',5'-triphosphate (GpppA) and S-adenosyl methionine (SAM) bind in proximity in a highly constricted pocket between two β-sheets to accomplish Me transfer.  Our studies provide the first glimpses, to our knowledge, into the architecture of the nsp14-nsp10 complex involved in RNA viral proofreading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4g1b9tJjK_rVg90H21EOLACvtfcHk0lh9YWtXe0m30A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGkt7vJ&md5=f19a48e43faff6c92632a108d87641c1</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1508686112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1508686112%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DShaw%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DZ.%26atitle%3DStructural%2520basis%2520and%2520functional%2520analysis%2520of%2520the%2520SARS%2520coronavirus%2520nsp14-nsp10%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26issue%3D30%26spage%3D9436%26epage%3D9441%26doi%3D10.1073%2Fpnas.1508686112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirchdoerfer, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span> <span> </span><span class="NLM_article-title">Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">2342</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-10280-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41467-019-10280-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31138817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB3M3gslGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2342&issue=1&author=R.+N.+Kirchdoerferauthor=A.+B.+Ward&title=Structure+of+the+SARS-CoV+nsp12+polymerase+bound+to+nsp7+and+nsp8+co-factors&doi=10.1038%2Fs41467-019-10280-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors</span></div><div class="casAuthors">Kirchdoerfer Robert N; Ward Andrew B</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2342</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent history is punctuated by the emergence of highly pathogenic coronaviruses such as SARS- and MERS-CoV into human circulation.  Upon infecting host cells, coronaviruses assemble a multi-subunit RNA-synthesis complex of viral non-structural proteins (nsp) responsible for the replication and transcription of the viral genome.  Here, we present the 3.1 ÅA resolution structure of the SARS-CoV nsp12 polymerase bound to its essential co-factors, nsp7 and nsp8, using single particle cryo-electron microscopy. nsp12 possesses an architecture common to all viral polymerases as well as a large N-terminal extension containing a kinase-like fold and is bound by two nsp8 co-factors.  This structure illuminates the assembly of the coronavirus core RNA-synthesis machinery, provides key insights into nsp12 polymerase catalysis and fidelity and acts as a template for the design of novel antiviral therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHhQTFTUGoc7HHuJhbyicZfW6udTcc2eZFA-7mcO6Jl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M3gslGnsg%253D%253D&md5=71c144c86c8cef5df8bd02905d93d6dc</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-10280-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-10280-3%26sid%3Dliteratum%253Aachs%26aulast%3DKirchdoerfer%26aufirst%3DR.%2BN.%26aulast%3DWard%26aufirst%3DA.%2BB.%26atitle%3DStructure%2520of%2520the%2520SARS-CoV%2520nsp12%2520polymerase%2520bound%2520to%2520nsp7%2520and%2520nsp8%2520co-factors%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D2342%26doi%3D10.1038%2Fs41467-019-10280-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Therapeutic options for the 2019 novel coronavirus (2019-nCoV)</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/d41573-020-00016-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fd41573-020-00016-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32127666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkt1GksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2020&pages=149-150&issue=3&author=G.+Liauthor=E.+De+Clercq&title=Therapeutic+options+for+the+2019+novel+coronavirus+%282019-nCoV%29&doi=10.1038%2Fd41573-020-00016-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic options for the 2019 novel coronavirus (2019-nCoV)</span></div><div class="casAuthors">Li, Guangdi; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-150</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Therapeutic options in response to the 2019-nCoV outbreak are urgently needed.  Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCBg8QqE24YbVg90H21EOLACvtfcHk0ljB225rrQhdWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkt1GksLo%253D&md5=60d91d88e6a0279829eecb74990c9d03</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fd41573-020-00016-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fd41573-020-00016-0%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DTherapeutic%2520options%2520for%2520the%25202019%2520novel%2520coronavirus%2520%25282019-nCoV%2529%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2020%26volume%3D19%26issue%3D3%26spage%3D149%26epage%3D150%26doi%3D10.1038%2Fd41573-020-00016-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elfiky, A. A.</span></span> <span> </span><span class="NLM_article-title">Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>253</i></span>,  <span class="NLM_fpage">117592</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2020.117592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.lfs.2020.117592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32222463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvFemurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=2020&pages=117592&author=A.+A.+Elfiky&title=Ribavirin%2C+Remdesivir%2C+Sofosbuvir%2C+Galidesivir%2C+and+Tenofovir+against+SARS-CoV-2+RNA+dependent+RNA+polymerase+%28RdRp%29%3A+A+molecular+docking+study&doi=10.1016%2Fj.lfs.2020.117592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study</span></div><div class="casAuthors">Elfiky, Abdo A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117592</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new human coronavirus (HCoV), which has been designated SARS-CoV-2, began spreading in Dec. 2019 in Wuhan City, China causing pneumonia called COVID-19.  The spread of SARS-CoV-2 has been faster than any other coronaviruses that have succeeded in crossing the animal-human barrier.  There is concern that this new virus will spread around the world as did the previous two HCoVs-Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)-each of which caused approx. 800 deaths in the years 2002 and 2012, resp.  Thus far, 11,268 deaths have been reported from the 258,842 confirmed infections in 168 countries.  In this study, the RNA-dependent RNA polymerase (RdRp) of the newly emerged coronavirus is modeled, validated, and then targeted using different anti-polymerase drugs currently on the market that have been approved for use against various viruses.  The results suggest the effectiveness of Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir as potent drugs against SARS-CoV-2 since they tightly bind to its RdRp.  In addn., the results suggest guanosine deriv. (IDX-184), Setrobuvir, and YAK as top seeds for antiviral treatments with high potential to fight the SARS-CoV-2 strain specifically.  The availability of FDA-approved anti-RdRp drugs can help treat patients and reduce the danger of the mysterious new viral infection COVID-19.  The drugs mentioned above can tightly bind to the RdRp of the SARS-CoV-2 strain and thus may be used to treat the disease.  No toxicity measurements are required for these drugs since they were previously tested prior to their approval by the FDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUsdjkpK0gpbVg90H21EOLACvtfcHk0ljB225rrQhdWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvFemurw%253D&md5=9f464ee51fef4510c659f03f996110fb</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2020.117592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2020.117592%26sid%3Dliteratum%253Aachs%26aulast%3DElfiky%26aufirst%3DA.%2BA.%26atitle%3DRibavirin%252C%2520Remdesivir%252C%2520Sofosbuvir%252C%2520Galidesivir%252C%2520and%2520Tenofovir%2520against%2520SARS-CoV-2%2520RNA%2520dependent%2520RNA%2520polymerase%2520%2528RdRp%2529%253A%2520A%2520molecular%2520docking%2520study%26jtitle%3DLife%2520Sci.%26date%3D2020%26volume%3D253%26spage%3D117592%26doi%3D10.1016%2Fj.lfs.2020.117592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span> <span> </span><span class="NLM_article-title">Expression, purification, and characterization of SARS coronavirus RNA polymerase</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>335</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2005.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2005.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15840516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlaisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2005&pages=165-176&issue=2&author=A.+Chengauthor=W.+Zhangauthor=Y.+Xieauthor=W.+Jiangauthor=E.+Arnoldauthor=S.+G.+Sarafianosauthor=J.+Ding&title=Expression%2C+purification%2C+and+characterization+of+SARS+coronavirus+RNA+polymerase&doi=10.1016%2Fj.virol.2005.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, purification, and characterization of SARS coronavirus RNA polymerase</span></div><div class="casAuthors">Cheng, Ao; Zhang, Wei; Xie, Youhua; Jiang, Weihong; Arnold, Eddy; Sarafianos, Stefan G.; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The RNA-dependent RNA polymerase (RdRp) of SARS coronavirus (SARS-CoV) is essential for viral replication and a potential target for anti-SARS drugs.  Here, the authors report the cloning, expression, and purifn. of N-terminal GST-fused SARS-CoV RdRp and its polymerase catalytic domain in Escherichia coli.  During purifn., the full-length GST-RdRp was found to cleave into 3 main fragments: an N-terminal p12 fragment, a middle p30 fragment, and a C-terminal p64 fragment comprising the catalytic domain, presumably due to bacterial proteases.  Biochem. assays showed that full-length GST-RdRp had RdRp activity and that the p64 and p12 fragments formed a complex that exhibited comparable RdRp activity, whereas the GST-p64 protein had no activity, suggesting that the p12 domain is required for polymerase activity possibly via involvement in template-primer binding.  Non-nucleoside HIV-1 RT inhibitors were shown to have no evident inhibitory effect on SARS-CoV RdRp activity.  This work provides a basis for biochem. and structural studies of SARS-CoV RdRp and for the development of anti-SARS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkqaXvp-3xvLVg90H21EOLACvtfcHk0ljB225rrQhdWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlaisb0%253D&md5=cdaf95f961394d5668bd4a27fd1a5b6a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2005.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2005.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DExpression%252C%2520purification%252C%2520and%2520characterization%2520of%2520SARS%2520coronavirus%2520RNA%2520polymerase%26jtitle%3DVirology%26date%3D2005%26volume%3D335%26issue%3D2%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.virol.2005.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheahan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menachery, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gralinski, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyrc, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trantcheva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babusis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spahn, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmiotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span> <span> </span><span class="NLM_article-title">Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">396</span>), <span class="NLM_elocation-id">eaal3653</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aal3653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscitranslmed.aal3653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28659436" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&issue=396&author=T.+P.+Sheahanauthor=A.+C.+Simsauthor=R.+L.+Grahamauthor=V.+D.+Menacheryauthor=L.+E.+Gralinskiauthor=J.+B.+Caseauthor=S.+R.+Leistauthor=K.+Pyrcauthor=J.+Y.+Fengauthor=I.+Trantchevaauthor=R.+Bannisterauthor=Y.+Parkauthor=D.+Babusisauthor=M.+O.+Clarkeauthor=R.+L.+Mackmanauthor=J.+E.+Spahnauthor=C.+A.+Palmiottiauthor=D.+Siegelauthor=A.+S.+Rayauthor=T.+Cihlarauthor=R.+Jordanauthor=M.+R.+Denisonauthor=R.+S.+Baric&title=Broad-spectrum+antiviral+GS-5734+inhibits+both+epidemic+and+zoonotic+coronaviruses&doi=10.1126%2Fscitranslmed.aal3653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aal3653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aal3653%26sid%3Dliteratum%253Aachs%26aulast%3DSheahan%26aufirst%3DT.%2BP.%26aulast%3DSims%26aufirst%3DA.%2BC.%26aulast%3DGraham%26aufirst%3DR.%2BL.%26aulast%3DMenachery%26aufirst%3DV.%2BD.%26aulast%3DGralinski%26aufirst%3DL.%2BE.%26aulast%3DCase%26aufirst%3DJ.%2BB.%26aulast%3DLeist%26aufirst%3DS.%2BR.%26aulast%3DPyrc%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DTrantcheva%26aufirst%3DI.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DBabusis%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DSpahn%26aufirst%3DJ.%2BE.%26aulast%3DPalmiotti%26aufirst%3DC.%2BA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26atitle%3DBroad-spectrum%2520antiviral%2520GS-5734%2520inhibits%2520both%2520epidemic%2520and%2520zoonotic%2520coronaviruses%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26issue%3D396%26doi%3D10.1126%2Fscitranslmed.aal3653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span> <span> </span><span class="NLM_article-title">Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1038/s41422-020-0282-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41422-020-0282-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32020029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkt1Ciu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=269-271&issue=3&author=M.+Wangauthor=R.+Caoauthor=L.+Zhangauthor=X.+Yangauthor=J.+Liuauthor=M.+Xuauthor=Z.+Shiauthor=Z.+Huauthor=W.+Zhongauthor=G.+Xiao&title=Remdesivir+and+chloroquine+effectively+inhibit+the+recently+emerged+novel+coronavirus+%282019-nCoV%29+in+vitro&doi=10.1038%2Fs41422-020-0282-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</span></div><div class="casAuthors">Wang, Manli; Cao, Ruiyuan; Zhang, Leike; Yang, Xinglou; Liu, Jia; Xu, Mingyue; Shi, Zhengli; Hu, Zhihong; Zhong, Wu; Xiao, Gengfu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-271</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">In Dec. 2019, a novel pneumonia caused by a previously unknown pathogen emerged in Wuhan, a city of 11 million people in central China.  The initial cases were linked to exposures in a seafood market in Wuhan.  The pathogen was soon identified as a novel coronavirus (2019-nCoV), which is closely related to severe acute respiratory syndrome CoV (SARS-CoV).  Currently, there is no specific treatment against the new virus.  Therefore, identifying effective antiviral agents to combat the disease is urgently needed.  In this study, we evaluated the antiviral efficiency of FAD-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine and two well-known broad-spectrum antiviral drugs remdesivir (GS-5734) and favipiravir (T-705) against a clin. isolate of 2019-nCoV in vitro.  Our findings reveal that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro.  Since these compds. have been used in human patients with a safety track record and shown to be effective against various ailments, we suggest that they should be assessed in human patients suffering from the novel coronavirus disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnj2tW4TeD7Vg90H21EOLACvtfcHk0lgL7pvv9aYOhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkt1Ciu7k%253D&md5=bdf16b352ebc06bc148ed5c513b7d414</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1038%2Fs41422-020-0282-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-020-0282-0%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DG.%26atitle%3DRemdesivir%2520and%2520chloroquine%2520effectively%2520inhibit%2520the%2520recently%2520emerged%2520novel%2520coronavirus%2520%25282019-nCoV%2529%2520in%2520vitro%26jtitle%3DCell%2520Res.%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D269%26epage%3D271%26doi%3D10.1038%2Fs41422-020-0282-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1126/science.abc1560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.abc1560" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=W.+Yinauthor=C.+Maoauthor=X.+Luanauthor=D.+D.+Shenauthor=Q.+Shenauthor=H.+Suauthor=X.+Wangauthor=F.+Zhouauthor=W.+Zhaoauthor=M.+Gaoauthor=S.+Changauthor=Y.+C.+Xieauthor=G.+Tianauthor=H.+W.+Jiangauthor=S.+C.+Taoauthor=J.+Shenauthor=Y.+Jiangauthor=H.+Jiangauthor=Y.+Xuauthor=S.+Zhangauthor=Y.+Zhangauthor=H.+E.+Xu&title=Structural+basis+for+inhibition+of+the+RNA-dependent+RNA+polymerase+from+SARS-CoV-2+by+remdesivir&doi=10.1126%2Fscience.abc1560"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1126%2Fscience.abc1560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.abc1560%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DMao%26aufirst%3DC.%26aulast%3DLuan%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DD.%2BD.%26aulast%3DShen%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DY.%2BC.%26aulast%3DTian%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DH.%2BW.%26aulast%3DTao%26aufirst%3DS.%2BC.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520basis%2520for%2520inhibition%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520SARS-CoV-2%2520by%2520remdesivir%26jtitle%3DScience%26date%3D2020%26doi%3D10.1126%2Fscience.abc1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupferschmidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, J.</span></span> <span> </span><span class="NLM_article-title">Race to find COVID-19 treatments accelerates</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>367</i></span> (<span class="NLM_issue">6485</span>),  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1413</span>, <span class="refDoi"> DOI: 10.1126/science.367.6485.1412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.367.6485.1412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32217705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlslyms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2020&pages=1412-1413&issue=6485&author=K.+Kupferschmidtauthor=J.+Cohen&title=Race+to+find+COVID-19+treatments+accelerates&doi=10.1126%2Fscience.367.6485.1412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Race to find COVID-19 treatments accelerates</span></div><div class="casAuthors">Kupferschmidt, Kai; Cohen, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6485</span>),
    <span class="NLM_cas:pages">1412-1413</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">1095-9203</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">As the race to find treatments for coronavirus disease 2019 (COVID-19) accelerates, the World Health Organization (WHO) last week announced a major study to compare treatment strategies in a streamlined clin. trial design that doctors around the world can join.  SOLIDARITY-an unprecedented, coordinated push to collect robust scientific data rapidly during a pandemic, could include many thousands of patients in dozens of countries and has emphasized simplicity so that even hospitals overwhelmed by an onslaught of COVID-19 patients can participate.  The study will examine an exptl. antiviral compd. called remdesivir; the malaria medication chloroquine (or its chem. cousin hydroxychloroquine); a combination of the HIV drugs lopinavir and ritonavir; and that combination plus interferon-beta, an immune system messenger that can help cripple viruses.  WHO hopes to start to enroll patients as early as this week.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh0Ms8vLr3QLVg90H21EOLACvtfcHk0lhi4ibcofwDyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlslyms7g%253D&md5=6daa35af38dc238a33c14e24af1035c3</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1126%2Fscience.367.6485.1412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.367.6485.1412%26sid%3Dliteratum%253Aachs%26aulast%3DKupferschmidt%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DRace%2520to%2520find%2520COVID-19%2520treatments%2520accelerates%26jtitle%3DScience%26date%3D2020%26volume%3D367%26issue%3D6485%26spage%3D1412%26epage%3D1413%26doi%3D10.1126%2Fscience.367.6485.1412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horby, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span> (<span class="NLM_issue">10236</span>),  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1578</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)31022-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2931022-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32423584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXosVWlurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=1569-1578&issue=10236&author=Y.+Wangauthor=D.+Zhangauthor=G.+Duauthor=R.+Duauthor=J.+Zhaoauthor=Y.+Jinauthor=S.+Fuauthor=L.+Gaoauthor=Z.+Chengauthor=Q.+Luauthor=Y.+Huauthor=G.+Luoauthor=K.+Wangauthor=Y.+Luauthor=H.+Liauthor=S.+Wangauthor=S.+Ruanauthor=C.+Yangauthor=C.+Meiauthor=Y.+Wangauthor=D.+Dingauthor=F.+Wuauthor=X.+Tangauthor=X.+Yeauthor=Y.+Yeauthor=B.+Liuauthor=J.+Yangauthor=W.+Yinauthor=A.+Wangauthor=G.+Fanauthor=F.+Zhouauthor=Z.+Liuauthor=X.+Guauthor=J.+Xuauthor=L.+Shangauthor=Y.+Zhangauthor=L.+Caoauthor=T.+Guoauthor=Y.+Wanauthor=H.+Qinauthor=Y.+Jiangauthor=T.+Jakiauthor=F.+G.+Haydenauthor=P.+W.+Horbyauthor=B.+Caoauthor=C.+Wang&title=Remdesivir+in+adults+with+severe+COVID-19%3A+a+randomised%2C+double-blind%2C+placebo-controlled%2C+multicentre+trial&doi=10.1016%2FS0140-6736%2820%2931022-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial</span></div><div class="casAuthors">Wang, Yeming; Zhang, Dingyu; Du, Guanhua; Du, Ronghui; Zhao, Jianping; Jin, Yang; Fu, Shouzhi; Gao, Ling; Cheng, Zhenshun; Lu, Qiaofa; Hu, Yi; Luo, Guangwei; Wang, Ke; Lu, Yang; Li, Huadong; Wang, Shuzhen; Ruan, Shunan; Yang, Chengqing; Mei, Chunlin; Wang, Yi; Ding, Dan; Wu, Feng; Tang, Xin; Ye, Xianzhi; Ye, Yingchun; Liu, Bing; Yang, Jie; Yin, Wen; Wang, Aili; Fan, Guohui; Zhou, Fei; Liu, Zhibo; Gu, Xiaoying; Xu, Jiuyang; Shang, Lianhan; Zhang, Yi; Cao, Lianjun; Guo, Tingting; Wan, Yan; Qin, Hong; Jiang, Yushen; Jaki, Thomas; Hayden, Frederick G.; Horby, Peter W.; Cao, Bin; Wang, Chen</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10236</span>),
    <span class="NLM_cas:pages">1569-1578</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19).  Remdesivir (GS-5734), a nucleoside analog prodrug, has inhibitory effects on pathogenic animal and human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro, and inhibits Middle East respiratory syndrome coronavirus, SARS-CoV-1, and SARS-CoV-2 replication in animal models.  We did a randomized, double-blind, placebo-controlled, multicenter trial at ten hospitals in Hubei, China.  Eligible patients were adults (aged ≥18 years) admitted to hospital with lab.-confirmed SARS-CoV-2 infection, with an interval from symptom onset to enrollment of 12 days or less, oxygen satn. of 94% or less on room air or a ratio of arterial oxygen partial pressure to fractional inspired oxygen of 300 mm Hg or less, and radiol. confirmed pneumonia.  Patients were randomly assigned in a 2:1 ratio to i.v. remdesivir (200 mg on day 1 followed by 100 mg on days 2-10 in single daily infusions) or the same vol. of placebo infusions for 10 days.  Patients were permitted concomitant use of lopinavir-ritonavir, interferons, and corticosteroids.  The primary endpoint was time to clin. improvement up to day 28, defined as the time (in days) from randomization to the point of a decline of two levels on a six-point ordinal scale of clin. status (from 1=discharged to 6=death) or discharged alive from hospital, whichever came first.  Primary anal. was done in the intention-to-treat (ITT) population and safety anal. was done in all patients who started their assigned treatment.  This trial is registered with ClinicalTrials.gov, NCT04257656.  Between Feb 6, 2020, and March 12, 2020, 237 patients were enrolled and randomly assigned to a treatment group (158 to remdesivir and 79 to placebo); one patient in the placebo group who withdrew after randomization was not included in the ITT population.  Remdesivir use was not assocd. with a difference in time to clin. improvement (hazard ratio 1·23 [95% CI 0·87-1·75]).  Although not statistically significant, patients receiving remdesivir had a numerically faster time to clin. improvement than those receiving placebo among patients with symptom duration of 10 days or less (hazard ratio 1·52 [0·95-2·43]).  Adverse events were reported in 102 (66%) of 155 remdesivir recipients vs. 50 (64%) of 78 placebo recipients.  Remdesivir was stopped early because of adverse events in 18 (12%) patients vs. four (5%) patients who stopped placebo early.  In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not assocd. with statistically significant clin. benefits.  However, the numerical redn. in time to clin. improvement in those treated earlier requires confirmation in larger studies.  Chinese Academy of Medical Sciences Emergency Project of COVID-19, National Key Research and Development Program of China, the Beijing Science and Technol. Project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmNUsjDSS-z7Vg90H21EOLACvtfcHk0lhi4ibcofwDyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXosVWlurc%253D&md5=160af7f665ed7fe089e9c07b3bec1acd</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2931022-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252931022-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DDu%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DMei%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DShang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJaki%26aufirst%3DT.%26aulast%3DHayden%26aufirst%3DF.%2BG.%26aulast%3DHorby%26aufirst%3DP.%2BW.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DRemdesivir%2520in%2520adults%2520with%2520severe%2520COVID-19%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%252C%2520multicentre%2520trial%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26issue%3D10236%26spage%3D1569%26epage%3D1578%26doi%3D10.1016%2FS0140-6736%2820%2931022-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">U.S. Food & Drug Administration</span>, <span> </span><span class="NLM_article-title">Coronavirus (COVID-19) Update: FDA
Issues Emergency
Use Authorization for Potential COVID-19 Treatment</span>, FDA News Release, May 1, 2020; <a href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment" class="extLink">https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment</a> (accessed <span class="NLM_year">2020</span>-05-29).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=U.S.+Food+%26+Drug+Administration&title=Coronavirus+%28COVID-19%29+Update%3A+FDA%0AIssues+Emergency%0AUse+Authorization+for+Potential+COVID-19+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCoronavirus%2520%2528COVID-19%2529%2520Update%253A%2520FDA%250AIssues%2520Emergency%250AUse%2520Authorization%2520for%2520Potential%2520COVID-19%2520Treatment%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mulangu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tshiani Mbaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukadi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusakibanza Manzo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nzolo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tshomba Oloma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulibaly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muyembe-Tamfum, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">the PALM Writing Group</span></span> <span> </span><span class="NLM_article-title">A randomized, controlled trial of Ebola virus disease therapeutics</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>381</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">2293</span>– <span class="NLM_lpage">2303</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1910993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa1910993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31774950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVylsLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2019&pages=2293-2303&issue=24&author=S.+Mulanguauthor=L.+E.+Doddauthor=R.+T.+Daveyauthor=O.+Tshiani+Mbayaauthor=M.+Proschanauthor=D.+Mukadiauthor=M.+Lusakibanza+Manzoauthor=D.+Nzoloauthor=A.+Tshomba+Olomaauthor=A.+Ibandaauthor=R.+Aliauthor=S.+Coulibalyauthor=A.+C.+Levineauthor=R.+Graisauthor=J.+Diazauthor=H.+C.+Laneauthor=J.-J.+Muyembe-Tamfumauthor=+the+PALM+Writing+Group&title=A+randomized%2C+controlled+trial+of+Ebola+virus+disease+therapeutics&doi=10.1056%2FNEJMoa1910993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, controlled trial of ebola virus disease therapeutics</span></div><div class="casAuthors">Mulangu, Sabue; Dodd, Lori E.; Davey, Richard T., Jr.; Mbaya, Olivier Tshiani; Proschan, Michael; Mukadi, Daniel; Manzo, Mariano Lusakibanza; Nzolo, Didier; Oloma, Antoine Tshomba; Ibanda, Augustin; Ali, Rosine; Coulibaly, Sinare; Levine, Adam C.; Grais, Rebecca; Diaz, Janet; Lane, H. Clifford; Muyembe-Tamfum, Jean-Jacques</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2293-2303</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Although several exptl. therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial. methods We conducted a trial of four investigational therapies for EVD in the Democratic Republic of Congo, where an outbreak began in August 2018.  Patients of any age who had a pos. result for Ebola virus RNA on reverse-transcriptase-polymerase-chain-reaction assay were enrolled.  All patients received std. care and were randomly assigned in a 1:1:1:1 ratio to i.v. administration of the triple monoclonal antibody ZMapp (the control group), the antiviral agent remdesivir, the single monoclonal antibody MAb114, or the triple monoclonal antibody REGN-EB3.  The REGN-EB3 group was added in a later version of the protocol, so data from these patients were compared with those of patients in the ZMapp group who were enrolled at or after the time the REGN-EB3 group was added (the ZMapp subgroup).  The primary end point was death at 28 days. results A total of 681 patients were enrolled from Nov. 20, 2018, to August 9, 2019, at which time the data and safety monitoring board recommended that patients be assigned only to the MAb114 and REGN-EB3 groups for the remainder of the trial; the recommendation was based on the results of an interim anal. that showed superiority of these groups to ZMapp and remdesivir with respect to mortality.  At 28 days, death had occurred in 61 of 174 patients (35.1%) in the MAb114 group, as compared with 84 of 169 (49.7%) in the ZMapp group (P = 0.007), and in 52 of 155 (33.5%) in the REGN-EB3 group, as compared with 79 of 154 (51.3%) in the ZMapp subgroup (P = 0.002).  A shorter duration of symptoms before admission and lower baseline values for viral load and for serum creatinine and aminotransferase levels each correlated with improved survival.  Four serious adverse events were judged to be potentially related to the trial drugs. conclusions Both MAb114 and REGN-EB3 were superior to ZMapp in reducing mortality from EVD.  Scientifically and ethically sound clin. research can be conducted during disease outbreaks and can help inform the outbreak response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsF31fomvTPrVg90H21EOLACvtfcHk0lhynkin782HXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVylsLzP&md5=ace616255b8372f99aef8dee4864d38f</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1910993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1910993%26sid%3Dliteratum%253Aachs%26aulast%3DMulangu%26aufirst%3DS.%26aulast%3DDodd%26aufirst%3DL.%2BE.%26aulast%3DDavey%26aufirst%3DR.%2BT.%26aulast%3DTshiani%2BMbaya%26aufirst%3DO.%26aulast%3DProschan%26aufirst%3DM.%26aulast%3DMukadi%26aufirst%3DD.%26aulast%3DLusakibanza%2BManzo%26aufirst%3DM.%26aulast%3DNzolo%26aufirst%3DD.%26aulast%3DTshomba%2BOloma%26aufirst%3DA.%26aulast%3DIbanda%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DR.%26aulast%3DCoulibaly%26aufirst%3DS.%26aulast%3DLevine%26aufirst%3DA.%2BC.%26aulast%3DGrais%26aufirst%3DR.%26aulast%3DDiaz%26aufirst%3DJ.%26aulast%3DLane%26aufirst%3DH.%2BC.%26aulast%3DMuyembe-Tamfum%26aufirst%3DJ.-J.%26aulast%3Dthe%2BPALM%2BWriting%2BGroup%26atitle%3DA%2520randomized%252C%2520controlled%2520trial%2520of%2520Ebola%2520virus%2520disease%2520therapeutics%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D381%26issue%3D24%26spage%3D2293%26epage%3D2303%26doi%3D10.1056%2FNEJMoa1910993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agostini, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheahan, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span> <span> </span><span class="NLM_article-title">Coronavirus susceptibility to the antiviral Remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>), <span class="NLM_elocation-id">e00221-18</span> <span class="refDoi"> DOI: 10.1128/mBio.00221-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FmBio.00221-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29511076" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&issue=2&author=M.+L.+Agostiniauthor=E.+L.+Andresauthor=A.+C.+Simsauthor=R.+L.+Grahamauthor=T.+P.+Sheahanauthor=X.+Luauthor=E.+C.+Smithauthor=J.+B.+Caseauthor=J.+Y.+Fengauthor=R.+Jordanauthor=A.+S.+Rayauthor=T.+Cihlarauthor=D.+Siegelauthor=R.+L.+Mackmanauthor=M.+O.+Clarkeauthor=R.+S.+Baricauthor=M.+R.+Denison&title=Coronavirus+susceptibility+to+the+antiviral+Remdesivir+%28GS-5734%29+is+mediated+by+the+viral+polymerase+and+the+proofreading+exoribonuclease&doi=10.1128%2FmBio.00221-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1128%2FmBio.00221-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00221-18%26sid%3Dliteratum%253Aachs%26aulast%3DAgostini%26aufirst%3DM.%2BL.%26aulast%3DAndres%26aufirst%3DE.%2BL.%26aulast%3DSims%26aufirst%3DA.%2BC.%26aulast%3DGraham%26aufirst%3DR.%2BL.%26aulast%3DSheahan%26aufirst%3DT.%2BP.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DE.%2BC.%26aulast%3DCase%26aufirst%3DJ.%2BB.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26atitle%3DCoronavirus%2520susceptibility%2520to%2520the%2520antiviral%2520Remdesivir%2520%2528GS-5734%2529%2520is%2520mediated%2520by%2520the%2520viral%2520polymerase%2520and%2520the%2520proofreading%2520exoribonuclease%26jtitle%3DmBio%26date%3D2018%26volume%3D9%26issue%3D2%26doi%3D10.1128%2FmBio.00221-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minskaia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbalenya, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campanacci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambillau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziebuhr, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of an RNA virus 3′->5′ exoribonuclease that is critically involved in coronavirus RNA synthesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5108</span>– <span class="NLM_lpage">5113</span>, <span class="refDoi"> DOI: 10.1073/pnas.0508200103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.0508200103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16549795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsVGltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=5108-5113&issue=13&author=E.+Minskaiaauthor=T.+Hertzigauthor=A.+E.+Gorbalenyaauthor=V.+Campanacciauthor=C.+Cambillauauthor=B.+Canardauthor=J.+Ziebuhr&title=Discovery+of+an+RNA+virus+3%E2%80%B2-%3E5%E2%80%B2+exoribonuclease+that+is+critically+involved+in+coronavirus+RNA+synthesis&doi=10.1073%2Fpnas.0508200103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an RNA virus 3'→5' exoribonuclease that is critically involved in coronavirus RNA synthesis</span></div><div class="casAuthors">Minskaia, Ekaterina; Hertzig, Tobias; Gorbalenya, Alexander E.; Campanacci, Valerie; Cambillau, Christian; Canard, Bruno; Ziebuhr, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5108-5113</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Replication of the giant RNA genome of severe acute respiratory syndrome (SARS) coronavirus (CoV) and synthesis of as many as eight subgenomic (sg) mRNAs are mediated by a viral replicase-transcriptase of outstanding complexity that includes an essential endoribonuclease activity.  Here, we show that the CoV replicative machinery, unlike that of other RNA viruses, also uses an exoribonuclease (ExoN) activity, which is assocd. with nonstructural protein (nsp) 14.  Bacterially expressed forms of SARS-CoV nsp14 were shown to act on both ssRNAs and dsRNAs in a 3'→5' direction.  The activity depended on residues that are conserved in the DEDD exonuclease superfamily.  The protein did not hydrolyze DNA or ribose-2'-O-methylated RNA substrates and required divalent metal ions for activity.  A range of 5'-labeled ssRNA substrates were processed to final products of ≈8-12 nucleotides.  When part of dsRNA or in the presence of nonlabeled dsRNA, the 5'-labeled RNA substrates were processed to significantly smaller products, indicating that binding to dsRNA in cis or trans modulates the exonucleolytic activity of nsp14.  Characterization of human CoV 229E ExoN active-site mutants revealed severe defects in viral RNA synthesis, and no viable virus could be recovered.  Besides strongly reduced genome replication, specific defects in sg RNA synthesis, such as aberrant sizes of specific sg RNAs and changes in the molar ratios between individual sg RNA species, were obsd.  Taken together, the study identifies an RNA virus ExoN activity that is involved in the synthesis of multiple RNAs from the exceptionally large genomic RNA templates of CoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6SF6y0gH--rVg90H21EOLACvtfcHk0lhLlj4yMeZcnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsVGltr0%253D&md5=bdf193d90a45d6b9433dbdd4d74d4a4f</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0508200103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0508200103%26sid%3Dliteratum%253Aachs%26aulast%3DMinskaia%26aufirst%3DE.%26aulast%3DHertzig%26aufirst%3DT.%26aulast%3DGorbalenya%26aufirst%3DA.%2BE.%26aulast%3DCampanacci%26aufirst%3DV.%26aulast%3DCambillau%26aufirst%3DC.%26aulast%3DCanard%26aufirst%3DB.%26aulast%3DZiebuhr%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520RNA%2520virus%25203%25E2%2580%25B2-%253E5%25E2%2580%25B2%2520exoribonuclease%2520that%2520is%2520critically%2520involved%2520in%2520coronavirus%2520RNA%2520synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D13%26spage%3D5108%26epage%3D5113%26doi%3D10.1073%2Fpnas.0508200103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanc, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denison, M. R.</span></span> <span> </span><span class="NLM_article-title">Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>), <span class="NLM_elocation-id">e1003565</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1003565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.ppat.1003565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23966862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVChs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&issue=8&author=E.+C.+Smithauthor=H.+Blancauthor=M.+Vignuzziauthor=M.+R.+Denison&title=Coronaviruses+lacking+exoribonuclease+activity+are+susceptible+to+lethal+mutagenesis%3A+evidence+for+proofreading+and+potential+therapeutics&doi=10.1371%2Fjournal.ppat.1003565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics</span></div><div class="casAuthors">Smith, Everett Clinton; Blanc, Herve; Surdel, Matthew C.; Vignuzzi, Marco; Denison, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e1003565</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">No therapeutics or vaccines currently exist for human coronaviruses (HCoVs).  The severe acute respiratory syndrome-assocd. coronavirus (SARS-CoV) epidemic in 2002-2003, and the recent emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in Apr. 2012, emphasize the high probability of future zoonotic HCoV emergence causing severe and lethal human disease.  Addnl., the resistance of SARS-CoV to ribavirin (RBV) demonstrates the need to define new targets for inhibition of CoV replication.  CoVs express a 3'-to-5' exoribonuclease in nonstructural protein 14 (nsp14-ExoN) that is required for high-fidelity replication and is conserved across the CoV family.  All genetic and biochem. data support the hypothesis that nsp14-ExoN has an RNA proofreading function.  Thus, we hypothesized that ExoN is responsible for CoV resistance to RNA mutagens.  We demonstrate that while wild-type (ExoN+) CoVs were resistant to RBV and 5-fluorouracil (5-FU), CoVs lacking ExoN activity (ExoN-) were up to 300-fold more sensitive.  While the primary antiviral activity of RBV against CoVs was not mutagenesis, ExoN- CoVs treated with 5-FU demonstrated both enhanced sensitivity during multi-cycle replication, as well as decreased specific infectivity, consistent with 5-FU functioning as a mutagen.  Comparison of full-genome next-generation sequencing of 5-FU treated SARS-CoV populations revealed a 16-fold increase in the no. of mutations within the ExoN- population as compared to ExoN+.  Ninety percent of these mutations represented A:G and U:C transitions, consistent with 5-FU incorporation during RNA synthesis.  Together our results constitute direct evidence that CoV ExoN activity provides a crit. proofreading function during virus replication.  Furthermore, these studies identify ExoN as the first viral protein distinct from the RdRp that dets. the sensitivity of RNA viruses to mutagens.  Finally, our results show the importance of ExoN as a target for inhibition, and suggest that small-mol. inhibitors of ExoN activity could be potential pan-CoV therapeutics in combination with RBV or RNA mutagens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgCfuqrEG6y7Vg90H21EOLACvtfcHk0ljH3--x7Dceiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVChs73K&md5=8ac64b4a35096342d4a879be0226e455</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1003565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1003565%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DE.%2BC.%26aulast%3DBlanc%26aufirst%3DH.%26aulast%3DVignuzzi%26aufirst%3DM.%26aulast%3DDenison%26aufirst%3DM.%2BR.%26atitle%3DCoronaviruses%2520lacking%2520exoribonuclease%2520activity%2520are%2520susceptible%2520to%2520lethal%2520mutagenesis%253A%2520evidence%2520for%2520proofreading%2520and%2520potential%2520therapeutics%26jtitle%3DPLoS%2520Pathog.%26date%3D2013%26volume%3D9%26issue%3D8%26doi%3D10.1371%2Fjournal.ppat.1003565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. P.</span></span> <span> </span><span class="NLM_article-title">Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/cpt.1844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcpt.1844" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+X.+Duauthor=X.+P.+Chen&title=Favipiravir%3A+pharmacokinetics+and+concerns+about+clinical+trials+for+2019-nCoV+infection&doi=10.1002%2Fcpt.1844"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1002%2Fcpt.1844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpt.1844%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DY.%2BX.%26aulast%3DChen%26aufirst%3DX.%2BP.%26atitle%3DFavipiravir%253A%2520pharmacokinetics%2520and%2520concerns%2520about%2520clinical%2520trials%2520for%25202019-nCoV%2520infection%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2020%26doi%3D10.1002%2Fcpt.1844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posthuma, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbalenya, A. E.</span></span> <span> </span><span class="NLM_article-title">What we know but do not understand about nidovirus helicases</span>. <i>Virus Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1016/j.virusres.2014.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virusres.2014.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25497126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVygs7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2015&pages=12-32&author=K.+C.+Lehmannauthor=E.+J.+Snijderauthor=C.+C.+Posthumaauthor=A.+E.+Gorbalenya&title=What+we+know+but+do+not+understand+about+nidovirus+helicases&doi=10.1016%2Fj.virusres.2014.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">What we know but do not understand about nidovirus helicases</span></div><div class="casAuthors">Lehmann, Kathleen C.; Snijder, Eric J.; Posthuma, Clara C.; Gorbalenya, Alexander E.</div><div class="citationInfo"><span class="NLM_cas:title">Virus Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12-32</span>CODEN:
                <span class="NLM_cas:coden">VIREDF</span>;
        ISSN:<span class="NLM_cas:issn">0168-1702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Helicases are versatile NTP-dependent motor proteins of monophyletic origin that are found in all kingdoms of life.  Their functions range from nucleic acid duplex unwinding to protein displacement and double-strand translocation.  This explains their participation in virtually every metabolic process that involves nucleic acids, including DNA replication, recombination and repair, transcription, translation, as well as RNA processing.  Helicases are encoded by all plant and animal viruses with a pos.-sense RNA genome that is larger than 7 kb, indicating a link to genome size evolution in this virus class.  Viral helicases belong to three out of the six currently recognized superfamilies, SF1, SF2, and SF3.  Despite being omnipresent, highly conserved and essential, only a few viral helicases, mostly from SF2, have been studied extensively.  In general, their specific roles in the viral replication cycle remain poorly understood at present.  The SF1 helicase protein of viruses classified in the order Nidovirales is encoded in replicase open reading frame 1b (ORF1b), which is translated to give rise to a large polyprotein following a ribosomal frameshift from the upstream ORF1a.  Proteolytic processing of the replicase polyprotein yields a dozen or so mature proteins, one of which includes a helicase.  Its hallmark is the presence of an N-terminal multi-nuclear zinc-binding domain, the nidoviral genetic marker and one of the most conserved domains across members of the order.  This review summarizes biochem., structural, and genetic data, including drug development studies, obtained using helicases originating from several mammalian nidoviruses, along with the results of the genomics characterization of a much larger no. of (putative) helicases of vertebrate and invertebrate nidoviruses.  In the context of our knowledge of related helicases of cellular and viral origin, it discusses the implications of these results for the protein's emerging crit. function(s) in nidovirus evolution, genome replication and expression, virion biogenesis, and possibly also post-transcriptional processing of viral RNAs.  Using our accumulated knowledge and highlighting gaps in our data, concepts and approaches, it concludes with a perspective on future research aimed at elucidating the role of helicases in the nidovirus replication cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqikWVbm4gKHrVg90H21EOLACvtfcHk0ljH3--x7Dceiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVygs7rO&md5=aeabad49055088b872719df294545d52</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.virusres.2014.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virusres.2014.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DK.%2BC.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DPosthuma%26aufirst%3DC.%2BC.%26aulast%3DGorbalenya%26aufirst%3DA.%2BE.%26atitle%3DWhat%2520we%2520know%2520but%2520do%2520not%2520understand%2520about%2520nidovirus%2520helicases%26jtitle%3DVirus%2520Res.%26date%3D2015%26volume%3D202%26spage%3D12%26epage%3D32%26doi%3D10.1016%2Fj.virusres.2014.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesel, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. D.</span></span> <span> </span><span class="NLM_article-title">The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2005.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.chembiol.2005.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15797214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXis1Knu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=303-311&issue=3&author=J.+A.+Tannerauthor=B.+J.+Zhengauthor=J.+Zhouauthor=R.+M.+Wattauthor=J.+Q.+Jiangauthor=K.+L.+Wongauthor=Y.+P.+Linauthor=L.+Y.+Luauthor=M.+L.+Heauthor=H.+F.+Kungauthor=A.+J.+Keselauthor=J.+D.+Huang&title=The+adamantane-derived+bananins+are+potent+inhibitors+of+the+helicase+activities+and+replication+of+SARS+coronavirus&doi=10.1016%2Fj.chembiol.2005.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS Coronavirus</span></div><div class="casAuthors">Tanner, Julian A.; Zheng, Bo-Jian; Zhou, Jie; Watt, Rory M.; Jiang, Jie-Qing; Wong, Kin-Ling; Lin, Yong-Ping; Lu, Lin-Yu; He, Ming-Liang; Kung, Hsiang-Fu; Kesel, Andreas J.; Huang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-311</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Bananins are a class of antiviral compds. with a unique structural signature incorporating a trioxa-adamantane moiety covalently bound to a pyridoxal deriv.  Six members of this class of compds.: bananin, iodobananin, vanillinbananin, ansabananin, eubananin, and adeninobananin were synthesized and tested as inhibitors of the SARS Coronavirus (SCV) helicase.  Bananin, iodobananin, vanillinbananin, and eubananin were effective inhibitors of the ATPase activity of the SCV helicase with IC50 values in the range 0.5-3 μM.  A similar trend, though at slightly higher inhibitor concns., was obsd. for inhibition of the helicase activities, using a FRET-based fluorescent assay.  In a cell culture system of SCV, bananin exhibited an EC50 of less than 10 μM and a CC50 of over 300 μM.  Kinetics of inhibition are consistent with bananin inhibiting an intracellular process or processes involved in SCV replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo73PymkPDSmLVg90H21EOLACvtfcHk0ljH3--x7Dceiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXis1Knu7c%253D&md5=829a6c9c03429f144b55be0ee7cd37ee</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DTanner%26aufirst%3DJ.%2BA.%26aulast%3DZheng%26aufirst%3DB.%2BJ.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DWatt%26aufirst%3DR.%2BM.%26aulast%3DJiang%26aufirst%3DJ.%2BQ.%26aulast%3DWong%26aufirst%3DK.%2BL.%26aulast%3DLin%26aufirst%3DY.%2BP.%26aulast%3DLu%26aufirst%3DL.%2BY.%26aulast%3DHe%26aufirst%3DM.%2BL.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DKesel%26aufirst%3DA.%2BJ.%26aulast%3DHuang%26aufirst%3DJ.%2BD.%26atitle%3DThe%2520adamantane-derived%2520bananins%2520are%2520potent%2520inhibitors%2520of%2520the%2520helicase%2520activities%2520and%2520replication%2520of%2520SARS%2520coronavirus%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D3%26spage%3D303%26epage%3D311%26doi%3D10.1016%2Fj.chembiol.2005.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y.</span></span> <span> </span><span class="NLM_article-title">2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5698</span>– <span class="NLM_lpage">5704</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.ejmech.2011.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21925774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKkurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=5698-5704&issue=11&author=M.+K.+Kimauthor=M.+S.+Yuauthor=H.+R.+Parkauthor=K.+B.+Kimauthor=C.+Leeauthor=S.+Y.+Choauthor=J.+Kangauthor=H.+Yoonauthor=D.+E.+Kimauthor=H.+Chooauthor=Y.+J.+Jeongauthor=Y.+Chong&title=2%2C6-Bis-arylmethyloxy-5-hydroxychromones+with+antiviral+activity+against+both+hepatitis+C+virus+%28HCV%29+and+SARS-associated+coronavirus+%28SCV%29&doi=10.1016%2Fj.ejmech.2011.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)</span></div><div class="casAuthors">Kim, Mi Kyoung; Yu, Mi-Sun; Park, Hye Ri; Kim, Kyung Bo; Lee, Chaewoon; Cho, Suh Young; Kang, Jihoon; Yoon, Hyunjun; Kim, Dong-Eun; Choo, Hyunah; Jeong, Yong-Joo; Chong, Youhoon</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5698-5704</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In this study, as a bioisosteric alternative scaffold of the antiviral aryl diketoacids (ADKs), we used 5-hydroxychromone on which two arylmethyloxy substituents were installed.  The 5-hydroxychromones (5b-5g) thus prepd. showed anti-HCV activity and, depending on the arom. substituents on the 2-arylmethyloxy moiety, some of the derivs. (5b-5f) were also active against SCV.  In addn., unlike the ADKs which showed selective inhibition against the helicase activity of the SCV NTPase/helicase, the 5-hydroxychromones (5b-5f) were active against both NTPase and helicase activities of the target enzyme.  Among those, 3-iodobenzyloxy-substituted deriv. 5e showed the most potent activity against HCV (EC50 = 4 μM) as well as SCV (IC50 = 4 μM for ATPase activity, 11 μM for helicase activity) and this might be used as a platform structure for future development of the multi-target or broad-spectrum antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT6c44qsYeWLVg90H21EOLACvtfcHk0ljDj4P0bl-GGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKkurjJ&md5=8e47e57e238d48afa61cecb1aa86af83</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DYu%26aufirst%3DM.%2BS.%26aulast%3DPark%26aufirst%3DH.%2BR.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%2BE.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DJeong%26aufirst%3DY.%2BJ.%26aulast%3DChong%26aufirst%3DY.%26atitle%3D2%252C6-Bis-arylmethyloxy-5-hydroxychromones%2520with%2520antiviral%2520activity%2520against%2520both%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520and%2520SARS-associated%2520coronavirus%2520%2528SCV%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26issue%3D11%26spage%3D5698%26epage%3D5704%26doi%3D10.1016%2Fj.ejmech.2011.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y.</span></span> <span> </span><span class="NLM_article-title">Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1636</span>– <span class="NLM_lpage">1638</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bmcl.2009.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19233643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1636-1638&issue=6&author=C.+Leeauthor=J.+M.+Leeauthor=N.+R.+Leeauthor=B.+S.+Jinauthor=K.+J.+Jangauthor=D.+E.+Kimauthor=Y.+J.+Jeongauthor=Y.+Chong&title=Aryl+diketoacids+%28ADK%29+selectively+inhibit+duplex+DNA-unwinding+activity+of+SARS+coronavirus+NTPase%2Fhelicase&doi=10.1016%2Fj.bmcl.2009.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase</span></div><div class="casAuthors">Lee, Chaewoon; Lee, Jin Moo; Lee, Na-Ra; Jin, Bong-Suk; Jang, Kyoung Jin; Kim, Dong-Eun; Jeong, Yong-Joo; Chong, Youhoon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1636-1638</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As anti-HCV aryl diketoacids (ADK) are good metal chelators, we anticipated that ADKs might serve as potential inhibitors of SARS CoV (SCV) NTPase/helicase (Hel) by mimicking the binding modes of the bismuth complexes which effectively competes for the Zn2+ ion binding sites in SCV Hel thereby disrupting and inhibiting both the NTPase and helicase activities.  Phosphate release assay and FRET-based assay of the ADK analogs showed that the ADKs selectively inhibit the duplex DNA-unwinding activity without significant impact on the helicase ATPase activity.  Also, antiviral activities of the ADKs were shown dependent upon the substituent.  Taken together, these results suggest that there might be ADK-specific binding site in the SCV Hel, which warrants further investigations with diverse ADKs to provide valuable insights into rational design of specific SCV Hel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvSD2WIZmbqrVg90H21EOLACvtfcHk0ljDj4P0bl-GGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSlsb0%253D&md5=768b511fde674d1d05a0e820e412119a</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DN.%2BR.%26aulast%3DJin%26aufirst%3DB.%2BS.%26aulast%3DJang%26aufirst%3DK.%2BJ.%26aulast%3DKim%26aufirst%3DD.%2BE.%26aulast%3DJeong%26aufirst%3DY.%2BJ.%26aulast%3DChong%26aufirst%3DY.%26atitle%3DAryl%2520diketoacids%2520%2528ADK%2529%2520selectively%2520inhibit%2520duplex%2520DNA-unwinding%2520activity%2520of%2520SARS%2520coronavirus%2520NTPase%252Fhelicase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D6%26spage%3D1636%26epage%3D1638%26doi%3D10.1016%2Fj.bmcl.2009.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adedeji, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calcaterra, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeDiego, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4718</span>– <span class="NLM_lpage">4728</span>, <span class="refDoi"> DOI: 10.1128/AAC.00957-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.00957-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22733076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12mtrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2012&pages=4718-4728&issue=9&author=A.+O.+Adedejiauthor=K.+Singhauthor=N.+E.+Calcaterraauthor=M.+L.+DeDiegoauthor=L.+Enjuanesauthor=S.+Weissauthor=S.+G.+Sarafianos&title=Severe+acute+respiratory+syndrome+coronavirus+replication+inhibitor+that+interferes+with+the+nucleic+acid+unwinding+of+the+viral+helicase&doi=10.1128%2FAAC.00957-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase</span></div><div class="casAuthors">Adedeji, Adeyemi O.; Singh, Kamalendra; Calcaterra, Nicholas E.; DeDiego, Marta L.; Enjuanes, Luis; Weiss, Susan; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4718-4728</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome (SARS) is a highly contagious disease, caused by SARS coronavirus (SARS-CoV), for which there are no approved treatments.  We report the discovery of a potent inhibitor of SARS-CoV that blocks replication by inhibiting the unwinding activity of the SARS-CoV helicase (nsp13).  We used a Forster resonance energy transfer (FRET)-based helicase assay to screen the Maybridge Hitfinder chem. library.  We identified and validated a compd. (SSYA10-001) that specifically blocks the double-stranded RNA (dsRNA) and dsDNA unwinding activities of nsp13, with 50% inhibitory concns. (IC50s) of 5.70 and 5.30 μM, resp.  This compd. also has inhibitory activity (50% effective concn. [EC50] = 8.95 μM) in a SARS-CoV replicon assay, with low cytotoxicity (50% cytotoxic concn. [CC50] = >250 μM), suggesting that the helicase plays a still unidentified crit. role in the SARS-CoV life cycle.  Enzyme kinetic studies on the mechanism of nsp13 inhibition revealed that SSYA10-001 acts as a noncompetitive inhibitor of nsp13 with respect to nucleic acid and ATP substrates.  Moreover, SSYA10-001 does not affect ATP hydrolysis or nsp13 binding to the nucleic acid substrate.  SSYA10-001 did not inhibit hepatitis C virus (HCV) helicase, other bacterial and viral RNA-dependent RNA polymerases, or reverse transcriptase.  These results suggest that SSYA10-001 specifically blocks nsp13 through a novel mechanism and is less likely to interfere with the functions of cellular enzymes that process nucleic acids or ATP.  Hence, it is possible that SSYA10-001 inhibits unwinding by nsp13 by affecting conformational changes during the course of the reaction or translocation on the nucleic acid.  SSYA10-001 will be a valuable tool for studying the specific role of nsp13 in the SARS-CoV life cycle, which could be a model for other nidoviruses and also a candidate for further development as a SARS antiviral target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzmNPIMRXGXrVg90H21EOLACvtfcHk0ljJUey7mHRrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12mtrfM&md5=6effa02a0e9a4dbfe85bced0eb585a1d</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1128%2FAAC.00957-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00957-12%26sid%3Dliteratum%253Aachs%26aulast%3DAdedeji%26aufirst%3DA.%2BO.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DCalcaterra%26aufirst%3DN.%2BE.%26aulast%3DDeDiego%26aufirst%3DM.%2BL.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DWeiss%26aufirst%3DS.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520replication%2520inhibitor%2520that%2520interferes%2520with%2520the%2520nucleic%2520acid%2520unwinding%2520of%2520the%2520viral%2520helicase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2012%26volume%3D56%26issue%3D9%26spage%3D4718%26epage%3D4728%26doi%3D10.1128%2FAAC.00957-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adedeji, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of SSYA10–001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4894</span>– <span class="NLM_lpage">4898</span>, <span class="refDoi"> DOI: 10.1128/AAC.02994-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.02994-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24841268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ajurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4894-4898&issue=8&author=A.+O.+Adedejiauthor=K.+Singhauthor=A.+Kassimauthor=C.+M.+Colemanauthor=R.+Elliottauthor=S.+R.+Weissauthor=M.+B.+Friemanauthor=S.+G.+Sarafianos&title=Evaluation+of+SSYA10%E2%80%93001+as+a+replication+inhibitor+of+severe+acute+respiratory+syndrome%2C+mouse+hepatitis%2C+and+Middle+East+respiratory+syndrome+coronaviruses&doi=10.1128%2FAAC.02994-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and middle east respiratory syndrome coronaviruses</span></div><div class="casAuthors">Adedeji, Adeyemi O.; Singh, Kamalendra; Kassim, Ademola; Coleman, Christopher M.; Elliott, Ruth; Weiss, Susan R.; Frieman, Matthew B.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4894-4898, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We have previously shown that SSYA10-001 blocks severe acute respiratory syndrome coronavirus (SARS-CoV) replication by inhibiting SARS-CoV helicase (nsp13).  Here, we show that SSYA10-001 also inhibits replication of two other coronaviruses, mouse hepatitis virus (MHV) and Middle Eastern respiratory syndrome coronavirus (MERS-CoV).  A putative binding pocket for SSYA10-001 was identified and shown to be similar in SARS-CoV, MERS-CoV, and MHV helicases.  These studies show that it is possible to target multiple coronaviruses through broad-spectrum inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Gi0xnfYsGLVg90H21EOLACvtfcHk0ljJUey7mHRrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ajurvM&md5=2cf5662f8617c429799c35c6ceb2fe97</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1128%2FAAC.02994-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02994-14%26sid%3Dliteratum%253Aachs%26aulast%3DAdedeji%26aufirst%3DA.%2BO.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DKassim%26aufirst%3DA.%26aulast%3DColeman%26aufirst%3DC.%2BM.%26aulast%3DElliott%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DS.%2BR.%26aulast%3DFrieman%26aufirst%3DM.%2BB.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DEvaluation%2520of%2520SSYA10%25E2%2580%2593001%2520as%2520a%2520replication%2520inhibitor%2520of%2520severe%2520acute%2520respiratory%2520syndrome%252C%2520mouse%2520hepatitis%252C%2520and%2520Middle%2520East%2520respiratory%2520syndrome%2520coronaviruses%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4894%26epage%3D4898%26doi%3D10.1128%2FAAC.02994-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span> <span> </span><span class="NLM_article-title">Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">6538</span>– <span class="NLM_lpage">6550</span>, <span class="refDoi"> DOI: 10.1093/nar/gkz409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1093%2Fnar%2Fgkz409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31131400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2019&pages=6538-6550&issue=12&author=Z.+Jiaauthor=L.+Yanauthor=Z.+Renauthor=L.+Wuauthor=J.+Wangauthor=J.+Guoauthor=L.+Zhengauthor=Z.+Mingauthor=L.+Zhangauthor=Z.+Louauthor=Z.+Rao&title=Delicate+structural+coordination+of+the+Severe+Acute+Respiratory+Syndrome+coronavirus+Nsp13+upon+ATP+hydrolysis&doi=10.1093%2Fnar%2Fgkz409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis</span></div><div class="casAuthors">Jia, Zhihui; Yan, Liming; Ren, Zhilin; Wu, Lijie; Wang, Jin; Guo, Jing; Zheng, Litao; Ming, Zhenhua; Zhang, Lianqi; Lou, Zhiyong; Rao, Zihe</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6538-6550</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">To date, an effective therapeutic treatment that confers strong attenuation toward coronaviruses (CoVs) remains elusive.  Of all the potential drug targets, the helicase of CoVs is considered to be one of the most important.  Here, we first present the structure of the full-length Nsp13 helicase of SARS-CoV (SARS-Nsp13) and investigate the structural coordination of its five domains and how these contribute to its translocation and unwinding activity.  A translocation model is proposed for the Upf1-like helicase members according to three different structural conditions in soln. characterized through H/D exchange assay, including substrate state (SARS-Nsp13-dsDNA bound with AMPPNP), transition state (bound with ADP-AlF4-) and product state (bound with ADP).  We obsd. that the β19-β20 loop on the 1A domain is involved in unwinding process directly.  Furthermore, we have shown that the RNA dependent RNA polymerase (RdRp), SARS-Nsp12, can enhance the helicase activity of SARS-Nsp13 through interacting with it directly.  The interacting regions were identified and can be considered common across CoVs, which provides new insights into the Replication and Transcription Complex (RTC) of CoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohBmwhTskMz7Vg90H21EOLACvtfcHk0ljJUey7mHRrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVCqtr4%253D&md5=dbc8758bb3d0c416dd5edebb555b128a</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkz409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkz409%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DMing%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DRao%26aufirst%3DZ.%26atitle%3DDelicate%2520structural%2520coordination%2520of%2520the%2520Severe%2520Acute%2520Respiratory%2520Syndrome%2520coronavirus%2520Nsp13%2520upon%2520ATP%2520hydrolysis%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2019%26volume%3D47%26issue%3D12%26spage%3D6538%26epage%3D6550%26doi%3D10.1093%2Fnar%2Fgkz409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slutsky, A. S.</span></span> <span> </span><span class="NLM_article-title">Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target</span>. <i>Intensive Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">586</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1007/s00134-020-05985-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs00134-020-05985-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32125455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkt1erurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2020&pages=586-590&issue=4&author=H.+Zhangauthor=J.+M.+Penningerauthor=Y.+Liauthor=N.+Zhongauthor=A.+S.+Slutsky&title=Angiotensin-converting+enzyme+2+%28ACE2%29+as+a+SARS-CoV-2+receptor%3A+molecular+mechanisms+and+potential+therapeutic+target&doi=10.1007%2Fs00134-020-05985-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target</span></div><div class="casAuthors">Zhang, Haibo; Penninger, Josef M.; Li, Yimin; Zhong, Nanshan; Slutsky, Arthur S.</div><div class="citationInfo"><span class="NLM_cas:title">Intensive Care Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">586-590</span>CODEN:
                <span class="NLM_cas:coden">ICMED9</span>;
        ISSN:<span class="NLM_cas:issn">0342-4642</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  A novel infectious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in Wuhan, China, in Dec. 2019.  The disease (COVID-19) spread rapidly, reaching epidemic proportions in China, and has been found in 27 other countries.  As of Feb. 27, 2020, over 82,000 cases of COVID-19 were reported, with > 2800 deaths.  No specific therapeutics are available, and current management includes travel restrictions, patient isolation, and supportive medical care.  There are a no. of pharmaceuticals already being tested, but a better understanding of the underlying pathobiol. is required.  In this context, this article will brief review the rationale for angiotensin-converting enzyme 2 (ACE2) receptor as a specific target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBiI5Ku63FLrVg90H21EOLACvtfcHk0lgYikA7Rp0vIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkt1erurY%253D&md5=705f72887420f24bdc15084bb6fdf193</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1007%2Fs00134-020-05985-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00134-020-05985-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DN.%26aulast%3DSlutsky%26aufirst%3DA.%2BS.%26atitle%3DAngiotensin-converting%2520enzyme%25202%2520%2528ACE2%2529%2520as%2520a%2520SARS-CoV-2%2520receptor%253A%2520molecular%2520mechanisms%2520and%2520potential%2520therapeutic%2520target%26jtitle%3DIntensive%2520Care%2520Med.%26date%3D2020%26volume%3D46%26issue%3D4%26spage%3D586%26epage%3D590%26doi%3D10.1007%2Fs00134-020-05985-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuba, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto-Nakanishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J. M.</span></span> <span> </span><span class="NLM_article-title">Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2010.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.pharmthera.2010.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=20599443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGjtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2010&pages=119-128&issue=1&author=K.+Kubaauthor=Y.+Imaiauthor=T.+Ohto-Nakanishiauthor=J.+M.+Penninger&title=Trilogy+of+ACE2%3A+a+peptidase+in+the+renin-angiotensin+system%2C+a+SARS+receptor%2C+and+a+partner+for+amino+acid+transporters&doi=10.1016%2Fj.pharmthera.2010.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters</span></div><div class="casAuthors">Kuba, Keiji; Imai, Yumiko; Ohto-Nakanishi, Takayo; Penninger, Josef M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Angiotensin-converting enzyme (ACE) 2 is a homolog to the carboxypeptidase ACE, which generates angiotensin II, the main active peptide of renin-angiotensin system (RAS).  After the cloning of ACE2 in 2000, three major ACE2 functions have been described so far.  First ACE2 has emerged as a potent neg. regulator of the RAS counterbalancing the multiple functions of ACE.  By targeting angiotensin II ACE2 exhibits a protective role in the cardiovascular system and many other organs.  Second ACE2 was identified as an essential receptor for the SARS coronavirus that causes severe acute lung failure.  Downregulation of ACE2 strongly contributes to the pathogenesis of severe lung failure.  Third, both ACE2 and its homolog Collectrin can assoc. with amino acid transporters and play essential role in the absorption of amino acids in the kidney and gut.  In this review, we will discuss the multiple biol. functions of ACE2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2-r-spyoTBbVg90H21EOLACvtfcHk0lgYikA7Rp0vIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGjtrrP&md5=1fa86a4ffe78ca408b178ad25cc46c0a</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DKuba%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DOhto-Nakanishi%26aufirst%3DT.%26aulast%3DPenninger%26aufirst%3DJ.%2BM.%26atitle%3DTrilogy%2520of%2520ACE2%253A%2520a%2520peptidase%2520in%2520the%2520renin-angiotensin%2520system%252C%2520a%2520SARS%2520receptor%252C%2520and%2520a%2520partner%2520for%2520amino%2520acid%2520transporters%26jtitle%3DPharmacol.%2520Ther.%26date%3D2010%26volume%3D128%26issue%3D1%26spage%3D119%26epage%3D128%26doi%3D10.1016%2Fj.pharmthera.2010.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takai, S.</span></span> <span> </span><span class="NLM_article-title">Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase</span>. <i>J. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1254/jphs.CPJ06008X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1254%2Fjphs.CPJ06008X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16799256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVWqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2006&pages=391-397&issue=5&author=M.+Miyazakiauthor=S.+Takai&title=Tissue+angiotensin+II+generating+system+by+angiotensin-converting+enzyme+and+chymase&doi=10.1254%2Fjphs.CPJ06008X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase</span></div><div class="casAuthors">Miyazaki, Mizuo; Takai, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-397</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A review.  It had been believed that angiotensin II (Ang II) was produced by the renin-angiotensin system (RAS), which was established in the 1950's.  After a while, people realized that the multiple functions of Ang II could not be explained by the conventional RAS.  We have tried to det. the existence of the tissue Ang II generating system.  At first, we found that vascular angiotensin-converting enzyme (ACE) was increased to generate local Ang II in the vessels of hypertension and was enhanced in lipid-loaded atherosclerosis, to respond to ACE inhibitor or Ang II antagonist (ARB).  In both cases, Ang II prodn. in vessels was independent from the systemic RAS that was estd. by the plasma renin activity.  On the way to clarifying the roles of the vascular ACE, we noticed that vascular Ang II prodn. was not completely suppressed by ACE inhibitor alone.  This evidence led us to discover different types of chymase as a new Ang II producing enzyme.  Now, we have obtained a strategy to distinguish the Ang II one by one, i.e., circulating RAS derived, tissue ACE derived, and chymase derived.  It is essential to understand not only the intracellular mechanisms of Ang II but also the process of Ang II productions in each disease to show accurate indications of the effectiveness of ACE inhibitor, ARB, and chymase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvMGqbjQZs2rVg90H21EOLACvtfcHk0lgLy8ujJVVjOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVWqu7k%253D&md5=e23357871ac213e2eb53825711683e12</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1254%2Fjphs.CPJ06008X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.CPJ06008X%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DTakai%26aufirst%3DS.%26atitle%3DTissue%2520angiotensin%2520II%2520generating%2520system%2520by%2520angiotensin-converting%2520enzyme%2520and%2520chymase%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D100%26issue%3D5%26spage%3D391%26epage%3D397%26doi%3D10.1254%2Fjphs.CPJ06008X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span> <span> </span><span class="NLM_article-title">Single-cell RNA expression profiling shows that ACE2, the putative receptor of Wuhan 2019-nCoV, has significant expression in the nasal, mouth, lung and colon tissues, and tends to be co-expressed with HLA-DRB1 in the four tissues</span>. <i>Preprints</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">2020020247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=2020020247&author=C.+Wuauthor=M.+Zheng&title=Single-cell+RNA+expression+profiling+shows+that+ACE2%2C+the+putative+receptor+of+Wuhan+2019-nCoV%2C+has+significant+expression+in+the+nasal%2C+mouth%2C+lung+and+colon+tissues%2C+and+tends+to+be+co-expressed+with+HLA-DRB1+in+the+four+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DM.%26atitle%3DSingle-cell%2520RNA%2520expression%2520profiling%2520shows%2520that%2520ACE2%252C%2520the%2520putative%2520receptor%2520of%2520Wuhan%25202019-nCoV%252C%2520has%2520significant%2520expression%2520in%2520the%2520nasal%252C%2520mouth%252C%2520lung%2520and%2520colon%2520tissues%252C%2520and%2520tends%2520to%2520be%2520co-expressed%2520with%2520HLA-DRB1%2520in%2520the%2520four%2520tissues%26jtitle%3DPreprints%26date%3D2020%26spage%3D2020020247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2: virus dynamics and host response</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(20)30235-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS1473-3099%2820%2930235-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32213336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXls1Ggsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=515-516&issue=5&author=Y.+Chenauthor=L.+Li&title=SARS-CoV-2%3A+virus+dynamics+and+host+response&doi=10.1016%2FS1473-3099%2820%2930235-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-CoV-2: virus dynamics and host response</span></div><div class="casAuthors">Chen, Yu; Li, Lanjuan</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">515-516</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  A commentary of Kelvin To et al. (2020).  Since Dec., 2019, coronavirus disease 2019 (COVID-19) has affected more than 100,000 patients globally.  COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has a case-fatality rate of 23%, with higher rates among elderly patients and patients with comorbidities.  Person-to-person transmission is efficient, with multiple clusters reported.  Clin., patients with COVID-19 present with respiratory symptoms, which is very similar to the presentation of other respiratory virus infections.  Radiol., COVID-19 is characterized by multifocal ground-glass opacities, even for patients with mild disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4yrWwqI1n3LVg90H21EOLACvtfcHk0lgLy8ujJVVjOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXls1Ggsrc%253D&md5=4b1353982030da09ad08cb38351c9007</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2820%2930235-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252820%252930235-8%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DSARS-CoV-2%253A%2520virus%2520dynamics%2520and%2520host%2520response%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2020%26volume%3D20%26issue%3D5%26spage%3D515%26epage%3D516%26doi%3D10.1016%2FS1473-3099%2820%2930235-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakagami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miwa, N.</span></span> <span> </span><span class="NLM_article-title">ACE2: The key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: Demon or Angel?</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">E491</span>, <span class="refDoi"> DOI: 10.3390/v12050491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv12050491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32354022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtF2gtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=E491&issue=5&author=L.+Xiaoauthor=H.+Sakagamiauthor=N.+Miwa&title=ACE2%3A+The+key+molecule+for+understanding+the+pathophysiology+of+severe+and+critical+conditions+of+COVID-19%3A+Demon+or+Angel%3F&doi=10.3390%2Fv12050491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">ACE2: the key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel?</span></div><div class="casAuthors">Xiao, Li; Sakagami, Hiroshi; Miwa, Nobuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">491</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review with commentary.  Recently, the SARS-CoV-2 induced disease COVID-19 has spread all over the world.  Nearly 20% of the patients have severe or crit. conditions.  SARS-CoV-2 exploits ACE2 for host cell entry.  ACE2 plays an essential role in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance.  ACE2 also protects organs from inflammatory injuries and regulates intestinal functions.  ACE2 can be shed by two proteases, ADAM17 and TMPRSS2.  TMPRSS2-cleaved ACE2 allows SARS-CoV-2 cell entry, whereas ADAM17-cleaved ACE2 offers protection to organs.  SARS-CoV-2 infection-caused ACE2 dysfunction worsens COVID-19 and could initiate multi-organ failure.  Here, we will explain the role of ACE2 in the pathogenesis of severe and crit. conditions of COVID-19 and discuss auspicious strategies for controlling the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFaezZMD4FMLVg90H21EOLACvtfcHk0lgLy8ujJVVjOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtF2gtLbJ&md5=06423b648ebc9ddfa6504b9009430d69</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.3390%2Fv12050491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv12050491%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DSakagami%26aufirst%3DH.%26aulast%3DMiwa%26aufirst%3DN.%26atitle%3DACE2%253A%2520The%2520key%2520molecule%2520for%2520understanding%2520the%2520pathophysiology%2520of%2520severe%2520and%2520critical%2520conditions%2520of%2520COVID-19%253A%2520Demon%2520or%2520Angel%253F%26jtitle%3DViruses%26date%3D2020%26volume%3D12%26issue%3D5%26spage%3DE491%26doi%3D10.3390%2Fv12050491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilieva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somasundaran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzuriaga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenough, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzan, M.</span></span> <span> </span><span class="NLM_article-title">Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>426</i></span> (<span class="NLM_issue">6965</span>),  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1038/nature02145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnature02145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=14647384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1GlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=450-454&issue=6965&author=W.+Liauthor=M.+J.+Mooreauthor=N.+Vasilievaauthor=J.+Suiauthor=S.+K.+Wongauthor=M.+A.+Berneauthor=M.+Somasundaranauthor=J.+L.+Sullivanauthor=K.+Luzuriagaauthor=T.+C.+Greenoughauthor=H.+Choeauthor=M.+Farzan&title=Angiotensin-converting+enzyme+2+is+a+functional+receptor+for+the+SARS+coronavirus&doi=10.1038%2Fnature02145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus</span></div><div class="casAuthors">Li, Wenhui; Moore, Michael J.; Vasilieva, Natalya; Sui, Jianhua; Wong, Swee Kee; Berne, Michael A.; Somasundaran, Mohan; Sullivan, John L.; Luzuriaga, Katherine; Greenough, Thomas C.; Choe, Hyeryun; Farzan, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6965</span>),
    <span class="NLM_cas:pages">450-454</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), assoc. with cellular receptors to mediate infection of their target cells.  Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein.  We found that a sol. form of ACE2, but not of the related enzyme ACE1, blocked assocn. of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein.  Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells.  Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells.  Together our data indicate that ACE2 is a functional receptor for SARS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqK17Cf3rQS7Vg90H21EOLACvtfcHk0lhO20PI7GyvMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1GlsLs%253D&md5=884851c53d0f77cbdd6520aaa79efbed</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnature02145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02145%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26aulast%3DVasilieva%26aufirst%3DN.%26aulast%3DSui%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%2BK.%26aulast%3DBerne%26aufirst%3DM.%2BA.%26aulast%3DSomasundaran%26aufirst%3DM.%26aulast%3DSullivan%26aufirst%3DJ.%2BL.%26aulast%3DLuzuriaga%26aufirst%3DK.%26aulast%3DGreenough%26aufirst%3DT.%2BC.%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DFarzan%26aufirst%3DM.%26atitle%3DAngiotensin-converting%2520enzyme%25202%2520is%2520a%2520functional%2520receptor%2520for%2520the%2520SARS%2520coronavirus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26issue%3D6965%26spage%3D450%26epage%3D454%26doi%3D10.1038%2Fnature02145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span> <span> </span><span class="NLM_article-title">Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface</span>. <i>ChemRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">11871402.v4</span>, (accessed 2020-05-30) <span class="refDoi"> DOI: 10.26434/chemrxiv.11871402.v4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.26434%2Fchemrxiv.11871402.v4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=11871402.v4&author=M.+Smithauthor=J.+C.+Smith&title=Repurposing+therapeutics+for+COVID-19%3A+Supercomputer-based+docking+to+the+SARS-CoV-2+viral+spike+protein+and+viral+spike+protein-human+ACE2+interface&doi=10.26434%2Fchemrxiv.11871402.v4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.26434%2Fchemrxiv.11871402.v4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26434%252Fchemrxiv.11871402.v4%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26atitle%3DRepurposing%2520therapeutics%2520for%2520COVID-19%253A%2520Supercomputer-based%2520docking%2520to%2520the%2520SARS-CoV-2%2520viral%2520spike%2520protein%2520and%2520viral%2520spike%2520protein-human%2520ACE2%2520interface%26jtitle%3DChemRxiv%2520Preprint%26date%3D2020%26spage%3D11871402.v4%26doi%3D10.26434%2Fchemrxiv.11871402.v4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batra, R.</span>; <span class="NLM_string-name">Chan, H.</span>; <span class="NLM_string-name">Kamath, G.</span>; <span class="NLM_string-name">Ramprasad, R.</span>; <span class="NLM_string-name">Cherukara, M. J.</span>; <span class="NLM_string-name">Sankaranarayanan, S.</span></span>, <span> </span><span class="NLM_article-title">Screening of therapeutic agents for COVID-19 using machine learning and ensemble docking simulations</span>.  <i>arXiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2004.03766 [q-bio.BM]</span> (accessed 2020-05-30). <a href="https://arxiv.org/abs/2004.03766" class="extLink">https://arxiv.org/abs/2004.03766</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=R.+Batra&author=H.+Chan&author=G.+Kamath&author=R.+Ramprasad&author=M.+J.+Cherukara&author=S.+Sankaranarayanan&title=Screening+of+therapeutic+agents+for+COVID-19+using+machine+learning+and+ensemble+docking+simulations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBatra%26aufirst%3DR.%26atitle%3DScreening%2520of%2520therapeutic%2520agents%2520for%2520COVID-19%2520using%2520machine%2520learning%2520and%2520ensemble%2520docking%2520simulations%26jtitle%3DarXiv%2520Preprint%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rothlin, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetulli, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelorosso, F. G.</span></span> <span> </span><span class="NLM_article-title">Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19</span>. <i>Drug Dev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/ddr.21679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fddr.21679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32356926" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=R.+P.+Rothlinauthor=H.+M.+Vetulliauthor=M.+Duarteauthor=F.+G.+Pelorosso&title=Telmisartan+as+tentative+angiotensin+receptor+blocker+therapeutic+for+COVID-19&doi=10.1002%2Fddr.21679"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2Fddr.21679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.21679%26sid%3Dliteratum%253Aachs%26aulast%3DRothlin%26aufirst%3DR.%2BP.%26aulast%3DVetulli%26aufirst%3DH.%2BM.%26aulast%3DDuarte%26aufirst%3DM.%26aulast%3DPelorosso%26aufirst%3DF.%2BG.%26atitle%3DTelmisartan%2520as%2520tentative%2520angiotensin%2520receptor%2520blocker%2520therapeutic%2520for%2520COVID-19%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2020%26doi%3D10.1002%2Fddr.21679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, J. H.</span></span> <span> </span><span class="NLM_article-title">Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19</span>. <i>J. Travel Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">3</span>), <span class="NLM_elocation-id">taaa041</span> <span class="refDoi"> DOI: 10.1093/jtm/taaa041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1093%2Fjtm%2Ftaaa041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32186711" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2020&issue=3&author=J.+H.+Diaz&title=Hypothesis%3A+angiotensin-converting+enzyme+inhibitors+and+angiotensin+receptor+blockers+may+increase+the+risk+of+severe+COVID-19&doi=10.1093%2Fjtm%2Ftaaa041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1093%2Fjtm%2Ftaaa041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjtm%252Ftaaa041%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DJ.%2BH.%26atitle%3DHypothesis%253A%2520angiotensin-converting%2520enzyme%2520inhibitors%2520and%2520angiotensin%2520receptor%2520blockers%2520may%2520increase%2520the%2520risk%2520of%2520severe%2520COVID-19%26jtitle%3DJ.%2520Travel%2520Med.%26date%3D2020%26volume%3D27%26issue%3D3%26doi%3D10.1093%2Fjtm%2Ftaaa041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chary, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbuto, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izadmehr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, M. M.</span></span> <span> </span><span class="NLM_article-title">COVID-19: Therapeutics and their toxicities</span>. <i>J. Med. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1007/s13181-020-00777-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs13181-020-00777-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=M.+A.+Charyauthor=A.+F.+Barbutoauthor=S.+Izadmehrauthor=B.+D.+Hayesauthor=M.+M.+Burns&title=COVID-19%3A+Therapeutics+and+their+toxicities&doi=10.1007%2Fs13181-020-00777-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1007%2Fs13181-020-00777-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13181-020-00777-5%26sid%3Dliteratum%253Aachs%26aulast%3DChary%26aufirst%3DM.%2BA.%26aulast%3DBarbuto%26aufirst%3DA.%2BF.%26aulast%3DIzadmehr%26aufirst%3DS.%26aulast%3DHayes%26aufirst%3DB.%2BD.%26aulast%3DBurns%26aufirst%3DM.%2BM.%26atitle%3DCOVID-19%253A%2520Therapeutics%2520and%2520their%2520toxicities%26jtitle%3DJ.%2520Med.%2520Toxicol.%26date%3D2020%26doi%3D10.1007%2Fs13181-020-00777-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wösten-Van Asperen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specht, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Woensel, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Loos, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Goor, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamilic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florquin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, A. P.</span></span> <span> </span><span class="NLM_article-title">Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1–7) or an angiotensin II receptor antagonist</span>. <i>J. Pathol</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>225</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1002/path.2987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fpath.2987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22009550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC3MbjslWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2011&pages=618-627&issue=4&author=R.+M.+W%C3%B6sten-Van+Asperenauthor=R.+Lutterauthor=P.+A.+Spechtauthor=G.+N.+Mollauthor=J.+B.+van+Woenselauthor=C.+M.+van+der+Loosauthor=H.+van+Goorauthor=J.+Kamilicauthor=S.+Florquinauthor=A.+P.+Bos&title=Acute+respiratory+distress+syndrome+leads+to+reduced+ratio+of+ACE%2FACE2+activities+and+is+prevented+by+angiotensin-%281%E2%80%937%29+or+an+angiotensin+II+receptor+antagonist&doi=10.1002%2Fpath.2987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist</span></div><div class="casAuthors">Wosten-van Asperen Roelie M; Lutter Rene; Specht Patricia A; Moll Gert N; van Woensel Job B; van der Loos Chris M; van Goor Harry; Kamilic Jelena; Florquin Sandrine; Bos Albert P</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">618-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acute respiratory distress syndrome (ARDS) is a devastating clinical syndrome.  Angiotensin-converting enzyme (ACE) and its effector peptide angiotensin (Ang) II have been implicated in the pathogenesis of ARDS.  A counter-regulatory enzyme of ACE, ie ACE2 that degrades Ang II to Ang-(1-7), offers a promising novel treatment modality for this syndrome.  As the involvement of ACE and ACE2 in ARDS is still unclear, this study investigated the role of these two enzymes in an animal model of ARDS.  ARDS was induced in rats by intratracheal administration of LPS followed by mechanical ventilation.  During ventilation, animals were treated with saline (placebo), losartan (Ang II receptor antagonist), or with a protease-resistant, cyclic form of Ang-(1-7) [cAng-(1-7)].  In bronchoalveolar lavage fluid (BALF) of ventilated LPS-exposed animals, ACE activity was enhanced, whereas ACE2 activity was reduced.  This was matched by enhanced BALF levels of Ang II and reduced levels of Ang-(1-7).  Therapeutic intervention with cAng-(1-7) attenuated the inflammatory mediator response, markedly decreased lung injury scores, and improved lung function, as evidenced by increased oxygenation.  These data indicate that ARDS develops, in part, due to reduced pulmonary levels of Ang-(1-7) and that repletion of this peptide halts the development of ARDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4PqrQm3be8VUIs6wFK5xJfW6udTcc2eZrrxQOTXc8b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbjslWgsg%253D%253D&md5=00a78b7627e754aa408327ac4dfb30df</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fpath.2987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2987%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B6sten-Van%2BAsperen%26aufirst%3DR.%2BM.%26aulast%3DLutter%26aufirst%3DR.%26aulast%3DSpecht%26aufirst%3DP.%2BA.%26aulast%3DMoll%26aufirst%3DG.%2BN.%26aulast%3Dvan%2BWoensel%26aufirst%3DJ.%2BB.%26aulast%3Dvan%2Bder%2BLoos%26aufirst%3DC.%2BM.%26aulast%3Dvan%2BGoor%26aufirst%3DH.%26aulast%3DKamilic%26aufirst%3DJ.%26aulast%3DFlorquin%26aufirst%3DS.%26aulast%3DBos%26aufirst%3DA.%2BP.%26atitle%3DAcute%2520respiratory%2520distress%2520syndrome%2520leads%2520to%2520reduced%2520ratio%2520of%2520ACE%252FACE2%2520activities%2520and%2520is%2520prevented%2520by%2520angiotensin-%25281%25E2%2580%25937%2529%2520or%2520an%2520angiotensin%2520II%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pathol%26date%3D2011%26volume%3D225%26issue%3D4%26spage%3D618%26epage%3D627%26doi%3D10.1002%2Fpath.2987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poglitsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loibner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salzberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggisser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krahenbuhl, S.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1007/s40262-013-0072-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs40262-013-0072-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23681967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=783-792&issue=9&author=M.+Haschkeauthor=M.+Schusterauthor=M.+Poglitschauthor=H.+Loibnerauthor=M.+Salzbergauthor=M.+Bruggisserauthor=J.+Penningerauthor=S.+Krahenbuhl&title=Pharmacokinetics+and+pharmacodynamics+of+recombinant+human+angiotensin-converting+enzyme+2+in+healthy+human+subjects&doi=10.1007%2Fs40262-013-0072-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects</span></div><div class="casAuthors">Haschke, Manuel; Schuster, Manfred; Poglitsch, Marko; Loibner, Hans; Salzberg, Marc; Bruggisser, Marcel; Penninger, Joseph; Kraehenbuehl, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">783-792</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background and Objectives Angiotensin-converting enzyme 2 (ACE2) converts angiotensin II (Ang1-8) to angiotensin 1-7 (Ang1-7), a functional antagonist of Ang1-8, with vasodilatory, antiproliferative, antiangiogenic, and anti-inflammatory properties.  In conditions with an unbalanced renin-angiotensin-aldosterone system with elevated Ang1-8, administration of ACE2 has shown promising effects in a variety of animal models.  Enhancing ACE2 activity by exogenous administration of ACE2 might also be beneficial in human diseases with pathol. elevated Ang1-8.  As a first step we performed a first-in-man study to det. pharmacokinetics, pharmacodynamics, safety, and tolerability of recombinant ACE2 in healthy volunteers.  Methods Recombinant human ACE2 (rhACE2) was administered i.v. to healthy human subjects in a randomized, double-blind, placebo-controlled, single-dose, dose-escalation study followed by an open-label multiple-dose study.  ACE2 concns. were detd. by quantifying ACE2 activity and ACE2 content in plasma samples.  Concns. of the angiotensin system effector peptides Ang1-8, Ang1-7, and Ang1-5 were detd. using a liq. chromatog.-tandem mass spectrometry method.  Results Single rhACE2 doses of 100-1,200 μg/kg caused a dose-dependent increase of systemic exposure with biphasic elimination and a dose-independent terminal half-life of 10 h.  In all single-dose cohorts, Ang1-8 decreased within 30 min postinfusion, angiotensin 1-7 (Ang1-7) either increased (100 and 200 μg/kg doses), decreased, or remained unchanged (400-1,200 μg/kg doses), whereas angiotensin 1-5 (Ang1-5) transiently increased for all doses investigated.  With the exception of the lowest rhACE2 dose, the decrease in Ang1-8 levels lasted for at least 24 h.  Repeated dosing (400 μg/kg for 3 or 6 days) caused only minimal accumulation of ACE2, and Ang1-8 levels were suppressed over the whole application period.  Conclusions Administration of rhACE2 was well tolerated by healthy human subjects.  Exposure was dose dependent with a dose-independent terminal elimination half-life in the range of 10 h.  Despite marked changes in angiotensin system peptide concns., cardiovascular effects were absent, suggesting the presence of effective compensatory mechanisms in healthy volunteers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonBawSLKLjO7Vg90H21EOLACvtfcHk0ljo7FJ7Uf6tOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmtLvF&md5=f3a6b30b22ce2a41e5d7989a6dc1242d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1007%2Fs40262-013-0072-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-013-0072-7%26sid%3Dliteratum%253Aachs%26aulast%3DHaschke%26aufirst%3DM.%26aulast%3DSchuster%26aufirst%3DM.%26aulast%3DPoglitsch%26aufirst%3DM.%26aulast%3DLoibner%26aufirst%3DH.%26aulast%3DSalzberg%26aufirst%3DM.%26aulast%3DBruggisser%26aufirst%3DM.%26aulast%3DPenninger%26aufirst%3DJ.%26aulast%3DKrahenbuhl%26aufirst%3DS.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520recombinant%2520human%2520angiotensin-converting%2520enzyme%25202%2520in%2520healthy%2520human%2520subjects%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2013%26volume%3D52%26issue%3D9%26spage%3D783%26epage%3D792%26doi%3D10.1007%2Fs40262-013-0072-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monteil, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prado, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagelkrüys, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wimmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leopoldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garreta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurtado del Pozo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosper, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirnsberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slutsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montserrat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirazimi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penninger, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cell.2020.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32333836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotVCnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=905-913&issue=4&author=V.+Monteilauthor=Y.+Kwonauthor=P.+Pradoauthor=A.+Hagelkr%C3%BCysauthor=R.+Wimmerauthor=M.+Stahlauthor=A.+Leopoldiauthor=E.+Garretaauthor=C.+Hurtado+del+Pozoauthor=F.+Prosperauthor=J.+Romeroauthor=G.+Wirnsbergerauthor=H.+Zhangauthor=A.+Slutskyauthor=R.+Conderauthor=N.+Montserratauthor=A.+Mirazimiauthor=J.+Penninger&title=Inhibition+of+SARS-CoV-2+infections+in+engineered+human+tissues+using+clinical-grade+soluble+human+ACE2&doi=10.1016%2Fj.cell.2020.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2</span></div><div class="casAuthors">Monteil, Vanessa; Kwon, Hyesoo; Prado, Patricia; Hagelkruys, Astrid; Wimmer, Reiner A.; Stahl, Martin; Leopoldi, Alexandra; Garreta, Elena; Hurtado del Pozo, Carmen; Prosper, Felipe; Romero, Juan Pablo; Wirnsberger, Gerald; Zhang, Haibo; Slutsky, Arthur S.; Conder, Ryan; Montserrat, Nuria; Mirazimi, Ali; Penninger, Josef M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">905-913.e7</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously provided the 1st genetic evidence that angiotensin converting enzyme 2 (ACE2) is the crit. receptor for severe acute respiratory syndrome coronavirus (SARS-CoV), and ACE2 protects the lung from injury, providing a mol. explanation for the severe lung failure and death due to SARS-CoV infections.  ACE2 has now also been identified as a key receptor for SARS-CoV-2 infections, and it has been proposed that inhibiting this interaction might be used in treating patients with COVID-19.  However, it is not known whether human recombinant sol. ACE2 (hrsACE2) blocks growth of SARS-CoV-2.  Here, we show that clin. grade hrsACE2 reduced SARS-CoV-2 recovery from Vero cells by a factor of 1000-5000.  An equivalent mouse rsACE2 had no effect.  SARS-CoV-2 can directly infect engineered human blood vessel organoids and human kidney organoids, which can be inhibited by hrsACE2.  These data demonstrate that hrsACE2 can significantly block early stages of SARS-CoV-2 infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5eOzP0qWiVLVg90H21EOLACvtfcHk0ljo7FJ7Uf6tOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotVCnsLY%253D&md5=c0d71bb0fb61ba1c1037ed7ecaea6f5a</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMonteil%26aufirst%3DV.%26aulast%3DKwon%26aufirst%3DY.%26aulast%3DPrado%26aufirst%3DP.%26aulast%3DHagelkr%25C3%25BCys%26aufirst%3DA.%26aulast%3DWimmer%26aufirst%3DR.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DLeopoldi%26aufirst%3DA.%26aulast%3DGarreta%26aufirst%3DE.%26aulast%3DHurtado%2Bdel%2BPozo%26aufirst%3DC.%26aulast%3DProsper%26aufirst%3DF.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DWirnsberger%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSlutsky%26aufirst%3DA.%26aulast%3DConder%26aufirst%3DR.%26aulast%3DMontserrat%26aufirst%3DN.%26aulast%3DMirazimi%26aufirst%3DA.%26aulast%3DPenninger%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520SARS-CoV-2%2520infections%2520in%2520engineered%2520human%2520tissues%2520using%2520clinical-grade%2520soluble%2520human%2520ACE2%26jtitle%3DCell%26date%3D2020%26volume%3D181%26issue%3D4%26spage%3D905%26epage%3D913%26doi%3D10.1016%2Fj.cell.2020.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iwata-Yoshikawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, N.</span></span> <span> </span><span class="NLM_article-title">TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">6</span>), <span class="NLM_elocation-id">e01815-18</span> <span class="refDoi"> DOI: 10.1128/JVI.01815-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.01815-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30626688" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2019&issue=6&author=N.+Iwata-Yoshikawaauthor=T.+Okamuraauthor=Y.+Shimizuauthor=H.+Hasegawaauthor=M.+Takedaauthor=N.+Nagata&title=TMPRSS2+contributes+to+virus+spread+and+immunopathology+in+the+airways+of+murine+models+after+coronavirus+infection&doi=10.1128%2FJVI.01815-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1128%2FJVI.01815-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01815-18%26sid%3Dliteratum%253Aachs%26aulast%3DIwata-Yoshikawa%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DHasegawa%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DNagata%26aufirst%3DN.%26atitle%3DTMPRSS2%2520contributes%2520to%2520virus%2520spread%2520and%2520immunopathology%2520in%2520the%2520airways%2520of%2520murine%2520models%2520after%2520coronavirus%2520infection%26jtitle%3DJ.%2520Virol.%26date%3D2019%26volume%3D93%26issue%3D6%26doi%3D10.1128%2FJVI.01815-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaarala, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porvari, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellokumpu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyllonen, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vihko, P. T.</span></span> <span> </span><span class="NLM_article-title">Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH743%3E3.0.CO%3B2-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=11169526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVemtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2001&pages=134-140&issue=1&author=M.+H.+Vaaralaauthor=K.+S.+Porvariauthor=S.+Kellokumpuauthor=A.+P.+Kyllonenauthor=P.+T.+Vihko&title=Expression+of+transmembrane+serine+protease+TMPRSS2+in+mouse+and+human+tissues&doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH743%3E3.0.CO%3B2-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues</span></div><div class="casAuthors">Vaarala, Markku H.; Porvari, Katja S.; Kellokumpu, Sakari; Kyllonen, Atte P.; Vihko, Pirkko T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-140</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The purpose of this study was to clarify the expression of TMPRSS2 in mice during development and to compare the tissue distribution of the transcripts in adult mouse and human tissues.  Mouse TMPRSS2 cDNA was cloned; the predicted amino acid sequence contains 490 residues sharing 81.4% similarity with human TMPRSS2.  According to northern blots, mouse TMPRSS2 is expressed mainly in the prostate and kidney, while human TMPRSS2 is expressed in the prostate, colon, stomach, and salivary gland.  In situ hybridization analyses of mouse embryos and adult tissues revealed that TMPRSS2 was expressed in the epithelia of the gastrointestinal, urogenital, and respiratory tracts.  Expression was very selective and const. after the gene was turned on during development.  Expression of TMPRSS2 was localized in the luminal epithelial cells of the mouse and human prostate.  The information presented here will be useful in further studies regarding the function and physiol. significance of TMPRSS2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7_ssoyHuvCrVg90H21EOLACvtfcHk0lgZdXBfdFnbGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVemtQ%253D%253D&md5=c124567922c2432f4213d6875805a49c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH743%3E3.0.CO%3B2-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-9896%25282000%25299999%253A9999%253C%253A%253AAID-PATH743%253E3.0.CO%253B2-T%26sid%3Dliteratum%253Aachs%26aulast%3DVaarala%26aufirst%3DM.%2BH.%26aulast%3DPorvari%26aufirst%3DK.%2BS.%26aulast%3DKellokumpu%26aufirst%3DS.%26aulast%3DKyllonen%26aufirst%3DA.%2BP.%26aulast%3DVihko%26aufirst%3DP.%2BT.%26atitle%3DExpression%2520of%2520transmembrane%2520serine%2520protease%2520TMPRSS2%2520in%2520mouse%2520and%2520human%2520tissues%26jtitle%3DJ.%2520Pathol.%26date%3D2001%26volume%3D193%26issue%3D1%26spage%3D134%26epage%3D140%26doi%3D10.1002%2F1096-9896%282000%299999%3A9999%3C%3A%3AAID-PATH743%3E3.0.CO%3B2-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuyama, S.</span></span> <span> </span><span class="NLM_article-title">Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>517</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2017.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2017.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29217279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWmtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2018&pages=9-15&author=K.+Shiratoauthor=M.+Kawaseauthor=S.+Matsuyama&title=Wild-type+human+coronaviruses+prefer+cell-surface+TMPRSS2+to+endosomal+cathepsins+for+cell+entry&doi=10.1016%2Fj.virol.2017.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry</span></div><div class="casAuthors">Shirato, Kazuya; Kawase, Miyuki; Matsuyama, Shutoku</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">517</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human coronaviruses (HCoVs) enter cells via two distinct pathways: the endosomal pathway using cathepsins to activate spike protein and the cell-surface or early endosome pathway using extracellular proteases such as transmembrane protease serine 2 (TMPRSS2).  We previously reported that clin. isolates of HCoV-229E preferred cell-surface TMPRSS2 to endosomal cathepsin for cell entry, and that they acquired the ability to use cathepsin L by repeated passage in cultured cells and were then able to enter cells via the endosomal pathway.  Here, we show that clin. isolates of HCoV-OC43 and -HKU1 preferred the cell-surface TMRRSS2 to endosomal cathepsins for cell entry, similar to HCoV-229E.  In addn., the cell-culture-adapted HCoV-OC43 lost the ability to infect and replicate in air-liq. interface cultures of human bronchial tracheal epithelial cells.  These results suggest that circulating HCoVs in the field generally use cell-surface TMPRSS2 for cell entry, not endosomal cathepsins, in human airway epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUMxI7pVE547Vg90H21EOLACvtfcHk0lgZdXBfdFnbGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWmtb3M&md5=db5fb4930c4ab42874f8c20580630d27</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2017.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2017.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DShirato%26aufirst%3DK.%26aulast%3DKawase%26aufirst%3DM.%26aulast%3DMatsuyama%26aufirst%3DS.%26atitle%3DWild-type%2520human%2520coronaviruses%2520prefer%2520cell-surface%2520TMPRSS2%2520to%2520endosomal%2520cathepsins%2520for%2520cell%2520entry%26jtitle%3DVirology%26date%3D2018%26volume%3D517%26spage%3D9%26epage%3D15%26doi%3D10.1016%2Fj.virol.2017.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lukassen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trefzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boots, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eils, R.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">10</span>), <span class="NLM_elocation-id">e105114</span> <span class="refDoi"> DOI: 10.15252/embj.20105114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.15252%2Fembj.2020105114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32246845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlaqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2020&issue=10&author=S.+Lukassenauthor=R.+L.+Chuaauthor=T.+Trefzerauthor=N.+C.+Kahnauthor=M.+A.+Schneiderauthor=T.+Muleyauthor=H.+Winterauthor=M.+Meisterauthor=C.+Veithauthor=A.+W.+Bootsauthor=B.+P.+Hennigauthor=M.+Kreuterauthor=C.+Conradauthor=R.+Eils&title=SARS-CoV-2+receptor+ACE2+and+TMPRSS2+are+primarily+expressed+in+bronchial+transient+secretory+cells&doi=10.15252%2Fembj.20105114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells</span></div><div class="casAuthors">Lukassen, Soeren; Chua, Robert Lorenz; Trefzer, Timo; Kahn, Nicolas C.; Schneider, Marc A.; Muley, Thomas; Winter, Hauke; Meister, Michael; Veith, Carmen; Boots, Agnes W.; Hennig, Bianca P.; Kreuter, Michael; Conrad, Christian; Eils, Roland</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e105114</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The SARS-CoV-2 pandemic affecting the human respiratory system severely challenges public health and urgently demands for increasing our understanding of COVID-19 pathogenesis, esp. host factors facilitating virus infection and replication.  SARS-CoV-2 was reported to enter cells via binding to ACE2, followed by its priming by TMPRSS2.  Here, we investigate ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue (twelve donors, 39,778 cells) and in cells derived from subsegmental bronchial branches (four donors, 17,521 cells) by single nuclei and single cell RNA sequencing, resp.  While TMPRSS2 is strongly expressed in both tissues, in the subsegmental bronchial branches ACE2 is predominantly expressed in a transient secretory cell type.  Interestingly, these transiently differentiating cells show an enrichment for pathways related to RHO GTPase function and viral processes suggesting increased vulnerability for SARS-CoV-2 infection.  Our data provide a rich resource for future investigations of COVID-19 infection and pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofOK-TEcosALVg90H21EOLACvtfcHk0lixVsGOosxo-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlaqsL4%253D&md5=3695fb3220d55a715e38088d118151b1</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.15252%2Fembj.2020105114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.2020105114%26sid%3Dliteratum%253Aachs%26aulast%3DLukassen%26aufirst%3DS.%26aulast%3DChua%26aufirst%3DR.%2BL.%26aulast%3DTrefzer%26aufirst%3DT.%26aulast%3DKahn%26aufirst%3DN.%2BC.%26aulast%3DSchneider%26aufirst%3DM.%2BA.%26aulast%3DMuley%26aufirst%3DT.%26aulast%3DWinter%26aufirst%3DH.%26aulast%3DMeister%26aufirst%3DM.%26aulast%3DVeith%26aufirst%3DC.%26aulast%3DBoots%26aufirst%3DA.%2BW.%26aulast%3DHennig%26aufirst%3DB.%2BP.%26aulast%3DKreuter%26aufirst%3DM.%26aulast%3DConrad%26aufirst%3DC.%26aulast%3DEils%26aufirst%3DR.%26atitle%3DSARS-CoV-2%2520receptor%2520ACE2%2520and%2520TMPRSS2%2520are%2520primarily%2520expressed%2520in%2520bronchial%2520transient%2520secretory%2520cells%26jtitle%3DEMBO%2520J.%26date%3D2020%26volume%3D39%26issue%3D10%26doi%3D10.15252%2Fembj.20105114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2017.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.biochi.2017.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28778717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yrtrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2017&pages=1&author=L.+W.+Shenauthor=H.+J.+Maoauthor=Y.+L.+Wuauthor=Y.+Tanakaauthor=W.+Zhang&title=TMPRSS2%3A+A+potential+target+for+treatment+of+influenza+virus+and+coronavirus+infections&doi=10.1016%2Fj.biochi.2017.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections</span></div><div class="casAuthors">Shen, Li Wen; Mao, Hui Juan; Wu, Yan Ling; Tanaka, Yoshimasa; Zhang, Wen</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Influenza virus and coronavirus epidemics or pandemics have occurred in succession worldwide throughout the early 21st century.  These epidemics or pandemics pose a major threat to human health.  Here, we outline a crit. role of the host cell protease TMPRSS2 in influenza virus and coronavirus infections and highlight an antiviral therapeutic strategy targeting TMPRSS2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHg-Ucbn3p7Vg90H21EOLACvtfcHk0lixVsGOosxo-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yrtrbJ&md5=f327e6e390b675cb99e2301c639acbf1</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2017.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2017.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DL.%2BW.%26aulast%3DMao%26aufirst%3DH.%2BJ.%26aulast%3DWu%26aufirst%3DY.%2BL.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DTMPRSS2%253A%2520A%2520potential%2520target%2520for%2520treatment%2520of%2520influenza%2520virus%2520and%2520coronavirus%2520infections%26jtitle%3DBiochimie%26date%3D2017%26volume%3D142%26spage%3D1%26doi%3D10.1016%2Fj.biochi.2017.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maggio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsini, G. U.</span></span> <span> </span><span class="NLM_article-title">Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">104837</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2020.104837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.phrs.2020.104837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32334052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovFKmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2020&pages=104837&author=R.+Maggioauthor=G.+U.+Corsini&title=Repurposing+the+mucolytic+cough+suppressant+and+TMPRSS2+protease+inhibitor+bromhexine+for+the+prevention+and+management+of+SARS-CoV-2+infection&doi=10.1016%2Fj.phrs.2020.104837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection</span></div><div class="casAuthors">Maggio, Roberto; Corsini, Giovanni U.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104837</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The spread of the COVID-19 coronavirus pandemic is a major crisis of public health and has stimulated intensive efforts to find treatments active against the SARS-CoV-2 virus.  The interaction of bromhexine with the TMPRSS2 enzyme together with its widespread clin. use and safety strongly support its evaluation inpatients with SARS-CoV-2 infection, esp. since the use of camostatmesylate is much less well established and very expensive.  Bromhexine hydrochloride is already in the pipeline for COVID-19 treatment, as a mucolytic medication for chest congestion and cough in patients with suspected and mild novel coronavirus pneumonia in China (ClinicalTrials.gov Identifier: NCT04273763).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjxuo_l3ao8bVg90H21EOLACvtfcHk0lixVsGOosxo-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovFKmt7s%253D&md5=0b8dcd8c431fb53f4dd1981b716ffdfc</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2020.104837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2020.104837%26sid%3Dliteratum%253Aachs%26aulast%3DMaggio%26aufirst%3DR.%26aulast%3DCorsini%26aufirst%3DG.%2BU.%26atitle%3DRepurposing%2520the%2520mucolytic%2520cough%2520suppressant%2520and%2520TMPRSS2%2520protease%2520inhibitor%2520bromhexine%2520for%2520the%2520prevention%2520and%2520management%2520of%2520SARS-CoV-2%2520infection%26jtitle%3DPharmacol.%2520Res.%26date%3D2020%26volume%3D157%26spage%3D104837%26doi%3D10.1016%2Fj.phrs.2020.104837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhindsa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povysil, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motelow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D.</span></span> <span> </span><span class="NLM_article-title">Transcriptional inhibition of host viral entry proteins as a therapeutic strategy for SARS-CoV-2</span>. <i>Preprints</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">2020030360</span>, <span class="refDoi"> DOI: 10.20944/preprints202003.0360.v1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.20944%2Fpreprints202003.0360.v1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=2020030360&author=X.+Wangauthor=R.+Dhindsaauthor=G.+Povysilauthor=A.+Zoghbiauthor=J.+Motelowauthor=J.+Hostykauthor=D.+Goldstein&title=Transcriptional+inhibition+of+host+viral+entry+proteins+as+a+therapeutic+strategy+for+SARS-CoV-2&doi=10.20944%2Fpreprints202003.0360.v1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.20944%2Fpreprints202003.0360.v1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.20944%252Fpreprints202003.0360.v1%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDhindsa%26aufirst%3DR.%26aulast%3DPovysil%26aufirst%3DG.%26aulast%3DZoghbi%26aufirst%3DA.%26aulast%3DMotelow%26aufirst%3DJ.%26aulast%3DHostyk%26aufirst%3DJ.%26aulast%3DGoldstein%26aufirst%3DD.%26atitle%3DTranscriptional%2520inhibition%2520of%2520host%2520viral%2520entry%2520proteins%2520as%2520a%2520therapeutic%2520strategy%2520for%2520SARS-CoV-2%26jtitle%3DPreprints%26date%3D2020%26spage%3D2020030360%26doi%3D10.20944%2Fpreprints202003.0360.v1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopsack, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucci, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonarakis, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantoff, P. W.</span></span> <span> </span><span class="NLM_article-title">TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?</span>. <i>Cancer Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">779</span>, <span class="refDoi"> DOI: 10.1158/2159-8290.CD-20-0451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1158%2F2159-8290.CD-20-0451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32276929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1antbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=779&author=K.+H.+Stopsackauthor=L.+A.+Mucciauthor=E.+S.+Antonarakisauthor=P.+S.+Nelsonauthor=P.+W.+Kantoff&title=TMPRSS2+and+COVID-19%3A+Serendipity+or+opportunity+for+intervention%3F&doi=10.1158%2F2159-8290.CD-20-0451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">TMPRSS2 and COVID-19: serendipity or opportunity for intervention?</span></div><div class="casAuthors">Stopsack, Konrad H.; Mucci, Lorelei A.; Antonarakis, Emmanuel S.; Nelson, Peter S.; Kantoff, Philip W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">779-782</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">TMPRSS2 is both the most frequently altered gene in primary prostate cancer and a crit. factor enabling cellular infection by coronaviruses, including SARS-CoV-2.  The modulation of its expression by sex steroids could contribute to the male predominance of severe infections, and given that TMPRSS2 has no known indispensable functions, and inhibitors are available, it is an appealing target for prevention or treatment of respiratory viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcm_SvWqdanrVg90H21EOLACvtfcHk0ljPD79MJTZ16A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1antbnE&md5=1781aef77259c9787167efed373440d5</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-20-0451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-20-0451%26sid%3Dliteratum%253Aachs%26aulast%3DStopsack%26aufirst%3DK.%2BH.%26aulast%3DMucci%26aufirst%3DL.%2BA.%26aulast%3DAntonarakis%26aufirst%3DE.%2BS.%26aulast%3DNelson%26aufirst%3DP.%2BS.%26aulast%3DKantoff%26aufirst%3DP.%2BW.%26atitle%3DTMPRSS2%2520and%2520COVID-19%253A%2520Serendipity%2520or%2520opportunity%2520for%2520intervention%253F%26jtitle%3DCancer%2520Discovery%26date%3D2020%26volume%3D10%26spage%3D779%26doi%3D10.1158%2F2159-8290.CD-20-0451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleine-Weber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohlmann, S.</span></span> <span> </span><span class="NLM_article-title">A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">784</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2020.04.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.molcel.2020.04.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32362314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovVCgs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2020&pages=779-784&issue=4&author=M.+Hoffmannauthor=H.+Kleine-Weberauthor=S.+Pohlmann&title=A+multibasic+cleavage+site+in+the+spike+protein+of+SARS-CoV-2+is+essential+for+infection+of+human+lung+cells&doi=10.1016%2Fj.molcel.2020.04.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells</span></div><div class="casAuthors">Hoffmann, Markus; Kleine-Weber, Hannah; Poehlmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">779-784.e5</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The pandemic coronavirus SARS-CoV-2 threatens public health worldwide.  The viral spike protein mediates SARS-CoV-2 entry into host cells and harbors a S1/S2 cleavage site contg. multiple arginine residues (multibasic) not found in closely related animal coronaviruses.  However, the role of this multibasic cleavage site in SARS-CoV-2 infection is unknown.  Here, we report that the cellular protease furin cleaves the spike protein at the S1/S2 site and that cleavage is essential for S-protein-mediated cell-cell fusion and entry into human lung cells.  Moreover, optimizing the S1/S2 site increased cell-cell, but not virus-cell, fusion, suggesting that the corresponding viral variants might exhibit increased cell-cell spread and potentially altered virulence.  Our results suggest that acquisition of a S1/S2 multibasic cleavage site was essential for SARS-CoV-2 infection of humans and identify furin as a potential target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvFjzWN78Da7Vg90H21EOLACvtfcHk0ljPD79MJTZ16A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovVCgs7o%253D&md5=18c626bd22d3d9c280d8b5e19c116db8</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2020.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2020.04.022%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DKleine-Weber%26aufirst%3DH.%26aulast%3DPohlmann%26aufirst%3DS.%26atitle%3DA%2520multibasic%2520cleavage%2520site%2520in%2520the%2520spike%2520protein%2520of%2520SARS-CoV-2%2520is%2520essential%2520for%2520infection%2520of%2520human%2520lung%2520cells%26jtitle%3DMol.%2520Cell%26date%3D2020%26volume%3D78%26issue%3D4%26spage%3D779%26epage%3D784%26doi%3D10.1016%2Fj.molcel.2020.04.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of neurotropism</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">972</span>, <span class="refDoi"> DOI: 10.3390/v11100972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv11100972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFehtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=972&issue=10&author=J.+Chengauthor=Y.+Zhaoauthor=G.+Xuauthor=K.+Zhangauthor=W.+Jiaauthor=Y.+Sunauthor=J.+Zhaoauthor=J.+Xueauthor=Y.+Huauthor=G.+Zhang&title=The+S2+subunit+of+QX-type+infectious+bronchitis+coronavirus+spike+protein+is+an+essential+determinant+of+neurotropism&doi=10.3390%2Fv11100972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of neurotropism</span></div><div class="casAuthors">Cheng, Jinlong; Zhao, Ye; Xu, Gang; Zhang, Keran; Jia, Wenfeng; Sun, Yali; Zhao, Jing; Xue, Jia; Hu, Yanxin; Zhang, Guozhong</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">972</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Some coronaviruses (CoVs) have an extra furin cleavage site (RRKR/S, furin-S2' site) upstream of the fusion peptide in the spike protein, which plays roles in virion adsorption and fusion.  Mutation of the S2' site of QX genotype (QX-type) infectious bronchitis virus (IBV) spike protein (S) in a recombinant virus background results in higher pathogenicity, pronounced neural symptoms and neurotropism when compared with conditions in wild-type IBV (WT-IBV) infected chickens.  In this study, we present evidence suggesting that recombinant IBV with a mutant S2' site (furin-S2' site) leads to higher mortality.  Infection with mutant IBV induces severe encephalitis and breaks the blood-brain barrier.  The results of a neutralization test and immunoprotection expt. show that an original serum and vaccine can still provide effective protection in vivo and in vitro.  This is the first demonstration of IBV-induced neural symptoms in chickens with encephalitis and the furin-S2' site as a determinant of neurotropism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg4yRAHYjIwbVg90H21EOLACvtfcHk0ljqPn5MjDP8IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFehtLw%253D&md5=239734d51586388fc02d8bf46c33a253</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.3390%2Fv11100972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv11100972%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DThe%2520S2%2520subunit%2520of%2520QX-type%2520infectious%2520bronchitis%2520coronavirus%2520spike%2520protein%2520is%2520an%2520essential%2520determinant%2520of%2520neurotropism%26jtitle%3DViruses%26date%3D2019%26volume%3D11%26issue%3D10%26spage%3D972%26doi%3D10.3390%2Fv11100972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Virus strain of a mild COVID-19 patient in Hangzhou representing a new trend in SARS-CoV-2 evolution related to Furin cleavage site</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1080/22221751.2020.1781551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F22221751.2020.1781551" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=X.+Jinauthor=K.+Xuauthor=P.+Jiangauthor=J.+Lianauthor=S.+Haoauthor=H.+Yaoauthor=H.+Jiaauthor=Y.+Zhangauthor=L.+Zhengauthor=N.+Zhengauthor=D.+Chenauthor=J.+Yaoauthor=J.+Huauthor=J.+Gaoauthor=L.+Wenauthor=J.+Shenauthor=Y.+Renauthor=G.+Yuauthor=X.+Wangauthor=Y.+Luauthor=X.+Yuauthor=L.+Yuauthor=D.+Xiangauthor=N.+Wuauthor=X.+Luauthor=L.+Chengauthor=F.+Liuauthor=H.+Wuauthor=C.+Jinauthor=X.+Yangauthor=P.+Qianauthor=Y.+Qiuauthor=J.+Shengauthor=T.+Liangauthor=L.+Liauthor=Y.+Yang&title=Virus+strain+of+a+mild+COVID-19+patient+in+Hangzhou+representing+a+new+trend+in+SARS-CoV-2+evolution+related+to+Furin+cleavage+site&doi=10.1080%2F22221751.2020.1781551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1080%2F22221751.2020.1781551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F22221751.2020.1781551%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DLian%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DS.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DP.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DVirus%2520strain%2520of%2520a%2520mild%2520COVID-19%2520patient%2520in%2520Hangzhou%2520representing%2520a%2520new%2520trend%2520in%2520SARS-CoV-2%2520evolution%2520related%2520to%2520Furin%2520cleavage%2520site%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2020%26doi%3D10.1080%2F22221751.2020.1781551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paray, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qadir, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aziz, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharifi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derakhshankhah, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehrabi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahpasand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saboury, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falahati, M.</span></span> <span> </span><span class="NLM_article-title">A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin</span>. <i>J. Biomol. Struct. Dyn.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1080/07391102.2020.1754293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1080%2F07391102.2020.1754293" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=A.+Hasanauthor=B.+A.+Parayauthor=A.+Hussainauthor=F.+A.+Qadirauthor=F.+Attarauthor=F.+M.+Azizauthor=M.+Sharifiauthor=H.+Derakhshankhahauthor=B.+Rastiauthor=M.+Mehrabiauthor=K.+Shahpasandauthor=A.+A.+Sabouryauthor=M.+Falahati&title=A+review+on+the+cleavage+priming+of+the+spike+protein+on+coronavirus+by+angiotensin-converting+enzyme-2+and+furin&doi=10.1080%2F07391102.2020.1754293"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1080%2F07391102.2020.1754293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07391102.2020.1754293%26sid%3Dliteratum%253Aachs%26aulast%3DHasan%26aufirst%3DA.%26aulast%3DParay%26aufirst%3DB.%2BA.%26aulast%3DHussain%26aufirst%3DA.%26aulast%3DQadir%26aufirst%3DF.%2BA.%26aulast%3DAttar%26aufirst%3DF.%26aulast%3DAziz%26aufirst%3DF.%2BM.%26aulast%3DSharifi%26aufirst%3DM.%26aulast%3DDerakhshankhah%26aufirst%3DH.%26aulast%3DRasti%26aufirst%3DB.%26aulast%3DMehrabi%26aufirst%3DM.%26aulast%3DShahpasand%26aufirst%3DK.%26aulast%3DSaboury%26aufirst%3DA.%2BA.%26aulast%3DFalahati%26aufirst%3DM.%26atitle%3DA%2520review%2520on%2520the%2520cleavage%2520priming%2520of%2520the%2520spike%2520protein%2520on%2520coronavirus%2520by%2520angiotensin-converting%2520enzyme-2%2520and%2520furin%26jtitle%3DJ.%2520Biomol.%2520Struct.%2520Dyn.%26date%3D2020%26doi%3D10.1080%2F07391102.2020.1754293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usul Afsar, C.</span></span> <span> </span><span class="NLM_article-title">2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of Furin and relevance with cancer</span>. <i>Med. Hypotheses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">109770</span>, <span class="refDoi"> DOI: 10.1016/j.mehy.2020.109770</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.mehy.2020.109770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32344311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFChu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2020&pages=109770&author=C.+Usul+Afsar&title=2019-nCoV-SARS-CoV-2+%28COVID-19%29+infection%3A+Cruciality+of+Furin+and+relevance+with+cancer&doi=10.1016%2Fj.mehy.2020.109770"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of furin and relevance with cancer</span></div><div class="casAuthors">Usul Afsar, Cigdem</div><div class="citationInfo"><span class="NLM_cas:title">Medical Hypotheses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109770</span>CODEN:
                <span class="NLM_cas:coden">MEHYDY</span>;
        ISSN:<span class="NLM_cas:issn">0306-9877</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review on relationship between furin activities of different populations and the different clin. scenarios of the 2019-nCoV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryNaEQ-4GUV7Vg90H21EOLACvtfcHk0liFwsMptPw5jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFChu7k%253D&md5=5c349dc1b0c512fc4ea561637a895d05</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.mehy.2020.109770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mehy.2020.109770%26sid%3Dliteratum%253Aachs%26aulast%3DUsul%2BAfsar%26aufirst%3DC.%26atitle%3D2019-nCoV-SARS-CoV-2%2520%2528COVID-19%2529%2520infection%253A%2520Cruciality%2520of%2520Furin%2520and%2520relevance%2520with%2520cancer%26jtitle%3DMed.%2520Hypotheses%26date%3D2020%26volume%3D140%26spage%3D109770%26doi%3D10.1016%2Fj.mehy.2020.109770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couture, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dory, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic uses of furin and its inhibitors: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1517/13543776.2014.1000303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1517%2F13543776.2014.1000303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25563687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktlKks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=379-396&issue=4&author=F.+Coutureauthor=A.+Kwiatkowskaauthor=Y.+L.+Doryauthor=R.+Day&title=Therapeutic+uses+of+furin+and+its+inhibitors%3A+a+patent+review&doi=10.1517%2F13543776.2014.1000303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic uses of furin and its inhibitors: a patent review</span></div><div class="casAuthors">Couture, Frederic; Kwiatkowska, Anna; Dory, Yves L.; Day, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-396</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Since the discovery of furin, numerous reports have studied its role in health and diseases, including cancer, inflammatory and infectious diseases.  This interest has led to the development of both large protein- and peptide-based inhibitors aiming to control furin activity to treat these disorders.  The most recent advances include the development of potent peptidomimetic furin inhibitors, considerably expanding the field of therapeutic applications.  Area covered: In this review, the use of furin or its inhibitors for therapeutic conditions is described through the patent literature since 1994.  Only compds. with biol. efficacy or augmented properties demonstrated within the patent literature or the assocd. publications concerning their claimed uses are discussed.  Expert opinion: Considering the diseases that may benefit from furin inhibition, several patents detail the use of the restricted no. of furin inhibitors.  However, there have been recent reports of new scaffolds, and even the use of furin itself, as a therapeutic agent.  Despite considerable evidence of in vivo efficacy, limited confirmation from clin. trials supports or refutes the further use of these compds. in a therapeutic context.  The most advanced application is the use of furin knockdown in the generation of an autologous cancer vaccine, which has initiated clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJX_XQ0ERUbVg90H21EOLACvtfcHk0liFwsMptPw5jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktlKks7w%253D&md5=59b351831debdf983beba1571fd395c2</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.1000303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.1000303%26sid%3Dliteratum%253Aachs%26aulast%3DCouture%26aufirst%3DF.%26aulast%3DKwiatkowska%26aufirst%3DA.%26aulast%3DDory%26aufirst%3DY.%2BL.%26aulast%3DDay%26aufirst%3DR.%26atitle%3DTherapeutic%2520uses%2520of%2520furin%2520and%2520its%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D379%26epage%3D396%26doi%3D10.1517%2F13543776.2014.1000303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottcher-Friebertshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartenschlager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span> <span> </span><span class="NLM_article-title">Optimization of substrate-analogue Furin inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">1953</span>– <span class="NLM_lpage">1968</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.201700596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29059503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWms7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1953-1968&issue=23&author=T.+Ivanovaauthor=K.+Hardesauthor=S.+Kallisauthor=S.+O.+Dahmsauthor=M.+E.+Thanauthor=S.+Kunzelauthor=E.+Bottcher-Friebertshauserauthor=I.+Lindbergauthor=G.+S.+Jiaoauthor=R.+Bartenschlagerauthor=T.+Steinmetzer&title=Optimization+of+substrate-analogue+Furin+inhibitors&doi=10.1002%2Fcmdc.201700596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Substrate-Analogue Furin Inhibitors</span></div><div class="casAuthors">Ivanova, Teodora; Hardes, Kornelia; Kallis, Stephanie; Dahms, Sven O.; Than, Manuel E.; Kuenzel, Sebastian; Boettcher-Friebertshaeuser, Eva; Lindberg, Iris; Jiao, Guan-Sheng; Bartenschlager, Ralf; Steinmetzer, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1953-1968</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The proprotein convertase furin is a potential target for drug design, esp. for the inhibition of furin-dependent virus replication.  All effective synthetic furin inhibitors identified thus far are multibasic compds.; the highest potency was found for our previously developed inhibitor 4-(guanidinomethyl)phenylacetyl-Arg-Tle-Arg-4-amidinobenzylamide (MI-1148).  An initial study in mice revealed a narrow therapeutic range for this tetrabasic compd., while significantly reduced toxicity was obsd. for some tribasic analogs.  This suggests that the toxicity depends at least to some extent on the overall multibasic character of this inhibitor.  Therefore, in a first approach, the C-terminal benzamidine of MI-1148 was replaced by less basic P1 residues.  Despite decreased potency, a few compds. still inhibit furin in the low nanomolar range, but display negligible efficacy in cells.  In a second approach, the P2 arginine was replaced by lysine; compared to MI-1148, this furin inhibitor has slightly decreased potency, but exhibits similar antiviral activity against West Nile and Dengue virus in cell culture and decreased toxicity in mice.  These results provide a promising starting point for the development of efficacious and well-tolerated furin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYo9s8FeFdOLVg90H21EOLACvtfcHk0ljbpb2LoGkiUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWms7vJ&md5=623b9176f4ba36292f2c30dd6f05f4f8</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700596%26sid%3Dliteratum%253Aachs%26aulast%3DIvanova%26aufirst%3DT.%26aulast%3DHardes%26aufirst%3DK.%26aulast%3DKallis%26aufirst%3DS.%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DThan%26aufirst%3DM.%2BE.%26aulast%3DKunzel%26aufirst%3DS.%26aulast%3DBottcher-Friebertshauser%26aufirst%3DE.%26aulast%3DLindberg%26aufirst%3DI.%26aulast%3DJiao%26aufirst%3DG.%2BS.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DSteinmetzer%26aufirst%3DT.%26atitle%3DOptimization%2520of%2520substrate-analogue%2520Furin%2520inhibitors%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26issue%3D23%26spage%3D1953%26epage%3D1968%26doi%3D10.1002%2Fcmdc.201700596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span> <span> </span><span class="NLM_article-title">Structural studies revealed active site distortions of human Furin by a small molecule inhibitor</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2474</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00633</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00633" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1OrsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2474&issue=9&author=S.+O.+Dahmsauthor=G.+S.+Jiaoauthor=M.+E.+Than&title=Structural+studies+revealed+active+site+distortions+of+human+Furin+by+a+small+molecule+inhibitor&doi=10.1021%2Facschembio.7b00633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor [Erratum to document cited in CA166:530543]</span></div><div class="casAuthors">Dahms, Sven O.; Jiao, Guan-Sheng; Than, Manuel E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2474</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On page 1215 the author information for Guan-Sheng Jiao was not included in the original article; the author information is given here.  On page 1214 Figure 2b is mislabeled; the correct labeling is provided for Figure 2b is given.  Figure 1a in the Supportinging Information is mislabeled; the correct labeling is give here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPyl_FXSG_hrVg90H21EOLACvtfcHk0ljbpb2LoGkiUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1OrsbzF&md5=a96ab6cdcd28e1fe17ff2be4d83b423c</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00633%26sid%3Dliteratum%253Aachs%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DJiao%26aufirst%3DG.%2BS.%26aulast%3DThan%26aufirst%3DM.%2BE.%26atitle%3DStructural%2520studies%2520revealed%2520active%2520site%2520distortions%2520of%2520human%2520Furin%2520by%2520a%2520small%2520molecule%2520inhibitor%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26issue%3D9%26spage%3D2474%26doi%3D10.1021%2Facschembio.7b00633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandstetter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span> <span> </span><span class="NLM_article-title">X-ray structures of human furin in complex with competitive inhibitors</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1113</span>– <span class="NLM_lpage">1118</span>, <span class="refDoi"> DOI: 10.1021/cb500087x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500087x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslChu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1113-1118&issue=5&author=S.+O.+Dahmsauthor=K.+Hardesauthor=G.+L.+Beckerauthor=T.+Steinmetzerauthor=H.+Brandstetterauthor=M.+E.+Than&title=X-ray+structures+of+human+furin+in+complex+with+competitive+inhibitors&doi=10.1021%2Fcb500087x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Structures of Human Furin in Complex with Competitive Inhibitors</span></div><div class="casAuthors">Dahms, Sven O.; Hardes, Kornelia; Becker, Gero L.; Steinmetzer, Torsten; Brandstetter, Hans; Than, Manuel E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1113-1118</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Furin inhibitors are promising therapeutics for the treatment of cancer and numerous infections caused by bacteria and viruses, including the highly lethal Bacillus anthracis or the pandemic influenza virus.  Development and improvement of inhibitors for pharmacol. use require a detailed knowledge of the protease's substrate and inhibitor binding properties.  Here we present a novel prepn. of human furin and the first crystal structures of this enzyme in complex with noncovalent inhibitors.  We show the inhibitor exchange by soaking, allowing the investigation of addnl. inhibitors and substrate analogs.  Thus, our work provides a basis for the rational design of furin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbro7cw_PVjrVg90H21EOLACvtfcHk0ljbpb2LoGkiUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslChu7c%253D&md5=a46cdfddbc0e1c9209d869ee067696de</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fcb500087x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500087x%26sid%3Dliteratum%253Aachs%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DHardes%26aufirst%3DK.%26aulast%3DBecker%26aufirst%3DG.%2BL.%26aulast%3DSteinmetzer%26aufirst%3DT.%26aulast%3DBrandstetter%26aufirst%3DH.%26aulast%3DThan%26aufirst%3DM.%2BE.%26atitle%3DX-ray%2520structures%2520of%2520human%2520furin%2520in%2520complex%2520with%2520competitive%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26issue%3D5%26spage%3D1113%26epage%3D1118%26doi%3D10.1021%2Fcb500087x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arciniega, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span> <span> </span><span class="NLM_article-title">Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">11196</span>– <span class="NLM_lpage">11201</span>, <span class="refDoi"> DOI: 10.1073/pnas.1613630113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1613630113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27647913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFarsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=11196-11201&issue=40&author=S.+O.+Dahmsauthor=M.+Arciniegaauthor=T.+Steinmetzerauthor=R.+Huberauthor=M.+E.+Than&title=Structure+of+the+unliganded+form+of+the+proprotein+convertase+furin+suggests+activation+by+a+substrate-induced+mechanism&doi=10.1073%2Fpnas.1613630113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism</span></div><div class="casAuthors">Dahms, Sven O.; Arciniega, Marcelino; Steinmetzer, Torsten; Huber, Robert; Than, Manuel E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">11196-11201</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proprotein convertases (PCs) are highly specific proteases required for the proteolytic modification of many secreted proteins.  An unbalanced activity of these enzymes is connected to pathologies like cancer, atherosclerosis, hypercholesterolemia, and infectious diseases.  Novel protein crystallog. structures of the prototypical PC family member furin in different functional states were detd. to 1.8-2.0 Å.  These, together with biochem. data and modeling by mol. dynamics calcns., suggest essential elements underlying its unusually high substrate specificity.  Furin shows a complex activation mechanism and exists in at least four defined states: (i) the "off state," incompatible with substrate binding as seen in the unliganded enzyme; (ii) the active "on state" seen in inhibitor-bound furin; and the resp. (iii) calcium-free and (iv) calcium-bound forms.  The transition from the off to the on state is triggered by ligand binding at subsites S1 to S4 and appears to underlie the preferential recognition of the four-residue sequence motif of furin.  The mol. dynamics simulations of the four structural states reflect the exptl. observations in general and provide approxns. of the resp. stabilities.  Ligation by calcium at the PC-specific binding site II influences the active-site geometry and dets. the rotamer state of the oxyanion hole-forming Asn295, and thus adds a second level of the activity modulation of furin.  The described crystal forms and the observations of different defined functional states may foster the development of new tools and strategies for pharmacol. intervention targeting furin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4ggTLvcRpCrVg90H21EOLACvtfcHk0lj4eWRFJYSc3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFarsLjE&md5=dfdb26447c366f1c928b10fd1252e767</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1613630113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1613630113%26sid%3Dliteratum%253Aachs%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DArciniega%26aufirst%3DM.%26aulast%3DSteinmetzer%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DThan%26aufirst%3DM.%2BE.%26atitle%3DStructure%2520of%2520the%2520unliganded%2520form%2520of%2520the%2520proprotein%2520convertase%2520furin%2520suggests%2520activation%2520by%2520a%2520substrate-induced%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D40%26spage%3D11196%26epage%3D11201%26doi%3D10.1073%2Fpnas.1613630113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahms, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmetzer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Than, M. E.</span></span> <span> </span><span class="NLM_article-title">X-ray structures of the proprotein convertase Furin bound with substrate analogue inhibitors reveal substrate specificity determinants beyond the S4 pocket</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.7b01124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.7b01124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvFahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=925-934&issue=6&author=S.+O.+Dahmsauthor=K.+Hardesauthor=T.+Steinmetzerauthor=M.+E.+Than&title=X-ray+structures+of+the+proprotein+convertase+Furin+bound+with+substrate+analogue+inhibitors+reveal+substrate+specificity+determinants+beyond+the+S4+pocket&doi=10.1021%2Facs.biochem.7b01124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray Structures of the Proprotein Convertase Furin Bound with Substrate Analogue Inhibitors Reveal Substrate Specificity Determinants beyond the S4 Pocket</span></div><div class="casAuthors">Dahms, Sven O.; Hardes, Kornelia; Steinmetzer, Torsten; Than, Manuel E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">925-934</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The proprotein convertase furin is a highly specific serine protease modifying and thereby activating proteins in the secretory pathway by proteolytic cleavage.  Its substrates are involved in many diseases, including cancer and infections caused by bacteria and viruses.  Understanding furin's substrate specificity is crucially important for the development of pharmacol. applicable inhibitors.  Using protein X-ray crystallog., we investigated the extended substrate binding site of furin in complex with three peptide-derived inhibitors at up to 1.9 Å resoln.  The structure of the protease bound with a hexapeptide inhibitor revealed mol. details of its S6 pocket, which remained completely unknown so far.  The arginine residue at P6 induced an unexpected turnlike conformation of the inhibitor backbone, which is stabilized by intra- and intermol. H-bonds.  In addn., we confirmed the binding of arginine to the previously proposed S5 pocket (S51).  An alternative S5 site (S52) could be utilized by shorter side chains as demonstrated for a 4-aminomethyl-phenylacetyl residue, which shows steric properties similar to those of a lysine side chain.  Interestingly, we also obsd. binding of a peptide with citrulline at P4 substituting for the highly conserved arginine.  The structural data might indicate an unusual protonation state of Asp264 maintaining the interaction with uncharged citrulline.  The herein identified mol. interaction sites at P5 and P6 can be utilized to improve next-generation furin inhibitors.  Our data will also help to predict furin substrates more precisely on the basis of the addnl. specificity determinants obsd. for P5 and P6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFa98y-uFMQLVg90H21EOLACvtfcHk0lj4eWRFJYSc3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvFahtA%253D%253D&md5=df6eb3676e8f0c196763fb6b83a41cd2</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.7b01124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.7b01124%26sid%3Dliteratum%253Aachs%26aulast%3DDahms%26aufirst%3DS.%2BO.%26aulast%3DHardes%26aufirst%3DK.%26aulast%3DSteinmetzer%26aufirst%3DT.%26aulast%3DThan%26aufirst%3DM.%2BE.%26atitle%3DX-ray%2520structures%2520of%2520the%2520proprotein%2520convertase%2520Furin%2520bound%2520with%2520substrate%2520analogue%2520inhibitors%2520reveal%2520substrate%2520specificity%2520determinants%2520beyond%2520the%2520S4%2520pocket%26jtitle%3DBiochemistry%26date%3D2018%26volume%3D57%26issue%3D6%26spage%3D925%26epage%3D934%26doi%3D10.1021%2Facs.biochem.7b01124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, E.</span></span> <span> </span><span class="NLM_article-title">A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">103417</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bioorg.2019.103417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31744600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitF2msLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2020&pages=103417&author=L.+Yuanauthor=C.+Zouauthor=W.+Geauthor=Y.+Liuauthor=B.+Huauthor=J.+Wangauthor=B.+Linauthor=Y.+Liauthor=E.+Ma&title=A+novel+cathepsin+L+inhibitor+prevents+the+progression+of+idiopathic+pulmonary+fibrosis&doi=10.1016%2Fj.bioorg.2019.103417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Yuan, Lei; Zou, Chunyang; Ge, Wentao; Liu, Yutong; Hu, Baichun; Wang, Jian; Lin, Bin; Li, Yanchun; Ma, Enlong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103417</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In previous work, the target of asperphenamate as a natural product was successfully detd. as cathepsin by the natural product consensus pharmacophore strategy.  In order to develop accurate SAR (structure-activity relationship) of asperphenamate-type cathepsin inhibitor, we chose several novel analogs with heterocyclic moiety to perform further study.  The mol. simulation showed that 4-pyridyl deriv. 3 (I) with the greatest cathepsin inhibitory activity presented new interaction modes with protein utilizing its B-ring moiety.  And then mol. dynamics (MD) simulation further revealed that I and cathepsin kept stable interaction in the binding site, which validated the mol. docking results.  In view that cathepsins play an important role in fibrosis and some cathepsin inhibitors display the therapeutic ability for fibrosis, we investigated the anti-fibrotic effect of I in vitro and in vivo.  The results indicated that I displayed the strongest inhibitory effect on the formation of α-SMA and collagen I as the protein markers of fibrosis among all tested derivs.  Further in vivo assay confirmed that Ι indeed showed significant inhibitory ability against pulmonary fibrosis by the method of H&E and Masson staining as well as immunohistochem. staining for characteristic α-SMA proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo_6vEOunQq7Vg90H21EOLACvtfcHk0lhUrE1JXVlmzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitF2msLjK&md5=aa63e00504254cbe28839056c1c69a2b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103417%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DC.%26aulast%3DGe%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DE.%26atitle%3DA%2520novel%2520cathepsin%2520L%2520inhibitor%2520prevents%2520the%2520progression%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D94%26spage%3D103417%26doi%3D10.1016%2Fj.bioorg.2019.103417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padmanabhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desikan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, N. M.</span></span> <span> </span><span class="NLM_article-title">Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection</span>. <i>ChemRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">12213125.v2</span>, (accessed 2020-05-30) <span class="refDoi"> DOI: 10.26434/chemrxiv.12213125.v2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.26434%2Fchemrxiv.12213125.v2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=12213125.v2&author=P.+Padmanabhanauthor=R.+Desikanauthor=N.+M.+Dixit&title=Targeting+TMPRSS2+and+Cathepsin+B%2FL+together+may+be+synergistic+against+SARS-CoV-2+infection&doi=10.26434%2Fchemrxiv.12213125.v2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.26434%2Fchemrxiv.12213125.v2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.26434%252Fchemrxiv.12213125.v2%26sid%3Dliteratum%253Aachs%26aulast%3DPadmanabhan%26aufirst%3DP.%26aulast%3DDesikan%26aufirst%3DR.%26aulast%3DDixit%26aufirst%3DN.%2BM.%26atitle%3DTargeting%2520TMPRSS2%2520and%2520Cathepsin%2520B%252FL%2520together%2520may%2520be%2520synergistic%2520against%2520SARS-CoV-2%2520infection%26jtitle%3DChemRxiv%2520Preprint%26date%3D2020%26spage%3D12213125.v2%26doi%3D10.26434%2Fchemrxiv.12213125.v2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartori, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, C. A.</span></span> <span> </span><span class="NLM_article-title">Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">12</span>), <span class="NLM_elocation-id">e0222055</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0222055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0222055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31856175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFSjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&issue=12&author=G.+R.+Sartoriauthor=A.+Leitaoauthor=C.+A.+Montanariauthor=C.+A.+Laughton&title=Ligand-induced+conformational+selection+predicts+the+selectivity+of+cysteine+protease+inhibitors&doi=10.1371%2Fjournal.pone.0222055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors</span></div><div class="casAuthors">Sartori, Geraldo Rodrigues; Leitao, Andrei; Montanari, Carlos A.; Laughton, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e0222055</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cruzain, a cysteine protease of Trypanosoma cruzi, is a validated target for the treatment of Chagas disease.  Due to its high similarity in three-dimensional structure with human cathepsins and their sequence identity above 70% in the active site regions, identifying potent but selective cruzain inhibitors with low side effects on the host organism represents a significant challenge.  Here a panel of nitrile ligands with varying potencies against cathepsin K, cathepsin L and cruzain, are studied by mol. dynamics simulations as both non-covalent and covalent complexes.  Principal component anal. (PCA), identifies and quantifies patterns of ligand-induced conformational selection that enable the construction of a decision tree which can predict with high confidence a low-nanomolar inhibitor of each of three proteins, and det. the selectivity for one against others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsCHQnQabhQLVg90H21EOLACvtfcHk0lhUrE1JXVlmzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFSjtbk%253D&md5=11e180ee1673141ec0f180f7e0187133</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0222055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0222055%26sid%3Dliteratum%253Aachs%26aulast%3DSartori%26aufirst%3DG.%2BR.%26aulast%3DLeitao%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26atitle%3DLigand-induced%2520conformational%2520selection%2520predicts%2520the%2520selectivity%2520of%2520cysteine%2520protease%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2019%26volume%3D14%26issue%3D12%26doi%3D10.1371%2Fjournal.pone.0222055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehmke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freymond, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirmeister, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">975</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.201300112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23658062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlSru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=967-975&issue=6&author=V.+Ehmkeauthor=E.+Winklerauthor=D.+W.+Bannerauthor=W.+Haapauthor=W.+B.+Schweizerauthor=M.+Rottmannauthor=M.+Kaiserauthor=C.+Freymondauthor=T.+Schirmeisterauthor=F.+Diederich&title=Optimization+of+triazine+nitriles+as+rhodesain+inhibitors%3A+structure-activity+relationships%2C+bioisosteric+imidazopyridine+nitriles%2C+and+X-ray+crystal+structure+analysis+with+human+cathepsin+L&doi=10.1002%2Fcmdc.201300112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Triazine Nitriles as Rhodesain Inhibitors: Structure-Activity Relationships, Bioisosteric Imidazopyridine Nitriles, and X-ray Crystal Structure Analysis with Human Cathepsin L</span></div><div class="casAuthors">Ehmke, Veronika; Winkler, Edwin; Banner, David W.; Haap, Wolfgang; Schweizer, W. Bernd; Rottmann, Matthias; Kaiser, Marcel; Freymond, Celine; Schirmeister, Tanja; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">967-975</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The cysteine protease rhodesain of Trypanosoma brucei parasites causing African sleeping sickness has emerged as a target for the development of new drug candidates.  Based on a triazine nitrile moiety as electrophilic headgroup, optimization studies on the substituents for the S1, S2, and S3 pockets of the enzyme were performed using structure-based design and resulted in inhibitors with inhibition consts. in the single-digit nanomolar range.  Comprehensive structure-activity relationships clarified the binding preferences of the individual pockets of the active site.  The S1 pocket tolerates various substituents with a preference for flexible and basic side chains.  Variation of the S2 substituent led to high-affinity ligands with inhibition consts. down to 2 nM for compds. bearing cyclohexyl substituents.  Systematic investigations on the S3 pocket revealed its potential to achieve high activities with arom. vectors that undergo stacking interactions with the planar peptide backbone forming part of the pocket.  X-ray crystal structure anal. with the structurally related enzyme human cathepsin L confirmed the binding mode of the triazine ligand series as proposed by mol. modeling.  Sub-micromolar inhibition of the proliferation of cultured parasites was achieved for ligands decorated with the best substituents identified through the optimization cycles.  In cell-based assays, the introduction of a basic side chain on the inhibitors resulted in a 35-fold increase in antitrypanosomal activity.  Finally, bioisosteric imidazopyridine nitriles were studied to prevent off-target effects with unselective nucleophiles by decreasing the inherent electrophilicity of the triazine nitrile headgroup.  Using this ligand, the stabilization by intramol. hydrogen bonding of the thioimidate intermediate, formed upon attack of the catalytic cysteine residue, compensates for the lower reactivity of the headgroup.  The imidazopyridine nitrile ligand showed excellent stability toward the thiol nucleophile glutathione in a quant. in vitro assay and fourfold lower cytotoxicity than the parent triazine nitrile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGwTj6sYRPi7Vg90H21EOLACvtfcHk0liciVOcIRqIyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlSru7k%253D&md5=0db889bf80bc6ea9fa3c16bfed80f614</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300112%26sid%3Dliteratum%253Aachs%26aulast%3DEhmke%26aufirst%3DV.%26aulast%3DWinkler%26aufirst%3DE.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DFreymond%26aufirst%3DC.%26aulast%3DSchirmeister%26aufirst%3DT.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DOptimization%2520of%2520triazine%2520nitriles%2520as%2520rhodesain%2520inhibitors%253A%2520structure-activity%2520relationships%252C%2520bioisosteric%2520imidazopyridine%2520nitriles%252C%2520and%2520X-ray%2520crystal%2520structure%2520analysis%2520with%2520human%2520cathepsin%2520L%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D967%26epage%3D975%26doi%3D10.1002%2Fcmdc.201300112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardegger, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinnler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anselm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecabert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plancher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isshiki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2048</span>– <span class="NLM_lpage">2054</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fcmdc.201100353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21898833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFajtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=2048-2054&issue=11&author=L.+A.+Hardeggerauthor=B.+Kuhnauthor=B.+Spinnlerauthor=L.+Anselmauthor=R.+Ecabertauthor=M.+Stihleauthor=B.+Gsellauthor=R.+Thomaauthor=J.+Diezauthor=J.+Benzauthor=J.+M.+Plancherauthor=G.+Hartmannauthor=Y.+Isshikiauthor=K.+Morikamiauthor=N.+Shimmaauthor=W.+Haapauthor=D.+W.+Bannerauthor=F.+Diederich&title=Halogen+bonding+at+the+active+sites+of+human+cathepsin+L+and+MEK1+kinase%3A+efficient+interactions+in+different+environments&doi=10.1002%2Fcmdc.201100353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments</span></div><div class="casAuthors">Hardegger, Leo A.; Kuhn, Bernd; Spinnler, Beat; Anselm, Lilli; Ecabert, Robert; Stihle, Martine; Gsell, Bernard; Thoma, Ralf; Diez, Joachim; Benz, Joerg; Plancher, Jean-Marc; Hartmann, Guido; Isshiki, Yoshiaki; Morikami, Kenji; Shimma, Nobuo; Haap, Wolfgang; Banner, David W.; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2048-2054</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In two series of small-mol. ligands, one inhibiting human cathepsin L (hcatL) and the other MEK1 kinase, biol. affinities were found to strongly increase when an aryl ring of the inhibitors is substituted with the larger halogens Cl, Br, and I, but to decrease upon F substitution.  X-ray co-crystal structure analyses revealed that the higher halides engage in halogen bonding (XB) with a backbone C=O in the S3 pocket of hcatL and in a back pocket of MEK1.  While the S3 pocket is located at the surface of the enzyme, which provides a polar environment, the back pocket in MEK1 is deeply buried in the protein and is of pronounced apolar character.  This study analyzes environmental effects on XB in protein-ligand complexes.  It is hypothesized that energetic gains by XB are predominantly not due to water replacements but originate from direct interactions between the XB donor (Caryl-X) and the XB acceptor (C=O) in the correct geometry.  New x-ray co-crystal structures in the same crystal form (space group P212121) were obtained for aryl chloride, bromide, and iodide ligands bound to hcatL.  These high-resoln. structures reveal that the backbone C=O group of Gly61 in most hcatL co-crystal structures maintains water solvation while engaging in XB.  An aryl-CF3-substituted ligand of hcatL with an unexpectedly high affinity was found to adopt the same binding geometry as the aryl halides, with the CF3 group pointing to the C=O group of Gly61 in the S3 pocket.  In this case, a repulsive F2C-F···O=C contact apparently is energetically overcompensated by other favorable protein-ligand contacts established by the CF3 group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnaNYbZ3KJUbVg90H21EOLACvtfcHk0liciVOcIRqIyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFajtr7E&md5=12c7cc93b65ba017acee37796811309d</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100353%26sid%3Dliteratum%253Aachs%26aulast%3DHardegger%26aufirst%3DL.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DSpinnler%26aufirst%3DB.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DEcabert%26aufirst%3DR.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DDiez%26aufirst%3DJ.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DPlancher%26aufirst%3DJ.%2BM.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DIsshiki%26aufirst%3DY.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DShimma%26aufirst%3DN.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DHalogen%2520bonding%2520at%2520the%2520active%2520sites%2520of%2520human%2520cathepsin%2520L%2520and%2520MEK1%2520kinase%253A%2520efficient%2520interactions%2520in%2520different%2520environments%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26issue%3D11%26spage%3D2048%26epage%3D2054%26doi%3D10.1002%2Fcmdc.201100353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardegger, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinnler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anselm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecabert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plancher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Systematic investigation of halogen bonding in protein-ligand interactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1002/anie.201006781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fanie.201006781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1alu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=314-318&issue=1&author=L.+A.+Hardeggerauthor=B.+Kuhnauthor=B.+Spinnlerauthor=L.+Anselmauthor=R.+Ecabertauthor=M.+Stihleauthor=B.+Gsellauthor=R.+Thomaauthor=J.+Diezauthor=J.+Benzauthor=J.+M.+Plancherauthor=G.+Hartmannauthor=D.+W.+Bannerauthor=W.+Haapauthor=F.+Diederich&title=Systematic+investigation+of+halogen+bonding+in+protein-ligand+interactions&doi=10.1002%2Fanie.201006781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions</span></div><div class="casAuthors">Hardegger, Leo A.; Kuhn, Bernd; Spinnler, Beat; Anselm, Lilli; Ecabert, Robert; Stihle, Martine; Gsell, Bernard; Thoma, Ralf; Diez, Joachim; Benz, Joerg; Plancher, Jean-Marc; Hartmann, Guido; Banner, David W.; Haap, Wolfgang; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">314-318, S314/1-S314/145</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Halogen bonding triggers activity.  Increasing binding affinity was obsd. for a series of covalent human Cathepsin L inhibitors by exchanging an aryl ring H atom with Cl, Br, and I, which undergo halogen bonding with the C=O group of Gly61 in the S3 pocket of the enzyme.  Fluorine, in contrast, strongly avoids halogen bonding.  The strong distance and angle dependence of halogen bonding was confirmed for biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsbCNMQhVu7Vg90H21EOLACvtfcHk0li1focw1HDGRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1alu73N&md5=1a7f2983a386fd133be0663657fc486b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2Fanie.201006781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201006781%26sid%3Dliteratum%253Aachs%26aulast%3DHardegger%26aufirst%3DL.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DSpinnler%26aufirst%3DB.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DEcabert%26aufirst%3DR.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DDiez%26aufirst%3DJ.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DPlancher%26aufirst%3DJ.%2BM.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DSystematic%2520investigation%2520of%2520halogen%2520bonding%2520in%2520protein-ligand%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26issue%3D1%26spage%3D314%26epage%3D318%26doi%3D10.1002%2Fanie.201006781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bekerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neveu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shulla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barouch-Bentov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakken, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mateo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamine, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdewijn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einav, S.</span></span> <span> </span><span class="NLM_article-title">Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1338</span>– <span class="NLM_lpage">1352</span>, <span class="refDoi"> DOI: 10.1172/JCI89857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1172%2FJCI89857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28240606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC1czgvFajtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=1338-1352&issue=4&author=E.+Bekermanauthor=G.+Neveuauthor=A.+Shullaauthor=J.+Brannanauthor=S.+Y.+Puauthor=S.+Wangauthor=F.+Xiaoauthor=R.+Barouch-Bentovauthor=R.+R.+Bakkenauthor=R.+Mateoauthor=J.+Goveroauthor=C.+M.+Nagamineauthor=M.+S.+Diamondauthor=S.+De+Jongheauthor=P.+Herdewijnauthor=J.+M.+Dyeauthor=G.+Randallauthor=S.+Einav&title=Anticancer+kinase+inhibitors+impair+intracellular+viral+trafficking+and+exert+broad-spectrum+antiviral+effects&doi=10.1172%2FJCI89857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects</span></div><div class="casAuthors">Bekerman Elena; Neveu Gregory; Shulla Ana; Brannan Jennifer; Pu Szu-Yuan; Wang Stanley; Xiao Fei; Barouch-Bentov Rina; Bakken Russell R; Mateo Roberto; Govero Jennifer; Nagamine Claude M; Diamond Michael S; De Jonghe Steven; Herdewijn Piet; Dye John M; Randall Glenn; Einav Shirit</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1338-1352</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Global health is threatened by emerging viral infections, which largely lack effective vaccines or therapies.  Targeting host pathways that are exploited by multiple viruses could offer broad-spectrum solutions.  We previously reported that AAK1 and GAK, kinase regulators of the host adaptor proteins AP1 and AP2, are essential for hepatitis C virus (HCV) infection, but the underlying mechanism and relevance to other viruses or in vivo infections remained unknown.  Here, we have discovered that AP1 and AP2 cotraffic with HCV particles in live cells.  Moreover, we found that multiple viruses, including dengue and Ebola, exploit AAK1 and GAK during entry and infectious virus production.  In cultured cells, treatment with sunitinib and erlotinib, approved anticancer drugs that inhibit AAK1 or GAK activity, or with more selective compounds inhibited intracellular trafficking of HCV and multiple unrelated RNA viruses with a high barrier to resistance.  In murine models of dengue and Ebola infection, sunitinib/erlotinib combination protected against morbidity and mortality.  We validated sunitinib- and erlotinib-mediated inhibition of AAK1 and GAK activity as an important mechanism of antiviral action.  Additionally, we revealed potential roles for additional kinase targets.  These findings advance our understanding of virus-host interactions and establish a proof of principle for a repurposed, host-targeted approach to combat emerging viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSeR1dYk1i_czQLBVDQn4bCfW6udTcc2eaSVX-S3Uqifbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czgvFajtg%253D%253D&md5=2de0a5d7668651f92be3c2e79823ced4</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1172%2FJCI89857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI89857%26sid%3Dliteratum%253Aachs%26aulast%3DBekerman%26aufirst%3DE.%26aulast%3DNeveu%26aufirst%3DG.%26aulast%3DShulla%26aufirst%3DA.%26aulast%3DBrannan%26aufirst%3DJ.%26aulast%3DPu%26aufirst%3DS.%2BY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DF.%26aulast%3DBarouch-Bentov%26aufirst%3DR.%26aulast%3DBakken%26aufirst%3DR.%2BR.%26aulast%3DMateo%26aufirst%3DR.%26aulast%3DGovero%26aufirst%3DJ.%26aulast%3DNagamine%26aufirst%3DC.%2BM.%26aulast%3DDiamond%26aufirst%3DM.%2BS.%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26aulast%3DHerdewijn%26aufirst%3DP.%26aulast%3DDye%26aufirst%3DJ.%2BM.%26aulast%3DRandall%26aufirst%3DG.%26aulast%3DEinav%26aufirst%3DS.%26atitle%3DAnticancer%2520kinase%2520inhibitors%2520impair%2520intracellular%2520viral%2520trafficking%2520and%2520exert%2520broad-spectrum%2520antiviral%2520effects%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2017%26volume%3D127%26issue%3D4%26spage%3D1338%26epage%3D1352%26doi%3D10.1172%2FJCI89857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, Z.</span></span> <span> </span><span class="NLM_article-title">The serine/threonine kinase AP2-associated kinase 1 plays an important role in Rabies virus entry</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">45</span>, <span class="refDoi"> DOI: 10.3390/v12010045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv12010045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsVCqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=45&issue=1&author=C.+Wangauthor=J.+Wangauthor=L.+Shuaiauthor=X.+Maauthor=H.+Zhangauthor=R.+Liuauthor=W.+Chenauthor=X.+Wangauthor=J.+Geauthor=Z.+Wenauthor=Z.+Bu&title=The+serine%2Fthreonine+kinase+AP2-associated+kinase+1+plays+an+important+role+in+Rabies+virus+entry&doi=10.3390%2Fv12010045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">The serine/threonine kinase AP2-associated kinase 1 plays an important role in rabies virus entry</span></div><div class="casAuthors">Wang, Chong; Wang, Jinliang; Shuai, Lei; Ma, Xiao; Zhang, Hailin; Liu, Renqiang; Chen, Weiye; Wang, Xijun; Ge, Jinying; Wen, Zhiyuan; Bu, Zhigao</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Rabies virus (RABV) invades the central nervous system and nearly always causes fatal disease in humans.  RABV enters cells via clathrin-mediated endocytosis upon receptor binding.  The detailed mechanism of this process and how it is regulated are not fully understood.  Here, we carried out a high-through-put RNAi anal. and identified AP2-assocd. kinase 1 (AAK1), a serine/threonine kinase, as an important cellular component in regulating the entry of RABV.  AAK1 knock-down greatly inhibits RABV infection of cells, and AAK1-induced phosphorylation of threonine 156 of the μ subunit of adaptor protein 2 (AP2M1) is found to be required for RABV entry.  Inhibition of AAK1 kinase activity by sunitinib blocked AP2M1 phosphorylation, significantly inhibiting RABV infection and preventing RABV from entering early endosomes.  In vivo studies revealed that sunitinib prolongs the survival of mice challenged with RABV street virus.  Our findings indicate that AAK1 is a potential drug target for postexposure prophylaxis against rabies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-BKEcc98NJrVg90H21EOLACvtfcHk0libVtJv7BwT6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsVCqsLc%253D&md5=94cf4d4ab31da60e23e50449c9e22830</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.3390%2Fv12010045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv12010045%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShuai%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DBu%26aufirst%3DZ.%26atitle%3DThe%2520serine%252Fthreonine%2520kinase%2520AP2-associated%2520kinase%25201%2520plays%2520an%2520important%2520role%2520in%2520Rabies%2520virus%2520entry%26jtitle%3DViruses%26date%3D2020%26volume%3D12%26issue%3D1%26spage%3D45%26doi%3D10.3390%2Fv12010045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keates, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzos-Skintges, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joachimiak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muyldermans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herberg, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, S.</span></span> <span> </span><span class="NLM_article-title">Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>459</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1042/BJ20131399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1042%2FBJ20131399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24438162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlekt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2014&pages=59-69&issue=1&author=A.+Chaikuadauthor=T.+Keatesauthor=C.+Vinckeauthor=M.+Kaufholzauthor=M.+Zennauthor=B.+Zimmermannauthor=C.+Gutierrezauthor=R.+G.+Zhangauthor=C.+Hatzos-Skintgesauthor=A.+Joachimiakauthor=S.+Muyldermansauthor=F.+W.+Herbergauthor=S.+Knappauthor=S.+Muller&title=Structure+of+cyclin+G-associated+kinase+%28GAK%29+trapped+in+different+conformations+using+nanobodies&doi=10.1042%2FBJ20131399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies</span></div><div class="casAuthors">Chaikuad, Apirat; Keates, Tracy; Vincke, Cecile; Kaufholz, Melanie; Zenn, Michael; Zimmermann, Bastian; Gutierrez, Carlos; Zhang, Rong-guang; Hatzos-Skintges, Catherine; Joachimiak, Andrzej; Muyldermans, Serge; Herberg, Friedrich W.; Knapp, Stefan; Mueller, Susanne</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">GAK (cyclin G-assocd. kinase) is a key regulator of clathrin-coated vesicle trafficking and plays a central role during development.  Addnl., due to the unusually high plasticity of its catalytic domain, it is a frequent 'off-target' of clin. kinase inhibitors assocd. with respiratory side effects of these drugs.  In the present paper, we detd. the crystal structure of the GAK catalytic domain alone and in complex with specific single-chain antibodies (nanobodies).  GAK is constitutively active and weakly assocs. in soln.  The GAK apo structure revealed a dimeric inactive state of the catalytic domain mediated by an unusual activation segment interaction.  Co-crystn. with the nanobody NbGAK4 trapped GAK in a dimeric arrangement similar to the one obsd. in the apo structure, whereas NbGAK1 captured the activation segment of monomeric GAK in a well-ordered conformation, representing features of the active kinase.  The presented structural and biochem. data provide insight into the domain plasticity of GAK and demonstrate the utility of nanobodies to gain insight into conformational changes of dynamic mols.  In addn., we present structural data on the binding mode of ATP mimetic inhibitors and enzyme kinetic data, which will support rational inhibitor design of inhibitors to reduce the off-target effect on GAK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_b7iAn08ebVg90H21EOLACvtfcHk0libVtJv7BwT6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlekt7w%253D&md5=e4f4a4146869d6a78b6b752fe73f7acc</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1042%2FBJ20131399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20131399%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DVincke%26aufirst%3DC.%26aulast%3DKaufholz%26aufirst%3DM.%26aulast%3DZenn%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DB.%26aulast%3DGutierrez%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DR.%2BG.%26aulast%3DHatzos-Skintges%26aufirst%3DC.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DMuyldermans%26aufirst%3DS.%26aulast%3DHerberg%26aufirst%3DF.%2BW.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DS.%26atitle%3DStructure%2520of%2520cyclin%2520G-associated%2520kinase%2520%2528GAK%2529%2520trapped%2520in%2520different%2520conformations%2520using%2520nanobodies%26jtitle%3DBiochem.%2520J.%26date%3D2014%26volume%3D459%26issue%3D1%26spage%3D59%26epage%3D69%26doi%3D10.1042%2FBJ20131399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdonck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froeyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prugar, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorosky, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brannan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barouch-Bentov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dye, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdewijn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einav, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of 3,5-disubstituted-pyrrolo[2,3- b]pyridines as inhibitors of Adaptor-Associated Kinase 1 with antiviral activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5810</span>– <span class="NLM_lpage">5831</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00136</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKgtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5810-5831&issue=12&author=S.+Verdonckauthor=S.+Y.+Puauthor=F.+J.+Sorrellauthor=J.+M.+Elkinsauthor=M.+Froeyenauthor=L.+J.+Gaoauthor=L.+I.+Prugarauthor=D.+E.+Doroskyauthor=J.+M.+Brannanauthor=R.+Barouch-Bentovauthor=S.+Knappauthor=J.+M.+Dyeauthor=P.+Herdewijnauthor=S.+Einavauthor=S.+De+Jonghe&title=Synthesis+and+structure-activity+relationships+of+3%2C5-disubstituted-pyrrolo%5B2%2C3-+b%5Dpyridines+as+inhibitors+of+Adaptor-Associated+Kinase+1+with+antiviral+activity&doi=10.1021%2Facs.jmedchem.9b00136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3-b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity</span></div><div class="casAuthors">Verdonck, Sven; Pu, Szu-Yuan; Sorrell, Fiona J.; Elkins, Jon M.; Froeyen, Mathy; Gao, Ling-Jie; Prugar, Laura I.; Dorosky, Danielle E.; Brannan, Jennifer M.; Barouch-Bentov, Rina; Knapp, Stefan; Dye, John M.; Herdewijn, Piet; Einav, Shirit; De Jonghe, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5810-5831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are currently no approved drugs for the treatment of emerging viral infections, such as dengue and Ebola.  Adaptor-assocd. kinase 1 (AAK1) is a cellular serine-threonine protein kinase that functions as a key regulator of the clathrin-assocd. host adaptor proteins and regulates the intracellular trafficking of multiple unrelated RNA viruses.  Moreover, AAK1 is overexpressed specifically in dengue virus-infected but not bystander cells.  Because AAK1 is a promising antiviral drug target, we have embarked on an optimization campaign of a previously identified 7-azaindole analog, yielding novel pyrrolo[2,3-b]pyridines with high AAK1 affinity.  The optimized compds. demonstrate improved activity against dengue virus both in vitro and in human primary dendritic cells and the unrelated Ebola virus.  These findings demonstrate that targeting cellular AAK1 may represent a promising broad-spectrum antiviral strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7SIdwEDKk_bVg90H21EOLACvtfcHk0lh3p4VFppu5rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKgtr7P&md5=bdec475534dbe2ad18d1c377f8b4c67d</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00136%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonck%26aufirst%3DS.%26aulast%3DPu%26aufirst%3DS.%2BY.%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFroeyen%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DL.%2BJ.%26aulast%3DPrugar%26aufirst%3DL.%2BI.%26aulast%3DDorosky%26aufirst%3DD.%2BE.%26aulast%3DBrannan%26aufirst%3DJ.%2BM.%26aulast%3DBarouch-Bentov%26aufirst%3DR.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DDye%26aufirst%3DJ.%2BM.%26aulast%3DHerdewijn%26aufirst%3DP.%26aulast%3DEinav%26aufirst%3DS.%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%25203%252C5-disubstituted-pyrrolo%255B2%252C3-%2520b%255Dpyridines%2520as%2520inhibitors%2520of%2520Adaptor-Associated%2520Kinase%25201%2520with%2520antiviral%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D12%26spage%3D5810%26epage%3D5831%26doi%3D10.1021%2Facs.jmedchem.9b00136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pu, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barouch-Bentov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagamine, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einav, S.</span></span> <span> </span><span class="NLM_article-title">Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2018.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2018.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29753658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpslaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2018&pages=67-75&author=S.+Y.+Puauthor=F.+Xiaoauthor=S.+Schorauthor=E.+Bekermanauthor=F.+Zaniniauthor=R.+Barouch-Bentovauthor=C.+M.+Nagamineauthor=S.+Einav&title=Feasibility+and+biological+rationale+of+repurposing+sunitinib+and+erlotinib+for+dengue+treatment&doi=10.1016%2Fj.antiviral.2018.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment</span></div><div class="casAuthors">Pu, Szu-Yuan; Xiao, Fei; Schor, Stanford; Bekerman, Elena; Zanini, Fabio; Barouch-Bentov, Rina; Nagamine, Claude M.; Einav, Shirit</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-75</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is an urgent need for strategies to combat dengue virus (DENV) infection; a major global threat.  We reported that the cellular kinases AAK1 and GAK regulate intracellular trafficking of multiple viruses and that sunitinib and erlotinib, approved anticancer drugs with potent activity against these kinases, protect DENV-infected mice from mortality.  Nevertheless, further characterization of the therapeutic potential and underlying mechanism of this approach is required prior to clin. evaluation.  Here, we demonstrate that sunitinib/erlotinib combination achieves sustained suppression of systemic infection at approved dose in DENV-infected IFN-α/β and IFN-γ receptor-deficient mice.  Nevertheless, treatment with these blood-brain barrier impermeable drugs delays, yet does not prevent, late-onset paralysis; a common manifestation in this immunodeficient mouse model but not in humans.  Sunitinib and erlotinib treatment also demonstrates efficacy in human primary monocyte-derived dendritic cells.  Addnl., DENV infection induces expression of AAK1 transcripts, but not GAK, via single-cell transcriptomics, and these kinases are important mol. targets underlying the anti-DENV effect of sunitinib and erlotinib.  Lastly, sunitinib/erlotinib combination alters inflammatory cytokine responses in DENV-infected mice.  These findings support feasibility of repurposing sunitinib/erlotinib combination as a host-targeted antiviral approach and contribute to understanding its mechanism of antiviral action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2cs8UpuoykLVg90H21EOLACvtfcHk0lh3p4VFppu5rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpslaqtbk%253D&md5=acde697b6e3c6d9f42a2011be6091e83</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2018.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2018.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DPu%26aufirst%3DS.%2BY.%26aulast%3DXiao%26aufirst%3DF.%26aulast%3DSchor%26aufirst%3DS.%26aulast%3DBekerman%26aufirst%3DE.%26aulast%3DZanini%26aufirst%3DF.%26aulast%3DBarouch-Bentov%26aufirst%3DR.%26aulast%3DNagamine%26aufirst%3DC.%2BM.%26aulast%3DEinav%26aufirst%3DS.%26atitle%3DFeasibility%2520and%2520biological%2520rationale%2520of%2520repurposing%2520sunitinib%2520and%2520erlotinib%2520for%2520dengue%2520treatment%26jtitle%3DAntiviral%2520Res.%26date%3D2018%26volume%3D155%26spage%3D67%26epage%3D75%26doi%3D10.1016%2Fj.antiviral.2018.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oechsle, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savory, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbing, J.</span></span> <span> </span><span class="NLM_article-title">Baricitinib as potential treatment for 2019-nCoV acute respiratory disease</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span> (<span class="NLM_issue">10223</span>),  <span class="NLM_fpage">e30</span>– <span class="NLM_lpage">e31</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)30304-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2930304-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32032529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1Chtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=e30-e31&issue=10223&author=P.+Richardsonauthor=I.+Griffinauthor=C.+Tuckerauthor=D.+Smithauthor=O.+Oechsleauthor=A.+Phelanauthor=M.+Rawlingauthor=E.+Savoryauthor=J.+Stebbing&title=Baricitinib+as+potential+treatment+for+2019-nCoV+acute+respiratory+disease&doi=10.1016%2FS0140-6736%2820%2930304-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Baricitinib as potential treatment for 2019-nCoV acute respiratory disease</span></div><div class="casAuthors">Richardson, Peter; Griffin, Ivan; Tucker, Catherine; Smith, Dan; Oechsle, Olly; Phelan, Anne; Stebbing, Justin</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10223</span>),
    <span class="NLM_cas:pages">e30-e31</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Given the scale and rapid spread of the 2019 novel coronavirus (2019-nCoV) acute respiratory disease, there is an immediate need for medicines that can help before a vaccine can be produced.  Results of rapid sequencing of 2019-nCoV, coupled with mol. modeling based on the genomes of related virus proteins, have suggested a few compds. that are likely to be effective, including the anti-HIV lopinavir plus ritonavir combination.  Most viruses enter cells through receptor-mediated endocytosis.  One of the known regulators of endocytosis is the AP2-assocd. protein kinase 1 (AAK1).  Disruption of AAK1 might, in turn, interrupt the passage of the virus into cells and also the intracellular assembly of virus particles.  One of six high affinity AAK1-binding drugs was the janus kinase inhibitor baricitinib, which also binds the cyclin G-assocd. kinase, another regulator of endocytosis.  Because the plasma concn. of baricitinib on therapeutic dosing (either as 2 mg or 4 mg once daily) is sufficient to inhibit AAK1, we suggest it could be trialled, using an appropriate patient population with 2019-nCoV acute respiratory disease, to reduce both the viral entry and inflammation in patients, using endpoints such as the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT8bDm3HM7aLVg90H21EOLACvtfcHk0lhj3G9v1HnUXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1Chtr4%253D&md5=9e884d046780c8aa5f3a0934bf4a59ed</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2930304-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252930304-4%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DGriffin%26aufirst%3DI.%26aulast%3DTucker%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DOechsle%26aufirst%3DO.%26aulast%3DPhelan%26aufirst%3DA.%26aulast%3DRawling%26aufirst%3DM.%26aulast%3DSavory%26aufirst%3DE.%26aulast%3DStebbing%26aufirst%3DJ.%26atitle%3DBaricitinib%2520as%2520potential%2520treatment%2520for%25202019-nCoV%2520acute%2520respiratory%2520disease%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26issue%3D10223%26spage%3De30%26epage%3De31%26doi%3D10.1016%2FS0140-6736%2820%2930304-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stebbing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oechsle, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span> <span> </span><span class="NLM_article-title">COVID-19: combining antiviral and anti-inflammatory treatments</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(20)30132-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS1473-3099%2820%2930132-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32113509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXktFCitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=400-402&issue=4&author=J.+Stebbingauthor=A.+Phelanauthor=I.+Griffinauthor=C.+Tuckerauthor=O.+Oechsleauthor=D.+Smithauthor=P.+Richardson&title=COVID-19%3A+combining+antiviral+and+anti-inflammatory+treatments&doi=10.1016%2FS1473-3099%2820%2930132-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">COVID-19: combining antiviral and anti-inflammatory treatments</span></div><div class="casAuthors">Stebbing, Justin; Phelan, Anne; Griffin, Ivan; Tucker, Catherine; Oechsle, Olly; Smith, Dan; Richardson, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">400-402</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The potential for combination therapy of the anti-inflammatory baricitinib with the direct-acting antivirals (lopinavir or ritonavir and remdesivir) currently being used in the COVID-19 outbreak, since it has a minimal interaction with the relevant CYP drug-metabolizing enzymes.  Combinations of baricitinib with these direct-acting antivirals could reduce viral infectivity, viral replication, and the aberrant host inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcjx8n9u2irVg90H21EOLACvtfcHk0lhj3G9v1HnUXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXktFCitb4%253D&md5=c311166386f148d130f49b72f3c0b381</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2820%2930132-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252820%252930132-8%26sid%3Dliteratum%253Aachs%26aulast%3DStebbing%26aufirst%3DJ.%26aulast%3DPhelan%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DI.%26aulast%3DTucker%26aufirst%3DC.%26aulast%3DOechsle%26aufirst%3DO.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DRichardson%26aufirst%3DP.%26atitle%3DCOVID-19%253A%2520combining%2520antiviral%2520and%2520anti-inflammatory%2520treatments%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2020%26volume%3D20%26issue%3D4%26spage%3D400%26epage%3D402%26doi%3D10.1016%2FS1473-3099%2820%2930132-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Praveen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puvvada, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">M, V. A.</span></span> <span> </span><span class="NLM_article-title">Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">105967</span>, <span class="refDoi"> DOI: 10.1016/j.ijantimicag.2020.105967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.ijantimicag.2020.105967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32259575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsV2rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2020&pages=105967&issue=5&author=D.+Praveenauthor=R.+C.+Puvvadaauthor=V.+A.+M&title=Janus+kinase+inhibitor+baricitinib+is+not+an+ideal+option+for+management+of+COVID-19&doi=10.1016%2Fj.ijantimicag.2020.105967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19</span></div><div class="casAuthors">Praveen, D.; Puvvada, Ranadheer Chowdary; M, Vijey Aanandhi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">105967</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Wuhan outbreak of novel Corona virus infection has been the global focus since Dec. 2019.  This infection has become a global pandemic.  It is highly important to understand the virol. of the pathogen and to explore the therapeutic options for management of this pandemic.  Drug repurposing strategies are being considered for management of COVID 19.  Among the identified drugs, Baricitinib has become a keen interest for researchers because of its ability to inhibit the viral assembly by the prevention of Clarithrin assocd. endocytosis.  We tried to explore the reasons on why Baricitinib is not an ideal option for COVID 19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl3tkQaMBwdbVg90H21EOLACvtfcHk0lhj3G9v1HnUXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsV2rtb0%253D&md5=53ee40e8ae424cf392fbf9c7987707c3</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2020.105967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2020.105967%26sid%3Dliteratum%253Aachs%26aulast%3DPraveen%26aufirst%3DD.%26aulast%3DPuvvada%26aufirst%3DR.%2BC.%26aulast%3DM%26aufirst%3DV.%2BA.%26atitle%3DJanus%2520kinase%2520inhibitor%2520baricitinib%2520is%2520not%2520an%2520ideal%2520option%2520for%2520management%2520of%2520COVID-19%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2020%26volume%3D55%26issue%3D5%26spage%3D105967%26doi%3D10.1016%2Fj.ijantimicag.2020.105967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sorrell, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklarz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul Azeez, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Family-wide structural analysis of human Numb-associated protein kinases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">411</span>, <span class="refDoi"> DOI: 10.1016/j.str.2015.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.str.2015.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26853940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=401-411&issue=3&author=F.+J.+Sorrellauthor=M.+Szklarzauthor=K.+R.+Abdul+Azeezauthor=J.+M.+Elkinsauthor=S.+Knapp&title=Family-wide+structural+analysis+of+human+Numb-associated+protein+kinases&doi=10.1016%2Fj.str.2015.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Family-wide Structural Analysis of Human Numb-Associated Protein Kinases</span></div><div class="casAuthors">Sorrell, Fiona J.; Szklarz, Marta; Abdul Azeez, Kamal R.; Elkins, Jon M.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-411</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The highly diverse Numb-assocd. kinase (NAK) family has been linked to broad cellular functions including receptor-mediated endocytosis, Notch pathway modulation, osteoblast differentiation, and dendrite morphogenesis.  Consequently, NAK kinases play a key role in a diverse range of diseases from Parkinson's and prostate cancer to HIV.  Due to the plasticity of this kinase family, NAK kinases are often inhibited by approved or investigational drugs and have been assocd. with side effects, but they are also potential drug targets.  The presence of cysteine residues in some NAK family members provides the possibility for selective targeting via covalent inhibition.  Here we report the first high-resoln. structures of kinases AAK1 and BIKE in complex with two drug candidates.  The presented data allow a comprehensive structural characterization of the NAK kinase family and provide the basis for rational design of selective NAK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryZi0QmT8YH7Vg90H21EOLACvtfcHk0lhELN75qltF6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCktLY%253D&md5=6a353c993ec9f2b7152e459d72bab9d3</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2015.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2015.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DSorrell%26aufirst%3DF.%2BJ.%26aulast%3DSzklarz%26aufirst%3DM.%26aulast%3DAbdul%2BAzeez%26aufirst%3DK.%2BR.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DFamily-wide%2520structural%2520analysis%2520of%2520human%2520Numb-associated%2520protein%2520kinases%26jtitle%3DStructure%26date%3D2016%26volume%3D24%26issue%3D3%26spage%3D401%26epage%3D411%26doi%3D10.1016%2Fj.str.2015.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohbayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Murayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukimoto-Niino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uejima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohsawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nojima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the inhibition of cyclin G-associated kinase by gefitinib</span>. <i>ChemistryOpen</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">713</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1002/open.201800177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fopen.201800177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVaqu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=713-719&issue=9&author=N.+Ohbayashiauthor=K.+Murayamaauthor=M.+Kato-Murayamaauthor=M.+Kukimoto-Niinoauthor=T.+Uejimaauthor=T.+Matsudaauthor=N.+Ohsawaauthor=S.+Yokoyamaauthor=H.+Nojimaauthor=M.+Shirouzu&title=Structural+basis+for+the+inhibition+of+cyclin+G-associated+kinase+by+gefitinib&doi=10.1002%2Fopen.201800177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Inhibition of Cyclin G-Associated Kinase by Gefitinib</span></div><div class="casAuthors">Ohbayashi, Naomi; Murayama, Kazutaka; Kato-Murayama, Miyuki; Kukimoto-Niino, Mutsuko; Uejima, Tamami; Matsuda, Takayoshi; Ohsawa, Noboru; Yokoyoma, Shigeyuki; Nojima, Hiroshi; Shirouzu, Mikako</div><div class="citationInfo"><span class="NLM_cas:title">ChemistryOpen</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">713-719</span>CODEN:
                <span class="NLM_cas:coden">CHOPCK</span>;
        ISSN:<span class="NLM_cas:issn">2191-1363</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Gefitinib is the mol. target drug for advanced non-small-cell lung cancer.  The primary target of gefitinib is the pos. mutation of epidermal growth factor receptor, but it also inhibits cyclin G-assocd. kinase (GAK).  To reveal the mol. bases of GAK and gefitinib binding, structure analyses were conducted and detd. two forms of the gefitinib-bound nanobody·GAK kinase domain complex structures.  The first form, GAK_1, has one gefitinib at the ATP binding pocket, whereas the second form, GAK_2, binds one each in the ATP binding site and a novel binding site adjacent to the activation segment C-terminal helix, a unique element of the Numb-assocd. kinase family.  In the novel binding site, gefitinib binds in the hydrophobic groove around the activation segment, disrupting the conserved hydrogen bonds for the catalytic activity.  These structures suggest possibilities for the development of selective GAK inhibitors for viral infections, such as the hepatitis C virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZeMIF-4YuzLVg90H21EOLACvtfcHk0lhELN75qltF6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVaqu7nF&md5=644dc1dd71349a0cdc5859838382c824</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1002%2Fopen.201800177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fopen.201800177%26sid%3Dliteratum%253Aachs%26aulast%3DOhbayashi%26aufirst%3DN.%26aulast%3DMurayama%26aufirst%3DK.%26aulast%3DKato-Murayama%26aufirst%3DM.%26aulast%3DKukimoto-Niino%26aufirst%3DM.%26aulast%3DUejima%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DOhsawa%26aufirst%3DN.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DNojima%26aufirst%3DH.%26aulast%3DShirouzu%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520cyclin%2520G-associated%2520kinase%2520by%2520gefitinib%26jtitle%3DChemistryOpen%26date%3D2018%26volume%3D7%26issue%3D9%26spage%3D713%26epage%3D719%26doi%3D10.1002%2Fopen.201800177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurbani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everley, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gondi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berberich, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westover, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorger, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Leveraging compound promiscuity to identify targetable cysteines within the kinome</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">829</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2019.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.chembiol.2019.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30982749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnt1CksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=818-829&issue=6&author=S.+Raoauthor=D.+Gurbaniauthor=G.+Duauthor=R.+A.+Everleyauthor=C.+M.+Browneauthor=A.+Chaikuadauthor=L.+Tanauthor=M.+Schroderauthor=S.+Gondiauthor=S.+B.+Ficarroauthor=T.+Simauthor=N.+D.+Kimauthor=M.+J.+Berberichauthor=S.+Knappauthor=J.+A.+Martoauthor=K.+D.+Westoverauthor=P.+K.+Sorgerauthor=N.+S.+Gray&title=Leveraging+compound+promiscuity+to+identify+targetable+cysteines+within+the+kinome&doi=10.1016%2Fj.chembiol.2019.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome</span></div><div class="casAuthors">Rao, Suman; Gurbani, Deepak; Du, Guangyan; Everley, Robert A.; Browne, Christopher M.; Chaikuad, Apirat; Li, Tan; Schroder, Martin; Gondi, Sudershan; Ficarro, Scott B.; Sim, Taebo; Kim, Nam Doo; Berberich, Matthew J.; Knapp, Stefan; Marto, Jarrod A.; Westover, Kenneth D.; Sorger, Peter K.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">818-829.e9</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Covalent kinase inhibitors, which typically target cysteine residues, represent an important class of clin. relevant compds.  Approx. 215 kinases are known to have potentially targetable cysteines distributed across 18 spatially distinct locations proximal to the ATP-binding pocket.  However, only 40 kinases have been covalently targeted, with certain cysteine sites being the primary focus.  To address this disparity, we have developed a strategy that combines the use of a multi-targeted acrylamide-modified inhibitor, SM1-71, with a suite of complementary chemoproteomic and cellular approaches to identify addnl. targetable cysteines.  Using this single multi-targeted compd., we successfully identified 23 kinases that are amenable to covalent inhibition including MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1, and RSK2.  The identification of nine of these kinases previously not targeted by a covalent inhibitor increases the no. of targetable kinases and highlights opportunities for covalent kinase inhibitor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUcHJFGWFTTrVg90H21EOLACvtfcHk0lhx95S4LJvAqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnt1CksL4%253D&md5=6a8656d083fc4d49fa8520b48e05d100</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2019.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2019.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DS.%26aulast%3DGurbani%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DG.%26aulast%3DEverley%26aufirst%3DR.%2BA.%26aulast%3DBrowne%26aufirst%3DC.%2BM.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DSchroder%26aufirst%3DM.%26aulast%3DGondi%26aufirst%3DS.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DBerberich%26aufirst%3DM.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DWestover%26aufirst%3DK.%2BD.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DLeveraging%2520compound%2520promiscuity%2520to%2520identify%2520targetable%2520cysteines%2520within%2520the%2520kinome%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2019%26volume%3D26%26issue%3D6%26spage%3D818%26epage%3D829%26doi%3D10.1016%2Fj.chembiol.2019.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsland, R.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyayula, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capraro, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillern, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhausen, T.</span></span> <span> </span><span class="NLM_article-title">Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>552</i></span> (<span class="NLM_issue">7685</span>),  <span class="NLM_fpage">410</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1038/nature25146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnature25146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29236694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOht7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2017&pages=410-414&issue=7685&author=K.+Heauthor=R.+Marslandauthor=S.+Upadhyayulaauthor=E.+Songauthor=S.+Dangauthor=B.+R.+Capraroauthor=W.+Wangauthor=W.+Skillernauthor=R.+Gaudinauthor=M.+Maauthor=T.+Kirchhausen&title=Dynamics+of+phosphoinositide+conversion+in+clathrin-mediated+endocytic+traffic&doi=10.1038%2Fnature25146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic</span></div><div class="casAuthors">He, Kangmin; Marsland, Robert, III; Upadhyayula, Srigokul; Song, Eli; Dang, Song; Capraro, Benjamin R.; Wang, Weiming; Skillern, Wesley; Gaudin, Raphael; Ma, Minghe; Kirchhausen, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">7685</span>),
    <span class="NLM_cas:pages">410-414</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Vesicular carriers transport proteins and lipids from one organelle to another, recognizing specific identifiers for the donor and acceptor membranes.  Two important identifiers are phosphoinositides and GTP-bound GTPases, which provide well-defined but mutable labels.  Phosphatidylinositol (PI) and its phosphorylated derivs. are present on the cytosolic faces of most cellular membranes.  Reversible phosphorylation of its headgroup produces 7 distinct phosphoinositides.  In endocytic traffic, PI 4,5-biphosphate marks the plasma membrane, and PI 3-phosphate and PI 4-phosphate mark distinct endosomal compartments.  It is unknown what sequence of changes in lipid content confers on the vesicles their distinct identity at each intermediate step.  Here, we describe 'coincidence-detecting' sensors that selectively report the phosphoinositide compn. of clathrin-assocd. structures, and the use of these sensors to follow the dynamics of phosphoinositide conversion during endocytosis.  The membrane of an assembling coated pit, in equil. with the surrounding plasma membrane, contains PI 4,5-biphosphate and a smaller amt. of PI 4-phosphate.  Closure of the vesicle interrupts free exchange with the plasma membrane.  A substantial burst of PI 4-phosphate immediately after budding coincides with a burst of PI 3-phosphate, distinct from any later encounter with the PI 3-phosphate pool in early endosomes; PI 3,4-bisphosphate and GTPase Rab5 then appear and remain as the uncoating vesicles mature into Rab5-pos. endocytic intermediates.  These observations show that a cascade of mol. conversions, made possible by the sepn. of a vesicle from its parent membrane, can label membrane-traffic intermediates and det. their destinations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzPWqG43V_UrVg90H21EOLACvtfcHk0lhx95S4LJvAqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOht7rL&md5=1cba4714dd3350c7c074ea8263fcabd9</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fnature25146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25146%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DK.%26aulast%3DMarsland%26aufirst%3DR.%26aulast%3DUpadhyayula%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DE.%26aulast%3DDang%26aufirst%3DS.%26aulast%3DCapraro%26aufirst%3DB.%2BR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSkillern%26aufirst%3DW.%26aulast%3DGaudin%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DM.%26aulast%3DKirchhausen%26aufirst%3DT.%26atitle%3DDynamics%2520of%2520phosphoinositide%2520conversion%2520in%2520clathrin-mediated%2520endocytic%2520traffic%26jtitle%3DNature%26date%3D2017%26volume%3D552%26issue%3D7685%26spage%3D410%26epage%3D414%26doi%3D10.1038%2Fnature25146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shisheva, A.</span></span> <span> </span><span class="NLM_article-title">PIKfyve: Partners, significance, debates and paradoxes</span>. <i>Cell Biol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1016/j.cellbi.2008.01.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cellbi.2008.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18304842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVSntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2008&pages=591-604&issue=6&author=A.+Shisheva&title=PIKfyve%3A+Partners%2C+significance%2C+debates+and+paradoxes&doi=10.1016%2Fj.cellbi.2008.01.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">PIKfyve: Partners, significance, debates and paradoxes</span></div><div class="casAuthors">Shisheva, Assia</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology International</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">591-604</span>CODEN:
                <span class="NLM_cas:coden">CBIIEV</span>;
        ISSN:<span class="NLM_cas:issn">1065-6995</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Key components of membrane trafficking and signaling machinery in eukaryotic cells are proteins that bind or synthesize phosphoinositides.  PIKfyve, a product of an evolutionarily conserved single-copy gene has both these features.  It binds to membrane phosphatidylinositol (PtdIns)3P and synthesizes PtdIns(3,5)P2 and PtdIns5P.  Mol. functions of PIKfyve are elusive but recent advances are consistent with a key role in the course of endosomal transport.  PIKfyve dysfunction induces endosome enlargement and profound cytoplasmic vacuolation, likely as a result of impaired normal endosome processing and membrane exit out of endosomes.  Multicellular organisms with genetically impaired function of PIKfyve or that of the PIKfyve protein partners regulating PtdIns(3,5)P2 homeostasis display severe disorders, including embryonic/perinatal death.  This review describes recent advances on PIKfyve functionality in higher eukaryotes, with particular ref. to biochem. and genetic insights in PIKfyve protein partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOgOq8yvtpALVg90H21EOLACvtfcHk0lgHWUWBTsVuSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVSntLc%253D&md5=54db4172e95de0cb38bcc47d371e7a88</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.cellbi.2008.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellbi.2008.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DShisheva%26aufirst%3DA.%26atitle%3DPIKfyve%253A%2520Partners%252C%2520significance%252C%2520debates%2520and%2520paradoxes%26jtitle%3DCell%2520Biol.%2520Int.%26date%3D2008%26volume%3D32%26issue%3D6%26spage%3D591%26epage%3D604%26doi%3D10.1016%2Fj.cellbi.2008.01.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Lartigue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tooze, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clague, M. J.</span></span> <span> </span><span class="NLM_article-title">PIKfyve regulation of endosome-linked pathways</span>. <i>Traffic</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0854.2009.00915.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1111%2Fj.1600-0854.2009.00915.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19582903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFGrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=883-893&issue=7&author=J.+de+Lartigueauthor=H.+Polsonauthor=M.+Feldmanauthor=K.+Shokatauthor=S.+A.+Toozeauthor=S.+Urbeauthor=M.+J.+Clague&title=PIKfyve+regulation+of+endosome-linked+pathways&doi=10.1111%2Fj.1600-0854.2009.00915.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">PIKfyve regulation of endosome-linked pathways</span></div><div class="casAuthors">de Lartigue, Jane; Polson, Hannah; Feldman, Morri; Shokat, Kevan; Tooze, Sharon A.; Urbe, Sylvie; Clague, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Traffic (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-893</span>CODEN:
                <span class="NLM_cas:coden">TRAFFA</span>;
        ISSN:<span class="NLM_cas:issn">1398-9219</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The phosphoinositide 5-kinase (PIKfyve) is a crit. enzyme for the synthesis of PtdIns(3,5)P2, that was implicated in various trafficking events assocd. with the endocytic pathway.  We have now directly compared the effects of siRNA-mediated knockdown of PIKfyve in HeLa cells with a specific pharmacol. inhibitor of enzyme activity.  Both approaches induce changes in the distribution of cation-independent mannose 6-phosphate receptor (CI-M6PR) and trans-Golgi network (TGN)-46 proteins, which cycles between endosomes and TGN, leading to their accumulation in dispersed punctae, while the TGN marker golgin-245 retains a perinuclear disposition.  Trafficking of CD8-CI-M6PR (retromer-dependent) and CD8-Furin (retromer-independent) chimeras from the cell surface to the TGN is delayed following drug administration, as is the transport of the Shiga toxin B-subunit.  SiRNA knockdown of PIKfyve produced no defect in epidermal growth factor receptor (EGFR) degrdn., unless combined with knockdown of its activator mol. Vac14, suggesting that a low threshold of PtdIns(3,5)P2 is necessary and sufficient for this pathway.  Accordingly pharmacol. inhibition of PIKfyve results in a profound block to the lysosomal degrdn. of activated epidermal growth factor (EGF) and Met receptors.  Immunofluorescence revealed EGF receptors to be trapped in the interior of a swollen endosomal compartment.  In cells starved of amino acids, PIKfyve inhibition leads to the accumulation of the lipidated form of GFP-LC3, a marker of autophagosomal structures, which can be visualized as fluorescent punctae.  We suggest that PIKfyve inhibition may render the late endosome/lysosome compartment refractory to fusion with both autophagosomes and with EGFR-contg. multivesicular bodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjAHcsNBejkbVg90H21EOLACvtfcHk0lgHWUWBTsVuSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFGrsb8%253D&md5=5522c9dfb2e576da77e2a6b166f08b51</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0854.2009.00915.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0854.2009.00915.x%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLartigue%26aufirst%3DJ.%26aulast%3DPolson%26aufirst%3DH.%26aulast%3DFeldman%26aufirst%3DM.%26aulast%3DShokat%26aufirst%3DK.%26aulast%3DTooze%26aufirst%3DS.%2BA.%26aulast%3DUrbe%26aufirst%3DS.%26aulast%3DClague%26aufirst%3DM.%2BJ.%26atitle%3DPIKfyve%2520regulation%2520of%2520endosome-linked%2520pathways%26jtitle%3DTraffic%26date%3D2009%26volume%3D10%26issue%3D7%26spage%3D883%26epage%3D893%26doi%3D10.1111%2Fj.1600-0854.2009.00915.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardinale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatcherian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatsuta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barsoum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krueger, J. G.</span></span> <span> </span><span class="NLM_article-title">Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e35069</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0035069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0035069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22493730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVyqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=4&author=Y.+Wadaauthor=I.+Cardinaleauthor=A.+Khatcherianauthor=J.+Chuauthor=A.+B.+Kantorauthor=A.+B.+Gottliebauthor=N.+Tatsutaauthor=E.+Jacobsonauthor=J.+Barsoumauthor=J.+G.+Krueger&title=Apilimod+inhibits+the+production+of+IL-12+and+IL-23+and+reduces+dendritic+cell+infiltration+in+psoriasis&doi=10.1371%2Fjournal.pone.0035069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis</span></div><div class="casAuthors">Wada, Yumiko; Cardinale, Irma; Khatcherian, Artemis; Chu, John; Kantor, Aaron B.; Gottlieb, Alice B.; Tatsuta, Noriaki; Jacobson, Eric; Barsoum, James; Krueger, James G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e35069</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Psoriasis is characterized by hyperplasia of the epidermis and infiltration of leukocytes into both the dermis and epidermis.  IL-23, a key cytokine that induces TH17 cells, has been found to play a crit. role in the pathogenesis of psoriasis.  Apilimod is a small-mol. compd. that selectively suppresses synthesis of IL-12 and IL-23.  An open-label clin. study of oral administration of apilimod was conducted in patients with psoriasis.  Substantial improvements in histol. and clin. measurements were obsd. in patients receiving 70mg QD.  The expression of IL-23p19 and IL-12/IL-23p40 in skin lesions was significantly reduced in this dose group, with a simultaneous increase in IL-10 obsd.  A decrease in the levels of TH1 and TH17 cytokines/chemokines in skin lesions followed these p19 and p40 changes.  In parallel, a redn. in skin-infiltrating CD11c+ dendritic cells and CD3+ T cells was seen, with a greater decrease in the CD11c+ population.  This was accompanied by increases in T and B cells, and decreases in neutrophils and eosinophils in the periphery.  This study demonstrates the immunomodulatory activity of apilimod and provides clin. evidence supporting the inhibition of IL-12/IL-23 synthesis for the treatment of TH1- and TH17-mediated inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxAQtGmEdUGbVg90H21EOLACvtfcHk0lg1o4TRX9dZUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVyqu7c%253D&md5=18f569c46e0e86ee9167ceb96cce2b49</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0035069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0035069%26sid%3Dliteratum%253Aachs%26aulast%3DWada%26aufirst%3DY.%26aulast%3DCardinale%26aufirst%3DI.%26aulast%3DKhatcherian%26aufirst%3DA.%26aulast%3DChu%26aufirst%3DJ.%26aulast%3DKantor%26aufirst%3DA.%2BB.%26aulast%3DGottlieb%26aufirst%3DA.%2BB.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DJacobson%26aufirst%3DE.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DApilimod%2520inhibits%2520the%2520production%2520of%2520IL-12%2520and%2520IL-23%2520and%2520reduces%2520dendritic%2520cell%2520infiltration%2520in%2520psoriasis%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D4%26doi%3D10.1371%2Fjournal.pone.0035069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikonomov, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbrissa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shisheva, A.</span></span> <span> </span><span class="NLM_article-title">YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2009.03.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bbrc.2009.03.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCnurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2009&pages=566-570&issue=3&author=O.+C.+Ikonomovauthor=D.+Sbrissaauthor=A.+Shisheva&title=YM201636%2C+an+inhibitor+of+retroviral+budding+and+PIKfyve-catalyzed+PtdIns%283%2C5%29P2+synthesis%2C+halts+glucose+entry+by+insulin+in+adipocytes&doi=10.1016%2Fj.bbrc.2009.03.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes</span></div><div class="casAuthors">Ikonomov, Ognian C.; Sbrissa, Diego; Shisheva, Assia</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">566-570</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Silencing of PIKfyve, the sole enzyme for PtdIns(3,5)P2 biosynthesis that controls proper endosome dynamics, inhibits retroviral replication.  A novel PIKfyve-specific inhibitor YM201636 disrupts retroviral budding at 800 nM, suggesting its potential use as an antiretroviral therapeutic.  Because PIKfyve is also required for optimal insulin activation of GLUT4 surface translocation and glucose influx, we tested the outcome of YM201636 application on insulin responsiveness in 3T3L1 adipocytes.  YM201636 almost completely inhibited basal and insulin-activated 2-deoxyglucose uptake at doses as low as 160 nM, with IC50 = 54 ± 4 nM for the net insulin response.  Insulin-induced GLUT4 translocation was partially inhibited at substantially higher doses, comparable to those required for inhibition of insulin-induced phosphorylation of Akt/PKB.  In addn. to PIKfyve, YM201636 also completely inhibited insulin-dependent activation of class IA PI 3-kinase.  We suggest that apart from PIKfyve, there are at least two addnl. targets for YM201636 in the context of insulin signaling to GLUT4 and glucose uptake: the insulin-activated class IA PI 3-kinase and a here-unidentified high-affinity target responsible for the greater inhibition of glucose entry vs. GLUT4 translocation.  The profound inhibition of the net insulin effect on glucose influx at YM201636 doses markedly lower than those required for efficient retroviral budding disruption warns of severe perturbations in glucose homeostasis assocd. with potential YM201636 use in antiretroviral therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl-6UuJwUK8rVg90H21EOLACvtfcHk0lg1o4TRX9dZUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCnurc%253D&md5=98f81b0aac7f16e916af4d847fbeef22</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.03.063%26sid%3Dliteratum%253Aachs%26aulast%3DIkonomov%26aufirst%3DO.%2BC.%26aulast%3DSbrissa%26aufirst%3DD.%26aulast%3DShisheva%26aufirst%3DA.%26atitle%3DYM201636%252C%2520an%2520inhibitor%2520of%2520retroviral%2520budding%2520and%2520PIKfyve-catalyzed%2520PtdIns%25283%252C5%2529P2%2520synthesis%252C%2520halts%2520glucose%2520entry%2520by%2520insulin%2520in%2520adipocytes%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D382%26issue%3D3%26spage%3D566%26epage%3D570%26doi%3D10.1016%2Fj.bbrc.2009.03.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothlauf, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccinotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cureton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whelan, S. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchhausen, T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PIKfyve kinase prevents infection by EBOV and SARS-CoV-2</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2020.04.21.053058</span> (accessed 2020-05-30) <span class="refDoi"> DOI: 10.1101/2020.04.21.053058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.04.21.053058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.-L.+Kangauthor=Y.+Y.+Chouauthor=P.+W.+Rothlaufauthor=Z.+Liuauthor=S.+Piccinottiauthor=T.+K.+Sohauthor=D.+Curetonauthor=J.+B.+Caseauthor=R.+E.+Chenauthor=M.+S.+Diamondauthor=S.+P.+J.+Whelanauthor=T.+Kirchhausen&title=Inhibition+of+PIKfyve+kinase+prevents+infection+by+EBOV+and+SARS-CoV-2&doi=10.1101%2F2020.04.21.053058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1101%2F2020.04.21.053058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.04.21.053058%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DY.-L.%26aulast%3DChou%26aufirst%3DY.%2BY.%26aulast%3DRothlauf%26aufirst%3DP.%2BW.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DPiccinotti%26aufirst%3DS.%26aulast%3DSoh%26aufirst%3DT.%2BK.%26aulast%3DCureton%26aufirst%3DD.%26aulast%3DCase%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DR.%2BE.%26aulast%3DDiamond%26aufirst%3DM.%2BS.%26aulast%3DWhelan%26aufirst%3DS.%2BP.%2BJ.%26aulast%3DKirchhausen%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520PIKfyve%2520kinase%2520prevents%2520infection%2520by%2520EBOV%2520and%2520SARS-CoV-2%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26doi%3D10.1101%2F2020.04.21.053058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl-Schott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span> <span> </span><span class="NLM_article-title">Two-pore channels: Catalyzers of endolysosomal transport and function</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">45</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3389%2Ffphar.2017.00045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28223936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFenu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=45&author=C.+Grimmauthor=C.+C.+Chenauthor=C.+Wahl-Schottauthor=M.+Biel&title=Two-pore+channels%3A+Catalyzers+of+endolysosomal+transport+and+function&doi=10.3389%2Ffphar.2017.00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Two-pore channels: catalyzers of endolysosomal transport and function</span></div><div class="casAuthors">Grimm, Christian; Chen, Cheng-Chang; Wahl-Schott, Christian; Biel, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45/1-45/6</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Two-pore channels (TPCs) have recently emerged as a novel class of non-selective cation channels in the endolysosomal system.  There are two members in the human genome, TPC1 and TPC2.  Studies with TPC knockout and knockdown models have revealed that these channels participate in the regulation of multiple endolysosomal trafficking pathways which when dysregulated can lead to or influence the development of a range of different diseases such as lysosomal storage, metabolic, or infectious diseases.  TPCs have been demonstrated to be activated by different endogenous stimuli, PI(3,5)P♂ and NAADP, and ATP has been found to block TPC activation via mTOR.  Loss of TPCs can lead to obesity and hypercholesterolemia, and to a slowdown of intracellular virus and bacterial toxin trafficking, it can affect VEGF-induced neoangiogenesis, autophagy, human hair pigmentation or the acrosome reaction in sperm.  Moreover, physiol. roles of TPCs in cardiac myocytes and pancreatic b cells have been postulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlRYMGWXTA4rVg90H21EOLACvtfcHk0lgWtaaMaAlPJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFenu7k%253D&md5=cd56e3259d160d144bd25609d855a287</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00045%26sid%3Dliteratum%253Aachs%26aulast%3DGrimm%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DC.%2BC.%26aulast%3DWahl-Schott%26aufirst%3DC.%26aulast%3DBiel%26aufirst%3DM.%26atitle%3DTwo-pore%2520channels%253A%2520Catalyzers%2520of%2520endolysosomal%2520transport%2520and%2520function%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D45%26doi%3D10.3389%2Ffphar.2017.00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kintzer, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span> <span> </span><span class="NLM_article-title">On the structure and mechanism of two-pore channels</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1111/febs.14154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1111%2Ffebs.14154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28656706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Wgu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2018&pages=233-243&issue=2&author=A.+F.+Kintzerauthor=R.+M.+Stroud&title=On+the+structure+and+mechanism+of+two-pore+channels&doi=10.1111%2Ffebs.14154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">On the structure and mechanism of two-pore channels</span></div><div class="casAuthors">Kintzer, Alexander F.; Stroud, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-243</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In eukaryotes, two-pore channels 1-3 (TPC1-3) comprise a family of ion channels that regulate the conductance of Na+ and Ca2+ ions across cellular membranes.  TPC1-3 form endolysosomal channels, but TPC3 can also function in the plasma membrane.  TPC1/3 are voltage-gated channels, but TPC2 opens in response to binding the endolysosome-specific lipid, phosphatidylinositol 3,5-diphosphate (PI(3,5)P2).  Filoviruses, such as Ebola virus, exploit TPC-mediated ion release as a means of escape from the endolysosome during infection.  Antagonists that block TPC1/2 channel conductance abrogate filoviral infections.  TPC1/2 form complexes with the mechanistic target of rapamycin complex 1 (mTORC1) at the endolysosomal surface that couple cellular metabolic state and cytosolic nutrient concns. to the control of membrane potential and pH.  We previously detd. the x-ray structure of TPC1 from Arabidopsis thaliana (AtTPC1) to 2.87Å resoln., which is one of the 2 1st reports of TPC channel structure.  Here, we summarize these findings and the implications that the structure may have for understanding endolysosomal control mechanisms and their role in human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvV4yLcwNonbVg90H21EOLACvtfcHk0lgWtaaMaAlPJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Wgu7zN&md5=134e6d1f38a19a0329da866a016e6a6b</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14154%26sid%3Dliteratum%253Aachs%26aulast%3DKintzer%26aufirst%3DA.%2BF.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DOn%2520the%2520structure%2520and%2520mechanism%2520of%2520two-pore%2520channels%26jtitle%3DFEBS%2520J.%26date%3D2018%26volume%3D285%26issue%3D2%26spage%3D233%26epage%3D243%26doi%3D10.1111%2Ffebs.14154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolokoltsov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidwell, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauta, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klugbauer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl-Schott, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, R. A.</span></span> <span> </span><span class="NLM_article-title">Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span> (<span class="NLM_issue">6225</span>),  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">998</span>, <span class="refDoi"> DOI: 10.1126/science.1258758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1126%2Fscience.1258758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25722412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtF2qtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=995-998&issue=6225&author=Y.+Sakuraiauthor=A.+A.+Kolokoltsovauthor=C.+C.+Chenauthor=M.+W.+Tidwellauthor=W.+E.+Bautaauthor=N.+Klugbauerauthor=C.+Grimmauthor=C.+Wahl-Schottauthor=M.+Bielauthor=R.+A.+Davey&title=Ebola+virus.+Two-pore+channels+control+Ebola+virus+host+cell+entry+and+are+drug+targets+for+disease+treatment&doi=10.1126%2Fscience.1258758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment</span></div><div class="casAuthors">Sakurai, Yasuteru; Kolokoltsov, Andrey A.; Chen, Cheng-Chang; Tidwell, Michael W.; Bauta, William E.; Klugbauer, Norbert; Grimm, Christian; Wahl-Schott, Christian; Biel, Martin; Davey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6225</span>),
    <span class="NLM_cas:pages">995-998</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Ebola virus causes sporadic outbreaks of lethal hemorrhagic fever in humans, but there is no currently approved therapy.  Cells take up Ebola virus by macropinocytosis, followed by trafficking through endosomal vesicles.  However, few factors controlling endosomal virus movement are known.  Here we find that Ebola virus entry into host cells requires the endosomal calcium channels called two-pore channels (TPCs).  Disrupting TPC function by gene knockout, small interfering RNAs, or small-mol. inhibitors halted virus trafficking and prevented infection.  Tetrandrine, the most potent small mol. that we tested, inhibited infection of human macrophages, the primary target of Ebola virus in vivo, and also showed therapeutic efficacy in mice.  Therefore, TPC proteins play a key role in Ebola virus infection and may be effective targets for antiviral therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJDhOEyzuYirVg90H21EOLACvtfcHk0lgWtaaMaAlPJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtF2qtbk%253D&md5=d5964238acb39481595dba3419222ec2</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1126%2Fscience.1258758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1258758%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DKolokoltsov%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DC.%2BC.%26aulast%3DTidwell%26aufirst%3DM.%2BW.%26aulast%3DBauta%26aufirst%3DW.%2BE.%26aulast%3DKlugbauer%26aufirst%3DN.%26aulast%3DGrimm%26aufirst%3DC.%26aulast%3DWahl-Schott%26aufirst%3DC.%26aulast%3DBiel%26aufirst%3DM.%26aulast%3DDavey%26aufirst%3DR.%2BA.%26atitle%3DEbola%2520virus.%2520Two-pore%2520channels%2520control%2520Ebola%2520virus%2520host%2520cell%2520entry%2520and%2520are%2520drug%2520targets%2520for%2520disease%2520treatment%26jtitle%3DScience%26date%3D2015%26volume%3D347%26issue%3D6225%26spage%3D995%26epage%3D998%26doi%3D10.1126%2Fscience.1258758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">She, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span> <span> </span><span class="NLM_article-title">Structural mechanisms of phospholipid activation of the human TPC2 channel</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e45222</span> <span class="refDoi"> DOI: 10.7554/eLife.45222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.7554%2FeLife.45222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30860481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVegtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=J.+Sheauthor=W.+Zengauthor=J.+Guoauthor=Q.+Chenauthor=X.+C.+Baiauthor=Y.+Jiang&title=Structural+mechanisms+of+phospholipid+activation+of+the+human+TPC2+channel&doi=10.7554%2FeLife.45222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanisms of phospholipid activation of the human TPC2 channel</span></div><div class="casAuthors">She, Ji; Zeng, Weizhong; Guo, Jiangtao; Chen, Qingfeng; Bai, Xiao-Chen; Jiang, Youxing</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45222</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Mammalian two-pore channels (TPCs) regulate the physiol. functions of the endolysosome.  Here we present cryo-EM structures of human TPC2 (HsTPC2), a phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2)-activated, Na+ selective channel, in the ligand- bound and apo states.  The apo structure captures the closed conformation, while the ligand-bound form features the channel in both open and closed conformations.  Combined with functional anal., these structures provide insights into the mechanism of PI(3,5)P2-regulated gating of TPC2, which is distinct from that of TPC1.  Specifically, the endolysosome-specific PI(3,5)P2 binds at the first 6-TM and activates the channel - independently of the membrane potential - by inducing a structural change at the pore-lining inner helix (IS6), which forms a continuous helix in the open state but breaks into two segments at Gly317 in the closed state.  Addnl., structural comparison to the voltage-dependent TPC1 structure allowed us to identify Ile551 as being responsible for the loss of voltage dependence in TPC2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqll32J6e0i6LVg90H21EOLACvtfcHk0lhMeb307T7RUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVegtb%252FP&md5=32c8f36f13d357aec53c7c563d4e3095</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.7554%2FeLife.45222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.45222%26sid%3Dliteratum%253Aachs%26aulast%3DShe%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DBai%26aufirst%3DX.%2BC.%26aulast%3DJiang%26aufirst%3DY.%26atitle%3DStructural%2520mechanisms%2520of%2520phospholipid%2520activation%2520of%2520the%2520human%2520TPC2%2520channel%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2FeLife.45222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penny, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassileva, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chee, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilpatrick, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muallem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span> <span> </span><span class="NLM_article-title">Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1866</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1151</span>– <span class="NLM_lpage">1161</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bbamcr.2018.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=30408544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlWnsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1866&publication_year=2019&pages=1151-1161&issue=7&author=C.+J.+Pennyauthor=K.+Vassilevaauthor=A.+Jhaauthor=Y.+Yuanauthor=X.+Cheeauthor=E.+Yatesauthor=M.+Mazzonauthor=B.+S.+Kilpatrickauthor=S.+Muallemauthor=M.+Marshauthor=T.+Rahmanauthor=S.+Patel&title=Mining+of+Ebola+virus+entry+inhibitors+identifies+approved+drugs+as+two-pore+channel+pore+blockers&doi=10.1016%2Fj.bbamcr.2018.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers</span></div><div class="casAuthors">Penny, Christopher J.; Vassileva, Kristin; Jha, Archana; Yuan, Yu; Chee, Xavier; Yates, Elizabeth; Mazzon, Michela; Kilpatrick, Bethan S.; Muallem, Shmuel; Marsh, Mark; Rahman, Taufiq; Patel, Sandip</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1866</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1151-1161</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Two-pore channels (TPCs) are Ca2+-permeable ion channels localised to the endo-lysosomal system where they regulate trafficking of various cargoes including viruses.  As a result, TPCs are emerging as important drug targets.  However, their pharmacol. is ill-defined.  There are no approved drugs to target them.  And their mechanism of ligand activation is largely unknown.  Here, we identify a no. of FDA-approved drugs as TPC pore blockers.  Using a model of the pore of human TPC2 based on recent structures of mammalian TPCs, we virtually screened a database of ∼1500 approved drugs.  Because TPCs have recently emerged as novel host factors for Ebola virus entry, we reasoned that Ebola virus entry inhibitors may exert their effects through inhibition of TPCs.  Cross-referencing hits from the TPC virtual screen with two recent high throughput anti-Ebola screens yielded approved drugs targeting dopamine and estrogen receptors as common hits.  These compds. inhibited endogenous NAADP-evoked Ca2+ release from sea urchin egg homogenates, NAADP-mediated channel activity of TPC2 re-routed to the plasma membrane, and PI(3,5)P2-mediated channel activity of TPC2 expressed in enlarged lysosomes.  Mechanistically, single channel analyses showed that the drugs reduced mean open time consistent with a direct action on the pore.  Functionally, drug potency in blocking TPC2 activity correlated with inhibition of Ebola virus-like particle entry.  Our results expand TPC pharmacol. through the identification of approved drugs as novel blockers, support a role for TPCs in Ebola virus entry, and provide insight into the mechanisms underlying channel regulation.  This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeAbsnnebkILVg90H21EOLACvtfcHk0lhMeb307T7RUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlWnsb%252FI&md5=9cd83d471e0a264fdb5d780427ca62d9</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DPenny%26aufirst%3DC.%2BJ.%26aulast%3DVassileva%26aufirst%3DK.%26aulast%3DJha%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DChee%26aufirst%3DX.%26aulast%3DYates%26aufirst%3DE.%26aulast%3DMazzon%26aufirst%3DM.%26aulast%3DKilpatrick%26aufirst%3DB.%2BS.%26aulast%3DMuallem%26aufirst%3DS.%26aulast%3DMarsh%26aufirst%3DM.%26aulast%3DRahman%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DS.%26atitle%3DMining%2520of%2520Ebola%2520virus%2520entry%2520inhibitors%2520identifies%2520approved%2520drugs%2520as%2520two-pore%2520channel%2520pore%2520blockers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2019%26volume%3D1866%26issue%3D7%26spage%3D1151%26epage%3D1161%26doi%3D10.1016%2Fj.bbamcr.2018.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Coronavirus infections and immune responses</span>. <i>J. Med. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">432</span>, <span class="refDoi"> DOI: 10.1002/jmv.25685</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fjmv.25685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31981224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntVKntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2020&pages=424-432&issue=4&author=G.+Liauthor=Y.+Fanauthor=Y.+Laiauthor=T.+Hanauthor=Z.+Liauthor=P.+Zhouauthor=P.+Panauthor=W.+Wangauthor=D.+Huauthor=X.+Liuauthor=Q.+Zhangauthor=J.+Wu&title=Coronavirus+infections+and+immune+responses&doi=10.1002%2Fjmv.25685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Coronavirus infections and immune responses</span></div><div class="casAuthors">Li, Geng; Fan, Yaohua; Lai, Yanni; Han, Tiantian; Li, Zonghui; Zhou, Peiwen; Pan, Pan; Wang, Wenbiao; Hu, Dingwen; Liu, Xiaohong; Zhang, Qiwei; Wu, Jianguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Virology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">424-432</span>CODEN:
                <span class="NLM_cas:coden">JMVIDB</span>;
        ISSN:<span class="NLM_cas:issn">0146-6615</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Coronaviruses (CoVs) are by far the largest group of known pos.-sense RNA viruses having an extensive range of natural hosts.  In the past few decades, newly evolved Coronaviruses have posed a global threat to public health.  The immune response is essential to control and eliminate CoV infections, however, maladjusted immune responses may result in immunopathol. and impaired pulmonary gas exchange.  Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs.  In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clin. treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV2qgbg4xqk7Vg90H21EOLACvtfcHk0lgnoHnCxSR1HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntVKntr4%253D&md5=f2de904af37ab888695f51c9b9222ac0</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1002%2Fjmv.25685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmv.25685%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DPan%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DCoronavirus%2520infections%2520and%2520immune%2520responses%26jtitle%3DJ.%2520Med.%2520Virol.%26date%3D2020%26volume%3D92%26issue%3D4%26spage%3D424%26epage%3D432%26doi%3D10.1002%2Fjmv.25685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. X.</span></span> <span> </span><span class="NLM_article-title">Human coronaviruses: A review of virus-host interactions</span>. <i>Diseases</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">26</span>, <span class="refDoi"> DOI: 10.3390/diseases4030026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fdiseases4030026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXms1Ortbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=26&issue=3&author=Y.+X.+Limauthor=Y.+L.+Ngauthor=J.+P.+Tamauthor=D.+X.+Liu&title=Human+coronaviruses%3A+A+review+of+virus-host+interactions&doi=10.3390%2Fdiseases4030026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Human coronaviruses: a review of virus-host interactions</span></div><div class="casAuthors">Lim, Yvonne Xinyi; Ng, Yan Ling; Tam, James P.; Liu, Ding Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">26/1-26/28</span>CODEN:
                <span class="NLM_cas:coden">DISECP</span>;
        ISSN:<span class="NLM_cas:issn">2079-9721</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Human coronaviruses (HCoVs) are known respiratory pathogens assocd. with a range of respiratory outcomes.  In the past 14 years, the onset of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) have thrust HCoVs into spotlight of the research community due to their high pathogenicity in humans.  The study of HCoV-host interactions has contributed extensively to our understanding of HCoV pathogenesis.  In this review, we discuss some of the recent findings of host cell factors that might be exploited by HCoVs to facilitate their own replication cycle.  We also discuss various cellular processes, such as apoptosis, innate immunity, ER stress response, mitogen-activated protein kinase (MAPK) pathway and nuclear factor kappa B (NF-B) pathway that may be modulated by HCoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEr8IbYfvpAbVg90H21EOLACvtfcHk0lgnoHnCxSR1HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXms1Ortbw%253D&md5=5c4c7595bb32f559621c152afe43c153</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.3390%2Fdiseases4030026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fdiseases4030026%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DY.%2BX.%26aulast%3DNg%26aufirst%3DY.%2BL.%26aulast%3DTam%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DD.%2BX.%26atitle%3DHuman%2520coronaviruses%253A%2520A%2520review%2520of%2520virus-host%2520interactions%26jtitle%3DDiseases%26date%3D2016%26volume%3D4%26issue%3D3%26spage%3D26%26doi%3D10.3390%2Fdiseases4030026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, G.</span></span> <span> </span><span class="NLM_article-title">Virology, epidemiology, pathogenesis, and control of COVID-19</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">E372</span>, <span class="refDoi"> DOI: 10.3390/v12040372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fv12040372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32230900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1SjtL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=E372&issue=4&author=Y.+Jinauthor=H.+Yangauthor=W.+Jiauthor=W.+Wuauthor=S.+Chenauthor=W.+Zhangauthor=G.+Duan&title=Virology%2C+epidemiology%2C+pathogenesis%2C+and+control+of+COVID-19&doi=10.3390%2Fv12040372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Virology, epidemiology, pathogenesis, and control of COVID-19</span></div><div class="casAuthors">Jin, Yuefei; Yang, Haiyan; Ji, Wangquan; Wu, Weidong; Chen, Shuaiyin; Zhang, Weiguo; Duan, Guangcai</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">372</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020.  Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~ 2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiol. and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection.  As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health.  To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvPIi9IdgAu7Vg90H21EOLACvtfcHk0lgnoHnCxSR1HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1SjtL7J&md5=c0d8fb7964b01cf9c52bab3869f36e74</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.3390%2Fv12040372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv12040372%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DDuan%26aufirst%3DG.%26atitle%3DVirology%252C%2520epidemiology%252C%2520pathogenesis%252C%2520and%2520control%2520of%2520COVID-19%26jtitle%3DViruses%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3DE372%26doi%3D10.3390%2Fv12040372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prompetchara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketloy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palaga, T.</span></span> <span> </span><span class="NLM_article-title">Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic</span>. <i>Asian Pac. J. Allergy Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">0772</span>, <span class="refDoi"> DOI: 10.12932/AP-200220-0772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.12932%2FAP-200220-0772" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2020&pages=0772&issue=1&author=E.+Prompetcharaauthor=C.+Ketloyauthor=T.+Palaga&title=Immune+responses+in+COVID-19+and+potential+vaccines%3A+Lessons+learned+from+SARS+and+MERS+epidemic&doi=10.12932%2FAP-200220-0772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.12932%2FAP-200220-0772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12932%252FAP-200220-0772%26sid%3Dliteratum%253Aachs%26aulast%3DPrompetchara%26aufirst%3DE.%26aulast%3DKetloy%26aufirst%3DC.%26aulast%3DPalaga%26aufirst%3DT.%26atitle%3DImmune%2520responses%2520in%2520COVID-19%2520and%2520potential%2520vaccines%253A%2520Lessons%2520learned%2520from%2520SARS%2520and%2520MERS%2520epidemic%26jtitle%3DAsian%2520Pac.%2520J.%2520Allergy%2520Immunol.%26date%3D2020%26volume%3D38%26issue%3D1%26spage%3D0772%26doi%3D10.12932%2FAP-200220-0772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanco-Melo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson-Payant, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoagland, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Møller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, T. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oishi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">tenOever, B. R.</span></span> <span> </span><span class="NLM_article-title">Imbalanced host response to SARS-CoV-2 drives development of COVID-19</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>181</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1036</span>– <span class="NLM_lpage">1045</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.cell.2020.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32416070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXps1yjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2020&pages=1036-1045&issue=5&author=D.+Blanco-Meloauthor=B.+E.+Nilsson-Payantauthor=W.-C.+Liuauthor=S.+Uhlauthor=D.+Hoaglandauthor=R.+M%C3%B8llerauthor=T.+X.+Jordanauthor=K.+Oishiauthor=M.+Panisauthor=D.+Sachsauthor=T.+T.+Wangauthor=R.+E.+Schwartzauthor=J.+K.+Limauthor=R.+A.+Albrechtauthor=B.+R.+tenOever&title=Imbalanced+host+response+to+SARS-CoV-2+drives+development+of+COVID-19&doi=10.1016%2Fj.cell.2020.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19</span></div><div class="casAuthors">Blanco-Melo, Daniel; Nilsson-Payant, Benjamin E.; Liu, Wen-Chun; Uhl, Skyler; Hoagland, Daisy; Moeller, Rasmus; Jordan, Tristan X.; Oishi, Kohei; Panis, Maryline; Sachs, David; Wang, Taia T.; Schwartz, Robert E.; Lim, Jean K.; Albrecht, Randy A.; tenOever, Benjamin R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1036-1045.e9</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity.  Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection.  Here we offer an in-depth anal. of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses.  Cell and animal models of SARS-CoV-2 infection, in addn. to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.  This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6.  We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine prodn. are the defining and driving features of COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMWwpoPQkdl7Vg90H21EOLACvtfcHk0linmQx_AodZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXps1yjtrk%253D&md5=cd1c1b429265a563ec1625972e3b07f7</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco-Melo%26aufirst%3DD.%26aulast%3DNilsson-Payant%26aufirst%3DB.%2BE.%26aulast%3DLiu%26aufirst%3DW.-C.%26aulast%3DUhl%26aufirst%3DS.%26aulast%3DHoagland%26aufirst%3DD.%26aulast%3DM%25C3%25B8ller%26aufirst%3DR.%26aulast%3DJordan%26aufirst%3DT.%2BX.%26aulast%3DOishi%26aufirst%3DK.%26aulast%3DPanis%26aufirst%3DM.%26aulast%3DSachs%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%2BT.%26aulast%3DSchwartz%26aufirst%3DR.%2BE.%26aulast%3DLim%26aufirst%3DJ.%2BK.%26aulast%3DAlbrecht%26aufirst%3DR.%2BA.%26aulast%3DtenOever%26aufirst%3DB.%2BR.%26atitle%3DImbalanced%2520host%2520response%2520to%2520SARS-CoV-2%2520drives%2520development%2520of%2520COVID-19%26jtitle%3DCell%26date%3D2020%26volume%3D181%26issue%3D5%26spage%3D1036%26epage%3D1045%26doi%3D10.1016%2Fj.cell.2020.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sia, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiris, J. S.</span></span> <span> </span><span class="NLM_article-title">Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">7819</span>– <span class="NLM_lpage">7826</span>, <span class="refDoi"> DOI: 10.1128/JVI.79.12.7819-7826.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.79.12.7819-7826.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15919935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=7819-7826&issue=12&author=C.+Y.+Cheungauthor=L.+L.+Poonauthor=I.+H.+Ngauthor=W.+Lukauthor=S.+F.+Siaauthor=M.+H.+Wuauthor=K.+H.+Chanauthor=K.+Y.+Yuenauthor=S.+Gordonauthor=Y.+Guanauthor=J.+S.+Peiris&title=Cytokine+responses+in+severe+acute+respiratory+syndrome+coronavirus-infected+macrophages+in+vitro%3A+possible+relevance+to+pathogenesis&doi=10.1128%2FJVI.79.12.7819-7826.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: Possible relevance to pathogenesis</span></div><div class="casAuthors">Cheung, Chung Y.; Poon, Leo L. M.; Ng, Iris H. Y.; Luk, Winsie; Sia, Sin-Fun; Wu, Mavis H. S.; Chan, Kwok-Hung; Yuen, Kwok-Yung; Gordon, Siamon; Guan, Yi; Peiris, Joseph S. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7819-7826</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The pathogenesis of severe acute respiratory syndrome (SARS) remains unclear.  Macrophages are key sentinel cells in the respiratory system, and it is therefore relevant to compare the responses of human macrophages to infections with the SARS coronavirus (SARS-CoV) and other respiratory viruses.  Primary human monocyte-derived macrophages were infected with SARS-CoV in vitro.  Virus replication was monitored by measuring the levels of pos.- and neg.-strand RNA, by immunofluorescence detection of the SARS-CoV nucleoprotein, and by titrn. of the infectious virus.  The gene expression profiles of macrophages infected with SARS-CoV, human coronavirus 229E, and influenza A (H1N1) virus were compared by using microarrays and real-time quant. reverse transcriptase PCR.  Secreted cytokines were measured with an ELISA.  SARS-CoV initiated viral gene transcription and protein synthesis in macrophages, but replication was abortive and no infectious virus was produced.  In contrast to the case with human coronavirus 229E and influenza A virus, there was little or no induction of beta interferon (IFN-β) in SARS-CoV-infected macrophages.  Furthermore, SARS-CoV induced the expression of chemokines such as CXCL10/IFN-γ-inducible protein 10 and CCL2/monocyte chemotactic protein 1.  The poor induction of IFN-β, a key component of innate immunity, and the ability of the virus to induce chemokines could explain aspects of the pathogenesis of SARS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCZlR8OL6YkrVg90H21EOLACvtfcHk0linmQx_AodZTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFCmsbs%253D&md5=b6a5095ca2f10e6b42ab4bd30127a62e</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.12.7819-7826.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.12.7819-7826.2005%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DC.%2BY.%26aulast%3DPoon%26aufirst%3DL.%2BL.%26aulast%3DNg%26aufirst%3DI.%2BH.%26aulast%3DLuk%26aufirst%3DW.%26aulast%3DSia%26aufirst%3DS.%2BF.%26aulast%3DWu%26aufirst%3DM.%2BH.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26aulast%3DGordon%26aufirst%3DS.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DPeiris%26aufirst%3DJ.%2BS.%26atitle%3DCytokine%2520responses%2520in%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus-infected%2520macrophages%2520in%2520vitro%253A%2520possible%2520relevance%2520to%2520pathogenesis%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26issue%3D12%26spage%3D7819%26epage%3D7826%26doi%3D10.1128%2FJVI.79.12.7819-7826.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heise, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R.</span></span> <span> </span><span class="NLM_article-title">SARS coronavirus and innate immunity</span>. <i>Virus Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/j.virusres.2007.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virusres.2007.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=17451827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlWksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2008&pages=101-112&issue=1&author=M.+Friemanauthor=M.+Heiseauthor=R.+Baric&title=SARS+coronavirus+and+innate+immunity&doi=10.1016%2Fj.virusres.2007.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">SARS coronavirus and innate immunity</span></div><div class="casAuthors">Frieman, Matthew; Heise, Mark; Baric, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Virus Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">VIREDF</span>;
        ISSN:<span class="NLM_cas:issn">0168-1702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The emergence of the highly pathogenic SARS coronavirus (SARS-CoV) has re-ignited interest in coronavirus biol. and pathogenesis.  An emerging theme in coronavirus pathogenesis is that the interaction between specific viral genes and the host immune system, specifically the innate immune system, functions as a key determinant in regulating virulence and disease outcomes.  Using SARS-CoV as a model, the authors will review the current knowledge of the interplay between coronavirus infection and the host innate immune system in vivo, and then discuss the mechanisms by which specific gene products antagonize the host innate immune response in cell culture models.  The data suggests that the SARS-CoV uses specific strategies to evade and antagonize the sensing and signaling arms of the interferon pathway.  The authors summarize by identifying future points of consideration that will contribute greatly to understanding of the mol. mechanisms governing coronavirus pathogenesis and virulence, and the development of severe disease in humans and animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUGUtu2pZpfbVg90H21EOLACvtfcHk0ljvBV_VveAQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlWksLo%253D&md5=1088f342138eb126db5681a516e6fd36</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.virusres.2007.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virusres.2007.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DFrieman%26aufirst%3DM.%26aulast%3DHeise%26aufirst%3DM.%26aulast%3DBaric%26aufirst%3DR.%26atitle%3DSARS%2520coronavirus%2520and%2520innate%2520immunity%26jtitle%3DVirus%2520Res.%26date%3D2008%26volume%3D133%26issue%3D1%26spage%3D101%26epage%3D112%26doi%3D10.1016%2Fj.virusres.2007.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Randall, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodbourn, S.</span></span> <span> </span><span class="NLM_article-title">Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1099/vir.0.83391-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.83391-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18089727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Wiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2008&pages=1-47&issue=1&author=R.+E.+Randallauthor=S.+Goodbourn&title=Interferons+and+viruses%3A+an+interplay+between+induction%2C+signalling%2C+antiviral+responses+and+virus+countermeasures&doi=10.1099%2Fvir.0.83391-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures</span></div><div class="casAuthors">Randall, Richard E.; Goodbourn, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-47</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">A review.  The interferon (IFN) system is an extremely powerful antiviral response that is capable of controlling most, if not all, virus infections in the absence of adaptive immunity.  However, viruses can still replicate and cause disease in vivo, because they have some strategy for at least partially circumventing the IFN response.  We reviewed this topic in 2000 but, since then, a great deal has been discovered about the mol. mechanisms of the IFN response and how different viruses circumvent it.  This information is of fundamental interest, but may also have practical application in the design and manuf. of attenuated virus vaccines and the development of novel antiviral drugs.  In the first part of this review, we describe how viruses activate the IFN system, how IFNs induce transcription of their target genes and the mechanism of action of IFN-induced proteins with antiviral action.  In the second part, we describe how viruses circumvent the IFN response.  Here, we reflect upon possible consequences for both the virus and host of the different strategies that viruses have evolved and discuss whether certain viruses have exploited the IFN response to modulate their life cycle (e.g. to establish and maintain persistent/latent infections), whether perturbation of the IFN response by persistent infections can lead to chronic disease, and the importance of the IFN system as a species barrier to virus infections.  Lastly, we briefly describe applied aspects that arise from an increase in our knowledge in this area, including vaccine design and manuf., the development of novel antiviral drugs and the use of IFN-sensitive oncolytic viruses in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKY95HYaAoirVg90H21EOLACvtfcHk0ljvBV_VveAQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Wiug%253D%253D&md5=14603d812131ca5552562623bcbf8811</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.83391-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.83391-0%26sid%3Dliteratum%253Aachs%26aulast%3DRandall%26aufirst%3DR.%2BE.%26aulast%3DGoodbourn%26aufirst%3DS.%26atitle%3DInterferons%2520and%2520viruses%253A%2520an%2520interplay%2520between%2520induction%252C%2520signalling%252C%2520antiviral%2520responses%2520and%2520virus%2520countermeasures%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2008%26volume%3D89%26issue%3D1%26spage%3D1%26epage%3D47%26doi%3D10.1099%2Fvir.0.83391-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kok, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D. Y.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">16202</span>– <span class="NLM_lpage">16209</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.008227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M109.008227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19380580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFSjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=16202-16209&issue=24&author=K.+L.+Siuauthor=K.+H.+Kokauthor=M.+H.+Ngauthor=V.+K.+Poonauthor=K.+Y.+Yuenauthor=B.+J.+Zhengauthor=D.+Y.+Jin&title=Severe+acute+respiratory+syndrome+coronavirus+M+protein+inhibits+type+I+interferon+production+by+impeding+the+formation+of+TRAF3.TANK.TBK1%2FIKKepsilon+complex&doi=10.1074%2Fjbc.M109.008227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKε Complex</span></div><div class="casAuthors">Siu, Kam-Leung; Kok, Kin-Hang; Ng, Ming-Him James; Poon, Vincent K. M.; Yuen, Kwok-Yung; Zheng, Bo-Jian; Jin, Dong-Yan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">16202-16209</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome (SARS) coronavirus is highly pathogenic in humans and evades innate immunity at multiple levels.  It has evolved various strategies to counteract the prodn. and action of type I interferons, which mobilize the front-line defense against viral infection.  Here, the authors demonstrate that SARS coronavirus M protein inhibits gene transcription of type I interferons.  M protein potently antagonizes the activation of interferon-stimulated response element-dependent transcription by double-stranded RNA, RIG-I, MDA5, TBK1, IKKε, and virus-induced signaling adaptor (VISA) but has no influence on the transcriptional activity of this element when IRF3 or IRF7 is overexpressed.  M protein phys. assocs. with RIG-I, TBK1, IKKε, and TRAF3 and likely sequesters some of them in membrane-assocd. cytoplasmic compartments.  Consequently, the expression of M protein prevents the formation of TRAF3·TANK·TBK1/IKKε complex and thereby inhibits TBK1/IKKε-dependent activation of IRF3/IRF7 transcription factors.  The authors' findings thus reveal a new mechanism by which SARS coronavirus circumvents the prodn. of type I interferons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEmqnN6kjIbVg90H21EOLACvtfcHk0ljvBV_VveAQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFSjtr8%253D&md5=c6510323dd5985b014ee72808d8a44db</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.008227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.008227%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DK.%2BL.%26aulast%3DKok%26aufirst%3DK.%2BH.%26aulast%3DNg%26aufirst%3DM.%2BH.%26aulast%3DPoon%26aufirst%3DV.%2BK.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26aulast%3DZheng%26aufirst%3DB.%2BJ.%26aulast%3DJin%26aufirst%3DD.%2BY.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520M%2520protein%2520inhibits%2520type%2520I%2520interferon%2520production%2520by%2520impeding%2520the%2520formation%2520of%2520TRAF3.TANK.TBK1%252FIKKepsilon%2520complex%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26issue%3D24%26spage%3D16202%26epage%3D16209%26doi%3D10.1074%2Fjbc.M109.008227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span> <span> </span><span class="NLM_article-title">The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists</span>. <i>Protein Cell</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">951</span>– <span class="NLM_lpage">961</span>, <span class="refDoi"> DOI: 10.1007/s13238-013-3096-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs13238-013-3096-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24318862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKgtbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=951-961&issue=12&author=Y.+Yangauthor=L.+Zhangauthor=H.+Gengauthor=Y.+Dengauthor=B.+Huangauthor=Y.+Guoauthor=Z.+Zhaoauthor=W.+Tan&title=The+structural+and+accessory+proteins+M%2C+ORF+4a%2C+ORF+4b%2C+and+ORF+5+of+Middle+East+respiratory+syndrome+coronavirus+%28MERS-CoV%29+are+potent+interferon+antagonists&doi=10.1007%2Fs13238-013-3096-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists</span></div><div class="casAuthors">Yang, Yang; Zhang, Ling; Geng, Heyuan; Deng, Yao; Huang, Baoying; Guo, Yin; Zhao, Zhengdong; Tan, Wenjie</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">951-961</span>CODEN:
                <span class="NLM_cas:coden">PCREFB</span>;
        ISSN:<span class="NLM_cas:issn">1674-800X</span>.
    
            (<span class="NLM_cas:orgname">Higher Education Press</span>)
        </div><div class="casAbstract">The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic respiratory virus with pathogenic mechanisms that may be driven by innate immune pathways.  The goal of this study is to characterize the expression of the structural (S, E, M, N) and accessory (ORF 3, ORF 4a, ORF 4b, ORF 5) proteins of MERS-CoV and to det. whether any of these proteins acts as an interferon antagonist.  Individual structural and accessory protein-coding plasmids with an N-terminal HA tag were constructed and transiently transfected into cells, and their native expression and subcellular localization were assessed using Wes tern blotting and indirect immunofluorescence.  While ORF 4b demonstrated majorly nuclear localization, all of the other proteins demonstrated cytoplasmic localization.  In addn., for the first time, our expts. revealed that the M, ORF 4a, ORF 4b, and ORF 5 proteins are potent interferon antagonists.  Further examn. revealed that the ORF 4a protein of MERS-CoV has the most potential to counteract the antiviral effects of IFN via the inhibition of both the interferon prodn. (IFN-β promoter activity, IRF-3/7 and NF-κB activation) and ISRE promoter element signaling pathways.  Together, our results provide new insights into the function and pathogenic role of the structural and accessory proteins of MERS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvWEJgFShHYLVg90H21EOLACvtfcHk0ljvBV_VveAQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKgtbjN&md5=4ba698ca16113333a8f6a65813bbe95c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1007%2Fs13238-013-3096-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13238-013-3096-8%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DW.%26atitle%3DThe%2520structural%2520and%2520accessory%2520proteins%2520M%252C%2520ORF%25204a%252C%2520ORF%25204b%252C%2520and%2520ORF%25205%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520%2528MERS-CoV%2529%2520are%2520potent%2520interferon%2520antagonists%26jtitle%3DProtein%2520Cell%26date%3D2013%26volume%3D4%26issue%3D12%26spage%3D951%26epage%3D961%26doi%3D10.1007%2Fs13238-013-3096-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopecky-Bromberg, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Sobrido, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palese, P.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">557</span>, <span class="refDoi"> DOI: 10.1128/JVI.01782-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.01782-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=17108024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1ShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=548-557&issue=2&author=S.+A.+Kopecky-Brombergauthor=L.+Martinez-Sobridoauthor=M.+Friemanauthor=R.+A.+Baricauthor=P.+Palese&title=Severe+acute+respiratory+syndrome+coronavirus+open+reading+frame+%28ORF%29+3b%2C+ORF+6%2C+and+nucleocapsid+proteins+function+as+interferon+antagonists&doi=10.1128%2FJVI.01782-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists</span></div><div class="casAuthors">Kopecky-Bromberg, Sarah A.; Martinez-Sobrido, Luis; Frieman, Matthew; Baric, Ralph A.; Palese, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">548-557</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The severe acute respiratory syndrome coronavirus (SARS-CoV) is highly pathogenic in humans, with a death rate near 10%.  This high pathogenicity suggests that SARS-CoV has developed mechanisms to overcome the host innate immune response.  It has now been detd. that SARS-CoV open reading frame (ORF) 3b, ORF 6, and N proteins antagonize interferon, a key component of the innate immune response.  All 3 proteins inhibit the expression of β interferon (IFN-β), and further examn. revealed that these SARS-CoV proteins inhibit a key protein necessary for the expression of IFN-β, IRF-3.  N protein dramatically inhibited expression of an NF-κB-responsive promoter.  All 3 proteins were able to inhibit expression of an interferon-stimulated response element (ISRE) promoter after infection with Sendai virus, while only ORF 3b and ORF 6 proteins were able to inhibit expression of the ISRE promoter after treatment with interferon.  This indicates that N protein inhibits only the synthesis of interferon, while ORF 3b and ORF 6 proteins inhibit both interferon synthesis and signaling.  ORF 6 protein, but not ORF 3b or N protein, inhibited nuclear translocation but not phosphorylation of STAT1.  Thus, these 3 interferon antagonists of SARS-CoV inhibit the interferon response by different mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOBL2P61aFJbVg90H21EOLACvtfcHk0lh1cUn59mFm4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1ShtA%253D%253D&md5=44d12f784cd5c9ded5cb51686394ad95</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1128%2FJVI.01782-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01782-06%26sid%3Dliteratum%253Aachs%26aulast%3DKopecky-Bromberg%26aufirst%3DS.%2BA.%26aulast%3DMartinez-Sobrido%26aufirst%3DL.%26aulast%3DFrieman%26aufirst%3DM.%26aulast%3DBaric%26aufirst%3DR.%2BA.%26aulast%3DPalese%26aufirst%3DP.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520open%2520reading%2520frame%2520%2528ORF%2529%25203b%252C%2520ORF%25206%252C%2520and%2520nucleocapsid%2520proteins%2520function%2520as%2520interferon%2520antagonists%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26issue%3D2%26spage%3D548%26epage%3D557%26doi%3D10.1128%2FJVI.01782-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism</span>. <i>Virus Genes</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1007/s11262-010-0544-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs11262-010-0544-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=20976535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvFartbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2011&pages=37-45&issue=1&author=X.+Luauthor=J.+Panauthor=J.+Taoauthor=D.+Guo&title=SARS-CoV+nucleocapsid+protein+antagonizes+IFN-beta+response+by+targeting+initial+step+of+IFN-beta+induction+pathway%2C+and+its+C-terminal+region+is+critical+for+the+antagonism&doi=10.1007%2Fs11262-010-0544-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism</span></div><div class="casAuthors">Lu, Xiaolu; Pan, Ji'an; Tao, Jiali; Guo, Deyin</div><div class="citationInfo"><span class="NLM_cas:title">Virus Genes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-45</span>CODEN:
                <span class="NLM_cas:coden">VIGEET</span>;
        ISSN:<span class="NLM_cas:issn">0920-8569</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) encodes a highly basic nucleocapsid (N) protein which can inhibit the synthesis of type I interferon (IFN), but the mol. mechanism of this antagonism remains to be identified.  In this study, we demonstrated that the N protein of SARS-CoV could inhibit IFN-beta (IFN-β) induced by poly(I:C) or Sendai virus.  However, we found that N protein could not inhibit IFN-β prodn. induced by overexpression of downstream signaling mols. of two important IFN-β induction pathways, toll-like receptor 3 (TLR3)- and RIG-I-like receptors (RLR)-dependent pathways.  These results indicate that SARS-CoV N protein targets the initial step, probably the cellular PRRs (pattern recognition receptors)-RNAs-recognition step in the innate immune pathways, to suppress IFN expression responses.  In addn., co-immunopptn. assays revealed that N protein did not interact with RIG-I or MDA5.  Further, an assay using truncated mutants revealed that the C-terminal domain of N protein was crit. for its antagonism of IFN induction, and the N deletion mutant impaired for RNA-binding almost completely lost the IFN-β antagonist activity.  These results contribute to our further understanding of the pathogenesis of SARS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwPrJTNDUxy7Vg90H21EOLACvtfcHk0lh1cUn59mFm4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvFartbk%253D&md5=e5d3ecff3da8a58183e8819dea18c793</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1007%2Fs11262-010-0544-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11262-010-0544-x%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DSARS-CoV%2520nucleocapsid%2520protein%2520antagonizes%2520IFN-beta%2520response%2520by%2520targeting%2520initial%2520step%2520of%2520IFN-beta%2520induction%2520pathway%252C%2520and%2520its%2520C-terminal%2520region%2520is%2520critical%2520for%2520the%2520antagonism%26jtitle%3DVirus%2520Genes%26date%3D2011%26volume%3D42%26issue%3D1%26spage%3D37%26epage%3D45%26doi%3D10.1007%2Fs11262-010-0544-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span> <span> </span><span class="NLM_article-title">The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I Interferon production by interfering with TRIM25-mediated RIG-I ubiquitination</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span> (<span class="NLM_issue">8</span>), <span class="NLM_elocation-id">e02143-16</span> <span class="refDoi"> DOI: 10.1128/JVI.02143-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.02143-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28148787" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&issue=8&author=Y.+Huauthor=W.+Liauthor=T.+Gaoauthor=Y.+Cuiauthor=Y.+Jinauthor=P.+Liauthor=Q.+Maauthor=X.+Liuauthor=C.+Cao&title=The+severe+acute+respiratory+syndrome+coronavirus+nucleocapsid+inhibits+type+I+Interferon+production+by+interfering+with+TRIM25-mediated+RIG-I+ubiquitination&doi=10.1128%2FJVI.02143-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1128%2FJVI.02143-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02143-16%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DC.%26atitle%3DThe%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520nucleocapsid%2520inhibits%2520type%2520I%2520Interferon%2520production%2520by%2520interfering%2520with%2520TRIM25-mediated%2520RIG-I%2520ubiquitination%26jtitle%3DJ.%2520Virol.%26date%3D2017%26volume%3D91%26issue%3D8%26doi%3D10.1128%2FJVI.02143-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dosch, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, A. R.</span></span> <span> </span><span class="NLM_article-title">SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro</span>. <i>Virus Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.virusres.2009.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virusres.2009.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19185596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlKqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2009&pages=19-27&issue=1%E2%80%932&author=S.+F.+Doschauthor=S.+D.+Mahajanauthor=A.+R.+Collins&title=SARS+coronavirus+spike+protein-induced+innate+immune+response+occurs+via+activation+of+the+NF-kappaB+pathway+in+human+monocyte+macrophages+in+vitro&doi=10.1016%2Fj.virusres.2009.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro</span></div><div class="casAuthors">Dosch, Susan F.; Mahajan, Supriya D.; Collins, Arlene R.</div><div class="citationInfo"><span class="NLM_cas:title">Virus Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">19-27</span>CODEN:
                <span class="NLM_cas:coden">VIREDF</span>;
        ISSN:<span class="NLM_cas:issn">0168-1702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A purified recombinant spike (S) protein was studied for its effect on stimulating human peripheral blood monocyte macrophages (PBMC).  The authors examd. inflammatory gene mRNA levels found in S protein-treated PBMC using gene arrays.  They identified differential mRNA levels of genes with functional properties assocd. with antiviral (CXCL10) and inflammatory (IL-6 and IL-8) responses.  They confirmed cytokine mRNA increases by real-time quant. RT-PCR or ELISA.  They further analyzed the sensitivity and specificity of the prominent IL-8 response.  By real-time qRT-PCR, S protein was shown to stimulate IL-8 mRNA accumulation in a dose dependent manner while treatment with E protein did not.  Also, titrn. of S protein-specific prodn. and secretion of IL-8 by ELISA showed that the dose of 5.6 nM of S produced an increase in IL-8 compared to mock-treated controls.  The increase in IL-8 stimulated by a concn. of 5.6 nM of S was comparable to concns. seen for S protein binding to ACE2 or to neutralizing monoclonal antibody suggesting a physiol. relevance.  An NF-κB inhibitor, TPCK (N-tosyl-L-phenylalanine chloromethyl ketone) could suppress IL-8 prodn. and secretion in response to S protein in PBMC and THP-1 cells and in HCoV-229E virus-infected PBMC.  Activation and translocation of NF-κB was shown to occur rapidly following exposure of PBMC or THP-1 cells to S protein using a highly sensitive assay for active nuclear NF-κB p65 transcription factor.  The results further suggested that released or secreted S protein could activate blood monocytes via recognition by toll-like receptor (TLR)2 ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHsbRwdZ_Dx7Vg90H21EOLACvtfcHk0lgcasH5COJmsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlKqtbw%253D&md5=8ea269e400b3922901ba05eca8787689</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.virusres.2009.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virusres.2009.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DDosch%26aufirst%3DS.%2BF.%26aulast%3DMahajan%26aufirst%3DS.%2BD.%26aulast%3DCollins%26aufirst%3DA.%2BR.%26atitle%3DSARS%2520coronavirus%2520spike%2520protein-induced%2520innate%2520immune%2520response%2520occurs%2520via%2520activation%2520of%2520the%2520NF-kappaB%2520pathway%2520in%2520human%2520monocyte%2520macrophages%2520in%2520vitro%26jtitle%3DVirus%2520Res.%26date%3D2009%26volume%3D142%26issue%3D1%25E2%2580%25932%26spage%3D19%26epage%3D27%26doi%3D10.1016%2Fj.virusres.2009.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieto-Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdia-Baguena, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Guardeno, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regla-Nava, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castano-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Delgado, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilella, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2015.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2015.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26331680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyls7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2015&pages=330-339&author=J.+L.+Nieto-Torresauthor=C.+Verdia-Baguenaauthor=J.+M.+Jimenez-Guardenoauthor=J.+A.+Regla-Navaauthor=C.+Castano-Rodriguezauthor=R.+Fernandez-Delgadoauthor=J.+Torresauthor=V.+M.+Aguilellaauthor=L.+Enjuanes&title=Severe+acute+respiratory+syndrome+coronavirus+E+protein+transports+calcium+ions+and+activates+the+NLRP3+inflammasome&doi=10.1016%2Fj.virol.2015.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome</span></div><div class="casAuthors">Nieto-Torres, Jose L.; Verdia-Baguena, Carmina; Jimenez-Guardeno, Jose M.; Regla-Nava, Jose A.; Castano-Rodriguez, Carlos; Fernandez-Delgado, Raul; Torres, Jaume; Aguilella, Vicente M.; Enjuanes, Luis</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">330-339</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) envelope (E) protein is a viroporin involved in virulence.  E protein ion channel (IC) activity is specifically correlated with enhanced pulmonary damage, edema accumulation and death.  IL-1β driven proinflammation is assocd. with those pathol. signatures, however its link to IC activity remains unknown.  In this report, we demonstrate that SARS-CoV E protein forms protein-lipid channels in ERGIC/Golgi membranes that are permeable to calcium ions, a highly relevant feature never reported before.  Calcium ions together with pH modulated E protein pore charge and selectivity.  Interestingly, E protein IC activity boosted the activation of the NLRP3 inflammasome, leading to IL-1β overprodn.  Calcium transport through the E protein IC was the main trigger of this process.  These findings strikingly link SARS-CoV E protein IC induced ionic disturbances at the cell level to immunopathol. consequences and disease worsening in the infected organism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF2C4rAutetbVg90H21EOLACvtfcHk0lgcasH5COJmsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyls7fP&md5=27d428b5b025c92e4c62721935903fd3</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2015.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2015.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DNieto-Torres%26aufirst%3DJ.%2BL.%26aulast%3DVerdia-Baguena%26aufirst%3DC.%26aulast%3DJimenez-Guardeno%26aufirst%3DJ.%2BM.%26aulast%3DRegla-Nava%26aufirst%3DJ.%2BA.%26aulast%3DCastano-Rodriguez%26aufirst%3DC.%26aulast%3DFernandez-Delgado%26aufirst%3DR.%26aulast%3DTorres%26aufirst%3DJ.%26aulast%3DAguilella%26aufirst%3DV.%2BM.%26aulast%3DEnjuanes%26aufirst%3DL.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520E%2520protein%2520transports%2520calcium%2520ions%2520and%2520activates%2520the%2520NLRP3%2520inflammasome%26jtitle%3DVirology%26date%3D2015%26volume%3D485%26spage%3D330%26epage%3D339%26doi%3D10.1016%2Fj.virol.2015.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ru, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span> <span> </span><span class="NLM_article-title">G3BP1 inhibits RNA virus replication by positively regulating RIG-I-mediated cellular antiviral response</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">946</span>, <span class="refDoi"> DOI: 10.1038/s41419-019-2178-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41419-019-2178-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31827077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVykurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=946&issue=12&author=W.+Yangauthor=Y.+Ruauthor=J.+Renauthor=J.+Baiauthor=J.+Weiauthor=S.+Fuauthor=X.+Liuauthor=D.+Liauthor=H.+Zheng&title=G3BP1+inhibits+RNA+virus+replication+by+positively+regulating+RIG-I-mediated+cellular+antiviral+response&doi=10.1038%2Fs41419-019-2178-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">G3BP1 inhibits RNA virus replication by positively regulating RIG-I-mediated cellular antiviral response</span></div><div class="casAuthors">Yang, Wenping; Ru, Yi; Ren, Jingjing; Bai, Juncui; Wei, Junshu; Fu, Shaozu; Liu, Xiangtao; Li, Dan; Zheng, Haixue</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">946</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Retinoic acid-inducible gene I (RIG-I) is a pattern recognition receptor and is involved in the innate immune response against RNA viruses infection.  Here, we demonstrate that the Ras-GTPase-activating protein SH3-domain-binding protein 1 (G3BP1) serves as a pos. regulator of the RIG-I-mediated signaling pathway.  G3BP1-deficient cells inhibited RNA virus-triggered induction of downstream antiviral genes.  Furthermore, we found that G3BP1 inhibited the replication of Sendai virus and vesicular stomatitis virus, indicating a pos. regulation of G3BP1 to cellular antiviral responses.  Mechanistically, G3BP1 formed a complex with RNF125 and RIG-I, leading to decreased RNF125 via its auto-ubiquitination; thus, promoting expression of RIG-I.  Overall, the results suggest a novel mechanism for G3BP1 in the pos. regulation of antiviral signaling mediated by RIG-I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8P89UWLRK0LVg90H21EOLACvtfcHk0lgcasH5COJmsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVykurzI&md5=78d2007816d4c146c595ad6b0f462384</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-2178-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-2178-9%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DRu%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DG3BP1%2520inhibits%2520RNA%2520virus%2520replication%2520by%2520positively%2520regulating%2520RIG-I-mediated%2520cellular%2520antiviral%2520response%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26issue%3D12%26spage%3D946%26doi%3D10.1038%2Fs41419-019-2178-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhaddou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obernier, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rezelj, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huettenhain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaake, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tutuncuoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foussard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polacco, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabius, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucheray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cakir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Kain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miorin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naing, Z. Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chorba, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrio-Hernandez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Armenta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathy, C. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perica, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilla, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltzberg, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calviello, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataramanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liboy-Lugo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wankowicz, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugur, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savar, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shengjuler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neal, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broadhurst, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klippsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzuoglu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavero, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiatt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathore, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verba, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agard, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Zastrow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">d’Enfert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimori, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ideker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floor, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortemme, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltrao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Sastre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogan, N. J.</span></span> <span> </span><span class="NLM_article-title">A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1038/s41586-020-2286-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41586-020-2286-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32353859" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=D.+E.+Gordonauthor=G.+M.+Jangauthor=M.+Bouhaddouauthor=J.+Xuauthor=K.+Obernierauthor=K.+M.+Whiteauthor=M.+J.+O%E2%80%99Mearaauthor=V.+V.+Rezeljauthor=J.+Z.+Guoauthor=D.+L.+Swaneyauthor=T.+A.+Tumminoauthor=R.+Huettenhainauthor=R.+M.+Kaakeauthor=A.+L.+Richardsauthor=B.+Tutuncuogluauthor=H.+Foussardauthor=J.+Batraauthor=K.+Haasauthor=M.+Modakauthor=M.+Kimauthor=P.+Haasauthor=B.+J.+Polaccoauthor=H.+Brabergauthor=J.+M.+Fabiusauthor=M.+Eckhardtauthor=M.+Soucherayauthor=M.+J.+Bennettauthor=M.+Cakirauthor=M.+J.+McGregorauthor=Q.+Liauthor=B.+Meyerauthor=F.+Roeschauthor=T.+Valletauthor=A.+Mac+Kainauthor=L.+Miorinauthor=E.+Morenoauthor=Z.+Z.+C.+Naingauthor=Y.+Zhouauthor=S.+Pengauthor=Y.+Shiauthor=Z.+Zhangauthor=W.+Shenauthor=I.+T.+Kirbyauthor=J.+E.+Melnykauthor=J.+S.+Chorbaauthor=K.+Louauthor=S.+A.+Daiauthor=I.+Barrio-Hernandezauthor=D.+Memonauthor=C.+Hernandez-Armentaauthor=J.+Lyuauthor=C.+J.+P.+Mathyauthor=T.+Pericaauthor=K.+B.+Pillaauthor=S.+J.+Ganesanauthor=D.+J.+Saltzbergauthor=R.+Rakeshauthor=X.+Liuauthor=S.+B.+Rosenthalauthor=L.+Calvielloauthor=S.+Venkataramananauthor=J.+Liboy-Lugoauthor=Y.+Linauthor=X.+P.+Huangauthor=Y.+Liuauthor=S.+A.+Wankowiczauthor=M.+Bohnauthor=M.+Safariauthor=F.+S.+Ugurauthor=C.+Kohauthor=N.+S.+Savarauthor=Q.+D.+Tranauthor=D.+Shengjulerauthor=S.+J.+Fletcherauthor=M.+C.+O%E2%80%99Nealauthor=Y.+Caiauthor=J.+C.+J.+Changauthor=D.+J.+Broadhurstauthor=S.+Klippstenauthor=P.+P.+Sharpauthor=N.+A.+Wenzellauthor=D.+Kuzuogluauthor=H.+Y.+Wangauthor=R.+Trenkerauthor=J.+M.+Youngauthor=D.+A.+Caveroauthor=J.+Hiattauthor=T.+L.+Rothauthor=U.+Rathoreauthor=A.+Subramanianauthor=J.+Noackauthor=M.+Hubertauthor=R.+M.+Stroudauthor=A.+D.+Frankelauthor=O.+S.+Rosenbergauthor=K.+A.+Verbaauthor=D.+A.+Agardauthor=M.+Ottauthor=M.+Emermanauthor=N.+Juraauthor=M.+von+Zastrowauthor=E.+Verdinauthor=A.+Ashworthauthor=O.+Schwartzauthor=C.+d%E2%80%99Enfertauthor=S.+Mukherjeeauthor=M.+Jacobsonauthor=H.+S.+Malikauthor=D.+G.+Fujimoriauthor=T.+Idekerauthor=C.+S.+Craikauthor=S.+N.+Floorauthor=J.+S.+Fraserauthor=J.+D.+Grossauthor=A.+Saliauthor=B.+L.+Rothauthor=D.+Ruggeroauthor=J.+Tauntonauthor=T.+Kortemmeauthor=P.+Beltraoauthor=M.+Vignuzziauthor=A.+Garcia-Sastreauthor=K.+M.+Shokatauthor=B.+K.+Shoichetauthor=N.+J.+Krogan&title=A+SARS-CoV-2+protein+interaction+map+reveals+targets+for+drug+repurposing&doi=10.1038%2Fs41586-020-2286-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1038%2Fs41586-020-2286-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-020-2286-9%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BE.%26aulast%3DJang%26aufirst%3DG.%2BM.%26aulast%3DBouhaddou%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DObernier%26aufirst%3DK.%26aulast%3DWhite%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%2BJ.%26aulast%3DRezelj%26aufirst%3DV.%2BV.%26aulast%3DGuo%26aufirst%3DJ.%2BZ.%26aulast%3DSwaney%26aufirst%3DD.%2BL.%26aulast%3DTummino%26aufirst%3DT.%2BA.%26aulast%3DHuettenhain%26aufirst%3DR.%26aulast%3DKaake%26aufirst%3DR.%2BM.%26aulast%3DRichards%26aufirst%3DA.%2BL.%26aulast%3DTutuncuoglu%26aufirst%3DB.%26aulast%3DFoussard%26aufirst%3DH.%26aulast%3DBatra%26aufirst%3DJ.%26aulast%3DHaas%26aufirst%3DK.%26aulast%3DModak%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DHaas%26aufirst%3DP.%26aulast%3DPolacco%26aufirst%3DB.%2BJ.%26aulast%3DBraberg%26aufirst%3DH.%26aulast%3DFabius%26aufirst%3DJ.%2BM.%26aulast%3DEckhardt%26aufirst%3DM.%26aulast%3DSoucheray%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26aulast%3DCakir%26aufirst%3DM.%26aulast%3DMcGregor%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DRoesch%26aufirst%3DF.%26aulast%3DVallet%26aufirst%3DT.%26aulast%3DMac%2BKain%26aufirst%3DA.%26aulast%3DMiorin%26aufirst%3DL.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DZ.%2BZ.%2BC.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DKirby%26aufirst%3DI.%2BT.%26aulast%3DMelnyk%26aufirst%3DJ.%2BE.%26aulast%3DChorba%26aufirst%3DJ.%2BS.%26aulast%3DLou%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DS.%2BA.%26aulast%3DBarrio-Hernandez%26aufirst%3DI.%26aulast%3DMemon%26aufirst%3DD.%26aulast%3DHernandez-Armenta%26aufirst%3DC.%26aulast%3DLyu%26aufirst%3DJ.%26aulast%3DMathy%26aufirst%3DC.%2BJ.%2BP.%26aulast%3DPerica%26aufirst%3DT.%26aulast%3DPilla%26aufirst%3DK.%2BB.%26aulast%3DGanesan%26aufirst%3DS.%2BJ.%26aulast%3DSaltzberg%26aufirst%3DD.%2BJ.%26aulast%3DRakesh%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DRosenthal%26aufirst%3DS.%2BB.%26aulast%3DCalviello%26aufirst%3DL.%26aulast%3DVenkataramanan%26aufirst%3DS.%26aulast%3DLiboy-Lugo%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWankowicz%26aufirst%3DS.%2BA.%26aulast%3DBohn%26aufirst%3DM.%26aulast%3DSafari%26aufirst%3DM.%26aulast%3DUgur%26aufirst%3DF.%2BS.%26aulast%3DKoh%26aufirst%3DC.%26aulast%3DSavar%26aufirst%3DN.%2BS.%26aulast%3DTran%26aufirst%3DQ.%2BD.%26aulast%3DShengjuler%26aufirst%3DD.%26aulast%3DFletcher%26aufirst%3DS.%2BJ.%26aulast%3DO%25E2%2580%2599Neal%26aufirst%3DM.%2BC.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DJ.%2BC.%2BJ.%26aulast%3DBroadhurst%26aufirst%3DD.%2BJ.%26aulast%3DKlippsten%26aufirst%3DS.%26aulast%3DSharp%26aufirst%3DP.%2BP.%26aulast%3DWenzell%26aufirst%3DN.%2BA.%26aulast%3DKuzuoglu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DTrenker%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DCavero%26aufirst%3DD.%2BA.%26aulast%3DHiatt%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DT.%2BL.%26aulast%3DRathore%26aufirst%3DU.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DNoack%26aufirst%3DJ.%26aulast%3DHubert%26aufirst%3DM.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26aulast%3DFrankel%26aufirst%3DA.%2BD.%26aulast%3DRosenberg%26aufirst%3DO.%2BS.%26aulast%3DVerba%26aufirst%3DK.%2BA.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DEmerman%26aufirst%3DM.%26aulast%3DJura%26aufirst%3DN.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DAshworth%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DO.%26aulast%3Dd%25E2%2580%2599Enfert%26aufirst%3DC.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DMalik%26aufirst%3DH.%2BS.%26aulast%3DFujimori%26aufirst%3DD.%2BG.%26aulast%3DIdeker%26aufirst%3DT.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DFloor%26aufirst%3DS.%2BN.%26aulast%3DFraser%26aufirst%3DJ.%2BS.%26aulast%3DGross%26aufirst%3DJ.%2BD.%26aulast%3DSali%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DKortemme%26aufirst%3DT.%26aulast%3DBeltrao%26aufirst%3DP.%26aulast%3DVignuzzi%26aufirst%3DM.%26aulast%3DGarcia-Sastre%26aufirst%3DA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DKrogan%26aufirst%3DN.%2BJ.%26atitle%3DA%2520SARS-CoV-2%2520protein%2520interaction%2520map%2520reveals%2520targets%2520for%2520drug%2520repurposing%26jtitle%3DNature%26date%3D2020%26doi%3D10.1038%2Fs41586-020-2286-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jauregui, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savalia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowry, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wathelet, M. G.</span></span> <span> </span><span class="NLM_article-title">Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e62416</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0062416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0062416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=23658627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlCrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=4&author=A.+R.+Jaureguiauthor=D.+Savaliaauthor=V.+K.+Lowryauthor=C.+M.+Farrellauthor=M.+G.+Wathelet&title=Identification+of+residues+of+SARS-CoV+nsp1+that+differentially+affect+inhibition+of+gene+expression+and+antiviral+signaling&doi=10.1371%2Fjournal.pone.0062416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling</span></div><div class="casAuthors">Jauregui, Andrew R.; Savalia, Dhruti; Lowry, Virginia K.; Farrell, Cara M.; Wathelet, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e62416</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">An epidemic of severe acute respiratory syndrome (SARS) led to the identification of an assocd. coronavirus, SARS-CoV.  This virus evades the host innate immune response in part through the expression of its non-structural protein (nsp) 1, which inhibits both host gene expression and virus- and interferon (IFN)-dependent signaling.  Thus, nsp1 is a promising target for drugs, as inhibition of nsp1 would make SARS-CoV more susceptible to the host antiviral defenses.  To gain a better understanding of nsp1 mode of action, we generated and analyzed 38 mutants of the SARS-CoV nsp1, targeting 62 solvent-exposed residues out of the 180 amino acid protein.  From this work, we identified six classes of mutants that abolished, attenuated or increased nsp1 inhibition of host gene expression and/or antiviral signaling.  Each class of mutants clustered on SARS-CoV nsp1 surface and suggested nsp1 interacts with distinct host factors to exert its inhibitory activities.  Identification of the nsp1 residues crit. for its activities and the pathways involved in these activities should help in the design of drugs targeting nsp1.  Significantly, several point mutants increased the inhibitory activity of nsp1, suggesting that coronaviruses could evolve a greater ability to evade the host response through mutations of such residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz0ex8tf9VbLVg90H21EOLACvtfcHk0ljVYV6Lgf77Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlCrtr0%253D&md5=94c9a53c22276d9b894e947cd4ee50f5</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0062416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0062416%26sid%3Dliteratum%253Aachs%26aulast%3DJauregui%26aufirst%3DA.%2BR.%26aulast%3DSavalia%26aufirst%3DD.%26aulast%3DLowry%26aufirst%3DV.%2BK.%26aulast%3DFarrell%26aufirst%3DC.%2BM.%26aulast%3DWathelet%26aufirst%3DM.%2BG.%26atitle%3DIdentification%2520of%2520residues%2520of%2520SARS-CoV%2520nsp1%2520that%2520differentially%2520affect%2520inhibition%2520of%2520gene%2520expression%2520and%2520antiviral%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D4%26doi%3D10.1371%2Fjournal.pone.0062416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devaraj, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barretto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span> <span> </span><span class="NLM_article-title">Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">32208</span>– <span class="NLM_lpage">32221</span>, <span class="refDoi"> DOI: 10.1074/jbc.M704870200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1074%2Fjbc.M704870200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=17761676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Wls7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=32208-32221&issue=44&author=S.+G.+Devarajauthor=N.+Wangauthor=Z.+Chenauthor=Z.+Chenauthor=M.+Tsengauthor=N.+Barrettoauthor=R.+Linauthor=C.+J.+Petersauthor=C.+T.+Tsengauthor=S.+C.+Bakerauthor=K.+Li&title=Regulation+of+IRF-3-dependent+innate+immunity+by+the+papain-like+protease+domain+of+the+severe+acute+respiratory+syndrome+coronavirus&doi=10.1074%2Fjbc.M704870200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus</span></div><div class="casAuthors">Devaraj, Santhana G.; Wang, Nan; Chen, Zhongbin; Chen, Zihong; Tseng, Monica; Barretto, Naina; Lin, Rongtuan; Peters, Clarence J.; Tseng, Chien-Te K.; Baker, Susan C.; Li, Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">32208-32221</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) is a novel coronavirus that causes a highly contagious respiratory disease, SARS, with significant mortality.  Although factors contributing to the highly pathogenic nature of SARS-CoV remain poorly understood, it has been reported that SARS-CoV infection does not induce type I interferons (IFNs) in cell culture.  However, it is uncertain whether SARS-CoV evades host detection or has evolved mechanisms to counteract innate host defenses.  The authors show here that infection of SARS-CoV triggers a weak IFN response in cultured human lung/bronchial epithelial cells without inducing the phosphorylation of IFN-regulatory factor 3 (IRF-3), a latent cellular transcription factor that is pivotal for type I IFN synthesis.  Furthermore, SARS-CoV infection blocked the induction of IFN antiviral activity and the up-regulation of protein expression of a subset of IFN-stimulated genes triggered by double-stranded RNA or an unrelated paramyxovirus.  In searching for a SARS-CoV protein capable of counteracting innate immunity, the authors identified the papain-like protease (PLpro) domain as a potent IFN antagonist.  The inhibition of the IFN response does not require the protease activity of PLpro.  Rather, PLpro interacts with IRF-3 and inhibits the phosphorylation and nuclear translocation of IRF-3, thereby disrupting the activation of type I IFN responses through either Toll-like receptor 3 or retinoic acid-inducible gene I/melanoma differentiation-assocd. gene 5 pathways.  The authors' data suggest that regulation of IRF-3-dependent innate antiviral defenses by PLpro may contribute to the establishment of SARS-CoV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCaHrUo-VWzrVg90H21EOLACvtfcHk0li4YijbFdW4Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Wls7zE&md5=7358d227da9cdd535ec2d13ac771786c</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M704870200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M704870200%26sid%3Dliteratum%253Aachs%26aulast%3DDevaraj%26aufirst%3DS.%2BG.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DTseng%26aufirst%3DM.%26aulast%3DBarretto%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DR.%26aulast%3DPeters%26aufirst%3DC.%2BJ.%26aulast%3DTseng%26aufirst%3DC.%2BT.%26aulast%3DBaker%26aufirst%3DS.%2BC.%26aulast%3DLi%26aufirst%3DK.%26atitle%3DRegulation%2520of%2520IRF-3-dependent%2520innate%2520immunity%2520by%2520the%2520papain-like%2520protease%2520domain%2520of%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D44%26spage%3D32208%26epage%3D32221%26doi%3D10.1074%2Fjbc.M704870200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotouhi-Ardakani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lytvyn, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulea, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menard, R.</span></span> <span> </span><span class="NLM_article-title">The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">15199</span>– <span class="NLM_lpage">15208</span>, <span class="refDoi"> DOI: 10.1128/JVI.79.24.15199-15208.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.79.24.15199-15208.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=16306591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslOitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=15199-15208&issue=24&author=H.+A.+Lindnerauthor=N.+Fotouhi-Ardakaniauthor=V.+Lytvynauthor=P.+Lachanceauthor=T.+Suleaauthor=R.+Menard&title=The+papain-like+protease+from+the+severe+acute+respiratory+syndrome+coronavirus+is+a+deubiquitinating+enzyme&doi=10.1128%2FJVI.79.24.15199-15208.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme</span></div><div class="casAuthors">Lindner, Holger A.; Fotouhi-Ardakani, Nasser; Lytvyn, Viktoria; Lachance, Paule; Sulea, Traian; Menard, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15199-15208</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The severe acute respiratory syndrome coronavirus papain-like protease (SARS-CoV PLpro) is involved in the processing of the viral polyprotein and, thereby, contributes to the biogenesis of the virus replication complex.  Structural bioinformatics has revealed a relationship for the SARS-CoV PLpro to herpesvirus-assocd. ubiquitin-specific protease (HAUSP), a ubiquitin-specific protease, indicating potential deubiquitinating activity in addn. to its function in polyprotein processing.  In order to confirm this prediction, we overexpressed and purified SARS-CoV PLpro (amino acids [aa]1507 to 1858) from Escherichia coli.  The purified enzyme hydrolyzed ubiquitin-7-amino-4-methylcoumarin (Ub-AMC), a general deubiquitinating enzyme substrate, with a catalytic efficiency of 13,100 M-1 s-1, 220-fold more efficiently than the small synthetic peptide substrate Z-LRGG-AMC, which incorporates the C-terminal four residues of ubiquitin.  In addn., SARS-CoV PLpro was inhibited by the specific deubiquitinating enzyme inhibitor ubiquitin aldehyde, with an inhibition const. of 210 nM.  The purified SARS-CoV PLpro disassembles branched polyubiquitin chains with lengths of two to seven (Ub2-7) or four (Ub4) units, which involves isopeptide bond cleavage.  SARS-CoV PLpro processing activity was also detected against a protein fused to the C terminus of the ubiquitin-like modifier ISG15, both in vitro using the purified enzyme and in HeLa cells by coexpression with SARS-CoV PLpro (aa 1198 to 2009).  These results clearly establish that SARS-CoV PLpro is a deubiquitinating enzyme, thereby confirming our earlier prediction.  This unexpected activity for a coronavirus papain-like protease suggests a novel viral strategy to modulate the host cell ubiquitination machinery to its advantage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1m1bqW9GpybVg90H21EOLACvtfcHk0li4YijbFdW4Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslOitw%253D%253D&md5=dff5e5e3d3b2fc8838413a8551480383</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.24.15199-15208.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.24.15199-15208.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLindner%26aufirst%3DH.%2BA.%26aulast%3DFotouhi-Ardakani%26aufirst%3DN.%26aulast%3DLytvyn%26aufirst%3DV.%26aulast%3DLachance%26aufirst%3DP.%26aulast%3DSulea%26aufirst%3DT.%26aulast%3DMenard%26aufirst%3DR.%26atitle%3DThe%2520papain-like%2520protease%2520from%2520the%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520is%2520a%2520deubiquitinating%2520enzyme%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26issue%3D24%26spage%3D15199%26epage%3D15208%26doi%3D10.1128%2FJVI.79.24.15199-15208.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1099/vir.0.059014-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.059014-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24362959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyms7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2014&pages=614-626&issue=3&author=X.+Yangauthor=X.+Chenauthor=G.+Bianauthor=J.+Tuauthor=Y.+Xingauthor=Y.+Wangauthor=Z.+Chen&title=Proteolytic+processing%2C+deubiquitinase+and+interferon+antagonist+activities+of+Middle+East+respiratory+syndrome+coronavirus+papain-like+protease&doi=10.1099%2Fvir.0.059014-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease</span></div><div class="casAuthors">Yang, Xingxing; Chen, Xiaojuan; Bian, Guangxing; Tu, Jian; Xing, Yaling; Wang, Yayun; Chen, Zhongbin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-626</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">The emerging Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe pulmonary disease in humans and represents the second example of a highly pathogenic coronavirus (CoV) following severe acute respiratory syndrome coronavirus (SARS-CoV).  Genomic studies revealed that two viral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), process the polyproteins encoded by the MERS-CoV genomic RNA.  We previously reported that SARS-CoV PLpro acts as both deubiquitinase (DUB) and IFN antagonist, but the function of the MERS-CoV PLpro was poorly understood.  In this study, we characterized MERS-CoV PLpro, which is a protease and can recognize and process the cleavage sites (CS) of nsp1-2, nsp2-3 and nsp3-4.  The LXGG consensus cleavage sites in the N terminus of pp1a/1ab, which is generally essential for CoV PLpro-mediated processing, were also characterized in MERS-CoV.  MERS-CoV PLpro, like human SARS-CoV PLpro and NL63-CoV PLP2, is a viral deubiquitinating enzyme.  It acts on both K48- and K63-linked ubiquitination and ISG15-linked ISGylation.  We confirmed that MERS-CoV PLpro acts as an IFN antagonist through blocking the phosphorylation and nuclear translocation of IFN regulatory factor 3 (IRF3).  These findings indicate that MERS-CoV PLpro acts as a viral DUB and suppresses prodn. of IFN-β by an interfering IRF3-mediated signalling pathway, in addn. to recognizing and processing the CS at the N terminus of replicase polyprotein to release the non-structural proteins.  The characterization of proteolytic processing, DUB and IFN antagonist activities of MERS-CoV PLpro would reveal the interactions between MERS-CoV and its host, and be applicable to develop strategies targeting PLpro for the effective control of MERS-CoV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKNBrp1z7PFrVg90H21EOLACvtfcHk0lj-Mjh9__6glQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyms7zN&md5=6681725064519d5fc1a743ebd912c07f</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.059014-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.059014-0%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DG.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DProteolytic%2520processing%252C%2520deubiquitinase%2520and%2520interferon%2520antagonist%2520activities%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520papain-like%2520protease%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2014%26volume%3D95%26issue%3D3%26spage%3D614%26epage%3D626%26doi%3D10.1099%2Fvir.0.059014-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. W.</span></span> <span> </span><span class="NLM_article-title">SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">678</span>, <span class="refDoi"> DOI: 10.3390/ijms17050678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3390%2Fijms17050678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslCktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=678&issue=5&author=S.+W.+Liauthor=C.+Y.+Wangauthor=Y.+J.+Jouauthor=S.+H.+Huangauthor=L.+H.+Hsiaoauthor=L.+Wanauthor=Y.+J.+Linauthor=S.+H.+Kungauthor=C.+W.+Lin&title=SARS+coronavirus+papain-like+protease+inhibits+the+TLR7+signaling+pathway+through+removing+Lys63-linked+polyubiquitination+of+TRAF3+and+TRAF6&doi=10.3390%2Fijms17050678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6</span></div><div class="casAuthors">Li, Shih-Wen; Wang, Ching-Ying; Jou, Yu-Jen; Huang, Su-Hua; Hsiao, Li-Hsin; Wan, Lei; Lin, Ying-Ju; Kung, Szu-Hao; Lin, Cheng-Wen</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">678/1-678/10</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) papain-like protease (PLPro) reportedly inhibits the prodn. of type I interferons (IFNs) and pro-inflammatory cytokines in Toll-like receptor 3 (TLR3) and retinoic acid-inducible gene 1 (RIG-I) pathways.  The study investigated the inhibitory effect and its antagonistic mechanism of SARS-CoV PLPro on TLR7-mediated cytokine prodn.  TLR7 agonist (imiquimod (IMQ)) concn.-dependently induced activation of ISRE-, NF-κB- and AP-1-luciferase reporters, as well as the prodn. of IFN-α, IFN-β, TNF-α, IL-6 and IL-8 in human promonocyte cells.  However, SARS-CoV PLPro significantly inhibited IMQ-induced cytokine prodn. through suppressing the activation of transcription factors IRF-3, NF-κB and AP-1.  Western blot anal. with anti-Lys48 and anti-Lys63 ubiquitin antibodies indicated the SARS-CoV PLPro removed Lys63-linked ubiquitin chains of TRAF3 and TRAF6, but not Lys48-linked ubiquitin chains in un-treated and treated cells.  The decrease in the activated state of TRAF3 and TRAF6 correlated with the inactivation of TBK1 in response to IMQ by PLPro.  The results revealed that the antagonism of SARS-CoV PLPro on TLR7-mediated innate immunity was assocd. with the neg. regulation of TRAF3/6-TBK1-IRF3/NF-κB/AP1 signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogHrXOidYFQLVg90H21EOLACvtfcHk0lj-Mjh9__6glQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslCktbY%253D&md5=46328304cb29f501e142ac46c3865bde</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.3390%2Fijms17050678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17050678%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DJou%26aufirst%3DY.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%2BH.%26aulast%3DHsiao%26aufirst%3DL.%2BH.%26aulast%3DWan%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DY.%2BJ.%26aulast%3DKung%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BW.%26atitle%3DSARS%2520coronavirus%2520papain-like%2520protease%2520inhibits%2520the%2520TLR7%2520signaling%2520pathway%2520through%2520removing%2520Lys63-linked%2520polyubiquitination%2520of%2520TRAF3%2520and%2520TRAF6%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26issue%3D5%26spage%3D678%26doi%3D10.3390%2Fijms17050678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mielech, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilianski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baez-Santos, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesecar, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, S. C.</span></span> <span> </span><span class="NLM_article-title">MERS-CoV papain-like protease has deISGylating and deubiquitinating activities</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>450–451</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2013.11.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.virol.2013.11.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24503068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450%E2%80%93451&publication_year=2014&pages=64-70&author=A.+M.+Mielechauthor=A.+Kilianskiauthor=Y.+M.+Baez-Santosauthor=A.+D.+Mesecarauthor=S.+C.+Baker&title=MERS-CoV+papain-like+protease+has+deISGylating+and+deubiquitinating+activities&doi=10.1016%2Fj.virol.2013.11.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">MERS-CoV papain-like protease has deISGylating and deubiquitinating activities</span></div><div class="casAuthors">Mielech, Anna M.; Kilianski, Andy; Baez-Santos, Yahira M.; Mesecar, Andrew D.; Baker, Susan C.</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">450-451</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-70</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Coronaviruses encode papain-like proteases (PLpro) that are often multifunctional enzymes with protease activity to process the viral replicase polyprotein and deubiquitinating (DUB)/deISGylating activity, which is hypothesized to modify the innate immune response to infection.  Here, we investigate the predicted DUB activity of the PLpro domain of the recently described Middle East Respiratory Syndrome Coronavirus (MERS-CoV).  We found that expression of MERS-CoV PLpro reduces the levels of ubiquitinated and ISGylated host cell proteins; consistent with multifunctional PLpro activity.  Further, we compared the ability of MERS-CoV PLpro and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) PLpro to block innate immune signaling of proinflammatory cytokines.  We show that expression of SARS-CoV and MERS-CoV PLpros blocks upregulation of cytokines CCL5, IFN-β and CXCL10 in stimulated cells.  Overall these results indicate that the PLpro domains of MERS-CoV and SARS-CoV have the potential to modify the innate immune response to viral infection and contribute to viral pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOR-nvL34lf7Vg90H21EOLACvtfcHk0lj-Mjh9__6glQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGlsLY%253D&md5=ff468bc8c6b5d1e18247a999f6e64555</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2013.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2013.11.040%26sid%3Dliteratum%253Aachs%26aulast%3DMielech%26aufirst%3DA.%2BM.%26aulast%3DKilianski%26aufirst%3DA.%26aulast%3DBaez-Santos%26aufirst%3DY.%2BM.%26aulast%3DMesecar%26aufirst%3DA.%2BD.%26aulast%3DBaker%26aufirst%3DS.%2BC.%26atitle%3DMERS-CoV%2520papain-like%2520protease%2520has%2520deISGylating%2520and%2520deubiquitinating%2520activities%26jtitle%3DVirology%26date%3D2014%26volume%3D450%25E2%2580%2593451%26spage%3D64%26epage%3D70%26doi%3D10.1016%2Fj.virol.2013.11.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuri, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putics, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddell, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziebuhr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, F.</span></span> <span> </span><span class="NLM_article-title">The ADP-ribose-1′’-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1899</span>– <span class="NLM_lpage">1905</span>, <span class="refDoi"> DOI: 10.1099/vir.0.031856-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.031856-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21525212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFektbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2011&pages=1899-1905&issue=8&author=T.+Kuriauthor=K.+K.+Erikssonauthor=A.+Puticsauthor=R.+Zustauthor=E.+J.+Snijderauthor=A.+D.+Davidsonauthor=S.+G.+Siddellauthor=V.+Thielauthor=J.+Ziebuhrauthor=F.+Weber&title=The+ADP-ribose-1%E2%80%B2%E2%80%99-monophosphatase+domains+of+severe+acute+respiratory+syndrome+coronavirus+and+human+coronavirus+229E+mediate+resistance+to+antiviral+interferon+responses&doi=10.1099%2Fvir.0.031856-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">The ADP-ribose-1-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses</span></div><div class="casAuthors">Kuri, Thomas; Eriksson, Klara K.; Putics, Akos; Zuest, Roland; Snijder, Eric J.; Davidson, Andrew D.; Siddell, Stuart G.; Thiel, Volker; Ziebuhr, John; Weber, Friedemann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1899-1905</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Several plus-strand RNA viruses encode proteins contg. macrodomains.  These domains possess ADP-ribose-1''-phosphatase (ADRP) activity and/or bind poly(ADP-ribose), poly(A) or poly(G).  The relevance of these activities in the viral life cycle has not yet been resolved.  Here, the authors report that genetically engineered mutants of severe acute respiratory syndrome coronavirus (SARS-CoV) and human coronavirus 229E (HCoV-229E) expressing ADRP-deficient macrodomains displayed an increased sensitivity to the antiviral effect of alpha interferon compared with their wild-type counterparts.  The data suggest that macrodomain-assocd. ADRP activities may have a role in viral escape from the innate immune responses of the host.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn6DyERvUW47Vg90H21EOLACvtfcHk0lj39jodqLykvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFektbc%253D&md5=b5ff6bf8e1f5f13db6b296de60f18497</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.031856-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.031856-0%26sid%3Dliteratum%253Aachs%26aulast%3DKuri%26aufirst%3DT.%26aulast%3DEriksson%26aufirst%3DK.%2BK.%26aulast%3DPutics%26aufirst%3DA.%26aulast%3DZust%26aufirst%3DR.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26aulast%3DDavidson%26aufirst%3DA.%2BD.%26aulast%3DSiddell%26aufirst%3DS.%2BG.%26aulast%3DThiel%26aufirst%3DV.%26aulast%3DZiebuhr%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DF.%26atitle%3DThe%2520ADP-ribose-1%25E2%2580%25B2%25E2%2580%2599-monophosphatase%2520domains%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520and%2520human%2520coronavirus%2520229E%2520mediate%2520resistance%2520to%2520antiviral%2520interferon%2520responses%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2011%26volume%3D92%26issue%3D8%26spage%3D1899%26epage%3D1905%26doi%3D10.1099%2Fvir.0.031856-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma-Lauer, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo-Lozoya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Brunn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bairad, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermeking, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonhardt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Brunn, A.</span></span> <span> </span><span class="NLM_article-title">p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">E5192</span>– <span class="NLM_lpage">E5201</span>, <span class="refDoi"> DOI: 10.1073/pnas.1603435113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1603435113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27519799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlChsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E5192-E5201&issue=35&author=Y.+Ma-Lauerauthor=J.+Carbajo-Lozoyaauthor=M.+Y.+Heinauthor=M.+A.+Mullerauthor=W.+Dengauthor=J.+Leiauthor=B.+Meyerauthor=Y.+Kusovauthor=B.+von+Brunnauthor=D.+R.+Bairadauthor=S.+Huntenauthor=C.+Drostenauthor=H.+Hermekingauthor=H.+Leonhardtauthor=M.+Mannauthor=R.+Hilgenfeldauthor=A.+von+Brunn&title=p53+down-regulates+SARS+coronavirus+replication+and+is+targeted+by+the+SARS-unique+domain+and+PLpro+via+E3+ubiquitin+ligase+RCHY1&doi=10.1073%2Fpnas.1603435113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1</span></div><div class="casAuthors">Ma-Lauer, Yue; Carbajo-Lozoya, Javier; Hein, Marco Y.; Mueller, Marcel A.; Deng, Wen; Lei, Jian; Meyer, Benjamin; Kusov, Yuri; von Brunn, Brigitte; Bairad, Dev Raj; Huenten, Sabine; Drosten, Christian; Hermeking, Heiko; Leonhardt, Heinrich; Mann, Matthias; Hilgenfeld, Rolf; von Brunn, Albrecht</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">E5192-E5201</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV) has developed strategies to inhibit host immune recognition.  We identify cellular E3 ubiquitin ligase ring-finger and CHY zinc-finger domain-contg. 1 (RCHY1) as an interacting partner of the viral SARS-unique domain (SUD) and papain-like protease (PLpro), and, as a consequence, the involvement of cellular p53 as antagonist of coronaviral replication.  Residues 95-144 of RCHY1 and 389-652 of SUD (SUD-NM) subdomains are crucial for interaction.  Assocn. with SUD increases the stability of RCHY1 and augments RCHY1-mediated ubiquitination as well as degrdn. of p53.  The calcium/calmodulin-dependent protein kinase II delta (CAMK2D), which normally influences RCHY1 stability by phosphorylation, also binds to SUD.  In vivo phosphorylation shows that SUD does not regulate phosphorylation of RCHY1 via CAMK2D.  Similarly to SUD, the PLpros from SARS-CoV, MERS-CoV, and HCoV-NL63 phys. interact with and stabilize RCHY1, and thus trigger degrdn. of endogenous p53.  The SARS-CoV papain-like protease is encoded next to SUD within nonstructural protein 3.  A SUD-PLpro fusion interacts with RCHY1 more intensively and causes stronger p53 degrdn. than SARS-CoV PLpro alone.  We show that p53 inhibits replication of infectious SARS-CoV as well as of replicons and human coronavirus NL63.  Hence, human coronaviruses antagonize the viral inhibitor p53 via stabilizing RCHY1 and promoting RCHY1-mediated p53 degrdn.  SUD functions as an enhancer to strengthen interaction between RCHY1 and nonstructural protein 3, leading to a further increase in in p53 degrdn.  The significance of these findings is that down-regulation of p53 as a major player in antiviral innate immunity provides a long-sought explanation for delayed activities of resp. genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyOwBYxS8GJ7Vg90H21EOLACvtfcHk0lj39jodqLykvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlChsLnL&md5=e31c8dfbb5f7ca89b7e7fa337a8daf0d</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1603435113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1603435113%26sid%3Dliteratum%253Aachs%26aulast%3DMa-Lauer%26aufirst%3DY.%26aulast%3DCarbajo-Lozoya%26aufirst%3DJ.%26aulast%3DHein%26aufirst%3DM.%2BY.%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DB.%26aulast%3DKusov%26aufirst%3DY.%26aulast%3Dvon%2BBrunn%26aufirst%3DB.%26aulast%3DBairad%26aufirst%3DD.%2BR.%26aulast%3DHunten%26aufirst%3DS.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DHermeking%26aufirst%3DH.%26aulast%3DLeonhardt%26aufirst%3DH.%26aulast%3DMann%26aufirst%3DM.%26aulast%3DHilgenfeld%26aufirst%3DR.%26aulast%3Dvon%2BBrunn%26aufirst%3DA.%26atitle%3Dp53%2520down-regulates%2520SARS%2520coronavirus%2520replication%2520and%2520is%2520targeted%2520by%2520the%2520SARS-unique%2520domain%2520and%2520PLpro%2520via%2520E3%2520ubiquitin%2520ligase%2520RCHY1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D35%26spage%3DE5192%26epage%3DE5201%26doi%3D10.1073%2Fpnas.1603435113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil-Cruz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spanier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabouw, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">V’Kovski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habjan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervantes-Barragan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaughan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludewig, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziebuhr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, V.</span></span> <span> </span><span class="NLM_article-title">Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">2</span>), <span class="NLM_elocation-id">e1006195</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1006195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.ppat.1006195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28158275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&issue=2&author=E.+Kindlerauthor=C.+Gil-Cruzauthor=J.+Spanierauthor=Y.+Liauthor=J.+Wilhelmauthor=H.+H.+Rabouwauthor=R.+Zustauthor=M.+Hwangauthor=P.+V%E2%80%99Kovskiauthor=H.+Stalderauthor=S.+Martiauthor=M.+Habjanauthor=L.+Cervantes-Barraganauthor=R.+Elliotauthor=N.+Karlauthor=C.+Gaughanauthor=F.+J.+van+Kuppeveldauthor=R.+H.+Silvermanauthor=M.+Kellerauthor=B.+Ludewigauthor=C.+C.+Bergmannauthor=J.+Ziebuhrauthor=S.+R.+Weissauthor=U.+Kalinkeauthor=V.+Thiel&title=Early+endonuclease-mediated+evasion+of+RNA+sensing+ensures+efficient+coronavirus+replication&doi=10.1371%2Fjournal.ppat.1006195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication</span></div><div class="casAuthors">Kindler, Eveline; Gil-Cruz, Cristina; Spanier, Julia; Li, Yize; Wilhelm, Jochen; Rabouw, Huib H.; Zust, Roland; Hwang, Mihyun; V'kovski, Philip; Stalder, Hanspeter; Marti, Sabrina; Habjan, Matthias; Cervantes-Barragan, Luisa; Elliot, Ruth; Karl, Nadja; Gaughan, Christina; van Kuppeveld, Frank J. M.; Silverman, Robert H.; Keller, Markus; Ludewig, Burkhard; Bergmann, Cornelia C.; Ziebuhr, John; Weiss, Susan R.; Kalinke, Ulrich; Thiel, Volker</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1006195/1-e1006195/26</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Coronaviruses are of veterinary and medical importance and include highly pathogenic zoonotic viruses, such as SARS-CoV and MERS-CoV.  They are known to efficiently evade early innate immune responses, manifesting in almost negligible expression of type-I interferons (IFN-I).  This evasion strategy suggests an evolutionary conserved viral function that has evolved to prevent RNA-based sensing of infection in vertebrate hosts.  Here we show that the coronavirus endonuclease (EndoU) activity is key to prevent early induction of double-stranded RNA (dsRNA) host cell responses.  Replication of EndoU-deficient coronaviruses is greatly attenuated in vivo and severely restricted in primary cells even during the early phase of the infection.  In macrophages we found immediate induction of IFN-I expression and RNase L-mediated breakdown of rRNA.  Accordingly, EndoU-deficient viruses can retain replication only in cells that are deficient in IFN-I expression or sensing, and in cells lacking both RNase L and PKR.  Collectively our results demonstrate that the coronavirus EndoU efficiently prevents simultaneous activation of host cell dsRNA sensors, such as Mda5, OAS and PKR.  The localization of the EndoU activity at the site of viral RNA synthesis-within the replicase complex-suggests that coronaviruses have evolved a viral RNA decay pathway to evade early innate and intrinsic antiviral host cell responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJihv7-Ahq6rVg90H21EOLACvtfcHk0lj39jodqLykvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCqtrvP&md5=12cd5c885b2b147fe10fe55fc5ccd19c</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1006195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1006195%26sid%3Dliteratum%253Aachs%26aulast%3DKindler%26aufirst%3DE.%26aulast%3DGil-Cruz%26aufirst%3DC.%26aulast%3DSpanier%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWilhelm%26aufirst%3DJ.%26aulast%3DRabouw%26aufirst%3DH.%2BH.%26aulast%3DZust%26aufirst%3DR.%26aulast%3DHwang%26aufirst%3DM.%26aulast%3DV%25E2%2580%2599Kovski%26aufirst%3DP.%26aulast%3DStalder%26aufirst%3DH.%26aulast%3DMarti%26aufirst%3DS.%26aulast%3DHabjan%26aufirst%3DM.%26aulast%3DCervantes-Barragan%26aufirst%3DL.%26aulast%3DElliot%26aufirst%3DR.%26aulast%3DKarl%26aufirst%3DN.%26aulast%3DGaughan%26aufirst%3DC.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BH.%26aulast%3DKeller%26aufirst%3DM.%26aulast%3DLudewig%26aufirst%3DB.%26aulast%3DBergmann%26aufirst%3DC.%2BC.%26aulast%3DZiebuhr%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DS.%2BR.%26aulast%3DKalinke%26aufirst%3DU.%26aulast%3DThiel%26aufirst%3DV.%26atitle%3DEarly%2520endonuclease-mediated%2520evasion%2520of%2520RNA%2520sensing%2520ensures%2520efficient%2520coronavirus%2520replication%26jtitle%3DPLoS%2520Pathog.%26date%3D2017%26volume%3D13%26issue%3D2%26doi%3D10.1371%2Fjournal.ppat.1006195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becares, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual-Iglesias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogales, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuniga, S.</span></span> <span> </span><span class="NLM_article-title">Mutagenesis of coronavirus nsp14 reveals its potential role in modulation of the innate immune response</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5399</span>– <span class="NLM_lpage">5414</span>, <span class="refDoi"> DOI: 10.1128/JVI.03259-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.03259-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27009949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFejsbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=5399-5414&issue=11&author=M.+Becaresauthor=A.+Pascual-Iglesiasauthor=A.+Nogalesauthor=I.+Solaauthor=L.+Enjuanesauthor=S.+Zuniga&title=Mutagenesis+of+coronavirus+nsp14+reveals+its+potential+role+in+modulation+of+the+innate+immune+response&doi=10.1128%2FJVI.03259-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Mutagenesis of coronavirus nsp14 reveals its potential role in modulation of the innate immune response</span></div><div class="casAuthors">Becares, Martina; Pascual-Iglesias, Alejandro; Nogales, Aitor; Sola, Isabel; Enjuanes, Luis; Zuniga, Sonia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5399-5414</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Coronavirus (CoV) nonstructural protein 14 (nsp14) is a 60-kDa protein encoded by the replicase gene that is part of the replication-transcription complex.  It is a bifunctional enzyme bearing 3'-to-5' exoribonuclease (ExoN) and guanine-N7-methyltransferase (N7-MTase) activities.  ExoN hydrolyzes single-stranded RNAs and double-stranded RNAs (dsRNAs) and is part of a proofreading system responsible for the high fidelity of CoV replication.  Nsp14 N7-MTase activity is required for viral mRNA cap synthesis and prevents the recognition of viral mRNAs as non-self by the host cell.  In this work, a set of point mutants affecting different motifs within the ExoN domain of nsp14 was generated, using transmissible gastroenteritis virus as a model of Alphacoronavirus.  Mutants lacking ExoN activity were nonviable despite being competent in both viral RNA and protein synthesis.  A specific mutation within zinc finger 1 (ZF-C) led to prodn. of a viable virus with growth and viral RNA synthesis kinetics similar to that of the parental virus.  Mutant recombinant transmissible gastroenteritis virus (TGEV) ZF-C (rTGEV-ZF-C) caused decreased cytopathic effect and apoptosis compared with the wild-type virus and reduced levels of dsRNA accumulation at late times postinfection.  Consequently, the mutant triggered a reduced antiviral response, which was confirmed by evaluating different stages of the dsRNA-induced antiviral pathway.  The expression of β-interferon (IFN-β), tumor necrosis factor (TNF), and interferon-stimulated genes in cells infected with mutant rTGEV-ZF-C was reduced compared to the levels seen with the parental virus.  Overall, our data revealed a potential role for CoV nsp14 in modulation of the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGB3-IxTwnM7Vg90H21EOLACvtfcHk0ljcOatBQG8ILg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFejsbvI&md5=919e9bf908e45df16ca2861e59b252c5</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1128%2FJVI.03259-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.03259-15%26sid%3Dliteratum%253Aachs%26aulast%3DBecares%26aufirst%3DM.%26aulast%3DPascual-Iglesias%26aufirst%3DA.%26aulast%3DNogales%26aufirst%3DA.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DZuniga%26aufirst%3DS.%26atitle%3DMutagenesis%2520of%2520coronavirus%2520nsp14%2520reveals%2520its%2520potential%2520role%2520in%2520modulation%2520of%2520the%2520innate%2520immune%2520response%26jtitle%3DJ.%2520Virol.%26date%3D2016%26volume%3D90%26issue%3D11%26spage%3D5399%26epage%3D5414%26doi%3D10.1128%2FJVI.03259-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenfeld, R.</span></span> <span> </span><span class="NLM_article-title">Accessory proteins of SARS-CoV and other coronaviruses</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2014.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2014.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24995382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Klsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2014&pages=97-109&author=D.+X.+Liuauthor=T.+S.+Fungauthor=K.+K.+Chongauthor=A.+Shuklaauthor=R.+Hilgenfeld&title=Accessory+proteins+of+SARS-CoV+and+other+coronaviruses&doi=10.1016%2Fj.antiviral.2014.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Accessory proteins of SARS-CoV and other coronaviruses</span></div><div class="casAuthors">Liu, Ding Xiang; Fung, To Sing; Chong, Kelvin Kian-Long; Shukla, Aditi; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">97-109</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The huge RNA genome of SARS coronavirus comprises a no. of open reading frames that code for a total of eight accessory proteins.  Although none of these are essential for virus replication, some appear to have a role in virus pathogenesis.  Notably, some SARS-CoV accessory proteins have been shown to modulate the interferon signaling pathways and the prodn. of pro-inflammatory cytokines.  The structural information on these proteins is also limited, with only two (p7a and p9b) having their structures detd. by X-ray crystallog.  This review makes an attempt to summarize the published knowledge on SARS-CoV accessory proteins, with an emphasis on their involvement in virus-host interaction.  The accessory proteins of other coronaviruses are also briefly discussed.  This paper forms part of a series of invited articles in Antiviral Research on "From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses" (see Introduction by Hilgenfeld and Peiris (2013)).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9B_fwxwUQULVg90H21EOLACvtfcHk0ljcOatBQG8ILg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Klsr3M&md5=7e44f77c8b47f5d41e466b7813774c0d</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2014.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2014.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%2BX.%26aulast%3DFung%26aufirst%3DT.%2BS.%26aulast%3DChong%26aufirst%3DK.%2BK.%26aulast%3DShukla%26aufirst%3DA.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DAccessory%2520proteins%2520of%2520SARS-CoV%2520and%2520other%2520coronaviruses%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D109%26spage%3D97%26epage%3D109%26doi%3D10.1016%2Fj.antiviral.2014.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castano-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D. Y.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">8865</span>– <span class="NLM_lpage">8877</span>, <span class="refDoi"> DOI: 10.1096/fj.201802418R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1096%2Ffj.201802418R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31034780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVWnsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=8865-8877&issue=8&author=K.+L.+Siuauthor=K.+S.+Yuenauthor=C.+Castano-Rodriguezauthor=Z.+W.+Yeauthor=M.+L.+Yeungauthor=S.+Y.+Fungauthor=S.+Yuanauthor=C.+P.+Chanauthor=K.+Y.+Yuenauthor=L.+Enjuanesauthor=D.+Y.+Jin&title=Severe+acute+respiratory+syndrome+coronavirus+ORF3a+protein+activates+the+NLRP3+inflammasome+by+promoting+TRAF3-dependent+ubiquitination+of+ASC&doi=10.1096%2Ffj.201802418R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC</span></div><div class="casAuthors">Siu, Kam-Leung; Yuen, Kit-San; Castano-Rodriguez, Carlos; Ye, Zi-Wei; Yeung, Man-Lung; Fung, Sin-Yee; Yuan, Shuofeng; Chan, Chi-Ping; Yuen, Kwok-Yung; Enjuanes, Luis; Jin, Dong-Yan</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">8865-8877</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) is capable of inducing a storm of proinflammatory cytokines.  In this study, we show that the SARS-CoV open reading frame 3a (ORF3a) accessory protein activates the NLRP3 inflammasome by promoting TNF receptor-assocd. factor 3 (TRAF3)-mediated ubiquitination of apoptosis-assocd. speck-like protein contg. a caspase recruitment domain (ASC).  SARS-CoV and its ORF3a protein were found to be potent activators of pro-IL-1b gene transcription and protein maturation, the 2 signals required for activation of the NLRP3 inflammasome.  ORF3a induced pro-IL-1b transcription through activation of NF-kB, which was mediated by TRAF3-dependent ubiquitination and processing of p105.  ORF3a induced elevation of IL-1b secretion was independent of its ion channel activity or absent in melanoma 2 but required NLRP3, ASC, and TRAF3.  ORF3a interacted with TRAF3 and ASC, colocalized with them in discrete punctate structures in the cytoplasm, and facilitated ASC speck formation.  TRAF3-dependent K63-linked ubiquitination of ASC was more pronounced in SARS-CoV-infected cells or when ORF3a was expressed.  Taken together, our findings reveal a new mechanism by which SARS-CoV ORF3a protein activates NF-kB and the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of p105 and ASC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9PzhM5DkKdLVg90H21EOLACvtfcHk0ljcOatBQG8ILg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVWnsLrP&md5=f5b36378f985b3e16047b00a0e5e5bde</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1096%2Ffj.201802418R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201802418R%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DK.%2BL.%26aulast%3DYuen%26aufirst%3DK.%2BS.%26aulast%3DCastano-Rodriguez%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DZ.%2BW.%26aulast%3DYeung%26aufirst%3DM.%2BL.%26aulast%3DFung%26aufirst%3DS.%2BY.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DC.%2BP.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DD.%2BY.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520ORF3a%2520protein%2520activates%2520the%2520NLRP3%2520inflammasome%2520by%2520promoting%2520TRAF3-dependent%2520ubiquitination%2520of%2520ASC%26jtitle%3DFASEB%2520J.%26date%3D2019%26volume%3D33%26issue%3D8%26spage%3D8865%26epage%3D8877%26doi%3D10.1096%2Ffj.201802418R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. W.</span></span> <span> </span><span class="NLM_article-title">Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism</span>. <i>J. Microbiol Immunol Infect</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.1016/j.jmii.2015.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jmii.2015.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26320399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCru7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2017&pages=277-285&issue=3&author=S.+H.+Huangauthor=T.+Y.+Leeauthor=Y.+J.+Linauthor=L.+Wanauthor=C.+H.+Laiauthor=C.+W.+Lin&title=Phage+display+technique+identifies+the+interaction+of+severe+acute+respiratory+syndrome+coronavirus+open+reading+frame+6+protein+with+nuclear+pore+complex+interacting+protein+NPIPB3+in+modulating+Type+I+interferon+antagonism&doi=10.1016%2Fj.jmii.2015.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism</span></div><div class="casAuthors">Huang, Su-Hua; Lee, Tzu-Ying; Lin, Ying-Ju; Wan, Lei; Lai, Chih-Ho; Lin, Cheng-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Microbiology, Immunology and Infection</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">JMIIFG</span>;
        ISSN:<span class="NLM_cas:issn">1995-9133</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Taiwan LLC</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) proteins including ORF6 inhibit type I interferon (IFN) signaling.  This study identified SARS-CoV ORF6-interacting proteins using the phage displayed human lung cDNA libraries, and examd. the assocn. of ORF6-host factor interaction with type I IFN antagonism.  After the fifth round of biopanning with Escherichia coli-synthesized ORF6-His tagged protein, the relative binding affinity of phage clones to ORF6 was detd. using direct ELISA.  The highest affinity clone to ORF6 displayed the C-terminal domain of NPIPB3 (nuclear pore complex interacting protein family member B3, also named as phosphatidylinositol-3-kinase-related kinase SMG-1 isoform 1 homolog).  The coimmunopptn. assay demonstrated the direct binding of ORF6 to the C-terminal domain of NPIPB3 in vitro.  Confocal imaging revealed a close colocalization of SARS-CoV ORF6 protein with NPIPB3 in human promonocytes.  The dual luciferase reporter assay showed that the C-terminal domain of NPIPB3 attenuated the antagonistic activity of SARS-CoV ORF6 on IFN-β-induced ISRE (IFN-stimulated response element)-responsive firefly luciferase activity.  In addn., confocal imaging and Western blotting assays revealed that the increases in STAT-1 nuclear translocation and phosphorylation occurred in the transfected cells expressing both genes of ORF6 and NPIPB3, but not in the ORF6-expressing cells in response to IFN-β.  The overexpression of NPIPB3 restored the IFN-β responses in SARS-CoV ORF6 expressing cells, indicating that the interaction of SARS CoV ORF6 and NPIPB3 reduced type I IFN antagonism by SARS-CoV ORF6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogwBju9yFTQbVg90H21EOLACvtfcHk0lhhQs20Qa2y3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCru7nP&md5=3cd9ce0635d2402fa9bf97467f236f99</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.jmii.2015.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmii.2015.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DT.%2BY.%26aulast%3DLin%26aufirst%3DY.%2BJ.%26aulast%3DWan%26aufirst%3DL.%26aulast%3DLai%26aufirst%3DC.%2BH.%26aulast%3DLin%26aufirst%3DC.%2BW.%26atitle%3DPhage%2520display%2520technique%2520identifies%2520the%2520interaction%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520open%2520reading%2520frame%25206%2520protein%2520with%2520nuclear%2520pore%2520complex%2520interacting%2520protein%2520NPIPB3%2520in%2520modulating%2520Type%2520I%2520interferon%2520antagonism%26jtitle%3DJ.%2520Microbiol%2520Immunol%2520Infect%26date%3D2017%26volume%3D50%26issue%3D3%26spage%3D277%26epage%3D285%26doi%3D10.1016%2Fj.jmii.2015.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabouw, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langereis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaap, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalebout, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bredenbeek, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikkert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J.</span></span> <span> </span><span class="NLM_article-title">Middle East respiratory coronavirus accessory protein 4a inhibits PKR-mediated antiviral stress responses</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">10</span>), <span class="NLM_elocation-id">e1005982</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1005982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.ppat.1005982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27783669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&issue=10&author=H.+H.+Rabouwauthor=M.+A.+Langereisauthor=R.+C.+Knaapauthor=T.+J.+Daleboutauthor=J.+Cantonauthor=I.+Solaauthor=L.+Enjuanesauthor=P.+J.+Bredenbeekauthor=M.+Kikkertauthor=R.+J.+de+Grootauthor=F.+J.+van+Kuppeveld&title=Middle+East+respiratory+coronavirus+accessory+protein+4a+inhibits+PKR-mediated+antiviral+stress+responses&doi=10.1371%2Fjournal.ppat.1005982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Middle East respiratory coronavirus accessory protein 4a inhibits PKR-mediated antiviral stress responses</span></div><div class="casAuthors">Rabouw, Huib H.; Langereis, Martijn A.; Knaap, Robert C. M.; Dalebout, Tim J.; Canton, Javier; Sola, Isabel; Enjuanes, Luis; Bredenbeek, Peter J.; Kikkert, Marjolein; de Groot, Raoul J.; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1005982/1-e1005982/26</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory infections that can be life-threatening.  To establish an infection and spread, MERS-CoV, like most other viruses, must navigate through an intricate network of antiviral host responses.  Besides the well-known type I interferon (IFN-α/β) response, the protein kinase R (PKR)-mediated stress response is being recognized as an important innate response pathway.  Upon detecting viral dsRNA, PKR phosphorylates eIF2α, leading to the inhibition of cellular and viral translation and the formation of stress granules (SGs), which are increasingly recognized as platforms for antiviral signaling pathways.  It is unknown whether cellular infection by MERS-CoV activates the stress response pathway or whether the virus has evolved strategies to suppress this infection-limiting pathway.  Here, we show that cellular infection with MERS-CoV does not lead to the formation of SGs.  By transiently expressing the MERS-CoV accessory proteins individually, we identified a role of protein 4a (p4a) in preventing activation of the stress response pathway.  Expression of MERS-CoV p4a impeded dsRNA-mediated PKR activation, thereby rescuing translation inhibition and preventing SG formation.  In contrast, p4a failed to suppress stress response pathway activation that is independent of PKR and dsRNA.  MERS-CoV p4a is a dsRNA binding protein.  Mutation of the dsRNA binding motif in p4a disrupted its PKR antagonistic activity.  By inserting p4a in a picornavirus lacking its natural PKR antagonist, we showed that p4a exerts PKR antagonistic activity also under infection conditions.  However, a recombinant MERS-CoV deficient in p4a expression still suppressed SG formation, indicating the expression of at least one other stress response antagonist.  This virus also suppressed the dsRNA-independent stress response pathway.  Thus, MERS-CoV interferes with antiviral stress responses using at least two different mechanisms, with p4a suppressing the PKRPLOS dependent stress response pathway, probably by sequestering dsRNA.  MERS-CoV p4a represents the first coronavirus stress response antagonist described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgh_AxI7g1gLVg90H21EOLACvtfcHk0lhhQs20Qa2y3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCmsLg%253D&md5=735e048c05d79a88f9e4a96ae9be8f98</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1005982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1005982%26sid%3Dliteratum%253Aachs%26aulast%3DRabouw%26aufirst%3DH.%2BH.%26aulast%3DLangereis%26aufirst%3DM.%2BA.%26aulast%3DKnaap%26aufirst%3DR.%2BC.%26aulast%3DDalebout%26aufirst%3DT.%2BJ.%26aulast%3DCanton%26aufirst%3DJ.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DBredenbeek%26aufirst%3DP.%2BJ.%26aulast%3DKikkert%26aufirst%3DM.%26aulast%3Dde%2BGroot%26aufirst%3DR.%2BJ.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%26atitle%3DMiddle%2520East%2520respiratory%2520coronavirus%2520accessory%2520protein%25204a%2520inhibits%2520PKR-mediated%2520antiviral%2520stress%2520responses%26jtitle%3DPLoS%2520Pathog.%26date%3D2016%26volume%3D12%26issue%3D10%26doi%3D10.1371%2Fjournal.ppat.1005982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boularan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Asab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelhamer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehrl, J. H.</span></span> <span> </span><span class="NLM_article-title">SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>193</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3080</span>– <span class="NLM_lpage">3089</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1303196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.4049%2Fjimmunol.1303196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25135833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2qur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2014&pages=3080-3089&issue=6&author=C.+S.+Shiauthor=H.+Y.+Qiauthor=C.+Boularanauthor=N.+N.+Huangauthor=M.+Abu-Asabauthor=J.+H.+Shelhamerauthor=J.+H.+Kehrl&title=SARS-coronavirus+open+reading+frame-9b+suppresses+innate+immunity+by+targeting+mitochondria+and+the+MAVS%2FTRAF3%2FTRAF6+signalosome&doi=10.4049%2Fjimmunol.1303196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">SARS-Coronavirus Open Reading Frame-9b Suppresses Innate Immunity by Targeting Mitochondria and the MAVS/TRAF3/TRAF6 Signalosome</span></div><div class="casAuthors">Shi, Chong-Shan; Qi, Hai-Yan; Boularan, Cedric; Huang, Ning-Na; Abu-Asab, Mones; Shelhamer, James H.; Kehrl, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3080-3089</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Coronaviruses (CoV) have recently emerged as potentially serious pathogens that can cause significant human morbidity and death.  The severe acute respiratory syndrome (SARS)-CoV was identified as the etiol. agent of the 2002-2003 international SARS outbreak.  Yet, how SARS evades innate immune responses to cause human disease remains poorly understood.  In this study, we show that a protein encoded by SARS-CoV designated as open reading frame-9b (ORF-9b) localizes to mitochondria and causes mitochondrial elongation by triggering ubiquitination and proteasomal degrdn. of dynamin-like protein 1, a host protein involved in mitochondrial fission.  Also, acting on mitochondria, ORF-9b targets the mitochondrial-assocd. adaptor mol. MAVS signalosome by usurping PCBP2 and the HECT domain E3 ligase AIP4 to trigger the degrdn. of MAVS, TRAF3, and TRAF 6.  This severely limits host cell IFN responses.  Reducing either PCBP2 or AIP4 expression substantially reversed the ORF-9b-mediated redn. of MAVS and the suppression of antiviral transcriptional responses.  Finally, transient ORF-9b expression led to a strong induction of autophagy in cells.  The induction of autophagy depended upon ATG5, a crit. autophagy regulator, but the inhibition of MAVS signaling did not.  These results indicate that SARS-CoV ORF-9b manipulates host cell mitochondria and mitochondrial function to help evade host innate immunity.  This study has uncovered an important clue to the pathogenesis of SARS-CoV infection and illustrates the havoc that a small ORF can cause in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEFurKcfqnO7Vg90H21EOLACvtfcHk0lhhQs20Qa2y3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2qur3E&md5=aaac5ff549aa06a3ea33b419bfaec921</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1303196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1303196%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%2BS.%26aulast%3DQi%26aufirst%3DH.%2BY.%26aulast%3DBoularan%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DN.%2BN.%26aulast%3DAbu-Asab%26aufirst%3DM.%26aulast%3DShelhamer%26aufirst%3DJ.%2BH.%26aulast%3DKehrl%26aufirst%3DJ.%2BH.%26atitle%3DSARS-coronavirus%2520open%2520reading%2520frame-9b%2520suppresses%2520innate%2520immunity%2520by%2520targeting%2520mitochondria%2520and%2520the%2520MAVS%252FTRAF3%252FTRAF6%2520signalosome%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D193%26issue%3D6%26spage%3D3080%26epage%3D3089%26doi%3D10.4049%2Fjimmunol.1303196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span> <span> </span><span class="NLM_article-title">Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor</span>. <i>Virol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1007/s12250-015-3581-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs12250-015-3581-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25907116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsVamtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=153-161&issue=2&author=W.+Chengauthor=S.+Chenauthor=R.+Liauthor=Y.+Chenauthor=M.+Wangauthor=D.+Guo&title=Severe+acute+respiratory+syndrome+coronavirus+protein+6+mediates+ubiquitin-dependent+proteosomal+degradation+of+N-Myc+%28and+STAT%29+interactor&doi=10.1007%2Fs12250-015-3581-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor</span></div><div class="casAuthors">Cheng, Weijia; Chen, Shiyou; Li, Ruiling; Chen, Yu; Wang, Min; Guo, Deyin</div><div class="citationInfo"><span class="NLM_cas:title">Virologica Sinica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-161</span>CODEN:
                <span class="NLM_cas:coden">VSIICH</span>;
        ISSN:<span class="NLM_cas:issn">1674-0769</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) encodes eight accessory proteins, the functions of which are not yet fully understood.  SARS-CoV protein 6 (P6) is one of the previously studied accessory proteins that have been documented to enhance viral replication and suppress host interferon (IFN) signaling pathways.  Through yeast two-hybrid screening, we identified eight potential cellular P6-interacting proteins from a human spleen cDNA library.  For further investigation, we targeted the IFN signaling pathway-mediating protein, N-Myc (and STAT) interactor (Nmi).  Its interaction with P6 was confirmed within cells.  The results showed that P6 can promote the ubiquitin-dependent proteosomal degrdn. of Nmi.  This study revealed a new mechanism of SARS-CoV P6 in limiting the IFN signaling to promote SARS-CoV survival in host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDht5aAI4QWLVg90H21EOLACvtfcHk0liOOAU9JaEV-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsVamtL4%253D&md5=c06c5fdd1d599ddb49b35f99fee71050</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1007%2Fs12250-015-3581-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12250-015-3581-8%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DD.%26atitle%3DSevere%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520protein%25206%2520mediates%2520ubiquitin-dependent%2520proteosomal%2520degradation%2520of%2520N-Myc%2520%2528and%2520STAT%2529%2520interactor%26jtitle%3DVirol.%2520Sin.%26date%3D2015%26volume%3D30%26issue%3D2%26spage%3D153%26epage%3D161%26doi%3D10.1007%2Fs12250-015-3581-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span> <span> </span><span class="NLM_article-title">NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">483</span>, <span class="refDoi"> DOI: 10.1186/s13046-019-1448-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1186%2Fs13046-019-1448-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31805977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitl2ltrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=483&issue=1&author=P.+Xuauthor=S.+Yeauthor=K.+Liauthor=M.+Huangauthor=Q.+Wangauthor=S.+Zengauthor=X.+Chenauthor=W.+Gaoauthor=J.+Chenauthor=Q.+Zhangauthor=Z.+Zhongauthor=Y.+Linauthor=Z.+Rongauthor=Y.+Xuauthor=B.+Haoauthor=A.+Pengauthor=M.+Ouyangauthor=Q.+Liu&title=NOS1+inhibits+the+interferon+response+of+cancer+cells+by+S-nitrosylation+of+HDAC2&doi=10.1186%2Fs13046-019-1448-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2</span></div><div class="casAuthors">Xu, Pengfei; Ye, Shuangyan; Li, Keyi; Huang, Mengqiu; Wang, Qianli; Zeng, Sisi; Chen, Xi; Gao, Wenwen; Chen, Jianping; Zhang, Qianbing; Zhong, Zhuo; Lin, Ying; Rong, Zhili; Xu, Yang; Hao, Bingtao; Peng, Anghui; Ouyang, Manzhao; Liu, Qiuzhen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">483</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">In this study, we investigated the regulation of NOS1 on the interferon response and clarified the relevant mol. mechanisms.  After stable transfection of A375 cells with NOS1 expression plasmids, the transcription and expression of IFNα-stimulated genes (ISGs) were assessed using pISRE luciferase reporter gene anal., RT-PCR, and western blotting, resp.  A biotin-switch assay was performed to detect the S-nitrosylation of HDAC2 by NOS1.  This effect was further evaluated by altering the expression level of HDAC2 or by transfecting the HDAC2-C262A/C274A site mutant plasmids into cells.  The coimmunopptn. assay was performed to detect the interaction of HDAC2 with STAT1 and STAT2.  Overexpression of NOS1 in melanoma cells decreases IFNα-responsiveness and induces the S-nitrosylation of HDAC2-C262/C274.  This modification decreases the binding of HDAC2 with STAT1, thereby reducing the recruitment of HDAC2 to the ISG promoter and the deacetylation of H4K16.  Moreover, expression of a mutant form of HDAC2, which cannot be nitrosylated, reverses the inhibition of ISG expression by NOS1 in vitro and decreases NOS1-induced lung metastasis and inhibition of tumor infiltrating lymphocytes in a melanoma mouse model.  This study provides evidence that NOS1 induces dysfunctional IFN signaling to promote lung metastasis in melanoma, highlighting NOS1-induced S-nitrosylation of HDAC2 in the regulation of IFN signaling via histone modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCu4FXuJSFN7Vg90H21EOLACvtfcHk0liOOAU9JaEV-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitl2ltrzM&md5=2da754594c5f1bd75d20d1b5967a1bfc</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1186%2Fs13046-019-1448-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-019-1448-9%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DP.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DRong%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DA.%26aulast%3DOuyang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DQ.%26atitle%3DNOS1%2520inhibits%2520the%2520interferon%2520response%2520of%2520cancer%2520cells%2520by%2520S-nitrosylation%2520of%2520HDAC2%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2019%26volume%3D38%26issue%3D1%26spage%3D483%26doi%3D10.1186%2Fs13046-019-1448-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span> <span> </span><span class="NLM_article-title">The E3 ubiquitin ligase Nrdp1 ‘preferentially’ promotes TLR-mediated production of type I interferon</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">744</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1038/ni.1742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fni.1742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19483718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1alt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=744-752&issue=7&author=C.+Wangauthor=T.+Chenauthor=J.+Zhangauthor=M.+Yangauthor=N.+Liauthor=X.+Xuauthor=X.+Cao&title=The+E3+ubiquitin+ligase+Nrdp1+%E2%80%98preferentially%E2%80%99+promotes+TLR-mediated+production+of+type+I+interferon&doi=10.1038%2Fni.1742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">The E3 ubiquitin ligase Nrdp1 "preferentially" promotes TLR-mediated production of type I interferon</span></div><div class="casAuthors">Wang, Chen; Chen, Taoyong; Zhang, Jia; Yang, Mingjin; Li, Nan; Xu, Xiongfei; Cao, Xuetao</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">744-752</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases are important in both innate and adaptive immunity.  Here the authors report that Nrdp1, an E3 ubiquitin ligase, inhibited the prodn. of proinflammatory cytokines but increased interferon-β prodn. in Toll-like receptor-triggered macrophages by suppressing adaptor MyD88-dependent activation of transcription factors NF-κB and AP-1 while promoting activation of the kinase TBK1 and transcription factor IRF3.  Nrdp1 directly bound and polyubiquitinated MyD88 and TBK1, which led to degrdn. of MyD88 and activation of TBK1.  Knockdown of Nrdp1 inhibited the degrdn. of MyD88 and the activation of TBK1 and IRF3.  Nrdp1-transgenic mice showed resistance to lipopolysaccharide-induced endotoxin shock and to infection with vesicular stomatitis virus.  Apparently, Nrdp1 functions as both an adaptor protein and an E3 ubiquitin ligase to regulate TLR responses in different ways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgPSbpA3sf0rVg90H21EOLACvtfcHk0liOOAU9JaEV-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1alt7s%253D&md5=4721e0bf029130f74cd8909082d77a54</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1038%2Fni.1742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1742%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DX.%26atitle%3DThe%2520E3%2520ubiquitin%2520ligase%2520Nrdp1%2520%25E2%2580%2598preferentially%25E2%2580%2599%2520promotes%2520TLR-mediated%2520production%2520of%2520type%2520I%2520interferon%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D10%26issue%3D7%26spage%3D744%26epage%3D752%26doi%3D10.1038%2Fni.1742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pucci, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittet, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scadden, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweetser, D. A.</span></span> <span> </span><span class="NLM_article-title">Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-kappaB inflammatory pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1871</span>– <span class="NLM_lpage">1876</span>, <span class="refDoi"> DOI: 10.1073/pnas.1511380113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1511380113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26831087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=1871-1876&issue=7&author=S.+Ramasamyauthor=B.+Saezauthor=S.+Mukhopadhyayauthor=D.+Dingauthor=A.+M.+Ahmedauthor=X.+Chenauthor=F.+Pucciauthor=R.+Yaminauthor=J.+Wangauthor=M.+J.+Pittetauthor=C.+M.+Kelleherauthor=D.+T.+Scaddenauthor=D.+A.+Sweetser&title=Tle1+tumor+suppressor+negatively+regulates+inflammation+in+vivo+and+modulates+NF-kappaB+inflammatory+pathway&doi=10.1073%2Fpnas.1511380113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway</span></div><div class="casAuthors">Ramasamy, Selvi; Saez, Borja; Mukhopadhyay, Subhankar; Ding, Daching; Ahmed, Alwiya M.; Chen, Xi; Pucci, Ferdinando; Yamin, Rae'e; Wang, Jianfeng; Pittet, Mikael J.; Kelleher, Cassandra M.; Scadden, David T.; Sweetser, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1871-1876</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tle1 (transducin-like enhancer of split 1) is a corepressor that interacts with a variety of DNA-binding transcription factors and has been implicated in many cellular functions; however, physiol. studies are limited.  Tle1-deficient Tle1Δ/Δ mice, although grossly normal at birth, exhibit skin defects, lung hypoplasia, severe runting, poor body condition, and early mortality.  Tle1-deficient mice display a chronic inflammatory phenotype with increased expression of inflammatory cytokines and chemokines in the skin, lung, and intestine and increased circulatory IL-6 and G-CSF, along with a hematopoietic shift toward granulocyte macrophage progenitor and myeloid cells.  Tle1-deficient macrophages produce increased inflammatory cytokines in response to Toll-like receptor (TLR) agonists and lipopolysaccharides (LPS), and Tle1-deficient mice display an enhanced inflammatory response to ear skin 12-O-tetradecanoylphorbol-13-acetate treatment.  Loss of Tle1 not only results in increased phosphorylation and activation of proinflammatory NF-κB but also results in decreased Hes1 (hairy and enhancer of split-1), a neg. regulator of inflammation in macrophages.  Furthermore, Tle1-deficient mice exhibit accelerated growth of B6-F10 melanoma xenografts.  The authors' work provides the first in vivo evidence, to the authors' knowledge, that TLE1 is a major counterregulator of inflammation with potential roles in a variety of inflammatory diseases and in cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV9MGdYFsuArVg90H21EOLACvtfcHk0ljxJVMh3F4j8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWhu78%253D&md5=80639dceed8fd33bfd0907be9ad0cff0</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1511380113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1511380113%26sid%3Dliteratum%253Aachs%26aulast%3DRamasamy%26aufirst%3DS.%26aulast%3DSaez%26aufirst%3DB.%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPucci%26aufirst%3DF.%26aulast%3DYamin%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPittet%26aufirst%3DM.%2BJ.%26aulast%3DKelleher%26aufirst%3DC.%2BM.%26aulast%3DScadden%26aufirst%3DD.%2BT.%26aulast%3DSweetser%26aufirst%3DD.%2BA.%26atitle%3DTle1%2520tumor%2520suppressor%2520negatively%2520regulates%2520inflammation%2520in%2520vivo%2520and%2520modulates%2520NF-kappaB%2520inflammatory%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D7%26spage%3D1871%26epage%3D1876%26doi%3D10.1073%2Fpnas.1511380113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lokugamage, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hage, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindewolf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajsbaum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menachery, V. D.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 is sensitive to type I interferon pretreatment</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2020.03.07.982264</span> (accessed 2020-05-31) <span class="refDoi"> DOI: 10.1101/2020.03.07.982264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.03.07.982264" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=K.+G.+Lokugamageauthor=A.+Hageauthor=C.+Schindewolfauthor=R.+Rajsbaumauthor=V.+D.+Menachery&title=SARS-CoV-2+is+sensitive+to+type+I+interferon+pretreatment&doi=10.1101%2F2020.03.07.982264"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1101%2F2020.03.07.982264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.03.07.982264%26sid%3Dliteratum%253Aachs%26aulast%3DLokugamage%26aufirst%3DK.%2BG.%26aulast%3DHage%26aufirst%3DA.%26aulast%3DSchindewolf%26aufirst%3DC.%26aulast%3DRajsbaum%26aufirst%3DR.%26aulast%3DMenachery%26aufirst%3DV.%2BD.%26atitle%3DSARS-CoV-2%2520is%2520sensitive%2520to%2520type%2520I%2520interferon%2520pretreatment%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26doi%3D10.1101%2F2020.03.07.982264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Konno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyanagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span> <span> </span><span class="NLM_article-title">SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2020.05.11.088179</span> (accessed 2020-05-31) <span class="refDoi"> DOI: 10.1101/2020.05.11.088179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.05.11.088179" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+Konnoauthor=I.+Kimuraauthor=K.+Uriuauthor=M.+Fukushiauthor=T.+Irieauthor=Y.+Koyanagiauthor=S.+Nakagawaauthor=K.+Sato&title=SARS-CoV-2+ORF3b+is+a+potent+interferon+antagonist+whose+activity+is+further+increased+by+a+naturally+occurring+elongation+variant&doi=10.1101%2F2020.05.11.088179"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1101%2F2020.05.11.088179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.05.11.088179%26sid%3Dliteratum%253Aachs%26aulast%3DKonno%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DI.%26aulast%3DUriu%26aufirst%3DK.%26aulast%3DFukushi%26aufirst%3DM.%26aulast%3DIrie%26aufirst%3DT.%26aulast%3DKoyanagi%26aufirst%3DY.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DK.%26atitle%3DSARS-CoV-2%2520ORF3b%2520is%2520a%2520potent%2520interferon%2520antagonist%2520whose%2520activity%2520is%2520further%2520increased%2520by%2520a%2520naturally%2520occurring%2520elongation%2520variant%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26doi%3D10.1101%2F2020.05.11.088179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Channappanavar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span> <span> </span><span class="NLM_article-title">Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology</span>. <i>Semin. Immunopathol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1007/s00281-017-0629-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs00281-017-0629-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28466096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntVGquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2017&pages=529-539&issue=5&author=R.+Channappanavarauthor=S.+Perlman&title=Pathogenic+human+coronavirus+infections%3A+causes+and+consequences+of+cytokine+storm+and+immunopathology&doi=10.1007%2Fs00281-017-0629-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology</span></div><div class="casAuthors">Channappanavar, Rudragouda; Perlman, Stanley</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunopathology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">529-539</span>CODEN:
                <span class="NLM_cas:coden">SIEMB7</span>;
        ISSN:<span class="NLM_cas:issn">1863-2297</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Human coronaviruses (hCoVs) can be divided into low pathogenic and highly pathogenic coronaviruses.  The low pathogenic CoVs infect the upper respiratory tract and cause mild, cold-like respiratory illness.  In contrast, highly pathogenic hCoVs such as severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV) predominantly infect lower airways and cause fatal pneumonia.  Severe pneumonia caused by pathogenic hCoVs is often assocd. with rapid virus replication, massive inflammatory cell infiltration and elevated pro-inflammatory cytokine/chemokine responses resulting in acute lung injury (ALI), and acute respiratory distress syndrome (ARDS).  Recent studies in exptl. infected animal strongly suggest a crucial role for virus-induced immunopathol. events in causing fatal pneumonia after hCoV infections.  Here we review the current understanding of how a dysregulated immune response may cause lung immunopathol. leading to deleterious clin. manifestations after pathogenic hCoV infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirTei_9NOcbVg90H21EOLACvtfcHk0ljxJVMh3F4j8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntVGquro%253D&md5=0a03e70c30c8d2f39db0a359f9e2e362</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1007%2Fs00281-017-0629-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00281-017-0629-x%26sid%3Dliteratum%253Aachs%26aulast%3DChannappanavar%26aufirst%3DR.%26aulast%3DPerlman%26aufirst%3DS.%26atitle%3DPathogenic%2520human%2520coronavirus%2520infections%253A%2520causes%2520and%2520consequences%2520of%2520cytokine%2520storm%2520and%2520immunopathology%26jtitle%3DSemin.%2520Immunopathol.%26date%3D2017%26volume%3D39%26issue%3D5%26spage%3D529%26epage%3D539%26doi%3D10.1007%2Fs00281-017-0629-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span> <span> </span><span class="NLM_article-title">Pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection</span>. <i>SSRN</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.2139/ssrn.3527420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.2139%2Fssrn.3527420" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=M.+Yang&title=Pyroptosis%2C+a+potential+pathogenic+mechanism+of+2019-nCoV+infection&doi=10.2139%2Fssrn.3527420"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.2139%2Fssrn.3527420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2139%252Fssrn.3527420%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26atitle%3DPyroptosis%252C%2520a%2520potential%2520pathogenic%2520mechanism%2520of%25202019-nCoV%2520infection%26jtitle%3DSSRN%26date%3D2020%26doi%3D10.2139%2Fssrn.3527420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.H</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, R.Y.T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, V.C.C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, W.H.W</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I.F.N</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.S.W</span></span> <span> </span><span class="NLM_article-title">In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds</span>. <i>J. Clin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1016/j.jcv.2004.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jcv.2004.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15288617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Onurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2004&pages=69-75&issue=1&author=F+Chenauthor=K.H+Chanauthor=Y+Jiangauthor=R.Y.T+Kaoauthor=H.T+Luauthor=K.W+Fanauthor=V.C.C+Chengauthor=W.H.W+Tsuiauthor=I.F.N+Hungauthor=T.S.W+Lee&title=In+vitro+susceptibility+of+10+clinical+isolates+of+SARS+coronavirus+to+selected+antiviral+compounds&doi=10.1016%2Fj.jcv.2004.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds</span></div><div class="casAuthors">Chen, F.; Chan, K. H.; Jiang, Y.; Kao, R. Y. T.; Lu, H. T.; Fan, K. W.; Cheng, V. C. C.; Tsui, W. H. W.; Hung, I. F. N.; Lee, T. S. W.; Guan, Y.; Peiris, J. S. M.; Yuen, K. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-75</span>CODEN:
                <span class="NLM_cas:coden">JCVIFB</span>;
        ISSN:<span class="NLM_cas:issn">1386-6532</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Effective antiviral agents are urgently needed to combat the possible return of severe acute respiratory syndrome (SARS).  Com. antiviral agents and pure chem. compds. extd. from traditional Chinese medicinal herbs were screened against 10 clin. isolates of SARS coronavirus by neutralization tests with confirmation by plaque redn. assays.  Interferon-beta-1a, leukocytic interferon-alpha, ribavirin, lopinavir, rimantadine, baicalin and glycyrrhizin showed antiviral activity.  The two interferons were only active if the cell lines were pre-incubated with the drugs 16 h before viral inoculation.  Results were confirmed by plaque redn. assays.  Antiviral activity varied with the use of different cell lines.  Checkerboard assays for synergy were performed showing combinations of interferon beta-1a or leukocytic interferon-alpha with ribavirin are synergistic.  Since the clin. and toxicity profiles of these agents are well known, they should be considered either singly or in combination for prophylaxis or treatment of SARS in randomized placebo controlled trials in future epidemics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx0935yAiE4LVg90H21EOLACvtfcHk0lh7d_Iwb4xw_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Onurg%253D&md5=157e8ed46e0290359ba28a7211eca170</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1016%2Fj.jcv.2004.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcv.2004.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF%26aulast%3DChan%26aufirst%3DK.H%26aulast%3DJiang%26aufirst%3DY%26aulast%3DKao%26aufirst%3DR.Y.T%26aulast%3DLu%26aufirst%3DH.T%26aulast%3DFan%26aufirst%3DK.W%26aulast%3DCheng%26aufirst%3DV.C.C%26aulast%3DTsui%26aufirst%3DW.H.W%26aulast%3DHung%26aufirst%3DI.F.N%26aulast%3DLee%26aufirst%3DT.S.W%26atitle%3DIn%2520vitro%2520susceptibility%2520of%252010%2520clinical%2520isolates%2520of%2520SARS%2520coronavirus%2520to%2520selected%2520antiviral%2520compounds%26jtitle%3DJ.%2520Clin.%2520Virol.%26date%3D2004%26volume%3D31%26issue%3D1%26spage%3D69%26epage%3D75%26doi%3D10.1016%2Fj.jcv.2004.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenstern, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerr, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinatl, J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>326</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">908</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.11.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.bbrc.2004.11.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15607755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVykurzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2005&pages=905-908&issue=4&author=B.+Morgensternauthor=M.+Michaelisauthor=P.+C.+Baerauthor=H.+W.+Doerrauthor=J.+Cinatl&title=Ribavirin+and+interferon-beta+synergistically+inhibit+SARS-associated+coronavirus+replication+in+animal+and+human+cell+lines&doi=10.1016%2Fj.bbrc.2004.11.128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines</span></div><div class="casAuthors">Morgenstern, Birgit; Michaelis, Martin; Baer, Patrick C.; Doerr, Hans W.; Cinatl, Jindrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">905-908</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Initial in vitro investigations demonstrated type I interferons (IFNs: IFN-α, IFN-β) to inhibit replication of SARS coronavirus (SARS-CoV), but found the nucleoside analog ribavirin ineffective in Vero cells.  In this report, ribavirin was shown to inhibit SARS-CoV replication in five different cell types of animal or human origin at therapeutically achievable concns.  Since clin. anti-SARS-CoV activity of type I interferons or ribavirin is limited, we investigated the combination of IFN-β and ribavirin.  Detn. of the virus yield indicated highly synergistic anti-SARS-CoV action of the combination suggesting the consideration of ribavirin plus IFN-β for the treatment of SARS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptUzigPDhnprVg90H21EOLACvtfcHk0lh7d_Iwb4xw_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVykurzK&md5=938eb92c0e021aea3cb999bb60f5ba6a</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.11.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.11.128%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenstern%26aufirst%3DB.%26aulast%3DMichaelis%26aufirst%3DM.%26aulast%3DBaer%26aufirst%3DP.%2BC.%26aulast%3DDoerr%26aufirst%3DH.%2BW.%26aulast%3DCinatl%26aufirst%3DJ.%26atitle%3DRibavirin%2520and%2520interferon-beta%2520synergistically%2520inhibit%2520SARS-associated%2520coronavirus%2520replication%2520in%2520animal%2520and%2520human%2520cell%2520lines%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D326%26issue%3D4%26spage%3D905%26epage%3D908%26doi%3D10.1016%2Fj.bbrc.2004.11.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Falzarano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okumura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brining, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushmaker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martellaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baseler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benecke, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katze, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munster, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, H.</span></span> <span> </span><span class="NLM_article-title">Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1038/nm.3362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnm.3362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24013700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2ktr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1313-1317&issue=10&author=D.+Falzaranoauthor=E.+de+Witauthor=A.+L.+Rasmussenauthor=F.+Feldmannauthor=A.+Okumuraauthor=D.+P.+Scottauthor=D.+Briningauthor=T.+Bushmakerauthor=C.+Martellaroauthor=L.+Baselerauthor=A.+G.+Beneckeauthor=M.+G.+Katzeauthor=V.+J.+Munsterauthor=H.+Feldmann&title=Treatment+with+interferon-alpha2b+and+ribavirin+improves+outcome+in+MERS-CoV-infected+rhesus+macaques&doi=10.1038%2Fnm.3362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques</span></div><div class="casAuthors">Falzarano, Darryl; de Wit, Emmie; Rasmussen, Angela L.; Feldmann, Friederike; Okumura, Atsushi; Scott, Dana P.; Brining, Doug; Bushmaker, Trenton; Martellaro, Cynthia; Baseler, Laura; Benecke, Arndt G.; Katze, Michael G.; Munster, Vincent J.; Feldmann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1313-1317</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) is of global concern: the virus has caused severe respiratory illness, with 111 confirmed cases and 52 deaths at the time of this article's publication.  Therapeutic interventions have not been evaluated in vivo; thus, patient management relies exclusively on supportive care, which, given the high case-fatality rate, is not highly effective.  The rhesus macaque is the only known model organism for MERS-CoV infection, developing an acute localized to widespread pneumonia with transient clin. disease that recapitulates mild to moderate human MERS-CoV cases.  The combination of interferon-α2b and ribavirin was effective in reducing MERS-CoV replication in vitro; therefore, we initiated this treatment 8 h after inoculation of rhesus macaques.  In contrast to untreated, infected macaques, treated animals did not develop breathing abnormalities and showed no or very mild radiog. evidence of pneumonia.  Moreover, treated animals showed lower levels of systemic (serum) and local (lung) proinflammatory markers, in addn. to fewer viral genome copies, distinct gene expression and less severe histopathol. changes in the lungs.  Taken together, these data suggest that treatment of MERS-CoV infected rhesus macaques with IFN-α2b and ribavirin reduces virus replication, moderates the host response and improves clin. outcome.  As these two drugs are already used in combination in the clinic for other infections, IFN-α2b and ribavirin should be considered for the management of MERS-CoV cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7KRGZlqCpC7Vg90H21EOLACvtfcHk0lh7d_Iwb4xw_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2ktr3J&md5=fa75c7f4bef47ddd13487708188ccb34</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1038%2Fnm.3362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3362%26sid%3Dliteratum%253Aachs%26aulast%3DFalzarano%26aufirst%3DD.%26aulast%3Dde%2BWit%26aufirst%3DE.%26aulast%3DRasmussen%26aufirst%3DA.%2BL.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DOkumura%26aufirst%3DA.%26aulast%3DScott%26aufirst%3DD.%2BP.%26aulast%3DBrining%26aufirst%3DD.%26aulast%3DBushmaker%26aufirst%3DT.%26aulast%3DMartellaro%26aufirst%3DC.%26aulast%3DBaseler%26aufirst%3DL.%26aulast%3DBenecke%26aufirst%3DA.%2BG.%26aulast%3DKatze%26aufirst%3DM.%2BG.%26aulast%3DMunster%26aufirst%3DV.%2BJ.%26aulast%3DFeldmann%26aufirst%3DH.%26atitle%3DTreatment%2520with%2520interferon-alpha2b%2520and%2520ribavirin%2520improves%2520outcome%2520in%2520MERS-CoV-infected%2520rhesus%2520macaques%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26issue%3D10%26spage%3D1313%26epage%3D1317%26doi%3D10.1038%2Fnm.3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span> <span> </span><span class="NLM_article-title">Treatment with Lopinavir/Ritonavir or Interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>212</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1904</span>– <span class="NLM_lpage">1913</span>, <span class="refDoi"> DOI: 10.1093/infdis/jiv392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1093%2Finfdis%2Fjiv392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26198719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVOqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=1904-1913&issue=12&author=J.+F.+Chanauthor=Y.+Yaoauthor=M.+L.+Yeungauthor=W.+Dengauthor=L.+Baoauthor=L.+Jiaauthor=F.+Liauthor=C.+Xiaoauthor=H.+Gaoauthor=P.+Yuauthor=J.+P.+Caiauthor=H.+Chuauthor=J.+Zhouauthor=H.+Chenauthor=C.+Qinauthor=K.+Y.+Yuen&title=Treatment+with+Lopinavir%2FRitonavir+or+Interferon-beta1b+improves+outcome+of+MERS-CoV+infection+in+a+nonhuman+primate+model+of+common+marmoset&doi=10.1093%2Finfdis%2Fjiv392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERSCoV infection in a nonhuman primate model of common marmoset</span></div><div class="casAuthors">Chan, Jasper Fuk-Woo; Yao, Yanfeng; Yeung, Man-Lung; Deng, Wei; Bao, Linlin; Jia, Lilong; Li, Fengdi; Xiao, Chong; Gao, Hong; Yu, Pin; Cai, Jian-Piao; Chu, Hin; Zhou, Jie; Chen, Honglin; Qin, Chuan; Yuen, Kwok-Yung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1904-1913</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe disease in human with an overall case-fatality rate of >35%.  Effective antivirals are crucial for improving the clin. outcome of MERS.  Although a no. of repurposed drugs, convalescent-phase plasma, antiviral peptides, and neutralizing antibodies exhibit anti-MERS-CoV activity in vitro, most are not readily available or have not been evaluated in nonhuman primates.  We assessed 3 repurposed drugs with potent in vitro anti-MERS-CoV activity (mycophenolate mofetil [MMF], lopinavir/ritonavir, and interferon-β1b) in common marmosets with severe disease resembling MERS in humans.  The lopinavir/ritonavir-treated and interferon-β1b-treated animals had better outcome than the untreated animals, with improved clin. (mean clin. scores ↓50.9%-95.0% and ↓wt. loss than the untreated animals), radiol. (minimal pulmonary infiltrates), and pathol. (mild bronchointerstitial pneumonia) findings, and lower mean viral loads in necropsied lung (↓0.59-1.06 log10 copies/glyceraldehyde 3-phosphate dehydrogenase [GAPDH]; P < .050) and extrapulmonary (↓0.11-1.29 log10 copies/GAPDH; P < .050 in kidney) tissues.  In contrast, all MMF-treated animals developed severe and/or fatal disease with higher mean viral loads (↑0.15-0.54 log10 copies/GAPDH) than the untreated animals.  The mortality rate at 36 h postinoculation was 67% (untreated and MMF-treated) vs. 0-33% (lopinavir/ritonavir-treated and interferon-β1b-treated).  Lopinavir/ritonavir and interferon-β1b alone or in combination should be evaluated in clin. trials.  MMF alone may worsen MERS and should not be used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5dKSKmz6KkLVg90H21EOLACvtfcHk0liUFotOoTbmAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVOqtQ%253D%253D&md5=3a46776e71712f1779b3680c890b882d</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiv392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiv392%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DYeung%26aufirst%3DM.%2BL.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DBao%26aufirst%3DL.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DCai%26aufirst%3DJ.%2BP.%26aulast%3DChu%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26atitle%3DTreatment%2520with%2520Lopinavir%252FRitonavir%2520or%2520Interferon-beta1b%2520improves%2520outcome%2520of%2520MERS-CoV%2520infection%2520in%2520a%2520nonhuman%2520primate%2520model%2520of%2520common%2520marmoset%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D212%26issue%3D12%26spage%3D1904%26epage%3D1913%26doi%3D10.1093%2Finfdis%2Fjiv392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hung, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lung, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tso, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shum, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lung, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lie, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">To, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, K. Y.</span></span> <span> </span><span class="NLM_article-title">Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span>,  <span class="NLM_fpage">1695</span>– <span class="NLM_lpage">1704</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)31042-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2931042-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32401715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovFOjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=1695-1704&author=I.+F.+Hungauthor=K.+C.+Lungauthor=E.+Y.+Tsoauthor=R.+Liuauthor=T.+W.+Chungauthor=M.+Y.+Chuauthor=Y.+Y.+Ngauthor=J.+Loauthor=J.+Chanauthor=A.+R.+Tamauthor=H.+P.+Shumauthor=V.+Chanauthor=A.+K.+Wuauthor=K.+M.+Sinauthor=W.+S.+Leungauthor=W.+L.+Lawauthor=D.+C.+Lungauthor=S.+Sinauthor=P.+Yeungauthor=C.+C.+Yipauthor=R.+R.+Zhangauthor=A.+Y.+Fungauthor=E.+Y.+Yanauthor=K.+H.+Leungauthor=J.+D.+Ipauthor=A.+W.+Chuauthor=W.+M.+Chanauthor=A.+C.+Ngauthor=R.+Leeauthor=K.+Fungauthor=A.+Yeungauthor=T.+C.+Wuauthor=J.+W.+Chanauthor=W.+W.+Yanauthor=W.+M.+Chanauthor=J.+F.+Chanauthor=A.+K.+Lieauthor=O.+T.+Tsangauthor=V.+C.+Chengauthor=T.+L.+Queauthor=C.+S.+Lauauthor=K.+H.+Chanauthor=K.+K.+Toauthor=K.+Y.+Yuen&title=Triple+combination+of+interferon+beta-1b%2C+lopinavir-ritonavir%2C+and+ribavirin+in+the+treatment+of+patients+admitted+to+hospital+with+COVID-19%3A+an+open-label%2C+randomised%2C+phase+2+trial&doi=10.1016%2FS0140-6736%2820%2931042-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial</span></div><div class="casAuthors">Hung, Ivan Fan-Ngai; Lung, Kwok-Cheung; Tso, Eugene Yuk-Keung; Liu, Raymond; Chung, Tom Wai-Hin; Chu, Man-Yee; Ng, Yuk-Yung; Lo, Jenny; Chan, Jacky; Tam, Anthony Raymond; Shum, Hoi-Ping; Chan, Veronica; Wu, Alan Ka-Lun; Sin, Kit-Man; Leung, Wai-Shing; Law, Wai-Lam; Lung, David Christopher; Sin, Simon; Yeung, Pauline; Yip, Cyril Chik-Yan; Zhang, Ricky Ruiqi; Fung, Agnes Yim-Fong; Yan, Erica Yuen-Wing; Leung, Kit-Hang; Ip, Jonathan Daniel; Chu, Allen Wing-Ho; Chan, Wan-Mui; Ng, Anthony Chin-Ki; Lee, Rodney; Fung, Kitty; Yeung, Alwin; Wu, Tak-Chiu; Chan, Johnny Wai-Man; Yan, Wing-Wah; Chan, Wai-Ming; Chan, Jasper Fuk-Woo; Lie, Albert Kwok-Wai; Tsang, Owen Tak-Yin; Cheng, Vincent Chi-Chung; Que, Tak-Lun; Lau, Chak-Sing; Chan, Kwok-Hung; To, Kelvin Kai-Wang; Yuen, Kwok-Yung</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10238</span>),
    <span class="NLM_cas:pages">1695-1704</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic.  We assessed the efficacy and safety of combined interferon beta-1b, lopinavir-ritonavir, and ribavirin for treating patients with COVID-19.  This was a multicenter, prospective, open-label, randomized, phase 2 trial in adults with COVID-19 who were admitted to six hospitals in Hong Kong.  Patients were randomly assigned (2:1) to a 14-day combination of lopinavir 400 mg and ritonavir 100 mg every 12 h, ribavirin 400 mg every 12 h, and three doses of 8 million IU of interferon beta-1b on alternate days (combination group) or to 14 days of lopinavir 400 mg and ritonavir 100 mg every 12 h (control group).  The primary endpoint was the time to providing a nasopharyngeal swab neg. for severe acute respiratory syndrome coronavirus 2 RT-PCR, and was done in the intention-to-treat population.  The study is registered with ClinicalTrials.gov, NCT04276688.  Between Feb 10 and March 20, 2020, 127 patients were recruited; 86 were randomly assigned to the combination group and 41 were assigned to the control group.  The median no. of days from symptom onset to start of study treatment was 5 days (IQR 3-7).  The combination group had a significantly shorter median time from start of study treatment to neg. nasopharyngeal swab (7 days [IQR 5-11]) than the control group (12 days [8-15]; hazard ratio 4·37 [95% CI 1·86-10·24], p=0·0010).  Adverse events included self-limited nausea and diarrhea with no difference between the two groups.  One patient in the control group discontinued lopinavir-ritonavir because of biochem. hepatitis.  No patients died during the study.  Early triple antiviral therapy was safe and superior to lopinavir-ritonavir alone in alleviating symptoms and shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19.  Future clin. study of a double antiviral therapy with interferon beta-1b as a backbone is warranted.  The Shaw-Foundation, Richard and Carol Yu, May Tam Mak Mei Yin, and Sanming Project of Medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriJEGOjYCdy7Vg90H21EOLACvtfcHk0liUFotOoTbmAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovFOjsr0%253D&md5=3729ea5b5e707167e9c26296e4ce2dbb</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2931042-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252931042-4%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DI.%2BF.%26aulast%3DLung%26aufirst%3DK.%2BC.%26aulast%3DTso%26aufirst%3DE.%2BY.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DChung%26aufirst%3DT.%2BW.%26aulast%3DChu%26aufirst%3DM.%2BY.%26aulast%3DNg%26aufirst%3DY.%2BY.%26aulast%3DLo%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DA.%2BR.%26aulast%3DShum%26aufirst%3DH.%2BP.%26aulast%3DChan%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DA.%2BK.%26aulast%3DSin%26aufirst%3DK.%2BM.%26aulast%3DLeung%26aufirst%3DW.%2BS.%26aulast%3DLaw%26aufirst%3DW.%2BL.%26aulast%3DLung%26aufirst%3DD.%2BC.%26aulast%3DSin%26aufirst%3DS.%26aulast%3DYeung%26aufirst%3DP.%26aulast%3DYip%26aufirst%3DC.%2BC.%26aulast%3DZhang%26aufirst%3DR.%2BR.%26aulast%3DFung%26aufirst%3DA.%2BY.%26aulast%3DYan%26aufirst%3DE.%2BY.%26aulast%3DLeung%26aufirst%3DK.%2BH.%26aulast%3DIp%26aufirst%3DJ.%2BD.%26aulast%3DChu%26aufirst%3DA.%2BW.%26aulast%3DChan%26aufirst%3DW.%2BM.%26aulast%3DNg%26aufirst%3DA.%2BC.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DFung%26aufirst%3DK.%26aulast%3DYeung%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DT.%2BC.%26aulast%3DChan%26aufirst%3DJ.%2BW.%26aulast%3DYan%26aufirst%3DW.%2BW.%26aulast%3DChan%26aufirst%3DW.%2BM.%26aulast%3DChan%26aufirst%3DJ.%2BF.%26aulast%3DLie%26aufirst%3DA.%2BK.%26aulast%3DTsang%26aufirst%3DO.%2BT.%26aulast%3DCheng%26aufirst%3DV.%2BC.%26aulast%3DQue%26aufirst%3DT.%2BL.%26aulast%3DLau%26aufirst%3DC.%2BS.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DTo%26aufirst%3DK.%2BK.%26aulast%3DYuen%26aufirst%3DK.%2BY.%26atitle%3DTriple%2520combination%2520of%2520interferon%2520beta-1b%252C%2520lopinavir-ritonavir%252C%2520and%2520ribavirin%2520in%2520the%2520treatment%2520of%2520patients%2520admitted%2520to%2520hospital%2520with%2520COVID-19%253A%2520an%2520open-label%252C%2520randomised%252C%2520phase%25202%2520trial%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26spage%3D1695%26epage%3D1704%26doi%3D10.1016%2FS0140-6736%2820%2931042-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mordstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neugebauer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditt, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jessen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorgeloos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwemmle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michiels, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staeheli, P.</span></span> <span> </span><span class="NLM_article-title">Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5670</span>– <span class="NLM_lpage">5677</span>, <span class="refDoi"> DOI: 10.1128/JVI.00272-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FJVI.00272-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=20335250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3cXms1aktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=5670-5677&issue=11&author=M.+Mordsteinauthor=E.+Neugebauerauthor=V.+Dittauthor=B.+Jessenauthor=T.+Riegerauthor=V.+Falconeauthor=F.+Sorgeloosauthor=S.+Ehlauthor=D.+Mayerauthor=G.+Kochsauthor=M.+Schwemmleauthor=S.+Guntherauthor=C.+Drostenauthor=T.+Michielsauthor=P.+Staeheli&title=Lambda+interferon+renders+epithelial+cells+of+the+respiratory+and+gastrointestinal+tracts+resistant+to+viral+infections&doi=10.1128%2FJVI.00272-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections</span></div><div class="casAuthors">Mordstein, Markus; Neugebauer, Eva; Ditt, Vanessa; Jessen, Birthe; Rieger, Toni; Falcone, Valeria; Sorgeloos, Frederic; Ehl, Stephan; Mayer, Daniel; Kochs, Georg; Schwemmle, Martin; Guenther, Stephan; Drosten, Christian; Michiels, Thomas; Staeheli, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5670-5677</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Virus-infected cells secrete a broad range of interferons (IFN) which confer resistance to yet uninfected cells by triggering the synthesis of antiviral factors.  The relative contributions of the various IFN subtypes to innate immunity against virus infections remain elusive.  IFN-α, IFN-β, and other type I IFN mols. signal through a common, universally expressed cell surface receptor, whereas type III IFN (IFN-λ) uses a distinct cell-type-specific receptor complex for signaling.  Using mice lacking functional receptors for type I IFN, type III IFN, or both, we found that IFN-λ plays an important role in the defense against several human pathogens that infect the respiratory tract, such as influenza A virus, influenza B virus, respiratory syncytial virus, human metapneumovirus, and severe acute respiratory syndrome (SARS) coronavirus.  These viruses were more pathogenic and replicated to higher titers in the lungs of mice lacking both IFN receptors than in mice with single IFN receptor defects.  In contrast, Lassa fever virus, which infects via the respiratory tract but primarily replicates in the liver, was not influenced by the IFN-λ receptor defect.  Careful anal. revealed that expression of functional IFN-λ receptor complexes in the lung and intestinal tract is restricted to epithelial cells and a few other, undefined cell types.  Interestingly, we found that SARS coronavirus was present in feces from infected mice lacking receptors for both type I and type III IFN but not in those from mice lacking single receptors, supporting the view that IFN-λ contributes to the control of viral infections in epithelial cells of both respiratory and gastrointestinal tracts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojNv3xmJUl_LVg90H21EOLACvtfcHk0lg-WmNdt5PRww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXms1aktLc%253D&md5=8ac1aae5fb35c311008df99440eb0441</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1128%2FJVI.00272-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00272-10%26sid%3Dliteratum%253Aachs%26aulast%3DMordstein%26aufirst%3DM.%26aulast%3DNeugebauer%26aufirst%3DE.%26aulast%3DDitt%26aufirst%3DV.%26aulast%3DJessen%26aufirst%3DB.%26aulast%3DRieger%26aufirst%3DT.%26aulast%3DFalcone%26aufirst%3DV.%26aulast%3DSorgeloos%26aufirst%3DF.%26aulast%3DEhl%26aufirst%3DS.%26aulast%3DMayer%26aufirst%3DD.%26aulast%3DKochs%26aufirst%3DG.%26aulast%3DSchwemmle%26aufirst%3DM.%26aulast%3DGunther%26aufirst%3DS.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DMichiels%26aufirst%3DT.%26aulast%3DStaeheli%26aufirst%3DP.%26atitle%3DLambda%2520interferon%2520renders%2520epithelial%2520cells%2520of%2520the%2520respiratory%2520and%2520gastrointestinal%2520tracts%2520resistant%2520to%2520viral%2520infections%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26issue%3D11%26spage%3D5670%26epage%3D5677%26doi%3D10.1128%2FJVI.00272-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahlakoiv, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeDiego, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drosten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staeheli, P.</span></span> <span> </span><span class="NLM_article-title">Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2601</span>– <span class="NLM_lpage">2605</span>, <span class="refDoi"> DOI: 10.1099/vir.0.046284-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.046284-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=22956738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVWisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2012&pages=2601-2605&issue=12&author=T.+Mahlakoivauthor=D.+Ritzauthor=M.+Mordsteinauthor=M.+L.+DeDiegoauthor=L.+Enjuanesauthor=M.+A.+Mullerauthor=C.+Drostenauthor=P.+Staeheli&title=Combined+action+of+type+I+and+type+III+interferon+restricts+initial+replication+of+severe+acute+respiratory+syndrome+coronavirus+in+the+lung+but+fails+to+inhibit+systemic+virus+spread&doi=10.1099%2Fvir.0.046284-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread</span></div><div class="casAuthors">Mahlakoiv, Tanel; Ritz, Daniel; Mordstein, Markus; DeDiego, Marta L.; Enjuanes, Luis; Mueller, Marcel A.; Drosten, Christian; Staeheli, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2601-2605</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">STAT1-deficient mice are more susceptible to infection with severe acute respiratory syndrome coronavirus (SARS-CoV) than type I interferon (IFN) receptor-deficient mice.  We used mice lacking functional receptors for both type I and type III IFN (double knockout, dKO) to evaluate the possibility that type III IFN plays a decisive role in SARS-CoV protection.  We found that viral peak titers in lungs of dKO and STAT1-deficient mice were similar, but significantly higher than in wild-type mice.  The kinetics of viral clearance from the lung were also comparable in dKO and STAT1-deficient mice.  Surprisingly, however, infected dKO mice remained healthy, whereas infected STAT1-deficient mice developed liver pathol. and eventually succumbed to neurol. disease.  Our data suggest that the failure of STAT1-deficient mice to control initial SARS-CoV replication efficiently in the lung is due to impaired type I and type III IFN signalling, whereas the failure to control subsequent systemic viral spread is due to unrelated defects in STAT1-deficient mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVs0kbieLFibVg90H21EOLACvtfcHk0lg-WmNdt5PRww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVWisg%253D%253D&md5=7ca5ee98b8d50b328f8a25ad86dc3970</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.046284-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.046284-0%26sid%3Dliteratum%253Aachs%26aulast%3DMahlakoiv%26aufirst%3DT.%26aulast%3DRitz%26aufirst%3DD.%26aulast%3DMordstein%26aufirst%3DM.%26aulast%3DDeDiego%26aufirst%3DM.%2BL.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DDrosten%26aufirst%3DC.%26aulast%3DStaeheli%26aufirst%3DP.%26atitle%3DCombined%2520action%2520of%2520type%2520I%2520and%2520type%2520III%2520interferon%2520restricts%2520initial%2520replication%2520of%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%2520in%2520the%2520lung%2520but%2520fails%2520to%2520inhibit%2520systemic%2520virus%2520spread%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2012%26volume%3D93%26issue%3D12%26spage%3D2601%26epage%3D2605%26doi%3D10.1099%2Fvir.0.046284-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span> <span> </span><span class="NLM_article-title">Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia</span>. <i>Signal Transduct Target Ther</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">18</span>, <span class="refDoi"> DOI: 10.1038/s41392-020-0127-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fs41392-020-0127-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32296012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB38zlsl2itw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2020&pages=18&issue=1&author=W.+Zhouauthor=Y.+Liuauthor=D.+Tianauthor=C.+Wangauthor=S.+Wangauthor=J.+Chengauthor=M.+Huauthor=M.+Fangauthor=Y.+Gao&title=Potential+benefits+of+precise+corticosteroids+therapy+for+severe+2019-nCoV+pneumonia&doi=10.1038%2Fs41392-020-0127-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia</span></div><div class="casAuthors">Zhou Wei; Gao Yue; Liu Yisi; Tian Dongdong; Wang Cheng; Wang Sa; Cheng Jing; Hu Ming; Fang Minghao</div><div class="citationInfo"><span class="NLM_cas:title">Signal transduction and targeted therapy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRJP91n08onw_6AExegM5LLfW6udTcc2eYgMVTj7MK3wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38zlsl2itw%253D%253D&md5=44f46586d789976a4c059526e9030037</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1038%2Fs41392-020-0127-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41392-020-0127-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DY.%26atitle%3DPotential%2520benefits%2520of%2520precise%2520corticosteroids%2520therapy%2520for%2520severe%25202019-nCoV%2520pneumonia%26jtitle%3DSignal%2520Transduct%2520Target%2520Ther%26date%3D2020%26volume%3D5%26issue%3D1%26spage%3D18%26doi%3D10.1038%2Fs41392-020-0127-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span> <span> </span><span class="NLM_article-title">On the use of corticosteroids for 2019-nCoV pneumonia</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>395</i></span> (<span class="NLM_issue">10225</span>),  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">684</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(20)30361-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS0140-6736%2820%2930361-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32122468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtVarsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=395&publication_year=2020&pages=683-684&issue=10225&author=L.+Shangauthor=J.+Zhaoauthor=Y.+Huauthor=R.+Duauthor=B.+Cao&title=On+the+use+of+corticosteroids+for+2019-nCoV+pneumonia&doi=10.1016%2FS0140-6736%2820%2930361-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">On the use of corticosteroids for 2019-nCoV pneumonia</span></div><div class="casAuthors">Shang, Lianhan; Zhao, Jianping; Hu, Yi; Du, Ronghui; Cao, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">395</span>
        (<span class="NLM_cas:issue">10225</span>),
    <span class="NLM_cas:pages">683-684</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review discussing use of corticosteroids for 2019-nCoV pneumonia.  It also discusses liberal use of corticosteroids is not recommend but low dose is advisable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq02_7GcA2c8bVg90H21EOLACvtfcHk0ljqEkphVwXDjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtVarsbY%253D&md5=de66bbea0c31e3985b7c241bf87288ad</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2820%2930361-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252820%252930361-5%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DB.%26atitle%3DOn%2520the%2520use%2520of%2520corticosteroids%2520for%25202019-nCoV%2520pneumonia%26jtitle%3DLancet%26date%3D2020%26volume%3D395%26issue%3D10225%26spage%3D683%26epage%3D684%26doi%3D10.1016%2FS0140-6736%2820%2930361-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, K.</span></span> <span> </span><span class="NLM_article-title">Tocilizumab treatment in severe COVID-19 patients attenuates the inflammatory storm incited by monocyte centric immune interactions revealed by single-cell analysis</span>. <i>bioRxiv Preprint</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="NLM_elocation-id">2020.04.08.029769</span> (accessed 2020-05-30) <span class="refDoi"> DOI: 10.1101/2020.04.08.029769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1101%2F2020.04.08.029769" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=C.+Guoauthor=B.+Liauthor=H.+Maauthor=X.+Wangauthor=P.+Caiauthor=Q.+Yuauthor=L.+Zhuauthor=L.+Jinauthor=C.+Jiangauthor=J.+Fangauthor=Q.+Liuauthor=D.+Zongauthor=W.+Zhangauthor=Y.+Luauthor=K.+Liauthor=X.+Gaoauthor=B.+Fuauthor=L.+Liuauthor=X.+Maauthor=J.+Wengauthor=H.+Weiauthor=T.+Jinauthor=J.+Linauthor=K.+Qu&title=Tocilizumab+treatment+in+severe+COVID-19+patients+attenuates+the+inflammatory+storm+incited+by+monocyte+centric+immune+interactions+revealed+by+single-cell+analysis&doi=10.1101%2F2020.04.08.029769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1101%2F2020.04.08.029769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F2020.04.08.029769%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZong%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DWeng%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DK.%26atitle%3DTocilizumab%2520treatment%2520in%2520severe%2520COVID-19%2520patients%2520attenuates%2520the%2520inflammatory%2520storm%2520incited%2520by%2520monocyte%2520centric%2520immune%2520interactions%2520revealed%2520by%2520single-cell%2520analysis%26jtitle%3DbioRxiv%2520Preprint%26date%3D2020%26doi%3D10.1101%2F2020.04.08.029769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koretzky, G. A.</span></span> <span> </span><span class="NLM_article-title">Review: Cytokine storm syndrome: Looking toward the precision medicine era</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1135</span>– <span class="NLM_lpage">1143</span>, <span class="refDoi"> DOI: 10.1002/art.40071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fart.40071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28217930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC1c3os1Gmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2017&pages=1135-1143&issue=6&author=E.+M.+Behrensauthor=G.+A.+Koretzky&title=Review%3A+Cytokine+storm+syndrome%3A+Looking+toward+the+precision+medicine+era&doi=10.1002%2Fart.40071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era</span></div><div class="casAuthors">Behrens Edward M; Koretzky Gary A</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & rheumatology (Hoboken, N.J.)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1135-1143</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlE2jpru5mMnRxY89Cm6SyfW6udTcc2ebP6HPqRVeXR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3os1Gmtg%253D%253D&md5=956cf037eb1f6804f6c9fe70e66c4401</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1002%2Fart.40071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.40071%26sid%3Dliteratum%253Aachs%26aulast%3DBehrens%26aufirst%3DE.%2BM.%26aulast%3DKoretzky%26aufirst%3DG.%2BA.%26atitle%3DReview%253A%2520Cytokine%2520storm%2520syndrome%253A%2520Looking%2520toward%2520the%2520precision%2520medicine%2520era%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2017%26volume%3D69%26issue%3D6%26spage%3D1135%26epage%3D1143%26doi%3D10.1002%2Fart.40071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimabukuro-Vornhagen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subklewe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stemmler, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlosser, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlaak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochanek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boll, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Bergwelt-Baildon, M. S.</span></span> <span> </span><span class="NLM_article-title">Cytokine release syndrome</span>. <i>J. Immunother. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">56</span>, <span class="refDoi"> DOI: 10.1186/s40425-018-0343-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1186%2Fs40425-018-0343-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29907163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC1Mbnslylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=56&issue=1&author=A.+Shimabukuro-Vornhagenauthor=P.+Godelauthor=M.+Subkleweauthor=H.+J.+Stemmlerauthor=H.+A.+Schlosserauthor=M.+Schlaakauthor=M.+Kochanekauthor=B.+Bollauthor=M.+S.+von+Bergwelt-Baildon&title=Cytokine+release+syndrome&doi=10.1186%2Fs40425-018-0343-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine release syndrome</span></div><div class="casAuthors">Shimabukuro-Vornhagen Alexander; Godel Philipp; Schlosser Hans Anton; von Bergwelt-Baildon Michael S; Shimabukuro-Vornhagen Alexander; Godel Philipp; Kochanek Matthias; Boll Boris; Shimabukuro-Vornhagen Alexander; Godel Philipp; Kochanek Matthias; Boll Boris; Shimabukuro-Vornhagen Alexander; Kochanek Matthias; Boll Boris; von Bergwelt-Baildon Michael S; Subklewe Marion; Stemmler Hans Joachim; von Bergwelt-Baildon Michael S; Subklewe Marion; Subklewe Marion; von Bergwelt-Baildon Michael S; Subklewe Marion; Stemmler Hans Joachim; von Bergwelt-Baildon Michael S; Schlosser Hans Anton; Schlaak Max</div><div class="citationInfo"><span class="NLM_cas:title">Journal for immunotherapy of cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the last decade the field of cancer immunotherapy has witnessed impressive progress.  Highly effective immunotherapies such as immune checkpoint inhibition, and T-cell engaging therapies like bispecific T-cell engaging (BiTE) single-chain antibody constructs and chimeric antigen receptor (CAR) T cells have shown remarkable efficacy in clinical trials and some of these agents have already received regulatory approval.  However, along with growing experience in the clinical application of these potent immunotherapeutic agents comes the increasing awareness of their inherent and potentially fatal adverse effects, most notably the cytokine release syndrome (CRS).  This review provides a comprehensive overview of the mechanisms underlying CRS pathophysiology, risk factors, clinical presentation, differential diagnoses, and prognostic factors.  In addition, based on the current evidence we give practical guidance to the management of the cytokine release syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRG6qqRA8_CemlSCSgBhwJFfW6udTcc2eaLLOtS65XUCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mbnslylsg%253D%253D&md5=84052edc102063547e56efa00969765b</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1186%2Fs40425-018-0343-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40425-018-0343-9%26sid%3Dliteratum%253Aachs%26aulast%3DShimabukuro-Vornhagen%26aufirst%3DA.%26aulast%3DGodel%26aufirst%3DP.%26aulast%3DSubklewe%26aufirst%3DM.%26aulast%3DStemmler%26aufirst%3DH.%2BJ.%26aulast%3DSchlosser%26aufirst%3DH.%2BA.%26aulast%3DSchlaak%26aufirst%3DM.%26aulast%3DKochanek%26aufirst%3DM.%26aulast%3DBoll%26aufirst%3DB.%26aulast%3Dvon%2BBergwelt-Baildon%26aufirst%3DM.%2BS.%26atitle%3DCytokine%2520release%2520syndrome%26jtitle%3DJ.%2520Immunother.%2520Cancer%26date%3D2018%26volume%3D6%26issue%3D1%26spage%3D56%26doi%3D10.1186%2Fs40425-018-0343-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todorov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandeel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span> <span> </span><span class="NLM_article-title">HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4796</span>– <span class="NLM_lpage">4801</span>, <span class="refDoi"> DOI: 10.1073/pnas.0712051105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.0712051105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18347343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlSrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=4796-4801&issue=12&author=N.+Liauthor=D.+Zhaoauthor=M.+Kirschbaumauthor=C.+Zhangauthor=C.+L.+Linauthor=I.+Todorovauthor=F.+Kandeelauthor=S.+Formanauthor=D.+Zeng&title=HDAC+inhibitor+reduces+cytokine+storm+and+facilitates+induction+of+chimerism+that+reverses+lupus+in+anti-CD3+conditioning+regimen&doi=10.1073%2Fpnas.0712051105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen</span></div><div class="casAuthors">Li, Nainong; Zhao, Dongchang; Kirschbaum, Mark; Zhang, Chunyan; Lin, Chia-Lei; Todorov, Ivan; Kandeel, Fouad; Forman, Stephen; Zeng, Defu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4796-4801</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In allogeneic hematopoietic cell transplantation (HCT), donor T cell-mediated graft vs. host leukemia (GVL) and graft vs. autoimmune (GVA) activity play crit. roles in treatment of hematol. malignancies and refractory autoimmune diseases.  However, graft vs. host disease (GVHD), which sometimes can be fatal, remains a major obstacle in classical HCT, where recipients are conditioned with total body irradn. or high-dose chemotherapy.  We previously reported that anti-CD3 conditioning allows donor CD8+ T cells to facilitate engraftment and mediate GVL without causing GVHD.  However, the clin. application of this radiation-free and GVHD preventative conditioning regimen is hindered by the cytokine storm syndrome triggered by anti-CD3 and the high-dose donor bone marrow (BM) cells required for induction of chimerism.  Histone deacetylase (HDAC) inhibitors such as suberoylanilide hydroxamic acid (SAHA) are known to induce apoptosis of cancer cells and reduce prodn. of proinflammatory cytokines by nonmalignant cells.  Here, we report that SAHA inhibits the proliferative and cytotoxic activity of anti-CD3-activated T cells.  Administration of low-dose SAHA reduces cytokine prodn. and ameliorates the cytokine storm syndrome triggered by anti-CD3.  Conditioning with anti-CD3 and SAHA allows induction of chimerism with lower doses of donor BM cells in old nonautoimmune and autoimmune lupus mice.  In addn., conditioning with anti-CD3 and SAHA allows donor CD8+ T cell-mediated GVA activity to reverse lupus glomerulonephritis without causing GVHD.  These results indicate that conditioning with anti-CD3 and HDAC inhibitors represent a radiation-free and GVHD-preventative regimen with clin. application potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqamfEM1QBw77Vg90H21EOLACvtfcHk0lgKYHyqggXDyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlSrt70%253D&md5=5323fe693943d494e4d3775b9477469a</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0712051105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0712051105%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DKirschbaum%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DTodorov%26aufirst%3DI.%26aulast%3DKandeel%26aufirst%3DF.%26aulast%3DForman%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DD.%26atitle%3DHDAC%2520inhibitor%2520reduces%2520cytokine%2520storm%2520and%2520facilitates%2520induction%2520of%2520chimerism%2520that%2520reverses%2520lupus%2520in%2520anti-CD3%2520conditioning%2520regimen%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26issue%3D12%26spage%3D4796%26epage%3D4801%26doi%3D10.1073%2Fpnas.0712051105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlford-Lenane, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnihothram, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, M. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baric, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enjuanes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCray, P. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlman, S.</span></span> <span> </span><span class="NLM_article-title">Rapid generation of a mouse model for Middle East respiratory syndrome</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4970</span>– <span class="NLM_lpage">4975</span>, <span class="refDoi"> DOI: 10.1073/pnas.1323279111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1073%2Fpnas.1323279111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24599590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsFGrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=4970-4975&issue=13&author=J.+Zhaoauthor=K.+Liauthor=C.+Wohlford-Lenaneauthor=S.+S.+Agnihothramauthor=C.+Fettauthor=J.+Zhaoauthor=M.+J.+Galeauthor=R.+S.+Baricauthor=L.+Enjuanesauthor=T.+Gallagherauthor=P.+B.+McCrayauthor=S.+Perlman&title=Rapid+generation+of+a+mouse+model+for+Middle+East+respiratory+syndrome&doi=10.1073%2Fpnas.1323279111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid generation of a mouse model for Middle East respiratory syndrome</span></div><div class="casAuthors">Zhao, Jincun; Li, Kun; Wohlford-Lenane, Christine; Agnihothram, Sudhakar S.; Fett, Craig; Zhao, Jingxian; Gale, Michael J., Jr.; Baric, Ralph S.; Enjuanes, Luis; Gallagher, Tom; McCray, Paul B., Jr.; Perlman, Stanley</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4970-4975</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In this era of continued emergence of zoonotic virus infections, the rapid development of rodent models represents a crit. barrier to public health preparedness, including the testing of antivirus therapy and vaccines.  The Middle East respiratory syndrome coronavirus (MERS-CoV) was recently identified as the causative agent of a severe pneumonia.  Given the ability of coronavirus to rapidly adapt to new hosts, a major public health concern is that MERS-CoV will further adapt to replication in humans, triggering a pandemic.  No small-animal model for this infection is currently available, but studies suggest that virus entry factors can confer virus susceptibility.  Here, we show that mice were sensitized to MERS-CoV infection by prior transduction with adenoviral vectors expressing the human host-cell receptor dipeptidyl peptidase 4.  Mice developed a pneumonia characterized by extensive inflammatory-cell infiltration with virus clearance occurring 6-8 d after infection.  Clin. disease and histopathol. changes were more severe in the absence of type-I IFN signaling whereas the T-cell response was required for virus clearance.  Using these mice, we demonstrated the efficacy of a therapeutic intervention (poly I:C) and a potential vaccine [Venezuelan equine encephalitis replicon particles expressing MERS-CoV spike protein].  We also found little protective cross-reactivity between MERS-CoV and the severe acute respiratory syndrome-CoV.  Our results demonstrate that this system will be useful for MERS-CoV studies and for the rapid development of relevant animal models for emerging respiratory viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLfnfP41n0L7Vg90H21EOLACvtfcHk0lgKYHyqggXDyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsFGrsb4%253D&md5=ad32a7a980d59b20056f45e569d5b1d5</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1323279111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1323279111%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DWohlford-Lenane%26aufirst%3DC.%26aulast%3DAgnihothram%26aufirst%3DS.%2BS.%26aulast%3DFett%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DGale%26aufirst%3DM.%2BJ.%26aulast%3DBaric%26aufirst%3DR.%2BS.%26aulast%3DEnjuanes%26aufirst%3DL.%26aulast%3DGallagher%26aufirst%3DT.%26aulast%3DMcCray%26aufirst%3DP.%2BB.%26aulast%3DPerlman%26aufirst%3DS.%26atitle%3DRapid%2520generation%2520of%2520a%2520mouse%2520model%2520for%2520Middle%2520East%2520respiratory%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D13%26spage%3D4970%26epage%3D4975%26doi%3D10.1073%2Fpnas.1323279111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, J. F.</span></span> <span> </span><span class="NLM_article-title">Nitazoxanide: a first-in-class broad-spectrum antiviral agent</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2014.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2014.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25108173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleisL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2014&pages=94-103&author=J.+F.+Rossignol&title=Nitazoxanide%3A+a+first-in-class+broad-spectrum+antiviral+agent&doi=10.1016%2Fj.antiviral.2014.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Nitazoxanide: A first-in-class broad-spectrum antiviral agent</span></div><div class="casAuthors">Rossignol, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-103</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza.  A Phase 2b/3 clin. trial recently published in The Lancet Infectious Diseases found that oral administration of nitazoxanide 600 mg twice daily for five days reduced the duration of clin. symptoms and reduced viral shedding compared to placebo in persons with lab.-confirmed influenza.  The same study also suggested a potential benefit for subjects with influenza-like illness who did not have influenza or other documented respiratory viral infection.  From a chem. perspective, nitazoxanide is the scaffold for a new class of drugs called thiazolides.  These small-mol. drugs target host-regulated processes involved in viral replication.  Nitazoxanide is orally bioavailable and safe with extensive post-marketing experience involving more than 75 million adults and children.  A new dosage formulation of nitazoxanide is presently undergoing global Phase 3 clin. development for the treatment of influenza.  Nitazoxanide inhibits a broad range of influenza A and B viruses including influenza A(pH1N1) and the avian A(H7N9) as well as viruses that are resistant to neuraminidase inhibitors.  It is synergistic with neuraminidase inhibitors, and combination therapy with oseltamivir is being studied in humans as part of ongoing Phase 3 clin. development.  Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, coronavirus, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, Japanese encephalitis virus and human immunodeficiency virus in cell culture assays.  Clin. trials have indicated a potential role for thiazolides in treating rotavirus and norovirus gastroenteritis and chronic hepatitis B and chronic hepatitis C.  Ongoing and future clin. development is focused on viral respiratory infections, viral gastroenteritis and emerging infections such as dengue fever.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_XyG4B6HlO7Vg90H21EOLACvtfcHk0ljQPyqZApk-uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleisL%252FK&md5=12dd8a143876626fc31303da2c5f24c4</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2014.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2014.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DRossignol%26aufirst%3DJ.%2BF.%26atitle%3DNitazoxanide%253A%2520a%2520first-in-class%2520broad-spectrum%2520antiviral%2520agent%26jtitle%3DAntiviral%2520Res.%26date%3D2014%26volume%3D110%26spage%3D94%26epage%3D103%26doi%3D10.1016%2Fj.antiviral.2014.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haffizulla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resnick, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samudrala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginocchio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, J.-F.</span></span> <span> </span><span class="NLM_article-title">Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(14)70717-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2FS1473-3099%2814%2970717-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24852376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFamsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=609-618&issue=7&author=J.+Haffizullaauthor=A.+Hartmanauthor=M.+Hoppersauthor=H.+Resnickauthor=S.+Samudralaauthor=C.+Ginocchioauthor=M.+Bardinauthor=J.-F.+Rossignol&title=Effect+of+nitazoxanide+in+adults+and+adolescents+with+acute+uncomplicated+influenza%3A+a+double-blind%2C+randomised%2C+placebo-controlled%2C+phase+2b%2F3+trial&doi=10.1016%2FS1473-3099%2814%2970717-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial</span></div><div class="casAuthors">Haffizulla, Jason; Hartman, Aaron; Hoppers, Melanie; Resnick, Harvey; Samudrala, Steve; Ginocchio, Christine; Bardin, Matthew; Rossignol, Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">609-618</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Influenza is an important cause of morbidity and mortality worldwide.  Treatment options are scarce, and new drugs with novel mechanisms of action are needed.  We aimed to assess the efficacy and safety of nitazoxanide, a thiazolide anti-infective, for treatment of acute uncomplicated influenza.  We did a double-blind, randomised, placebo-controlled, phase 2b/3 trial in 74 primary care clinics in the USA between Dec 27, 2010, and Apr. 30, 2011.  We enrolled participants aged 12-65 years with fever, at least one respiratory symptom, and one constitutional symptom of influenza within 48 h of symptom onset.  We randomly assigned participants to receive either nitazoxanide 600 mg, nitazoxanide 300 mg, or placebo twice daily for 5 days, (ratio 1:1:1) and followed them up for 28 days.  Randomisation lists were computer generated and done in blocks of three.  Sponsor, investigators, study monitors, patients, and lab. personnel were all masked to treatment allocation in the study.  The primary endpoint was the time from first dose to alleviation of symptoms.  The primary anal. was by intention-to-treat for participants with influenza infection confirmed by RT-PCR or culture at baseline.  This trial is registered with ClinicalTrials.gov, no. NCT01227421.Of 650 participants screened, 624 (96%) were enrolled.  Of these, 212 were randomly assigned to receive placebo twice a day, 201 to receive nitazoxanide 300 mg twice a day, and 211 to receive nitazoxanide 600 mg a day.  The median duration of symptoms for participants receiving placebo was 116·7 h (95% CI 108·1-122·1) compared with 95·5 h (84·0-108·0; p=0·0084) for those receiving 600 mg nitazoxanide and 109·1 h (96·1-129·5, p=0·52) for those receiving 300 mg nitazoxanide.  Adverse events were similar between the three groups, the most common being headache reported by 24 (11%) of 212 patients enrolled in placebo group, 12 (6%) of 201 patients in the low-dose group, and 17 (8%) of 211 patients in the high-dose group, or diarrhoea, reported by seven (3%) patients in the placebo group, four (2%) patients enrolled in the low-dose group, and 17 (8%) patients in the high-dose group.  Treatment with nitazoxanide 600 mg twice daily for 5 days was assocd. with a redn. of the duration of symptoms in participants with acute uncomplicated influenza.  Further studies are warranted to confirm these findings and to assess efficacy of the drug alone or in combination with existing drugs in seriously ill patients and those at risk of influenza complications.  Romark Labs. LC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZqUjE_Nmo_7Vg90H21EOLACvtfcHk0ljQPyqZApk-uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFamsLs%253D&md5=fa49c09ee5706e17ca6c92dc3f15bead</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2814%2970717-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252814%252970717-0%26sid%3Dliteratum%253Aachs%26aulast%3DHaffizulla%26aufirst%3DJ.%26aulast%3DHartman%26aufirst%3DA.%26aulast%3DHoppers%26aufirst%3DM.%26aulast%3DResnick%26aufirst%3DH.%26aulast%3DSamudrala%26aufirst%3DS.%26aulast%3DGinocchio%26aufirst%3DC.%26aulast%3DBardin%26aufirst%3DM.%26aulast%3DRossignol%26aufirst%3DJ.-F.%26atitle%3DEffect%2520of%2520nitazoxanide%2520in%2520adults%2520and%2520adolescents%2520with%2520acute%2520uncomplicated%2520influenza%253A%2520a%2520double-blind%252C%2520randomised%252C%2520placebo-controlled%252C%2520phase%25202b%252F3%2520trial%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2014%26volume%3D14%26issue%3D7%26spage%3D609%26epage%3D618%26doi%3D10.1016%2FS1473-3099%2814%2970717-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabil, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Gohary, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elfert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeffe, E. B.</span></span> <span> </span><span class="NLM_article-title">Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4</span>. <i>Aliment. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">574</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2036.2008.03781.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1111%2Fj.1365-2036.2008.03781.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18616643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWms7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=574-580&issue=5&author=J.+F.+Rossignolauthor=S.+M.+Kabilauthor=Y.+El-Goharyauthor=A.+Elfertauthor=E.+B.+Keeffe&title=Clinical+trial%3A+randomized%2C+double-blind%2C+placebo-controlled+study+of+nitazoxanide+monotherapy+for+the+treatment+of+patients+with+chronic+hepatitis+C+genotype+4&doi=10.1111%2Fj.1365-2036.2008.03781.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4</span></div><div class="casAuthors">Rossignol, J. F.; Kabil, S. M.; El-Gohary, Y.; Elfert, A.; Keeffe, E. B.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">574-580</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Nitazoxanide, licensed in the US for treatment of Cryptosporidium parvum and Giardia lamblia, inhibits hepatitis C virus replication in replicon systems.  Aim: To evaluate the safety and efficacy of nitazoxanide monotherapy for the treatment of chronic hepatitis C.  Methods: This multicentre, randomized, double-blind, placebo-controlled study randomized 50 adult patients with chronic hepatitis C genotype 4 at three centers in Egypt to nitazoxanide 500 mg tablet or placebo twice daily for 24 wk.  Patients were followed up every 4 wk during treatment and for 24 wk after therapy.  Results: Seven of 23 patients (30.4%) in the nitazoxanide group achieved undetectable serum HCV RNA compared to 0 of 24 in the placebo group during therapy (P = 0.004).  Each of the seven responders had baseline HCV RNA levels ≤400 000 IU/mL.  Six of the seven virol. responders were followed up for 24 wk after the end of treatment, and four patients (17.4% of 23 treated) had a sustained virol. response.  Adverse events were similar in the nitazoxanide and placebo groups.  Conclusion: Nitazoxanide monotherapy is safe and effective in achieving sustained virol. response in a modest no. of patients with chronic hepatitis C genotype 4, particularly in patients with low baseline serum HCV RNA levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3c5PPbFXpc7Vg90H21EOLACvtfcHk0ljQPyqZApk-uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWms7nI&md5=b890e1b4d0f03b0af6d2926d956cfed7</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2008.03781.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2008.03781.x%26sid%3Dliteratum%253Aachs%26aulast%3DRossignol%26aufirst%3DJ.%2BF.%26aulast%3DKabil%26aufirst%3DS.%2BM.%26aulast%3DEl-Gohary%26aufirst%3DY.%26aulast%3DElfert%26aufirst%3DA.%26aulast%3DKeeffe%26aufirst%3DE.%2BB.%26atitle%3DClinical%2520trial%253A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520nitazoxanide%2520monotherapy%2520for%2520the%2520treatment%2520of%2520patients%2520with%2520chronic%2520hepatitis%2520C%2520genotype%25204%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D28%26issue%3D5%26spage%3D574%26epage%3D580%26doi%3D10.1111%2Fj.1365-2036.2008.03781.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossignol, J. F.</span></span> <span> </span><span class="NLM_article-title">Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus</span>. <i>J. Infect Public Health</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1016/j.jiph.2016.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jiph.2016.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=27095301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BC28bhsFamsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=227-230&issue=3&author=J.+F.+Rossignol&title=Nitazoxanide%2C+a+new+drug+candidate+for+the+treatment+of+Middle+East+respiratory+syndrome+coronavirus&doi=10.1016%2Fj.jiph.2016.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus</span></div><div class="casAuthors">Rossignol Jean-Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of infection and public health</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nitazoxanide is a broad-spectrum antiviral agent undergoing clinical development for treatment of influenza and other viral respiratory infections.  Nitazoxanide exhibits in vitro activity against Middle East respiratory syndrome coronavirus (MERS-CoV) and other coronaviruses, inhibiting expression of the viral N protein.  Nitazoxanide also suppresses production of pro-inflammatory cytokines in peripheral blood mononuclear cells and suppresses interleukin 6 production in mice.  Having been used extensively in clinical trials and in post-marketing experience, nitazoxanide is an attractive drug candidate for treatment of Middle East respiratory syndrome.  Future research should include in vitro mechanism studies, animal models of MERS-CoV infection, clinical trials, including dose-ranging trials, and evaluation of combination therapy with other potential MERS-CoV antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSL6Iq5eC6xumPgL4LrC-0VfW6udTcc2eY5q4o6pjiyn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bhsFamsw%253D%253D&md5=375ed45c28b8797a4eec4aa24dc67d02</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.1016%2Fj.jiph.2016.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jiph.2016.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DRossignol%26aufirst%3DJ.%2BF.%26atitle%3DNitazoxanide%252C%2520a%2520new%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%26jtitle%3DJ.%2520Infect%2520Public%2520Health%26date%3D2016%26volume%3D9%26issue%3D3%26spage%3D227%26epage%3D230%26doi%3D10.1016%2Fj.jiph.2016.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asl, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseinzadeh, H.</span></span> <span> </span><span class="NLM_article-title">Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">709</span>– <span class="NLM_lpage">724</span>, <span class="refDoi"> DOI: 10.1002/ptr.2362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1002%2Fptr.2362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=18446848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVCqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=709-724&issue=6&author=M.+N.+Aslauthor=H.+Hosseinzadeh&title=Review+of+pharmacological+effects+of+Glycyrrhiza+sp.+and+its+bioactive+compounds&doi=10.1002%2Fptr.2362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit230R"><div class="casContent"><span class="casTitleNuber">230</span><div class="casTitle"><span class="NLM_cas:atitle">Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds</span></div><div class="casAuthors">Asl, Marjan Nassiri; Hosseinzadeh, Hossein</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">709-724</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The roots and rhizomes of licorice (Glycyrrhiza) species have long been used worldwide as a herbal medicine and natural sweetener.  Licorice root is a traditional medicine used mainly for the treatment of peptic ulcer, hepatitis C, and pulmonary and skin diseases, although clin. and exptl. studies suggest that it has several other useful pharmacol. properties such as antiinflammatory, antiviral, antimicrobial, antioxidative, anticancer activities, immunomodulatory, hepatoprotective and cardioprotective effects.  A large no. of components have been isolated from licorice, including triterpene saponins, flavonoids, isoflavonoids and chalcones, with glycyrrhizic acid normally being considered to be the main biol. active component.  This review summarizes the phytochem., pharmacol. and pharmacokinetics data, together with the clin. and adverse effects of licorice and its bioactive components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc76W9fK7UIbVg90H21EOLACvtfcHk0ljBnjvdRwPO5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVCqu7s%253D&md5=b81eeec27c70653e91e49b961822d006</span></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1002%2Fptr.2362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.2362%26sid%3Dliteratum%253Aachs%26aulast%3DAsl%26aufirst%3DM.%2BN.%26aulast%3DHosseinzadeh%26aufirst%3DH.%26atitle%3DReview%2520of%2520pharmacological%2520effects%2520of%2520Glycyrrhiza%2520sp.%2520and%2520its%2520bioactive%2520compounds%26jtitle%3DPhytother.%2520Res.%26date%3D2008%26volume%3D22%26issue%3D6%26spage%3D709%26epage%3D724%26doi%3D10.1002%2Fptr.2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolkerstorfer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachhofner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szolar, O. H.</span></span> <span> </span><span class="NLM_article-title">Glycyrrhizin inhibits influenza A virus uptake into the cell</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">178</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2009.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2009.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19416738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFKnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2009&pages=171-178&issue=2&author=A.+Wolkerstorferauthor=H.+Kurzauthor=N.+Bachhofnerauthor=O.+H.+Szolar&title=Glycyrrhizin+inhibits+influenza+A+virus+uptake+into+the+cell&doi=10.1016%2Fj.antiviral.2009.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhizin inhibits influenza A virus uptake into the cell</span></div><div class="casAuthors">Wolkerstorfer, Andrea; Kurz, Harald; Bachhofner, Nicole; Szolar, Oliver H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-178</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigated the mechanism by which glycyrrhizin (GL), the main active component of licorice roots, protects cells from infection with influenza A virus (IAV).  We found that GL treatment leads to a clear redn. in the no. of IAV-infected human lung cells as well as a redn. in the CCID50 titer by 90%.  The antiviral effect, however, was limited to one or two virus replication cycles.  Anal. of different GL treatment protocols suggested that the antiviral effect of GL was limited to an early step in the virus replication cycle.  A direct inhibitory action of GL on IAV particles could be excluded and GL did not interact with virus receptor binding either.  The antiviral effect of GL was abolished by treatment 1 h after virus infection, whereas pre-treatment and treatment during and after virus adsorption led to a redn. in the cytopathic effect, reduced viral RNA within the cells and in the cell supernatants, and reduced viral hemagglutination titers.  Detailed virus uptake analyses unambiguously demonstrated reduced virus uptake in various GL-treated cells.  These observations lead to the conclusion, that the antiviral activity of GL is mediated by an interaction with the cell membrane which most likely results in reduced endocytic activity and hence reduced virus uptake.  These insights might help in the design of structurally related compds. leading to potent anti-influenza therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbK5YVUB9067Vg90H21EOLACvtfcHk0ljBnjvdRwPO5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFKnurg%253D&md5=692658ff3129046df8b19885768b433c</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2009.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2009.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DWolkerstorfer%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DH.%26aulast%3DBachhofner%26aufirst%3DN.%26aulast%3DSzolar%26aufirst%3DO.%2BH.%26atitle%3DGlycyrrhizin%2520inhibits%2520influenza%2520A%2520virus%2520uptake%2520into%2520the%2520cell%26jtitle%3DAntiviral%2520Res.%26date%3D2009%26volume%3D83%26issue%3D2%26spage%3D171%26epage%3D178%26doi%3D10.1016%2Fj.antiviral.2009.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michaelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naczk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sithisarn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leutz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerr, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinatl, J.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e19705</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0019705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1371%2Fjournal.pone.0019705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=21611183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&issue=5&author=M.+Michaelisauthor=J.+Geilerauthor=P.+Naczkauthor=P.+Sithisarnauthor=A.+Leutzauthor=H.+W.+Doerrauthor=J.+Cinatl&title=Glycyrrhizin+exerts+antioxidative+effects+in+H5N1+influenza+A+virus-infected+cells+and+inhibits+virus+replication+and+pro-inflammatory+gene+expression&doi=10.1371%2Fjournal.pone.0019705"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit232R"><div class="casContent"><span class="casTitleNuber">232</span><div class="casTitle"><span class="NLM_cas:atitle">Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression</span></div><div class="casAuthors">Michaelis, Martin; Geiler, Janina; Naczk, Patrizia; Sithisarn, Patchima; Leutz, Anke; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19705</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Glycyrrhizin is known to exert antiviral and anti-inflammatory effects.  Here, the effects of an approved parenteral glycyrrhizin prepn. (Stronger Neo-Minophafen C) were investigated on highly pathogenic influenza A H5N1 virus replication, H5N1-induced apoptosis, and H5N1-induced pro-inflammatory responses in lung epithelial (A549) cells.  Therapeutic glycyrrhizin concns. substantially inhibited H5N1-induced expression of the pro-inflammatory mols. CXCL10, interleukin 6, CCL2, and CCL5 (effective glycyrrhizin concns. 25 to 50 μg/mL) but interfered with H5N1 replication and H5N1-induced apoptosis to a lesser extent (effective glycyrrhizin concns. 100 μg/mL or higher).  Glycyrrhizin also diminished monocyte migration towards supernatants of H5N1-infected A549 cells.  The mechanism by which glycyrrhizin interferes with H5N1 replication and H5N1-induced pro-inflammatory gene expression includes inhibition of H5N1-induced formation of reactive oxygen species and (in turn) reduced activation of NFκB, JNK, and p38, redox-sensitive signalling events known to be relevant for influenza A virus replication.  Therefore, glycyrrhizin may complement the arsenal of potential drugs for the treatment of H5N1 disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQDXOxpPtb7Vg90H21EOLACvtfcHk0ljBnjvdRwPO5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGqsbw%253D&md5=207f17b0a280b6f5f703c0a024bf8f88</span></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019705%26sid%3Dliteratum%253Aachs%26aulast%3DMichaelis%26aufirst%3DM.%26aulast%3DGeiler%26aufirst%3DJ.%26aulast%3DNaczk%26aufirst%3DP.%26aulast%3DSithisarn%26aufirst%3DP.%26aulast%3DLeutz%26aufirst%3DA.%26aulast%3DDoerr%26aufirst%3DH.%2BW.%26aulast%3DCinatl%26aufirst%3DJ.%26atitle%3DGlycyrrhizin%2520exerts%2520antioxidative%2520effects%2520in%2520H5N1%2520influenza%2520A%2520virus-infected%2520cells%2520and%2520inhibits%2520virus%2520replication%2520and%2520pro-inflammatory%2520gene%2520expression%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D5%26doi%3D10.1371%2Fjournal.pone.0019705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suebsasana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pongnaratorn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattayasai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkaravichien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiamkao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aromdee, C.</span></span> <span> </span><span class="NLM_article-title">Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1191</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1007/s12272-009-1902-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs12272-009-1902-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=19784573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOrtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=1191-1200&issue=9&author=S.+Suebsasanaauthor=P.+Pongnaratornauthor=J.+Sattayasaiauthor=T.+Arkaravichienauthor=S.+Tiamkaoauthor=C.+Aromdee&title=Analgesic%2C+antipyretic%2C+anti-inflammatory+and+toxic+effects+of+andrographolide+derivatives+in+experimental+animals&doi=10.1007%2Fs12272-009-1902-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals</span></div><div class="casAuthors">Suebsasana, Supawadee; Pongnaratorn, Panicha; Sattayasai, Jintana; Arkaravichien, Tarinee; Tiamkao, Siriporn; Aromdee, Chantana</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1191-1200</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Andrographolide (1) and 14-deoxy-11,12-didehydroandrographolide (2) are active constituents of Andrographis paniculata (Burm. f.), family Acanthaceae.  A. paniculata exts. are reported to have antiviral, antipyretic, immunostimulant and anticancer activities.  In this study, 1 and its 14-acetyl- (4) and 3,19-isopropylidenyl- (3) derivs., as well as 2 and its 3,19-dipalmitoyl-deriv. (5), were i.p. tested for their analgesic, antipyretic, anti-inflammatory and acute toxicity effects in animal models.  Analgesic effects were tested in mice using hot plate and writhing tests to distinguish the central and peripheral effects, resp.  The results showed that, at 4 mg/kg, all tested substances have significant analgesic effects, and the highest potency was seen with 3, 4 and 5.  Increasing the dose of 3 and 5 to 8 mg/kg did not increase the analgesic effect.  In the writhing test, 3 and 5, but not 1, showed significant results.  In a baker's yeast-induced fever model, 3 and 5 significantly reduced rats' rectal temp. (p < 0.05).  In a carrageenan-induced inflammation model, 1, 3 and 5 significantly reduced rats' paw vol.  Doses of 3 and 5 up to 100 mg/kg did not show any serious toxic effects.  From this study, 3 and 5 are the most interesting derivs., showing much greater potency than their parent compds.  These could be further developed as analgesic, antipyretic and anti-inflammatory agents, without any serious toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplWGAe_XzEkrVg90H21EOLACvtfcHk0ljFol1Ucx7Ldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOrtbrE&md5=8cc629c3ff6154e6863da3d382bcbb48</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1007%2Fs12272-009-1902-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-009-1902-x%26sid%3Dliteratum%253Aachs%26aulast%3DSuebsasana%26aufirst%3DS.%26aulast%3DPongnaratorn%26aufirst%3DP.%26aulast%3DSattayasai%26aufirst%3DJ.%26aulast%3DArkaravichien%26aufirst%3DT.%26aulast%3DTiamkao%26aufirst%3DS.%26aulast%3DAromdee%26aufirst%3DC.%26atitle%3DAnalgesic%252C%2520antipyretic%252C%2520anti-inflammatory%2520and%2520toxic%2520effects%2520of%2520andrographolide%2520derivatives%2520in%2520experimental%2520animals%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2009%26volume%3D32%26issue%3D9%26spage%3D1191%26epage%3D1200%26doi%3D10.1007%2Fs12272-009-1902-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M.</span></span> <span> </span><span class="NLM_article-title">14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2015.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2015.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25800824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVWkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2015&pages=82-92&author=W.+Caiauthor=Y.+Liauthor=S.+Chenauthor=M.+Wangauthor=A.+Zhangauthor=H.+Zhouauthor=H.+Chenauthor=M.+Jin&title=14-Deoxy-11%2C12-dehydroandrographolide+exerts+anti-influenza+A+virus+activity+and+inhibits+replication+of+H5N1+virus+by+restraining+nuclear+export+of+viral+ribonucleoprotein+complexes&doi=10.1016%2Fj.antiviral.2015.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes</span></div><div class="casAuthors">Cai, Wentao; Li, Yongtao; Chen, Sunrui; Wang, Mengli; Zhang, Anding; Zhou, Hongbo; Chen, Huanchun; Jin, Meilin</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-92</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The highly pathogenic avian influenza H5N1 virus has become a worldwide public health threat, and current antiviral therapies have limited activity against the emerging, resistant influenza viruses.  Therefore, effective drugs with novel targets against influenza A viruses, H5N1 strains in particular, should be developed.  In the present study, 14-deoxy-11,12-dehydroandrographolide (DAP), a major component of the traditional Chinese medicine Andrographis paniculata, exerted potent anti-influenza A virus activity against A/chicken/Hubei/327/2004 (H5N1), A/duck/Hubei/XN/2007 (H5N1), A/PR/8/34 (H1N1), A/NanChang/08/2010 (H1N1) and A/HuNan/01/2014 (H3N2) in vitro.  To elucidate the underlying mechanisms, a series of expts. was conducted using A/chicken/Hubei/327/2004 (H5N1) as an example.  Our results demonstrated that DAP strongly inhibited H5N1 replication by reducing the prodn. of viral nucleoprotein (NP) mRNA, NP and NS1proteins, whereas DAP had no effect on the absorption and release of H5N1 towards/from A549 cells.  DAP also effectively restrained the nuclear export of viral ribonucleoprotein (vRNP) complexes.  This inhibitory effect ought to be an important anti-H5N1 mechanism of DAP.  Meanwhile, DAP significantly reduced the upregulated expression of all the tested proinflammatory cytokines (TNF-α, IL-6, IL-8, IFN-α, IL-1β and IFN-β) and chemokines (CXCL-10 and CCL-2) stimulated by H5N1.  Overall results suggest that DAP impairs H5N1 replication at least in part by restraining nuclear export of vRNP complexes, and the inhibition of viral replication leads to a subsequent decrease of the intense proinflammatory cytokine/chemokine expression.  In turn, the effect of modification of the host excessive immune response may contribute to overcoming H5N1.  To our knowledge, this study is the first to reveal the antiviral and anti-inflammatory activities of DAP in vitro against H5N1 influenza A virus infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXT0VtoHWVrVg90H21EOLACvtfcHk0ljFol1Ucx7Ldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVWkur0%253D&md5=86a7a31793fcdf2f32e2f098d5db8b8b</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DM.%26atitle%3D14-Deoxy-11%252C12-dehydroandrographolide%2520exerts%2520anti-influenza%2520A%2520virus%2520activity%2520and%2520inhibits%2520replication%2520of%2520H5N1%2520virus%2520by%2520restraining%2520nuclear%2520export%2520of%2520viral%2520ribonucleoprotein%2520complexes%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D118%26spage%3D82%26epage%3D92%26doi%3D10.1016%2Fj.antiviral.2015.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassaganya-Riera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubau-Juni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoccoli-Rodriguez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godfrey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hontecillas, R.</span></span> <span> </span><span class="NLM_article-title">Lanthionine synthetase C-like 2 modulates immune responses to Influenza virus infection</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">178</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2017.00178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.3389%2Ffimmu.2017.00178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28270815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFegt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=178&author=A.+Leberauthor=J.+Bassaganya-Rieraauthor=N.+Tubau-Juniauthor=V.+Zoccoli-Rodriguezauthor=P.+Luauthor=V.+Godfreyauthor=S.+Kaleauthor=R.+Hontecillas&title=Lanthionine+synthetase+C-like+2+modulates+immune+responses+to+Influenza+virus+infection&doi=10.3389%2Ffimmu.2017.00178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">Lanthionine synthetase C-like 2 modulates immune responses to influenza virus infection</span></div><div class="casAuthors">Leber, Andrew; Bassaganya-Riera, Josep; Tubau-Juni, Nuria; Zoccoli-Rodriguez, Victoria; Lu, Pinyi; Godfrey, Victoria; Kale, Shiv; Hontecillas, Raquel</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178/1-178/14</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Broad-based, host-targeted therapeutics have the potential to ameliorate viral infections without inducing antiviral resistance.  We identified lanthionine synthetase C-like 2 (LANCL2) as a new therapeutic target for immunoinflammatory diseases.  To examine the therapeutic efficacy of oral NSC61610 administration on influenza, we infected C57BL/6 mice with influenza A H1N1pdm virus and evaluated influenza-related mortality, lung inflammatory profiles, and pulmonary histopathol.  Oral treatment with NSC61610 ameliorates influenza virus infection by down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and redn. in the infiltration of neutrophils.  NSC61610 treatment increases IL10-producing CD8+ T cells and macrophages in the lungs during the resoln. phase of disease.  The loss of LANCL2 or neutralization of IL-10 in mice infected with influenza virus abrogates the ability of NSC61610 to accelerate recovery and induce IL-10-mediated regulatory responses.  These studies validate that oral treatment with NSC61610 ameliorates morbidity and mortality and accelerates recovery during influenza virus infection through a mechanism mediated by activation of LANCL2 and subsequent induction of IL-10 responses by CD8+ T cells and macrophages in the lungs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOC-09yPF_qrVg90H21EOLACvtfcHk0ljFol1Ucx7Ldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFegt78%253D&md5=3bd15a369d2bc8757b64514dde3ec423</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2017.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2017.00178%26sid%3Dliteratum%253Aachs%26aulast%3DLeber%26aufirst%3DA.%26aulast%3DBassaganya-Riera%26aufirst%3DJ.%26aulast%3DTubau-Juni%26aufirst%3DN.%26aulast%3DZoccoli-Rodriguez%26aufirst%3DV.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DGodfrey%26aufirst%3DV.%26aulast%3DKale%26aufirst%3DS.%26aulast%3DHontecillas%26aufirst%3DR.%26atitle%3DLanthionine%2520synthetase%2520C-like%25202%2520modulates%2520immune%2520responses%2520to%2520Influenza%2520virus%2520infection%26jtitle%3DFront.%2520Immunol.%26date%3D2017%26volume%3D8%26spage%3D178%26doi%3D10.3389%2Ffimmu.2017.00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z. D.</span></span> <span> </span><span class="NLM_article-title">Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-gamma</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2015.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jep.2015.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=26190352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtFWntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2016&pages=128-136&author=X.+P.+Huauthor=M.+M.+Shaoauthor=X.+Songauthor=X.+L.+Wuauthor=L.+Qiauthor=K.+Zhengauthor=L.+Fanauthor=C.+H.+Liaoauthor=C.+Y.+Liauthor=J.+Heauthor=Y.+J.+Huauthor=H.+Q.+Wuauthor=S.+H.+Liauthor=J.+Zhangauthor=F.+X.+Zhangauthor=Z.+D.+He&title=Anti-influenza+virus+effects+of+crude+phenylethanoid+glycosides+isolated+from+ligustrum+purpurascens+via+inducing+endogenous+interferon-gamma&doi=10.1016%2Fj.jep.2015.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit236R"><div class="casContent"><span class="casTitleNuber">236</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γ</span></div><div class="casAuthors">Hu, Xiao-peng; Shao, Min-ming; Song, Xun; Wu, Xu-li; Qi, Ling; Zheng, Kai; Fan, Long; Liao, Cheng-hui; Li, Chen-yang; He, Jiang; Hu, Ying-jie; Wu, Hai-qiang; Li, Shi-he; Zhang, Jian; Zhang, Feng-xue; He, Zhen-dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">128-136</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Ligustrum purpurascens Y.  C. Yang (Oleaceae) is traditionally recorded as "Ku Ding Cha", a kind of functional tea in southern China for about two thousand years, which has been reported with sore throat alleviating and pathogenic heat expelling effects.  However, there are no scientific studies demonstrating its antiviral activity.  This study is aimed at investigating the anti-influenza virus effects of phenylethanoid glycosides isolated from L. purpurascens (LPG) as well as its corresponding mechanisms.  In vitro, hemagglutination assay was employed to detect the influenza virus titer; In vivo, C57BL/6J mice were given oral administration of LPG (100 mg/kg, 300 mg/kg, 900 mg/kg) or ribavirin (100 mg/kg) once daily for 5 successive days.  Meanwhile, on the second day, mice were infected intranasally (i.n.) with A/FM/1/47 H1N1 virus.  Mice survival rate and other clin. index were monitored for 15 days.  Infected mice were sacrificed to measure the lung lesion and stained with hematoxylin-eosin.  Flow cytometry analyses spleen lymphocytes and interferon-γ (IFN-γ) level.  The IFN-γ knockout mice (IFN-γ-/- mice, C57BL/6J) which had been verified lacking IFN-γ through Western Blot, were applied in the death-protection test to identify the role of IFN-γ played in LPG antiviral effect.In vitro, LPG at 0.5 mg/mL inhibited Influenza A Virus H1N1 type (H1N1) infection of MDCK cells.  In vivo, LPG at 300 and 900 mg/kg significantly decreased the mouse lung index (p<0.05), alleviated influenza-induced lethality and clin. symptoms, and therefore enhanced mouse survival (p<0.05).  More detailed expts. demonstrated that antiviral cytokine IFN-γ was involved in the antiviral effect of LPG.  Flow cytometric anal. revealed that LPG (900 mg/kg) significantly induced secretion of IFN-γ by splenic CD4+ and CD8+ cells (p<0.05).  Moreover, LPG (900 mg/kg) protected wild-type C57BL/6J mice from H1N1 injury, whereas LPG-mediated survival protection disappeared in IFN-γ-/- mice.  These results suggest that up-regulating endogenous IFN-γ by LPG may represent a novel therapeutic approach for H1N1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo865uUzhg6e7Vg90H21EOLACvtfcHk0liGN_atBGIZ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtFWntA%253D%253D&md5=1b7649906cf0de80d8f17ee064a1a2f7</span></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2015.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2015.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%2BP.%26aulast%3DShao%26aufirst%3DM.%2BM.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%2BL.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DC.%2BH.%26aulast%3DLi%26aufirst%3DC.%2BY.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%2BJ.%26aulast%3DWu%26aufirst%3DH.%2BQ.%26aulast%3DLi%26aufirst%3DS.%2BH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DF.%2BX.%26aulast%3DHe%26aufirst%3DZ.%2BD.%26atitle%3DAnti-influenza%2520virus%2520effects%2520of%2520crude%2520phenylethanoid%2520glycosides%2520isolated%2520from%2520ligustrum%2520purpurascens%2520via%2520inducing%2520endogenous%2520interferon-gamma%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2016%26volume%3D179%26spage%3D128%26epage%3D136%26doi%3D10.1016%2Fj.jep.2015.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felsenstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbert, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrich, C. M.</span></span> <span> </span><span class="NLM_article-title">COVID-19: Immunology and treatment options</span>. <i>Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">108448</span>, <span class="refDoi"> DOI: 10.1016/j.clim.2020.108448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.clim.2020.108448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32353634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1aqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2020&pages=108448&author=S.+Felsensteinauthor=J.+A.+Herbertauthor=P.+S.+McNamaraauthor=C.+M.+Hedrich&title=COVID-19%3A+Immunology+and+treatment+options&doi=10.1016%2Fj.clim.2020.108448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">COVID-19: Immunology and treatment options</span></div><div class="casAuthors">Felsenstein, Susanna; Herbert, Jenny A.; McNamara, Paul S.; Hedrich, Christian M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108448</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions.  As protective immunity does not exist in humans and the virus is capable of escaping innate immune responses, it can proliferate, unhindered, in primarily infected tissues.  Subsequent cell death results in the release of virus particles and intracellular components to the extracellular space, which result in immune cell recruitment, the generation of immune complexes and assocd. damage.  Infection of monocytes/macrophages and/or recruitment of uninfected immune cells can result in massive inflammatory responses later in the disease.  Uncontrolled prodn. of pro-inflammatory mediators contributes to ARDS and cytokine storm syndrome.  Antiviral agents and immune modulating treatments are currently being trialled.  Understanding immune evasion strategies of SARS-CoV2 and the resulting delayed massive immune response will result in the identification of biomarkers that predict outcomes as well as phenotype and disease stage specific treatments that will likely include both antiviral and immune modulating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCEfmBuJUQ_bVg90H21EOLACvtfcHk0liGN_atBGIZ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1aqsbs%253D&md5=9d9b3b983b60f625bcedf058c9cecb8b</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2020.108448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2020.108448%26sid%3Dliteratum%253Aachs%26aulast%3DFelsenstein%26aufirst%3DS.%26aulast%3DHerbert%26aufirst%3DJ.%2BA.%26aulast%3DMcNamara%26aufirst%3DP.%2BS.%26aulast%3DHedrich%26aufirst%3DC.%2BM.%26atitle%3DCOVID-19%253A%2520Immunology%2520and%2520treatment%2520options%26jtitle%3DClin.%2520Immunol.%26date%3D2020%26volume%3D215%26spage%3D108448%26doi%3D10.1016%2Fj.clim.2020.108448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, P. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span> <span> </span><span class="NLM_article-title">Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>191</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1086/427811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1086%2F427811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=15688292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVentrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2005&pages=755-760&issue=5&author=Z.+Chenauthor=L.+Miauthor=J.+Xuauthor=J.+Yuauthor=X.+Wangauthor=J.+Jiangauthor=J.+Xingauthor=P.+Shangauthor=A.+Qianauthor=Y.+Liauthor=P.+X.+Shawauthor=J.+Wangauthor=S.+Duanauthor=J.+Dingauthor=C.+Fanauthor=Y.+Zhangauthor=Y.+Yangauthor=X.+Yuauthor=Q.+Fengauthor=B.+Liauthor=X.+Yaoauthor=Z.+Zhangauthor=L.+Liauthor=X.+Xueauthor=P.+Zhu&title=Function+of+HAb18G%2FCD147+in+invasion+of+host+cells+by+severe+acute+respiratory+syndrome+coronavirus&doi=10.1086%2F427811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus</span></div><div class="casAuthors">Chen, Zhinan; Mi, Li; Xu, Jing; Yu, Jiyun; Wang, Xianhui; Jiang, Jianli; Xing, Jinliang; Shang, Peng; Qian, Airong; Li, Yu; Shaw, Peter X.; Wang, Jianwei; Duan, Shumin; Ding, Jin; Fan, Chunmei; Zhang, Yang; Yang, Yong; Yu, Xiaoling; Feng, Qiang; Li, Biehu; Yao, Xiying; Zhang, Zheng; Li, Ling; Xue, Xiaoping; Zhu, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">755-760</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">To identify the function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome (SARS) coronavirus (CoV), we analyzed the protein-protein interaction among HAb18G/CD147, cyclophilin A (CyPA), and SARS-CoV structural proteins by coimmunopptn. and surface plasmon resonance anal.  Although none of the SARS-CoV proteins was found to be directly bound to HAb18G/CD147, the nucleocapsid (N) protein of SARS-CoV was bound to CyPA, which interacted with HAb18G/CD147.  Further research showed that HAb18G/CD147, a transmembrane mol., was highly expressed on 293 cells and that CyPA was integrated with SARS-CoV.  HAb18G/CD147-antagonistic peptide (AP)-9, an AP of HAb18G/CD147, had a high rate of binding to 293 cells and an inhibitory effect on SARS-CoV.  These results show that HAb18G/CD147, mediated by CyPA bound to SARS-CoV N protein, plays a functional role in facilitating invasion of host cells by SARS-CoV.  Our findings provide some evidence for the cytol. mechanism of invasion by SARS-CoV and provide a mol. basis for screening anti-SARS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokFLnbxoWjlbVg90H21EOLACvtfcHk0liGN_atBGIZ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVentrw%253D&md5=be73edfebb2c293880f6c3367dec028d</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1086%2F427811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F427811%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMi%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DShang%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShaw%26aufirst%3DP.%2BX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDuan%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DP.%26atitle%3DFunction%2520of%2520HAb18G%252FCD147%2520in%2520invasion%2520of%2520host%2520cells%2520by%2520severe%2520acute%2520respiratory%2520syndrome%2520coronavirus%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D191%26issue%3D5%26spage%3D755%26epage%3D760%26doi%3D10.1086%2F427811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillat, M. M.</span></span> <span> </span><span class="NLM_article-title">CD147 as a target for COVID-19 treatment: Suggested effects of Azithromycin and stem cell engagement</span>. <i>Stem Cell Rev. Rep</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1007/s12015-020-09976-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1007%2Fs12015-020-09976-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32307653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsV2mtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=434-440&issue=3&author=H.+Ulrichauthor=M.+M.+Pillat&title=CD147+as+a+target+for+COVID-19+treatment%3A+Suggested+effects+of+Azithromycin+and+stem+cell+engagement&doi=10.1007%2Fs12015-020-09976-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement</span></div><div class="casAuthors">Ulrich, Henning; Pillat, Micheli M.</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Reviews and Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">SCRREE</span>;
        ISSN:<span class="NLM_cas:issn">2629-3277</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Abstr.: The expressive no. of deaths and confirmed cases of SARS-CoV-2 call for an urgent demand of effective and available drugs for COVID-19 treatment.  CD147, a receptor on host cells, is a novel route for SARS-CoV-2 invasion.  Thus, drugs that interfere in the spike protein/CD147 interaction or CD147 expression may inhibit viral invasion and dissemination among other cells, including in progenitor/stem cells.  Studies suggest beneficial effects of azithromycin in reducing viral load of hospitalized patients, possibly interfering with ligand/CD147 receptor interactions; however, its possible effects on SARS-CoV-2 invasion has not yet been evaluated.  In addn. to the possible effect in invasion, azithromycin decreases the expression of some metalloproteinases (downstream to CD147), induces anti-viral responses in primary human bronchial epithelial infected with rhinovirus, decreasing viral replication and release.  Moreover, resident lung progenitor/stem are extensively differentiated into myofibroblasts during pulmonary fibrosis, a complication obsd. in COVID-19 patients.  This process, and the possible direct viral invasion of progenitor/stem cells via CD147 or ACE2, could result in the decline of these cellular stocks and failing lung repair.  Clin. tests with allogeneic MSCs from healthy individuals are underway to enhance endogenous lung repair and suppress inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEpbHkoVQGHLVg90H21EOLACvtfcHk0ljr0VDlfG9elA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsV2mtLY%253D&md5=383e7dd8417a9cc29238d9f942a58dcc</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1007%2Fs12015-020-09976-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12015-020-09976-7%26sid%3Dliteratum%253Aachs%26aulast%3DUlrich%26aufirst%3DH.%26aulast%3DPillat%26aufirst%3DM.%2BM.%26atitle%3DCD147%2520as%2520a%2520target%2520for%2520COVID-19%2520treatment%253A%2520Suggested%2520effects%2520of%2520Azithromycin%2520and%2520stem%2520cell%2520engagement%26jtitle%3DStem%2520Cell%2520Rev.%2520Rep%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D434%26epage%3D440%26doi%3D10.1007%2Fs12015-020-09976-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindrachuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrling, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laidlaw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansen, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lear-Rooney, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M. B.</span></span> <span> </span><span class="NLM_article-title">Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4885</span>– <span class="NLM_lpage">4893</span>, <span class="refDoi"> DOI: 10.1128/AAC.03036-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.03036-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24841273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1art73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4885-4893&issue=8&author=J.+Dyallauthor=C.+M.+Colemanauthor=B.+J.+Hartauthor=T.+Venkataramanauthor=M.+R.+Holbrookauthor=J.+Kindrachukauthor=R.+F.+Johnsonauthor=G.+G.+Olingerauthor=P.+B.+Jahrlingauthor=M.+Laidlawauthor=L.+M.+Johansenauthor=C.+M.+Lear-Rooneyauthor=P.+J.+Glassauthor=L.+E.+Hensleyauthor=M.+B.+Frieman&title=Repurposing+of+clinically+developed+drugs+for+treatment+of+Middle+East+respiratory+syndrome+coronavirus+infection&doi=10.1128%2FAAC.03036-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection</span></div><div class="casAuthors">Dyall, Julie; Coleman, Christopher M.; Hart, Brit J.; Venkataraman, Thiagarajan; Holbrook, Michael R.; Kindrachuk, Jason; Johnson, Reed F.; Olinger, Gene G.; Jahrling, Peter B.; Laidlaw, Monique; Johansen, Lisa M.; Lear-Rooney, Calli M.; Glass, Pamela J.; Hensley, Lisa E.; Frieman, Matthew B.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4885-4893, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Outbreaks of emerging infections present health professionals with the unique challenge of trying to select appropriate pharmacol. treatments in the clinic with little time available for drug testing and development.  Typically, clinicians are left with general supportive care and often untested convalescent-phase plasma as available treatment options.  Repurposing of approved pharmaceutical drugs for new indications presents an attractive alternative to clinicians, researchers, public health agencies, drug developers and funding agencies.  Given the development times and manufg. requirements for new products, repurposing of existing drugs is likely the only soln. for outbreaks due to emerging viruses.  In the studies described here, a library of 290 compds. was screened for antiviral activity against Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV).  Selection of compds. for inclusion in the library was dependent on current or previous FDA approval or advanced clin. development.  Some drugs that had a well-defined cellular pathway as target were included.  In total, 27 compds. with activity against both MERS-CoV and SARS-CoV were identified.  The compds. belong to 13 different classes of pharmaceuticals, including inhibitors of estrogen receptors used for cancer treatment and inhibitors of dopamine receptor used as antipsychotics.  The drugs identified in these screens provide new targets for in vivo studies as well as incorporation into ongoing clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE_PH7j54pPrVg90H21EOLACvtfcHk0ljr0VDlfG9elA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1art73L&md5=4cd7f71c09de4c1965b7c6f42f3ae2ce</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1128%2FAAC.03036-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03036-14%26sid%3Dliteratum%253Aachs%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DC.%2BM.%26aulast%3DHart%26aufirst%3DB.%2BJ.%26aulast%3DVenkataraman%26aufirst%3DT.%26aulast%3DHolbrook%26aufirst%3DM.%2BR.%26aulast%3DKindrachuk%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BF.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DJahrling%26aufirst%3DP.%2BB.%26aulast%3DLaidlaw%26aufirst%3DM.%26aulast%3DJohansen%26aufirst%3DL.%2BM.%26aulast%3DLear-Rooney%26aufirst%3DC.%2BM.%26aulast%3DGlass%26aufirst%3DP.%2BJ.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DFrieman%26aufirst%3DM.%2BB.%26atitle%3DRepurposing%2520of%2520clinically%2520developed%2520drugs%2520for%2520treatment%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4885%26epage%3D4893%26doi%3D10.1128%2FAAC.03036-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kindrachuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ork, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrling, P. B.</span></span> <span> </span><span class="NLM_article-title">Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1088</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.1128/AAC.03659-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.03659-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=25487801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVagsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=1088-1099&issue=2&author=J.+Kindrachukauthor=B.+Orkauthor=B.+J.+Hartauthor=S.+Mazurauthor=M.+R.+Holbrookauthor=M.+B.+Friemanauthor=D.+Traynorauthor=R.+F.+Johnsonauthor=J.+Dyallauthor=J.+H.+Kuhnauthor=G.+G.+Olingerauthor=L.+E.+Hensleyauthor=P.+B.+Jahrling&title=Antiviral+potential+of+ERK%2FMAPK+and+PI3K%2FAKT%2FmTOR+signaling+modulation+for+Middle+East+respiratory+syndrome+coronavirus+infection+as+identified+by+temporal+kinome+analysis&doi=10.1128%2FAAC.03659-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit241R"><div class="casContent"><span class="casTitleNuber">241</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for middle east respiratory syndrome coronavirus infection as identified by temporal kinome analysis</span></div><div class="casAuthors">Kindrachuk, Jason; Ork, Britini; Hart, Brit J.; Mazur, Steven; Holbrook, Michael R.; Frieman, Matthew B.; Traynor, Dawn; Johnson, Reed F.; Dyall, Julie; Kuhn, Jens H.; Olinger, Gene G.; Hensley, Lisa E.; Jahrling, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1088-1099/1-1088-1099/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus, and infections with this virus can result in acute respiratory syndrome with renal failure.  Globally, MERS-CoV has been responsible for 877 lab.-confirmed infections, including 317 deaths, since Sept. 2012.  As there is a paucity of information regarding the mol. pathogenesis assocd. with this virus or the identities of novel antiviral drug targets, we performed temporal kinome anal. on human hepatocytes infected with the Erasmus isolate of MERS-CoV with peptide kinome arrays. bioinformatics anal. of our kinome data, including pathway overrepresentation anal. (ORA) and functional network anal., suggested that extracellular signalregulated kinase (ERK)/mitogen-activated protein kinase (MAPK) and phosphoinositol 3-kinase (PI3K)/serine-threonine kinase (AKT)/mammalian target of rapamycin (mTOR) signaling responses were specifically modulated in response to MERS-CoV infection in vitro throughout the course of infection.  The overrepresentation of specific intermediates within these pathways detd. by pathway and functional network anal. of our kinome data correlated with similar patterns of phosphorylation detd. through Western blot array anal.  In addn., anal. of the effects of specific kinase inhibitors on MERS-CoV infection in tissue culture models confirmed these cellular response observations.  Further, we have demonstrated that a subset of licensed kinase inhibitors targeting the ERK/MAPK and PI3K/AKT/mTOR pathways significantly inhibited MERS-CoV replication in vitro whether they were added before or after viral infection.  Taken together, our data suggest that ERK/MAPK and PI3K/AKT/mTOR signaling responses play important roles in MERS-CoV infection and may represent novel drug targets for therapeutic intervention strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwo9H9W_zXg7Vg90H21EOLACvtfcHk0lg656krcO2nZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVagsbw%253D&md5=1fef3dd7bccc643cec0762fdfbee27bb</span></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1128%2FAAC.03659-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03659-14%26sid%3Dliteratum%253Aachs%26aulast%3DKindrachuk%26aufirst%3DJ.%26aulast%3DOrk%26aufirst%3DB.%26aulast%3DHart%26aufirst%3DB.%2BJ.%26aulast%3DMazur%26aufirst%3DS.%26aulast%3DHolbrook%26aufirst%3DM.%2BR.%26aulast%3DFrieman%26aufirst%3DM.%2BB.%26aulast%3DTraynor%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DR.%2BF.%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DKuhn%26aufirst%3DJ.%2BH.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DHensley%26aufirst%3DL.%2BE.%26aulast%3DJahrling%26aufirst%3DP.%2BB.%26atitle%3DAntiviral%2520potential%2520of%2520ERK%252FMAPK%2520and%2520PI3K%252FAKT%252FmTOR%2520signaling%2520modulation%2520for%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520infection%2520as%2520identified%2520by%2520temporal%2520kinome%2520analysis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26issue%3D2%26spage%3D1088%26epage%3D1099%26doi%3D10.1128%2FAAC.03659-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hart, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postnikova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindrachuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olinger, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieman, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahrling, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, L.</span></span> <span> </span><span class="NLM_article-title">Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1099/vir.0.061911-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1099%2Fvir.0.061911-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24323636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyms7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2014&pages=571-577&issue=3&author=B.+J.+Hartauthor=J.+Dyallauthor=E.+Postnikovaauthor=H.+Zhouauthor=J.+Kindrachukauthor=R.+F.+Johnsonauthor=G.+G.+Olingerauthor=M.+B.+Friemanauthor=M.+R.+Holbrookauthor=P.+B.+Jahrlingauthor=L.+Hensley&title=Interferon-beta+and+mycophenolic+acid+are+potent+inhibitors+of+Middle+East+respiratory+syndrome+coronavirus+in+cell-based+assays&doi=10.1099%2Fvir.0.061911-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit242R"><div class="casContent"><span class="casTitleNuber">242</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays</span></div><div class="casAuthors">Hart, Brit J.; Dyall, Julie; Postnikova, Elena; Zhou, Huanying; Kindrachuk, Jason; Johnson, Reed F.; Olinger, Gene G., Jr.; Frieman, Matthew B.; Holbrook, Michael R.; Jahrling, Peter B.; Hensley, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">571-577</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">The Middle East respiratory syndrome coronavirus (MERS-CoV) presents a novel emerging threat to public health worldwide.  Several treatments for infected individuals have been suggested including IFN, ribavirin and passive immunotherapy with convalescent plasma.  Administration of IFN-α2b and ribavirin has improved outcomes of MERS-CoV infection in rhesus macaques when administered within 8 h post-challenge.  However, detailed and systematic evidence on the activity of other clin. available drugs is limited.  Here we compared the susceptibility of MERS-CoV with different IFN products (IFN-α2b, IFN-γ, IFN-universal, IFN-α2a and IFN-β), as well as with two antivirals, ribavirin and mycophenolic acid (MPA), against MERS-CoV (Hu/Jordan-N3/2012) in vitro.  Of all the IFNs tested, IFN-β showed the strongst inhibition of MERS-CoV in vitro, with an IC50 of 1.37 U ml-1, 41 times lower than the previously reported IC50 (56.08 U ml-1) of IFN-α2b.  IFN-β inhibition was confirmed in the virus yield redn. assay, with an IC90 of 38.8 U ml-1.  Ribavirin did not inhibit viral replication in vitro at a dose that would be applicable to current treatment protocols in humans.  In contrast, MPA showed strong inhibition, with an IC50 of 2.87 μM.  This drug has not been previously tested against MERS-CoV and may provide an alternative to ribavirin for treatment of MERS-CoV.  In conclusion, IFN-β, MPA or a combination of the two may be beneficial in the treatment of MERS-CoV or as a post-exposure intervention in high-risk patients with known exposures to MERS-CoV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wny_RT-Vi7Vg90H21EOLACvtfcHk0lg656krcO2nZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyms7%252FL&md5=1c222918737c4960fcc70b107c7e148b</span></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.061911-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.061911-0%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DB.%2BJ.%26aulast%3DDyall%26aufirst%3DJ.%26aulast%3DPostnikova%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKindrachuk%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BF.%26aulast%3DOlinger%26aufirst%3DG.%2BG.%26aulast%3DFrieman%26aufirst%3DM.%2BB.%26aulast%3DHolbrook%26aufirst%3DM.%2BR.%26aulast%3DJahrling%26aufirst%3DP.%2BB.%26aulast%3DHensley%26aufirst%3DL.%26atitle%3DInterferon-beta%2520and%2520mycophenolic%2520acid%2520are%2520potent%2520inhibitors%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520in%2520cell-based%2520assays%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2014%26volume%3D95%26issue%3D3%26spage%3D571%26epage%3D577%26doi%3D10.1099%2Fvir.0.061911-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horby, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1787</span>– <span class="NLM_lpage">1799</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa2001282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa2001282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32187464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A280%3ADC%252BB383kvFOjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2020&pages=1787-1799&issue=19&author=B.+Caoauthor=Y.+Wangauthor=D.+Wenauthor=W.+Liuauthor=J.+Wangauthor=G.+Fanauthor=L.+Ruanauthor=B.+Songauthor=Y.+Caiauthor=M.+Weiauthor=X.+Liauthor=J.+Xiaauthor=N.+Chenauthor=J.+Xiangauthor=T.+Yuauthor=T.+Baiauthor=X.+Xieauthor=L.+Zhangauthor=C.+Liauthor=Y.+Yuanauthor=H.+Chenauthor=H.+Liauthor=H.+Huangauthor=S.+Tuauthor=F.+Gongauthor=Y.+Liuauthor=Y.+Weiauthor=C.+Dongauthor=F.+Zhouauthor=X.+Guauthor=J.+Xuauthor=Z.+Liuauthor=Y.+Zhangauthor=H.+Liauthor=L.+Shangauthor=K.+Wangauthor=K.+Liauthor=X.+Zhouauthor=X.+Dongauthor=Z.+Quauthor=S.+Luauthor=X.+Huauthor=S.+Ruanauthor=S.+Luoauthor=J.+Wuauthor=L.+Pengauthor=F.+Chengauthor=L.+Panauthor=J.+Zouauthor=C.+Jiaauthor=J.+Wangauthor=X.+Liuauthor=S.+Wangauthor=X.+Wuauthor=Q.+Geauthor=J.+Heauthor=H.+Zhanauthor=F.+Qiuauthor=L.+Guoauthor=C.+Huangauthor=T.+Jakiauthor=F.+G.+Haydenauthor=P.+W.+Horbyauthor=D.+Zhangauthor=C.+Wang&title=A+trial+of+Lopinavir-Ritonavir+in+adults+hospitalized+with+severe+Covid-19&doi=10.1056%2FNEJMoa2001282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19</span></div><div class="casAuthors">Cao Bin; Wang Yeming; Wen Danning; Liu Wen; Wang Jingli; Fan Guohui; Ruan Lianguo; Song Bin; Cai Yanping; Wei Ming; Li Xingwang; Xia Jiaan; Chen Nanshan; Xiang Jie; Yu Ting; Bai Tao; Xie Xuelei; Zhang Li; Li Caihong; Yuan Ye; Chen Hua; Li Huadong; Huang Hanping; Tu Shengjing; Gong Fengyun; Liu Ying; Wei Yuan; Dong Chongya; Zhou Fei; Gu Xiaoying; Xu Jiuyang; Liu Zhibo; Zhang Yi; Li Hui; Shang Lianhan; Wang Ke; Li Kunxia; Zhou Xia; Dong Xuan; Qu Zhaohui; Lu Sixia; Hu Xujuan; Ruan Shunan; Luo Shanshan; Wu Jing; Peng Lu; Cheng Fang; Pan Lihong; Zou Jun; Jia Chunmin; Wang Juan; Liu Xia; Wang Shuzhen; Wu Xudong; Ge Qin; He Jing; Zhan Haiyan; Qiu Fang; Guo Li; Huang Chaolin; Jaki Thomas; Hayden Frederick G; Horby Peter W; Zhang Dingyu; Wang Chen</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1787-1799</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.  METHODS:  We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao2) to the fraction of inspired oxygen (Fio2) of less than 300 mm Hg.  Patients were randomly assigned in a 1:1 ratio to receive either lopinavir-ritonavir (400 mg and 100 mg, respectively) twice a day for 14 days, in addition to standard care, or standard care alone.  The primary end point was the time to clinical improvement, defined as the time from randomization to either an improvement of two points on a seven-category ordinal scale or discharge from the hospital, whichever came first.  RESULTS:  A total of 199 patients with laboratory-confirmed SARS-CoV-2 infection underwent randomization; 99 were assigned to the lopinavir-ritonavir group, and 100 to the standard-care group.  Treatment with lopinavir-ritonavir was not associated with a difference from standard care in the time to clinical improvement (hazard ratio for clinical improvement, 1.31; 95% confidence interval [CI], 0.95 to 1.80).  Mortality at 28 days was similar in the lopinavir-ritonavir group and the standard-care group (19.2% vs. 25.0%; difference, -5.8 percentage points; 95% CI, -17.3 to 5.7).  The percentages of patients with detectable viral RNA at various time points were similar.  In a modified intention-to-treat analysis, lopinavir-ritonavir led to a median time to clinical improvement that was shorter by 1 day than that observed with standard care (hazard ratio, 1.39; 95% CI, 1.00 to 1.91).  Gastrointestinal adverse events were more common in the lopinavir-ritonavir group, but serious adverse events were more common in the standard-care group.  Lopinavir-ritonavir treatment was stopped early in 13 patients (13.8%) because of adverse events.  CONCLUSIONS:  In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir-ritonavir treatment beyond standard care.  Future trials in patients with severe illness may help to confirm or exclude the possibility of a treatment benefit. (Funded by Major Projects of National Science and Technology on New Drug Creation and Development and others; Chinese Clinical Trial Register number, ChiCTR2000029308.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLXU2_2H1oIv6BottYdIAWfW6udTcc2ebcNxu48sd2qbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383kvFOjtQ%253D%253D&md5=affdbe91481a3ada1a2fed29e2ad17f9</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa2001282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa2001282%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DRuan%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DB.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXia%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DBai%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DTu%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DShang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DQu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DF.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGe%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DZhan%26aufirst%3DH.%26aulast%3DQiu%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJaki%26aufirst%3DT.%26aulast%3DHayden%26aufirst%3DF.%2BG.%26aulast%3DHorby%26aufirst%3DP.%2BW.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DA%2520trial%2520of%2520Lopinavir-Ritonavir%2520in%2520adults%2520hospitalized%2520with%2520severe%2520Covid-19%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D382%26issue%3D19%26spage%3D1787%26epage%3D1799%26doi%3D10.1056%2FNEJMoa2001282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holshue, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBolt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lofy, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkerson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tural, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallansch, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weldon, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyeki, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, S. K.</span></span> <span> </span><span class="NLM_article-title">Washington State -nCo, V. C. I. T. First case of 2019 novel coronavirus in the United States</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>382</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa2001191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1056%2FNEJMoa2001191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32004427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvVKrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2020&pages=929-936&issue=10&author=M.+L.+Holshueauthor=C.+DeBoltauthor=S.+Lindquistauthor=K.+H.+Lofyauthor=J.+Wiesmanauthor=H.+Bruceauthor=C.+Spittersauthor=K.+Ericsonauthor=S.+Wilkersonauthor=A.+Turalauthor=G.+Diazauthor=A.+Cohnauthor=L.+Foxauthor=A.+Patelauthor=S.+I.+Gerberauthor=L.+Kimauthor=S.+Tongauthor=X.+Luauthor=S.+Lindstromauthor=M.+A.+Pallanschauthor=W.+C.+Weldonauthor=H.+M.+Biggsauthor=T.+M.+Uyekiauthor=S.+K.+Pillai&title=Washington+State+-nCo%2C+V.+C.+I.+T.+First+case+of+2019+novel+coronavirus+in+the+United+States&doi=10.1056%2FNEJMoa2001191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">First case of 2019 novel coronavirus in the United States</span></div><div class="casAuthors">Holshue, Michelle L.; DeBolt, Chas; Lindquist, Scott; Lofy, Kathy H.; Wiesman, John; Bruce, Hollianne; Spitters, Christopher; Ericson, Keith; Wilkerson, Sara; Tural, Ahmet; Diaz, George; Cohn, Amanda; Fox, LeAnne; Patel, Anita; Gerber, Susan I.; Kim, Lindsay; Tong, Suxiang; Lu, Xiaoyan; Lindstrom, Steve; Pallansch, Mark A.; Weldon, William C.; Biggs, Holly M.; Uyeki, Timothy M.; Pillai, Satish K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">929-936</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries.  We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clin. course, and management of the case, including the patient's initial mild symptoms at presentation with progression to pneumonia on day 9 of illness.  This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clin. information related to the care of patients with this emerging infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrthESVAgZg7LVg90H21EOLACvtfcHk0lj1KDZp_Y2Hhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvVKrsbo%253D&md5=bbd55e08e80c31c36bf686f09a5a797c</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa2001191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa2001191%26sid%3Dliteratum%253Aachs%26aulast%3DHolshue%26aufirst%3DM.%2BL.%26aulast%3DDeBolt%26aufirst%3DC.%26aulast%3DLindquist%26aufirst%3DS.%26aulast%3DLofy%26aufirst%3DK.%2BH.%26aulast%3DWiesman%26aufirst%3DJ.%26aulast%3DBruce%26aufirst%3DH.%26aulast%3DSpitters%26aufirst%3DC.%26aulast%3DEricson%26aufirst%3DK.%26aulast%3DWilkerson%26aufirst%3DS.%26aulast%3DTural%26aufirst%3DA.%26aulast%3DDiaz%26aufirst%3DG.%26aulast%3DCohn%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DGerber%26aufirst%3DS.%2BI.%26aulast%3DKim%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DLindstrom%26aufirst%3DS.%26aulast%3DPallansch%26aufirst%3DM.%2BA.%26aulast%3DWeldon%26aufirst%3DW.%2BC.%26aulast%3DBiggs%26aufirst%3DH.%2BM.%26aulast%3DUyeki%26aufirst%3DT.%2BM.%26aulast%3DPillai%26aufirst%3DS.%2BK.%26atitle%3DWashington%2520State%2520-nCo%252C%2520V.%2520C.%2520I.%2520T.%2520First%2520case%2520of%25202019%2520novel%2520coronavirus%2520in%2520the%2520United%2520States%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2020%26volume%3D382%26issue%3D10%26spage%3D929%26epage%3D936%26doi%3D10.1056%2FNEJMoa2001191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref245"><div class="reference"><strong class="refLabel"><a href="#ref245" class="rightTabRefNumLink">245</a></strong><div class="NLM_citation" id="rightTab-cit245"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, J.</span></span> <span> </span><span class="NLM_article-title">Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study</span>. <i>J. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">e1</span>– <span class="NLM_lpage">e5</span>, <span class="refDoi"> DOI: 10.1016/j.jinf.2020.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jinf.2020.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32171872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCjtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2020&pages=e1-e5&author=L.+Dengauthor=C.+Liauthor=Q.+Zengauthor=X.+Liuauthor=X.+Liauthor=H.+Zhangauthor=Z.+Hongauthor=J.+Xia&title=Arbidol+combined+with+LPV%2Fr+versus+LPV%2Fr+alone+against+Corona+Virus+Disease+2019%3A+A+retrospective+cohort+study&doi=10.1016%2Fj.jinf.2020.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit245R"><div class="casContent"><span class="casTitleNuber">245</span><div class="casTitle"><span class="NLM_cas:atitle">Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study</span></div><div class="casAuthors">Deng, Lisi; Li, Chunna; Zeng, Qi; Liu, Xi; Li, Xinghua; Zhang, Haitang; Hong, Zhongsi; Xia, Jinyu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infection</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1-e5</span>CODEN:
                <span class="NLM_cas:coden">JINFD2</span>;
        ISSN:<span class="NLM_cas:issn">1532-2742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Corona Virus Disease 2019 (COVID-19) due to the 2019 novel coronavirus (SARS-CoV-2) emerged in Wuhan city and rapidly spread throughout China.  We aimed to compare arbidol and lopinavir/ritonavir(LPV/r) treatment for patients with COVID-19 with LPV/r only.  In this retrospective cohort study, we included adults (age≥18years) with lab.-confirmed COVID-19 without Invasive ventilation, diagnosed between Jan 17, 2020, and Feb 13, 2020.  Patients, diagnosed after Jan 17, 2020, were given oral arbidol and LPV/r in the combination group and oral LPV/r only in the monotherapy group for 5-21 days.  The primary endpoint was a neg. conversion rate of coronavirus from the date of COVID-19 diagnosis(day7, day14), and assessed whether the pneumonia was progressing or improving by chest CT (day7).  We analyzed 16 patients who received oral arbidol and LPV/r in the combination group and 17 who oral LPV/r only in the monotherapy group, and both initiated after diagnosis.  Baseline clin., lab., and chest CT characteristics were similar between groups.  The SARS-CoV-2 could not be detected for 12(75%) of 16 patients' nasopharyngeal specimens in the combination group after seven days, compared with 6 (35%) of 17 in the monotherapy group (p < 0·05).  After 14 days, 15 (94%) of 16 and 9 (52·9%) of 17, resp., SARS-CoV-2 could not be detected (p < 0·05).  The chest CT scans were improving for 11(69%) of 16 patients in the combination group after seven days, compared with 5(29%) of 17 in the monotherapy group (p < 0·05).  In patients with COVID-19, the apparent favorable clin. response with arbidol and LPV/r supports further LPV/r only.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopNN5US_y047Vg90H21EOLACvtfcHk0liErfW_Cb_7RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCjtLbL&md5=cb21ca380cca48db5f317bf82ddd25b6</span></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1016%2Fj.jinf.2020.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinf.2020.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DXia%26aufirst%3DJ.%26atitle%3DArbidol%2520combined%2520with%2520LPV%252Fr%2520versus%2520LPV%252Fr%2520alone%2520against%2520Corona%2520Virus%2520Disease%25202019%253A%2520A%2520retrospective%2520cohort%2520study%26jtitle%3DJ.%2520Infect.%26date%3D2020%26volume%3D81%26spage%3De1%26epage%3De5%26doi%3D10.1016%2Fj.jinf.2020.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref246"><div class="reference"><strong class="refLabel"><a href="#ref246" class="rightTabRefNumLink">246</a></strong><div class="NLM_citation" id="rightTab-cit246"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zha, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span> <span> </span><span class="NLM_article-title">Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19</span>. <i>J. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">e21</span>– <span class="NLM_lpage">e23</span>, <span class="refDoi"> DOI: 10.1016/j.jinf.2020.03.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.jinf.2020.03.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32283143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFCjtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2020&pages=e21-e23&author=Z.+Zhuauthor=Z.+Luauthor=T.+Xuauthor=C.+Chenauthor=G.+Yangauthor=T.+Zhaauthor=J.+Luauthor=Y.+Xue&title=Arbidol+monotherapy+is+superior+to+lopinavir%2Fritonavir+in+treating+COVID-19&doi=10.1016%2Fj.jinf.2020.03.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19</span></div><div class="casAuthors">Zhu, Zhen; Lu, Zhaohui; Xu, Tianmin; Chen, Cong; Yang, Gang; Zha, Tao; Lu, Jianchun; Xue, Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infection</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e21-e23</span>CODEN:
                <span class="NLM_cas:coden">JINFD2</span>;
        ISSN:<span class="NLM_cas:issn">1532-2742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Lopinavir/ritonavir and arbidol have been previously used to treat acute respiratory syndrome- coronavirus 2 (SARS-CoV-2) replication in clin. practice; nevertheless, their effectiveness remains controversial.  In this study, we evaluated the antiviral effects and safety of lopinavir/ritonavir and arbidol in patients with the 2019-nCoV disease (COVID-19).  Fifty patients with lab.-confirmed COVID-19 were divided into two groups: including lopinavir/ritonavir group (34 cases) and arbidol group (16 cases).  Lopinavir/ritonavir group received 400 mg/100mg of Lopinavir/ritonavir, twice a day for a week, while the arbidol group was given 0.2 g arbidol, three times a day.  Data from these patients were retrospectively analyzed.  The cycle threshold values of open reading frame 1ab and nucleocapsid genes by RT-PCR assay were monitored during antiviral therapy.  None of the patients developed severe pneumonia or ARDS.  There was no difference in fever duration between the two groups (P=0.61).  On day 14 after the admission, no viral load was detected in arbidol group, but the viral load was found in 15(44.1%) patients treated with lopinavir/ritonavir.  Patients in the arbidol group had a shorter duration of pos. RNA test compared to those in the lopinavir/ritonavir group (P<0.01).  Moreover, no apparent side effects were found in both groups.  In conclusion, our data indicate that arbidol monotherapy may be superior to lopinavir/ritonavir in treating COVID-19.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpusZ0NCuBeZrVg90H21EOLACvtfcHk0liErfW_Cb_7RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFCjtLfO&md5=0d8722f018affa4c2ee6e3086bef446c</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1016%2Fj.jinf.2020.03.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinf.2020.03.060%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZha%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DY.%26atitle%3DArbidol%2520monotherapy%2520is%2520superior%2520to%2520lopinavir%252Fritonavir%2520in%2520treating%2520COVID-19%26jtitle%3DJ.%2520Infect.%26date%3D2020%26volume%3D81%26spage%3De21%26epage%3De23%26doi%3D10.1016%2Fj.jinf.2020.03.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref247"><div class="reference"><strong class="refLabel"><a href="#ref247" class="rightTabRefNumLink">247</a></strong><div class="NLM_citation" id="rightTab-cit247"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arabi, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalhoub, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandourah, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Hameed, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Omari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Qasim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alraddadi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almotairi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Khatib, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulmomen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qushmaq, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mady, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solaiman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Raddadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maghrabi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Mekhlafi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balkhy, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Harthy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharaba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gramish, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Aithan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Dawood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, R.</span></span> <span> </span><span class="NLM_article-title">Ribavirin and interferon therapy for critically Ill patients with Middle East respiratory syndrome: A multicenter observational study</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1837</span>– <span class="NLM_lpage">1844</span>, <span class="refDoi"> DOI: 10.1093/cid/ciz544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1093%2Fcid%2Fciz544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=31925415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsFGlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2020&pages=1837-1844&issue=9&author=Y.+M.+Arabiauthor=S.+Shalhoubauthor=Y.+Mandourahauthor=F.+Al-Hameedauthor=A.+Al-Omariauthor=E.+Al+Qasimauthor=J.+Joseauthor=B.+Alraddadiauthor=A.+Almotairiauthor=K.+Al+Khatibauthor=A.+Abdulmomenauthor=I.+Qushmaqauthor=A.+A.+Sindiauthor=A.+Madyauthor=O.+Solaimanauthor=R.+Al-Raddadiauthor=K.+Maghrabiauthor=A.+Ragabauthor=G.+A.+Al+Mekhlafiauthor=H.+H.+Balkhyauthor=A.+Al+Harthyauthor=A.+Kharabaauthor=J.+A.+Gramishauthor=A.+M.+Al-Aithanauthor=A.+Al-Dawoodauthor=L.+Mersonauthor=F.+G.+Haydenauthor=R.+Fowler&title=Ribavirin+and+interferon+therapy+for+critically+Ill+patients+with+Middle+East+respiratory+syndrome%3A+A+multicenter+observational+study&doi=10.1093%2Fcid%2Fciz544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit247R"><div class="casContent"><span class="casTitleNuber">247</span><div class="casTitle"><span class="NLM_cas:atitle">Ribavirin and interferon therapy for critically ill patients with middle east respiratory syndrome: a multicenter observational study</span></div><div class="casAuthors">Arabi, Yaseen M.; Shalhoub, Sarah; Mandourah, Yasser; Al-Hameed, Fahad; Al-Omari, Awad; Al Qasim, Eman; Jose, Jesna; Alraddadi, Basem; Almotairi, Abdullah; Al Khatib, Kasim; Abdulmomen, Ahmed; Qushmaq, Ismael; Sindi, Anees A.; Mady, Ahmed; Solaiman, Othman; Al-Raddadi, Rajaa; Maghrabi, Khalid; Ragab, Ahmed; Al Mekhlafi, Ghaleb A.; Balkhy, Hanan H.; Al Harthy, Abdulrahman; Kharaba, Ayman; Gramish, Jawaher A.; Al-Aithan, Abdulsalam M.; Al-Dawood, Abdulaziz; Merson, Laura; Hayden, Frederick G.; Fowler, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1837-1844</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1537-6591</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The objective of this study was to evaluate the effect of ribavirin and recombinant interferon (RBV/rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syndrome (MERS), accounting for time-varying confounders.  This is a retrospective cohort study of critically ill patients with lab.-confirmed MERS from 14 hospitals in Saudi Arabia diagnosed between Sept. 2012 and Jan. 2018.  We evaluated the assocn. of RBV/rIFN with 90-day mortality and MERS coronavirus (MERS-CoV) RNA clearance using marginal structural modeling to account for baseline and time-varying confounders.  Of 349 MERS patients, 144 (41.3%) patients received RBV/rIFN (RBV and/or rIFN-α2a, rIFN-α2b, or rIFN-β1a; none received rIFN-β1b).  RBV/rIFN was initiated at a median of 2 days (Q1, Q3: 1, 3 days) from intensive care unit admission.  Crude 90-day mortality was higher in patients with RBV/rIFN compared to no RBV/rIFN (106/144 [73.6%] vs 126/205 [61.5%]; P = .02).  After adjusting for baseline and time-varying confounders using a marginal structural model, RBV/rIFN was not assocd. with changes in 90-day mortality (adjusted odds ratio, 1.03 [95% confidence interval {CI}, .73-1.44]; P = .87) or with more rapid MERS-CoV RNA clearance (adjusted hazard ratio, 0.65 [95% CI, .30-1.44]; P = .29).  In this observational study, RBV/rIFN (RBV and/or rIFN-α2a, rIFN-α2b, or rIFN-β1a) therapy was commonly used in critically ill MERS patients but was not assocd. with redn. in 90-day mortality or in faster MERS-CoV RNA clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohyYIFPQwdTrVg90H21EOLACvtfcHk0lituVfSjNucaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsFGlsLs%253D&md5=98356465247f1acf47c8dc6ba3b09d2d</span></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciz544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciz544%26sid%3Dliteratum%253Aachs%26aulast%3DArabi%26aufirst%3DY.%2BM.%26aulast%3DShalhoub%26aufirst%3DS.%26aulast%3DMandourah%26aufirst%3DY.%26aulast%3DAl-Hameed%26aufirst%3DF.%26aulast%3DAl-Omari%26aufirst%3DA.%26aulast%3DAl%2BQasim%26aufirst%3DE.%26aulast%3DJose%26aufirst%3DJ.%26aulast%3DAlraddadi%26aufirst%3DB.%26aulast%3DAlmotairi%26aufirst%3DA.%26aulast%3DAl%2BKhatib%26aufirst%3DK.%26aulast%3DAbdulmomen%26aufirst%3DA.%26aulast%3DQushmaq%26aufirst%3DI.%26aulast%3DSindi%26aufirst%3DA.%2BA.%26aulast%3DMady%26aufirst%3DA.%26aulast%3DSolaiman%26aufirst%3DO.%26aulast%3DAl-Raddadi%26aufirst%3DR.%26aulast%3DMaghrabi%26aufirst%3DK.%26aulast%3DRagab%26aufirst%3DA.%26aulast%3DAl%2BMekhlafi%26aufirst%3DG.%2BA.%26aulast%3DBalkhy%26aufirst%3DH.%2BH.%26aulast%3DAl%2BHarthy%26aufirst%3DA.%26aulast%3DKharaba%26aufirst%3DA.%26aulast%3DGramish%26aufirst%3DJ.%2BA.%26aulast%3DAl-Aithan%26aufirst%3DA.%2BM.%26aulast%3DAl-Dawood%26aufirst%3DA.%26aulast%3DMerson%26aufirst%3DL.%26aulast%3DHayden%26aufirst%3DF.%2BG.%26aulast%3DFowler%26aufirst%3DR.%26atitle%3DRibavirin%2520and%2520interferon%2520therapy%2520for%2520critically%2520Ill%2520patients%2520with%2520Middle%2520East%2520respiratory%2520syndrome%253A%2520A%2520multicenter%2520observational%2520study%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2020%26volume%3D70%26issue%3D9%26spage%3D1837%26epage%3D1844%26doi%3D10.1093%2Fcid%2Fciz544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref248"><div class="reference"><strong class="refLabel"><a href="#ref248" class="rightTabRefNumLink">248</a></strong><div class="NLM_citation" id="rightTab-cit248"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuthman, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garza, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tongeren, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retterer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegoraro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honnold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotian, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taubenheim, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minning, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span> <span> </span><span class="NLM_article-title">Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>508</i></span> (<span class="NLM_issue">7496</span>),  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1038/nature13027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1038%2Fnature13027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24590073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtlWhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=508&publication_year=2014&pages=402-405&issue=7496&author=T.+K.+Warrenauthor=J.+Wellsauthor=R.+G.+Panchalauthor=K.+S.+Stuthmanauthor=N.+L.+Garzaauthor=S.+A.+Van+Tongerenauthor=L.+Dongauthor=C.+J.+Rettererauthor=B.+P.+Eatonauthor=G.+Pegoraroauthor=S.+Honnoldauthor=S.+Bantiaauthor=P.+Kotianauthor=X.+Chenauthor=B.+R.+Taubenheimauthor=L.+S.+Welchauthor=D.+M.+Minningauthor=Y.+S.+Babuauthor=W.+P.+Sheridanauthor=S.+Bavari&title=Protection+against+filovirus+diseases+by+a+novel+broad-spectrum+nucleoside+analogue+BCX4430&doi=10.1038%2Fnature13027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430</span></div><div class="casAuthors">Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Welch, Lisa S.; Minning, Dena M.; Babu, Yarlagadda S.; Sheridan, William P.; Bavari, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">508</span>
        (<span class="NLM_cas:issue">7496</span>),
    <span class="NLM_cas:pages">402-405</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever.  Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen, exceeding 90% (ref. 1).  Licensed therapeutic or vaccine products are not available to treat filovirus diseases.  Candidate therapeutics previously shown to be efficacious in non-human primate disease models are based on virus-specific designs and have limited broad-spectrum antiviral potential.  Here we show that BCX4430, a novel synthetic adenosine analog, inhibits infection of distinct filoviruses in human cells.  Biochem., reporter-based and primer-extension assays indicate that BCX4430 inhibits viral RNA polymerase function, acting as a non-obligate RNA chain terminator.  Post-exposure i.m. administration of BCX4430 protects against Ebola virus and Marburg virus disease in rodent models.  Most importantly, BCX4430 completely protects cynomolgus macaques from Marburg virus infection when administered as late as 48 h after infection.  In addn., BCX4430 exhibits broad-spectrum antiviral activity against numerous viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses.  This is the first report, to our knowledge, of non-human primate protection from filovirus disease by a synthetic drug-like small mol.  We provide addnl. pharmacol. characterizations supporting the potential development of BCX4430 as a countermeasure against human filovirus diseases and other viral diseases representing major public health threats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpev8c7g-X43rVg90H21EOLACvtfcHk0lituVfSjNucaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtlWhu7w%253D&md5=dc7d390055ecf253e4b21c95b4e9e1a2</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1038%2Fnature13027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13027%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DWells%26aufirst%3DJ.%26aulast%3DPanchal%26aufirst%3DR.%2BG.%26aulast%3DStuthman%26aufirst%3DK.%2BS.%26aulast%3DGarza%26aufirst%3DN.%2BL.%26aulast%3DVan%2BTongeren%26aufirst%3DS.%2BA.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DRetterer%26aufirst%3DC.%2BJ.%26aulast%3DEaton%26aufirst%3DB.%2BP.%26aulast%3DPegoraro%26aufirst%3DG.%26aulast%3DHonnold%26aufirst%3DS.%26aulast%3DBantia%26aufirst%3DS.%26aulast%3DKotian%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DTaubenheim%26aufirst%3DB.%2BR.%26aulast%3DWelch%26aufirst%3DL.%2BS.%26aulast%3DMinning%26aufirst%3DD.%2BM.%26aulast%3DBabu%26aufirst%3DY.%2BS.%26aulast%3DSheridan%26aufirst%3DW.%2BP.%26aulast%3DBavari%26aufirst%3DS.%26atitle%3DProtection%2520against%2520filovirus%2520diseases%2520by%2520a%2520novel%2520broad-spectrum%2520nucleoside%2520analogue%2520BCX4430%26jtitle%3DNature%26date%3D2014%26volume%3D508%26issue%3D7496%26spage%3D402%26epage%3D405%26doi%3D10.1038%2Fnature13027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref249"><div class="reference"><strong class="refLabel"><a href="#ref249" class="rightTabRefNumLink">249</a></strong><div class="NLM_citation" id="rightTab-cit249"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. Y.</span></span> <span> </span><span class="NLM_article-title">Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2017.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2017.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=29289665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis12rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=155-163&author=M.+H.+Linauthor=D.+C.+Mosesauthor=C.+H.+Hsiehauthor=S.+C.+Chengauthor=Y.+H.+Chenauthor=C.+Y.+Sunauthor=C.+Y.+Chou&title=Disulfiram+can+inhibit+MERS+and+SARS+coronavirus+papain-like+proteases+via+different+modes&doi=10.1016%2Fj.antiviral.2017.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes</span></div><div class="casAuthors">Lin, Min-Han; Moses, David C.; Hsieh, Chih-Hua; Cheng, Shu-Chun; Chen, Yau-Hung; Sun, Chiao-Yin; Chou, Chi-Yuan</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in southern China in late 2002 and caused a global outbreak with a fatality rate around 10% in 2003.  Ten years later, a second highly pathogenic human CoV, MERS-CoV, emerged in the Middle East and has spread to other countries in Europe, North Africa, North America and Asia.  As of Nov. 2017, MERS-CoV had infected at least 2102 people with a fatality rate of about 35% globally, and hence there is an urgent need to identify antiviral drugs that are active against MERS-CoV.  Here we show that a clin. available alc.-aversive drug, disulfiram, can inhibit the papain-like proteases (PLpros) of MERS-CoV and SARS-CoV.  Our findings suggest that disulfiram acts as an allosteric inhibitor of MERS-CoV PLpro but as a competitive (or mixed) inhibitor of SARS-CoV PLpro.  The phenomenon of slow-binding inhibition and the irrecoverability of enzyme activity after removing unbound disulfiram indicate covalent inactivation of SARS-CoV PLpro by disulfiram, while synergistic inhibition of MERS-CoV PLpro by disulfiram and 6-thioguanine or mycophenolic acid implies the potential for combination treatments using these three clin. available drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO7GTDzTmBF7Vg90H21EOLACvtfcHk0li9QlpbtzDl7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis12rsg%253D%253D&md5=623c128a81c27178b6c5d58fa7e6a8e7</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2017.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2017.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BH.%26aulast%3DMoses%26aufirst%3DD.%2BC.%26aulast%3DHsieh%26aufirst%3DC.%2BH.%26aulast%3DCheng%26aufirst%3DS.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BH.%26aulast%3DSun%26aufirst%3DC.%2BY.%26aulast%3DChou%26aufirst%3DC.%2BY.%26atitle%3DDisulfiram%2520can%2520inhibit%2520MERS%2520and%2520SARS%2520coronavirus%2520papain-like%2520proteases%2520via%2520different%2520modes%26jtitle%3DAntiviral%2520Res.%26date%3D2018%26volume%3D150%26spage%3D155%26epage%3D163%26doi%3D10.1016%2Fj.antiviral.2017.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref250"><div class="reference"><strong class="refLabel"><a href="#ref250" class="rightTabRefNumLink">250</a></strong><div class="NLM_citation" id="rightTab-cit250"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouokam, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lasnik, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foreman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojdani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, K. E.</span></span> <span> </span><span class="NLM_article-title">Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.1128/AAC.01407-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.01407-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24145548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFCiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=120-127&issue=1&author=C.+Bartonauthor=J.+C.+Kouokamauthor=A.+B.+Lasnikauthor=O.+Foremanauthor=A.+Cambonauthor=G.+Brockauthor=D.+C.+Montefioriauthor=F.+Vojdaniauthor=A.+A.+McCormickauthor=B.+R.+O%E2%80%99Keefeauthor=K.+E.+Palmer&title=Activity+of+and+effect+of+subcutaneous+treatment+with+the+broad-spectrum+antiviral+lectin+griffithsin+in+two+laboratory+rodent+models&doi=10.1128%2FAAC.01407-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models</span></div><div class="casAuthors">Barton, Christopher; Kouokam, J. Calvin; Lasnik, Amanda B.; Foreman, Oded; Cambon, Alexander; Brock, Guy; Montefiori, David C.; Vojdani, Fakhrieh; McCormick, Alison A.; O'Keefe, Barry R.; Palmer, Kenneth E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">120-127, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Griffithsin (GRFT) is a red-alga-derived lectin that binds the terminal mannose residues of N-linked glycans found on the surface of human immunodeficiency virus type 1 (HIV-1), HIV-2, and other enveloped viruses, including hepatitis C virus (HCV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Ebola virus.  GRFT displays no human T-cell mitogenic activity and does not induce prodn. of proinflammatory cytokines in treated human cell lines.  However, despite the growing evidence showing the broad-spectrum nanomolar or better antiviral activity of GRFT, no study has reported a comprehensive assessment of GRFT safety as a potential systemic antiviral treatment.  The results presented in this work show that minimal toxicity was induced by a range of single and repeated daily s.c. doses of GRFT in two rodent species, although we noted treatment-assocd. increases in spleen and liver mass suggestive of an antidrug immune response.  The drug is systemically distributed, accumulating to high levels in the serum and plasma after s.c. delivery.  Further, we showed that serum from GRFT-treated animals retained antiviral activity against HIV-1-enveloped pseudoviruses in a cell-based neutralization assay.  Overall, our data presented here show that GRFT accumulates to relevant therapeutic concns. which are tolerated with minimal toxicity.  These studies support further development of GRFT as a systemic antiviral therapeutic agent against enveloped viruses, although deimmunizing the mol. may be necessary if it is to be used in long-term treatment of chronic viral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNS7hlCTdbMbVg90H21EOLACvtfcHk0li9QlpbtzDl7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFCiu7o%253D&md5=a901e479ffbce75f45a84ada5081e0d7</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1128%2FAAC.01407-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01407-13%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DC.%26aulast%3DKouokam%26aufirst%3DJ.%2BC.%26aulast%3DLasnik%26aufirst%3DA.%2BB.%26aulast%3DForeman%26aufirst%3DO.%26aulast%3DCambon%26aufirst%3DA.%26aulast%3DBrock%26aufirst%3DG.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DVojdani%26aufirst%3DF.%26aulast%3DMcCormick%26aufirst%3DA.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DB.%2BR.%26aulast%3DPalmer%26aufirst%3DK.%2BE.%26atitle%3DActivity%2520of%2520and%2520effect%2520of%2520subcutaneous%2520treatment%2520with%2520the%2520broad-spectrum%2520antiviral%2520lectin%2520griffithsin%2520in%2520two%2520laboratory%2520rodent%2520models%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D1%26spage%3D120%26epage%3D127%26doi%3D10.1128%2FAAC.01407-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref251"><div class="reference"><strong class="refLabel"><a href="#ref251" class="rightTabRefNumLink">251</a></strong><div class="NLM_citation" id="rightTab-cit251"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuo, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. C.</span></span> <span> </span><span class="NLM_article-title">Effective inhibition of MERS-CoV infection by resveratrol</span>. <i>BMC Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">144</span>, <span class="refDoi"> DOI: 10.1186/s12879-017-2253-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1186%2Fs12879-017-2253-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=28193191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvVWitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=144&issue=1&author=S.+C.+Linauthor=C.+T.+Hoauthor=W.+H.+Chuoauthor=S.+Liauthor=T.+T.+Wangauthor=C.+C.+Lin&title=Effective+inhibition+of+MERS-CoV+infection+by+resveratrol&doi=10.1186%2Fs12879-017-2253-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">Effective inhibition of MERS-CoV infection by resveratrol</span></div><div class="casAuthors">Lin, Shih-Chao; Ho, Chi-Tang; Chuo, Wen-Ho; Li, Shiming; Wang, Tony T.; Lin, Chi-Chen</div><div class="citationInfo"><span class="NLM_cas:title">BMC Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144/1-144/10</span>CODEN:
                <span class="NLM_cas:coden">BIDMBJ</span>;
        ISSN:<span class="NLM_cas:issn">1471-2334</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging viral pathogen that causes severe morbidity and mortality.  Up to date, there is no approved or licensed vaccine or antiviral medicines can be used to treat MERS-CoV-infected patients.  Here, we analyzed the antiviral activities of resveratrol, a natural compd. found in grape seeds and skin and in red wine, against MERS-CoV infection.  We performed MTT and neutral red uptake assays to assess the survival rates of MERS-infected Vero E6 cells.  In addn., quant. PCR, western blotting, and immunofluorescent assays detd. the intracellular viral RNA and protein expression.  For viral productivity, we utilized plaque assays to confirm the antiviral properties of resveratrol against MERS-CoV.  Resveratrol significantly inhibited MERS-CoV infection and prolonged cellular survival after virus infection.  We also found that the expression of nucleocapsid (N) protein essential for MERS-CoV replication was decreased after resveratrol treatment.  Furthermore, resveratrol down-regulated the apoptosis induced by MERS-CoV in vitro.  By consecutive administration of resveratrol, we were able to reduce the concn. of resveratrol while achieving inhibitory effectiveness against MERS-CoV.  In this study, we first demonstrated that resveratrol is a potent anti-MERS agent in vitro.  We perceive that resveratrol can be a potential antiviral agent against MERS-CoV infection in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIbNu3h_xCX7Vg90H21EOLACvtfcHk0lidNG-5j2tk1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvVWitro%253D&md5=f6709c845629205c7f3498d0a6ae4990</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.1186%2Fs12879-017-2253-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12879-017-2253-8%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%2BC.%26aulast%3DHo%26aufirst%3DC.%2BT.%26aulast%3DChuo%26aufirst%3DW.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.%2BT.%26aulast%3DLin%26aufirst%3DC.%2BC.%26atitle%3DEffective%2520inhibition%2520of%2520MERS-CoV%2520infection%2520by%2520resveratrol%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2017%26volume%3D17%26issue%3D1%26spage%3D144%26doi%3D10.1186%2Fs12879-017-2253-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref252"><div class="reference"><strong class="refLabel"><a href="#ref252" class="rightTabRefNumLink">252</a></strong><div class="NLM_citation" id="rightTab-cit252"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Wilde, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochmans, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posthuma, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zevenhoven-Dobbe, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Nieuwkoop, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestebroer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Hoogen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, E. J.</span></span> <span> </span><span class="NLM_article-title">Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4875</span>– <span class="NLM_lpage">4884</span>, <span class="refDoi"> DOI: 10.1128/AAC.03011-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1128%2FAAC.03011-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=24841269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1artrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=4875-4884&issue=8&author=A.+H.+de+Wildeauthor=D.+Jochmansauthor=C.+C.+Posthumaauthor=J.+C.+Zevenhoven-Dobbeauthor=S.+van+Nieuwkoopauthor=T.+M.+Bestebroerauthor=B.+G.+van+den+Hoogenauthor=J.+Neytsauthor=E.+J.+Snijder&title=Screening+of+an+FDA-approved+compound+library+identifies+four+small-molecule+inhibitors+of+Middle+East+respiratory+syndrome+coronavirus+replication+in+cell+culture&doi=10.1128%2FAAC.03011-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit252R"><div class="casContent"><span class="casTitleNuber">252</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture</span></div><div class="casAuthors">de Wilde, Adriaan H.; Jochmans, Dirk; Posthuma, Clara C.; Zevenhoven-Dobbe, Jessika C.; van Nieuwkoop, Stefan; Bestebroer, Theo M.; van den Hoogen, Bernadette G.; Neyts, Johan; Snijder, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4875-4884, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Coronaviruses can cause respiratory and enteric disease in a wide variety of human and animal hosts.  The 2003 outbreak of severe acute respiratory syndrome (SARS) first demonstrated the potentially lethal consequences of zoonotic coronavirus infections in humans.  In 2012, a similar previously unknown coronavirus emerged, Middle East respiratory syndrome coronavirus (MERS-CoV), thus far causing over 650 lab.-confirmed infections, with an unexplained steep rise in the no. of cases being recorded over recent months.  The human MERS fatality rate of ∼30% is alarmingly high, even though many deaths were assocd. with underlying medical conditions.  Registered therapeutics for the treatment of coronavirus infections are not available.  Moreover, the pace of drug development and registration for human use is generally incompatible with strategies to combat emerging infectious diseases.  Therefore, we have screened a library of 348 FDA-approved drugs for anti-MERS-CoV activity in cell culture.  If such compds. proved sufficiently potent, their efficacy might be directly assessed in MERS patients.  We identified four compds. (chloroquine, chlorpromazine, loperamide, and lopinavir) inhibiting MERS-CoV replication in the low-micromolar range (50% effective concns. [EC50s], 3 to 8 μM).  Moreover, these compds. also inhibit the replication of SARS coronavirus and human coronavirus 229E.  Although their protective activity (alone or in combination) remains to be assessed in animal models, our findings may offer a starting point for treatment of patients infected with zoonotic coronaviruses like MERS-CoV.  Although they may not necessarily reduce viral replication to very low levels, a moderate viral load redn. may create a window during which to mount a protective immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5b8wPhhGmhbVg90H21EOLACvtfcHk0lidNG-5j2tk1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1artrfJ&md5=3fac7c18295ca0aca41632cbb9bd1280</span></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1128%2FAAC.03011-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03011-14%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BWilde%26aufirst%3DA.%2BH.%26aulast%3DJochmans%26aufirst%3DD.%26aulast%3DPosthuma%26aufirst%3DC.%2BC.%26aulast%3DZevenhoven-Dobbe%26aufirst%3DJ.%2BC.%26aulast%3Dvan%2BNieuwkoop%26aufirst%3DS.%26aulast%3DBestebroer%26aufirst%3DT.%2BM.%26aulast%3Dvan%2Bden%2BHoogen%26aufirst%3DB.%2BG.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DSnijder%26aufirst%3DE.%2BJ.%26atitle%3DScreening%2520of%2520an%2520FDA-approved%2520compound%2520library%2520identifies%2520four%2520small-molecule%2520inhibitors%2520of%2520Middle%2520East%2520respiratory%2520syndrome%2520coronavirus%2520replication%2520in%2520cell%2520culture%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26issue%3D8%26spage%3D4875%26epage%3D4884%26doi%3D10.1128%2FAAC.03011-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref253"><div class="reference"><strong class="refLabel"><a href="#ref253" class="rightTabRefNumLink">253</a></strong><div class="NLM_citation" id="rightTab-cit253"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caly, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druce, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catton, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jans, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagstaff, K. M.</span></span> <span> </span><span class="NLM_article-title">The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">104787</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2020.104787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=10.1016%2Fj.antiviral.2020.104787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=32251768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsFalsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2020&pages=104787&author=L.+Calyauthor=J.+D.+Druceauthor=M.+G.+Cattonauthor=D.+A.+Jansauthor=K.+M.+Wagstaff&title=The+FDA-approved+drug+Ivermectin+inhibits+the+replication+of+SARS-CoV-2+in+vitro&doi=10.1016%2Fj.antiviral.2020.104787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit253R"><div class="casContent"><span class="casTitleNuber">253</span><div class="casTitle"><span class="NLM_cas:atitle">The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro</span></div><div class="casAuthors">Caly, Leon; Druce, Julian D.; Catton, Mike G.; Jans, David A.; Wagstaff, Kylie M.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104787</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Although several clin. trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment.  We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addn. to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ∼5000-fold redn. in viral RNA at 48 h.  Ivermectin therefore warrants further investigation for possible benefits in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHJsrOxupqz7Vg90H21EOLACvtfcHk0lidNG-5j2tk1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsFalsL8%253D&md5=d5bac8cb28292f4dc5a2feac22ce6824</span></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2020.104787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2020.104787%26sid%3Dliteratum%253Aachs%26aulast%3DCaly%26aufirst%3DL.%26aulast%3DDruce%26aufirst%3DJ.%2BD.%26aulast%3DCatton%26aufirst%3DM.%2BG.%26aulast%3DJans%26aufirst%3DD.%2BA.%26aulast%3DWagstaff%26aufirst%3DK.%2BM.%26atitle%3DThe%2520FDA-approved%2520drug%2520Ivermectin%2520inhibits%2520the%2520replication%2520of%2520SARS-CoV-2%2520in%2520vitro%26jtitle%3DAntiviral%2520Res.%26date%3D2020%26volume%3D178%26spage%3D104787%26doi%3D10.1016%2Fj.antiviral.2020.104787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref254"><div class="reference"><strong class="refLabel"><a href="#ref254" class="rightTabRefNumLink">254</a></strong><div class="NLM_citation" id="rightTab-cit254"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smoot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jervey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaiu, D.</span></span> <span> </span><span class="NLM_article-title">Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.0c00272</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.0c00272" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkslWrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=315-331&issue=3&author=C.+Liuauthor=Q.+Zhouauthor=Y.+Liauthor=L.+V.+Garnerauthor=S.+P.+Watkinsauthor=L.+J.+Carterauthor=J.+Smootauthor=A.+C.+Greggauthor=A.+D.+Danielsauthor=S.+Jerveyauthor=D.+Albaiu&title=Research+and+development+on+therapeutic+agents+and+vaccines+for+COVID-19+and+related+human+coronavirus+diseases&doi=10.1021%2Facscentsci.0c00272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases</span></div><div class="casAuthors">Liu, Cynthia; Zhou, Qiongqiong; Li, Yingzhu; Garner, Linda V.; Watkins, Steve P.; Carter, Linda J.; Smoot, Jeffrey; Gregg, Anne C.; Daniels, Angela D.; Jervey, Susan; Albaiu, Dana</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-331</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Since the outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus, this disease has spread rapidly around the globe.  Considering the potential threat of a pandemic, scientists and physicians have been racing to understand this new virus and the pathophysiol. of this disease to uncover possible treatment regimens and discover effective therapeutic agents and vaccines.  To support the current research and development, CAS has produced a special report to provide an overview of published scientific information with an emphasis on patents in the CAS content collection.  It highlights antiviral strategies involving small mols. and biologics targeting complex mol. interactions involved in coronavirus infection and replication.  The drug-repurposing effort documented herein focuses primarily on agents known to be effective against other RNA viruses including SARS-CoV and MERS-CoV.  The patent anal. of coronavirus-related biologics includes therapeutic antibodies, cytokines, and nucleic acid-based therapies targeting virus gene expression as well as various types of vaccines.  More than 500 patents disclose methodologies of these four biologics with the potential for treating and preventing coronavirus infections, which may be applicable to COVID-19.  The information included in this report provides a strong intellectual groundwork for the ongoing development of therapeutic agents and vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAA030tIyfebVg90H21EOLACvtfcHk0liqSQp7dNj7Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkslWrsbo%253D&md5=fa29fb4cc3353a140e3a6a74059a99b1</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.0c00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.0c00272%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGarner%26aufirst%3DL.%2BV.%26aulast%3DWatkins%26aufirst%3DS.%2BP.%26aulast%3DCarter%26aufirst%3DL.%2BJ.%26aulast%3DSmoot%26aufirst%3DJ.%26aulast%3DGregg%26aufirst%3DA.%2BC.%26aulast%3DDaniels%26aufirst%3DA.%2BD.%26aulast%3DJervey%26aufirst%3DS.%26aulast%3DAlbaiu%26aufirst%3DD.%26atitle%3DResearch%2520and%2520development%2520on%2520therapeutic%2520agents%2520and%2520vaccines%2520for%2520COVID-19%2520and%2520related%2520human%2520coronavirus%2520diseases%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2020%26volume%3D6%26issue%3D3%26spage%3D315%26epage%3D331%26doi%3D10.1021%2Facscentsci.0c00272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M3M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M3M','PDB','6M3M'); return false;">PDB: 6M3M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VYO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VYO','PDB','6VYO'); return false;">PDB: 6VYO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VSB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VSB','PDB','6VSB'); return false;">PDB: 6VSB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VXX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VXX','PDB','6VXX'); return false;">PDB: 6VXX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Y2E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6Y2E','PDB','6Y2E'); return false;">PDB: 6Y2E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W9C" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W9C','PDB','6W9C'); return false;">PDB: 6W9C</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M71" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M71','PDB','6M71'); return false;">PDB: 6M71</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W61" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W61','PDB','6W61'); return false;">PDB: 6W61</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W75" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W75','PDB','6W75'); return false;">PDB: 6W75</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W4H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W4H','PDB','6W4H'); return false;">PDB: 6W4H</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W4B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W4B','PDB','6W4B'); return false;">PDB: 6W4B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VWW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VWW','PDB','6VWW'); return false;">PDB: 6VWW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LU7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LU7','PDB','6LU7'); return false;">PDB: 6LU7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JYT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JYT','PDB','6JYT'); return false;">PDB: 6JYT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M17" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M17','PDB','6M17'); return false;">PDB: 6M17</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M18" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M18','PDB','6M18'); return false;">PDB: 6M18</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M0J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6M0J','PDB','6M0J'); return false;">PDB: 6M0J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JXG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JXG','PDB','5JXG'); return false;">PDB: 5JXG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQV','PDB','6EQV'); return false;">PDB: 6EQV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQW','PDB','6EQW'); return false;">PDB: 6EQW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EQX','PDB','6EQX'); return false;">PDB: 6EQX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AXL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AXL','PDB','4AXL'); return false;">PDB: 4AXL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJC','PDB','2YJC'); return false;">PDB: 2YJC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJB','PDB','2YJB'); return false;">PDB: 2YJB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ9','PDB','2YJ9'); return false;">PDB: 2YJ9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ8','PDB','2YJ8'); return false;">PDB: 2YJ8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YJ2','PDB','2YJ2'); return false;">PDB: 2YJ2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU5','PDB','2XU5'); return false;">PDB: 2XU5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU4','PDB','2XU4'); return false;">PDB: 2XU4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU3','PDB','2XU3'); return false;">PDB: 2XU3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU1','PDB','2XU1'); return false;">PDB: 2XU1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WSQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WSQ','PDB','4WSQ'); return false;">PDB: 4WSQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TE0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TE0','PDB','5TE0'); return false;">PDB: 5TE0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L4Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L4Q','PDB','5L4Q'); return false;">PDB: 5L4Q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C57" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C57','PDB','4C57'); return false;">PDB: 4C57</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C58" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C58','PDB','4C58'); return false;">PDB: 4C58</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C59" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C59','PDB','4C59'); return false;">PDB: 4C59</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y7Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y7Z','PDB','5Y7Z'); return false;">PDB: 5Y7Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y80" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5Y80','PDB','5Y80'); return false;">PDB: 5Y80</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ0','PDB','6NQ0'); return false;">PDB: 6NQ0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ2','PDB','6NQ2'); return false;">PDB: 6NQ2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NQ1','PDB','6NQ1'); return false;">PDB: 6NQ1</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i28"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00606">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80523"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00606?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00606</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">3D structures available (PDB) of SARS-CoV-2 proteins (Table S1); Web resources for COVID-19 drug discovery (Table S2) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00606/suppl_file/jm0c00606_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00606/suppl_file/jm0c00606_si_001.pdf">jm0c00606_si_001.pdf (96.38 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00606&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00606%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-21" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00606" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a8e368e89195b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
